data_6prp_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6prp _Structure_validation_residue.Date_analyzed 2019-09-13 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 26.9 t70 . . . . . 0 N--CA 1.475 0.802 0 N-CA-C 107.984 -1.117 . . . . 72.25 107.984 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.458 HG23 ' HB3' ' A' ' 234' ' ' ARG . 17.1 m -85.99 143.02 12.35 Favored 'Isoleucine or valine' 0 C--O 1.245 0.835 0 N-CA-C 108.016 -1.105 . . . . 72.31 108.016 167.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 15.2 tt -73.83 141.26 16.43 Favored 'Isoleucine or valine' 0 C--O 1.246 0.876 0 N-CA-C 108.701 -0.852 . . . . 61.42 108.701 174.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -63.93 118.57 8.61 Favored 'General case' 0 C--N 1.349 0.554 0 O-C-N 123.903 0.752 . . . . 73.13 110.906 -173.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.437 ' HB1' HD23 ' A' ' 233' ' ' LEU . . . -124.02 160.66 27.16 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.267 1.027 . . . . 73.44 109.813 -174.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -149.08 163.75 36.65 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.488 0.715 . . . . 74.35 109.75 -178.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.422 ' CD2' ' HB ' ' A' ' 219' ' ' VAL . 7.9 p90 -150.08 178.76 8.65 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 122.899 0.479 . . . . 74.22 110.773 174.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 41.4 mmtm -141.67 132.33 13.05 Favored Pre-proline 0 N--CA 1.483 1.222 0 C-N-CA 124.73 1.212 . . . . 75.04 109.007 175.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . 0.444 ' HA ' HG11 ' A' ' 219' ' ' VAL . 55.7 Cg_endo -67.54 105.54 1.09 Allowed 'Trans proline' 0 C--N 1.384 2.415 0 C-N-CA 122.946 2.431 . . . . 75.2 111.866 -177.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . 0.488 ' HB2' ' HG3' ' A' ' 220' ' ' GLU . . . . . . . . 0 CA--C 1.537 0.48 0 C-N-CA 123.46 0.704 . . . . 73.32 109.235 178.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 121.708 0.766 . . . . 64.21 110.314 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.475 ' HA ' ' O ' ' A' ' 248' ' ' ASP . 3.7 p-10 -88.17 145.57 25.85 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 114.653 -1.158 . . . . 62.13 110.153 171.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 67.9 mt -127.11 140.43 52.28 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.682 0.793 . . . . 72.25 108.954 172.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -107.21 120.87 43.31 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 108.919 -0.771 . . . . 75.32 108.919 175.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -143.81 161.62 38.17 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.836 0.854 . . . . 74.35 109.452 -177.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 2.7 m -112.97 141.27 47.0 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 109.072 -0.714 . . . . 74.54 109.072 -178.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.493 HD13 HG22 ' A' ' 210' ' ' VAL . 37.6 tp -113.22 117.93 33.26 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.281 0.632 . . . . 74.25 111.052 -168.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -82.34 101.18 10.41 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.91 -0.774 . . . . 74.32 108.91 168.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.526 ' HA ' HG12 ' A' ' 210' ' ' VAL . 2.6 p -115.31 112.71 43.73 Favored Pre-proline 0 CA--C 1.546 0.79 0 N-CA-C 109.218 -0.66 . . . . 74.33 109.218 173.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -54.08 146.1 50.02 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 123.349 2.699 . . . . 74.23 113.029 175.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -49.38 -49.32 71.69 Favored Pre-proline 0 CA--C 1.561 1.383 0 O-C-N 124.356 1.035 . . . . 64.42 113.489 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -60.19 -42.13 45.47 Favored 'Trans proline' 0 C--N 1.393 2.91 0 C-N-CA 121.919 1.746 . . . . 73.24 112.528 177.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 43.0 mt -70.92 -27.33 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 123.602 0.761 . . . . 72.1 110.932 -177.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.05 -48.13 63.6 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.069 0.548 . . . . 53.32 110.709 175.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 88.6 t -68.12 -46.17 81.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 123.742 0.817 . . . . 73.42 111.591 -176.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 17.0 m -73.65 -33.13 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 CA-C-N 116.691 -0.231 . . . . 73.55 111.109 178.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 74.66 77.17 0.68 Allowed Glycine 0 C--N 1.349 1.268 0 CA-C-N 115.987 -0.551 . . . . 72.14 112.243 -173.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -107.58 -133.64 7.21 Favored Glycine 0 C--N 1.344 1.025 0 N-CA-C 111.566 -0.614 . . . . 75.5 111.566 178.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm -131.49 147.24 52.53 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.858 0.863 . . . . 74.33 109.633 171.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.526 HG12 ' HA ' ' A' ' 199' ' ' VAL . 17.4 m -133.62 143.57 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 124.401 1.08 . . . . 74.34 109.278 174.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . 0.409 ' HA ' ' O ' ' A' ' 219' ' ' VAL . 14.8 ttm180 -85.56 116.31 23.78 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 122.486 0.314 . . . . 75.42 110.882 -175.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -100.68 141.36 33.66 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.454 1.102 . . . . 73.32 110.113 177.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 2.2 mmt -88.23 125.03 34.43 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 123.881 0.873 . . . . 70.14 110.051 176.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 41.3 p -134.42 177.75 7.52 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.791 0.836 . . . . 62.12 110.605 178.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . 0.401 HD11 ' HE1' ' A' ' 240' ' ' PHE . 20.1 mt -69.19 -26.28 64.75 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 122.811 0.445 . . . . 73.44 110.503 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -79.84 -19.38 48.55 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.483 0.713 . . . . 74.11 110.967 178.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 127.47 -157.28 20.82 Favored Glycine 0 C--N 1.352 1.438 0 CA-C-O 119.797 -0.446 . . . . 71.41 112.653 178.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . 0.451 ' HG2' ' O ' ' A' ' 178' ' ' ALA . 58.7 Cg_endo -76.37 134.06 15.22 Favored 'Trans proline' 0 C--N 1.369 1.657 0 C-N-CA 122.744 2.296 . . . . 55.14 111.655 175.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.444 HG11 ' HA ' ' A' ' 177' ' ' PRO . 19.7 m -135.34 145.41 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 123.722 0.809 . . . . 74.34 109.106 -178.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.488 ' HG3' ' HB2' ' A' ' 178' ' ' ALA . 56.0 mt-10 -105.32 110.66 23.1 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 118.942 0.792 . . . . 73.3 109.545 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 45.5 t -97.06 122.43 48.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 124.975 1.31 . . . . 75.2 111.021 -170.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -65.25 105.31 1.08 Allowed 'General case' 0 C--O 1.241 0.641 0 C-N-CA 124.28 1.032 . . . . 74.03 110.94 175.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 51.5 t -76.8 128.14 82.36 Favored Pre-proline 0 CA--C 1.548 0.866 0 CA-C-N 114.741 -1.118 . . . . 72.33 109.008 173.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.48 141.99 96.86 Favored 'Trans proline' 0 CA--C 1.561 1.84 0 C-N-CA 122.504 2.136 . . . . 60.43 112.445 174.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -59.41 126.61 21.25 Favored 'Trans proline' 0 C--N 1.375 1.97 0 C-N-CA 122.696 2.264 . . . . 74.45 112.771 173.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 86.6 mtt-85 70.74 71.47 0.19 Allowed 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 125.638 1.575 . . . . 73.11 110.065 179.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.596 HG23 ' HD2' ' A' ' 231' ' ' ARG . 15.9 m -103.45 136.8 42.52 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 114.264 -1.335 . . . . 65.51 110.622 -177.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 22.3 mp0 -103.91 158.04 16.68 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.209 1.004 . . . . 65.52 109.764 177.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -74.47 144.97 43.97 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 109.424 -0.584 . . . . 72.44 109.424 173.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 89.89 2.0 75.77 Favored Glycine 0 C--N 1.341 0.86 0 CA-C-O 120.112 -0.271 . . . . 75.05 112.687 -175.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.596 ' HD2' HG23 ' A' ' 227' ' ' THR . 83.1 mtt180 -70.13 160.83 31.33 Favored 'General case' 0 C--N 1.356 0.848 0 CA-C-O 121.528 0.68 . . . . 70.53 110.179 170.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 16.1 pttp -130.53 138.42 50.2 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 114.863 -1.062 . . . . 75.11 108.885 175.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.437 HD23 ' HB1' ' A' ' 173' ' ' ALA . 67.0 mt -119.89 141.41 49.61 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.564 1.146 . . . . 74.23 107.925 178.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . 0.458 ' HB3' HG23 ' A' ' 170' ' ' VAL . 33.8 ttt180 -129.53 107.98 9.89 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.452 -0.944 . . . . 74.22 108.452 171.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.411 HD11 ' HD1' ' A' ' 175' ' ' TYR . 19.6 mt -81.08 83.99 6.62 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.833 1.253 . . . . 71.32 109.099 -177.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -69.75 134.43 48.6 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.108 0.963 . . . . 64.33 111.123 -175.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 65.18 21.95 68.59 Favored Glycine 0 C--N 1.35 1.338 0 O-C-N 123.892 0.745 . . . . 70.31 112.826 -176.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.415 ' HD3' HH21 ' A' ' 246' ' ' ARG . 29.5 mmtp -138.32 19.87 2.76 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.028 0.931 . . . . 74.2 110.899 -174.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -92.83 -133.25 6.35 Favored Glycine 0 N--CA 1.466 0.657 0 N-CA-C 111.919 -0.472 . . . . 72.15 111.919 174.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . 0.401 ' HE1' HD11 ' A' ' 215' ' ' LEU . 0.1 OUTLIER -61.35 138.72 94.75 Favored Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 123.888 0.875 . . . . 74.11 110.133 177.746 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_exo -48.12 146.18 9.81 Favored 'Trans proline' 0 C--N 1.377 2.045 0 C-N-CA 123.9 3.066 . . . . 74.23 115.107 177.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -159.79 138.67 5.71 Favored Glycine 0 CA--C 1.534 1.238 0 CA-C-O 118.559 -1.134 . . . . 73.14 110.469 177.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -65.82 -40.21 17.63 Favored 'Trans proline' 0 C--N 1.378 2.12 0 C-N-CA 123.274 2.649 . . . . 61.14 113.551 -171.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -97.55 -18.44 18.97 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.59 0.756 . . . . 73.4 111.454 -177.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 175.67 148.51 6.89 Favored Glycine 0 C--N 1.341 0.847 0 N-CA-C 110.76 -0.936 . . . . 74.22 110.76 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.415 HH21 ' HD3' ' A' ' 238' ' ' LYS . 21.0 mtm180 -90.12 170.53 10.24 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 117.18 0.49 . . . . 75.43 110.425 -176.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -78.27 -153.6 6.73 Favored Glycine 0 C--N 1.343 0.954 0 CA-C-N 115.862 -0.608 . . . . 64.41 112.19 173.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . 0.475 ' O ' ' HA ' ' A' ' 192' ' ' ASP . 4.6 p30 -122.92 155.78 36.03 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 117.617 0.708 . . . . 73.21 110.849 176.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 55.2 tp -121.76 108.41 13.48 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 108.907 -0.775 . . . . 74.41 108.907 174.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 42.7 t80 -90.45 108.69 19.94 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 115.099 -0.955 . . . . 75.0 110.105 -175.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 62.9 mt -105.91 121.93 45.09 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.721 0.808 . . . . 74.32 110.517 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -84.16 110.63 18.66 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 122.935 0.494 . . . . 74.34 109.795 172.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 57.6 t -64.84 119.27 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 123.83 0.852 . . . . 65.45 111.763 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 21.7 mmt180 -119.66 117.78 29.21 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 108.011 -1.107 . . . . 74.41 108.011 171.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 17.5 mt -75.53 117.38 19.84 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 N-CA-C 109.037 -0.727 . . . . 72.44 109.037 175.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 27.2 m . . . . . 0 C--O 1.25 1.115 0 C-N-CA 124.931 1.292 . . . . 74.44 108.848 -175.57 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 35.7 t70 . . . . . 0 N--CA 1.477 0.894 0 CA-C-O 121.398 0.618 . . . . 75.21 110.256 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.472 HG13 ' HG3' ' A' ' 232' ' ' LYS . 13.9 m -91.71 162.41 2.42 Favored 'Isoleucine or valine' 0 C--O 1.244 0.782 0 CA-C-N 115.043 -0.98 . . . . 75.3 109.377 173.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 16.7 tt -79.38 135.35 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 N-CA-C 107.694 -1.225 . . . . 74.13 107.694 166.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -70.92 142.89 51.08 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.365 0.666 . . . . 74.22 110.737 -172.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.431 ' HB3' HD21 ' A' ' 233' ' ' LEU . . . -149.17 162.14 40.58 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.418 0.687 . . . . 71.04 110.127 -178.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -136.51 156.63 48.32 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 123.795 0.838 . . . . 75.31 110.024 -177.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.431 ' H ' ' HD3' ' A' ' 238' ' ' LYS . 7.3 p90 -150.3 171.92 16.19 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.084 0.553 . . . . 75.52 111.486 167.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . 0.419 ' HE2' ' HD2' ' A' ' 177' ' ' PRO . 12.6 mmmm -137.79 140.41 29.57 Favored Pre-proline 0 C--O 1.241 0.629 0 C-N-CA 124.291 1.036 . . . . 75.34 108.564 173.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . 0.57 ' HA ' HG13 ' A' ' 219' ' ' VAL . 18.2 Cg_endo -61.29 109.05 0.66 Allowed 'Trans proline' 0 C--N 1.368 1.553 0 C-N-CA 122.486 2.124 . . . . 73.44 111.104 172.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . 0.509 ' HB3' ' HG3' ' A' ' 220' ' ' GLU . . . . . . . . 0 N--CA 1.475 0.795 0 C-N-CA 123.711 0.804 . . . . 72.32 110.691 177.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.409 ' HA ' ' HB2' ' A' ' 240' ' ' PHE . 91.5 mm-40 . . . . . 0 C--O 1.248 1.013 0 CA-C-O 120.929 0.395 . . . . 74.13 110.848 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -82.74 120.87 26.15 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.113 -0.949 . . . . 73.31 110.012 175.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 81.3 mt -110.49 147.8 33.38 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.916 0.886 . . . . 74.33 108.697 171.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -130.08 122.77 28.97 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.543 0.737 . . . . 74.02 109.664 -177.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.404 ' O ' ' HA ' ' A' ' 251' ' ' LEU . . . -160.68 169.9 21.9 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.584 0.754 . . . . 74.05 110.27 -178.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' THR . . . . . 0.538 HG22 ' HB2' ' A' ' 252' ' ' GLU . 8.9 p -101.83 145.84 28.63 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.365 0.666 . . . . 75.12 109.783 174.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.566 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . 51.8 tp -113.75 113.72 25.35 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.276 1.031 . . . . 72.44 110.09 -174.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -75.51 101.81 5.0 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 109.557 -0.534 . . . . 71.31 109.557 173.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.517 ' HA ' HG12 ' A' ' 210' ' ' VAL . 44.7 t -104.92 118.84 55.19 Favored Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 108.404 -0.961 . . . . 75.33 108.404 174.131 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -55.23 140.28 81.29 Favored 'Trans proline' 0 C--N 1.372 1.799 0 C-N-CA 122.727 2.285 . . . . 65.25 111.514 169.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -51.75 -47.87 89.05 Favored Pre-proline 0 CA--C 1.559 1.308 0 N-CA-C 114.432 1.271 . . . . 74.22 114.432 -175.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . 0.421 ' O ' HG13 ' A' ' 206' ' ' VAL . 16.3 Cg_endo -55.93 -45.43 38.73 Favored 'Trans proline' 0 C--N 1.385 2.469 0 C-N-CA 122.218 1.945 . . . . 72.22 112.743 174.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 47.5 mt -65.83 -31.07 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 123.714 0.806 . . . . 64.03 110.902 -178.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . 0.408 ' HB1' ' O ' ' A' ' 227' ' ' THR . . . -70.91 -40.21 72.28 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.29 0.636 . . . . 73.43 111.415 177.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 64.8 t -72.47 -54.98 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 123.858 0.863 . . . . 73.31 111.512 -177.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.421 HG13 ' O ' ' A' ' 202' ' ' PRO . 8.3 p -86.97 -16.73 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 C-N-CA 122.492 0.317 . . . . 74.51 111.831 -174.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 83.02 162.18 32.03 Favored Glycine 0 C--N 1.349 1.251 0 N-CA-C 111.234 -0.746 . . . . 74.11 111.234 -173.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 161.47 -134.12 3.42 Favored Glycine 0 N--CA 1.464 0.533 0 CA-C-N 117.429 0.615 . . . . 73.45 112.326 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.453 ' HD3' ' HB3' ' A' ' 220' ' ' GLU . 92.8 mttt -134.69 144.83 48.01 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.875 0.87 . . . . 72.43 109.963 175.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.517 HG12 ' HA ' ' A' ' 199' ' ' VAL . 22.3 m -129.29 144.61 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 N-CA-C 108.451 -0.944 . . . . 74.02 108.451 168.188 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 36.3 ttp180 -86.63 110.91 20.16 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 109.612 -0.514 . . . . 75.24 109.612 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -101.89 151.71 21.77 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.176 0.591 . . . . 65.22 110.203 179.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -98.29 117.94 33.82 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 123.078 0.551 . . . . 75.33 109.724 178.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 43.6 p -111.84 179.02 4.13 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.387 0.675 . . . . 73.12 109.417 171.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . 0.401 HD13 ' HE1' ' A' ' 240' ' ' PHE . 20.7 mt -81.81 -7.49 59.61 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.075 0.55 . . . . 73.42 112.102 -173.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -98.9 -19.83 17.14 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.335 1.054 . . . . 75.03 110.859 178.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 144.36 -165.69 27.4 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-N 115.911 -0.586 . . . . 64.42 111.842 -177.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -74.78 147.45 34.99 Favored 'Trans proline' 0 C--N 1.367 1.501 0 C-N-CA 122.935 2.423 . . . . 74.51 112.224 176.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.57 HG13 ' HA ' ' A' ' 177' ' ' PRO . 14.1 m -135.56 157.15 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 123.762 0.825 . . . . 75.22 109.524 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.509 ' HG3' ' HB3' ' A' ' 178' ' ' ALA . 51.9 mt-10 -108.06 106.19 16.3 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 109.349 -0.612 . . . . 71.35 109.349 176.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 56.1 t -92.96 112.21 25.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 109.19 -0.67 . . . . 71.23 109.19 -177.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -65.06 101.09 0.48 Allowed 'General case' 0 CA--C 1.539 0.545 0 O-C-N 123.999 0.812 . . . . 72.34 109.436 173.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 64.7 t -73.46 127.39 88.93 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-N 115.018 -0.992 . . . . 75.12 109.231 174.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.94 157.57 57.73 Favored 'Trans proline' 0 CA--C 1.559 1.75 0 C-N-CA 121.491 1.461 . . . . 73.44 110.824 171.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -70.05 164.28 35.42 Favored 'Trans proline' 0 C--N 1.366 1.455 0 C-N-CA 122.064 1.843 . . . . 72.12 111.942 176.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 75.7 mtm180 59.32 25.8 14.53 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 124.834 1.254 . . . . 73.12 112.146 174.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.482 HG22 ' HD2' ' A' ' 231' ' ' ARG . 96.7 m -90.85 99.6 12.61 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.943 0.897 . . . . 75.44 110.064 -176.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 19.7 mp0 -84.76 166.78 16.69 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 121.318 0.58 . . . . 72.22 111.542 -176.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . 0.525 ' HB3' ' HB ' ' A' ' 255' ' ' ILE . . . -66.98 124.2 22.36 Favored 'General case' 0 C--N 1.346 0.455 0 CA-C-N 114.549 -1.205 . . . . 62.3 109.699 177.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 114.05 -12.46 22.16 Favored Glycine 0 C--N 1.335 0.518 0 CA-C-O 119.401 -0.666 . . . . 74.32 112.645 -174.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.482 ' HD2' HG22 ' A' ' 227' ' ' THR . 42.6 mtt180 -71.62 162.88 28.75 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.738 0.78 . . . . 72.05 111.459 172.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.472 ' HG3' HG13 ' A' ' 170' ' ' VAL . 20.4 pttm -129.04 136.23 50.0 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.84 1.256 . . . . 74.31 109.294 -178.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.431 HD21 ' HB3' ' A' ' 173' ' ' ALA . 96.1 mt -116.83 113.95 23.24 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.011 0.924 . . . . 62.53 108.749 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . 0.405 ' HB3' HG22 ' A' ' 170' ' ' VAL . 19.9 ttt180 -96.45 101.02 12.58 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 107.381 -1.34 . . . . 74.04 107.381 170.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.421 HD11 ' CD1' ' A' ' 175' ' ' TYR . 22.2 mt -78.86 84.26 4.92 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 114.714 -1.13 . . . . 73.02 107.992 178.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.517 ' HZ3' ' HB2' ' A' ' 236' ' ' LYS . 10.2 mtmp? -72.38 123.81 23.84 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 113.752 -1.567 . . . . 64.23 111.093 -172.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 67.28 32.05 78.77 Favored Glycine 0 C--N 1.346 1.133 0 O-C-N 123.733 0.646 . . . . 73.12 112.391 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.461 ' HE2' ' HA ' ' A' ' 238' ' ' LYS . 10.3 mmpt? -125.3 -31.58 3.03 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.313 1.045 . . . . 73.04 112.248 -174.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -59.22 -112.09 0.01 OUTLIER Glycine 0 C--N 1.357 1.704 0 N-CA-C 116.092 1.197 . . . . 62.11 116.092 -168.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . 0.409 ' HB2' ' HA ' ' A' ' 191' ' ' GLN . 0.2 OUTLIER -71.54 136.16 83.62 Favored Pre-proline 0 N--CA 1.485 1.278 0 CA-C-N 117.393 0.596 . . . . 75.34 110.334 -178.805 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.567 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 13.7 Cg_exo -67.48 127.07 15.83 Favored 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.409 2.073 . . . . 73.32 111.981 -179.079 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -137.23 145.05 16.75 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-O 118.963 -0.91 . . . . 72.11 111.447 -179.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.6 -32.65 30.51 Favored 'Trans proline' 0 C--N 1.374 1.89 0 C-N-CA 123.215 2.61 . . . . 71.23 113.627 -174.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -91.96 -18.94 22.98 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.143 0.577 . . . . 74.41 110.935 178.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 163.26 151.87 6.6 Favored Glycine 0 C--N 1.343 0.948 0 N-CA-C 111.521 -0.631 . . . . 54.11 111.521 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.567 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 37.2 mtt-85 -78.52 164.05 25.04 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.371 0.669 . . . . 74.43 111.195 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -83.17 -154.72 17.39 Favored Glycine 0 C--N 1.342 0.879 0 CA-C-N 115.249 -0.887 . . . . 74.44 113.078 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -119.25 127.02 52.86 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 117.122 0.461 . . . . 71.45 110.011 177.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.518 ' HG ' ' HG ' ' A' ' 251' ' ' LEU . 60.6 tp -100.22 108.01 20.0 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 107.547 -1.279 . . . . 74.23 107.547 170.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . 0.426 ' OH ' ' HD2' ' A' ' 232' ' ' LYS . 23.0 t80 -97.14 108.18 20.85 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.754 -0.832 . . . . 74.43 108.754 -175.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.566 ' HB3' ' HB2' ' A' ' 197' ' ' LEU . 55.3 mt -115.7 120.42 39.29 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.931 0.892 . . . . 74.21 110.894 -173.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . 0.538 ' HB2' HG22 ' A' ' 196' ' ' THR . 3.6 mp0 -84.76 115.13 22.54 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.15 0.58 . . . . 74.44 109.93 175.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 0.473 HG11 HG23 ' A' ' 227' ' ' THR . 61.5 t -65.84 109.05 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 C-N-CA 123.497 0.719 . . . . 74.41 111.744 -176.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -104.77 107.99 19.24 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.891 1.277 . . . . 74.44 108.322 171.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.525 ' HB ' ' HB3' ' A' ' 229' ' ' ALA . 16.2 mt -75.69 132.77 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 122.907 0.483 . . . . 75.25 109.782 177.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 20.7 p . . . . . 0 CA--C 1.557 1.226 0 C-N-CA 124.435 1.094 . . . . 72.51 108.924 -177.885 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 32.9 t70 . . . . . 0 N--CA 1.478 0.966 0 CA-C-O 120.627 0.251 . . . . 62.12 110.873 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.439 HG11 ' HG3' ' A' ' 232' ' ' LYS . 31.9 m -108.97 168.64 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 123.37 0.668 . . . . 73.44 110.688 177.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 10.4 tt -89.3 150.32 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.976 0 N-CA-C 108.489 -0.93 . . . . 73.31 108.489 167.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -58.07 142.36 47.16 Favored 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 124.75 1.22 . . . . 72.01 111.888 178.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -164.76 149.43 9.43 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.317 1.447 . . . . 74.23 108.394 176.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -146.43 154.85 42.08 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 123.346 0.658 . . . . 73.34 109.825 175.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.416 ' CD1' HD11 ' A' ' 235' ' ' LEU . 44.4 p90 -118.17 177.34 4.83 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.249 0.62 . . . . 74.42 111.052 -177.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -145.32 145.79 27.8 Favored Pre-proline 0 N--CA 1.472 0.667 0 CA-C-N 114.325 -1.307 . . . . 73.13 108.569 168.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . 0.515 ' HA ' HG13 ' A' ' 219' ' ' VAL . 20.9 Cg_endo -59.26 127.53 24.31 Favored 'Trans proline' 0 C--N 1.376 2.023 0 C-N-CA 122.747 2.298 . . . . 75.1 111.545 174.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.164 0 C-N-CA 124.133 0.973 . . . . 74.44 111.489 -178.704 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 . . . . . 0 C--O 1.24 0.58 0 CA-C-O 120.838 0.352 . . . . 74.53 110.387 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -91.16 127.5 36.61 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.81 0.844 . . . . 65.22 109.599 -176.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 76.8 mt -109.6 146.9 33.95 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.279 1.032 . . . . 65.04 108.978 177.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -128.02 123.29 34.32 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 108.22 -1.03 . . . . 74.33 108.22 177.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -152.28 162.0 41.78 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.768 0.827 . . . . 73.22 110.329 -178.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' THR . . . . . 0.475 HG23 ' HE ' ' A' ' 254' ' ' ARG . 13.0 p -85.35 149.61 25.33 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.896 0.878 . . . . 71.44 110.691 174.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.552 HD11 HD12 ' A' ' 251' ' ' LEU . 43.7 tp -115.29 114.47 25.22 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.928 0.891 . . . . 73.22 109.017 179.068 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -88.83 101.2 13.8 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.254 0.622 . . . . 73.42 109.873 -177.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.545 ' HA ' HG12 ' A' ' 210' ' ' VAL . 7.4 p -118.39 123.12 29.54 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 123.784 0.834 . . . . 71.41 110.299 -177.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -57.73 146.3 85.98 Favored 'Trans proline' 0 C--N 1.372 1.796 0 C-N-CA 122.694 2.263 . . . . 75.32 112.311 168.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -51.77 -46.91 91.69 Favored Pre-proline 0 CA--C 1.559 1.319 0 N-CA-C 113.725 1.009 . . . . 75.21 113.725 179.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . 0.407 ' O ' HG23 ' A' ' 206' ' ' VAL . 11.3 Cg_endo -53.6 -48.75 20.18 Favored 'Trans proline' 0 C--N 1.398 3.159 0 C-N-CA 122.327 2.018 . . . . 72.23 112.995 173.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 31.4 mt -66.36 -31.3 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 123.778 0.831 . . . . 74.11 111.359 -177.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.52 -41.23 76.29 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 122.708 0.403 . . . . 75.53 111.515 178.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 84.8 t -72.87 -51.41 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 122.96 0.504 . . . . 63.53 111.433 -178.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 202' ' ' PRO . 19.3 m -85.73 -20.15 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 N-CA-C 112.497 0.554 . . . . 75.24 112.497 -174.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 90.98 162.65 38.34 Favored Glycine 0 N--CA 1.476 1.323 0 N-CA-C 111.249 -0.74 . . . . 63.11 111.249 -171.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 161.92 -147.93 14.75 Favored Glycine 0 N--CA 1.467 0.722 0 CA-C-N 117.635 0.718 . . . . 64.14 111.918 178.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 33.2 mtmm -133.13 139.52 47.13 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.239 0.616 . . . . 70.44 109.759 175.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.545 HG12 ' HA ' ' A' ' 199' ' ' VAL . 27.1 m -135.83 144.85 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 123.649 0.78 . . . . 73.42 109.404 175.152 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 25.1 ttm180 -85.8 116.42 24.04 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 123.196 0.598 . . . . 74.22 111.227 -171.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -102.81 164.66 11.5 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.564 1.146 . . . . 61.4 110.158 173.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -105.4 123.19 47.46 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.896 0.878 . . . . 71.35 110.183 -178.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 81.1 p -124.52 177.94 5.66 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.131 0.973 . . . . 72.01 109.936 175.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 14.7 mt -78.9 -9.7 59.57 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.058 0.543 . . . . 72.43 111.739 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -94.34 -18.65 21.39 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.699 0.8 . . . . 73.02 110.569 176.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 137.64 -164.21 25.45 Favored Glycine 0 C--N 1.349 1.292 0 CA-C-N 116.057 -0.52 . . . . 64.13 112.174 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -74.1 134.05 18.9 Favored 'Trans proline' 0 C--N 1.365 1.43 0 C-N-CA 122.439 2.093 . . . . 73.44 111.304 171.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.515 HG13 ' HA ' ' A' ' 177' ' ' PRO . 33.2 m -133.42 132.68 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 123.782 0.833 . . . . 75.33 109.071 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -91.72 116.47 28.91 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 122.028 -0.42 . . . . 73.11 110.014 179.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 36.9 t -96.54 127.22 48.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 C-N-CA 124.961 1.304 . . . . 73.45 109.995 -173.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -69.22 99.69 1.19 Allowed 'General case' 0 CA--C 1.54 0.589 0 O-C-N 123.959 0.787 . . . . 64.01 109.92 175.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 58.9 t -72.63 121.75 85.72 Favored Pre-proline 0 C--O 1.239 0.551 0 C-N-CA 124.583 1.153 . . . . 74.21 108.917 174.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -61.12 152.43 71.67 Favored 'Trans proline' 0 C--N 1.375 1.93 0 C-N-CA 122.297 1.998 . . . . 74.11 111.474 172.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_exo -64.57 157.4 55.53 Favored 'Trans proline' 0 C--N 1.37 1.66 0 C-N-CA 122.255 1.97 . . . . 63.2 111.87 171.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 62.41 33.42 16.26 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.925 1.29 . . . . 72.13 110.894 174.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.477 HG22 ' HD2' ' A' ' 231' ' ' ARG . 21.1 m -88.52 126.32 35.2 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.917 0.887 . . . . 74.25 110.477 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 -94.2 163.73 13.33 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.218 1.007 . . . . 72.2 111.361 -176.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -69.14 114.76 7.7 Favored 'General case' 0 C--N 1.348 0.528 0 CA-C-N 115.029 -0.987 . . . . 73.13 109.289 173.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 105.38 4.6 40.59 Favored Glycine 0 C--N 1.338 0.648 0 O-C-N 123.756 0.66 . . . . 63.22 112.799 -179.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.477 ' HD2' HG22 ' A' ' 227' ' ' THR . 28.3 mtt180 -63.68 152.9 37.81 Favored 'General case' 0 C--N 1.359 0.989 0 CA-C-N 117.404 0.602 . . . . 74.1 110.466 171.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.439 ' HG3' HG11 ' A' ' 170' ' ' VAL . 20.8 pttm -115.63 130.52 56.89 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 123.575 0.75 . . . . 65.32 109.877 -179.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 89.1 mt -120.44 132.67 55.33 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 107.766 -1.198 . . . . 75.21 107.766 176.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 35.5 ttm-85 -121.92 106.89 11.65 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 108.149 -1.056 . . . . 74.51 108.149 170.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.416 HD11 ' CD1' ' A' ' 175' ' ' TYR . 15.4 mt -76.06 82.57 2.91 Favored 'General case' 0 C--O 1.243 0.715 0 N-CA-C 107.375 -1.342 . . . . 73.1 107.375 174.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -71.28 133.04 45.77 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-N 115.318 -0.855 . . . . 74.43 110.746 -173.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 65.14 26.3 71.44 Favored Glycine 0 C--N 1.345 1.029 0 O-C-N 124.083 0.864 . . . . 74.34 112.563 -177.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -142.82 36.93 1.43 Allowed 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 124.008 0.923 . . . . 75.35 111.11 -177.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -100.97 -111.66 3.43 Favored Glycine 0 N--CA 1.478 1.498 0 CA-C-O 119.579 -0.567 . . . . 62.41 112.26 175.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -62.92 133.89 95.46 Favored Pre-proline 0 N--CA 1.487 1.411 0 CA-C-O 118.178 -0.915 . . . . 73.44 110.557 173.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -62.45 130.41 29.98 Favored 'Trans proline' 0 C--N 1.38 2.233 0 C-N-CA 123.119 2.546 . . . . 74.33 112.159 178.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -166.02 124.27 1.22 Allowed Glycine 0 CA--C 1.533 1.184 0 CA-C-O 118.71 -1.05 . . . . 62.53 111.42 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -68.68 -26.95 32.65 Favored 'Trans proline' 0 C--N 1.382 2.337 0 C-N-CA 123.528 2.819 . . . . 73.22 113.273 -176.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -80.97 -25.64 37.19 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.356 0.662 . . . . 75.33 111.083 178.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 161.79 117.78 0.44 Allowed Glycine 0 C--N 1.342 0.906 0 N-CA-C 111.232 -0.747 . . . . 70.52 111.232 -178.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 29.8 mtt-85 -69.58 164.99 22.04 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.668 0.787 . . . . 75.41 110.518 176.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -80.09 -158.21 16.1 Favored Glycine 0 N--CA 1.472 1.038 0 CA-C-N 115.886 -0.597 . . . . 74.32 112.387 172.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -115.39 153.57 30.8 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 108.998 -0.742 . . . . 75.51 108.998 173.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 46.7 tp -123.42 107.63 11.81 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 108.124 -1.065 . . . . 75.2 108.124 171.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 24.6 t80 -96.67 107.74 20.24 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 115.331 -0.85 . . . . 73.25 108.978 -172.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.552 HD12 HD11 ' A' ' 197' ' ' LEU . 76.5 mt -103.96 120.65 41.48 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 123.77 0.828 . . . . 74.44 110.639 -176.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -89.6 103.51 16.15 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.093 0.957 . . . . 73.45 108.448 177.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 0.465 HG11 HG23 ' A' ' 227' ' ' THR . 72.6 t -58.1 116.68 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 123.69 0.796 . . . . 73.51 111.179 -179.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . 0.475 ' HE ' HG23 ' A' ' 196' ' ' THR . 20.4 mmt180 -117.07 107.27 14.31 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 107.801 -1.185 . . . . 72.32 107.801 173.019 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 40.6 mt -75.95 135.47 26.9 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.929 0 N-CA-C 109.464 -0.569 . . . . 64.22 109.464 175.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 14.5 t . . . . . 0 C--O 1.26 1.607 0 C-N-CA 124.673 1.189 . . . . 72.43 109.718 -176.568 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 28.1 t70 . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 121.132 0.492 . . . . 73.22 110.038 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.531 HG23 ' HB3' ' A' ' 234' ' ' ARG . 33.2 m -106.93 162.15 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 CA-C-N 115.146 -0.934 . . . . 74.44 109.232 172.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 10.0 tt -83.38 147.8 5.56 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.08 0 N-CA-C 109.781 -0.451 . . . . 75.35 109.781 175.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -62.69 139.94 58.68 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.383 1.073 . . . . 72.42 111.941 -178.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.473 ' HB2' HD22 ' A' ' 233' ' ' LEU . . . -156.78 166.56 33.03 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 114.833 -1.076 . . . . 73.0 109.853 178.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -154.53 158.78 40.36 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 124.882 1.273 . . . . 73.3 108.268 173.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.629 ' HE1' ' HB3' ' A' ' 238' ' ' LYS . 45.6 p90 -118.52 -177.49 3.31 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 122.753 0.421 . . . . 63.53 110.102 173.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -144.21 129.27 9.5 Favored Pre-proline 0 N--CA 1.475 0.796 0 N-CA-C 107.61 -1.256 . . . . 65.42 107.61 170.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . 0.526 ' HA ' HG12 ' A' ' 219' ' ' VAL . 32.7 Cg_endo -62.81 111.63 1.42 Allowed 'Trans proline' 0 C--N 1.371 1.731 0 C-N-CA 122.823 2.349 . . . . 74.13 111.094 -179.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.068 0 C-N-CA 123.77 0.828 . . . . 63.45 111.179 -177.848 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 . . . . . 0 CA--C 1.544 0.713 0 N-CA-C 108.312 -0.996 . . . . 74.04 108.312 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -98.98 155.56 17.36 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.143 0.977 . . . . 63.05 110.326 -177.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 48.0 mt -142.53 134.77 27.54 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.599 1.16 . . . . 73.52 109.128 169.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -106.5 122.44 46.3 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 108.479 -0.934 . . . . 75.42 108.479 171.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.456 ' O ' ' HA ' ' A' ' 251' ' ' LEU . . . -145.96 140.52 26.96 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 109.388 -0.597 . . . . 55.42 109.388 178.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 9.4 p -81.33 137.53 35.74 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 109.459 -0.571 . . . . 74.42 109.459 173.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.408 HD12 HG21 ' A' ' 210' ' ' VAL . 51.4 tp -106.76 111.5 24.05 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 108.39 -0.966 . . . . 74.44 108.39 -176.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -81.86 99.47 9.05 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 108.678 -0.86 . . . . 74.34 108.678 178.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.465 ' HA ' HG13 ' A' ' 210' ' ' VAL . 3.2 p -106.34 116.89 58.5 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 123.713 0.805 . . . . 75.31 109.321 178.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -54.94 140.05 79.18 Favored 'Trans proline' 0 C--N 1.367 1.534 0 C-N-CA 122.422 2.082 . . . . 73.42 112.206 172.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . 0.407 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -49.04 -44.92 73.92 Favored Pre-proline 0 CA--C 1.559 1.311 0 N-CA-C 114.184 1.179 . . . . 55.54 114.184 179.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . 0.407 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 18.6 Cg_endo -57.4 -48.72 16.2 Favored 'Trans proline' 0 C--N 1.388 2.628 0 C-N-CA 121.838 1.692 . . . . 54.43 112.764 174.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 53.3 mt -65.79 -31.63 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 C-N-CA 123.781 0.833 . . . . 75.02 111.074 -178.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -64.1 -52.09 60.86 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.287 0.635 . . . . 74.1 110.746 177.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 91.8 t -67.63 -51.96 45.77 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-N 115.567 -0.742 . . . . 75.41 111.385 -176.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 15.5 m -79.68 -22.74 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 112.591 0.589 . . . . 74.54 112.591 -174.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 82.1 154.39 13.66 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 112.126 -0.39 . . . . 75.03 112.126 -171.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 164.58 -135.16 3.62 Favored Glycine 0 C--N 1.337 0.629 0 N-CA-C 111.74 -0.544 . . . . 51.52 111.74 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.546 ' HZ1' ' HB2' ' A' ' 209' ' ' LYS . 9.4 mtmp? -133.87 153.19 51.92 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 124.12 0.968 . . . . 75.44 109.247 173.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.465 HG13 ' HA ' ' A' ' 199' ' ' VAL . 15.6 m -134.8 141.03 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 124.106 0.962 . . . . 72.2 108.817 172.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -81.7 114.16 20.17 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.175 0.59 . . . . 74.12 109.705 -177.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -106.51 154.83 20.29 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.583 1.153 . . . . 74.34 110.351 178.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.71 126.03 52.55 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.461 0.704 . . . . 73.13 109.9 173.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 65.2 p -126.62 -178.72 4.47 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.354 1.062 . . . . 74.31 109.539 177.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 10.3 mt -73.12 -20.42 60.94 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-O 120.721 0.296 . . . . 71.44 110.602 176.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -78.67 -19.78 51.73 Favored 'General case' 0 CA--C 1.561 1.376 0 C-N-CA 124.05 0.94 . . . . 74.13 110.827 173.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 120.05 -158.06 15.46 Favored Glycine 0 C--N 1.35 1.327 0 CA-C-O 119.614 -0.548 . . . . 74.43 112.294 178.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.78 126.87 11.75 Favored 'Trans proline' 0 C--N 1.369 1.649 0 C-N-CA 122.275 1.983 . . . . 74.01 111.294 178.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.526 HG12 ' HA ' ' A' ' 177' ' ' PRO . 28.7 m -136.72 128.02 42.38 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.977 0 C-N-CA 123.879 0.872 . . . . 72.43 109.325 178.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -85.01 113.45 21.45 Favored 'General case' 0 N--CA 1.482 1.128 0 O-C-N 121.972 -0.455 . . . . 73.13 110.405 177.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . 0.496 ' HA ' ' HA ' ' A' ' 175' ' ' TYR . 58.7 t -93.51 120.77 43.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 C-N-CA 123.267 0.627 . . . . 75.34 109.648 -177.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -63.57 101.51 0.35 Allowed 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.054 0.942 . . . . 75.4 110.566 176.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 62.5 t -70.03 121.04 81.65 Favored Pre-proline 0 CA--C 1.544 0.74 0 CA-C-N 114.663 -1.153 . . . . 73.03 108.79 172.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -63.92 157.52 52.17 Favored 'Trans proline' 0 CA--C 1.571 2.338 0 C-N-CA 122.029 1.819 . . . . 64.43 111.674 174.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -66.79 127.0 16.24 Favored 'Trans proline' 0 C--N 1.368 1.579 0 C-N-CA 122.868 2.378 . . . . 73.43 112.243 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 38.5 mtm180 64.61 79.21 0.26 Allowed 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.984 1.314 . . . . 75.31 110.459 -175.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.508 HG23 HG12 ' A' ' 253' ' ' VAL . 99.3 m -117.12 106.81 13.75 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.11 0.964 . . . . 74.32 109.006 177.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -88.54 153.47 21.11 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.838 -0.619 . . . . 74.54 110.787 -173.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -62.9 138.69 58.61 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.108 0.963 . . . . 72.34 111.115 -178.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 89.94 10.66 64.4 Favored Glycine 0 C--N 1.338 0.646 0 CA-C-N 115.713 -0.676 . . . . 71.34 112.689 -174.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.436 ' HD2' HG22 ' A' ' 227' ' ' THR . 78.0 mtt180 -78.15 162.49 26.59 Favored 'General case' 0 C--O 1.244 0.778 0 CA-C-O 121.591 0.71 . . . . 73.11 110.429 169.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 19.6 pttm -127.52 129.11 46.8 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 114.739 -1.119 . . . . 74.33 109.869 179.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.473 HD22 ' HB2' ' A' ' 173' ' ' ALA . 66.2 mt -110.45 134.09 52.67 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 107.517 -1.29 . . . . 74.2 107.517 172.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . 0.531 ' HB3' HG23 ' A' ' 170' ' ' VAL . 42.3 ttm105 -123.28 98.95 6.1 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 107.044 -1.465 . . . . 72.24 107.044 167.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.502 ' HB3' ' HB2' ' A' ' 238' ' ' LYS . 65.8 mt -74.43 82.93 1.95 Allowed 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 114.213 -1.358 . . . . 72.14 108.526 177.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -75.8 137.68 40.68 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 122.664 0.386 . . . . 74.54 110.434 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 69.86 24.48 76.37 Favored Glycine 0 C--N 1.339 0.724 0 O-C-N 124.066 0.854 . . . . 64.4 111.973 -175.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.629 ' HB3' ' HE1' ' A' ' 175' ' ' TYR . 73.8 mmtt -138.87 -9.35 1.36 Allowed 'General case' 0 CA--C 1.561 1.37 0 C-N-CA 124.171 0.988 . . . . 72.34 111.88 -170.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -80.8 -120.81 0.46 Allowed Glycine 0 N--CA 1.478 1.494 0 CA-C-O 119.93 -0.372 . . . . 72.53 113.8 -175.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.31 119.02 49.26 Favored Pre-proline 0 N--CA 1.485 1.315 0 CA-C-O 118.472 -0.775 . . . . 72.54 109.251 175.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.724 ' HA ' ' HG3' ' A' ' 246' ' ' ARG . 25.1 Cg_exo -59.45 128.59 27.81 Favored 'Trans proline' 0 C--N 1.38 2.215 0 C-N-CA 122.824 2.349 . . . . 64.51 111.747 -176.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -141.14 123.91 2.42 Favored Glycine 0 CA--C 1.534 1.222 0 CA-C-O 118.798 -1.001 . . . . 71.44 111.641 -176.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -70.76 -15.05 33.35 Favored 'Trans proline' 0 C--N 1.385 2.452 0 C-N-CA 123.09 2.527 . . . . 75.45 113.18 178.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -97.56 -6.45 33.48 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.211 0.604 . . . . 72.15 111.155 173.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 142.77 115.61 1.11 Allowed Glycine 0 C--N 1.344 0.988 0 N-CA-C 111.005 -0.838 . . . . 61.55 111.005 -177.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.724 ' HG3' ' HA ' ' A' ' 241' ' ' PRO . 8.0 ttm180 -65.64 139.85 58.45 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.226 1.011 . . . . 71.13 110.744 176.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -73.17 -155.14 3.03 Favored Glycine 0 C--N 1.347 1.179 0 O-C-N 123.459 0.475 . . . . 74.01 113.501 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -126.51 132.89 51.29 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 117.738 0.769 . . . . 73.24 112.667 -176.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 51.9 tp -101.24 107.08 18.37 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.14 0.976 . . . . 73.4 108.949 175.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -89.6 108.24 19.55 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.313 0.645 . . . . 63.54 109.604 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.456 ' HA ' ' O ' ' A' ' 195' ' ' ALA . 68.1 mt -101.46 112.11 24.54 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 123.752 0.821 . . . . 73.23 110.597 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -79.77 103.38 9.63 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.589 0.756 . . . . 75.55 109.47 174.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 0.508 HG12 HG23 ' A' ' 227' ' ' THR . 75.0 t -61.66 114.59 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.306 1.042 . . . . 73.21 111.223 -177.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 67.4 mmt-85 -123.19 112.08 17.26 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.672 1.189 . . . . 74.1 108.565 175.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 48.8 mt -76.48 126.58 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 123.152 0.581 . . . . 75.51 109.91 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 24.0 p . . . . . 0 C--O 1.255 1.394 0 C-N-CA 124.99 1.316 . . . . 74.11 108.411 179.258 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 28.5 t70 . . . . . 0 N--CA 1.469 0.522 0 CA-C-O 121.468 0.651 . . . . 71.02 111.181 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.68 HG23 ' HB3' ' A' ' 234' ' ' ARG . 19.7 m -79.69 174.47 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 CA-C-N 114.587 -1.188 . . . . 71.33 110.218 175.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 14.8 tt -82.72 139.82 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 N-CA-C 108.467 -0.938 . . . . 74.34 108.467 167.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -70.12 93.32 0.8 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.535 0.734 . . . . 75.12 109.37 -179.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -98.37 152.23 19.69 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.838 -0.619 . . . . 74.1 110.113 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -140.84 149.28 41.8 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.285 0.634 . . . . 73.23 109.996 175.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.418 ' CD2' ' HB ' ' A' ' 219' ' ' VAL . 9.5 p90 -122.43 172.11 8.59 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 123.281 0.633 . . . . 72.03 110.554 176.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -138.04 121.88 11.61 Favored Pre-proline 0 N--CA 1.468 0.445 0 N-CA-C 107.268 -1.382 . . . . 72.34 107.268 175.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -64.51 141.41 73.56 Favored 'Trans proline' 0 C--N 1.367 1.544 0 C-N-CA 122.768 2.312 . . . . 70.54 110.801 -175.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.714 0 CA-C-O 121.586 0.708 . . . . 73.25 109.743 -178.167 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.534 ' HA ' ' HB2' ' A' ' 240' ' ' PHE . 10.7 mm100 . . . . . 0 C--O 1.244 0.782 0 CA-C-O 121.128 0.489 . . . . 71.31 110.358 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -86.17 135.64 33.51 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 114.959 -1.019 . . . . 72.11 108.374 172.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 94.6 mt -134.01 155.98 49.02 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.81 0.844 . . . . 75.14 109.817 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -130.08 136.81 49.75 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 108.008 -1.108 . . . . 72.12 108.008 173.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -160.42 171.34 19.23 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.211 0.529 . . . . 64.24 110.917 -177.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 17.6 p -104.83 151.62 23.59 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.6 0.76 . . . . 74.25 109.829 173.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.504 HD12 HG23 ' A' ' 210' ' ' VAL . 47.6 tp -123.13 118.3 27.37 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 123.863 0.865 . . . . 75.12 109.195 -175.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -82.61 100.11 9.96 Favored 'General case' 0 C--O 1.241 0.627 0 C-N-CA 123.329 0.652 . . . . 74.22 109.549 -178.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.503 ' HA ' HG13 ' A' ' 210' ' ' VAL . 23.6 t -110.06 109.02 59.12 Favored Pre-proline 0 CA--C 1.538 0.509 0 N-CA-C 108.489 -0.93 . . . . 73.24 108.489 176.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . 0.405 ' HA ' HG23 ' A' ' 256' ' ' THR . 74.8 Cg_exo -54.2 138.46 71.92 Favored 'Trans proline' 0 C--N 1.377 2.062 0 C-N-CA 122.777 2.318 . . . . 72.25 112.008 172.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -48.41 -47.56 68.44 Favored Pre-proline 0 CA--C 1.564 1.504 0 N-CA-C 113.772 1.027 . . . . 64.14 113.772 -177.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -56.07 -45.52 37.77 Favored 'Trans proline' 0 C--N 1.391 2.785 0 C-N-CA 121.845 1.697 . . . . 73.51 112.775 173.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 45.3 mt -69.93 -27.89 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 123.917 0.887 . . . . 62.41 111.181 -176.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.88 -48.9 64.77 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.075 0.55 . . . . 70.13 110.59 177.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 61.9 t -67.34 -48.42 77.86 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 CA-C-N 115.488 -0.778 . . . . 74.44 111.701 -177.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 11.8 p -75.44 -34.05 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 C-N-CA 122.391 0.277 . . . . 73.41 111.459 -178.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 83.7 141.02 4.47 Favored Glycine 0 C--N 1.344 0.982 0 N-CA-C 112.119 -0.392 . . . . 65.55 112.119 -172.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -178.07 -129.66 1.3 Allowed Glycine 0 C--N 1.34 0.777 0 N-CA-C 111.417 -0.673 . . . . 74.42 111.417 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 60.5 mttm -137.98 144.86 41.34 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.246 0.619 . . . . 71.54 109.771 173.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.504 HG23 HD12 ' A' ' 197' ' ' LEU . 31.1 m -134.87 155.57 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 124.333 1.053 . . . . 74.31 108.506 171.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 35.0 mtm-85 -97.47 126.36 42.7 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 121.015 0.436 . . . . 75.43 111.718 -176.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . 0.501 ' HB3' HD13 ' A' ' 197' ' ' LEU . . . -101.47 133.87 45.44 Favored 'General case' 0 C--O 1.241 0.628 0 C-N-CA 124.687 1.195 . . . . 72.03 109.14 173.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.56 112.77 21.88 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 108.793 -0.817 . . . . 75.04 108.793 175.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 68.3 p -111.39 177.1 4.77 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.393 0.677 . . . . 64.34 109.192 175.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 26.5 mt -62.9 -39.02 93.22 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 122.831 0.453 . . . . 72.42 111.487 -172.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -86.0 -18.22 33.16 Favored 'General case' 0 CA--C 1.551 1.003 0 CA-C-N 115.824 -0.625 . . . . 74.3 111.364 -175.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 153.53 -166.06 31.63 Favored Glycine 0 C--N 1.352 1.444 0 N-CA-C 114.37 0.508 . . . . 75.32 114.37 174.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -77.8 142.9 20.53 Favored 'Trans proline' 0 C--N 1.376 1.988 0 C-N-CA 123.088 2.525 . . . . 74.04 111.858 176.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.418 ' HB ' ' CD2' ' A' ' 175' ' ' TYR . 11.7 m -135.91 140.44 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 N-CA-C 109.237 -0.653 . . . . 74.21 109.237 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -96.96 108.1 20.75 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 122.819 0.448 . . . . 64.01 110.123 -178.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 22.3 t -95.08 135.12 30.12 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 C-N-CA 124.404 1.082 . . . . 62.43 109.815 -175.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -77.38 109.2 11.1 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 123.305 0.642 . . . . 72.23 110.666 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 57.3 t -79.11 117.7 68.37 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 123.681 0.793 . . . . 73.31 109.07 173.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -60.69 158.02 34.72 Favored 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 122.458 2.105 . . . . 74.13 112.371 174.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -71.26 133.45 22.85 Favored 'Trans proline' 0 C--N 1.368 1.582 0 C-N-CA 121.5 1.467 . . . . 71.52 110.563 171.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 67.82 67.21 0.36 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.81 1.244 . . . . 74.35 110.141 -176.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.476 HG21 HG11 ' A' ' 253' ' ' VAL . 72.9 m -103.02 132.89 48.96 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.188 0.995 . . . . 74.41 109.595 176.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -110.7 155.48 22.38 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.632 0.773 . . . . 75.4 110.555 -177.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . 0.489 ' HB2' ' HB ' ' A' ' 255' ' ' ILE . . . -69.22 121.58 17.1 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.981 0.912 . . . . 71.12 110.225 -178.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 111.64 -7.6 28.02 Favored Glycine 0 C--N 1.333 0.398 0 CA-C-O 119.222 -0.765 . . . . 71.41 112.555 -176.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.439 ' HD2' HG23 ' A' ' 227' ' ' THR . 58.7 mtt180 -61.24 145.77 50.12 Favored 'General case' 0 C--N 1.361 1.097 0 CA-C-N 117.326 0.563 . . . . 75.42 109.915 174.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.443 ' HG3' HG13 ' A' ' 170' ' ' VAL . 20.1 pttm -117.06 104.35 11.16 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.282 -0.872 . . . . 73.12 109.215 -175.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 82.8 mt -90.11 97.35 11.14 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 108.723 -0.844 . . . . 74.15 108.723 176.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . 0.68 ' HB3' HG23 ' A' ' 170' ' ' VAL . 64.7 ttt180 -88.07 107.18 18.62 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 108.676 -0.861 . . . . 64.12 108.676 171.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.409 HD11 ' CD1' ' A' ' 175' ' ' TYR . 16.0 mt -77.67 84.23 4.02 Favored 'General case' 0 C--O 1.248 0.989 0 N-CA-C 107.659 -1.237 . . . . 70.53 107.659 174.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.416 ' HB2' ' HZ3' ' A' ' 236' ' ' LYS . 10.5 mtmp? -71.43 118.49 14.31 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 113.835 -1.529 . . . . 73.21 111.988 -169.09 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 64.14 28.82 73.44 Favored Glycine 0 C--N 1.348 1.212 0 O-C-N 124.044 0.84 . . . . 61.1 112.803 179.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 30.8 mmtp -125.47 -6.92 6.94 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 118.278 -0.868 . . . . 73.41 112.774 -173.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -62.57 -108.17 0.01 OUTLIER Glycine 0 C--N 1.354 1.538 0 O-C-N 123.827 0.704 . . . . 60.44 114.731 -171.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . 0.534 ' HB2' ' HA ' ' A' ' 191' ' ' GLN . 0.1 OUTLIER -75.97 140.02 69.96 Favored Pre-proline 0 N--CA 1.477 0.91 0 CA-C-O 118.574 -0.727 . . . . 73.23 109.811 177.72 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.461 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 53.1 Cg_exo -57.37 149.07 67.63 Favored 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 122.587 2.192 . . . . 72.31 113.293 175.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -164.81 123.58 1.18 Allowed Glycine 0 CA--C 1.538 1.512 0 CA-C-O 118.414 -1.215 . . . . 62.42 111.661 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -57.54 -46.16 29.14 Favored 'Trans proline' 0 C--N 1.386 2.521 0 C-N-CA 123.806 3.004 . . . . 74.32 113.646 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -78.87 -24.13 44.47 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 122.756 0.422 . . . . 72.44 110.81 178.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 168.19 142.0 3.36 Favored Glycine 0 C--N 1.345 1.057 0 CA-C-N 115.782 -0.645 . . . . 75.41 111.798 178.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.461 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 27.3 mtt-85 -73.63 166.54 23.08 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.495 0.718 . . . . 73.52 110.969 178.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -85.23 -156.99 27.35 Favored Glycine 0 C--N 1.336 0.579 0 CA-C-N 115.391 -0.822 . . . . 73.41 111.463 168.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -131.61 157.99 42.19 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 109.077 -0.712 . . . . 74.43 109.077 -176.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 42.4 tp -141.42 112.18 7.15 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 109.652 -0.499 . . . . 73.44 109.652 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -102.77 109.36 20.91 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.759 0.824 . . . . 74.41 109.838 -176.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 65.9 mt -104.92 136.09 45.05 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.727 0.811 . . . . 73.05 110.156 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -97.69 116.56 30.15 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.691 0.796 . . . . 75.34 109.303 170.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 0.476 HG11 HG21 ' A' ' 227' ' ' THR . 94.1 t -61.33 106.38 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-O 121.506 0.67 . . . . 74.11 110.465 172.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 17.0 mmt85 -104.37 102.49 12.16 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-N 114.67 -1.15 . . . . 74.32 108.065 173.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.489 ' HB ' ' HB2' ' A' ' 229' ' ' ALA . 24.1 mt -76.36 119.0 23.68 Favored 'Isoleucine or valine' 0 C--O 1.245 0.83 0 C-N-CA 122.901 0.481 . . . . 73.45 109.767 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' THR . . . . . 0.405 HG23 ' HA ' ' A' ' 200' ' ' PRO . 2.5 t . . . . . 0 CA--C 1.558 1.288 0 N-CA-C 108.682 -0.858 . . . . 72.31 108.682 175.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 32.9 t70 . . . . . 0 N--CA 1.482 1.158 0 CA-C-O 121.638 0.733 . . . . 73.42 110.501 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.602 HG13 ' HG3' ' A' ' 232' ' ' LYS . 27.6 m -111.43 164.57 7.25 Favored 'Isoleucine or valine' 0 C--O 1.243 0.76 0 CA-C-N 114.305 -1.316 . . . . 74.34 109.16 175.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 17.6 tt -89.51 145.71 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 N-CA-C 108.236 -1.024 . . . . 75.33 108.236 168.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -58.75 122.21 12.98 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.671 0.788 . . . . 74.53 110.879 -179.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.438 ' HB1' HD23 ' A' ' 233' ' ' LEU . . . -135.99 154.78 50.97 Favored 'General case' 0 C--O 1.243 0.729 0 C-N-CA 124.5 1.12 . . . . 74.03 108.449 174.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -152.88 151.22 30.13 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.938 0.895 . . . . 71.42 109.404 -178.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.406 ' CD1' HD11 ' A' ' 235' ' ' LEU . 2.6 p90 -130.14 173.93 10.28 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-O 121.39 0.614 . . . . 72.42 111.025 176.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 78.2 mttt -139.23 144.39 40.26 Favored Pre-proline 0 C--O 1.243 0.746 0 CA-C-N 114.692 -1.14 . . . . 73.44 109.203 174.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -55.1 103.9 0.11 Allowed 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 123.279 2.652 . . . . 71.31 112.105 178.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . 0.455 ' HB1' ' HG3' ' A' ' 220' ' ' GLU . . . . . . . . 0 N--CA 1.478 0.948 0 C-N-CA 123.834 0.854 . . . . 74.41 111.345 -178.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 . . . . . 0 N--CA 1.479 1.017 0 N-CA-C 108.745 -0.835 . . . . 75.13 108.745 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -76.79 150.38 36.17 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 114.296 -1.32 . . . . 70.53 110.613 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 36.6 mt -133.92 139.31 46.06 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 124.89 1.276 . . . . 74.13 107.639 171.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -128.21 125.01 38.15 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.204 0.602 . . . . 73.5 109.498 -176.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -161.85 171.51 17.63 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 123.736 0.815 . . . . 62.33 110.756 -175.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 15.6 p -105.89 149.86 26.16 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.633 0.773 . . . . 61.3 109.967 173.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.537 HD12 HD11 ' A' ' 251' ' ' LEU . 51.7 tp -115.01 118.72 34.22 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.999 0.92 . . . . 71.02 109.875 -175.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -83.39 119.62 24.86 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 109.319 -0.623 . . . . 74.31 109.319 175.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.505 ' HA ' HG13 ' A' ' 210' ' ' VAL . 3.5 p -133.7 123.24 17.16 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 123.638 0.775 . . . . 75.24 109.675 178.042 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -59.02 139.61 91.58 Favored 'Trans proline' 0 C--N 1.375 1.968 0 C-N-CA 122.725 2.283 . . . . 73.14 111.447 171.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . 0.434 ' O ' HG22 ' A' ' 205' ' ' VAL . . . -49.11 -47.58 75.12 Favored Pre-proline 0 CA--C 1.557 1.232 0 CA-C-O 117.792 -1.099 . . . . 70.52 113.022 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -55.93 -45.28 39.81 Favored 'Trans proline' 0 C--N 1.395 2.978 0 C-N-CA 122.206 1.938 . . . . 71.43 113.019 175.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 39.9 mt -65.93 -31.98 56.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 123.458 0.703 . . . . 71.51 111.02 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -71.84 -37.86 70.23 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.269 0.628 . . . . 74.15 111.48 179.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . 0.434 HG22 ' O ' ' A' ' 201' ' ' ALA . 98.9 t -74.54 -53.69 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 123.647 0.779 . . . . 62.22 111.359 -178.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 7.1 p -73.03 -31.03 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 122.627 0.371 . . . . 54.44 111.11 -178.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 84.94 117.43 0.8 Allowed Glycine 0 C--N 1.344 0.979 0 N-CA-C 111.357 -0.697 . . . . 73.0 111.357 -172.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -151.8 -136.88 2.51 Favored Glycine 0 C--N 1.34 0.789 0 N-CA-C 111.564 -0.614 . . . . 74.33 111.564 -178.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 34.3 mtmm -136.95 146.09 45.01 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.003 0.921 . . . . 75.51 109.383 175.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.505 HG13 ' HA ' ' A' ' 199' ' ' VAL . 24.2 m -133.05 142.3 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 123.855 0.862 . . . . 70.43 109.22 172.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . 0.437 ' NH1' ' HB2' ' A' ' 178' ' ' ALA . 24.1 ttm-85 -87.7 110.45 20.44 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 122.817 0.447 . . . . 71.51 110.15 -170.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -101.8 164.47 11.71 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.656 1.182 . . . . 72.21 110.634 -178.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' MET . . . . . 0.519 ' HA ' ' HE3' ' A' ' 213' ' ' MET . 10.1 mmt -105.92 123.23 47.65 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.862 0.865 . . . . 74.11 110.784 -179.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' THR . . . . . 0.469 HG22 HD23 ' A' ' 249' ' ' LEU . 47.5 p -114.63 171.29 7.73 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.304 1.042 . . . . 75.5 109.211 170.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 13.2 mt -72.28 -9.33 58.34 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 112.091 0.404 . . . . 73.13 112.091 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -99.97 -19.45 16.57 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 123.127 0.571 . . . . 63.22 111.772 175.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 143.58 -155.02 25.91 Favored Glycine 0 C--N 1.36 1.901 0 CA-C-O 119.695 -0.503 . . . . 64.54 113.995 174.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -76.64 136.33 17.07 Favored 'Trans proline' 0 C--N 1.379 2.14 0 C-N-CA 123.442 2.761 . . . . 75.2 113.229 178.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.42 ' HA ' ' H ' ' A' ' 178' ' ' ALA . 27.0 m -136.5 145.5 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 124.177 0.991 . . . . 74.44 109.293 177.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.455 ' HG3' ' HB1' ' A' ' 178' ' ' ALA . 37.4 mt-10 -102.3 112.11 24.68 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 109.52 -0.548 . . . . 73.21 109.52 178.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 46.7 t -94.7 118.09 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 124.41 1.084 . . . . 74.31 109.527 -174.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -66.96 102.19 0.94 Allowed 'General case' 0 C--O 1.24 0.561 0 C-N-CA 123.958 0.903 . . . . 75.12 110.427 176.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.436 HG13 HG22 ' A' ' 199' ' ' VAL . 64.6 t -80.24 120.88 80.89 Favored Pre-proline 0 CA--C 1.546 0.801 0 CA-C-N 115.162 -0.926 . . . . 74.53 108.969 174.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -60.6 162.38 18.26 Favored 'Trans proline' 0 CA--C 1.566 2.097 0 C-N-CA 122.904 2.403 . . . . 74.21 113.219 176.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -76.25 135.39 16.78 Favored 'Trans proline' 0 C--N 1.374 1.88 0 C-N-CA 122.622 2.215 . . . . 72.11 112.271 175.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 20.0 mtm180 66.54 57.25 0.71 Allowed 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 125.129 1.371 . . . . 73.54 110.631 -176.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.534 HG22 HG13 ' A' ' 253' ' ' VAL . 60.5 m -106.81 107.34 18.31 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.851 0.86 . . . . 72.1 109.381 178.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 22.5 mp0 -85.7 160.26 19.59 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.297 0.639 . . . . 73.24 111.678 -172.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -70.35 130.18 41.28 Favored 'General case' 0 C--N 1.352 0.682 0 N-CA-C 108.867 -0.79 . . . . 74.54 108.867 175.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 114.47 -19.08 17.16 Favored Glycine 0 N--CA 1.466 0.634 0 CA-C-O 119.636 -0.536 . . . . 71.41 111.897 -173.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 81.2 mtt180 -67.19 161.85 23.84 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-O 121.579 0.704 . . . . 74.34 111.877 175.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.602 ' HG3' HG13 ' A' ' 170' ' ' VAL . 19.5 pttm -130.19 142.11 50.6 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.344 1.058 . . . . 75.53 109.42 177.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.438 HD23 ' HB1' ' A' ' 173' ' ' ALA . 75.2 mt -120.61 129.02 53.56 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 107.89 -1.152 . . . . 75.14 107.89 178.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 40.4 ttt180 -113.7 102.14 9.97 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 108.816 -0.809 . . . . 74.0 108.816 171.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.605 ' HB3' ' HB2' ' A' ' 238' ' ' LYS . 21.3 mt -76.19 84.01 3.01 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 114.246 -1.343 . . . . 74.14 108.632 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -72.65 127.37 32.35 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.641 -0.709 . . . . 64.11 110.67 -173.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 69.48 20.52 75.51 Favored Glycine 0 C--N 1.342 0.901 0 O-C-N 123.764 0.665 . . . . 71.45 112.053 -175.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.605 ' HB2' ' HB3' ' A' ' 235' ' ' LEU . 22.3 mmtp -136.37 58.05 1.75 Allowed 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.581 1.152 . . . . 75.21 108.54 -176.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -139.9 -113.48 1.08 Allowed Glycine 0 N--CA 1.472 1.093 0 CA-C-O 119.226 -0.764 . . . . 71.4 111.74 175.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -64.11 146.32 97.54 Favored Pre-proline 0 N--CA 1.484 1.254 0 CA-C-O 118.47 -0.776 . . . . 71.11 110.699 175.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -54.79 160.0 8.23 Favored 'Trans proline' 0 C--N 1.38 2.204 0 C-N-CA 123.488 2.792 . . . . 71.41 112.871 176.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -169.85 136.43 4.0 Favored Glycine 0 CA--C 1.525 0.702 0 CA-C-O 118.742 -1.032 . . . . 52.5 112.024 -178.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -70.23 -41.54 3.6 Favored 'Trans proline' 0 C--N 1.378 2.091 0 C-N-CA 123.184 2.59 . . . . 73.2 113.305 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -102.11 -18.79 15.41 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.702 0.801 . . . . 75.0 111.222 -177.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 175.66 145.68 5.57 Favored Glycine 0 C--N 1.341 0.847 0 N-CA-C 111.262 -0.735 . . . . 73.04 111.262 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 21.1 mtm180 -88.19 165.32 15.15 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.088 0.555 . . . . 74.24 110.589 -176.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -74.14 -168.07 17.54 Favored Glycine 0 C--N 1.35 1.312 0 N-CA-C 111.486 -0.646 . . . . 74.1 111.486 168.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -118.27 151.84 36.89 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 118.406 1.103 . . . . 71.22 111.247 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.469 HD23 HG22 ' A' ' 214' ' ' THR . 35.9 tp -113.75 118.21 33.66 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 108.559 -0.904 . . . . 71.01 108.559 171.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . 0.527 ' OH ' ' HD2' ' A' ' 232' ' ' LYS . 2.7 t80 -96.4 115.9 28.17 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.84 -1.17 . . . . 74.4 107.84 -178.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.537 HD11 HD12 ' A' ' 197' ' ' LEU . 57.6 mt -118.93 117.22 28.23 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.79 0.836 . . . . 73.14 110.38 -177.323 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -77.32 116.07 17.62 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 108.997 -0.742 . . . . 75.11 108.997 171.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 0.534 HG13 HG22 ' A' ' 227' ' ' THR . 94.8 t -62.09 104.27 0.3 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.934 0 CA-C-O 121.322 0.582 . . . . 72.35 110.433 176.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 19.6 mmm180 -110.15 106.37 15.79 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 107.952 -1.129 . . . . 73.02 107.952 175.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.423 HD11 ' O ' ' A' ' 227' ' ' THR . 45.0 mt -77.77 143.8 12.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 122.898 0.479 . . . . 73.34 110.483 178.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 4.9 t . . . . . 0 C--O 1.261 1.68 0 C-N-CA 124.48 1.112 . . . . 74.42 108.721 174.739 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 33.1 t70 . . . . . 0 CA--C 1.543 0.692 0 CA-C-O 120.296 0.093 . . . . 63.12 111.082 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 33.0 m -89.82 157.15 3.01 Favored 'Isoleucine or valine' 0 C--O 1.243 0.75 0 C-N-CA 122.835 0.454 . . . . 74.25 110.054 176.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.451 HG22 ' HD3' ' A' ' 231' ' ' ARG . 15.1 tt -83.09 146.73 6.59 Favored 'Isoleucine or valine' 0 C--O 1.249 1.057 0 N-CA-C 108.496 -0.927 . . . . 54.12 108.496 172.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -58.06 136.08 57.1 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.718 0.807 . . . . 70.22 111.52 -176.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.503 ' HB2' HD23 ' A' ' 233' ' ' LEU . . . -158.31 158.18 33.87 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 124.885 1.274 . . . . 74.54 109.337 173.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -164.27 149.42 10.25 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.924 0.89 . . . . 75.54 109.221 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.509 ' HB3' HG21 ' A' ' 221' ' ' VAL . 1.6 p90 -122.39 175.93 6.16 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 121.807 0.813 . . . . 74.43 112.34 177.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . 0.404 ' HA ' ' HD3' ' A' ' 177' ' ' PRO . 31.6 mmmt -138.22 129.31 15.64 Favored Pre-proline 0 C--O 1.241 0.629 0 CA-C-N 113.639 -1.619 . . . . 74.0 107.575 167.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . 0.473 ' HA ' HG11 ' A' ' 219' ' ' VAL . 35.7 Cg_exo -54.37 128.25 29.29 Favored 'Trans proline' 0 C--N 1.369 1.657 0 C-N-CA 123.486 2.791 . . . . 74.31 111.639 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.927 0 O-C-N 123.737 0.648 . . . . 75.33 110.429 -175.86 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 120.949 0.404 . . . . 74.23 111.145 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -85.59 153.51 22.35 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.574 0.75 . . . . 74.4 109.965 178.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 58.4 mt -131.81 152.93 50.64 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.546 0.738 . . . . 73.21 109.251 176.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -119.18 132.41 55.96 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 108.489 -0.93 . . . . 72.51 108.489 170.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -157.79 164.46 37.01 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.22 0.608 . . . . 53.24 110.022 178.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 99.4 m -96.03 146.67 24.44 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 115.647 -0.706 . . . . 74.5 109.64 175.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.476 HD12 HG23 ' A' ' 210' ' ' VAL . 42.7 tp -113.85 117.87 32.64 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.713 0.805 . . . . 72.41 109.288 175.242 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -89.26 100.71 13.44 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 123.783 0.833 . . . . 74.44 108.917 175.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.486 ' HA ' HG13 ' A' ' 210' ' ' VAL . 7.1 p -113.04 116.74 46.87 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 123.496 0.718 . . . . 74.52 109.839 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -56.18 145.91 73.91 Favored 'Trans proline' 0 C--N 1.374 1.904 0 C-N-CA 122.839 2.359 . . . . 54.3 112.4 173.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -50.28 -49.48 76.28 Favored Pre-proline 0 CA--C 1.558 1.285 0 O-C-N 124.542 1.151 . . . . 74.54 112.987 -179.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -55.06 -46.71 31.08 Favored 'Trans proline' 0 C--N 1.401 3.315 0 C-N-CA 122.484 2.123 . . . . 72.23 112.735 175.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . 0.516 HG21 HG11 ' A' ' 210' ' ' VAL . 42.1 mt -68.73 -32.54 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 123.664 0.786 . . . . 74.53 110.798 -176.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.59 -44.9 73.37 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.62 0.768 . . . . 52.41 110.459 179.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 95.4 t -64.64 -55.82 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 122.999 0.519 . . . . 71.04 110.602 178.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 17.0 m -69.49 -30.31 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 O-C-N 123.531 0.52 . . . . 75.32 112.171 -173.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 78.3 69.96 1.35 Allowed Glycine 0 C--N 1.348 1.222 0 N-CA-C 111.648 -0.581 . . . . 62.53 111.648 -172.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -104.13 -136.84 9.02 Favored Glycine 0 C--N 1.348 1.247 0 N-CA-C 111.657 -0.577 . . . . 60.44 111.657 -177.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 35.1 mtmm -133.03 137.04 46.33 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.432 0.693 . . . . 74.11 109.31 176.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.516 HG11 HG21 ' A' ' 203' ' ' ILE . 14.9 m -127.9 142.32 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 123.645 0.778 . . . . 74.02 109.731 174.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 61.5 ttp180 -83.68 117.12 23.0 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 116.13 -0.486 . . . . 73.43 110.049 -178.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -100.79 156.72 17.19 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.685 0.794 . . . . 72.25 109.194 174.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 76.1 mmm -107.18 121.29 44.23 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 122.729 0.412 . . . . 72.14 110.159 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 36.2 p -108.86 173.51 6.29 Favored 'General case' 0 C--O 1.243 0.726 0 C-N-CA 124.351 1.06 . . . . 64.53 108.62 170.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 13.3 mt -67.4 -24.38 65.66 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 122.625 0.37 . . . . 71.45 111.472 -175.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -87.55 -20.59 26.25 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.431 0.693 . . . . 65.2 111.498 -178.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 149.66 -160.68 28.58 Favored Glycine 0 C--N 1.35 1.318 0 CA-C-O 119.772 -0.46 . . . . 72.23 113.135 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -84.65 147.56 10.94 Favored 'Trans proline' 0 C--N 1.364 1.344 0 C-N-CA 123.061 2.507 . . . . 72.1 112.583 178.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.473 HG11 ' HA ' ' A' ' 177' ' ' PRO . 21.3 m -137.07 147.24 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 108.499 -0.926 . . . . 73.14 108.499 178.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -103.01 108.4 19.56 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 109.044 -0.724 . . . . 72.4 109.044 179.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . 0.509 HG21 ' HB3' ' A' ' 175' ' ' TYR . 49.1 t -94.49 120.5 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.565 1.146 . . . . 73.3 109.888 -174.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -71.95 107.55 4.75 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 109.662 -0.495 . . . . 70.33 109.662 174.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 41.8 t -71.65 129.88 87.92 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 124.152 0.981 . . . . 72.24 109.166 174.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -63.45 157.18 52.15 Favored 'Trans proline' 0 CA--C 1.56 1.797 0 C-N-CA 122.047 1.831 . . . . 74.12 111.799 170.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.7 151.1 85.47 Favored 'Trans proline' 0 C--N 1.366 1.491 0 C-N-CA 122.095 1.863 . . . . 73.43 111.646 173.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 73.3 mtt85 55.65 57.97 4.88 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.166 0.986 . . . . 73.42 111.661 177.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.532 HG23 ' HD2' ' A' ' 231' ' ' ARG . 28.1 m -98.85 113.94 26.3 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 114.719 -1.128 . . . . 64.32 110.476 -179.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -92.11 157.87 16.51 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.47 0.708 . . . . 73.24 110.03 177.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . 0.45 ' HB2' ' HB ' ' A' ' 255' ' ' ILE . . . -66.74 134.85 53.03 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 108.708 -0.849 . . . . 52.31 108.708 169.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 100.6 -3.06 56.11 Favored Glycine 0 C--O 1.241 0.585 0 O-C-N 123.53 0.519 . . . . 62.14 112.604 -173.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.532 ' HD2' HG23 ' A' ' 227' ' ' THR . 63.2 mtt-85 -69.61 159.65 33.01 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-O 121.382 0.611 . . . . 75.11 110.367 171.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 48.2 pttt -131.01 137.49 49.23 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.432 -0.804 . . . . 72.32 110.374 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.503 HD23 ' HB2' ' A' ' 173' ' ' ALA . 29.6 mt -123.52 135.14 53.87 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 108.156 -1.054 . . . . 74.24 108.156 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 18.9 ttt85 -122.4 101.59 7.59 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.364 -0.976 . . . . 73.53 108.364 167.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.454 HD12 ' CD1' ' A' ' 175' ' ' TYR . 13.3 mt -75.33 85.3 2.49 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 125.278 1.431 . . . . 73.53 109.441 -176.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.693 ' HA ' ' HB3' ' A' ' 248' ' ' ASP . 59.2 mttm -66.78 129.44 39.89 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.174 -0.921 . . . . 75.24 111.19 -176.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 75.89 12.43 83.94 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 123.811 0.695 . . . . 74.51 113.025 -178.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -137.21 49.97 2.0 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.588 1.155 . . . . 70.13 109.366 -176.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -113.68 -119.76 3.53 Favored Glycine 0 N--CA 1.473 1.157 0 N-CA-C 111.217 -0.753 . . . . 75.51 111.217 173.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -76.63 140.84 68.3 Favored Pre-proline 0 N--CA 1.48 1.058 0 C-N-CA 123.516 0.727 . . . . 63.44 109.853 176.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -66.88 128.1 18.18 Favored 'Trans proline' 0 C--N 1.376 2.004 0 C-N-CA 122.636 2.224 . . . . 71.14 111.3 170.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -129.09 161.16 22.6 Favored Glycine 0 N--CA 1.476 1.332 0 CA-C-O 119.548 -0.585 . . . . 71.3 112.196 176.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -68.5 -33.01 23.79 Favored 'Trans proline' 0 C--N 1.37 1.69 0 C-N-CA 122.457 2.105 . . . . 74.22 113.083 -177.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -99.03 -2.08 38.12 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.146 0.578 . . . . 65.42 112.298 -177.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 157.9 -151.07 22.23 Favored Glycine 0 C--N 1.344 0.981 0 N-CA-C 111.143 -0.783 . . . . 75.42 111.143 -177.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 29.8 mtt-85 -129.43 163.17 26.42 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 117.889 0.845 . . . . 71.43 111.019 174.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -87.61 -156.99 30.86 Favored Glycine 0 C--N 1.345 1.058 0 CA-C-N 115.051 -0.977 . . . . 53.15 111.641 167.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . 0.693 ' HB3' ' HA ' ' A' ' 236' ' ' LYS . 1.0 OUTLIER -130.07 135.6 48.42 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 122.935 0.494 . . . . 71.12 112.035 -177.78 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 34.5 tp -98.59 116.97 31.99 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.354 0.661 . . . . 74.51 109.586 178.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -91.01 107.8 19.44 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.69 0.796 . . . . 73.42 109.335 178.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 48.8 mt -97.23 141.85 29.85 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.201 0.6 . . . . 74.35 111.255 178.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -101.53 108.13 19.61 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.084 -0.962 . . . . 72.24 108.882 175.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 69.0 t -66.09 116.24 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-O 121.119 0.485 . . . . 74.03 111.025 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 36.7 mmm-85 -121.55 115.05 22.09 Favored 'General case' 0 C--O 1.242 0.677 0 N-CA-C 107.594 -1.261 . . . . 75.01 107.594 173.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.45 ' HB ' ' HB2' ' A' ' 229' ' ' ALA . 21.9 mt -75.07 129.03 37.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 N-CA-C 109.513 -0.551 . . . . 74.4 109.513 175.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 8.3 t . . . . . 0 CA--C 1.562 1.407 0 CA-C-O 117.418 -1.277 . . . . 70.45 108.3 178.439 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 37.4 t70 . . . . . 0 N--CA 1.475 0.815 0 N-CA-C 107.456 -1.313 . . . . 64.35 107.456 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.504 HG22 ' HB3' ' A' ' 234' ' ' ARG . 16.2 m -88.22 161.59 2.74 Favored 'Isoleucine or valine' 0 C--O 1.244 0.78 0 N-CA-C 108.249 -1.019 . . . . 72.43 108.249 161.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 16.2 tt -91.02 133.18 33.55 Favored 'Isoleucine or valine' 0 C--O 1.243 0.721 0 N-CA-C 107.07 -1.456 . . . . 73.52 107.07 164.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -68.57 117.89 10.9 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 123.659 0.784 . . . . 74.23 110.152 -170.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.432 ' HB1' HD23 ' A' ' 233' ' ' LEU . . . -123.57 172.61 8.64 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.662 1.185 . . . . 73.4 108.834 178.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -152.81 158.25 41.95 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.386 0.674 . . . . 71.13 109.659 177.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -141.21 168.39 19.9 Favored 'General case' 0 C--N 1.35 0.59 0 C-N-CA 122.731 0.412 . . . . 73.51 110.761 177.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -142.78 149.23 49.23 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 124.95 1.3 . . . . 72.21 108.705 173.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . 0.544 ' HA ' HG12 ' A' ' 219' ' ' VAL . 20.4 Cg_endo -58.76 123.78 14.29 Favored 'Trans proline' 0 C--N 1.377 2.051 0 C-N-CA 122.931 2.42 . . . . 75.22 111.757 176.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . 0.52 ' HB3' ' HG3' ' A' ' 220' ' ' GLU . . . . . . . . 0 N--CA 1.477 0.912 0 C-N-CA 123.694 0.798 . . . . 71.45 109.827 179.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.416 ' O ' ' HA3' ' A' ' 247' ' ' GLY . 25.0 mm-40 . . . . . 0 N--CA 1.477 0.913 0 CA-C-O 120.938 0.399 . . . . 73.45 111.423 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -93.41 157.72 16.08 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.462 0.705 . . . . 75.22 110.047 175.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 43.1 mt -136.24 143.35 44.25 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.323 1.049 . . . . 75.03 108.282 171.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -129.61 120.76 25.79 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 123.791 0.836 . . . . 74.23 109.079 -178.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -159.37 165.18 33.82 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 121.47 0.653 . . . . 74.51 110.931 -177.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 2.9 p -93.25 138.3 31.76 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.798 0.839 . . . . 74.33 109.56 173.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.552 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . 57.9 tp -108.6 119.34 39.22 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.597 1.159 . . . . 71.3 109.497 -177.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -82.2 103.2 11.63 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 109.562 -0.533 . . . . 72.02 109.562 176.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.521 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 47.5 t -106.21 111.17 64.36 Favored Pre-proline 0 CA--C 1.542 0.643 0 N-CA-C 108.195 -1.039 . . . . 73.33 108.195 175.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . 0.488 ' HA ' ' HG1' ' A' ' 256' ' ' THR . 50.5 Cg_exo -57.38 142.1 94.98 Favored 'Trans proline' 0 C--N 1.373 1.862 0 C-N-CA 122.498 2.132 . . . . 72.15 111.874 172.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . 0.4 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -50.66 -47.5 84.87 Favored Pre-proline 0 CA--C 1.559 1.298 0 CA-C-O 117.793 -1.099 . . . . 62.3 112.985 -177.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . 0.4 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 16.3 Cg_endo -55.49 -41.93 73.05 Favored 'Trans proline' 0 C--N 1.398 3.178 0 C-N-CA 122.095 1.863 . . . . 64.23 112.891 176.021 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . 0.434 HD13 ' HD2' ' A' ' 200' ' ' PRO . 34.5 mt -69.71 -36.2 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 C-N-CA 123.379 0.671 . . . . 74.45 110.894 -177.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.24 -38.32 78.44 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.227 0.611 . . . . 64.42 111.651 -178.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 89.3 t -72.7 -56.29 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 CA-C-N 115.689 -0.687 . . . . 74.34 110.82 -178.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 9.4 m -80.39 -24.69 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 CA-C-N 116.294 -0.412 . . . . 73.51 111.985 -172.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 82.47 136.92 2.56 Favored Glycine 0 C--N 1.349 1.254 0 O-C-N 123.433 0.458 . . . . 44.1 112.622 -175.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 179.49 -124.91 0.93 Allowed Glycine 0 C--N 1.341 0.844 0 N-CA-C 111.776 -0.529 . . . . 74.34 111.776 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.506 ' HD2' ' HB3' ' A' ' 220' ' ' GLU . 46.9 mtmt -137.63 153.02 49.93 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.654 0.781 . . . . 74.22 109.817 176.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.484 HG12 ' HA ' ' A' ' 199' ' ' VAL . 27.3 m -128.84 168.23 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.578 1.151 . . . . 72.32 108.707 170.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 45.9 ttp180 -94.78 141.48 28.58 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 109.761 -0.459 . . . . 72.23 109.761 173.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -129.77 154.78 46.87 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.02 0.928 . . . . 75.34 109.036 173.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -103.66 114.45 28.72 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 109.218 -0.66 . . . . 73.13 109.218 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 64.4 p -114.57 175.62 5.41 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.246 0.618 . . . . 73.53 109.439 174.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 11.8 mt -81.12 -3.17 51.14 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 116.109 -0.496 . . . . 70.5 110.283 173.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -91.54 -20.34 21.8 Favored 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 123.862 0.865 . . . . 74.42 110.403 170.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 133.23 -163.64 24.3 Favored Glycine 0 C--N 1.352 1.446 0 CA-C-O 119.752 -0.471 . . . . 62.43 112.595 177.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -74.93 131.03 13.91 Favored 'Trans proline' 0 C--N 1.37 1.705 0 C-N-CA 123.042 2.495 . . . . 75.13 110.278 172.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.544 HG12 ' HA ' ' A' ' 177' ' ' PRO . 17.9 m -131.19 161.83 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 123.538 0.735 . . . . 63.32 110.478 -173.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.52 ' HG3' ' HB3' ' A' ' 178' ' ' ALA . 35.4 mt-10 -112.18 113.25 25.4 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.645 0.778 . . . . 74.51 109.681 178.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 57.5 t -95.46 118.99 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.229 1.011 . . . . 74.1 109.059 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -67.54 100.13 0.84 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.777 0.831 . . . . 70.43 110.149 176.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 91.7 t -81.77 121.02 79.09 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 124.562 1.145 . . . . 73.1 109.858 176.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -65.56 155.27 69.84 Favored 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 122.22 1.947 . . . . 71.24 111.482 173.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -66.77 156.23 66.91 Favored 'Trans proline' 0 C--N 1.37 1.702 0 C-N-CA 122.322 2.015 . . . . 74.35 111.731 172.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 49.0 mtm-85 63.34 31.53 15.2 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.19 0.996 . . . . 74.34 111.151 172.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 92.1 m -86.84 122.62 30.97 Favored 'General case' 0 C--N 1.344 0.367 0 C-N-CA 123.58 0.752 . . . . 73.2 109.256 176.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -94.35 167.79 11.3 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.499 0.719 . . . . 75.04 110.715 177.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -78.71 149.21 32.81 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-N 114.936 -1.029 . . . . 74.12 109.816 177.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 87.34 1.43 83.88 Favored Glycine 0 C--N 1.339 0.716 0 CA-C-N 115.681 -0.69 . . . . 75.13 111.963 -173.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 54.3 mtt-85 -79.25 163.05 25.27 Favored 'General case' 0 C--N 1.353 0.76 0 CA-C-O 121.419 0.628 . . . . 71.22 110.103 170.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 15.9 pttm -128.41 139.97 52.08 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 124.344 1.058 . . . . 72.25 109.491 -178.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.432 HD23 ' HB1' ' A' ' 173' ' ' ALA . 90.0 mt -120.29 105.95 11.42 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.25 1.02 . . . . 74.24 108.906 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . 0.504 ' HB3' HG22 ' A' ' 170' ' ' VAL . 71.4 ttt180 -90.49 101.45 14.19 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 107.278 -1.378 . . . . 74.21 107.278 170.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 22.8 mt -77.13 83.41 3.62 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 107.718 -1.215 . . . . 73.3 107.718 174.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -68.68 129.0 38.67 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-N 113.049 -1.887 . . . . 75.54 111.861 -169.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 60.62 32.2 77.61 Favored Glycine 0 C--N 1.347 1.188 0 O-C-N 124.738 1.274 . . . . 72.15 112.473 177.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -136.79 -2.92 2.09 Favored 'General case' 0 C--N 1.358 0.964 0 N-CA-C 113.641 0.978 . . . . 74.25 113.641 -176.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . 0.407 ' HA2' ' HB2' ' A' ' 249' ' ' LEU . . . -61.69 -107.33 0.01 OUTLIER Glycine 0 N--CA 1.485 1.965 0 N-CA-C 114.603 0.601 . . . . 71.52 114.603 -178.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -67.81 136.31 92.38 Favored Pre-proline 0 N--CA 1.486 1.351 0 CA-C-O 118.328 -0.844 . . . . 73.33 109.523 171.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.432 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 37.8 Cg_exo -60.88 135.65 60.93 Favored 'Trans proline' 0 C--N 1.371 1.75 0 C-N-CA 122.648 2.232 . . . . 72.3 112.532 175.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -164.86 120.56 0.94 Allowed Glycine 0 CA--C 1.54 1.613 0 CA-C-O 118.556 -1.136 . . . . 73.22 111.99 -177.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -72.25 -20.13 24.95 Favored 'Trans proline' 0 C--N 1.387 2.554 0 C-N-CA 123.506 2.804 . . . . 73.12 112.811 176.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -93.29 12.64 23.91 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.231 0.612 . . . . 64.44 110.695 175.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 118.97 120.24 2.91 Favored Glycine 0 C--N 1.353 1.477 0 N-CA-C 110.592 -1.003 . . . . 72.35 110.592 -177.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.432 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 28.0 mtt180 -72.29 162.67 29.15 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.291 0.636 . . . . 73.32 109.71 174.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . 0.416 ' HA3' ' O ' ' A' ' 191' ' ' GLN . . . -80.56 -157.86 16.77 Favored Glycine 0 C--N 1.348 1.234 0 N-CA-C 112.435 -0.266 . . . . 73.13 112.435 174.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -121.43 128.85 52.58 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 117.407 0.603 . . . . 71.53 109.786 177.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.407 ' HB2' ' HA2' ' A' ' 239' ' ' GLY . 50.2 tp -100.19 108.18 20.22 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 108.263 -1.014 . . . . 71.51 108.263 173.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -98.69 116.43 30.91 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 108.522 -0.918 . . . . 72.1 108.522 -174.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.552 ' HB3' ' HB2' ' A' ' 197' ' ' LEU . 49.1 mt -127.22 119.17 25.78 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.024 0.93 . . . . 75.51 110.271 -173.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -83.57 121.33 27.09 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 122.979 0.511 . . . . 75.43 110.192 176.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 61.2 t -66.87 105.49 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 C-N-CA 123.691 0.796 . . . . 75.13 110.46 179.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 47.6 mmm-85 -107.25 100.02 9.51 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 107.703 -1.221 . . . . 74.04 107.703 173.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.521 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 39.8 mt -76.94 119.37 25.21 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 CA-C-N 116.063 -0.517 . . . . 75.42 110.422 -178.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' THR . . . . . 0.488 ' HG1' ' HA ' ' A' ' 200' ' ' PRO . 29.5 p . . . . . 0 C--O 1.249 1.06 0 N-CA-C 108.393 -0.965 . . . . 70.12 108.393 175.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 20.3 t70 . . . . . 0 N--CA 1.474 0.76 0 CA-C-O 121.299 0.571 . . . . 73.43 109.707 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.445 HG12 ' HG3' ' A' ' 232' ' ' LYS . 33.5 m -92.03 156.09 3.05 Favored 'Isoleucine or valine' 0 C--O 1.244 0.784 0 CA-C-N 114.87 -1.059 . . . . 61.45 109.147 171.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 16.6 tt -83.3 143.43 11.95 Favored 'Isoleucine or valine' 0 C--O 1.245 0.863 0 N-CA-C 108.703 -0.851 . . . . 75.33 108.703 171.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -59.92 137.96 57.94 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.301 1.041 . . . . 74.32 110.787 -176.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.45 ' HB1' HD23 ' A' ' 233' ' ' LEU . . . -157.69 159.34 36.81 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.319 1.048 . . . . 62.12 109.537 -178.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -160.42 152.22 19.93 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.604 0.762 . . . . 72.11 109.742 174.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.5 ' HB3' HG21 ' A' ' 221' ' ' VAL . 34.6 p90 -113.7 -178.67 3.43 Favored 'General case' 0 C--N 1.349 0.561 0 CA-C-O 121.23 0.538 . . . . 74.12 111.704 -178.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -135.78 140.71 34.43 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-N 114.394 -1.275 . . . . 73.24 107.955 170.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -60.87 113.92 1.93 Allowed 'Trans proline' 0 C--N 1.366 1.487 0 C-N-CA 123.212 2.608 . . . . 75.34 111.134 175.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . 0.441 ' HB3' ' HG3' ' A' ' 220' ' ' GLU . . . . . . . . 0 N--CA 1.48 1.039 0 C-N-CA 123.497 0.719 . . . . 73.41 110.848 175.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.461 ' HA ' ' HB2' ' A' ' 240' ' ' PHE . 18.2 mm100 . . . . . 0 CA--C 1.553 1.061 0 N-CA-C 112.683 0.623 . . . . 74.04 112.683 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -93.02 141.18 28.69 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.427 0.691 . . . . 71.52 110.07 -178.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 17.6 mt -123.44 148.4 46.2 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 124.971 1.308 . . . . 72.24 109.22 174.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -127.86 120.64 28.19 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.21 0.604 . . . . 75.41 109.673 177.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.425 ' O ' ' HA ' ' A' ' 251' ' ' LEU . . . -145.35 160.06 42.11 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.729 0.812 . . . . 74.15 109.939 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 11.5 m -102.55 143.79 31.8 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 108.771 -0.826 . . . . 74.1 108.771 176.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.534 HD11 HG22 ' A' ' 210' ' ' VAL . 49.0 tp -113.95 124.97 53.45 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.634 1.174 . . . . 74.01 109.858 -173.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -96.97 102.86 14.72 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.375 0.67 . . . . 73.22 109.522 175.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.517 ' HA ' HG12 ' A' ' 210' ' ' VAL . 3.2 p -104.45 125.9 32.89 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 124.093 0.957 . . . . 74.23 109.675 173.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . 0.462 ' HA ' ' HG1' ' A' ' 256' ' ' THR . 50.4 Cg_exo -56.86 148.44 66.93 Favored 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 122.698 2.265 . . . . 74.52 112.526 170.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . 0.488 ' HA ' HG22 ' A' ' 255' ' ' ILE . . . -49.38 -52.39 49.75 Favored Pre-proline 0 CA--C 1.56 1.359 0 C-N-CA 124.269 1.027 . . . . 73.43 112.452 178.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . 0.41 ' O ' HG12 ' A' ' 206' ' ' VAL . 30.8 Cg_endo -61.28 -40.3 50.76 Favored 'Trans proline' 0 C--N 1.4 3.266 0 C-N-CA 121.752 1.635 . . . . 75.32 112.877 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 29.1 mt -68.7 -30.48 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 123.233 0.613 . . . . 74.23 110.669 -178.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.92 -42.52 73.19 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 122.827 0.451 . . . . 62.2 110.662 177.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . 0.438 HG21 ' O ' ' A' ' 201' ' ' ALA . 61.4 t -71.05 -53.9 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 123.303 0.641 . . . . 75.33 111.438 -177.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.41 HG12 ' O ' ' A' ' 202' ' ' PRO . 7.7 p -80.09 -31.59 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 122.439 0.296 . . . . 73.11 111.787 -174.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 93.45 131.22 5.84 Favored Glycine 0 CA--C 1.532 1.105 0 N-CA-C 111.618 -0.593 . . . . 75.21 111.618 -172.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -166.72 -143.87 3.91 Favored Glycine 0 C--N 1.341 0.856 0 CA-C-O 119.339 -0.701 . . . . 74.34 111.899 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.546 ' HB2' ' HZ3' ' A' ' 209' ' ' LYS . 9.6 mtmp? -132.96 145.71 51.13 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.886 0.874 . . . . 73.31 109.704 174.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.534 HG22 HD11 ' A' ' 197' ' ' LEU . 22.1 m -139.44 158.54 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 124.385 1.074 . . . . 74.42 110.219 177.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 29.2 mtp-105 -79.76 132.87 36.27 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 122.917 0.487 . . . . 72.42 111.598 -177.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -121.12 125.21 46.67 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 125.368 1.467 . . . . 65.35 108.016 172.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.65 106.89 18.82 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 123.478 0.711 . . . . 71.02 110.124 -175.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 29.8 p -117.38 172.51 7.27 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.402 0.681 . . . . 73.21 109.928 -179.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 9.3 mt -71.54 -24.77 62.0 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 109.541 -0.541 . . . . 72.11 109.541 175.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -79.52 -18.87 50.93 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.128 0.971 . . . . 75.14 110.767 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 135.19 -175.51 20.61 Favored Glycine 0 C--N 1.353 1.495 0 CA-C-N 116.064 -0.517 . . . . 53.51 112.948 172.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -66.76 126.48 15.43 Favored 'Trans proline' 0 C--N 1.372 1.809 0 C-N-CA 122.931 2.42 . . . . 72.0 110.644 168.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 35.4 m -133.16 138.68 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 122.882 0.473 . . . . 64.44 110.67 -178.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.468 ' HB3' ' HB3' ' A' ' 209' ' ' LYS . 46.9 mt-10 -92.99 108.55 20.09 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.178 0.591 . . . . 72.13 110.777 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . 0.5 HG21 ' HB3' ' A' ' 175' ' ' TYR . 61.0 t -91.89 119.24 38.93 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 C-N-CA 124.451 1.101 . . . . 70.04 109.429 -176.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -65.04 102.61 0.64 Allowed 'General case' 0 C--O 1.239 0.534 0 O-C-N 124.309 1.005 . . . . 72.54 109.969 175.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.43 HG11 HG23 ' A' ' 199' ' ' VAL . 48.1 t -74.8 117.28 61.27 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 124.376 1.07 . . . . 70.03 109.061 172.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -59.62 156.64 35.96 Favored 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 122.32 2.013 . . . . 73.11 112.158 178.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -63.06 125.24 15.45 Favored 'Trans proline' 0 C--N 1.375 1.945 0 C-N-CA 122.389 2.059 . . . . 75.03 111.567 177.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 72.9 mtm180 68.13 83.51 0.16 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.962 1.305 . . . . 75.43 110.051 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.525 HG23 HG13 ' A' ' 253' ' ' VAL . 89.8 m -126.48 117.5 23.02 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.011 0.924 . . . . 73.01 109.464 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -85.79 158.35 20.02 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.939 0.895 . . . . 73.33 112.151 -172.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -72.54 124.33 24.99 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 114.635 -1.166 . . . . 64.45 109.951 179.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 102.28 2.85 51.07 Favored Glycine 0 C--N 1.335 0.52 0 CA-C-O 119.524 -0.598 . . . . 74.23 112.596 -176.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 87.1 mtt180 -72.66 161.27 30.98 Favored 'General case' 0 C--N 1.356 0.879 0 CA-C-O 121.264 0.554 . . . . 74.2 110.051 170.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.445 ' HG3' HG12 ' A' ' 170' ' ' VAL . 19.9 pttm -124.38 140.47 52.92 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.324 -0.853 . . . . 74.44 109.876 -179.116 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.45 HD23 ' HB1' ' A' ' 173' ' ' ALA . 61.4 mt -117.87 141.28 48.61 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 107.49 -1.3 . . . . 73.31 107.49 176.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 30.6 ttt180 -130.88 101.73 5.76 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 108.081 -1.081 . . . . 73.53 108.081 167.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 27.6 mt -71.03 87.31 0.74 Allowed 'General case' 0 C--O 1.24 0.603 0 CA-C-N 114.524 -1.216 . . . . 72.14 108.286 175.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 59.6 mtmt -68.75 122.98 19.7 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 114.272 -1.331 . . . . 75.1 111.006 -174.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 69.65 26.42 74.48 Favored Glycine 0 C--N 1.345 1.079 0 O-C-N 124.305 1.003 . . . . 72.43 112.303 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.438 ' HB3' ' CE1' ' A' ' 175' ' ' TYR . 31.3 mmtp -135.85 35.02 2.87 Favored 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 124.512 1.125 . . . . 74.21 110.985 -172.007 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -114.27 -115.36 3.14 Favored Glycine 0 N--CA 1.477 1.414 0 N-CA-C 111.952 -0.459 . . . . 73.31 111.952 177.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . 0.461 ' HB2' ' HA ' ' A' ' 191' ' ' GLN . 1.8 m-85 -69.83 142.03 90.49 Favored Pre-proline 0 N--CA 1.485 1.321 0 C-N-CA 123.17 0.588 . . . . 70.32 110.946 177.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -52.44 144.12 41.9 Favored 'Trans proline' 0 C--N 1.376 1.985 0 C-N-CA 123.687 2.925 . . . . 71.01 113.602 172.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -156.8 113.31 0.56 Allowed Glycine 0 CA--C 1.531 1.063 0 CA-C-O 118.399 -1.223 . . . . 73.23 110.248 -179.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.26 -14.98 45.33 Favored 'Trans proline' 0 C--N 1.386 2.521 0 C-N-CA 123.535 2.823 . . . . 70.32 114.565 -176.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -112.6 -12.24 13.46 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 123.529 0.732 . . . . 72.34 111.594 175.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 163.03 125.68 0.78 Allowed Glycine 0 C--N 1.344 0.998 0 N-CA-C 111.123 -0.791 . . . . 75.43 111.123 -178.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 12.3 mtm180 -73.63 162.32 29.33 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.135 0.574 . . . . 72.04 110.928 -178.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -83.82 -163.72 35.78 Favored Glycine 0 C--N 1.348 1.212 0 CA-C-N 115.894 -0.594 . . . . 65.15 112.971 178.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -108.36 157.46 18.37 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.213 0.605 . . . . 74.54 110.676 -176.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 45.6 tp -132.83 110.91 10.66 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.101 0.96 . . . . 74.34 108.571 170.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 21.9 t80 -96.28 120.97 37.55 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.382 1.073 . . . . 73.42 109.326 -176.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.425 ' HA ' ' O ' ' A' ' 195' ' ' ALA . 51.5 mt -120.02 126.98 52.14 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.727 0.811 . . . . 72.24 110.862 -176.288 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.99 116.52 25.1 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 122.886 0.474 . . . . 75.03 110.434 173.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 0.525 HG13 HG23 ' A' ' 227' ' ' THR . 96.7 t -65.71 115.58 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 123.381 0.673 . . . . 73.13 110.511 176.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -121.12 111.62 17.67 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.015 0.926 . . . . 71.42 109.193 172.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.488 HG22 ' HA ' ' A' ' 201' ' ' ALA . 44.7 mt -76.89 121.47 29.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 108.988 -0.745 . . . . 74.02 108.988 175.18 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' THR . . . . . 0.462 ' HG1' ' HA ' ' A' ' 200' ' ' PRO . 34.6 p . . . . . 0 C--O 1.253 1.254 0 N-CA-C 108.23 -1.026 . . . . 72.02 108.23 175.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 29.7 t70 . . . . . 0 N--CA 1.483 1.186 0 N-CA-C 113.409 0.892 . . . . 73.21 113.409 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.414 HG21 ' HB3' ' A' ' 234' ' ' ARG . 12.9 m -90.33 -174.82 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.019 0 C-N-CA 123.542 0.737 . . . . 73.13 110.651 -175.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 10.3 tt -93.85 137.46 22.73 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.124 0 N-CA-C 108.29 -1.004 . . . . 72.21 108.29 165.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -74.84 113.39 12.08 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.438 1.095 . . . . 52.54 110.02 -175.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.459 ' HB1' HD23 ' A' ' 233' ' ' LEU . . . -111.6 178.95 4.16 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.449 0.7 . . . . 73.03 110.711 -178.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -146.76 156.5 43.2 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.572 1.149 . . . . 72.43 109.456 178.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -130.67 172.06 12.38 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.086 0.47 . . . . 75.23 110.045 168.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -134.5 140.91 37.06 Favored Pre-proline 0 N--CA 1.476 0.837 0 C-N-CA 124.585 1.154 . . . . 75.21 108.27 175.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -64.04 106.08 0.63 Allowed 'Trans proline' 0 C--N 1.363 1.342 0 C-N-CA 122.775 2.317 . . . . 74.22 111.035 175.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.336 0 C-N-CA 123.535 0.734 . . . . 73.23 111.826 -175.652 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.467 ' HA ' ' HB2' ' A' ' 240' ' ' PHE . 23.9 mm-40 . . . . . 0 N--CA 1.477 0.904 0 CA-C-O 121.191 0.52 . . . . 64.34 110.084 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -89.6 146.92 24.22 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.031 0.932 . . . . 74.23 109.927 -170.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 13.7 mt -140.53 131.56 26.23 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 107.634 -1.247 . . . . 70.41 107.634 166.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -120.13 128.3 53.31 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 108.782 -0.822 . . . . 73.43 108.782 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -157.53 162.04 38.82 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.742 0.817 . . . . 73.25 110.157 178.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 17.2 p -91.87 149.12 21.74 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 109.033 -0.728 . . . . 70.32 109.033 170.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.61 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . 40.8 tp -113.4 115.01 27.4 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 123.622 0.769 . . . . 75.23 109.549 -175.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -80.03 100.96 8.42 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.625 0.77 . . . . 72.22 109.163 -179.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.565 ' HA ' HG12 ' A' ' 210' ' ' VAL . 40.9 t -109.84 104.39 55.38 Favored Pre-proline 0 CA--C 1.54 0.578 0 N-CA-C 108.509 -0.923 . . . . 60.54 108.509 178.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . 0.49 ' HA ' ' HG1' ' A' ' 256' ' ' THR . 77.1 Cg_exo -53.22 139.79 62.62 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 122.723 2.282 . . . . 74.43 112.07 174.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . 0.403 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -47.8 -47.84 61.78 Favored Pre-proline 0 CA--C 1.558 1.266 0 C-N-CA 124.377 1.071 . . . . 74.42 113.749 -175.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.1 -45.06 34.13 Favored 'Trans proline' 0 C--N 1.39 2.716 0 C-N-CA 121.977 1.785 . . . . 74.44 112.902 174.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 36.6 mt -66.1 -32.24 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 123.577 0.751 . . . . 64.54 110.84 -177.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -65.91 -50.64 63.75 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 122.994 0.518 . . . . 73.12 110.377 177.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 201' ' ' ALA . 81.4 t -64.3 -53.23 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 O-C-N 123.877 0.736 . . . . 74.45 111.685 -175.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 26.9 m -78.31 -26.28 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 N-CA-C 112.237 0.458 . . . . 73.33 112.237 -176.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 81.01 139.99 2.65 Favored Glycine 0 C--N 1.349 1.301 0 N-CA-C 112.147 -0.381 . . . . 74.45 112.147 -175.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -177.74 -124.27 0.84 Allowed Glycine 0 C--N 1.344 0.995 0 CA-C-N 117.202 0.501 . . . . 45.22 112.506 -178.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -136.59 153.13 51.05 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.977 0.911 . . . . 74.43 108.71 176.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.565 HG12 ' HA ' ' A' ' 199' ' ' VAL . 15.7 m -138.06 128.03 35.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 123.268 0.627 . . . . 72.5 109.381 171.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 63.6 mtm-85 -81.95 110.29 17.09 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.38 0.672 . . . . 73.35 110.796 -176.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -100.46 161.14 13.8 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.677 1.191 . . . . 74.32 109.93 178.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' MET . . . . . 0.436 ' HA ' ' HE2' ' A' ' 213' ' ' MET . 8.1 mmt -99.17 119.82 38.49 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.714 0.805 . . . . 72.32 109.889 -177.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 76.4 p -110.6 175.49 5.41 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.52 0.728 . . . . 74.24 109.113 170.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 29.1 mt -69.84 -10.43 58.41 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 112.712 0.634 . . . . 75.34 112.712 -174.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -117.43 -12.69 10.39 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.266 0.626 . . . . 73.51 112.284 -177.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 153.15 -169.62 32.05 Favored Glycine 0 C--N 1.356 1.655 0 N-CA-C 114.335 0.494 . . . . 71.42 114.335 173.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -70.22 141.23 42.85 Favored 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 123.558 2.839 . . . . 74.32 112.456 176.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 34.6 m -137.89 130.96 41.75 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 C-N-CA 123.547 0.739 . . . . 61.43 110.157 178.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -88.07 108.52 19.28 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.408 0.683 . . . . 71.34 110.173 -178.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 44.9 t -94.74 122.95 46.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 123.734 0.814 . . . . 73.24 109.682 -176.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -68.61 107.0 2.79 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.205 1.002 . . . . 73.51 111.452 -177.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 66.4 t -86.2 121.05 72.74 Favored Pre-proline 0 CA--C 1.553 1.065 0 C-N-CA 124.634 1.174 . . . . 71.44 110.047 176.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -63.52 164.38 20.98 Favored 'Trans proline' 0 C--N 1.379 2.183 0 C-N-CA 122.918 2.412 . . . . 65.42 112.527 174.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -66.28 128.35 19.25 Favored 'Trans proline' 0 C--N 1.376 2.008 0 C-N-CA 122.615 2.21 . . . . 72.3 112.184 173.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 63.3 mtm-85 62.81 70.54 0.55 Allowed 'General case' 0 C--N 1.353 0.746 0 C-N-CA 124.724 1.21 . . . . 72.3 110.846 178.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.573 HG22 HG13 ' A' ' 253' ' ' VAL . 56.8 m -101.57 114.72 29.01 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 114.829 -1.078 . . . . 63.11 109.376 -178.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 22.9 mp0 -84.79 153.03 23.25 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.271 0.628 . . . . 72.41 111.404 -174.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -73.15 127.89 33.91 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.734 -0.839 . . . . 64.13 108.734 174.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 110.08 -11.84 31.65 Favored Glycine 0 C--N 1.333 0.366 0 N-CA-C 111.533 -0.627 . . . . 55.14 111.533 -171.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.499 ' HD2' HG21 ' A' ' 227' ' ' THR . 90.7 mtt180 -66.81 156.79 34.61 Favored 'General case' 0 C--N 1.36 1.043 0 CA-C-O 121.361 0.601 . . . . 75.13 110.142 169.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 38.3 pttt -131.91 135.08 46.37 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 114.996 -1.002 . . . . 74.44 109.391 -176.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.459 HD23 ' HB1' ' A' ' 173' ' ' ALA . 75.9 mt -115.96 137.06 52.45 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 108.081 -1.081 . . . . 72.54 108.081 176.204 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . 0.414 ' HB3' HG21 ' A' ' 170' ' ' VAL . 40.8 ttm105 -119.52 120.49 36.92 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.565 -1.272 . . . . 75.5 107.565 166.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.518 ' O ' ' HA ' ' A' ' 248' ' ' ASP . 43.7 mt -101.88 78.82 1.84 Allowed 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 108.678 -0.86 . . . . 61.1 108.678 -177.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -75.95 144.15 41.17 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 122.883 0.473 . . . . 74.14 109.856 176.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 68.31 18.16 71.1 Favored Glycine 0 C--N 1.344 1.005 0 CA-C-N 115.639 -0.709 . . . . 64.43 112.336 -174.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 10.1 mmpt? -129.75 -30.58 2.04 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.352 1.061 . . . . 70.24 110.728 -175.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -66.84 -125.83 0.02 OUTLIER Glycine 0 C--N 1.36 1.863 0 N-CA-C 114.766 0.666 . . . . 64.41 114.766 -171.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . 0.467 ' HB2' ' HA ' ' A' ' 191' ' ' GLN . 1.1 m-85 -67.78 135.46 92.31 Favored Pre-proline 0 N--CA 1.482 1.15 0 CA-C-O 118.802 -0.618 . . . . 65.34 109.903 177.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.447 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 37.3 Cg_exo -42.51 138.46 3.41 Favored 'Trans proline' 0 C--N 1.378 2.101 0 C-N-CA 124.278 3.319 . . . . 74.42 114.92 175.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -164.46 113.16 0.54 Allowed Glycine 0 CA--C 1.531 1.046 0 N-CA-C 109.219 -1.552 . . . . 74.44 109.219 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -60.51 -40.13 59.43 Favored 'Trans proline' 0 C--N 1.379 2.142 0 C-N-CA 123.234 2.623 . . . . 72.11 113.296 -173.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -77.32 -25.05 50.81 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.057 0.543 . . . . 65.24 110.8 176.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 169.18 127.21 0.91 Allowed Glycine 0 C--N 1.338 0.673 0 N-CA-C 110.996 -0.842 . . . . 73.52 110.996 179.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.447 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 48.6 mtm180 -69.54 159.59 33.05 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.106 0.562 . . . . 73.33 109.874 178.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -74.08 -156.56 4.55 Favored Glycine 0 C--N 1.339 0.702 0 CA-C-N 116.069 -0.514 . . . . 75.14 112.911 175.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . 0.518 ' HA ' ' O ' ' A' ' 235' ' ' LEU . 2.6 p30 -122.7 136.46 54.88 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 122.332 -0.511 . . . . 70.25 112.018 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 32.5 tp -100.57 104.6 15.95 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 107.241 -1.392 . . . . 74.3 107.241 168.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -89.28 108.03 19.39 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.172 0.989 . . . . 72.43 109.02 -178.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.61 ' HB3' ' HB2' ' A' ' 197' ' ' LEU . 63.8 mt -110.43 110.75 21.63 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.412 1.085 . . . . 73.41 110.349 -176.069 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -80.37 110.23 15.63 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.119 0.568 . . . . 74.54 109.694 176.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 0.573 HG13 HG22 ' A' ' 227' ' ' THR . 89.8 t -59.49 110.76 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.417 0.687 . . . . 73.43 111.017 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 30.8 mmm180 -114.23 113.0 24.04 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 125.053 1.341 . . . . 74.53 108.45 173.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.478 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 56.9 mt -75.62 126.14 36.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 N-CA-C 109.253 -0.647 . . . . 73.42 109.253 178.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 256' ' ' THR . . . . . 0.49 ' HG1' ' HA ' ' A' ' 200' ' ' PRO . 45.2 p . . . . . 0 C--O 1.248 1.003 0 C-N-CA 124.167 0.987 . . . . 73.43 108.623 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 37.7 t70 . . . . . 0 N--CA 1.476 0.849 0 CA-C-O 121.283 0.563 . . . . 60.24 110.292 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.582 HG23 ' HB3' ' A' ' 234' ' ' ARG . 34.1 m -90.01 173.06 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-N 115.158 -0.928 . . . . 74.24 110.948 178.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 15.1 tt -96.34 143.81 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 N-CA-C 108.676 -0.861 . . . . 73.03 108.676 171.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -65.81 132.16 48.03 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.3 1.04 . . . . 75.21 112.065 -173.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.466 ' HB1' HD23 ' A' ' 233' ' ' LEU . . . -146.61 164.39 32.8 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.336 1.054 . . . . 72.43 110.816 -178.333 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -160.4 154.09 22.52 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.68 1.192 . . . . 74.34 109.161 179.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.527 ' HA ' ' HA ' ' A' ' 221' ' ' VAL . 31.7 p90 -117.72 -177.21 3.19 Favored 'General case' 0 C--N 1.347 0.475 0 CA-C-O 121.575 0.703 . . . . 74.31 110.953 178.341 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -136.15 131.81 18.88 Favored Pre-proline 0 N--CA 1.468 0.456 0 N-CA-C 107.438 -1.319 . . . . 75.23 107.438 173.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -65.25 95.25 0.26 Allowed 'Trans proline' 0 CA--C 1.551 1.359 0 C-N-CA 122.149 1.899 . . . . 74.43 110.787 177.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . 0.478 ' HB2' ' HG3' ' A' ' 220' ' ' GLU . . . . . . . . 0 N--CA 1.482 1.137 0 CA-C-N 115.522 -0.763 . . . . 73.52 110.294 176.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.585 ' HA ' ' HB2' ' A' ' 240' ' ' PHE . 16.8 mm100 . . . . . 0 N--CA 1.475 0.776 0 CA-C-O 121.15 0.5 . . . . 72.24 110.374 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.426 ' HA ' ' O ' ' A' ' 248' ' ' ASP . 8.0 p-10 -103.59 139.95 38.21 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.015 -0.539 . . . . 71.43 109.63 176.045 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 86.1 mt -118.83 150.8 39.22 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 108.632 -0.877 . . . . 74.33 108.632 -177.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -122.21 127.59 50.16 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 108.119 -1.067 . . . . 74.35 108.119 172.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -152.88 158.49 42.22 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 122.956 0.502 . . . . 72.45 110.203 -177.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 10.7 p -94.94 138.02 33.23 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 123.222 0.609 . . . . 72.14 109.917 174.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.43 HD12 HG22 ' A' ' 210' ' ' VAL . 52.0 tp -110.88 114.38 27.66 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.381 1.072 . . . . 71.2 109.543 -173.091 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -75.81 104.38 6.33 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 109.251 -0.648 . . . . 73.33 109.251 176.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.56 HG21 HG21 ' A' ' 210' ' ' VAL . 30.0 t -113.46 107.19 53.62 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 123.668 0.787 . . . . 52.44 108.936 175.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . 0.417 ' HA ' ' HG1' ' A' ' 256' ' ' THR . 74.0 Cg_exo -54.19 140.66 71.44 Favored 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.796 2.331 . . . . 73.24 112.267 172.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -47.7 -50.14 53.11 Favored Pre-proline 0 CA--C 1.571 1.752 0 N-CA-C 113.992 1.108 . . . . 74.11 113.992 -177.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -58.1 -39.25 87.13 Favored 'Trans proline' 0 C--N 1.401 3.318 0 C-N-CA 121.838 1.692 . . . . 74.24 112.806 177.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 47.5 mt -72.01 -31.31 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 123.95 0.9 . . . . 71.42 110.829 -178.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.68 -46.63 68.56 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.239 0.615 . . . . 73.25 110.944 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 83.2 t -70.54 -40.99 77.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-N 115.284 -0.871 . . . . 62.32 111.705 -176.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 8.2 p -77.45 -31.02 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 CA-C-N 116.473 -0.33 . . . . 44.52 111.404 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 80.55 69.07 1.42 Allowed Glycine 0 C--N 1.349 1.296 0 CA-C-N 116.055 -0.521 . . . . 73.24 112.344 -173.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -101.29 -150.68 24.14 Favored Glycine 0 C--N 1.346 1.106 0 CA-C-O 119.715 -0.492 . . . . 73.13 112.158 -176.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 55.0 mttp -117.39 143.39 46.04 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.229 0.612 . . . . 75.31 109.56 173.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.56 HG21 HG21 ' A' ' 199' ' ' VAL . 27.7 m -136.72 142.28 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 124.14 0.976 . . . . 74.0 109.192 174.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 88.9 mtm180 -73.72 137.9 44.3 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.127 0.489 . . . . 75.45 111.086 176.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -116.59 121.13 40.83 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.268 1.427 . . . . 73.23 107.394 172.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.0 111.6 19.85 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 109.382 -0.599 . . . . 64.22 109.382 -178.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 81.4 p -120.83 -179.88 4.14 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.457 0.703 . . . . 74.41 111.07 -176.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 12.3 mt -70.31 -22.68 62.8 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 115.466 -0.788 . . . . 73.33 110.003 175.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -87.44 -12.87 44.86 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 123.93 0.892 . . . . 72.14 110.621 177.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 117.37 -158.97 14.29 Favored Glycine 0 C--N 1.354 1.535 0 CA-C-N 116.353 -0.385 . . . . 62.04 113.109 175.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.7 127.9 14.46 Favored 'Trans proline' 0 C--N 1.367 1.533 0 C-N-CA 122.669 2.246 . . . . 74.13 111.381 175.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 29.6 m -132.39 125.03 53.02 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.827 0 N-CA-C 109.919 -0.4 . . . . 73.41 109.919 173.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.478 ' HG3' ' HB2' ' A' ' 178' ' ' ALA . 45.4 mt-10 -84.14 105.82 15.3 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.316 0.647 . . . . 70.21 110.285 -178.293 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . 0.527 ' HA ' ' HA ' ' A' ' 175' ' ' TYR . 46.5 t -90.03 116.94 32.34 Favored 'Isoleucine or valine' 0 C--O 1.243 0.717 0 C-N-CA 124.303 1.041 . . . . 74.42 108.576 -175.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -69.32 101.09 1.44 Allowed 'General case' 0 C--O 1.241 0.613 0 CA-C-N 114.873 -1.058 . . . . 75.14 109.146 176.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 47.1 t -69.18 131.55 90.47 Favored Pre-proline 0 CA--C 1.544 0.749 0 CA-C-N 114.781 -1.1 . . . . 70.42 109.05 176.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -62.81 159.49 37.37 Favored 'Trans proline' 0 CA--C 1.561 1.85 0 C-N-CA 122.06 1.84 . . . . 75.45 111.923 170.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -67.05 147.66 80.12 Favored 'Trans proline' 0 C--N 1.376 2.003 0 C-N-CA 122.159 1.906 . . . . 74.33 112.191 176.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 47.8 mtp180 53.54 54.79 9.5 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.919 1.288 . . . . 74.1 111.368 174.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.546 HG23 ' HD2' ' A' ' 231' ' ' ARG . 91.3 m -96.8 117.95 32.19 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 114.525 -1.216 . . . . 64.32 109.11 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 26.8 mp0 -90.38 161.67 15.48 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.277 0.631 . . . . 73.41 111.57 -177.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -64.42 127.62 32.27 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 114.454 -1.248 . . . . 71.43 110.239 177.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 103.85 -4.31 45.9 Favored Glycine 0 C--N 1.341 0.854 0 CA-C-O 119.374 -0.681 . . . . 73.44 113.526 -179.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.546 ' HD2' HG23 ' A' ' 227' ' ' THR . 87.5 mtt180 -68.65 162.07 26.78 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 117.741 0.771 . . . . 75.21 111.54 175.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -127.33 124.24 38.23 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 123.84 0.856 . . . . 75.42 110.679 -173.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.466 HD23 ' HB1' ' A' ' 173' ' ' ALA . 61.8 mt -113.32 100.0 8.22 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.049 0.939 . . . . 62.11 109.138 178.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . 0.582 ' HB3' HG23 ' A' ' 170' ' ' VAL . 22.6 ttt180 -85.4 102.15 13.19 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 107.966 -1.124 . . . . 70.32 107.966 169.074 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 53.5 mt -68.89 92.06 0.49 Allowed 'General case' 0 C--O 1.244 0.776 0 N-CA-C 107.808 -1.182 . . . . 75.43 107.808 172.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -71.28 114.11 9.0 Favored 'General case' 0 C--N 1.357 0.925 0 CA-C-N 114.137 -1.392 . . . . 75.13 111.813 -167.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . 0.404 ' O ' ' HD3' ' A' ' 246' ' ' ARG . . . 67.53 34.08 83.17 Favored Glycine 0 C--N 1.346 1.121 0 O-C-N 124.053 0.846 . . . . 62.34 112.056 178.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.455 ' HB3' ' CE1' ' A' ' 175' ' ' TYR . 32.9 mmtp -128.62 10.36 6.09 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.645 0.778 . . . . 74.42 111.97 -172.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -84.48 -129.14 1.82 Allowed Glycine 0 N--CA 1.47 0.948 0 N-CA-C 111.742 -0.543 . . . . 73.41 111.742 176.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . 0.585 ' HB2' ' HA ' ' A' ' 191' ' ' GLN . 3.2 m-85 -74.88 142.92 77.2 Favored Pre-proline 0 N--CA 1.48 1.072 0 C-N-CA 123.283 0.633 . . . . 74.34 110.894 175.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.672 ' HA ' ' HG3' ' A' ' 246' ' ' ARG . 21.3 Cg_exo -64.5 142.86 79.98 Favored 'Trans proline' 0 C--N 1.379 2.132 0 C-N-CA 123.003 2.469 . . . . 74.41 113.11 -176.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -157.48 118.25 0.82 Allowed Glycine 0 CA--C 1.535 1.291 0 CA-C-O 118.696 -1.058 . . . . 64.34 111.345 -179.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -64.04 -28.99 65.99 Favored 'Trans proline' 0 C--N 1.384 2.44 0 C-N-CA 123.131 2.554 . . . . 72.04 114.335 -178.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -86.61 -15.35 40.05 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.169 0.588 . . . . 61.51 111.18 176.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 163.29 118.33 0.45 Allowed Glycine 0 C--N 1.344 0.99 0 N-CA-C 110.072 -1.211 . . . . 63.24 110.072 178.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.672 ' HG3' ' HA ' ' A' ' 241' ' ' PRO . 45.4 ttt180 -69.25 140.27 54.47 Favored 'General case' 0 C--O 1.243 0.726 0 CA-C-N 117.505 0.653 . . . . 72.11 109.508 175.389 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -68.56 -169.47 5.54 Favored Glycine 0 C--N 1.351 1.4 0 O-C-N 123.563 0.539 . . . . 53.14 113.347 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . 0.426 ' O ' ' HA ' ' A' ' 192' ' ' ASP . 10.1 m-20 -122.11 169.7 10.6 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.134 0.573 . . . . 71.3 110.734 -175.286 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 43.2 tp -136.24 107.21 6.68 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 108.356 -0.979 . . . . 61.24 108.356 168.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -94.46 107.4 19.37 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 108.881 -0.785 . . . . 74.3 108.881 -174.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 66.2 mt -110.5 113.99 27.06 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.055 0.942 . . . . 75.31 110.117 -175.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -79.52 116.75 19.92 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 109.218 -0.66 . . . . 75.41 109.218 173.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 0.45 HG11 HG21 ' A' ' 227' ' ' THR . 69.5 t -65.45 105.42 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 CA-C-O 121.231 0.539 . . . . 75.34 110.168 177.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 15.3 mmt85 -103.17 106.75 17.33 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 108.043 -1.095 . . . . 73.15 108.043 172.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.489 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 15.3 mt -74.42 119.55 22.03 Favored 'Isoleucine or valine' 0 C--N 1.352 0.716 0 N-CA-C 109.265 -0.643 . . . . 72.4 109.265 179.388 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 256' ' ' THR . . . . . 0.417 ' HG1' ' HA ' ' A' ' 200' ' ' PRO . 23.5 p . . . . . 0 C--O 1.252 1.206 0 C-N-CA 124.736 1.214 . . . . 75.42 109.213 -176.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 27.5 t70 . . . . . 0 N--CA 1.477 0.885 0 CA-C-O 120.835 0.35 . . . . 75.23 110.233 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.432 HG21 ' HB3' ' A' ' 234' ' ' ARG . 25.6 m -98.13 167.86 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-N 115.083 -0.962 . . . . 74.24 110.468 175.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 16.8 tt -89.11 149.59 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.004 0 N-CA-C 108.953 -0.758 . . . . 73.32 108.953 171.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -60.56 142.44 55.4 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.77 1.228 . . . . 73.11 112.377 -175.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.476 ' HB3' HD21 ' A' ' 233' ' ' LEU . . . -159.94 155.45 25.55 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.805 1.242 . . . . 70.32 109.092 174.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -149.98 119.77 7.08 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 123.48 0.712 . . . . 75.34 110.013 177.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.54 ' HE1' ' HB3' ' A' ' 238' ' ' LYS . 17.7 p90 -93.11 164.76 13.14 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 109.451 -0.574 . . . . 75.15 109.451 174.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 46.3 mttm -138.9 143.83 38.96 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 123.519 0.728 . . . . 70.52 109.507 172.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -56.71 108.91 0.38 Allowed 'Trans proline' 0 C--N 1.382 2.312 0 C-N-CA 123.742 2.961 . . . . 72.14 112.984 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . 0.577 ' HB3' ' HG3' ' A' ' 220' ' ' GLU . . . . . . . . 0 N--CA 1.483 1.201 0 C-N-CA 123.131 0.572 . . . . 63.53 110.049 174.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 23.4 mp0 . . . . . 0 N--CA 1.478 0.953 0 CA-C-O 121.799 0.809 . . . . 74.24 109.039 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 19.2 p-10 -94.63 147.95 22.77 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 114.727 -1.124 . . . . 71.11 110.509 -178.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 95.6 mt -126.26 157.78 37.42 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.638 1.175 . . . . 74.14 109.667 178.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -135.31 122.95 22.2 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.911 0.884 . . . . 74.43 108.676 176.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -152.67 171.22 18.52 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.005 0.922 . . . . 73.42 109.711 178.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' THR . . . . . 0.44 HG21 ' HB2' ' A' ' 252' ' ' GLU . 11.7 p -97.96 146.31 25.61 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.335 0.654 . . . . 71.12 109.944 173.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.56 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . 39.1 tp -114.45 111.28 21.16 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.19 0.996 . . . . 71.22 109.112 178.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -87.28 101.41 13.5 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.135 0.493 . . . . 75.01 109.899 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.476 ' HA ' HG11 ' A' ' 210' ' ' VAL . 46.9 t -102.55 121.97 47.91 Favored Pre-proline 0 CA--C 1.542 0.655 0 C-N-CA 124.379 1.071 . . . . 71.14 108.904 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -56.03 142.34 85.66 Favored 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 122.809 2.339 . . . . 65.23 111.602 170.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . 0.448 ' O ' HG22 ' A' ' 205' ' ' VAL . . . -49.48 -49.4 71.82 Favored Pre-proline 0 CA--C 1.56 1.329 0 CA-C-O 118.045 -0.979 . . . . 74.3 113.496 -179.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -60.05 -40.1 64.23 Favored 'Trans proline' 0 C--N 1.394 2.973 0 C-N-CA 121.995 1.797 . . . . 63.42 112.87 178.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 34.7 mt -69.2 -33.26 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 C-N-CA 123.761 0.824 . . . . 71.24 110.6 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.63 -38.03 80.21 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.414 0.685 . . . . 73.43 111.437 178.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . 0.448 HG22 ' O ' ' A' ' 201' ' ' ALA . 99.1 t -74.13 -55.84 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.415 0.686 . . . . 75.35 110.96 -178.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 11.5 m -81.42 -23.37 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 N-CA-C 112.171 0.434 . . . . 74.3 112.171 -171.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 88.16 134.7 4.74 Favored Glycine 0 C--N 1.347 1.16 0 N-CA-C 111.378 -0.689 . . . . 63.23 111.378 -173.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -173.13 -147.54 5.93 Favored Glycine 0 C--N 1.338 0.692 0 N-CA-C 111.644 -0.582 . . . . 71.24 111.644 -177.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -137.02 134.89 37.08 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.22 0.608 . . . . 72.01 110.15 177.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.476 HG11 ' HA ' ' A' ' 199' ' ' VAL . 29.5 m -121.96 147.31 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 123.251 0.62 . . . . 75.14 109.73 179.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -86.68 111.89 21.11 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 116.169 -0.469 . . . . 74.42 109.767 -173.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -99.98 157.68 16.37 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.249 1.02 . . . . 72.03 109.917 177.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 2.0 mmt -105.28 108.81 20.52 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 115.336 -0.847 . . . . 73.13 109.747 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 45.4 p -109.79 -177.72 3.34 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.849 0.859 . . . . 73.51 109.039 171.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 19.0 mt -72.28 -26.74 62.09 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.125 0.57 . . . . 73.14 110.452 -175.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 10.6 mp0 -80.0 -20.54 45.2 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.27 1.028 . . . . 64.23 110.397 -178.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 133.46 -154.5 21.28 Favored Glycine 0 C--N 1.351 1.396 0 CA-C-O 119.56 -0.578 . . . . 71.54 112.104 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -67.83 142.18 56.63 Favored 'Trans proline' 0 C--N 1.369 1.641 0 C-N-CA 122.829 2.353 . . . . 63.52 112.313 172.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 30.0 m -139.61 147.82 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 124.007 0.923 . . . . 74.11 109.639 175.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.577 ' HG3' ' HB3' ' A' ' 178' ' ' ALA . 42.5 mt-10 -100.78 109.24 21.22 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.131 0.572 . . . . 72.35 109.672 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 47.9 t -94.53 122.61 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 123.82 0.848 . . . . 74.44 109.734 -175.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -69.72 99.96 1.42 Allowed 'General case' 0 C--N 1.35 0.62 0 O-C-N 123.952 0.783 . . . . 52.13 110.022 177.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 57.9 t -77.82 121.01 83.54 Favored Pre-proline 0 C--O 1.243 0.728 0 CA-C-N 114.558 -1.201 . . . . 71.32 108.849 173.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -61.5 157.13 42.91 Favored 'Trans proline' 0 CA--C 1.563 1.963 0 C-N-CA 122.25 1.967 . . . . 74.54 111.97 172.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -66.31 144.15 73.13 Favored 'Trans proline' 0 C--N 1.372 1.788 0 C-N-CA 122.251 1.967 . . . . 73.41 111.448 172.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 88.6 mtt180 69.12 32.24 3.77 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 125.126 1.37 . . . . 72.3 111.367 172.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.51 HG22 ' HD2' ' A' ' 231' ' ' ARG . 97.4 m -77.32 121.6 23.96 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.451 1.1 . . . . 74.11 110.325 174.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -95.18 163.3 13.34 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 109.603 -0.517 . . . . 74.11 109.603 178.189 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -70.69 118.84 13.99 Favored 'General case' 0 C--N 1.348 0.51 0 CA-C-N 115.469 -0.787 . . . . 72.21 108.925 170.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 115.01 -1.47 22.8 Favored Glycine 0 N--CA 1.464 0.544 0 CA-C-O 119.73 -0.483 . . . . 71.34 112.518 -172.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.51 ' HD2' HG22 ' A' ' 227' ' ' THR . 38.8 mtt180 -75.55 158.52 32.4 Favored 'General case' 0 C--N 1.358 0.958 0 CA-C-O 121.451 0.643 . . . . 72.51 110.289 168.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.431 ' HG3' HG13 ' A' ' 170' ' ' VAL . 23.0 pttm -124.7 129.19 50.02 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.653 1.181 . . . . 74.22 108.731 -177.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.476 HD21 ' HB3' ' A' ' 173' ' ' ALA . 87.6 mt -117.91 104.16 10.65 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.966 0.907 . . . . 74.41 108.905 -178.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . 0.432 ' HB3' HG21 ' A' ' 170' ' ' VAL . 41.8 ttm180 -97.01 100.43 11.93 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 107.254 -1.388 . . . . 74.12 107.254 175.267 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 20.8 mt -73.4 84.22 1.46 Allowed 'General case' 0 C--O 1.24 0.555 0 N-CA-C 107.185 -1.413 . . . . 74.5 107.185 173.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 6.6 mtpm? -73.53 132.34 42.75 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 115.199 -0.91 . . . . 74.14 110.328 -172.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 69.01 23.5 76.03 Favored Glycine 0 C--N 1.342 0.897 0 O-C-N 123.899 0.749 . . . . 75.44 112.431 -176.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.54 ' HB3' ' HE1' ' A' ' 175' ' ' TYR . 60.8 mmtt -138.72 17.7 2.69 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.995 1.318 . . . . 73.13 111.136 -170.293 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . 0.465 ' HA2' ' HB2' ' A' ' 249' ' ' LEU . . . -82.18 -89.48 0.65 Allowed Glycine 0 N--CA 1.471 0.984 0 N-CA-C 110.499 -1.04 . . . . 72.24 110.499 173.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -95.85 120.62 62.84 Favored Pre-proline 0 N--CA 1.47 0.557 0 N-CA-C 108.339 -0.985 . . . . 73.12 108.339 167.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -77.82 132.01 11.59 Favored 'Trans proline' 0 C--N 1.372 1.808 0 C-N-CA 122.417 2.078 . . . . 75.44 111.41 175.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 168.29 146.69 5.06 Favored Glycine 0 C--N 1.345 1.073 0 CA-C-O 119.228 -0.762 . . . . 51.53 112.688 177.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -68.98 -18.82 40.54 Favored 'Trans proline' 0 C--N 1.376 2.001 0 C-N-CA 123.635 2.89 . . . . 73.25 114.82 -173.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -81.26 -28.96 34.51 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 118.403 0.547 . . . . 64.42 111.134 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -179.34 105.94 0.2 Allowed Glycine 0 C--N 1.346 1.094 0 O-C-N 123.478 0.486 . . . . 72.01 112.205 -178.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 61.2 mtt-85 -86.8 122.55 30.84 Favored 'General case' 0 C--N 1.349 0.577 0 N-CA-C 108.012 -1.107 . . . . 74.2 108.012 173.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -83.41 -168.12 42.82 Favored Glycine 0 N--CA 1.469 0.866 0 O-C-N 123.661 0.601 . . . . 73.41 113.945 -176.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -120.29 126.5 50.73 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 108.674 -0.862 . . . . 75.41 108.674 177.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.465 ' HB2' ' HA2' ' A' ' 239' ' ' GLY . 46.3 tp -97.77 106.3 18.59 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 106.888 -1.523 . . . . 71.33 106.888 175.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -99.25 122.39 42.35 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.311 -0.859 . . . . 74.25 109.034 -170.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.56 ' HB3' ' HB2' ' A' ' 197' ' ' LEU . 65.0 mt -123.24 122.18 37.73 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.708 0.803 . . . . 61.31 110.157 -172.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . 0.44 ' HB2' HG21 ' A' ' 196' ' ' THR . 28.2 mm-40 -90.71 109.67 20.85 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.836 0.854 . . . . 74.0 109.686 178.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 0.506 HG13 HG23 ' A' ' 227' ' ' THR . 84.4 t -63.48 113.74 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 CA-C-O 121.424 0.631 . . . . 73.03 111.409 -176.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 28.1 mmm180 -114.21 105.27 12.97 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.72 1.608 . . . . 75.35 108.02 173.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.421 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 39.8 mt -76.95 128.59 37.87 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 N-CA-C 110.0 -0.37 . . . . 62.53 110.0 178.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 19.2 p . . . . . 0 C--O 1.248 1.015 0 C-N-CA 124.793 1.237 . . . . 51.12 108.79 -176.735 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 24.7 t70 . . . . . 0 N--CA 1.472 0.672 0 N-CA-C 111.878 0.325 . . . . 73.54 111.878 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.437 HG23 ' HB3' ' A' ' 234' ' ' ARG . 25.4 m -85.43 171.96 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 O-C-N 123.755 0.659 . . . . 72.44 110.749 -179.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.437 HG23 ' HD3' ' A' ' 231' ' ' ARG . 15.7 tt -93.05 145.69 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 N-CA-C 109.334 -0.617 . . . . 74.44 109.334 173.326 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -60.13 129.02 39.66 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.92 1.288 . . . . 73.53 111.329 -177.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.465 ' HB1' HD21 ' A' ' 233' ' ' LEU . . . -152.18 163.06 40.17 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 124.624 1.169 . . . . 61.43 109.219 175.539 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -149.17 176.68 10.29 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 108.56 -0.904 . . . . 72.34 108.56 173.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.419 ' CE1' ' HB3' ' A' ' 238' ' ' LYS . 22.8 p90 -144.07 177.23 8.72 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 118.029 0.377 . . . . 74.21 111.244 175.051 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -136.88 131.1 17.9 Favored Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 124.031 0.933 . . . . 74.04 109.52 176.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . 0.5 ' HA ' HG13 ' A' ' 219' ' ' VAL . 44.1 Cg_endo -66.07 95.39 0.3 Allowed 'Trans proline' 0 C--N 1.369 1.637 0 C-N-CA 122.927 2.418 . . . . 65.3 111.548 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . 0.538 ' HB3' ' HG3' ' A' ' 220' ' ' GLU . . . . . . . . 0 N--CA 1.479 1.005 0 C-N-CA 124.1 0.96 . . . . 72.11 111.561 -176.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 . . . . . 0 N--CA 1.477 0.888 0 N-CA-C 109.073 -0.714 . . . . 71.14 109.073 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.433 ' HA ' ' O ' ' A' ' 248' ' ' ASP . 1.2 p30 -102.61 129.39 49.17 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.292 -0.867 . . . . 63.24 109.443 175.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 68.4 mt -109.18 135.35 50.44 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 108.174 -1.047 . . . . 73.21 108.174 177.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -120.23 121.9 39.74 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 108.227 -1.027 . . . . 74.4 108.227 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -154.29 166.35 33.45 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 123.358 0.663 . . . . 74.21 110.56 -173.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 4.9 m -102.24 145.12 29.89 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 109.185 -0.672 . . . . 62.33 109.185 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.518 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . 43.0 tp -119.75 121.72 39.81 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.476 0.71 . . . . 74.43 110.183 -172.231 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -83.77 115.24 22.12 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 109.349 -0.612 . . . . 75.1 109.349 173.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.519 ' HA ' HG11 ' A' ' 210' ' ' VAL . 98.1 t -119.26 110.44 37.72 Favored Pre-proline 0 CA--C 1.537 0.478 0 C-N-CA 123.98 0.912 . . . . 75.33 109.0 177.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . 0.417 ' HA ' ' HG1' ' A' ' 256' ' ' THR . 54.5 Cg_exo -54.73 141.66 75.34 Favored 'Trans proline' 0 C--N 1.37 1.697 0 C-N-CA 122.755 2.303 . . . . 75.5 112.184 171.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . 0.409 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -48.48 -47.78 68.72 Favored Pre-proline 0 CA--C 1.563 1.447 0 CA-C-O 117.784 -1.103 . . . . 74.3 113.426 177.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . 0.409 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 15.7 Cg_endo -54.79 -46.33 34.14 Favored 'Trans proline' 0 C--N 1.398 3.163 0 C-N-CA 122.3 2.0 . . . . 73.25 112.787 175.214 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . 0.416 HG21 HG12 ' A' ' 210' ' ' VAL . 43.9 mt -68.74 -32.35 54.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 123.768 0.827 . . . . 74.5 111.115 -176.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -65.61 -44.9 85.1 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.251 0.62 . . . . 64.51 110.829 178.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 60.3 t -71.35 -52.3 27.67 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-N 115.82 -0.627 . . . . 74.43 110.909 -178.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 14.6 m -71.49 -25.85 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 N-CA-C 111.958 0.355 . . . . 70.51 111.958 -176.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 74.15 74.5 0.84 Allowed Glycine 0 C--N 1.341 0.833 0 N-CA-C 111.674 -0.57 . . . . 74.53 111.674 -174.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -118.88 -164.16 12.72 Favored Glycine 0 N--CA 1.472 1.08 0 N-CA-C 111.75 -0.54 . . . . 34.44 111.75 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -103.16 142.46 34.11 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 117.434 0.617 . . . . 74.32 110.317 -179.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.519 HG11 ' HA ' ' A' ' 199' ' ' VAL . 22.5 m -120.73 147.15 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 124.672 1.189 . . . . 74.31 109.077 175.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 19.3 ttm180 -90.46 109.55 20.67 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 122.024 -0.423 . . . . 72.4 110.034 -178.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -100.25 158.63 15.73 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.689 1.196 . . . . 72.33 110.803 -175.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' MET . . . . . 0.434 ' HA ' ' HE2' ' A' ' 213' ' ' MET . 2.0 mmt -105.87 108.63 20.25 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.636 0.774 . . . . 75.32 110.437 -178.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 68.7 p -111.32 175.41 5.43 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 109.434 -0.58 . . . . 75.23 109.434 170.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 19.3 mt -70.61 -17.82 62.88 Favored 'General case' 0 CA--C 1.55 0.978 0 CA-C-N 115.761 -0.654 . . . . 75.04 110.468 178.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -92.44 -0.32 57.37 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.868 1.267 . . . . 74.12 110.993 178.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 108.89 -161.76 13.07 Favored Glycine 0 C--N 1.349 1.264 0 C-N-CA 123.594 0.616 . . . . 74.14 113.281 175.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.46 132.16 18.66 Favored 'Trans proline' 0 C--N 1.363 1.313 0 C-N-CA 122.719 2.28 . . . . 74.43 112.864 178.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.5 HG13 ' HA ' ' A' ' 177' ' ' PRO . 34.2 m -130.13 160.24 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 124.344 1.058 . . . . 73.21 109.214 177.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.538 ' HG3' ' HB3' ' A' ' 178' ' ' ALA . 46.1 mt-10 -109.26 108.27 18.81 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.461 0.704 . . . . 73.2 110.297 178.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 72.9 t -92.69 116.13 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 123.363 0.665 . . . . 75.01 109.591 -176.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -66.57 100.45 0.67 Allowed 'General case' 0 CA--C 1.543 0.706 0 O-C-N 124.022 0.827 . . . . 52.11 109.647 174.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 61.1 t -75.16 131.11 78.98 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 124.944 1.297 . . . . 72.41 109.071 176.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.89 152.56 63.34 Favored 'Trans proline' 0 CA--C 1.565 2.055 0 C-N-CA 122.318 2.012 . . . . 74.54 112.76 173.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_exo -65.49 146.44 85.06 Favored 'Trans proline' 0 C--N 1.371 1.738 0 C-N-CA 122.453 2.102 . . . . 72.33 112.88 175.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 35.1 mtp180 65.29 23.34 12.13 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 125.009 1.323 . . . . 75.04 112.207 174.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.516 HG21 ' HD2' ' A' ' 231' ' ' ARG . 4.1 m -54.81 139.13 40.75 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.612 1.165 . . . . 72.41 112.397 179.441 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -102.94 158.34 16.35 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.868 0.867 . . . . 74.11 109.816 175.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -73.83 131.26 41.33 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 108.893 -0.781 . . . . 72.13 108.893 172.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 100.2 2.22 55.81 Favored Glycine 0 N--CA 1.464 0.528 0 CA-C-O 119.197 -0.78 . . . . 71.14 112.385 -172.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.516 ' HD2' HG21 ' A' ' 227' ' ' THR . 60.5 mtt-85 -69.18 159.34 33.17 Favored 'General case' 0 C--N 1.359 1.021 0 CA-C-O 121.457 0.646 . . . . 73.03 110.338 172.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 48.9 pttt -130.86 132.93 45.48 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 114.927 -1.033 . . . . 74.31 109.727 -175.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.465 HD21 ' HB1' ' A' ' 173' ' ' ALA . 37.3 mt -121.47 127.3 50.94 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 108.213 -1.032 . . . . 74.32 108.213 178.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . 0.437 ' HB3' HG23 ' A' ' 170' ' ' VAL . 31.4 ttt180 -116.83 102.78 9.68 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 107.797 -1.186 . . . . 73.14 107.797 170.578 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.435 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 16.3 mt -83.52 84.58 7.48 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 114.948 -1.024 . . . . 75.24 109.279 -176.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -71.09 137.1 48.62 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.143 -0.935 . . . . 73.4 110.86 -178.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 67.39 16.56 67.41 Favored Glycine 0 C--N 1.352 1.425 0 O-C-N 123.987 0.804 . . . . 64.03 112.567 -177.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.419 ' HB3' ' CE1' ' A' ' 175' ' ' TYR . 31.3 mmtp -139.96 23.37 2.42 Favored 'General case' 0 C--O 1.217 -0.64 0 C-N-CA 124.54 1.136 . . . . 75.42 109.861 -175.297 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -89.37 -127.25 3.08 Favored Glycine 0 N--CA 1.468 0.829 0 O-C-N 121.869 -0.519 . . . . 54.0 111.899 171.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.52 147.06 62.65 Favored Pre-proline 0 N--CA 1.476 0.863 0 CA-C-O 118.326 -0.845 . . . . 72.03 110.434 176.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.421 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 86.2 Cg_exo -46.08 140.72 10.25 Favored 'Trans proline' 0 C--N 1.392 2.856 0 C-N-CA 123.837 3.025 . . . . 72.11 114.409 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -157.26 129.37 2.36 Favored Glycine 0 CA--C 1.536 1.353 0 CA-C-O 118.5 -1.167 . . . . 70.24 111.459 -179.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -62.47 -45.45 14.6 Favored 'Trans proline' 0 C--N 1.378 2.089 0 C-N-CA 123.137 2.558 . . . . 75.44 113.869 -178.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -78.21 -28.19 47.96 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-O 121.146 0.498 . . . . 72.3 110.461 177.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 169.52 145.92 4.85 Favored Glycine 0 C--N 1.334 0.471 0 CA-C-N 115.13 -0.941 . . . . 75.02 110.854 176.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.421 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 23.9 mtt180 -69.46 156.08 39.44 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.3 0.64 . . . . 75.34 110.665 177.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -73.13 -155.96 3.39 Favored Glycine 0 C--N 1.348 1.196 0 CA-C-N 116.076 -0.511 . . . . 65.11 113.218 178.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . 0.433 ' O ' ' HA ' ' A' ' 192' ' ' ASP . 21.6 m-20 -106.99 148.63 28.45 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.551 0.74 . . . . 70.34 110.479 179.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.435 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 50.0 tp -125.23 105.12 8.89 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 107.663 -1.236 . . . . 74.14 107.663 169.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -96.96 109.09 21.91 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 123.637 0.775 . . . . 74.43 109.527 -174.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.518 ' HB3' ' HB2' ' A' ' 197' ' ' LEU . 71.8 mt -112.84 116.36 29.93 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.119 0.968 . . . . 73.32 109.918 -178.272 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -86.64 113.64 22.68 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.644 0.778 . . . . 73.34 110.192 177.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 97.0 t -65.68 125.0 21.84 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.218 0 C-N-CA 123.801 0.84 . . . . 75.11 112.314 -177.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 26.3 mmm180 -118.34 108.38 15.01 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.428 1.491 . . . . 74.25 107.905 170.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.497 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 34.6 mt -76.78 119.16 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 109.696 -0.483 . . . . 71.23 109.696 177.352 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 256' ' ' THR . . . . . 0.417 ' HG1' ' HA ' ' A' ' 200' ' ' PRO . 36.0 p . . . . . 0 CA--C 1.551 0.999 0 C-N-CA 124.437 1.095 . . . . 75.01 108.903 178.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 25.9 t70 . . . . . 0 N--CA 1.48 1.032 0 CA-C-O 121.772 0.796 . . . . 72.51 109.453 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.434 HG22 ' N ' ' A' ' 234' ' ' ARG . 27.1 m -107.28 -176.98 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-N 114.206 -1.361 . . . . 64.22 109.458 179.12 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 13.2 tt -84.83 139.77 17.0 Favored 'Isoleucine or valine' 0 C--O 1.246 0.891 0 N-CA-C 108.036 -1.098 . . . . 75.43 108.036 164.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -70.59 135.13 48.23 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 122.831 0.452 . . . . 75.23 110.065 177.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.441 ' HB3' HD22 ' A' ' 233' ' ' LEU . . . -138.98 175.37 9.61 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.062 0.945 . . . . 74.52 109.207 177.073 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -150.98 158.98 44.82 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 122.79 0.436 . . . . 73.04 110.337 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.48 ' CE1' ' HB3' ' A' ' 238' ' ' LYS . 9.8 p90 -140.63 176.12 9.05 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.346 0.593 . . . . 73.21 110.548 170.012 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -145.48 149.26 40.09 Favored Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 124.586 1.154 . . . . 72.25 108.614 170.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . 0.531 ' HA ' HG11 ' A' ' 219' ' ' VAL . 27.5 Cg_endo -58.24 123.79 14.42 Favored 'Trans proline' 0 C--N 1.373 1.85 0 C-N-CA 123.009 2.473 . . . . 73.21 111.99 -179.32 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . 0.532 ' HB3' ' HG3' ' A' ' 220' ' ' GLU . . . . . . . . 0 N--CA 1.476 0.846 0 N-CA-C 108.177 -1.046 . . . . 70.12 108.177 172.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.416 ' HA ' ' HB2' ' A' ' 240' ' ' PHE . 53.5 mt-30 . . . . . 0 N--CA 1.474 0.731 0 CA-C-O 120.989 0.423 . . . . 74.21 111.08 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 20.1 p-10 -85.18 126.5 33.7 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.311 0.644 . . . . 74.23 109.773 171.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 34.5 mt -108.9 145.07 35.97 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.191 1.396 . . . . 74.4 108.875 177.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -123.73 121.75 36.3 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 107.797 -1.186 . . . . 73.4 107.797 175.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.425 ' O ' ' HA ' ' A' ' 251' ' ' LEU . . . -149.51 165.59 31.71 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.065 0.946 . . . . 75.14 109.527 -171.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 10.5 m -108.77 140.72 41.81 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 109.969 -0.382 . . . . 74.3 109.969 -177.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.459 HD11 HG21 ' A' ' 210' ' ' VAL . 43.1 tp -108.79 121.52 45.24 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.748 0.819 . . . . 72.13 110.036 -176.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -93.11 103.02 15.35 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 109.161 -0.681 . . . . 62.43 109.161 172.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.505 HG22 HG11 ' A' ' 223' ' ' VAL . 2.7 p -106.57 119.52 51.4 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 123.676 0.791 . . . . 74.3 109.53 173.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -55.47 140.88 83.15 Favored 'Trans proline' 0 C--N 1.375 1.922 0 C-N-CA 122.331 2.021 . . . . 73.34 112.486 169.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -51.71 -49.17 84.72 Favored Pre-proline 0 CA--C 1.554 1.113 0 CA-C-O 118.077 -0.963 . . . . 73.55 113.451 -177.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -56.59 -39.83 88.62 Favored 'Trans proline' 0 C--N 1.39 2.724 0 C-N-CA 121.902 1.735 . . . . 73.2 112.877 176.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 28.4 mt -69.15 -34.28 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 123.259 0.624 . . . . 75.44 110.4 -178.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -66.33 -42.72 87.75 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.012 0.525 . . . . 72.0 111.073 178.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 87.1 t -71.96 -49.51 44.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 123.682 0.793 . . . . 70.24 111.282 -176.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 16.2 m -75.01 -22.75 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 CA-C-N 116.668 -0.242 . . . . 70.45 111.496 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 76.4 76.05 0.84 Allowed Glycine 0 C--N 1.346 1.106 0 N-CA-C 112.179 -0.369 . . . . 73.23 112.179 -177.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -110.69 -159.18 16.42 Favored Glycine 0 C--N 1.339 0.706 0 N-CA-C 111.699 -0.561 . . . . 73.32 111.699 -179.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 33.7 mtmm -115.13 145.45 42.34 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 108.88 -0.785 . . . . 74.14 108.88 173.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.486 HG13 ' HA ' ' A' ' 199' ' ' VAL . 19.6 m -128.06 168.17 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 123.95 0.9 . . . . 74.11 109.829 177.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 35.4 mtp-105 -99.38 117.49 33.93 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 121.218 0.532 . . . . 73.44 110.498 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -101.02 128.09 47.22 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 107.633 -1.247 . . . . 62.0 107.633 171.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.25 112.1 23.06 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 109.158 -0.682 . . . . 75.41 109.158 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 69.3 p -110.39 -177.96 3.38 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.62 0.768 . . . . 65.31 109.823 177.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 17.4 mt -67.44 -23.48 65.53 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 122.488 0.315 . . . . 75.13 111.021 178.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -86.31 -19.14 30.3 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.748 0.819 . . . . 71.23 111.895 178.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 127.42 -151.77 18.56 Favored Glycine 0 C--N 1.345 1.043 0 CA-C-O 119.568 -0.573 . . . . 53.11 112.594 176.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.65 135.14 17.56 Favored 'Trans proline' 0 C--N 1.372 1.799 0 C-N-CA 122.7 2.267 . . . . 74.04 111.65 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.531 HG11 ' HA ' ' A' ' 177' ' ' PRO . 33.3 m -135.41 142.07 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 123.306 0.642 . . . . 74.44 109.813 175.349 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.532 ' HG3' ' HB3' ' A' ' 178' ' ' ALA . 43.2 mt-10 -90.49 106.74 18.7 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.028 0.531 . . . . 73.02 110.281 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . 0.414 HG23 ' HB3' ' A' ' 175' ' ' TYR . 59.6 t -94.33 121.65 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 123.79 0.836 . . . . 73.33 109.423 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -71.19 107.95 4.46 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.257 0.623 . . . . 75.24 110.064 177.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.505 HG11 HG22 ' A' ' 199' ' ' VAL . 48.3 t -83.51 124.05 75.96 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 124.658 1.183 . . . . 75.05 108.897 175.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -58.97 152.49 57.97 Favored 'Trans proline' 0 CA--C 1.567 2.169 0 C-N-CA 122.675 2.25 . . . . 75.32 113.11 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -59.61 126.23 20.03 Favored 'Trans proline' 0 C--N 1.375 1.972 0 C-N-CA 122.511 2.141 . . . . 74.15 112.408 173.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 75.3 mtp180 65.52 61.58 0.69 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.97 1.308 . . . . 65.03 111.317 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.404 HG23 ' HD2' ' A' ' 231' ' ' ARG . 27.0 m -85.16 143.86 28.54 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.409 -0.814 . . . . 64.45 109.773 173.208 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -111.07 153.89 25.01 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.66 0.784 . . . . 74.35 110.863 179.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -70.46 135.82 48.98 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.576 0.75 . . . . 74.31 110.261 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.82 1.29 63.55 Favored Glycine 0 C--N 1.341 0.811 0 CA-C-O 119.689 -0.506 . . . . 72.3 113.174 -177.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.404 ' HD2' HG23 ' A' ' 227' ' ' THR . 52.4 mtt-85 -69.84 160.99 30.74 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 117.243 0.521 . . . . 74.14 110.551 171.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 20.9 pttm -126.98 135.06 50.34 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.864 -0.607 . . . . 74.01 110.603 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.441 HD22 ' HB3' ' A' ' 173' ' ' ALA . 74.4 mt -114.08 145.24 41.88 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.951 1.3 . . . . 73.2 108.173 175.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . 0.434 ' N ' HG22 ' A' ' 170' ' ' VAL . 51.7 ttt85 -136.53 102.18 4.86 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 107.952 -1.129 . . . . 74.52 107.952 166.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.415 HD11 ' HD1' ' A' ' 175' ' ' TYR . 14.8 mt -73.78 91.43 1.94 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.752 1.221 . . . . 73.32 109.433 179.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 51.9 mttp -62.29 124.74 21.7 Favored 'General case' 0 C--N 1.354 0.801 0 C-N-CA 123.437 0.695 . . . . 74.42 110.696 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 69.42 34.52 74.3 Favored Glycine 0 C--N 1.345 1.059 0 O-C-N 123.54 0.525 . . . . 72.24 113.061 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.48 ' HB3' ' CE1' ' A' ' 175' ' ' TYR . 32.8 mmtm -143.44 29.84 1.41 Allowed 'General case' 0 CA--C 1.559 1.321 0 C-N-CA 123.76 0.824 . . . . 74.4 112.616 -173.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -99.21 -111.05 3.15 Favored Glycine 0 N--CA 1.482 1.716 0 N-CA-C 111.134 -0.787 . . . . 72.43 111.134 175.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . 0.416 ' HB2' ' HA ' ' A' ' 191' ' ' GLN . 5.8 m-85 -71.19 151.88 94.57 Favored Pre-proline 0 N--CA 1.48 1.049 0 C-N-CA 123.728 0.811 . . . . 73.2 109.813 165.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.452 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 52.3 Cg_exo -57.3 155.68 28.86 Favored 'Trans proline' 0 C--N 1.373 1.838 0 C-N-CA 122.93 2.42 . . . . 73.3 112.418 165.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -162.76 125.03 1.35 Allowed Glycine 0 CA--C 1.535 1.296 0 CA-C-O 118.602 -1.11 . . . . 64.14 111.625 178.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -60.65 -49.01 9.58 Favored 'Trans proline' 0 C--N 1.381 2.237 0 C-N-CA 123.391 2.727 . . . . 74.43 112.644 177.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -76.31 -26.34 55.72 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 122.874 0.47 . . . . 75.03 110.692 178.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 165.01 145.17 4.31 Favored Glycine 0 C--N 1.344 1.005 0 CA-C-N 115.617 -0.72 . . . . 75.15 111.343 177.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.452 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 21.1 mtt180 -73.28 163.3 28.29 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.538 0.735 . . . . 73.42 111.127 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -81.55 -169.23 42.08 Favored Glycine 0 C--N 1.348 1.202 0 CA-C-N 115.824 -0.626 . . . . 74.45 111.768 170.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -107.37 152.1 24.62 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 118.003 0.902 . . . . 72.31 110.617 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 55.9 tp -120.92 106.7 11.87 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 108.706 -0.849 . . . . 74.54 108.706 173.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -91.37 123.66 34.97 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 123.806 0.843 . . . . 73.32 108.984 -177.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.425 ' HA ' ' O ' ' A' ' 195' ' ' ALA . 61.7 mt -119.53 122.37 41.48 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.374 0.67 . . . . 74.13 110.396 -176.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -81.07 114.0 19.63 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 108.975 -0.75 . . . . 71.11 108.975 172.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 88.4 t -66.92 109.52 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 122.905 0.482 . . . . 73.11 110.791 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 9.2 mmm180 -113.47 105.68 13.65 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 124.279 1.032 . . . . 75.23 108.848 173.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 28.9 mt -76.96 131.09 35.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-N 115.652 -0.703 . . . . 75.34 109.525 176.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 3.3 t . . . . . 0 CA--C 1.562 1.414 0 CA-C-O 117.849 -1.072 . . . . 71.11 108.763 -178.231 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 21.1 t70 . . . . . 0 N--CA 1.476 0.827 0 CA-C-O 120.976 0.417 . . . . 70.44 111.045 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.462 HG13 ' HB2' ' A' ' 234' ' ' ARG . 26.2 m -93.37 177.19 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 C-N-CA 123.061 0.545 . . . . 65.2 110.637 175.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.408 HG22 ' HD3' ' A' ' 231' ' ' ARG . 13.8 tt -103.17 147.59 9.37 Favored 'Isoleucine or valine' 0 C--O 1.245 0.863 0 N-CA-C 108.418 -0.956 . . . . 72.34 108.418 173.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -64.31 142.83 58.28 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.654 0.782 . . . . 72.33 110.656 -178.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.494 ' HB2' HD22 ' A' ' 233' ' ' LEU . . . -160.0 164.48 33.23 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 123.82 0.848 . . . . 75.23 109.616 -178.264 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -157.25 157.67 34.71 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.703 0.801 . . . . 73.02 109.665 -178.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.451 ' CE1' ' HB3' ' A' ' 238' ' ' LYS . 5.5 p90 -135.97 178.01 7.38 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.232 0.539 . . . . 75.53 111.537 177.124 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . 0.516 ' HE2' ' HA ' ' A' ' 176' ' ' LYS . 7.9 mmpt? -132.7 135.31 25.87 Favored Pre-proline 0 N--CA 1.472 0.632 0 C-N-CA 124.691 1.197 . . . . 73.32 108.924 174.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . 0.511 ' HA ' HG12 ' A' ' 219' ' ' VAL . 48.1 Cg_endo -65.86 94.96 0.28 Allowed 'Trans proline' 0 C--N 1.377 2.05 0 C-N-CA 122.74 2.294 . . . . 72.02 111.127 178.037 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . 0.5 ' H ' ' HA ' ' A' ' 219' ' ' VAL . . . . . . . . 0 N--CA 1.479 1.004 0 C-N-CA 124.371 1.068 . . . . 74.11 111.543 -177.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 . . . . . 0 N--CA 1.48 1.062 0 CA-C-O 121.184 0.516 . . . . 74.23 111.155 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.405 ' HA ' ' O ' ' A' ' 248' ' ' ASP . 6.7 p-10 -91.19 151.28 21.01 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 115.673 -0.694 . . . . 73.23 109.901 175.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 79.7 mt -132.76 130.79 40.39 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.792 0.837 . . . . 71.34 109.084 173.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -96.71 125.48 41.21 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 108.337 -0.986 . . . . 74.55 108.337 174.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.46 ' O ' ' HA ' ' A' ' 251' ' ' LEU . . . -148.63 143.23 26.41 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.408 0.683 . . . . 74.25 109.336 178.026 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' THR . . . . . 0.4 HG21 ' HB2' ' A' ' 252' ' ' GLU . 2.4 p -89.92 132.36 35.35 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 109.079 -0.712 . . . . 71.52 109.079 171.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.549 HD12 ' HB1' ' A' ' 212' ' ' ALA . 62.3 tp -107.3 110.96 23.1 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.81 0.844 . . . . 74.44 108.972 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -85.08 128.46 34.66 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-O 120.962 0.411 . . . . 75.21 109.918 175.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.504 ' HA ' HG13 ' A' ' 210' ' ' VAL . 3.1 p -133.29 123.67 17.85 Favored Pre-proline 0 CA--C 1.545 0.773 0 CA-C-N 114.775 -1.102 . . . . 71.4 108.954 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -57.61 143.15 95.51 Favored 'Trans proline' 0 C--N 1.37 1.662 0 C-N-CA 122.585 2.19 . . . . 71.55 111.653 171.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . 0.403 ' O ' HG21 ' A' ' 205' ' ' VAL . . . -50.42 -46.45 84.39 Favored Pre-proline 0 CA--C 1.563 1.443 0 CA-C-O 117.782 -1.104 . . . . 70.15 112.993 -178.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -55.51 -44.62 46.67 Favored 'Trans proline' 0 C--N 1.395 2.977 0 C-N-CA 122.3 2.0 . . . . 74.22 113.088 174.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . 0.473 HG21 HG11 ' A' ' 210' ' ' VAL . 45.4 mt -68.4 -32.03 53.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 C-N-CA 123.467 0.707 . . . . 63.35 110.598 -178.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.42 -44.02 75.91 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.224 0.61 . . . . 75.55 110.957 178.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . 0.403 HG21 ' O ' ' A' ' 201' ' ' ALA . 93.1 t -70.43 -48.19 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 123.532 0.733 . . . . 72.0 111.217 -177.601 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 7.2 p -72.47 -30.37 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 CA-C-O 120.601 0.239 . . . . 74.32 110.998 -179.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 78.76 67.57 1.59 Allowed Glycine 0 C--N 1.352 1.423 0 N-CA-C 111.637 -0.585 . . . . 43.02 111.637 -174.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -98.95 -145.71 19.1 Favored Glycine 0 C--N 1.352 1.444 0 N-CA-C 111.449 -0.66 . . . . 74.31 111.449 -177.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -120.73 146.68 46.22 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.561 0.745 . . . . 72.31 109.078 173.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.504 HG13 ' HA ' ' A' ' 199' ' ' VAL . 7.1 m -139.9 155.36 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 C-N-CA 124.679 1.192 . . . . 74.52 109.211 171.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 14.7 ttp180 -91.22 119.55 31.4 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-O 120.805 0.336 . . . . 74.52 111.126 -170.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . 0.549 ' HB1' HD12 ' A' ' 197' ' ' LEU . . . -100.53 151.78 21.17 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.969 0.907 . . . . 44.33 108.951 172.146 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -107.15 116.46 31.97 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 123.599 0.76 . . . . 73.24 110.222 -178.052 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 24.6 p -109.72 172.24 6.97 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.21 1.004 . . . . 73.05 108.631 172.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 17.5 mt -74.02 -5.9 44.22 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 122.819 0.448 . . . . 73.13 111.958 -176.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -107.16 -9.64 16.09 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.756 1.223 . . . . 75.23 111.349 -177.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 139.65 -165.92 25.72 Favored Glycine 0 C--N 1.352 1.439 0 CA-C-O 120.151 -0.25 . . . . 70.14 113.526 175.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.66 142.65 23.22 Favored 'Trans proline' 0 C--N 1.369 1.627 0 C-N-CA 123.225 2.617 . . . . 75.25 112.466 176.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.511 HG12 ' HA ' ' A' ' 177' ' ' PRO . 24.8 m -137.29 143.58 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 123.849 0.86 . . . . 73.45 109.733 176.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -97.3 114.65 26.45 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 118.27 0.487 . . . . 74.54 109.78 175.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . 0.415 HG23 ' HB3' ' A' ' 175' ' ' TYR . 52.9 t -95.47 126.02 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.277 1.031 . . . . 71.31 109.679 179.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -75.46 106.3 6.94 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 123.315 0.646 . . . . 63.33 109.397 175.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 44.9 t -68.39 132.09 91.53 Favored Pre-proline 0 CA--C 1.552 1.028 0 C-N-CA 124.417 1.087 . . . . 63.52 109.525 175.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -59.78 144.86 99.37 Favored 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 122.455 2.103 . . . . 63.23 111.853 173.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_exo -62.12 129.66 27.93 Favored 'Trans proline' 0 C--N 1.375 1.961 0 C-N-CA 122.667 2.245 . . . . 71.03 111.689 176.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 62.7 mtp180 67.33 79.18 0.23 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.247 1.419 . . . . 74.11 110.086 179.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.517 ' HA ' ' HE ' ' A' ' 231' ' ' ARG . 13.3 m -107.52 141.16 39.39 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 114.231 -1.35 . . . . 74.22 110.684 -177.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -118.11 147.23 43.5 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.356 1.062 . . . . 74.22 108.382 174.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -60.26 125.2 22.78 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.123 0.969 . . . . 72.33 110.571 -178.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 113.38 4.38 23.63 Favored Glycine 0 C--N 1.34 0.805 0 CA-C-O 119.537 -0.591 . . . . 74.43 113.12 -175.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.517 ' HE ' ' HA ' ' A' ' 227' ' ' THR . 72.4 mtt-85 -65.73 148.23 52.09 Favored 'General case' 0 C--N 1.363 1.162 0 N-CA-C 109.249 -0.649 . . . . 74.3 109.249 167.316 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.4 ' O ' ' HB ' ' A' ' 170' ' ' VAL . 18.9 pttm -124.84 117.08 23.32 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.971 -1.122 . . . . 64.4 107.971 176.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.494 HD22 ' HB2' ' A' ' 173' ' ' ALA . 30.6 mt -103.89 97.42 7.42 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 108.066 -1.087 . . . . 74.31 108.066 -179.466 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . 0.462 ' HB2' HG13 ' A' ' 170' ' ' VAL . 40.6 ttt180 -93.54 101.13 13.3 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 108.823 -0.806 . . . . 75.34 108.823 177.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.474 ' HB3' ' HB2' ' A' ' 238' ' ' LYS . 21.8 mt -82.92 83.92 7.61 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.481 -1.236 . . . . 75.14 109.669 -174.133 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 55.4 mttp -62.75 137.63 58.31 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 116.098 -0.501 . . . . 71.01 110.082 177.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 64.59 23.66 68.93 Favored Glycine 0 C--N 1.347 1.151 0 O-C-N 123.679 0.612 . . . . 70.24 113.004 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.474 ' HB2' ' HB3' ' A' ' 235' ' ' LEU . 45.7 mmtm -140.51 16.86 2.37 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.308 1.043 . . . . 70.13 111.247 -176.201 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -93.47 -116.99 2.62 Favored Glycine 0 N--CA 1.467 0.741 0 N-CA-C 111.568 -0.613 . . . . 75.22 111.568 179.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -71.45 130.29 87.73 Favored Pre-proline 0 CA--C 1.546 0.817 0 CA-C-O 118.619 -0.705 . . . . 74.01 109.781 179.191 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.446 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 22.2 Cg_endo -60.41 129.16 28.58 Favored 'Trans proline' 0 C--N 1.373 1.824 0 C-N-CA 123.154 2.569 . . . . 71.5 112.533 175.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -150.81 135.44 5.16 Favored Glycine 0 CA--C 1.532 1.103 0 CA-C-O 118.651 -1.083 . . . . 73.13 110.557 179.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -61.73 -41.67 37.08 Favored 'Trans proline' 0 C--N 1.382 2.331 0 C-N-CA 123.54 2.827 . . . . 74.31 112.746 -176.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -78.01 -26.64 48.61 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.177 0.591 . . . . 73.24 111.258 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 169.24 148.11 5.69 Favored Glycine 0 C--N 1.347 1.172 0 N-CA-C 111.457 -0.657 . . . . 75.23 111.457 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.446 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 36.4 mtt-85 -86.45 161.37 18.66 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 122.769 0.428 . . . . 65.41 110.148 178.079 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -81.84 -155.86 15.99 Favored Glycine 0 C--N 1.34 0.785 0 CA-C-N 115.591 -0.732 . . . . 52.13 112.368 172.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . 0.405 ' O ' ' HA ' ' A' ' 192' ' ' ASP . 6.5 p-10 -118.45 131.53 56.26 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.442 0.697 . . . . 75.23 110.381 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 58.5 tp -98.16 106.89 19.24 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 107.76 -1.2 . . . . 75.11 107.76 173.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -89.3 108.58 19.7 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 115.496 -0.775 . . . . 74.32 109.053 -177.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.504 HD11 HD22 ' A' ' 197' ' ' LEU . 63.6 mt -103.13 139.35 38.76 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.79 0.836 . . . . 65.34 110.096 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . 0.4 ' HB2' HG21 ' A' ' 196' ' ' THR . 46.3 mt-10 -111.44 108.79 18.47 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.63 -0.878 . . . . 74.11 108.63 172.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 72.5 t -66.5 109.37 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 C-N-CA 123.922 0.889 . . . . 74.4 111.33 -178.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 31.5 mmm180 -108.52 102.95 11.99 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.381 1.472 . . . . 74.14 108.312 177.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 30.4 mt -77.14 142.78 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 N-CA-C 109.855 -0.424 . . . . 73.4 109.855 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.9 t . . . . . 0 CA--C 1.558 1.277 0 C-N-CA 124.092 0.957 . . . . 74.12 109.207 176.377 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 25.5 t70 . . . . . 0 N--CA 1.474 0.758 0 CA-C-O 121.069 0.461 . . . . 74.34 110.053 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.44 HG21 ' HB3' ' A' ' 234' ' ' ARG . 15.4 m -97.41 161.7 2.78 Favored 'Isoleucine or valine' 0 C--O 1.247 0.942 0 CA-C-N 114.905 -1.043 . . . . 74.34 109.188 172.149 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 12.6 tt -85.63 151.96 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 N-CA-C 108.92 -0.771 . . . . 71.35 108.92 174.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -56.15 128.81 37.36 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.471 1.109 . . . . 74.33 110.961 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.445 ' HB2' HD22 ' A' ' 233' ' ' LEU . . . -158.66 143.95 16.37 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.258 1.023 . . . . 74.21 109.754 179.111 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -146.56 169.13 19.58 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 108.244 -1.021 . . . . 74.24 108.244 172.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.501 ' CE1' ' HB3' ' A' ' 238' ' ' LYS . 37.5 p90 -129.61 -177.81 4.42 Favored 'General case' 0 C--O 1.243 0.733 0 CA-C-O 121.739 0.781 . . . . 74.43 111.65 -176.166 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 11.9 mmmm -132.61 122.03 17.59 Favored Pre-proline 0 C--O 1.232 0.178 0 CA-C-N 114.368 -1.287 . . . . 75.05 107.536 174.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . 0.407 ' HA ' HG11 ' A' ' 219' ' ' VAL . 57.3 Cg_endo -66.92 93.71 0.33 Allowed 'Trans proline' 0 C--N 1.359 1.105 0 C-N-CA 122.856 2.371 . . . . 73.43 111.63 -177.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . 0.436 ' HB1' ' HG3' ' A' ' 220' ' ' GLU . . . . . . . . 0 CA--C 1.542 0.658 0 N-CA-C 109.45 -0.574 . . . . 72.34 109.45 179.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 25.5 mm-40 . . . . . 0 N--CA 1.478 0.927 0 N-CA-C 110.152 -0.314 . . . . 73.14 110.152 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -95.09 154.21 17.28 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 122.726 0.41 . . . . 61.15 110.74 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 33.3 mt -128.09 156.33 42.99 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.147 0.979 . . . . 70.21 109.863 175.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -130.5 121.91 26.67 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.892 0.877 . . . . 74.23 108.716 173.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -149.6 167.35 26.61 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 124.003 0.921 . . . . 61.12 109.58 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 17.7 m -112.14 137.04 50.77 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.779 -0.646 . . . . 70.0 109.4 -178.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 43.8 tp -108.92 122.13 46.57 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.181 0.992 . . . . 74.51 110.117 -170.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -87.45 104.64 16.65 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.566 0.746 . . . . 72.0 109.613 176.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.527 ' HA ' HG12 ' A' ' 210' ' ' VAL . 59.7 t -109.21 113.74 58.51 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 123.489 0.716 . . . . 74.15 109.436 174.123 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -58.56 141.84 97.72 Favored 'Trans proline' 0 C--N 1.379 2.17 0 C-N-CA 123.039 2.493 . . . . 64.2 111.937 171.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -51.6 -45.51 91.1 Favored Pre-proline 0 CA--C 1.562 1.419 0 N-CA-C 113.931 1.086 . . . . 74.32 113.931 -176.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -55.37 -47.09 27.76 Favored 'Trans proline' 0 C--N 1.391 2.775 0 C-N-CA 121.957 1.771 . . . . 73.22 113.184 173.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 56.6 mt -66.86 -29.82 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 123.641 0.776 . . . . 75.33 110.734 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.8 -46.77 67.82 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.585 0.754 . . . . 73.01 111.486 179.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 85.5 t -66.44 -54.43 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 115.937 -0.574 . . . . 73.51 110.501 -178.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 18.2 m -69.47 -30.44 45.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 N-CA-C 112.072 0.397 . . . . 73.24 112.072 -177.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 74.68 68.3 1.58 Allowed Glycine 0 C--N 1.345 1.038 0 O-C-N 123.431 0.457 . . . . 72.22 112.28 -176.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -97.58 -126.51 5.43 Favored Glycine 0 C--N 1.348 1.222 0 N-CA-C 111.74 -0.544 . . . . 44.44 111.74 -178.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 49.1 mtmt -131.55 158.93 39.64 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.741 0.816 . . . . 75.43 108.982 171.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.527 HG12 ' HA ' ' A' ' 199' ' ' VAL . 6.0 m -136.77 137.29 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 123.545 0.738 . . . . 74.3 109.917 174.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 51.1 ttt-85 -83.58 109.04 17.08 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 108.913 -0.773 . . . . 75.53 108.913 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -101.12 155.26 18.1 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.493 1.117 . . . . 73.41 110.213 -177.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 213' ' ' MET . . . . . 0.425 ' HA ' ' HE2' ' A' ' 213' ' ' MET . 16.1 mmt -105.62 118.45 36.61 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.022 0.929 . . . . 75.14 109.349 178.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 70.7 p -116.65 179.24 4.06 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.803 0.441 . . . . 72.02 109.825 170.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 20.8 mt -62.97 -36.15 82.52 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.752 -0.658 . . . . 74.45 111.091 -177.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -93.69 -20.14 20.44 Favored 'General case' 0 CA--C 1.554 1.1 0 CA-C-N 115.295 -0.866 . . . . 72.41 111.643 -170.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 155.56 177.73 29.09 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 120.881 -0.676 . . . . 43.44 114.183 177.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -64.5 142.11 76.68 Favored 'Trans proline' 0 C--N 1.376 1.975 0 C-N-CA 123.001 2.467 . . . . 73.4 112.513 174.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.407 HG11 ' HA ' ' A' ' 177' ' ' PRO . 34.4 m -139.3 128.49 29.34 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 C-N-CA 123.311 0.644 . . . . 74.41 109.84 179.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.436 ' HG3' ' HB1' ' A' ' 178' ' ' ALA . 36.7 mt-10 -83.42 104.02 13.24 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 109.778 -0.453 . . . . 73.23 109.778 177.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 48.1 t -93.49 118.13 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 109.121 -0.696 . . . . 74.13 109.121 -177.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -71.87 107.21 4.52 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 123.25 0.62 . . . . 73.34 110.16 -179.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 60.5 t -70.97 130.29 88.49 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 124.556 1.142 . . . . 74.52 109.709 -179.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -63.73 140.08 72.4 Favored 'Trans proline' 0 C--N 1.373 1.868 0 C-N-CA 122.387 2.058 . . . . 74.14 112.246 174.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -60.38 133.54 49.82 Favored 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 122.342 2.028 . . . . 70.43 111.758 174.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 82.1 mtt180 68.85 72.5 0.27 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.938 1.295 . . . . 74.21 109.795 -176.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.699 ' HA ' ' HE ' ' A' ' 231' ' ' ARG . 38.9 m -94.22 140.13 30.16 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 114.784 -1.098 . . . . 73.43 110.085 176.01 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -113.29 145.48 40.99 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 124.054 0.942 . . . . 73.42 108.738 174.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . 0.455 ' HB3' ' HB ' ' A' ' 255' ' ' ILE . . . -64.33 117.09 6.73 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.369 0.668 . . . . 73.33 109.587 178.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 108.47 9.74 26.64 Favored Glycine 0 CA--C 1.526 0.746 0 CA-C-O 119.426 -0.652 . . . . 63.42 112.565 -173.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.699 ' HE ' ' HA ' ' A' ' 227' ' ' THR . 57.5 mtt-85 -63.45 150.0 44.72 Favored 'General case' 0 C--N 1.361 1.072 0 N-CA-C 109.348 -0.612 . . . . 75.41 109.348 166.21 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 19.6 pttm -121.91 138.91 54.22 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 123.217 0.607 . . . . 70.43 109.762 174.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.445 HD22 ' HB2' ' A' ' 173' ' ' ALA . 57.4 mt -123.9 137.26 54.66 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.588 1.155 . . . . 75.34 108.221 177.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . 0.44 ' HB3' HG21 ' A' ' 170' ' ' VAL . 52.8 ttm-85 -128.75 102.41 6.55 Favored 'General case' 0 C--O 1.243 0.72 0 N-CA-C 108.734 -0.839 . . . . 73.31 108.734 176.114 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.424 HD11 ' CD1' ' A' ' 175' ' ' TYR . 17.0 mt -83.9 89.52 7.23 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.019 0.927 . . . . 71.44 109.361 -174.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -73.78 131.58 41.71 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.532 -0.758 . . . . 73.44 110.971 -175.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 66.81 24.82 72.98 Favored Glycine 0 C--N 1.35 1.348 0 O-C-N 123.858 0.724 . . . . 74.43 112.972 -178.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.501 ' HB3' ' CE1' ' A' ' 175' ' ' TYR . 32.1 mmtp -140.23 39.49 1.92 Allowed 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.038 0.935 . . . . 72.21 110.581 -172.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -120.85 -120.62 2.77 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-N 116.228 -0.442 . . . . 64.33 112.232 174.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -69.19 147.75 97.45 Favored Pre-proline 0 N--CA 1.49 1.557 0 C-N-CA 123.78 0.832 . . . . 74.34 111.684 178.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.436 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 22.6 Cg_endo -59.97 134.02 54.07 Favored 'Trans proline' 0 C--N 1.387 2.602 0 C-N-CA 123.329 2.686 . . . . 73.05 113.455 -179.545 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -151.04 131.74 3.62 Favored Glycine 0 CA--C 1.54 1.62 0 N-CA-C 110.287 -1.125 . . . . 62.21 110.287 179.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -65.27 -45.99 6.52 Favored 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 123.266 2.644 . . . . 75.23 113.69 -170.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -86.72 11.8 12.22 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 122.855 0.462 . . . . 73.45 111.828 -178.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 133.56 139.87 4.26 Favored Glycine 0 C--N 1.341 0.829 0 N-CA-C 109.766 -1.334 . . . . 62.1 109.766 -174.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.436 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 23.4 mtm180 -78.14 170.73 16.13 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-O 121.025 0.44 . . . . 75.55 111.248 -175.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.52 -156.93 8.45 Favored Glycine 0 C--N 1.344 1.027 0 CA-C-N 115.281 -0.872 . . . . 63.5 112.775 172.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -116.73 160.95 20.0 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.537 0.335 . . . . 73.23 111.148 -170.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 38.8 tp -140.66 106.87 5.23 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 108.258 -1.016 . . . . 74.13 108.258 173.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -94.98 116.31 28.53 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 109.277 -0.638 . . . . 74.21 109.277 -175.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 60.5 mt -116.13 117.99 31.61 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.542 0.737 . . . . 74.34 109.792 -178.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -89.74 112.4 23.67 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.65 0.78 . . . . 73.01 109.598 177.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 0.477 HG12 HG23 ' A' ' 227' ' ' THR . 60.2 t -71.2 118.79 16.44 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 CA-C-O 121.497 0.665 . . . . 62.22 112.059 -176.101 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 29.6 mmm180 -108.16 115.7 30.61 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 125.101 1.36 . . . . 73.33 108.293 170.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.455 ' HB ' ' HB3' ' A' ' 229' ' ' ALA . 30.5 mt -76.18 128.09 37.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 108.437 -0.949 . . . . 74.22 108.437 170.188 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 6.8 t . . . . . 0 CA--C 1.558 1.274 0 CA-C-O 117.427 -1.273 . . . . 73.2 107.927 -176.382 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 36.1 t70 . . . . . 0 N--CA 1.471 0.623 0 N-CA-C 109.743 -0.466 . . . . 74.55 109.743 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 33.3 m -109.67 -175.74 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 C-N-CA 124.586 1.155 . . . . 72.15 110.472 179.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 14.9 tt -91.94 144.7 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 N-CA-C 107.873 -1.158 . . . . 74.44 107.873 165.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -63.36 140.27 58.86 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.463 0.705 . . . . 70.44 112.745 -172.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -153.29 153.55 32.86 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.876 1.27 . . . . 75.31 108.494 171.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -147.42 156.5 42.93 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 108.244 -1.021 . . . . 62.23 108.244 172.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.433 ' CZ ' ' HB3' ' A' ' 238' ' ' LYS . 12.4 p90 -136.7 168.28 19.82 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.585 0.587 . . . . 74.03 112.585 179.078 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -140.25 150.11 60.33 Favored Pre-proline 0 N--CA 1.477 0.901 0 C-N-CA 125.042 1.337 . . . . 74.1 108.158 176.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . 0.535 ' HA ' HG12 ' A' ' 219' ' ' VAL . 38.8 Cg_endo -65.21 109.35 1.32 Allowed 'Trans proline' 0 C--N 1.374 1.885 0 C-N-CA 122.174 1.916 . . . . 72.44 110.909 179.395 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.03 0 C-N-CA 124.302 1.041 . . . . 71.31 111.382 -175.089 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.5 ' HB3' ' HA3' ' A' ' 247' ' ' GLY . 39.7 mt-30 . . . . . 0 N--CA 1.476 0.858 0 CA-C-O 120.527 0.204 . . . . 72.32 111.006 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -80.69 152.05 28.61 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.494 0.717 . . . . 73.41 111.107 177.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 13.5 mt -132.57 143.12 49.49 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.744 1.218 . . . . 75.22 108.707 168.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -111.8 135.39 52.48 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 106.474 -1.676 . . . . 73.25 106.474 166.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -159.73 171.61 19.22 Favored 'General case' 0 C--N 1.327 -0.382 0 O-C-N 123.696 0.622 . . . . 75.41 109.746 179.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 26.5 m -113.31 142.35 45.94 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.453 -0.943 . . . . 71.3 108.453 179.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.44 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . 51.2 tp -109.31 121.66 45.66 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 109.339 -0.615 . . . . 72.53 109.339 179.504 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -82.6 134.26 35.18 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 109.001 -0.74 . . . . 63.41 109.001 167.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.425 ' HA ' HG11 ' A' ' 210' ' ' VAL . 4.2 p -143.03 121.27 7.2 Favored Pre-proline 0 CA--C 1.539 0.553 0 N-CA-C 108.429 -0.952 . . . . 73.35 108.429 175.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . 0.539 ' HA ' ' HG1' ' A' ' 256' ' ' THR . 50.4 Cg_exo -56.22 142.29 87.36 Favored 'Trans proline' 0 C--N 1.366 1.48 0 C-N-CA 122.58 2.186 . . . . 74.13 112.12 175.051 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -49.4 -45.87 77.43 Favored Pre-proline 0 CA--C 1.558 1.259 0 C-N-CA 123.729 0.812 . . . . 74.4 113.065 178.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -53.9 -55.16 3.73 Favored 'Trans proline' 0 C--N 1.397 3.103 0 C-N-CA 122.273 1.982 . . . . 75.42 113.109 171.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 52.3 mt -63.66 -30.45 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 C-N-CA 123.304 0.642 . . . . 75.11 111.779 -177.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.73 -42.41 74.01 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 122.949 0.5 . . . . 73.12 111.443 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 97.2 t -73.66 -54.48 15.16 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 C-N-CA 123.138 0.575 . . . . 73.14 111.107 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 14.8 m -76.74 -22.03 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 N-CA-C 112.03 0.382 . . . . 73.43 112.03 -174.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 86.67 170.59 47.02 Favored Glycine 0 C--N 1.348 1.239 0 N-CA-C 112.047 -0.421 . . . . 64.45 112.047 -174.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 145.96 -129.14 3.29 Favored Glycine 0 C--N 1.333 0.397 0 N-CA-C 111.071 -0.812 . . . . 64.15 111.071 175.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -139.73 158.51 43.98 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.883 0.873 . . . . 75.13 109.709 176.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.425 HG11 ' HA ' ' A' ' 199' ' ' VAL . 18.7 m -138.51 155.43 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 123.722 0.809 . . . . 73.45 109.535 171.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 48.2 mtm180 -82.72 127.85 33.81 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 109.353 -0.61 . . . . 73.33 109.353 173.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -116.36 146.38 42.51 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 124.373 1.069 . . . . 74.55 109.156 179.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 213' ' ' MET . . . . . 0.448 ' HA ' ' HE2' ' A' ' 213' ' ' MET . 5.2 mmt -94.81 110.05 21.96 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 109.321 -0.622 . . . . 74.12 109.321 177.588 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 38.4 p -119.63 174.93 6.11 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 123.838 0.855 . . . . 71.13 109.416 174.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . 0.404 HD11 ' CE1' ' A' ' 240' ' ' PHE . 15.5 mt -78.72 -2.1 37.72 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 116.298 -0.41 . . . . 73.54 111.681 -177.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -100.67 -4.8 27.61 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.868 0.867 . . . . 73.23 110.936 171.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 114.67 -160.53 13.15 Favored Glycine 0 C--N 1.356 1.686 0 C-N-CA 123.611 0.624 . . . . 62.44 112.806 178.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.33 131.8 19.7 Favored 'Trans proline' 0 C--N 1.375 1.924 0 C-N-CA 122.771 2.314 . . . . 63.21 112.503 175.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.535 HG12 ' HA ' ' A' ' 177' ' ' PRO . 31.6 m -134.81 139.84 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 123.586 0.754 . . . . 75.21 110.484 -178.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -87.04 105.69 17.33 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 122.66 0.384 . . . . 75.2 110.139 178.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 76.8 t -92.5 117.66 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 N-CA-C 108.543 -0.91 . . . . 74.43 108.543 179.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -65.6 101.65 0.63 Allowed 'General case' 0 C--O 1.24 0.569 0 O-C-N 124.322 1.014 . . . . 74.54 110.254 178.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 63.0 t -77.84 117.98 69.26 Favored Pre-proline 0 CA--C 1.543 0.682 0 O-C-N 124.613 1.196 . . . . 73.52 108.823 174.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -65.31 151.62 84.68 Favored 'Trans proline' 0 CA--C 1.559 1.769 0 C-N-CA 122.033 1.822 . . . . 74.33 111.602 170.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_exo -63.62 141.53 80.07 Favored 'Trans proline' 0 C--N 1.373 1.867 0 C-N-CA 122.555 2.17 . . . . 74.4 112.357 178.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 51.7 mtm180 62.93 49.07 3.67 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.786 1.234 . . . . 71.51 110.638 176.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.495 HG23 HG12 ' A' ' 253' ' ' VAL . 55.3 m -98.85 109.2 22.0 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 114.271 -1.331 . . . . 65.23 109.244 173.287 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -85.47 161.49 19.37 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.606 -0.725 . . . . 71.21 111.773 -175.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -69.15 124.43 23.79 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.765 0.826 . . . . 74.31 110.084 177.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 111.43 -9.82 28.5 Favored Glycine 0 N--CA 1.471 0.992 0 O-C-N 123.306 0.378 . . . . 74.23 112.411 -175.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 66.0 mtt180 -70.15 162.69 27.84 Favored 'General case' 0 C--N 1.35 0.622 0 CA-C-O 121.532 0.682 . . . . 72.55 111.046 170.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 18.7 pttm -121.58 143.53 49.25 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 114.957 -1.02 . . . . 75.33 110.305 -177.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 93.1 mt -125.35 142.66 51.37 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.748 1.219 . . . . 74.24 108.325 174.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 65.8 ttt180 -133.18 124.27 27.14 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 108.22 -1.03 . . . . 74.4 108.22 -179.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.444 ' HB3' ' HG3' ' A' ' 238' ' ' LYS . 26.6 mt -120.88 84.04 2.17 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.671 0.788 . . . . 72.22 109.455 -166.117 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -79.32 140.01 37.66 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.875 0.87 . . . . 70.1 110.726 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 70.27 26.98 73.45 Favored Glycine 0 C--N 1.347 1.174 0 O-C-N 123.828 0.705 . . . . 45.02 112.336 -176.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.444 ' HG3' ' HB3' ' A' ' 235' ' ' LEU . 8.0 mmpt? -128.75 -48.34 1.25 Allowed 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.982 0.913 . . . . 60.31 111.583 -172.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -55.39 -102.42 0.01 OUTLIER Glycine 0 CA--C 1.549 2.162 0 N-CA-C 116.25 1.26 . . . . 53.54 116.25 -164.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . 0.404 ' CE1' HD11 ' A' ' 215' ' ' LEU . 0.7 OUTLIER -84.17 153.41 62.88 Favored Pre-proline 0 N--CA 1.485 1.292 0 C-N-CA 123.098 0.559 . . . . 72.51 110.181 177.301 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.477 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 18.2 Cg_endo -56.28 154.27 29.81 Favored 'Trans proline' 0 C--N 1.373 1.86 0 C-N-CA 123.813 3.009 . . . . 73.34 114.076 170.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -165.23 143.55 8.56 Favored Glycine 0 CA--C 1.535 1.34 0 CA-C-O 119.017 -0.88 . . . . 62.14 111.974 175.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -63.7 -45.13 11.73 Favored 'Trans proline' 0 C--N 1.382 2.323 0 C-N-CA 123.372 2.715 . . . . 64.2 113.096 179.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -80.38 -26.18 38.73 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 122.747 0.419 . . . . 75.44 110.946 -179.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 166.73 160.02 13.29 Favored Glycine 0 C--N 1.336 0.536 0 N-CA-C 111.029 -0.828 . . . . 61.43 111.029 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.477 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 23.9 mtm180 -78.81 160.67 27.26 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 122.547 0.339 . . . . 72.43 110.682 -179.337 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . 0.5 ' HA3' ' HB3' ' A' ' 191' ' ' GLN . . . -88.02 -155.82 29.6 Favored Glycine 0 C--N 1.344 0.98 0 CA-C-N 115.833 -0.621 . . . . 65.31 113.529 -175.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -102.47 155.59 18.16 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.125 0.57 . . . . 74.34 109.826 -175.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 36.6 tp -136.73 115.75 12.37 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 107.829 -1.175 . . . . 74.54 107.829 168.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -100.04 107.96 20.03 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.009 -0.737 . . . . 71.51 109.009 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.44 ' HB3' ' HB2' ' A' ' 197' ' ' LEU . 43.0 mt -102.33 121.06 41.54 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.61 0.764 . . . . 73.12 110.225 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -91.23 115.52 28.09 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 109.361 -0.607 . . . . 74.12 109.361 174.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 0.495 HG12 HG23 ' A' ' 227' ' ' THR . 85.2 t -62.42 127.94 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.533 1.133 . . . . 55.52 111.751 -176.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -131.39 116.21 17.24 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.717 1.207 . . . . 75.54 107.942 172.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 34.9 mt -77.51 126.61 38.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 O-C-N 123.769 0.668 . . . . 75.23 109.653 176.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 256' ' ' THR . . . . . 0.539 ' HG1' ' HA ' ' A' ' 200' ' ' PRO . 25.7 p . . . . . 0 C--O 1.254 1.313 0 N-CA-C 108.314 -0.995 . . . . 75.44 108.314 173.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 34.7 t70 . . . . . 0 N--CA 1.478 0.927 0 N-CA-C 110.285 -0.265 . . . . 65.33 110.285 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.437 HG11 ' HB2' ' A' ' 234' ' ' ARG . 14.0 m -95.99 176.43 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 123.49 0.716 . . . . 73.11 111.037 -178.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 17.7 tt -96.35 138.32 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 N-CA-C 107.611 -1.255 . . . . 74.24 107.611 162.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -71.87 145.64 48.43 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.761 0.824 . . . . 75.22 111.268 -174.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.401 ' HB2' HD22 ' A' ' 233' ' ' LEU . . . -155.58 178.16 10.56 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.587 1.155 . . . . 73.42 109.74 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -156.32 152.16 27.3 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.751 0.82 . . . . 72.12 109.962 178.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.437 ' CD1' HD13 ' A' ' 235' ' ' LEU . 33.0 p90 -129.04 168.01 16.68 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 121.139 0.495 . . . . 72.42 110.863 175.003 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -145.26 150.45 44.89 Favored Pre-proline 0 CA--C 1.548 0.885 0 CA-C-N 114.635 -1.166 . . . . 75.31 109.078 176.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -57.78 110.59 0.65 Allowed 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 123.604 2.869 . . . . 72.2 112.91 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . 0.429 ' HB2' ' HG3' ' A' ' 220' ' ' GLU . . . . . . . . 0 N--CA 1.482 1.134 0 C-N-CA 123.581 0.753 . . . . 52.23 111.236 -178.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.498 ' HA ' ' HB2' ' A' ' 240' ' ' PHE . 83.5 mm-40 . . . . . 0 N--CA 1.47 0.531 0 N-CA-C 108.434 -0.951 . . . . 73.05 108.434 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -93.63 158.65 15.59 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 115.992 -0.549 . . . . 74.34 110.046 174.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 93.8 mt -136.25 149.97 48.75 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.03 0.932 . . . . 71.41 109.024 176.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -123.68 123.38 40.41 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.746 0.818 . . . . 74.23 108.819 173.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -157.44 170.92 21.35 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.19 0.596 . . . . 75.41 110.653 179.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 19.3 p -96.3 152.44 18.58 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.719 0.808 . . . . 74.11 109.822 174.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.688 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . 34.6 tp -116.77 114.42 23.95 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.392 0.677 . . . . 75.42 109.978 -176.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -74.97 100.74 4.23 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 109.366 -0.605 . . . . 74.41 109.366 176.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.481 ' HA ' HG13 ' A' ' 210' ' ' VAL . 54.8 t -110.6 110.5 57.56 Favored Pre-proline 0 N--CA 1.473 0.677 0 N-CA-C 108.807 -0.812 . . . . 73.13 108.807 177.011 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -53.33 138.35 64.67 Favored 'Trans proline' 0 C--N 1.379 2.133 0 C-N-CA 122.741 2.294 . . . . 74.14 111.626 173.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -46.13 -47.97 43.53 Favored Pre-proline 0 CA--C 1.569 1.679 0 N-CA-C 113.798 1.036 . . . . 72.12 113.798 -178.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -54.3 -46.16 35.59 Favored 'Trans proline' 0 C--N 1.4 3.249 0 C-N-CA 122.627 2.218 . . . . 74.01 112.557 174.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 49.9 mt -68.88 -30.12 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 124.148 0.979 . . . . 73.42 111.063 -176.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.55 -39.85 80.89 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 122.956 0.503 . . . . 64.34 111.197 177.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 88.3 t -70.96 -52.63 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 123.489 0.716 . . . . 74.33 111.089 179.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 18.5 m -80.0 -29.68 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 CA-C-N 116.046 -0.525 . . . . 63.03 112.379 -172.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 83.95 103.8 0.56 Allowed Glycine 0 C--N 1.345 1.079 0 O-C-N 123.554 0.533 . . . . 70.12 112.772 -176.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -158.7 178.43 34.91 Favored Glycine 0 C--N 1.342 0.896 0 N-CA-C 112.175 -0.37 . . . . 64.3 112.175 -178.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.542 ' HB3' ' HB3' ' A' ' 220' ' ' GLU . 34.6 mtmm -82.79 148.51 27.76 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 122.917 0.487 . . . . 75.22 111.364 -178.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.481 HG13 ' HA ' ' A' ' 199' ' ' VAL . 32.8 m -136.6 147.86 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 C-N-CA 123.93 0.892 . . . . 71.5 110.156 176.314 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 11.3 mtm180 -82.02 111.47 18.21 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-O 121.216 0.531 . . . . 75.11 111.521 -178.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -102.0 142.69 32.89 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 125.005 1.322 . . . . 65.23 109.167 171.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 34.2 tpp -100.88 116.3 32.42 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 122.763 0.425 . . . . 75.55 109.854 176.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 81.0 p -110.69 -178.59 3.52 Favored 'General case' 0 C--O 1.247 0.926 0 C-N-CA 124.101 0.96 . . . . 73.31 109.424 177.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 14.9 mt -77.32 -5.53 49.87 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 122.924 0.49 . . . . 75.3 110.609 -177.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -102.31 -19.23 15.09 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.332 1.053 . . . . 75.33 110.65 177.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 133.07 -160.35 23.86 Favored Glycine 0 C--N 1.356 1.69 0 CA-C-O 119.954 -0.359 . . . . 72.33 113.305 176.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -78.09 126.64 7.96 Favored 'Trans proline' 0 C--N 1.376 1.998 0 C-N-CA 123.172 2.581 . . . . 73.31 111.772 -179.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.419 ' HA ' ' H ' ' A' ' 178' ' ' ALA . 28.1 m -132.54 143.49 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 124.123 0.969 . . . . 74.42 109.489 -178.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.542 ' HB3' ' HB3' ' A' ' 209' ' ' LYS . 35.0 mt-10 -101.82 115.77 31.26 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.901 0.481 . . . . 75.3 110.484 176.166 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 24.1 t -95.64 116.46 37.33 Favored 'Isoleucine or valine' 0 C--N 1.346 0.413 0 C-N-CA 124.507 1.123 . . . . 73.15 109.138 -177.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -64.51 100.79 0.39 Allowed 'General case' 0 C--O 1.239 0.544 0 O-C-N 124.156 0.91 . . . . 74.32 110.109 174.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 21.3 t -82.73 127.73 68.96 Favored Pre-proline 0 N--CA 1.47 0.531 0 CA-C-N 114.927 -1.033 . . . . 74.51 108.652 177.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -61.46 156.79 44.65 Favored 'Trans proline' 0 CA--C 1.559 1.766 0 C-N-CA 122.277 1.985 . . . . 75.33 112.418 173.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -70.45 161.53 45.7 Favored 'Trans proline' 0 C--N 1.373 1.865 0 C-N-CA 122.388 2.058 . . . . 71.24 112.136 173.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 72.5 mtm-85 58.25 33.54 23.24 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.38 1.072 . . . . 74.25 111.782 175.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.586 HG21 ' HD2' ' A' ' 231' ' ' ARG . 25.5 m -92.72 126.57 37.87 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.397 1.079 . . . . 75.42 110.154 -178.382 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -93.8 162.18 14.03 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.361 0.664 . . . . 72.2 111.158 -178.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . 0.451 ' HB3' ' HB ' ' A' ' 255' ' ' ILE . . . -71.82 119.22 15.68 Favored 'General case' 0 C--N 1.35 0.613 0 CA-C-N 115.177 -0.919 . . . . 64.12 109.324 174.075 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 114.82 -2.7 23.01 Favored Glycine 0 C--N 1.333 0.366 0 CA-C-O 119.527 -0.596 . . . . 72.51 112.414 -174.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.586 ' HD2' HG21 ' A' ' 227' ' ' THR . 91.3 mtt180 -74.81 161.15 29.85 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-N 117.45 0.625 . . . . 75.24 110.209 170.343 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.465 ' HD2' ' OH ' ' A' ' 250' ' ' TYR . 20.8 pttm -129.06 134.53 48.14 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.875 0.87 . . . . 74.54 109.768 -176.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.401 HD22 ' HB2' ' A' ' 173' ' ' ALA . 73.8 mt -111.5 126.79 55.35 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.065 -1.087 . . . . 74.5 108.065 175.06 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . 0.437 ' HB2' HG11 ' A' ' 170' ' ' VAL . 54.3 ttm-85 -108.37 102.91 11.98 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 107.324 -1.361 . . . . 73.23 107.324 170.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.437 HD13 ' CD1' ' A' ' 175' ' ' TYR . 20.3 mt -79.1 91.06 4.87 Favored 'General case' 0 C--O 1.245 0.835 0 N-CA-C 108.104 -1.073 . . . . 74.21 108.104 179.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.425 ' HA ' ' OD2' ' A' ' 248' ' ' ASP . 90.8 mttt -72.97 122.97 22.57 Favored 'General case' 0 C--O 1.243 0.762 0 CA-C-N 113.711 -1.586 . . . . 75.43 111.771 -170.059 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 64.87 27.4 72.09 Favored Glycine 0 C--N 1.346 1.094 0 O-C-N 123.864 0.727 . . . . 72.51 111.658 -176.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.428 ' HB3' ' CE1' ' A' ' 175' ' ' TYR . 30.5 mmtp -140.65 59.35 1.55 Allowed 'General case' 0 C--O 1.22 -0.481 0 C-N-CA 124.858 1.263 . . . . 71.11 108.083 -175.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -120.39 -131.47 4.11 Favored Glycine 0 N--CA 1.467 0.725 0 N-CA-C 109.914 -1.274 . . . . 73.04 109.914 165.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . 0.498 ' HB2' ' HA ' ' A' ' 191' ' ' GLN . 4.3 m-85 -60.17 146.23 83.77 Favored Pre-proline 0 N--CA 1.484 1.245 0 C-N-CA 123.408 0.683 . . . . 74.02 111.537 173.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.556 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 37.5 Cg_endo -63.13 132.02 34.83 Favored 'Trans proline' 0 C--N 1.381 2.284 0 C-N-CA 123.146 2.564 . . . . 72.22 112.435 179.327 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -141.94 136.11 7.13 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-O 118.329 -1.261 . . . . 74.51 110.523 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -57.2 -53.86 4.3 Favored 'Trans proline' 0 C--N 1.378 2.105 0 C-N-CA 123.493 2.795 . . . . 72.31 113.762 -176.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -81.97 -26.44 33.92 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 122.964 0.505 . . . . 64.51 111.362 -178.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -177.63 140.47 4.77 Favored Glycine 0 C--N 1.341 0.812 0 N-CA-C 111.352 -0.699 . . . . 52.31 111.352 -177.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.556 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 57.4 mtm180 -78.87 169.46 18.19 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.221 0.609 . . . . 74.43 110.536 177.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -78.55 -159.7 14.61 Favored Glycine 0 C--N 1.339 0.718 0 CA-C-N 116.137 -0.483 . . . . 60.24 112.299 175.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . 0.425 ' OD2' ' HA ' ' A' ' 236' ' ' LYS . 27.7 m-20 -125.69 127.5 46.33 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 109.836 -0.431 . . . . 74.05 109.836 178.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 58.3 tp -100.74 109.63 21.67 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 108.159 -1.052 . . . . 72.11 108.159 177.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . 0.465 ' OH ' ' HD2' ' A' ' 232' ' ' LYS . 33.9 t80 -98.07 108.38 21.08 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.497 -0.774 . . . . 74.13 109.082 -174.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.688 ' HB3' ' HB2' ' A' ' 197' ' ' LEU . 69.9 mt -121.3 106.71 11.73 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.85 0.86 . . . . 74.25 110.336 -174.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . 0.411 ' HA ' ' HA ' ' A' ' 232' ' ' LYS . 53.5 mt-10 -80.29 110.99 16.25 Favored 'General case' 0 C--O 1.241 0.605 0 CA-C-N 115.177 -0.92 . . . . 70.22 110.365 178.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 0.405 HG13 HG22 ' A' ' 227' ' ' THR . 95.2 t -57.58 113.58 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 124.048 0.939 . . . . 70.15 111.363 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 28.7 mmm180 -113.22 116.18 29.37 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 107.241 -1.392 . . . . 70.4 107.241 169.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.451 ' HB ' ' HB3' ' A' ' 229' ' ' ALA . 58.1 mt -76.24 123.19 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 122.988 0.515 . . . . 74.32 109.78 -179.434 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.2 t . . . . . 0 CA--C 1.559 1.318 0 N-CA-C 107.802 -1.185 . . . . 75.13 107.802 175.031 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 29.0 t70 . . . . . 0 N--CA 1.475 0.781 0 CA-C-O 120.851 0.358 . . . . 72.42 110.438 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.415 HG23 ' HB3' ' A' ' 234' ' ' ARG . 35.5 m -79.04 155.61 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 109.72 -0.474 . . . . 71.11 109.72 173.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 12.7 tt -81.59 141.51 15.01 Favored 'Isoleucine or valine' 0 C--O 1.243 0.756 0 N-CA-C 108.99 -0.744 . . . . 73.4 108.99 173.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -62.97 133.17 54.21 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.208 1.003 . . . . 72.23 111.524 -172.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.461 ' HB3' HD22 ' A' ' 233' ' ' LEU . . . -147.52 171.33 15.72 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 124.594 1.158 . . . . 73.32 110.038 177.17 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -157.75 151.85 24.43 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.4 1.08 . . . . 75.05 108.374 176.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.402 ' HD1' HD12 ' A' ' 235' ' ' LEU . 6.4 p90 -128.3 167.02 17.51 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 109.898 -0.408 . . . . 72.33 109.898 172.375 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -140.67 136.41 16.43 Favored Pre-proline 0 N--CA 1.471 0.599 0 C-N-CA 123.281 0.632 . . . . 72.23 109.859 169.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . 0.524 ' HA ' HG13 ' A' ' 219' ' ' VAL . 13.7 Cg_endo -55.07 113.16 1.27 Allowed 'Trans proline' 0 C--N 1.378 2.088 0 C-N-CA 123.646 2.897 . . . . 74.21 112.881 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . 0.527 ' HB1' ' HG3' ' A' ' 220' ' ' GLU . . . . . . . . 0 N--CA 1.478 0.97 0 C-N-CA 123.735 0.814 . . . . 73.2 112.007 -175.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.488 ' HA ' ' HB3' ' A' ' 240' ' ' PHE . 77.1 mt-30 . . . . . 0 N--CA 1.479 0.99 0 CA-C-O 121.052 0.453 . . . . 75.14 111.507 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.506 ' HB3' ' HE1' ' A' ' 194' ' ' TYR . 4.1 m-20 -79.77 114.79 18.96 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 114.654 -1.157 . . . . 55.53 109.718 -179.434 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 69.0 mt -112.27 135.97 52.29 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 108.808 -0.812 . . . . 74.41 108.808 172.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . 0.506 ' HE1' ' HB3' ' A' ' 192' ' ' ASP . 46.3 m-85 -129.05 122.99 31.14 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 108.648 -0.871 . . . . 70.42 108.648 -178.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -154.78 162.91 40.93 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 121.57 0.7 . . . . 74.51 110.333 -176.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 19.8 p -97.47 141.16 30.87 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-N 115.436 -0.802 . . . . 74.24 109.188 174.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.58 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . 45.7 tp -108.48 113.15 25.95 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.613 -0.721 . . . . 71.25 110.044 -175.345 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -79.32 99.89 7.32 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 109.22 -0.659 . . . . 64.43 109.22 178.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 43.1 t -106.86 118.43 54.21 Favored Pre-proline 0 N--CA 1.467 0.42 0 CA-C-N 115.334 -0.848 . . . . 74.4 108.721 176.03 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -54.74 143.25 70.96 Favored 'Trans proline' 0 C--N 1.371 1.747 0 C-N-CA 122.415 2.076 . . . . 74.24 111.796 169.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . 0.412 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -53.75 -44.41 97.92 Favored Pre-proline 0 CA--C 1.562 1.413 0 CA-C-O 118.03 -0.986 . . . . 64.13 112.454 179.012 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . 0.412 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 13.7 Cg_endo -55.7 -47.17 26.71 Favored 'Trans proline' 0 C--N 1.403 3.412 0 C-N-CA 122.543 2.162 . . . . 73.54 111.97 172.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 33.2 mt -70.82 -24.73 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 C-N-CA 123.291 0.636 . . . . 73.01 111.238 -176.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -73.48 -41.72 62.78 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.169 0.588 . . . . 75.24 110.513 178.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 98.0 t -69.3 -55.24 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 123.616 0.767 . . . . 73.34 110.985 178.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 8.8 p -73.18 -31.62 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 C-N-CA 122.767 0.427 . . . . 74.34 111.507 -175.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 78.9 95.03 0.28 Allowed Glycine 0 C--N 1.345 1.062 0 N-CA-C 112.131 -0.388 . . . . 52.54 112.131 -175.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -141.21 -177.76 16.76 Favored Glycine 0 N--CA 1.467 0.765 0 N-CA-C 111.544 -0.622 . . . . 71.04 111.544 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.445 ' HD2' ' HB3' ' A' ' 220' ' ' GLU . 46.0 mtmt -84.17 137.09 33.7 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 109.443 -0.577 . . . . 74.31 109.443 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 26.8 m -119.75 157.51 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 123.775 0.83 . . . . 74.31 109.082 170.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 78.4 mtm180 -86.41 119.46 26.7 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 109.667 -0.494 . . . . 74.43 109.667 172.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -101.47 140.01 36.35 Favored 'General case' 0 C--O 1.245 0.848 0 C-N-CA 124.311 1.044 . . . . 73.14 108.273 174.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.66 103.23 15.15 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.435 -0.95 . . . . 72.0 108.435 -178.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 47.5 p -111.73 177.76 4.54 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.997 0.919 . . . . 74.12 109.86 -179.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 11.2 mt -67.67 -27.76 67.12 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 122.973 0.509 . . . . 72.44 110.916 -176.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -82.66 -18.92 39.33 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.994 0.918 . . . . 72.3 111.408 179.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 129.08 -154.28 20.2 Favored Glycine 0 C--N 1.353 1.489 0 CA-C-O 119.501 -0.61 . . . . 61.15 112.746 178.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -73.32 133.86 19.94 Favored 'Trans proline' 0 C--N 1.374 1.887 0 C-N-CA 122.722 2.281 . . . . 75.32 111.78 175.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.524 HG13 ' HA ' ' A' ' 177' ' ' PRO . 26.9 m -133.29 147.61 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 123.581 0.752 . . . . 75.34 110.164 177.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.527 ' HG3' ' HB1' ' A' ' 178' ' ' ALA . 48.3 mt-10 -90.73 106.02 18.22 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.143 0.577 . . . . 61.42 110.028 178.685 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 61.6 t -94.72 113.71 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 N-CA-C 109.096 -0.705 . . . . 63.35 109.096 176.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -68.02 100.04 0.94 Allowed 'General case' 0 C--O 1.242 0.658 0 O-C-N 124.028 0.83 . . . . 73.11 109.229 173.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.402 HG13 HG11 ' A' ' 199' ' ' VAL . 25.5 t -79.7 124.53 83.52 Favored Pre-proline 0 C--O 1.24 0.591 0 C-N-CA 123.884 0.874 . . . . 74.14 109.046 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -55.83 146.49 66.92 Favored 'Trans proline' 0 C--N 1.374 1.9 0 C-N-CA 122.485 2.124 . . . . 72.33 112.574 174.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -67.4 150.68 80.84 Favored 'Trans proline' 0 C--N 1.373 1.862 0 C-N-CA 122.144 1.896 . . . . 71.05 112.62 175.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 61.58 37.74 16.02 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 124.904 1.281 . . . . 75.21 111.705 177.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 45.5 m -96.96 116.01 28.45 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.816 0.846 . . . . 75.25 110.622 -178.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 24.1 mp0 -86.18 165.7 16.33 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.771 0.828 . . . . 63.43 111.287 -178.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -70.49 133.67 47.03 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 114.799 -1.091 . . . . 72.21 109.46 176.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 112.68 -24.95 12.51 Favored Glycine 0 C--N 1.334 0.461 0 N-CA-C 111.441 -0.664 . . . . 53.15 111.441 -176.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 60.6 mtt180 -63.82 160.65 16.93 Favored 'General case' 0 C--N 1.36 1.038 0 C-N-CA 123.504 0.722 . . . . 74.03 111.526 178.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 16.1 pttm -130.21 134.42 47.26 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.202 1.001 . . . . 74.51 110.145 -171.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.461 HD22 ' HB3' ' A' ' 173' ' ' ALA . 58.5 mt -120.0 100.24 7.1 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.648 1.179 . . . . 75.34 108.524 179.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . 0.415 ' HB3' HG23 ' A' ' 170' ' ' VAL . 67.8 ttt180 -93.92 101.1 13.16 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 108.5 -0.926 . . . . 75.55 108.5 177.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.476 HD11 HD11 ' A' ' 251' ' ' LEU . 21.3 mt -79.14 83.35 5.21 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.187 0.995 . . . . 71.51 109.343 -178.448 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -79.3 140.97 37.41 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.529 0.732 . . . . 73.34 110.628 -177.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 65.41 24.82 71.02 Favored Glycine 0 C--N 1.349 1.26 0 O-C-N 124.045 0.841 . . . . 72.14 111.65 -174.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -130.33 -26.01 2.37 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.713 0.805 . . . . 75.2 110.859 -174.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -67.96 -145.53 0.12 Allowed Glycine 0 C--N 1.358 1.751 0 O-C-N 123.653 0.596 . . . . 62.14 113.718 -175.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . 0.488 ' HB3' ' HA ' ' A' ' 191' ' ' GLN . 0.1 OUTLIER -67.06 120.68 73.8 Favored Pre-proline 0 CA--C 1.552 1.055 0 O-C-N 122.369 -0.489 . . . . 74.21 110.912 -173.21 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.58 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 15.7 Cg_exo -70.67 160.19 50.25 Favored 'Trans proline' 0 C--N 1.385 2.499 0 C-N-CA 123.746 2.964 . . . . 70.43 115.499 -173.518 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -159.43 164.26 33.89 Favored Glycine 0 CA--C 1.532 1.095 0 CA-C-N 113.188 -1.824 . . . . 70.52 110.43 175.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -70.51 -23.31 27.53 Favored 'Trans proline' 0 C--N 1.37 1.685 0 C-N-CA 122.945 2.43 . . . . 74.41 113.291 -177.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -89.42 -27.08 20.65 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.227 0.611 . . . . 72.43 110.783 177.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 166.95 -170.12 41.21 Favored Glycine 0 C--N 1.349 1.269 0 N-CA-C 112.183 -0.367 . . . . 61.21 112.183 -178.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.58 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 26.6 mtm180 -117.92 155.36 30.34 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.875 0.87 . . . . 74.21 110.412 -177.382 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . 0.485 ' HA3' ' HB3' ' A' ' 191' ' ' GLN . . . -86.84 -156.13 28.59 Favored Glycine 0 C--N 1.343 0.951 0 CA-C-N 115.706 -0.679 . . . . 75.11 111.952 171.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -122.56 154.26 38.16 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 121.287 0.565 . . . . 62.31 110.894 176.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.42 ' HG ' ' HG ' ' A' ' 251' ' ' LEU . 41.4 tp -116.77 107.28 14.45 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 107.485 -1.302 . . . . 72.34 107.485 170.143 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -90.75 105.75 18.04 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.77 0.828 . . . . 75.42 108.773 -176.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.58 ' HB3' ' HB2' ' A' ' 197' ' ' LEU . 49.5 mt -109.71 106.73 16.49 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.498 1.119 . . . . 55.03 110.654 -177.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -82.81 115.63 21.79 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 109.62 -0.511 . . . . 74.31 109.62 176.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 61.6 t -60.03 104.55 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 124.425 1.09 . . . . 73.55 111.455 -177.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 21.3 mmm180 -101.56 107.13 18.32 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 125.115 1.366 . . . . 72.31 107.997 171.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.469 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 48.3 mt -77.43 132.39 32.8 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 CA-C-O 120.913 0.387 . . . . 74.21 110.512 178.58 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 3.1 t . . . . . 0 C--O 1.251 1.16 0 C-N-CA 124.766 1.226 . . . . 72.35 109.294 177.805 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . 0.49 ' O ' ' HE3' ' A' ' 232' ' ' LYS . 23.1 t70 . . . . . 0 N--CA 1.479 1.007 0 N-CA-C 110.08 -0.341 . . . . 75.44 110.08 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 29.3 m -113.04 157.92 13.57 Favored 'Isoleucine or valine' 0 C--O 1.244 0.797 0 C-N-CA 123.752 0.821 . . . . 71.11 110.491 178.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 15.5 tt -81.15 147.03 6.58 Favored 'Isoleucine or valine' 0 C--O 1.248 0.979 0 N-CA-C 107.398 -1.334 . . . . 73.32 107.398 166.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -57.58 123.82 16.91 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.196 0.598 . . . . 75.31 110.761 -178.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.472 ' HB3' HD23 ' A' ' 233' ' ' LEU . . . -146.64 159.05 43.94 Favored 'General case' 0 C--O 1.244 0.789 0 CA-C-N 115.102 -0.954 . . . . 75.05 109.649 177.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -158.95 163.03 36.87 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.037 -0.983 . . . . 71.52 108.964 179.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.494 ' HD1' HD12 ' A' ' 235' ' ' LEU . 16.8 p90 -135.21 170.89 15.23 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-O 121.402 0.62 . . . . 74.25 111.406 176.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -137.27 141.15 33.06 Favored Pre-proline 0 CA--C 1.542 0.671 0 CA-C-N 113.584 -1.643 . . . . 75.4 107.734 173.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . 0.463 ' HA ' HG12 ' A' ' 219' ' ' VAL . 32.1 Cg_exo -59.13 117.55 4.3 Favored 'Trans proline' 0 CA--C 1.551 1.372 0 C-N-CA 123.196 2.597 . . . . 74.24 111.707 179.502 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . 0.468 ' HB3' ' HG3' ' A' ' 220' ' ' GLU . . . . . . . . 0 N--CA 1.488 1.459 0 CA-C-O 121.85 0.833 . . . . 73.22 109.662 -177.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.42 ' HA ' ' HB2' ' A' ' 240' ' ' PHE . 77.2 mt-30 . . . . . 0 N--CA 1.481 1.082 0 CA-C-O 120.94 0.4 . . . . 74.32 111.036 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -76.06 129.65 37.16 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 115.216 -0.902 . . . . 74.41 108.951 174.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 42.5 mt -116.94 147.1 42.54 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.731 1.212 . . . . 74.3 108.72 173.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -139.81 122.25 16.13 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.086 0.955 . . . . 73.31 108.92 -175.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -163.1 169.03 20.05 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.009 0.524 . . . . 65.42 111.002 -175.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 8.7 p -95.56 149.74 21.1 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.54 0.736 . . . . 71.54 109.782 171.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.551 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . 38.4 tp -112.85 113.69 25.88 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.657 0.783 . . . . 75.14 109.926 -178.312 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -73.79 109.26 7.16 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 123.37 0.668 . . . . 74.13 109.76 174.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.449 ' HA ' HG13 ' A' ' 210' ' ' VAL . 89.5 t -118.83 120.37 31.55 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 108.716 -0.846 . . . . 74.55 108.716 175.61 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_exo -55.96 142.81 84.42 Favored 'Trans proline' 0 C--N 1.368 1.561 0 C-N-CA 123.147 2.565 . . . . 71.31 112.06 169.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -52.04 -46.18 93.15 Favored Pre-proline 0 CA--C 1.556 1.205 0 C-N-CA 124.512 1.125 . . . . 33.23 113.847 -179.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . 0.456 ' O ' HG12 ' A' ' 206' ' ' VAL . 12.7 Cg_endo -55.0 -50.43 13.25 Favored 'Trans proline' 0 C--N 1.394 2.923 0 C-N-CA 122.147 1.898 . . . . 71.25 112.835 173.543 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 36.6 mt -63.55 -30.43 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 123.842 0.857 . . . . 70.04 111.443 -177.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.44 -48.24 61.53 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.212 0.605 . . . . 71.32 111.407 177.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 86.5 t -67.04 -52.57 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 C-N-CA 123.461 0.704 . . . . 74.41 111.605 -175.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.456 HG12 ' O ' ' A' ' 202' ' ' PRO . 12.9 p -82.54 -30.13 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 C-N-CA 122.613 0.365 . . . . 72.4 111.466 -176.339 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 89.13 126.58 2.85 Favored Glycine 0 C--N 1.349 1.297 0 N-CA-C 111.76 -0.536 . . . . 72.23 111.76 -175.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -159.65 -141.97 3.27 Favored Glycine 0 C--N 1.341 0.831 0 CA-C-O 119.997 -0.335 . . . . 73.12 112.425 -177.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm -134.68 134.2 40.86 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 108.555 -0.906 . . . . 75.14 108.555 175.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.449 HG13 ' HA ' ' A' ' 199' ' ' VAL . 35.1 m -119.5 163.07 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 C-N-CA 123.994 0.918 . . . . 54.55 108.823 173.255 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 80.2 mtm180 -98.79 123.65 43.17 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 121.324 0.583 . . . . 74.23 110.459 175.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -100.71 137.28 39.32 Favored 'General case' 0 C--O 1.246 0.899 0 CA-C-N 114.934 -1.03 . . . . 72.25 108.77 179.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 213' ' ' MET . . . . . 0.471 ' HA ' ' HE2' ' A' ' 213' ' ' MET . 18.9 mmt -83.02 108.52 16.39 Favored 'General case' 0 C--O 1.238 0.465 0 O-C-N 124.179 0.925 . . . . 73.32 108.682 176.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 80.4 p -108.98 177.08 4.87 Favored 'General case' 0 C--O 1.244 0.768 0 N-CA-C 108.307 -0.997 . . . . 75.33 108.307 174.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 11.2 mt -66.78 -23.26 66.05 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 116.404 -0.362 . . . . 73.33 110.135 177.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -92.33 -19.61 21.95 Favored 'General case' 0 CA--C 1.558 1.259 0 C-N-CA 124.082 0.953 . . . . 74.45 111.509 -179.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 129.16 -149.56 18.59 Favored Glycine 0 C--N 1.355 1.589 0 CA-C-O 119.561 -0.577 . . . . 72.43 114.1 173.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -76.36 127.73 9.97 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 123.194 2.596 . . . . 74.04 112.066 -178.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.463 HG12 ' HA ' ' A' ' 177' ' ' PRO . 33.8 m -130.4 131.47 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 122.989 0.516 . . . . 72.4 110.524 176.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.468 ' HG3' ' HB3' ' A' ' 178' ' ' ALA . 40.0 mt-10 -77.41 104.2 7.78 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 122.944 0.498 . . . . 64.04 109.963 178.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 59.7 t -92.7 122.4 44.14 Favored 'Isoleucine or valine' 0 C--O 1.245 0.821 0 N-CA-C 108.149 -1.056 . . . . 73.33 108.149 178.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -68.65 99.72 1.04 Allowed 'General case' 0 C--O 1.24 0.605 0 O-C-N 124.215 0.947 . . . . 63.12 109.379 177.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 69.4 t -77.39 120.37 81.24 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-N 115.152 -0.931 . . . . 70.52 108.596 174.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -64.06 156.5 58.49 Favored 'Trans proline' 0 C--N 1.377 2.053 0 C-N-CA 122.72 2.28 . . . . 73.51 112.241 177.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -65.11 143.43 78.19 Favored 'Trans proline' 0 C--N 1.372 1.809 0 C-N-CA 122.349 2.032 . . . . 74.12 111.332 170.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 71.6 mtm180 65.42 66.14 0.54 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.675 1.19 . . . . 74.2 110.339 178.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.594 HG23 ' HD2' ' A' ' 231' ' ' ARG . 97.1 m -107.77 134.31 50.91 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.062 -0.972 . . . . 72.35 110.038 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -108.33 157.7 18.15 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.958 0.903 . . . . 71.44 110.264 176.539 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -72.49 118.81 15.86 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.126 0.97 . . . . 62.3 109.277 173.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 114.54 -6.5 22.68 Favored Glycine 0 CA--C 1.521 0.467 0 CA-C-O 119.295 -0.725 . . . . 61.54 112.014 -171.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.594 ' HD2' HG23 ' A' ' 227' ' ' THR . 49.8 mtt-85 -67.15 157.93 32.49 Favored 'General case' 0 C--N 1.364 1.21 0 CA-C-N 117.941 0.87 . . . . 74.51 110.286 169.343 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.49 ' HE3' ' O ' ' A' ' 169' ' ' ASP . 32.7 pttt -130.23 138.31 50.49 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 123.756 0.822 . . . . 73.43 109.348 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.472 HD23 ' HB3' ' A' ' 173' ' ' ALA . 59.8 mt -127.3 100.52 6.09 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.032 1.333 . . . . 74.45 108.212 -178.103 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 22.6 ttp180 -90.64 102.0 14.74 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.162 -1.051 . . . . 75.34 108.162 176.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.494 HD12 ' HD1' ' A' ' 175' ' ' TYR . 14.5 mt -76.41 83.28 3.14 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 114.188 -1.369 . . . . 73.43 108.271 -179.556 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -66.62 134.96 53.38 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 114.465 -1.243 . . . . 74.21 111.234 -173.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 69.57 10.21 63.17 Favored Glycine 0 CA--C 1.538 1.526 0 O-C-N 123.73 0.644 . . . . 75.05 112.782 -178.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.451 ' HB3' ' CE1' ' A' ' 175' ' ' TYR . 33.4 mmtp -134.03 42.54 2.91 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 125.126 1.371 . . . . 74.12 110.523 -171.072 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -100.97 -102.4 2.55 Favored Glycine 0 N--CA 1.472 1.044 0 N-CA-C 109.714 -1.354 . . . . 74.15 109.714 165.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . 0.42 ' HB2' ' HA ' ' A' ' 191' ' ' GLN . 8.8 m-85 -82.08 126.33 75.02 Favored Pre-proline 0 N--CA 1.475 0.795 0 C-N-CA 123.076 0.55 . . . . 73.43 109.667 167.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.471 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 12.9 Cg_exo -71.79 158.3 53.39 Favored 'Trans proline' 0 C--N 1.37 1.684 0 C-N-CA 122.901 2.401 . . . . 72.44 111.928 175.057 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -178.64 151.93 10.9 Favored Glycine 0 CA--C 1.529 0.916 0 CA-C-O 119.17 -0.794 . . . . 75.13 112.004 -178.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -71.36 -28.82 17.69 Favored 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 123.149 2.566 . . . . 74.3 113.671 179.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -121.42 -26.49 4.98 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.49 0.716 . . . . 74.3 112.215 -178.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -134.38 117.74 1.87 Allowed Glycine 0 C--N 1.345 1.058 0 N-CA-C 111.434 -0.666 . . . . 61.14 111.434 -174.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.471 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 70.5 mtt180 -127.29 126.83 43.33 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 108.666 -0.864 . . . . 75.22 108.666 178.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -80.69 -161.37 25.35 Favored Glycine 0 C--N 1.351 1.401 0 O-C-N 123.354 0.409 . . . . 72.12 112.843 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -130.74 156.64 44.62 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.227 0.611 . . . . 71.53 110.314 175.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.471 ' HG ' ' HG ' ' A' ' 251' ' ' LEU . 36.9 tp -114.33 109.92 19.1 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 108.811 -0.811 . . . . 72.34 108.811 172.112 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -93.01 107.79 19.5 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.915 0.886 . . . . 75.1 108.971 -176.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.551 ' HB3' ' HB2' ' A' ' 197' ' ' LEU . 48.3 mt -113.31 116.95 30.52 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.101 0.96 . . . . 74.12 111.455 -173.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -86.99 108.48 18.86 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 109.166 -0.679 . . . . 73.25 109.166 173.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 53.8 t -60.99 120.15 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 123.512 0.725 . . . . 73.52 110.68 179.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 26.2 mmm180 -117.21 113.53 22.36 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 106.898 -1.519 . . . . 73.24 106.898 173.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 55.5 mt -79.15 127.19 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 123.312 0.645 . . . . 73.14 110.906 -177.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 20.1 p . . . . . 0 C--O 1.25 1.096 0 C-N-CA 124.742 1.217 . . . . 73.32 108.304 177.447 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 64.5 mtt . . . . . 0 N--CA 1.476 0.862 0 N-CA-C 109.709 -0.478 . . . . 73.01 109.709 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -77.25 89.63 3.71 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 108.382 -0.97 . . . . 75.11 108.382 171.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -75.8 -77.68 0.13 Allowed 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 107.984 -1.117 . . . . 72.25 107.984 171.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.458 HG23 ' HB3' ' A' ' 234' ' ' ARG . 17.1 m -85.99 143.02 12.35 Favored 'Isoleucine or valine' 0 C--O 1.245 0.835 0 N-CA-C 108.016 -1.105 . . . . 72.31 108.016 167.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 15.2 tt -73.83 141.26 16.43 Favored 'Isoleucine or valine' 0 C--O 1.246 0.876 0 N-CA-C 108.701 -0.852 . . . . 61.42 108.701 174.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -63.93 118.57 8.61 Favored 'General case' 0 C--N 1.349 0.554 0 O-C-N 123.903 0.752 . . . . 73.13 110.906 -173.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.437 ' HB1' HD23 ' A' ' 233' ' ' LEU . . . -124.02 160.66 27.16 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.267 1.027 . . . . 73.44 109.813 -174.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -149.08 163.75 36.65 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.488 0.715 . . . . 74.35 109.75 -178.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.422 ' CD2' ' HB ' ' A' ' 219' ' ' VAL . 7.9 p90 -150.08 178.76 8.65 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 122.899 0.479 . . . . 74.22 110.773 174.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 41.4 mmtm -141.67 132.33 13.05 Favored Pre-proline 0 N--CA 1.483 1.222 0 C-N-CA 124.73 1.212 . . . . 75.04 109.007 175.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . 0.444 ' HA ' HG11 ' A' ' 219' ' ' VAL . 55.7 Cg_endo -67.54 105.54 1.09 Allowed 'Trans proline' 0 C--N 1.384 2.415 0 C-N-CA 122.946 2.431 . . . . 75.2 111.866 -177.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . 0.488 ' HB2' ' HG3' ' A' ' 220' ' ' GLU . . . -77.59 86.44 3.91 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.46 0.704 . . . . 73.32 109.235 178.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 68.18 13.47 9.08 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.883 1.273 . . . . 74.05 111.683 -174.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -69.12 149.67 49.31 Favored Glycine 0 C--N 1.36 1.888 0 CA-C-O 119.708 -0.496 . . . . 71.42 111.955 177.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 34.8 t -124.19 101.55 7.26 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 117.506 0.653 . . . . 74.13 110.413 -172.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -93.52 -146.2 19.26 Favored Glycine 0 CA--C 1.536 1.358 0 CA-C-N 115.945 -0.571 . . . . 71.41 112.503 176.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 166.66 -179.78 40.34 Favored Glycine 0 C--N 1.344 0.979 0 N-CA-C 110.619 -0.992 . . . . 71.21 110.619 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 32.6 p -78.64 88.13 4.56 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 109.114 -0.699 . . . . 62.34 109.114 173.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -80.42 -122.81 0.49 Allowed Glycine 0 C--N 1.349 1.271 0 CA-C-N 115.619 -0.719 . . . . 45.23 113.172 -177.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 76.5 11.92 84.76 Favored Glycine 0 C--N 1.349 1.305 0 C-N-CA 122.752 0.215 . . . . 43.01 112.883 -177.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 34.1 p -81.76 -4.11 55.52 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.102 0.961 . . . . 74.52 111.57 -178.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 96.95 -118.36 6.03 Favored Glycine 0 C--N 1.349 1.286 0 N-CA-C 111.334 -0.707 . . . . 74.55 111.334 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 70.75 -88.51 0.37 Allowed Glycine 0 C--N 1.345 1.072 0 N-CA-C 110.911 -0.875 . . . . 64.22 110.911 -176.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 66.9 m -156.24 94.74 1.53 Allowed 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.534 1.133 . . . . 73.33 108.365 175.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -57.53 -44.26 84.99 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-O 121.708 0.766 . . . . 64.21 110.314 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.475 ' HA ' ' O ' ' A' ' 248' ' ' ASP . 3.7 p-10 -88.17 145.57 25.85 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 114.653 -1.158 . . . . 62.13 110.153 171.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 67.9 mt -127.11 140.43 52.28 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.682 0.793 . . . . 72.25 108.954 172.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -107.21 120.87 43.31 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 108.919 -0.771 . . . . 75.32 108.919 175.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -143.81 161.62 38.17 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.836 0.854 . . . . 74.35 109.452 -177.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 2.7 m -112.97 141.27 47.0 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 109.072 -0.714 . . . . 74.54 109.072 -178.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.493 HD13 HG22 ' A' ' 210' ' ' VAL . 37.6 tp -113.22 117.93 33.26 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.281 0.632 . . . . 74.25 111.052 -168.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -82.34 101.18 10.41 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.91 -0.774 . . . . 74.32 108.91 168.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.526 ' HA ' HG12 ' A' ' 210' ' ' VAL . 2.6 p -115.31 112.71 43.73 Favored Pre-proline 0 CA--C 1.546 0.79 0 N-CA-C 109.218 -0.66 . . . . 74.33 109.218 173.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -54.08 146.1 50.02 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 123.349 2.699 . . . . 74.23 113.029 175.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -49.38 -49.32 71.69 Favored Pre-proline 0 CA--C 1.561 1.383 0 O-C-N 124.356 1.035 . . . . 64.42 113.489 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -60.19 -42.13 45.47 Favored 'Trans proline' 0 C--N 1.393 2.91 0 C-N-CA 121.919 1.746 . . . . 73.24 112.528 177.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 43.0 mt -70.92 -27.33 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 123.602 0.761 . . . . 72.1 110.932 -177.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.05 -48.13 63.6 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.069 0.548 . . . . 53.32 110.709 175.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 88.6 t -68.12 -46.17 81.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 123.742 0.817 . . . . 73.42 111.591 -176.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 17.0 m -73.65 -33.13 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 CA-C-N 116.691 -0.231 . . . . 73.55 111.109 178.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 74.66 77.17 0.68 Allowed Glycine 0 C--N 1.349 1.268 0 CA-C-N 115.987 -0.551 . . . . 72.14 112.243 -173.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -107.58 -133.64 7.21 Favored Glycine 0 C--N 1.344 1.025 0 N-CA-C 111.566 -0.614 . . . . 75.5 111.566 178.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm -131.49 147.24 52.53 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.858 0.863 . . . . 74.33 109.633 171.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.526 HG12 ' HA ' ' A' ' 199' ' ' VAL . 17.4 m -133.62 143.57 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 124.401 1.08 . . . . 74.34 109.278 174.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . 0.409 ' HA ' ' O ' ' A' ' 219' ' ' VAL . 14.8 ttm180 -85.56 116.31 23.78 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 122.486 0.314 . . . . 75.42 110.882 -175.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -100.68 141.36 33.66 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.454 1.102 . . . . 73.32 110.113 177.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 2.2 mmt -88.23 125.03 34.43 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 123.881 0.873 . . . . 70.14 110.051 176.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 41.3 p -134.42 177.75 7.52 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.791 0.836 . . . . 62.12 110.605 178.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . 0.401 HD11 ' HE1' ' A' ' 240' ' ' PHE . 20.1 mt -69.19 -26.28 64.75 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 122.811 0.445 . . . . 73.44 110.503 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -79.84 -19.38 48.55 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.483 0.713 . . . . 74.11 110.967 178.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 127.47 -157.28 20.82 Favored Glycine 0 C--N 1.352 1.438 0 CA-C-O 119.797 -0.446 . . . . 71.41 112.653 178.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . 0.451 ' HG2' ' O ' ' A' ' 178' ' ' ALA . 58.7 Cg_endo -76.37 134.06 15.22 Favored 'Trans proline' 0 C--N 1.369 1.657 0 C-N-CA 122.744 2.296 . . . . 55.14 111.655 175.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.444 HG11 ' HA ' ' A' ' 177' ' ' PRO . 19.7 m -135.34 145.41 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 123.722 0.809 . . . . 74.34 109.106 -178.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.488 ' HG3' ' HB2' ' A' ' 178' ' ' ALA . 56.0 mt-10 -105.32 110.66 23.1 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 118.942 0.792 . . . . 73.3 109.545 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 45.5 t -97.06 122.43 48.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 124.975 1.31 . . . . 75.2 111.021 -170.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -65.25 105.31 1.08 Allowed 'General case' 0 C--O 1.241 0.641 0 C-N-CA 124.28 1.032 . . . . 74.03 110.94 175.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 51.5 t -76.8 128.14 82.36 Favored Pre-proline 0 CA--C 1.548 0.866 0 CA-C-N 114.741 -1.118 . . . . 72.33 109.008 173.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.48 141.99 96.86 Favored 'Trans proline' 0 CA--C 1.561 1.84 0 C-N-CA 122.504 2.136 . . . . 60.43 112.445 174.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -59.41 126.61 21.25 Favored 'Trans proline' 0 C--N 1.375 1.97 0 C-N-CA 122.696 2.264 . . . . 74.45 112.771 173.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 86.6 mtt-85 70.74 71.47 0.19 Allowed 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 125.638 1.575 . . . . 73.11 110.065 179.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.596 HG23 ' HD2' ' A' ' 231' ' ' ARG . 15.9 m -103.45 136.8 42.52 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 114.264 -1.335 . . . . 65.51 110.622 -177.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 22.3 mp0 -103.91 158.04 16.68 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.209 1.004 . . . . 65.52 109.764 177.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -74.47 144.97 43.97 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 109.424 -0.584 . . . . 72.44 109.424 173.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 89.89 2.0 75.77 Favored Glycine 0 C--N 1.341 0.86 0 CA-C-O 120.112 -0.271 . . . . 75.05 112.687 -175.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.596 ' HD2' HG23 ' A' ' 227' ' ' THR . 83.1 mtt180 -70.13 160.83 31.33 Favored 'General case' 0 C--N 1.356 0.848 0 CA-C-O 121.528 0.68 . . . . 70.53 110.179 170.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 16.1 pttp -130.53 138.42 50.2 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 114.863 -1.062 . . . . 75.11 108.885 175.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.437 HD23 ' HB1' ' A' ' 173' ' ' ALA . 67.0 mt -119.89 141.41 49.61 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.564 1.146 . . . . 74.23 107.925 178.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . 0.458 ' HB3' HG23 ' A' ' 170' ' ' VAL . 33.8 ttt180 -129.53 107.98 9.89 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.452 -0.944 . . . . 74.22 108.452 171.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.411 HD11 ' HD1' ' A' ' 175' ' ' TYR . 19.6 mt -81.08 83.99 6.62 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.833 1.253 . . . . 71.32 109.099 -177.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -69.75 134.43 48.6 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.108 0.963 . . . . 64.33 111.123 -175.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 65.18 21.95 68.59 Favored Glycine 0 C--N 1.35 1.338 0 O-C-N 123.892 0.745 . . . . 70.31 112.826 -176.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.415 ' HD3' HH21 ' A' ' 246' ' ' ARG . 29.5 mmtp -138.32 19.87 2.76 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.028 0.931 . . . . 74.2 110.899 -174.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -92.83 -133.25 6.35 Favored Glycine 0 N--CA 1.466 0.657 0 N-CA-C 111.919 -0.472 . . . . 72.15 111.919 174.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . 0.401 ' HE1' HD11 ' A' ' 215' ' ' LEU . 0.1 OUTLIER -61.35 138.72 94.75 Favored Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 123.888 0.875 . . . . 74.11 110.133 177.746 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_exo -48.12 146.18 9.81 Favored 'Trans proline' 0 C--N 1.377 2.045 0 C-N-CA 123.9 3.066 . . . . 74.23 115.107 177.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -159.79 138.67 5.71 Favored Glycine 0 CA--C 1.534 1.238 0 CA-C-O 118.559 -1.134 . . . . 73.14 110.469 177.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -65.82 -40.21 17.63 Favored 'Trans proline' 0 C--N 1.378 2.12 0 C-N-CA 123.274 2.649 . . . . 61.14 113.551 -171.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -97.55 -18.44 18.97 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.59 0.756 . . . . 73.4 111.454 -177.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 175.67 148.51 6.89 Favored Glycine 0 C--N 1.341 0.847 0 N-CA-C 110.76 -0.936 . . . . 74.22 110.76 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.415 HH21 ' HD3' ' A' ' 238' ' ' LYS . 21.0 mtm180 -90.12 170.53 10.24 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 117.18 0.49 . . . . 75.43 110.425 -176.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -78.27 -153.6 6.73 Favored Glycine 0 C--N 1.343 0.954 0 CA-C-N 115.862 -0.608 . . . . 64.41 112.19 173.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . 0.475 ' O ' ' HA ' ' A' ' 192' ' ' ASP . 4.6 p30 -122.92 155.78 36.03 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 117.617 0.708 . . . . 73.21 110.849 176.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 55.2 tp -121.76 108.41 13.48 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 108.907 -0.775 . . . . 74.41 108.907 174.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 42.7 t80 -90.45 108.69 19.94 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 115.099 -0.955 . . . . 75.0 110.105 -175.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 62.9 mt -105.91 121.93 45.09 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.721 0.808 . . . . 74.32 110.517 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -84.16 110.63 18.66 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 122.935 0.494 . . . . 74.34 109.795 172.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 57.6 t -64.84 119.27 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 123.83 0.852 . . . . 65.45 111.763 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 21.7 mmt180 -119.66 117.78 29.21 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 108.011 -1.107 . . . . 74.41 108.011 171.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 17.5 mt -75.53 117.38 19.84 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 N-CA-C 109.037 -0.727 . . . . 72.44 109.037 175.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 27.2 m . . . . . 0 C--O 1.25 1.115 0 C-N-CA 124.931 1.292 . . . . 74.44 108.848 -175.57 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 59.8 mtt . . . . . 0 N--CA 1.483 1.218 0 N-CA-C 108.847 -0.797 . . . . 72.55 108.847 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -82.1 69.36 8.8 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-O 122.608 1.194 . . . . 75.5 110.633 -174.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -87.59 -51.44 5.89 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 114.855 -1.066 . . . . 75.21 110.256 -175.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.472 HG13 ' HG3' ' A' ' 232' ' ' LYS . 13.9 m -91.71 162.41 2.42 Favored 'Isoleucine or valine' 0 C--O 1.244 0.782 0 CA-C-N 115.043 -0.98 . . . . 75.3 109.377 173.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 16.7 tt -79.38 135.35 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 N-CA-C 107.694 -1.225 . . . . 74.13 107.694 166.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -70.92 142.89 51.08 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.365 0.666 . . . . 74.22 110.737 -172.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.431 ' HB3' HD21 ' A' ' 233' ' ' LEU . . . -149.17 162.14 40.58 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.418 0.687 . . . . 71.04 110.127 -178.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -136.51 156.63 48.32 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 123.795 0.838 . . . . 75.31 110.024 -177.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.431 ' H ' ' HD3' ' A' ' 238' ' ' LYS . 7.3 p90 -150.3 171.92 16.19 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.084 0.553 . . . . 75.52 111.486 167.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . 0.419 ' HE2' ' HD2' ' A' ' 177' ' ' PRO . 12.6 mmmm -137.79 140.41 29.57 Favored Pre-proline 0 C--O 1.241 0.629 0 C-N-CA 124.291 1.036 . . . . 75.34 108.564 173.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . 0.57 ' HA ' HG13 ' A' ' 219' ' ' VAL . 18.2 Cg_endo -61.29 109.05 0.66 Allowed 'Trans proline' 0 C--N 1.368 1.553 0 C-N-CA 122.486 2.124 . . . . 73.44 111.104 172.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . 0.509 ' HB3' ' HG3' ' A' ' 220' ' ' GLU . . . -74.51 -12.52 60.5 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.711 0.804 . . . . 72.32 110.691 177.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -67.35 138.93 57.14 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.221 1.008 . . . . 74.31 111.779 178.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -71.21 -20.64 78.21 Favored Glycine 0 C--N 1.353 1.5 0 CA-C-O 119.465 -0.631 . . . . 73.12 114.307 -173.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 13.1 m -70.54 -14.48 62.53 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 117.365 0.583 . . . . 72.11 110.741 175.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 82.55 7.18 87.84 Favored Glycine 0 C--N 1.353 1.493 0 C-N-CA 123.558 0.599 . . . . 75.03 114.131 173.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 65.49 64.46 3.45 Favored Glycine 0 C--N 1.344 0.994 0 N-CA-C 112.014 -0.434 . . . . 64.03 112.014 -174.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 31.7 m -84.74 107.93 17.18 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 123.359 0.663 . . . . 73.02 109.591 175.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -92.75 -155.71 32.18 Favored Glycine 0 C--N 1.347 1.146 0 CA-C-N 116.537 -0.301 . . . . 43.32 113.029 179.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 136.07 -51.19 0.82 Allowed Glycine 0 C--N 1.338 0.681 0 N-CA-C 110.784 -0.926 . . . . 63.42 110.784 -177.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 57.9 p -102.67 130.62 49.64 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.628 0.771 . . . . 72.14 109.921 177.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 123.47 98.02 1.32 Allowed Glycine 0 C--N 1.346 1.128 0 N-CA-C 111.713 -0.555 . . . . 74.21 111.713 178.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -71.17 -24.18 77.3 Favored Glycine 0 C--N 1.349 1.267 0 C-N-CA 122.639 0.161 . . . . 55.35 113.265 177.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 35.5 m -75.78 87.19 2.8 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.373 0.669 . . . . 53.41 110.302 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.409 ' HA ' ' HB2' ' A' ' 240' ' ' PHE . 91.5 mm-40 -76.43 -33.52 58.79 Favored 'General case' 0 C--O 1.248 1.013 0 CA-C-N 114.752 -1.113 . . . . 74.13 110.848 -178.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -82.74 120.87 26.15 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.113 -0.949 . . . . 73.31 110.012 175.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 81.3 mt -110.49 147.8 33.38 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.916 0.886 . . . . 74.33 108.697 171.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -130.08 122.77 28.97 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.543 0.737 . . . . 74.02 109.664 -177.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.404 ' O ' ' HA ' ' A' ' 251' ' ' LEU . . . -160.68 169.9 21.9 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.584 0.754 . . . . 74.05 110.27 -178.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' THR . . . . . 0.538 HG22 ' HB2' ' A' ' 252' ' ' GLU . 8.9 p -101.83 145.84 28.63 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.365 0.666 . . . . 75.12 109.783 174.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.566 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . 51.8 tp -113.75 113.72 25.35 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.276 1.031 . . . . 72.44 110.09 -174.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -75.51 101.81 5.0 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 109.557 -0.534 . . . . 71.31 109.557 173.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.517 ' HA ' HG12 ' A' ' 210' ' ' VAL . 44.7 t -104.92 118.84 55.19 Favored Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 108.404 -0.961 . . . . 75.33 108.404 174.131 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -55.23 140.28 81.29 Favored 'Trans proline' 0 C--N 1.372 1.799 0 C-N-CA 122.727 2.285 . . . . 65.25 111.514 169.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -51.75 -47.87 89.05 Favored Pre-proline 0 CA--C 1.559 1.308 0 N-CA-C 114.432 1.271 . . . . 74.22 114.432 -175.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.421 ' O ' HG13 ' A' ' 206' ' ' VAL . 16.3 Cg_endo -55.93 -45.43 38.73 Favored 'Trans proline' 0 C--N 1.385 2.469 0 C-N-CA 122.218 1.945 . . . . 72.22 112.743 174.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 47.5 mt -65.83 -31.07 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 123.714 0.806 . . . . 64.03 110.902 -178.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . 0.408 ' HB1' ' O ' ' A' ' 227' ' ' THR . . . -70.91 -40.21 72.28 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.29 0.636 . . . . 73.43 111.415 177.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 64.8 t -72.47 -54.98 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 123.858 0.863 . . . . 73.31 111.512 -177.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.421 HG13 ' O ' ' A' ' 202' ' ' PRO . 8.3 p -86.97 -16.73 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 C-N-CA 122.492 0.317 . . . . 74.51 111.831 -174.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 83.02 162.18 32.03 Favored Glycine 0 C--N 1.349 1.251 0 N-CA-C 111.234 -0.746 . . . . 74.11 111.234 -173.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 161.47 -134.12 3.42 Favored Glycine 0 N--CA 1.464 0.533 0 CA-C-N 117.429 0.615 . . . . 73.45 112.326 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.453 ' HD3' ' HB3' ' A' ' 220' ' ' GLU . 92.8 mttt -134.69 144.83 48.01 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.875 0.87 . . . . 72.43 109.963 175.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.517 HG12 ' HA ' ' A' ' 199' ' ' VAL . 22.3 m -129.29 144.61 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 N-CA-C 108.451 -0.944 . . . . 74.02 108.451 168.188 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 36.3 ttp180 -86.63 110.91 20.16 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 109.612 -0.514 . . . . 75.24 109.612 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -101.89 151.71 21.77 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.176 0.591 . . . . 65.22 110.203 179.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -98.29 117.94 33.82 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 123.078 0.551 . . . . 75.33 109.724 178.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 43.6 p -111.84 179.02 4.13 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.387 0.675 . . . . 73.12 109.417 171.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . 0.401 HD13 ' HE1' ' A' ' 240' ' ' PHE . 20.7 mt -81.81 -7.49 59.61 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.075 0.55 . . . . 73.42 112.102 -173.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -98.9 -19.83 17.14 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.335 1.054 . . . . 75.03 110.859 178.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 144.36 -165.69 27.4 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-N 115.911 -0.586 . . . . 64.42 111.842 -177.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -74.78 147.45 34.99 Favored 'Trans proline' 0 C--N 1.367 1.501 0 C-N-CA 122.935 2.423 . . . . 74.51 112.224 176.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.57 HG13 ' HA ' ' A' ' 177' ' ' PRO . 14.1 m -135.56 157.15 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 123.762 0.825 . . . . 75.22 109.524 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.509 ' HG3' ' HB3' ' A' ' 178' ' ' ALA . 51.9 mt-10 -108.06 106.19 16.3 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 109.349 -0.612 . . . . 71.35 109.349 176.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 56.1 t -92.96 112.21 25.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 109.19 -0.67 . . . . 71.23 109.19 -177.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -65.06 101.09 0.48 Allowed 'General case' 0 CA--C 1.539 0.545 0 O-C-N 123.999 0.812 . . . . 72.34 109.436 173.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 64.7 t -73.46 127.39 88.93 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-N 115.018 -0.992 . . . . 75.12 109.231 174.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.94 157.57 57.73 Favored 'Trans proline' 0 CA--C 1.559 1.75 0 C-N-CA 121.491 1.461 . . . . 73.44 110.824 171.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -70.05 164.28 35.42 Favored 'Trans proline' 0 C--N 1.366 1.455 0 C-N-CA 122.064 1.843 . . . . 72.12 111.942 176.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 75.7 mtm180 59.32 25.8 14.53 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 124.834 1.254 . . . . 73.12 112.146 174.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.482 HG22 ' HD2' ' A' ' 231' ' ' ARG . 96.7 m -90.85 99.6 12.61 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.943 0.897 . . . . 75.44 110.064 -176.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 19.7 mp0 -84.76 166.78 16.69 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 121.318 0.58 . . . . 72.22 111.542 -176.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . 0.525 ' HB3' ' HB ' ' A' ' 255' ' ' ILE . . . -66.98 124.2 22.36 Favored 'General case' 0 C--N 1.346 0.455 0 CA-C-N 114.549 -1.205 . . . . 62.3 109.699 177.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 114.05 -12.46 22.16 Favored Glycine 0 C--N 1.335 0.518 0 CA-C-O 119.401 -0.666 . . . . 74.32 112.645 -174.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.482 ' HD2' HG22 ' A' ' 227' ' ' THR . 42.6 mtt180 -71.62 162.88 28.75 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.738 0.78 . . . . 72.05 111.459 172.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.472 ' HG3' HG13 ' A' ' 170' ' ' VAL . 20.4 pttm -129.04 136.23 50.0 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.84 1.256 . . . . 74.31 109.294 -178.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.431 HD21 ' HB3' ' A' ' 173' ' ' ALA . 96.1 mt -116.83 113.95 23.24 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.011 0.924 . . . . 62.53 108.749 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . 0.405 ' HB3' HG22 ' A' ' 170' ' ' VAL . 19.9 ttt180 -96.45 101.02 12.58 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 107.381 -1.34 . . . . 74.04 107.381 170.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.421 HD11 ' CD1' ' A' ' 175' ' ' TYR . 22.2 mt -78.86 84.26 4.92 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 114.714 -1.13 . . . . 73.02 107.992 178.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.517 ' HZ3' ' HB2' ' A' ' 236' ' ' LYS . 10.2 mtmp? -72.38 123.81 23.84 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 113.752 -1.567 . . . . 64.23 111.093 -172.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 67.28 32.05 78.77 Favored Glycine 0 C--N 1.346 1.133 0 O-C-N 123.733 0.646 . . . . 73.12 112.391 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.461 ' HE2' ' HA ' ' A' ' 238' ' ' LYS . 10.3 mmpt? -125.3 -31.58 3.03 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.313 1.045 . . . . 73.04 112.248 -174.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -59.22 -112.09 0.01 OUTLIER Glycine 0 C--N 1.357 1.704 0 N-CA-C 116.092 1.197 . . . . 62.11 116.092 -168.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . 0.409 ' HB2' ' HA ' ' A' ' 191' ' ' GLN . 0.2 OUTLIER -71.54 136.16 83.62 Favored Pre-proline 0 N--CA 1.485 1.278 0 CA-C-N 117.393 0.596 . . . . 75.34 110.334 -178.805 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.567 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 13.7 Cg_exo -67.48 127.07 15.83 Favored 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.409 2.073 . . . . 73.32 111.981 -179.079 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -137.23 145.05 16.75 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-O 118.963 -0.91 . . . . 72.11 111.447 -179.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.6 -32.65 30.51 Favored 'Trans proline' 0 C--N 1.374 1.89 0 C-N-CA 123.215 2.61 . . . . 71.23 113.627 -174.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -91.96 -18.94 22.98 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.143 0.577 . . . . 74.41 110.935 178.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 163.26 151.87 6.6 Favored Glycine 0 C--N 1.343 0.948 0 N-CA-C 111.521 -0.631 . . . . 54.11 111.521 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.567 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 37.2 mtt-85 -78.52 164.05 25.04 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.371 0.669 . . . . 74.43 111.195 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -83.17 -154.72 17.39 Favored Glycine 0 C--N 1.342 0.879 0 CA-C-N 115.249 -0.887 . . . . 74.44 113.078 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -119.25 127.02 52.86 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 117.122 0.461 . . . . 71.45 110.011 177.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.518 ' HG ' ' HG ' ' A' ' 251' ' ' LEU . 60.6 tp -100.22 108.01 20.0 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 107.547 -1.279 . . . . 74.23 107.547 170.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . 0.426 ' OH ' ' HD2' ' A' ' 232' ' ' LYS . 23.0 t80 -97.14 108.18 20.85 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.754 -0.832 . . . . 74.43 108.754 -175.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.566 ' HB3' ' HB2' ' A' ' 197' ' ' LEU . 55.3 mt -115.7 120.42 39.29 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.931 0.892 . . . . 74.21 110.894 -173.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . 0.538 ' HB2' HG22 ' A' ' 196' ' ' THR . 3.6 mp0 -84.76 115.13 22.54 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.15 0.58 . . . . 74.44 109.93 175.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.473 HG11 HG23 ' A' ' 227' ' ' THR . 61.5 t -65.84 109.05 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 C-N-CA 123.497 0.719 . . . . 74.41 111.744 -176.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -104.77 107.99 19.24 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.891 1.277 . . . . 74.44 108.322 171.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.525 ' HB ' ' HB3' ' A' ' 229' ' ' ALA . 16.2 mt -75.69 132.77 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 122.907 0.483 . . . . 75.25 109.782 177.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 20.7 p . . . . . 0 CA--C 1.557 1.226 0 C-N-CA 124.435 1.094 . . . . 72.51 108.924 -177.885 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' MET . . . . . 0.452 ' SD ' ' N ' ' A' ' 167' ' ' MET . 1.3 mpt? . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.152 0.025 . . . . 74.12 111.042 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -78.39 91.59 4.49 Favored 'General case' 0 C--N 1.355 0.833 0 N-CA-C 108.546 -0.909 . . . . 55.2 108.546 174.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -64.15 -60.04 3.7 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 115.792 -0.64 . . . . 62.12 110.873 -179.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.439 HG11 ' HG3' ' A' ' 232' ' ' LYS . 31.9 m -108.97 168.64 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 123.37 0.668 . . . . 73.44 110.688 177.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 10.4 tt -89.3 150.32 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.976 0 N-CA-C 108.489 -0.93 . . . . 73.31 108.489 167.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -58.07 142.36 47.16 Favored 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 124.75 1.22 . . . . 72.01 111.888 178.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -164.76 149.43 9.43 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.317 1.447 . . . . 74.23 108.394 176.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -146.43 154.85 42.08 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 123.346 0.658 . . . . 73.34 109.825 175.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.416 ' CD1' HD11 ' A' ' 235' ' ' LEU . 44.4 p90 -118.17 177.34 4.83 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.249 0.62 . . . . 74.42 111.052 -177.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -145.32 145.79 27.8 Favored Pre-proline 0 N--CA 1.472 0.667 0 CA-C-N 114.325 -1.307 . . . . 73.13 108.569 168.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . 0.515 ' HA ' HG13 ' A' ' 219' ' ' VAL . 20.9 Cg_endo -59.26 127.53 24.31 Favored 'Trans proline' 0 C--N 1.376 2.023 0 C-N-CA 122.747 2.298 . . . . 75.1 111.545 174.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.33 -32.7 72.58 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.133 0.973 . . . . 74.44 111.489 -178.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -131.5 -161.93 1.18 Allowed 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.501 1.12 . . . . 75.32 108.257 176.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -76.36 67.38 2.51 Favored Glycine 0 C--N 1.348 1.243 0 N-CA-C 110.757 -0.937 . . . . 61.21 110.757 168.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 16.8 m -71.7 95.53 1.48 Allowed 'General case' 0 C--N 1.351 0.662 0 C-N-CA 123.979 0.912 . . . . 72.31 110.496 -172.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -124.67 33.19 3.83 Favored Glycine 0 C--N 1.339 0.743 0 CA-C-N 115.392 -0.822 . . . . 62.43 111.387 177.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -66.32 133.03 33.2 Favored Glycine 0 C--N 1.352 1.457 0 N-CA-C 111.044 -0.823 . . . . 72.33 111.044 175.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 70.1 p -62.1 121.6 13.46 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.668 0.787 . . . . 71.13 110.527 -177.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -61.68 121.67 26.64 Favored Glycine 0 C--N 1.354 1.532 0 O-C-N 123.896 0.748 . . . . 41.34 112.319 178.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -64.58 162.48 37.58 Favored Glycine 0 C--N 1.351 1.383 0 C-N-CA 123.123 0.392 . . . . 64.31 113.552 -177.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 50.8 m -63.66 123.48 18.97 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.103 0.961 . . . . 73.33 111.966 -175.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -169.41 127.85 1.57 Allowed Glycine 0 C--N 1.338 0.692 0 N-CA-C 111.246 -0.742 . . . . 72.42 111.246 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -84.62 50.66 4.44 Favored Glycine 0 C--N 1.35 1.36 0 N-CA-C 111.667 -0.573 . . . . 73.22 111.667 176.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 38.3 t -158.34 131.14 7.21 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 124.429 1.092 . . . . 63.04 108.089 179.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -81.3 -21.08 39.56 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 123.571 0.748 . . . . 74.53 110.387 173.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -91.16 127.5 36.61 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.81 0.844 . . . . 65.22 109.599 -176.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 76.8 mt -109.6 146.9 33.95 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.279 1.032 . . . . 65.04 108.978 177.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -128.02 123.29 34.32 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 108.22 -1.03 . . . . 74.33 108.22 177.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -152.28 162.0 41.78 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.768 0.827 . . . . 73.22 110.329 -178.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' THR . . . . . 0.475 HG23 ' HE ' ' A' ' 254' ' ' ARG . 13.0 p -85.35 149.61 25.33 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.896 0.878 . . . . 71.44 110.691 174.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.552 HD11 HD12 ' A' ' 251' ' ' LEU . 43.7 tp -115.29 114.47 25.22 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.928 0.891 . . . . 73.22 109.017 179.068 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -88.83 101.2 13.8 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.254 0.622 . . . . 73.42 109.873 -177.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.545 ' HA ' HG12 ' A' ' 210' ' ' VAL . 7.4 p -118.39 123.12 29.54 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 123.784 0.834 . . . . 71.41 110.299 -177.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -57.73 146.3 85.98 Favored 'Trans proline' 0 C--N 1.372 1.796 0 C-N-CA 122.694 2.263 . . . . 75.32 112.311 168.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -51.77 -46.91 91.69 Favored Pre-proline 0 CA--C 1.559 1.319 0 N-CA-C 113.725 1.009 . . . . 75.21 113.725 179.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.407 ' O ' HG23 ' A' ' 206' ' ' VAL . 11.3 Cg_endo -53.6 -48.75 20.18 Favored 'Trans proline' 0 C--N 1.398 3.159 0 C-N-CA 122.327 2.018 . . . . 72.23 112.995 173.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 31.4 mt -66.36 -31.3 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 123.778 0.831 . . . . 74.11 111.359 -177.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.52 -41.23 76.29 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 122.708 0.403 . . . . 75.53 111.515 178.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 84.8 t -72.87 -51.41 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 122.96 0.504 . . . . 63.53 111.433 -178.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 202' ' ' PRO . 19.3 m -85.73 -20.15 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 N-CA-C 112.497 0.554 . . . . 75.24 112.497 -174.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 90.98 162.65 38.34 Favored Glycine 0 N--CA 1.476 1.323 0 N-CA-C 111.249 -0.74 . . . . 63.11 111.249 -171.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 161.92 -147.93 14.75 Favored Glycine 0 N--CA 1.467 0.722 0 CA-C-N 117.635 0.718 . . . . 64.14 111.918 178.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 33.2 mtmm -133.13 139.52 47.13 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.239 0.616 . . . . 70.44 109.759 175.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.545 HG12 ' HA ' ' A' ' 199' ' ' VAL . 27.1 m -135.83 144.85 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 123.649 0.78 . . . . 73.42 109.404 175.152 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 25.1 ttm180 -85.8 116.42 24.04 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 123.196 0.598 . . . . 74.22 111.227 -171.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -102.81 164.66 11.5 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.564 1.146 . . . . 61.4 110.158 173.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -105.4 123.19 47.46 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.896 0.878 . . . . 71.35 110.183 -178.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 81.1 p -124.52 177.94 5.66 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.131 0.973 . . . . 72.01 109.936 175.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 14.7 mt -78.9 -9.7 59.57 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.058 0.543 . . . . 72.43 111.739 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -94.34 -18.65 21.39 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.699 0.8 . . . . 73.02 110.569 176.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 137.64 -164.21 25.45 Favored Glycine 0 C--N 1.349 1.292 0 CA-C-N 116.057 -0.52 . . . . 64.13 112.174 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -74.1 134.05 18.9 Favored 'Trans proline' 0 C--N 1.365 1.43 0 C-N-CA 122.439 2.093 . . . . 73.44 111.304 171.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.515 HG13 ' HA ' ' A' ' 177' ' ' PRO . 33.2 m -133.42 132.68 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 123.782 0.833 . . . . 75.33 109.071 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -91.72 116.47 28.91 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 122.028 -0.42 . . . . 73.11 110.014 179.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 36.9 t -96.54 127.22 48.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 C-N-CA 124.961 1.304 . . . . 73.45 109.995 -173.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -69.22 99.69 1.19 Allowed 'General case' 0 CA--C 1.54 0.589 0 O-C-N 123.959 0.787 . . . . 64.01 109.92 175.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 58.9 t -72.63 121.75 85.72 Favored Pre-proline 0 C--O 1.239 0.551 0 C-N-CA 124.583 1.153 . . . . 74.21 108.917 174.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -61.12 152.43 71.67 Favored 'Trans proline' 0 C--N 1.375 1.93 0 C-N-CA 122.297 1.998 . . . . 74.11 111.474 172.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_exo -64.57 157.4 55.53 Favored 'Trans proline' 0 C--N 1.37 1.66 0 C-N-CA 122.255 1.97 . . . . 63.2 111.87 171.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 62.41 33.42 16.26 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.925 1.29 . . . . 72.13 110.894 174.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.477 HG22 ' HD2' ' A' ' 231' ' ' ARG . 21.1 m -88.52 126.32 35.2 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.917 0.887 . . . . 74.25 110.477 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 -94.2 163.73 13.33 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.218 1.007 . . . . 72.2 111.361 -176.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -69.14 114.76 7.7 Favored 'General case' 0 C--N 1.348 0.528 0 CA-C-N 115.029 -0.987 . . . . 73.13 109.289 173.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 105.38 4.6 40.59 Favored Glycine 0 C--N 1.338 0.648 0 O-C-N 123.756 0.66 . . . . 63.22 112.799 -179.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.477 ' HD2' HG22 ' A' ' 227' ' ' THR . 28.3 mtt180 -63.68 152.9 37.81 Favored 'General case' 0 C--N 1.359 0.989 0 CA-C-N 117.404 0.602 . . . . 74.1 110.466 171.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.439 ' HG3' HG11 ' A' ' 170' ' ' VAL . 20.8 pttm -115.63 130.52 56.89 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 123.575 0.75 . . . . 65.32 109.877 -179.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 89.1 mt -120.44 132.67 55.33 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 107.766 -1.198 . . . . 75.21 107.766 176.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 35.5 ttm-85 -121.92 106.89 11.65 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 108.149 -1.056 . . . . 74.51 108.149 170.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.416 HD11 ' CD1' ' A' ' 175' ' ' TYR . 15.4 mt -76.06 82.57 2.91 Favored 'General case' 0 C--O 1.243 0.715 0 N-CA-C 107.375 -1.342 . . . . 73.1 107.375 174.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -71.28 133.04 45.77 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-N 115.318 -0.855 . . . . 74.43 110.746 -173.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 65.14 26.3 71.44 Favored Glycine 0 C--N 1.345 1.029 0 O-C-N 124.083 0.864 . . . . 74.34 112.563 -177.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -142.82 36.93 1.43 Allowed 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 124.008 0.923 . . . . 75.35 111.11 -177.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -100.97 -111.66 3.43 Favored Glycine 0 N--CA 1.478 1.498 0 CA-C-O 119.579 -0.567 . . . . 62.41 112.26 175.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -62.92 133.89 95.46 Favored Pre-proline 0 N--CA 1.487 1.411 0 CA-C-O 118.178 -0.915 . . . . 73.44 110.557 173.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -62.45 130.41 29.98 Favored 'Trans proline' 0 C--N 1.38 2.233 0 C-N-CA 123.119 2.546 . . . . 74.33 112.159 178.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -166.02 124.27 1.22 Allowed Glycine 0 CA--C 1.533 1.184 0 CA-C-O 118.71 -1.05 . . . . 62.53 111.42 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -68.68 -26.95 32.65 Favored 'Trans proline' 0 C--N 1.382 2.337 0 C-N-CA 123.528 2.819 . . . . 73.22 113.273 -176.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -80.97 -25.64 37.19 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.356 0.662 . . . . 75.33 111.083 178.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 161.79 117.78 0.44 Allowed Glycine 0 C--N 1.342 0.906 0 N-CA-C 111.232 -0.747 . . . . 70.52 111.232 -178.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 29.8 mtt-85 -69.58 164.99 22.04 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.668 0.787 . . . . 75.41 110.518 176.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -80.09 -158.21 16.1 Favored Glycine 0 N--CA 1.472 1.038 0 CA-C-N 115.886 -0.597 . . . . 74.32 112.387 172.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -115.39 153.57 30.8 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 108.998 -0.742 . . . . 75.51 108.998 173.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 46.7 tp -123.42 107.63 11.81 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 108.124 -1.065 . . . . 75.2 108.124 171.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 24.6 t80 -96.67 107.74 20.24 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 115.331 -0.85 . . . . 73.25 108.978 -172.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.552 HD12 HD11 ' A' ' 197' ' ' LEU . 76.5 mt -103.96 120.65 41.48 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 123.77 0.828 . . . . 74.44 110.639 -176.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -89.6 103.51 16.15 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.093 0.957 . . . . 73.45 108.448 177.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.465 HG11 HG23 ' A' ' 227' ' ' THR . 72.6 t -58.1 116.68 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 123.69 0.796 . . . . 73.51 111.179 -179.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . 0.475 ' HE ' HG23 ' A' ' 196' ' ' THR . 20.4 mmt180 -117.07 107.27 14.31 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 107.801 -1.185 . . . . 72.32 107.801 173.019 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 40.6 mt -75.95 135.47 26.9 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.929 0 N-CA-C 109.464 -0.569 . . . . 64.22 109.464 175.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 14.5 t . . . . . 0 C--O 1.26 1.607 0 C-N-CA 124.673 1.189 . . . . 72.43 109.718 -176.568 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 90.4 mtp . . . . . 0 N--CA 1.477 0.888 0 N-CA-C 109.854 -0.424 . . . . 72.42 109.854 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -104.01 -37.64 7.29 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.185 0.594 . . . . 74.15 110.904 -178.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -59.8 -57.78 11.43 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.652 0.781 . . . . 73.22 110.038 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.531 HG23 ' HB3' ' A' ' 234' ' ' ARG . 33.2 m -106.93 162.15 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 CA-C-N 115.146 -0.934 . . . . 74.44 109.232 172.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 10.0 tt -83.38 147.8 5.56 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.08 0 N-CA-C 109.781 -0.451 . . . . 75.35 109.781 175.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -62.69 139.94 58.68 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.383 1.073 . . . . 72.42 111.941 -178.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.473 ' HB2' HD22 ' A' ' 233' ' ' LEU . . . -156.78 166.56 33.03 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 114.833 -1.076 . . . . 73.0 109.853 178.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -154.53 158.78 40.36 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 124.882 1.273 . . . . 73.3 108.268 173.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.629 ' HE1' ' HB3' ' A' ' 238' ' ' LYS . 45.6 p90 -118.52 -177.49 3.31 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 122.753 0.421 . . . . 63.53 110.102 173.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -144.21 129.27 9.5 Favored Pre-proline 0 N--CA 1.475 0.796 0 N-CA-C 107.61 -1.256 . . . . 65.42 107.61 170.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . 0.526 ' HA ' HG12 ' A' ' 219' ' ' VAL . 32.7 Cg_endo -62.81 111.63 1.42 Allowed 'Trans proline' 0 C--N 1.371 1.731 0 C-N-CA 122.823 2.349 . . . . 74.13 111.094 -179.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -72.1 76.97 0.95 Allowed 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 123.77 0.828 . . . . 63.45 111.179 -177.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 21.3 t70 64.74 2.58 1.73 Allowed 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 125.36 1.464 . . . . 75.42 112.609 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -141.71 131.19 4.68 Favored Glycine 0 C--N 1.346 1.11 0 N-CA-C 111.794 -0.522 . . . . 53.25 111.794 -173.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 21.0 t -144.87 162.4 36.93 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.7 0.8 . . . . 71.12 109.381 -178.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . 0.479 ' N ' ' HG3' ' A' ' 216' ' ' GLU . . . -88.01 -83.05 1.23 Allowed Glycine 0 C--N 1.344 1.009 0 O-C-N 123.5 0.5 . . . . 72.42 112.947 -173.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 157.73 -95.86 0.15 Allowed Glycine 0 C--N 1.343 0.926 0 N-CA-C 111.73 -0.548 . . . . 64.21 111.73 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 73.8 m -146.88 157.15 43.57 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.169 0.988 . . . . 62.44 110.033 178.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 170.99 -133.41 2.77 Favored Glycine 0 C--N 1.343 0.931 0 N-CA-C 110.762 -0.935 . . . . 73.11 110.762 -177.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 79.69 96.49 0.32 Allowed Glycine 0 C--N 1.351 1.383 0 N-CA-C 111.745 -0.542 . . . . 73.23 111.745 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 27.7 m -85.88 -175.2 5.49 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.035 0.534 . . . . 74.13 110.557 178.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -79.9 66.4 3.58 Favored Glycine 0 C--N 1.348 1.237 0 N-CA-C 112.154 -0.378 . . . . 54.2 112.154 177.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 153.85 -55.36 0.43 Allowed Glycine 0 C--N 1.34 0.78 0 N-CA-C 110.977 -0.849 . . . . 74.33 110.977 -177.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 35.6 p -80.89 75.9 7.83 Favored 'General case' 0 C--N 1.351 0.646 0 CA-C-O 121.918 0.866 . . . . 74.41 110.35 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -117.8 -19.63 9.18 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 114.29 -1.323 . . . . 74.04 108.312 168.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -98.98 155.56 17.36 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.143 0.977 . . . . 63.05 110.326 -177.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 48.0 mt -142.53 134.77 27.54 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.599 1.16 . . . . 73.52 109.128 169.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -106.5 122.44 46.3 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 108.479 -0.934 . . . . 75.42 108.479 171.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.456 ' O ' ' HA ' ' A' ' 251' ' ' LEU . . . -145.96 140.52 26.96 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 109.388 -0.597 . . . . 55.42 109.388 178.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 9.4 p -81.33 137.53 35.74 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 109.459 -0.571 . . . . 74.42 109.459 173.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.408 HD12 HG21 ' A' ' 210' ' ' VAL . 51.4 tp -106.76 111.5 24.05 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 108.39 -0.966 . . . . 74.44 108.39 -176.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -81.86 99.47 9.05 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 108.678 -0.86 . . . . 74.34 108.678 178.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.465 ' HA ' HG13 ' A' ' 210' ' ' VAL . 3.2 p -106.34 116.89 58.5 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 123.713 0.805 . . . . 75.31 109.321 178.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -54.94 140.05 79.18 Favored 'Trans proline' 0 C--N 1.367 1.534 0 C-N-CA 122.422 2.082 . . . . 73.42 112.206 172.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . 0.407 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -49.04 -44.92 73.92 Favored Pre-proline 0 CA--C 1.559 1.311 0 N-CA-C 114.184 1.179 . . . . 55.54 114.184 179.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.407 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 18.6 Cg_endo -57.4 -48.72 16.2 Favored 'Trans proline' 0 C--N 1.388 2.628 0 C-N-CA 121.838 1.692 . . . . 54.43 112.764 174.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 53.3 mt -65.79 -31.63 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 C-N-CA 123.781 0.833 . . . . 75.02 111.074 -178.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -64.1 -52.09 60.86 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.287 0.635 . . . . 74.1 110.746 177.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 91.8 t -67.63 -51.96 45.77 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-N 115.567 -0.742 . . . . 75.41 111.385 -176.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 15.5 m -79.68 -22.74 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 112.591 0.589 . . . . 74.54 112.591 -174.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 82.1 154.39 13.66 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 112.126 -0.39 . . . . 75.03 112.126 -171.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 164.58 -135.16 3.62 Favored Glycine 0 C--N 1.337 0.629 0 N-CA-C 111.74 -0.544 . . . . 51.52 111.74 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.546 ' HZ1' ' HB2' ' A' ' 209' ' ' LYS . 9.4 mtmp? -133.87 153.19 51.92 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 124.12 0.968 . . . . 75.44 109.247 173.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.465 HG13 ' HA ' ' A' ' 199' ' ' VAL . 15.6 m -134.8 141.03 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 124.106 0.962 . . . . 72.2 108.817 172.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -81.7 114.16 20.17 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.175 0.59 . . . . 74.12 109.705 -177.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -106.51 154.83 20.29 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.583 1.153 . . . . 74.34 110.351 178.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.71 126.03 52.55 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.461 0.704 . . . . 73.13 109.9 173.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 65.2 p -126.62 -178.72 4.47 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.354 1.062 . . . . 74.31 109.539 177.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 10.3 mt -73.12 -20.42 60.94 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-O 120.721 0.296 . . . . 71.44 110.602 176.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . 0.479 ' HG3' ' N ' ' A' ' 182' ' ' GLY . 27.0 tt0 -78.67 -19.78 51.73 Favored 'General case' 0 CA--C 1.561 1.376 0 C-N-CA 124.05 0.94 . . . . 74.13 110.827 173.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 120.05 -158.06 15.46 Favored Glycine 0 C--N 1.35 1.327 0 CA-C-O 119.614 -0.548 . . . . 74.43 112.294 178.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.78 126.87 11.75 Favored 'Trans proline' 0 C--N 1.369 1.649 0 C-N-CA 122.275 1.983 . . . . 74.01 111.294 178.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.526 HG12 ' HA ' ' A' ' 177' ' ' PRO . 28.7 m -136.72 128.02 42.38 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.977 0 C-N-CA 123.879 0.872 . . . . 72.43 109.325 178.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -85.01 113.45 21.45 Favored 'General case' 0 N--CA 1.482 1.128 0 O-C-N 121.972 -0.455 . . . . 73.13 110.405 177.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . 0.496 ' HA ' ' HA ' ' A' ' 175' ' ' TYR . 58.7 t -93.51 120.77 43.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 C-N-CA 123.267 0.627 . . . . 75.34 109.648 -177.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -63.57 101.51 0.35 Allowed 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.054 0.942 . . . . 75.4 110.566 176.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 62.5 t -70.03 121.04 81.65 Favored Pre-proline 0 CA--C 1.544 0.74 0 CA-C-N 114.663 -1.153 . . . . 73.03 108.79 172.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -63.92 157.52 52.17 Favored 'Trans proline' 0 CA--C 1.571 2.338 0 C-N-CA 122.029 1.819 . . . . 64.43 111.674 174.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -66.79 127.0 16.24 Favored 'Trans proline' 0 C--N 1.368 1.579 0 C-N-CA 122.868 2.378 . . . . 73.43 112.243 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 38.5 mtm180 64.61 79.21 0.26 Allowed 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.984 1.314 . . . . 75.31 110.459 -175.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.508 HG23 HG12 ' A' ' 253' ' ' VAL . 99.3 m -117.12 106.81 13.75 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.11 0.964 . . . . 74.32 109.006 177.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -88.54 153.47 21.11 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.838 -0.619 . . . . 74.54 110.787 -173.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -62.9 138.69 58.61 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.108 0.963 . . . . 72.34 111.115 -178.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 89.94 10.66 64.4 Favored Glycine 0 C--N 1.338 0.646 0 CA-C-N 115.713 -0.676 . . . . 71.34 112.689 -174.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.436 ' HD2' HG22 ' A' ' 227' ' ' THR . 78.0 mtt180 -78.15 162.49 26.59 Favored 'General case' 0 C--O 1.244 0.778 0 CA-C-O 121.591 0.71 . . . . 73.11 110.429 169.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 19.6 pttm -127.52 129.11 46.8 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 114.739 -1.119 . . . . 74.33 109.869 179.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.473 HD22 ' HB2' ' A' ' 173' ' ' ALA . 66.2 mt -110.45 134.09 52.67 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 107.517 -1.29 . . . . 74.2 107.517 172.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . 0.531 ' HB3' HG23 ' A' ' 170' ' ' VAL . 42.3 ttm105 -123.28 98.95 6.1 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 107.044 -1.465 . . . . 72.24 107.044 167.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.502 ' HB3' ' HB2' ' A' ' 238' ' ' LYS . 65.8 mt -74.43 82.93 1.95 Allowed 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 114.213 -1.358 . . . . 72.14 108.526 177.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -75.8 137.68 40.68 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 122.664 0.386 . . . . 74.54 110.434 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 69.86 24.48 76.37 Favored Glycine 0 C--N 1.339 0.724 0 O-C-N 124.066 0.854 . . . . 64.4 111.973 -175.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.629 ' HB3' ' HE1' ' A' ' 175' ' ' TYR . 73.8 mmtt -138.87 -9.35 1.36 Allowed 'General case' 0 CA--C 1.561 1.37 0 C-N-CA 124.171 0.988 . . . . 72.34 111.88 -170.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -80.8 -120.81 0.46 Allowed Glycine 0 N--CA 1.478 1.494 0 CA-C-O 119.93 -0.372 . . . . 72.53 113.8 -175.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.31 119.02 49.26 Favored Pre-proline 0 N--CA 1.485 1.315 0 CA-C-O 118.472 -0.775 . . . . 72.54 109.251 175.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.724 ' HA ' ' HG3' ' A' ' 246' ' ' ARG . 25.1 Cg_exo -59.45 128.59 27.81 Favored 'Trans proline' 0 C--N 1.38 2.215 0 C-N-CA 122.824 2.349 . . . . 64.51 111.747 -176.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -141.14 123.91 2.42 Favored Glycine 0 CA--C 1.534 1.222 0 CA-C-O 118.798 -1.001 . . . . 71.44 111.641 -176.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -70.76 -15.05 33.35 Favored 'Trans proline' 0 C--N 1.385 2.452 0 C-N-CA 123.09 2.527 . . . . 75.45 113.18 178.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -97.56 -6.45 33.48 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.211 0.604 . . . . 72.15 111.155 173.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 142.77 115.61 1.11 Allowed Glycine 0 C--N 1.344 0.988 0 N-CA-C 111.005 -0.838 . . . . 61.55 111.005 -177.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.724 ' HG3' ' HA ' ' A' ' 241' ' ' PRO . 8.0 ttm180 -65.64 139.85 58.45 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.226 1.011 . . . . 71.13 110.744 176.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -73.17 -155.14 3.03 Favored Glycine 0 C--N 1.347 1.179 0 O-C-N 123.459 0.475 . . . . 74.01 113.501 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -126.51 132.89 51.29 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 117.738 0.769 . . . . 73.24 112.667 -176.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 51.9 tp -101.24 107.08 18.37 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.14 0.976 . . . . 73.4 108.949 175.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -89.6 108.24 19.55 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.313 0.645 . . . . 63.54 109.604 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.456 ' HA ' ' O ' ' A' ' 195' ' ' ALA . 68.1 mt -101.46 112.11 24.54 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 123.752 0.821 . . . . 73.23 110.597 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -79.77 103.38 9.63 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.589 0.756 . . . . 75.55 109.47 174.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.508 HG12 HG23 ' A' ' 227' ' ' THR . 75.0 t -61.66 114.59 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.306 1.042 . . . . 73.21 111.223 -177.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 67.4 mmt-85 -123.19 112.08 17.26 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.672 1.189 . . . . 74.1 108.565 175.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 48.8 mt -76.48 126.58 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 123.152 0.581 . . . . 75.51 109.91 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 24.0 p . . . . . 0 C--O 1.255 1.394 0 C-N-CA 124.99 1.316 . . . . 74.11 108.411 179.258 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 22.5 ptp . . . . . 0 N--CA 1.484 1.231 0 CA-C-O 120.84 0.352 . . . . 74.2 110.411 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -102.06 49.31 0.86 Allowed 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 107.586 -1.265 . . . . 74.21 107.586 173.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -65.66 -52.92 47.91 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 114.047 -1.433 . . . . 71.02 111.181 -176.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.68 HG23 ' HB3' ' A' ' 234' ' ' ARG . 19.7 m -79.69 174.47 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 CA-C-N 114.587 -1.188 . . . . 71.33 110.218 175.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 14.8 tt -82.72 139.82 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 N-CA-C 108.467 -0.938 . . . . 74.34 108.467 167.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -70.12 93.32 0.8 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.535 0.734 . . . . 75.12 109.37 -179.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -98.37 152.23 19.69 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.838 -0.619 . . . . 74.1 110.113 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -140.84 149.28 41.8 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.285 0.634 . . . . 73.23 109.996 175.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.418 ' CD2' ' HB ' ' A' ' 219' ' ' VAL . 9.5 p90 -122.43 172.11 8.59 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 123.281 0.633 . . . . 72.03 110.554 176.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -138.04 121.88 11.61 Favored Pre-proline 0 N--CA 1.468 0.445 0 N-CA-C 107.268 -1.382 . . . . 72.34 107.268 175.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -64.51 141.41 73.56 Favored 'Trans proline' 0 C--N 1.367 1.544 0 C-N-CA 122.768 2.312 . . . . 70.54 110.801 -175.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -65.33 94.27 0.16 Allowed 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 121.586 0.708 . . . . 73.25 109.743 -178.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -80.91 142.32 33.67 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 114.398 -1.274 . . . . 74.34 111.811 -169.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -122.5 -57.3 0.2 Allowed Glycine 0 C--N 1.338 0.685 0 N-CA-C 110.592 -1.003 . . . . 50.4 110.592 173.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 66.6 m -129.87 -8.23 4.46 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.725 0.81 . . . . 63.03 111.622 177.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 89.86 158.8 34.81 Favored Glycine 0 C--N 1.348 1.239 0 N-CA-C 112.658 -0.177 . . . . 65.02 112.658 -171.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 144.22 112.91 0.85 Allowed Glycine 0 C--N 1.338 0.685 0 CA-C-O 119.526 -0.597 . . . . 74.25 111.682 176.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 42.6 p -167.72 102.07 0.48 Allowed 'General case' 0 C--O 1.242 0.701 0 C-N-CA 124.299 1.04 . . . . 75.43 109.407 175.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -89.34 -62.97 1.31 Allowed Glycine 0 C--N 1.344 0.973 0 N-CA-C 112.328 -0.309 . . . . 75.05 112.328 -178.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 153.77 77.33 0.02 OUTLIER Glycine 0 C--N 1.334 0.452 0 N-CA-C 111.42 -0.672 . . . . 63.22 111.42 -177.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 56.6 m -77.07 156.26 31.87 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.043 0.537 . . . . 72.24 110.277 178.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -127.5 147.37 17.06 Favored Glycine 0 C--N 1.343 0.921 0 O-C-N 123.231 0.332 . . . . 74.14 112.404 -175.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 157.13 -55.34 0.39 Allowed Glycine 0 C--N 1.341 0.816 0 N-CA-C 110.432 -1.067 . . . . 74.54 110.432 178.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 51.0 p -150.97 96.76 2.37 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 108.392 -0.966 . . . . 74.4 108.392 173.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.534 ' HA ' ' HB2' ' A' ' 240' ' ' PHE . 10.7 mm100 -75.49 -40.14 57.66 Favored 'General case' 0 C--O 1.244 0.782 0 CA-C-N 115.876 -0.602 . . . . 71.31 110.358 -177.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -86.17 135.64 33.51 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 114.959 -1.019 . . . . 72.11 108.374 172.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 94.6 mt -134.01 155.98 49.02 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.81 0.844 . . . . 75.14 109.817 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -130.08 136.81 49.75 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 108.008 -1.108 . . . . 72.12 108.008 173.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -160.42 171.34 19.23 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.211 0.529 . . . . 64.24 110.917 -177.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 17.6 p -104.83 151.62 23.59 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.6 0.76 . . . . 74.25 109.829 173.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.504 HD12 HG23 ' A' ' 210' ' ' VAL . 47.6 tp -123.13 118.3 27.37 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 123.863 0.865 . . . . 75.12 109.195 -175.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -82.61 100.11 9.96 Favored 'General case' 0 C--O 1.241 0.627 0 C-N-CA 123.329 0.652 . . . . 74.22 109.549 -178.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.503 ' HA ' HG13 ' A' ' 210' ' ' VAL . 23.6 t -110.06 109.02 59.12 Favored Pre-proline 0 CA--C 1.538 0.509 0 N-CA-C 108.489 -0.93 . . . . 73.24 108.489 176.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . 0.405 ' HA ' HG23 ' A' ' 256' ' ' THR . 74.8 Cg_exo -54.2 138.46 71.92 Favored 'Trans proline' 0 C--N 1.377 2.062 0 C-N-CA 122.777 2.318 . . . . 72.25 112.008 172.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -48.41 -47.56 68.44 Favored Pre-proline 0 CA--C 1.564 1.504 0 N-CA-C 113.772 1.027 . . . . 64.14 113.772 -177.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -56.07 -45.52 37.77 Favored 'Trans proline' 0 C--N 1.391 2.785 0 C-N-CA 121.845 1.697 . . . . 73.51 112.775 173.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 45.3 mt -69.93 -27.89 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 123.917 0.887 . . . . 62.41 111.181 -176.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.88 -48.9 64.77 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.075 0.55 . . . . 70.13 110.59 177.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 61.9 t -67.34 -48.42 77.86 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 CA-C-N 115.488 -0.778 . . . . 74.44 111.701 -177.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 11.8 p -75.44 -34.05 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 C-N-CA 122.391 0.277 . . . . 73.41 111.459 -178.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 83.7 141.02 4.47 Favored Glycine 0 C--N 1.344 0.982 0 N-CA-C 112.119 -0.392 . . . . 65.55 112.119 -172.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -178.07 -129.66 1.3 Allowed Glycine 0 C--N 1.34 0.777 0 N-CA-C 111.417 -0.673 . . . . 74.42 111.417 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 60.5 mttm -137.98 144.86 41.34 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.246 0.619 . . . . 71.54 109.771 173.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.504 HG23 HD12 ' A' ' 197' ' ' LEU . 31.1 m -134.87 155.57 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 124.333 1.053 . . . . 74.31 108.506 171.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 35.0 mtm-85 -97.47 126.36 42.7 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 121.015 0.436 . . . . 75.43 111.718 -176.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.501 ' HB3' HD13 ' A' ' 197' ' ' LEU . . . -101.47 133.87 45.44 Favored 'General case' 0 C--O 1.241 0.628 0 C-N-CA 124.687 1.195 . . . . 72.03 109.14 173.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.56 112.77 21.88 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 108.793 -0.817 . . . . 75.04 108.793 175.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 68.3 p -111.39 177.1 4.77 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.393 0.677 . . . . 64.34 109.192 175.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 26.5 mt -62.9 -39.02 93.22 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 122.831 0.453 . . . . 72.42 111.487 -172.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -86.0 -18.22 33.16 Favored 'General case' 0 CA--C 1.551 1.003 0 CA-C-N 115.824 -0.625 . . . . 74.3 111.364 -175.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 153.53 -166.06 31.63 Favored Glycine 0 C--N 1.352 1.444 0 N-CA-C 114.37 0.508 . . . . 75.32 114.37 174.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -77.8 142.9 20.53 Favored 'Trans proline' 0 C--N 1.376 1.988 0 C-N-CA 123.088 2.525 . . . . 74.04 111.858 176.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.418 ' HB ' ' CD2' ' A' ' 175' ' ' TYR . 11.7 m -135.91 140.44 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 N-CA-C 109.237 -0.653 . . . . 74.21 109.237 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -96.96 108.1 20.75 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 122.819 0.448 . . . . 64.01 110.123 -178.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 22.3 t -95.08 135.12 30.12 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 C-N-CA 124.404 1.082 . . . . 62.43 109.815 -175.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -77.38 109.2 11.1 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 123.305 0.642 . . . . 72.23 110.666 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 57.3 t -79.11 117.7 68.37 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 123.681 0.793 . . . . 73.31 109.07 173.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -60.69 158.02 34.72 Favored 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 122.458 2.105 . . . . 74.13 112.371 174.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -71.26 133.45 22.85 Favored 'Trans proline' 0 C--N 1.368 1.582 0 C-N-CA 121.5 1.467 . . . . 71.52 110.563 171.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 67.82 67.21 0.36 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.81 1.244 . . . . 74.35 110.141 -176.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.476 HG21 HG11 ' A' ' 253' ' ' VAL . 72.9 m -103.02 132.89 48.96 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.188 0.995 . . . . 74.41 109.595 176.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -110.7 155.48 22.38 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.632 0.773 . . . . 75.4 110.555 -177.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . 0.489 ' HB2' ' HB ' ' A' ' 255' ' ' ILE . . . -69.22 121.58 17.1 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.981 0.912 . . . . 71.12 110.225 -178.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 111.64 -7.6 28.02 Favored Glycine 0 C--N 1.333 0.398 0 CA-C-O 119.222 -0.765 . . . . 71.41 112.555 -176.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.439 ' HD2' HG23 ' A' ' 227' ' ' THR . 58.7 mtt180 -61.24 145.77 50.12 Favored 'General case' 0 C--N 1.361 1.097 0 CA-C-N 117.326 0.563 . . . . 75.42 109.915 174.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.443 ' HG3' HG13 ' A' ' 170' ' ' VAL . 20.1 pttm -117.06 104.35 11.16 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.282 -0.872 . . . . 73.12 109.215 -175.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 82.8 mt -90.11 97.35 11.14 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 108.723 -0.844 . . . . 74.15 108.723 176.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . 0.68 ' HB3' HG23 ' A' ' 170' ' ' VAL . 64.7 ttt180 -88.07 107.18 18.62 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 108.676 -0.861 . . . . 64.12 108.676 171.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.409 HD11 ' CD1' ' A' ' 175' ' ' TYR . 16.0 mt -77.67 84.23 4.02 Favored 'General case' 0 C--O 1.248 0.989 0 N-CA-C 107.659 -1.237 . . . . 70.53 107.659 174.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.416 ' HB2' ' HZ3' ' A' ' 236' ' ' LYS . 10.5 mtmp? -71.43 118.49 14.31 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 113.835 -1.529 . . . . 73.21 111.988 -169.09 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 64.14 28.82 73.44 Favored Glycine 0 C--N 1.348 1.212 0 O-C-N 124.044 0.84 . . . . 61.1 112.803 179.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 30.8 mmtp -125.47 -6.92 6.94 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 118.278 -0.868 . . . . 73.41 112.774 -173.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -62.57 -108.17 0.01 OUTLIER Glycine 0 C--N 1.354 1.538 0 O-C-N 123.827 0.704 . . . . 60.44 114.731 -171.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . 0.534 ' HB2' ' HA ' ' A' ' 191' ' ' GLN . 0.1 OUTLIER -75.97 140.02 69.96 Favored Pre-proline 0 N--CA 1.477 0.91 0 CA-C-O 118.574 -0.727 . . . . 73.23 109.811 177.72 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.461 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 53.1 Cg_exo -57.37 149.07 67.63 Favored 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 122.587 2.192 . . . . 72.31 113.293 175.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -164.81 123.58 1.18 Allowed Glycine 0 CA--C 1.538 1.512 0 CA-C-O 118.414 -1.215 . . . . 62.42 111.661 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -57.54 -46.16 29.14 Favored 'Trans proline' 0 C--N 1.386 2.521 0 C-N-CA 123.806 3.004 . . . . 74.32 113.646 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -78.87 -24.13 44.47 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 122.756 0.422 . . . . 72.44 110.81 178.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 168.19 142.0 3.36 Favored Glycine 0 C--N 1.345 1.057 0 CA-C-N 115.782 -0.645 . . . . 75.41 111.798 178.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.461 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 27.3 mtt-85 -73.63 166.54 23.08 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.495 0.718 . . . . 73.52 110.969 178.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -85.23 -156.99 27.35 Favored Glycine 0 C--N 1.336 0.579 0 CA-C-N 115.391 -0.822 . . . . 73.41 111.463 168.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -131.61 157.99 42.19 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 109.077 -0.712 . . . . 74.43 109.077 -176.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 42.4 tp -141.42 112.18 7.15 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 109.652 -0.499 . . . . 73.44 109.652 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -102.77 109.36 20.91 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.759 0.824 . . . . 74.41 109.838 -176.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 65.9 mt -104.92 136.09 45.05 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.727 0.811 . . . . 73.05 110.156 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -97.69 116.56 30.15 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.691 0.796 . . . . 75.34 109.303 170.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.476 HG11 HG21 ' A' ' 227' ' ' THR . 94.1 t -61.33 106.38 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-O 121.506 0.67 . . . . 74.11 110.465 172.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 17.0 mmt85 -104.37 102.49 12.16 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-N 114.67 -1.15 . . . . 74.32 108.065 173.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.489 ' HB ' ' HB2' ' A' ' 229' ' ' ALA . 24.1 mt -76.36 119.0 23.68 Favored 'Isoleucine or valine' 0 C--O 1.245 0.83 0 C-N-CA 122.901 0.481 . . . . 73.45 109.767 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' THR . . . . . 0.405 HG23 ' HA ' ' A' ' 200' ' ' PRO . 2.5 t . . . . . 0 CA--C 1.558 1.288 0 N-CA-C 108.682 -0.858 . . . . 72.31 108.682 175.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 64.0 mtt . . . . . 0 N--CA 1.478 0.927 0 N-CA-C 109.462 -0.57 . . . . 74.22 109.462 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -85.94 71.99 10.54 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 122.029 0.919 . . . . 72.5 109.401 176.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -65.47 -44.63 86.54 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 115.243 -0.89 . . . . 73.42 110.501 177.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.602 HG13 ' HG3' ' A' ' 232' ' ' LYS . 27.6 m -111.43 164.57 7.25 Favored 'Isoleucine or valine' 0 C--O 1.243 0.76 0 CA-C-N 114.305 -1.316 . . . . 74.34 109.16 175.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 17.6 tt -89.51 145.71 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 N-CA-C 108.236 -1.024 . . . . 75.33 108.236 168.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -58.75 122.21 12.98 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.671 0.788 . . . . 74.53 110.879 -179.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.438 ' HB1' HD23 ' A' ' 233' ' ' LEU . . . -135.99 154.78 50.97 Favored 'General case' 0 C--O 1.243 0.729 0 C-N-CA 124.5 1.12 . . . . 74.03 108.449 174.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -152.88 151.22 30.13 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.938 0.895 . . . . 71.42 109.404 -178.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.406 ' CD1' HD11 ' A' ' 235' ' ' LEU . 2.6 p90 -130.14 173.93 10.28 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-O 121.39 0.614 . . . . 72.42 111.025 176.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 78.2 mttt -139.23 144.39 40.26 Favored Pre-proline 0 C--O 1.243 0.746 0 CA-C-N 114.692 -1.14 . . . . 73.44 109.203 174.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -55.1 103.9 0.11 Allowed 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 123.279 2.652 . . . . 71.31 112.105 178.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . 0.455 ' HB1' ' HG3' ' A' ' 220' ' ' GLU . . . -68.41 -22.68 64.6 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.834 0.854 . . . . 74.41 111.345 -178.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -68.34 -38.24 81.32 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.883 0.873 . . . . 71.31 110.564 171.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 111.54 -22.91 18.96 Favored Glycine 0 C--N 1.353 1.517 0 CA-C-O 119.746 -0.474 . . . . 73.11 113.892 175.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 49.2 m -88.04 -64.41 1.15 Allowed 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 117.662 0.731 . . . . 72.41 109.997 178.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 81.36 -177.65 54.12 Favored Glycine 0 C--N 1.353 1.483 0 CA-C-N 116.528 -0.305 . . . . 73.42 112.994 -175.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -138.47 155.03 23.33 Favored Glycine 0 C--N 1.341 0.834 0 C-N-CA 122.58 0.133 . . . . 65.43 112.943 178.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 47.3 p -160.15 25.61 0.17 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.035 0.934 . . . . 75.42 110.667 -175.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -62.32 -87.59 0.04 OUTLIER Glycine 0 C--N 1.354 1.544 0 CA-C-N 115.594 -0.73 . . . . 72.31 114.219 -177.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -174.64 134.26 2.73 Favored Glycine 0 C--N 1.346 1.126 0 N-CA-C 112.052 -0.419 . . . . 45.33 112.052 -178.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 23.9 p -71.3 94.12 1.18 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.639 0.776 . . . . 75.31 110.289 178.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -80.74 79.34 1.78 Allowed Glycine 0 C--N 1.345 1.036 0 CA-C-N 115.726 -0.67 . . . . 74.14 112.781 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 85.16 -59.63 4.85 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 112.03 -0.428 . . . . 74.24 112.03 -179.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 48.8 m -80.46 139.22 36.53 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.073 0.549 . . . . 71.45 110.369 174.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -129.88 -49.29 1.13 Allowed 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.366 1.066 . . . . 75.13 108.745 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -76.79 150.38 36.17 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 114.296 -1.32 . . . . 70.53 110.613 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 36.6 mt -133.92 139.31 46.06 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 124.89 1.276 . . . . 74.13 107.639 171.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -128.21 125.01 38.15 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.204 0.602 . . . . 73.5 109.498 -176.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -161.85 171.51 17.63 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 123.736 0.815 . . . . 62.33 110.756 -175.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 15.6 p -105.89 149.86 26.16 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.633 0.773 . . . . 61.3 109.967 173.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.537 HD12 HD11 ' A' ' 251' ' ' LEU . 51.7 tp -115.01 118.72 34.22 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.999 0.92 . . . . 71.02 109.875 -175.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -83.39 119.62 24.86 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 109.319 -0.623 . . . . 74.31 109.319 175.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.505 ' HA ' HG13 ' A' ' 210' ' ' VAL . 3.5 p -133.7 123.24 17.16 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 123.638 0.775 . . . . 75.24 109.675 178.042 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -59.02 139.61 91.58 Favored 'Trans proline' 0 C--N 1.375 1.968 0 C-N-CA 122.725 2.283 . . . . 73.14 111.447 171.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . 0.434 ' O ' HG22 ' A' ' 205' ' ' VAL . . . -49.11 -47.58 75.12 Favored Pre-proline 0 CA--C 1.557 1.232 0 CA-C-O 117.792 -1.099 . . . . 70.52 113.022 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -55.93 -45.28 39.81 Favored 'Trans proline' 0 C--N 1.395 2.978 0 C-N-CA 122.206 1.938 . . . . 71.43 113.019 175.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 39.9 mt -65.93 -31.98 56.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 123.458 0.703 . . . . 71.51 111.02 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -71.84 -37.86 70.23 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.269 0.628 . . . . 74.15 111.48 179.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.434 HG22 ' O ' ' A' ' 201' ' ' ALA . 98.9 t -74.54 -53.69 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 123.647 0.779 . . . . 62.22 111.359 -178.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 7.1 p -73.03 -31.03 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 122.627 0.371 . . . . 54.44 111.11 -178.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 84.94 117.43 0.8 Allowed Glycine 0 C--N 1.344 0.979 0 N-CA-C 111.357 -0.697 . . . . 73.0 111.357 -172.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -151.8 -136.88 2.51 Favored Glycine 0 C--N 1.34 0.789 0 N-CA-C 111.564 -0.614 . . . . 74.33 111.564 -178.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 34.3 mtmm -136.95 146.09 45.01 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.003 0.921 . . . . 75.51 109.383 175.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.505 HG13 ' HA ' ' A' ' 199' ' ' VAL . 24.2 m -133.05 142.3 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 123.855 0.862 . . . . 70.43 109.22 172.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . 0.437 ' NH1' ' HB2' ' A' ' 178' ' ' ALA . 24.1 ttm-85 -87.7 110.45 20.44 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 122.817 0.447 . . . . 71.51 110.15 -170.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -101.8 164.47 11.71 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.656 1.182 . . . . 72.21 110.634 -178.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' MET . . . . . 0.519 ' HA ' ' HE3' ' A' ' 213' ' ' MET . 10.1 mmt -105.92 123.23 47.65 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.862 0.865 . . . . 74.11 110.784 -179.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' THR . . . . . 0.469 HG22 HD23 ' A' ' 249' ' ' LEU . 47.5 p -114.63 171.29 7.73 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.304 1.042 . . . . 75.5 109.211 170.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 13.2 mt -72.28 -9.33 58.34 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 112.091 0.404 . . . . 73.13 112.091 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -99.97 -19.45 16.57 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 123.127 0.571 . . . . 63.22 111.772 175.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 143.58 -155.02 25.91 Favored Glycine 0 C--N 1.36 1.901 0 CA-C-O 119.695 -0.503 . . . . 64.54 113.995 174.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -76.64 136.33 17.07 Favored 'Trans proline' 0 C--N 1.379 2.14 0 C-N-CA 123.442 2.761 . . . . 75.2 113.229 178.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.42 ' HA ' ' H ' ' A' ' 178' ' ' ALA . 27.0 m -136.5 145.5 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 124.177 0.991 . . . . 74.44 109.293 177.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.455 ' HG3' ' HB1' ' A' ' 178' ' ' ALA . 37.4 mt-10 -102.3 112.11 24.68 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 109.52 -0.548 . . . . 73.21 109.52 178.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 46.7 t -94.7 118.09 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 124.41 1.084 . . . . 74.31 109.527 -174.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -66.96 102.19 0.94 Allowed 'General case' 0 C--O 1.24 0.561 0 C-N-CA 123.958 0.903 . . . . 75.12 110.427 176.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.436 HG13 HG22 ' A' ' 199' ' ' VAL . 64.6 t -80.24 120.88 80.89 Favored Pre-proline 0 CA--C 1.546 0.801 0 CA-C-N 115.162 -0.926 . . . . 74.53 108.969 174.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -60.6 162.38 18.26 Favored 'Trans proline' 0 CA--C 1.566 2.097 0 C-N-CA 122.904 2.403 . . . . 74.21 113.219 176.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -76.25 135.39 16.78 Favored 'Trans proline' 0 C--N 1.374 1.88 0 C-N-CA 122.622 2.215 . . . . 72.11 112.271 175.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 20.0 mtm180 66.54 57.25 0.71 Allowed 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 125.129 1.371 . . . . 73.54 110.631 -176.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.534 HG22 HG13 ' A' ' 253' ' ' VAL . 60.5 m -106.81 107.34 18.31 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.851 0.86 . . . . 72.1 109.381 178.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 22.5 mp0 -85.7 160.26 19.59 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.297 0.639 . . . . 73.24 111.678 -172.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -70.35 130.18 41.28 Favored 'General case' 0 C--N 1.352 0.682 0 N-CA-C 108.867 -0.79 . . . . 74.54 108.867 175.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 114.47 -19.08 17.16 Favored Glycine 0 N--CA 1.466 0.634 0 CA-C-O 119.636 -0.536 . . . . 71.41 111.897 -173.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 81.2 mtt180 -67.19 161.85 23.84 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-O 121.579 0.704 . . . . 74.34 111.877 175.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.602 ' HG3' HG13 ' A' ' 170' ' ' VAL . 19.5 pttm -130.19 142.11 50.6 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.344 1.058 . . . . 75.53 109.42 177.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.438 HD23 ' HB1' ' A' ' 173' ' ' ALA . 75.2 mt -120.61 129.02 53.56 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 107.89 -1.152 . . . . 75.14 107.89 178.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 40.4 ttt180 -113.7 102.14 9.97 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 108.816 -0.809 . . . . 74.0 108.816 171.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.605 ' HB3' ' HB2' ' A' ' 238' ' ' LYS . 21.3 mt -76.19 84.01 3.01 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 114.246 -1.343 . . . . 74.14 108.632 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -72.65 127.37 32.35 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.641 -0.709 . . . . 64.11 110.67 -173.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 69.48 20.52 75.51 Favored Glycine 0 C--N 1.342 0.901 0 O-C-N 123.764 0.665 . . . . 71.45 112.053 -175.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.605 ' HB2' ' HB3' ' A' ' 235' ' ' LEU . 22.3 mmtp -136.37 58.05 1.75 Allowed 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.581 1.152 . . . . 75.21 108.54 -176.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -139.9 -113.48 1.08 Allowed Glycine 0 N--CA 1.472 1.093 0 CA-C-O 119.226 -0.764 . . . . 71.4 111.74 175.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -64.11 146.32 97.54 Favored Pre-proline 0 N--CA 1.484 1.254 0 CA-C-O 118.47 -0.776 . . . . 71.11 110.699 175.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -54.79 160.0 8.23 Favored 'Trans proline' 0 C--N 1.38 2.204 0 C-N-CA 123.488 2.792 . . . . 71.41 112.871 176.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -169.85 136.43 4.0 Favored Glycine 0 CA--C 1.525 0.702 0 CA-C-O 118.742 -1.032 . . . . 52.5 112.024 -178.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -70.23 -41.54 3.6 Favored 'Trans proline' 0 C--N 1.378 2.091 0 C-N-CA 123.184 2.59 . . . . 73.2 113.305 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -102.11 -18.79 15.41 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.702 0.801 . . . . 75.0 111.222 -177.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 175.66 145.68 5.57 Favored Glycine 0 C--N 1.341 0.847 0 N-CA-C 111.262 -0.735 . . . . 73.04 111.262 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 21.1 mtm180 -88.19 165.32 15.15 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.088 0.555 . . . . 74.24 110.589 -176.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -74.14 -168.07 17.54 Favored Glycine 0 C--N 1.35 1.312 0 N-CA-C 111.486 -0.646 . . . . 74.1 111.486 168.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -118.27 151.84 36.89 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 118.406 1.103 . . . . 71.22 111.247 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.469 HD23 HG22 ' A' ' 214' ' ' THR . 35.9 tp -113.75 118.21 33.66 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 108.559 -0.904 . . . . 71.01 108.559 171.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . 0.527 ' OH ' ' HD2' ' A' ' 232' ' ' LYS . 2.7 t80 -96.4 115.9 28.17 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.84 -1.17 . . . . 74.4 107.84 -178.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.537 HD11 HD12 ' A' ' 197' ' ' LEU . 57.6 mt -118.93 117.22 28.23 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.79 0.836 . . . . 73.14 110.38 -177.323 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -77.32 116.07 17.62 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 108.997 -0.742 . . . . 75.11 108.997 171.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.534 HG13 HG22 ' A' ' 227' ' ' THR . 94.8 t -62.09 104.27 0.3 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.934 0 CA-C-O 121.322 0.582 . . . . 72.35 110.433 176.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 19.6 mmm180 -110.15 106.37 15.79 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 107.952 -1.129 . . . . 73.02 107.952 175.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.423 HD11 ' O ' ' A' ' 227' ' ' THR . 45.0 mt -77.77 143.8 12.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 122.898 0.479 . . . . 73.34 110.483 178.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 4.9 t . . . . . 0 C--O 1.261 1.68 0 C-N-CA 124.48 1.112 . . . . 74.42 108.721 174.739 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' MET . . . . . 0.556 ' SD ' ' HE3' ' A' ' 236' ' ' LYS . 26.1 ptt? . . . . . 0 N--CA 1.488 1.458 0 CA-C-O 121.344 0.593 . . . . 72.53 110.243 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -78.61 6.79 7.96 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.653 1.181 . . . . 73.32 112.566 -175.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -56.74 -61.47 2.4 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.007 0.923 . . . . 63.12 111.082 178.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 33.0 m -89.82 157.15 3.01 Favored 'Isoleucine or valine' 0 C--O 1.243 0.75 0 C-N-CA 122.835 0.454 . . . . 74.25 110.054 176.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.451 HG22 ' HD3' ' A' ' 231' ' ' ARG . 15.1 tt -83.09 146.73 6.59 Favored 'Isoleucine or valine' 0 C--O 1.249 1.057 0 N-CA-C 108.496 -0.927 . . . . 54.12 108.496 172.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -58.06 136.08 57.1 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.718 0.807 . . . . 70.22 111.52 -176.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.503 ' HB2' HD23 ' A' ' 233' ' ' LEU . . . -158.31 158.18 33.87 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 124.885 1.274 . . . . 74.54 109.337 173.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -164.27 149.42 10.25 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.924 0.89 . . . . 75.54 109.221 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.509 ' HB3' HG21 ' A' ' 221' ' ' VAL . 1.6 p90 -122.39 175.93 6.16 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 121.807 0.813 . . . . 74.43 112.34 177.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . 0.404 ' HA ' ' HD3' ' A' ' 177' ' ' PRO . 31.6 mmmt -138.22 129.31 15.64 Favored Pre-proline 0 C--O 1.241 0.629 0 CA-C-N 113.639 -1.619 . . . . 74.0 107.575 167.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . 0.473 ' HA ' HG11 ' A' ' 219' ' ' VAL . 35.7 Cg_exo -54.37 128.25 29.29 Favored 'Trans proline' 0 C--N 1.369 1.657 0 C-N-CA 123.486 2.791 . . . . 74.31 111.639 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -63.99 99.26 0.25 Allowed 'General case' 0 CA--C 1.549 0.927 0 O-C-N 123.737 0.648 . . . . 75.33 110.429 -175.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 35.4 t70 70.25 15.0 7.54 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 125.801 1.64 . . . . 73.22 111.701 -178.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -114.17 165.14 12.03 Favored Glycine 0 C--N 1.346 1.133 0 C-N-CA 123.344 0.497 . . . . 54.0 112.516 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 24.9 p -90.63 132.86 35.51 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.353 0.661 . . . . 74.33 110.095 177.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -168.99 60.45 0.2 Allowed Glycine 0 C--N 1.338 0.682 0 N-CA-C 111.084 -0.806 . . . . 65.24 111.084 -177.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -95.57 81.51 0.83 Allowed Glycine 0 C--N 1.339 0.75 0 N-CA-C 111.515 -0.634 . . . . 71.23 111.515 176.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 49.4 m -137.35 156.06 48.67 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.286 0.634 . . . . 71.24 110.601 -178.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -139.76 -170.36 11.93 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 110.976 -0.85 . . . . 55.11 110.976 175.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 88.55 -151.2 22.32 Favored Glycine 0 C--N 1.343 0.96 0 CA-C-N 117.031 0.416 . . . . 64.24 112.661 -178.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 68.5 m -158.2 -172.65 3.97 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.268 1.027 . . . . 61.24 109.755 -177.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -178.25 135.78 2.77 Favored Glycine 0 C--N 1.34 0.76 0 CA-C-O 119.695 -0.503 . . . . 51.22 111.994 171.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -63.51 -22.16 65.48 Favored Glycine 0 C--N 1.358 1.8 0 CA-C-O 121.423 0.457 . . . . 64.55 112.257 172.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 50.3 m -115.55 173.75 6.37 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.703 1.201 . . . . 65.54 108.915 168.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 67.54 14.92 9.72 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 124.49 1.116 . . . . 74.23 111.145 -172.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -85.59 153.51 22.35 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.574 0.75 . . . . 74.4 109.965 178.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 58.4 mt -131.81 152.93 50.64 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.546 0.738 . . . . 73.21 109.251 176.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -119.18 132.41 55.96 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 108.489 -0.93 . . . . 72.51 108.489 170.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -157.79 164.46 37.01 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.22 0.608 . . . . 53.24 110.022 178.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 99.4 m -96.03 146.67 24.44 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 115.647 -0.706 . . . . 74.5 109.64 175.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.476 HD12 HG23 ' A' ' 210' ' ' VAL . 42.7 tp -113.85 117.87 32.64 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.713 0.805 . . . . 72.41 109.288 175.242 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -89.26 100.71 13.44 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 123.783 0.833 . . . . 74.44 108.917 175.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.486 ' HA ' HG13 ' A' ' 210' ' ' VAL . 7.1 p -113.04 116.74 46.87 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 123.496 0.718 . . . . 74.52 109.839 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -56.18 145.91 73.91 Favored 'Trans proline' 0 C--N 1.374 1.904 0 C-N-CA 122.839 2.359 . . . . 54.3 112.4 173.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -50.28 -49.48 76.28 Favored Pre-proline 0 CA--C 1.558 1.285 0 O-C-N 124.542 1.151 . . . . 74.54 112.987 -179.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -55.06 -46.71 31.08 Favored 'Trans proline' 0 C--N 1.401 3.315 0 C-N-CA 122.484 2.123 . . . . 72.23 112.735 175.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . 0.516 HG21 HG11 ' A' ' 210' ' ' VAL . 42.1 mt -68.73 -32.54 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 123.664 0.786 . . . . 74.53 110.798 -176.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.59 -44.9 73.37 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.62 0.768 . . . . 52.41 110.459 179.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 95.4 t -64.64 -55.82 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 122.999 0.519 . . . . 71.04 110.602 178.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 17.0 m -69.49 -30.31 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 O-C-N 123.531 0.52 . . . . 75.32 112.171 -173.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 78.3 69.96 1.35 Allowed Glycine 0 C--N 1.348 1.222 0 N-CA-C 111.648 -0.581 . . . . 62.53 111.648 -172.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -104.13 -136.84 9.02 Favored Glycine 0 C--N 1.348 1.247 0 N-CA-C 111.657 -0.577 . . . . 60.44 111.657 -177.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 35.1 mtmm -133.03 137.04 46.33 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.432 0.693 . . . . 74.11 109.31 176.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.516 HG11 HG21 ' A' ' 203' ' ' ILE . 14.9 m -127.9 142.32 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 123.645 0.778 . . . . 74.02 109.731 174.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 61.5 ttp180 -83.68 117.12 23.0 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 116.13 -0.486 . . . . 73.43 110.049 -178.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -100.79 156.72 17.19 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.685 0.794 . . . . 72.25 109.194 174.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 76.1 mmm -107.18 121.29 44.23 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 122.729 0.412 . . . . 72.14 110.159 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 36.2 p -108.86 173.51 6.29 Favored 'General case' 0 C--O 1.243 0.726 0 C-N-CA 124.351 1.06 . . . . 64.53 108.62 170.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 13.3 mt -67.4 -24.38 65.66 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 122.625 0.37 . . . . 71.45 111.472 -175.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -87.55 -20.59 26.25 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.431 0.693 . . . . 65.2 111.498 -178.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 149.66 -160.68 28.58 Favored Glycine 0 C--N 1.35 1.318 0 CA-C-O 119.772 -0.46 . . . . 72.23 113.135 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -84.65 147.56 10.94 Favored 'Trans proline' 0 C--N 1.364 1.344 0 C-N-CA 123.061 2.507 . . . . 72.1 112.583 178.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.473 HG11 ' HA ' ' A' ' 177' ' ' PRO . 21.3 m -137.07 147.24 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 108.499 -0.926 . . . . 73.14 108.499 178.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -103.01 108.4 19.56 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 109.044 -0.724 . . . . 72.4 109.044 179.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . 0.509 HG21 ' HB3' ' A' ' 175' ' ' TYR . 49.1 t -94.49 120.5 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.565 1.146 . . . . 73.3 109.888 -174.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -71.95 107.55 4.75 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 109.662 -0.495 . . . . 70.33 109.662 174.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 41.8 t -71.65 129.88 87.92 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 124.152 0.981 . . . . 72.24 109.166 174.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -63.45 157.18 52.15 Favored 'Trans proline' 0 CA--C 1.56 1.797 0 C-N-CA 122.047 1.831 . . . . 74.12 111.799 170.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.7 151.1 85.47 Favored 'Trans proline' 0 C--N 1.366 1.491 0 C-N-CA 122.095 1.863 . . . . 73.43 111.646 173.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 73.3 mtt85 55.65 57.97 4.88 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.166 0.986 . . . . 73.42 111.661 177.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.532 HG23 ' HD2' ' A' ' 231' ' ' ARG . 28.1 m -98.85 113.94 26.3 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 114.719 -1.128 . . . . 64.32 110.476 -179.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -92.11 157.87 16.51 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.47 0.708 . . . . 73.24 110.03 177.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . 0.45 ' HB2' ' HB ' ' A' ' 255' ' ' ILE . . . -66.74 134.85 53.03 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 108.708 -0.849 . . . . 52.31 108.708 169.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 100.6 -3.06 56.11 Favored Glycine 0 C--O 1.241 0.585 0 O-C-N 123.53 0.519 . . . . 62.14 112.604 -173.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.532 ' HD2' HG23 ' A' ' 227' ' ' THR . 63.2 mtt-85 -69.61 159.65 33.01 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-O 121.382 0.611 . . . . 75.11 110.367 171.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 48.2 pttt -131.01 137.49 49.23 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.432 -0.804 . . . . 72.32 110.374 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.503 HD23 ' HB2' ' A' ' 173' ' ' ALA . 29.6 mt -123.52 135.14 53.87 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 108.156 -1.054 . . . . 74.24 108.156 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 18.9 ttt85 -122.4 101.59 7.59 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.364 -0.976 . . . . 73.53 108.364 167.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.454 HD12 ' CD1' ' A' ' 175' ' ' TYR . 13.3 mt -75.33 85.3 2.49 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 125.278 1.431 . . . . 73.53 109.441 -176.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.693 ' HA ' ' HB3' ' A' ' 248' ' ' ASP . 59.2 mttm -66.78 129.44 39.89 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.174 -0.921 . . . . 75.24 111.19 -176.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 75.89 12.43 83.94 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 123.811 0.695 . . . . 74.51 113.025 -178.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -137.21 49.97 2.0 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.588 1.155 . . . . 70.13 109.366 -176.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -113.68 -119.76 3.53 Favored Glycine 0 N--CA 1.473 1.157 0 N-CA-C 111.217 -0.753 . . . . 75.51 111.217 173.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -76.63 140.84 68.3 Favored Pre-proline 0 N--CA 1.48 1.058 0 C-N-CA 123.516 0.727 . . . . 63.44 109.853 176.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -66.88 128.1 18.18 Favored 'Trans proline' 0 C--N 1.376 2.004 0 C-N-CA 122.636 2.224 . . . . 71.14 111.3 170.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -129.09 161.16 22.6 Favored Glycine 0 N--CA 1.476 1.332 0 CA-C-O 119.548 -0.585 . . . . 71.3 112.196 176.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -68.5 -33.01 23.79 Favored 'Trans proline' 0 C--N 1.37 1.69 0 C-N-CA 122.457 2.105 . . . . 74.22 113.083 -177.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -99.03 -2.08 38.12 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.146 0.578 . . . . 65.42 112.298 -177.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 157.9 -151.07 22.23 Favored Glycine 0 C--N 1.344 0.981 0 N-CA-C 111.143 -0.783 . . . . 75.42 111.143 -177.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 29.8 mtt-85 -129.43 163.17 26.42 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 117.889 0.845 . . . . 71.43 111.019 174.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -87.61 -156.99 30.86 Favored Glycine 0 C--N 1.345 1.058 0 CA-C-N 115.051 -0.977 . . . . 53.15 111.641 167.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . 0.693 ' HB3' ' HA ' ' A' ' 236' ' ' LYS . 1.0 OUTLIER -130.07 135.6 48.42 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 122.935 0.494 . . . . 71.12 112.035 -177.78 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 34.5 tp -98.59 116.97 31.99 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.354 0.661 . . . . 74.51 109.586 178.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -91.01 107.8 19.44 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.69 0.796 . . . . 73.42 109.335 178.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 48.8 mt -97.23 141.85 29.85 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.201 0.6 . . . . 74.35 111.255 178.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -101.53 108.13 19.61 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.084 -0.962 . . . . 72.24 108.882 175.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 69.0 t -66.09 116.24 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-O 121.119 0.485 . . . . 74.03 111.025 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 36.7 mmm-85 -121.55 115.05 22.09 Favored 'General case' 0 C--O 1.242 0.677 0 N-CA-C 107.594 -1.261 . . . . 75.01 107.594 173.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.45 ' HB ' ' HB2' ' A' ' 229' ' ' ALA . 21.9 mt -75.07 129.03 37.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 N-CA-C 109.513 -0.551 . . . . 74.4 109.513 175.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 8.3 t . . . . . 0 CA--C 1.562 1.407 0 CA-C-O 117.418 -1.277 . . . . 70.45 108.3 178.439 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 53.3 tpp . . . . . 0 N--CA 1.475 0.824 0 N-CA-C 109.733 -0.469 . . . . 75.22 109.733 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 19.9 t70 63.89 88.84 0.1 Allowed 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.774 1.23 . . . . 74.34 111.202 178.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -152.78 -63.84 0.16 Allowed 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 107.456 -1.313 . . . . 64.35 107.456 175.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.504 HG22 ' HB3' ' A' ' 234' ' ' ARG . 16.2 m -88.22 161.59 2.74 Favored 'Isoleucine or valine' 0 C--O 1.244 0.78 0 N-CA-C 108.249 -1.019 . . . . 72.43 108.249 161.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 16.2 tt -91.02 133.18 33.55 Favored 'Isoleucine or valine' 0 C--O 1.243 0.721 0 N-CA-C 107.07 -1.456 . . . . 73.52 107.07 164.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -68.57 117.89 10.9 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 123.659 0.784 . . . . 74.23 110.152 -170.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.432 ' HB1' HD23 ' A' ' 233' ' ' LEU . . . -123.57 172.61 8.64 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.662 1.185 . . . . 73.4 108.834 178.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -152.81 158.25 41.95 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.386 0.674 . . . . 71.13 109.659 177.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -141.21 168.39 19.9 Favored 'General case' 0 C--N 1.35 0.59 0 C-N-CA 122.731 0.412 . . . . 73.51 110.761 177.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -142.78 149.23 49.23 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 124.95 1.3 . . . . 72.21 108.705 173.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . 0.544 ' HA ' HG12 ' A' ' 219' ' ' VAL . 20.4 Cg_endo -58.76 123.78 14.29 Favored 'Trans proline' 0 C--N 1.377 2.051 0 C-N-CA 122.931 2.42 . . . . 75.22 111.757 176.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . 0.52 ' HB3' ' HG3' ' A' ' 220' ' ' GLU . . . -77.98 -38.98 43.83 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.694 0.798 . . . . 71.45 109.827 179.201 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -93.34 152.74 18.95 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 114.637 -1.165 . . . . 74.23 109.58 175.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -74.7 85.2 0.76 Allowed Glycine 0 C--N 1.35 1.316 0 N-CA-C 111.312 -0.715 . . . . 73.13 111.312 177.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 29.3 p -78.23 130.79 36.7 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.885 0.874 . . . . 74.34 110.904 -178.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -101.89 -21.82 10.74 Favored Glycine 0 C--N 1.348 1.243 0 CA-C-N 116.317 -0.401 . . . . 71.1 113.011 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -92.93 37.88 3.29 Favored Glycine 0 C--N 1.348 1.248 0 C-N-CA 123.029 0.347 . . . . 65.33 112.503 -177.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 20.6 p -79.62 84.71 5.43 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.616 0.767 . . . . 75.12 110.698 -178.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 176.94 135.39 2.17 Favored Glycine 0 C--N 1.347 1.163 0 CA-C-N 115.428 -0.806 . . . . 53.41 111.722 176.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -110.21 -150.93 12.94 Favored Glycine 0 C--N 1.351 1.415 0 C-N-CA 123.557 0.598 . . . . 74.4 111.763 176.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 70.8 m -155.16 -50.6 0.09 Allowed 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.205 0.602 . . . . 74.43 110.146 177.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 177.22 -157.22 21.89 Favored Glycine 0 C--N 1.342 0.886 0 CA-C-N 116.234 -0.439 . . . . 70.34 112.013 -177.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 76.48 -124.72 7.3 Favored Glycine 0 C--N 1.346 1.132 0 N-CA-C 111.775 -0.53 . . . . 74.24 111.775 -179.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 49.5 m -104.43 94.02 5.11 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.387 0.675 . . . . 74.04 109.645 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.416 ' O ' ' HA3' ' A' ' 247' ' ' GLY . 25.0 mm-40 -85.61 5.4 31.96 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 115.317 -0.856 . . . . 73.45 111.423 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -93.41 157.72 16.08 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.462 0.705 . . . . 75.22 110.047 175.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 43.1 mt -136.24 143.35 44.25 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.323 1.049 . . . . 75.03 108.282 171.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -129.61 120.76 25.79 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 123.791 0.836 . . . . 74.23 109.079 -178.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -159.37 165.18 33.82 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 121.47 0.653 . . . . 74.51 110.931 -177.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 2.9 p -93.25 138.3 31.76 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.798 0.839 . . . . 74.33 109.56 173.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.552 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . 57.9 tp -108.6 119.34 39.22 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.597 1.159 . . . . 71.3 109.497 -177.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -82.2 103.2 11.63 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 109.562 -0.533 . . . . 72.02 109.562 176.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.521 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 47.5 t -106.21 111.17 64.36 Favored Pre-proline 0 CA--C 1.542 0.643 0 N-CA-C 108.195 -1.039 . . . . 73.33 108.195 175.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . 0.488 ' HA ' ' HG1' ' A' ' 256' ' ' THR . 50.5 Cg_exo -57.38 142.1 94.98 Favored 'Trans proline' 0 C--N 1.373 1.862 0 C-N-CA 122.498 2.132 . . . . 72.15 111.874 172.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . 0.4 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -50.66 -47.5 84.87 Favored Pre-proline 0 CA--C 1.559 1.298 0 CA-C-O 117.793 -1.099 . . . . 62.3 112.985 -177.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.4 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 16.3 Cg_endo -55.49 -41.93 73.05 Favored 'Trans proline' 0 C--N 1.398 3.178 0 C-N-CA 122.095 1.863 . . . . 64.23 112.891 176.021 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . 0.434 HD13 ' HD2' ' A' ' 200' ' ' PRO . 34.5 mt -69.71 -36.2 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 C-N-CA 123.379 0.671 . . . . 74.45 110.894 -177.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.24 -38.32 78.44 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.227 0.611 . . . . 64.42 111.651 -178.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 89.3 t -72.7 -56.29 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 CA-C-N 115.689 -0.687 . . . . 74.34 110.82 -178.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 9.4 m -80.39 -24.69 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 CA-C-N 116.294 -0.412 . . . . 73.51 111.985 -172.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 82.47 136.92 2.56 Favored Glycine 0 C--N 1.349 1.254 0 O-C-N 123.433 0.458 . . . . 44.1 112.622 -175.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 179.49 -124.91 0.93 Allowed Glycine 0 C--N 1.341 0.844 0 N-CA-C 111.776 -0.529 . . . . 74.34 111.776 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.506 ' HD2' ' HB3' ' A' ' 220' ' ' GLU . 46.9 mtmt -137.63 153.02 49.93 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.654 0.781 . . . . 74.22 109.817 176.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.484 HG12 ' HA ' ' A' ' 199' ' ' VAL . 27.3 m -128.84 168.23 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.578 1.151 . . . . 72.32 108.707 170.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 45.9 ttp180 -94.78 141.48 28.58 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 109.761 -0.459 . . . . 72.23 109.761 173.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -129.77 154.78 46.87 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.02 0.928 . . . . 75.34 109.036 173.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -103.66 114.45 28.72 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 109.218 -0.66 . . . . 73.13 109.218 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 64.4 p -114.57 175.62 5.41 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.246 0.618 . . . . 73.53 109.439 174.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 11.8 mt -81.12 -3.17 51.14 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 116.109 -0.496 . . . . 70.5 110.283 173.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -91.54 -20.34 21.8 Favored 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 123.862 0.865 . . . . 74.42 110.403 170.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 133.23 -163.64 24.3 Favored Glycine 0 C--N 1.352 1.446 0 CA-C-O 119.752 -0.471 . . . . 62.43 112.595 177.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -74.93 131.03 13.91 Favored 'Trans proline' 0 C--N 1.37 1.705 0 C-N-CA 123.042 2.495 . . . . 75.13 110.278 172.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.544 HG12 ' HA ' ' A' ' 177' ' ' PRO . 17.9 m -131.19 161.83 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 123.538 0.735 . . . . 63.32 110.478 -173.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.52 ' HG3' ' HB3' ' A' ' 178' ' ' ALA . 35.4 mt-10 -112.18 113.25 25.4 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.645 0.778 . . . . 74.51 109.681 178.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 57.5 t -95.46 118.99 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.229 1.011 . . . . 74.1 109.059 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -67.54 100.13 0.84 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.777 0.831 . . . . 70.43 110.149 176.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 91.7 t -81.77 121.02 79.09 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 124.562 1.145 . . . . 73.1 109.858 176.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -65.56 155.27 69.84 Favored 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 122.22 1.947 . . . . 71.24 111.482 173.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -66.77 156.23 66.91 Favored 'Trans proline' 0 C--N 1.37 1.702 0 C-N-CA 122.322 2.015 . . . . 74.35 111.731 172.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 49.0 mtm-85 63.34 31.53 15.2 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.19 0.996 . . . . 74.34 111.151 172.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 92.1 m -86.84 122.62 30.97 Favored 'General case' 0 C--N 1.344 0.367 0 C-N-CA 123.58 0.752 . . . . 73.2 109.256 176.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -94.35 167.79 11.3 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.499 0.719 . . . . 75.04 110.715 177.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -78.71 149.21 32.81 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-N 114.936 -1.029 . . . . 74.12 109.816 177.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 87.34 1.43 83.88 Favored Glycine 0 C--N 1.339 0.716 0 CA-C-N 115.681 -0.69 . . . . 75.13 111.963 -173.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 54.3 mtt-85 -79.25 163.05 25.27 Favored 'General case' 0 C--N 1.353 0.76 0 CA-C-O 121.419 0.628 . . . . 71.22 110.103 170.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 15.9 pttm -128.41 139.97 52.08 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 124.344 1.058 . . . . 72.25 109.491 -178.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.432 HD23 ' HB1' ' A' ' 173' ' ' ALA . 90.0 mt -120.29 105.95 11.42 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.25 1.02 . . . . 74.24 108.906 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . 0.504 ' HB3' HG22 ' A' ' 170' ' ' VAL . 71.4 ttt180 -90.49 101.45 14.19 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 107.278 -1.378 . . . . 74.21 107.278 170.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 22.8 mt -77.13 83.41 3.62 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 107.718 -1.215 . . . . 73.3 107.718 174.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -68.68 129.0 38.67 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-N 113.049 -1.887 . . . . 75.54 111.861 -169.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 60.62 32.2 77.61 Favored Glycine 0 C--N 1.347 1.188 0 O-C-N 124.738 1.274 . . . . 72.15 112.473 177.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -136.79 -2.92 2.09 Favored 'General case' 0 C--N 1.358 0.964 0 N-CA-C 113.641 0.978 . . . . 74.25 113.641 -176.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . 0.407 ' HA2' ' HB2' ' A' ' 249' ' ' LEU . . . -61.69 -107.33 0.01 OUTLIER Glycine 0 N--CA 1.485 1.965 0 N-CA-C 114.603 0.601 . . . . 71.52 114.603 -178.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -67.81 136.31 92.38 Favored Pre-proline 0 N--CA 1.486 1.351 0 CA-C-O 118.328 -0.844 . . . . 73.33 109.523 171.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.432 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 37.8 Cg_exo -60.88 135.65 60.93 Favored 'Trans proline' 0 C--N 1.371 1.75 0 C-N-CA 122.648 2.232 . . . . 72.3 112.532 175.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -164.86 120.56 0.94 Allowed Glycine 0 CA--C 1.54 1.613 0 CA-C-O 118.556 -1.136 . . . . 73.22 111.99 -177.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -72.25 -20.13 24.95 Favored 'Trans proline' 0 C--N 1.387 2.554 0 C-N-CA 123.506 2.804 . . . . 73.12 112.811 176.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -93.29 12.64 23.91 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.231 0.612 . . . . 64.44 110.695 175.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 118.97 120.24 2.91 Favored Glycine 0 C--N 1.353 1.477 0 N-CA-C 110.592 -1.003 . . . . 72.35 110.592 -177.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.432 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 28.0 mtt180 -72.29 162.67 29.15 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.291 0.636 . . . . 73.32 109.71 174.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . 0.416 ' HA3' ' O ' ' A' ' 191' ' ' GLN . . . -80.56 -157.86 16.77 Favored Glycine 0 C--N 1.348 1.234 0 N-CA-C 112.435 -0.266 . . . . 73.13 112.435 174.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -121.43 128.85 52.58 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 117.407 0.603 . . . . 71.53 109.786 177.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.407 ' HB2' ' HA2' ' A' ' 239' ' ' GLY . 50.2 tp -100.19 108.18 20.22 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 108.263 -1.014 . . . . 71.51 108.263 173.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -98.69 116.43 30.91 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 108.522 -0.918 . . . . 72.1 108.522 -174.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.552 ' HB3' ' HB2' ' A' ' 197' ' ' LEU . 49.1 mt -127.22 119.17 25.78 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.024 0.93 . . . . 75.51 110.271 -173.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -83.57 121.33 27.09 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 122.979 0.511 . . . . 75.43 110.192 176.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 61.2 t -66.87 105.49 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 C-N-CA 123.691 0.796 . . . . 75.13 110.46 179.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 47.6 mmm-85 -107.25 100.02 9.51 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 107.703 -1.221 . . . . 74.04 107.703 173.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.521 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 39.8 mt -76.94 119.37 25.21 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 CA-C-N 116.063 -0.517 . . . . 75.42 110.422 -178.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' THR . . . . . 0.488 ' HG1' ' HA ' ' A' ' 200' ' ' PRO . 29.5 p . . . . . 0 C--O 1.249 1.06 0 N-CA-C 108.393 -0.965 . . . . 70.12 108.393 175.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 67.2 mtm . . . . . 0 N--CA 1.48 1.072 0 N-CA-C 109.752 -0.462 . . . . 74.43 109.752 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -89.21 48.33 1.6 Allowed 'General case' 0 N--CA 1.48 1.074 0 CA-C-O 121.89 0.853 . . . . 64.14 110.148 177.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -58.14 -55.64 32.38 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 114.757 -1.111 . . . . 73.43 109.707 174.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.445 HG12 ' HG3' ' A' ' 232' ' ' LYS . 33.5 m -92.03 156.09 3.05 Favored 'Isoleucine or valine' 0 C--O 1.244 0.784 0 CA-C-N 114.87 -1.059 . . . . 61.45 109.147 171.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 16.6 tt -83.3 143.43 11.95 Favored 'Isoleucine or valine' 0 C--O 1.245 0.863 0 N-CA-C 108.703 -0.851 . . . . 75.33 108.703 171.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -59.92 137.96 57.94 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.301 1.041 . . . . 74.32 110.787 -176.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.45 ' HB1' HD23 ' A' ' 233' ' ' LEU . . . -157.69 159.34 36.81 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.319 1.048 . . . . 62.12 109.537 -178.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -160.42 152.22 19.93 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.604 0.762 . . . . 72.11 109.742 174.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.5 ' HB3' HG21 ' A' ' 221' ' ' VAL . 34.6 p90 -113.7 -178.67 3.43 Favored 'General case' 0 C--N 1.349 0.561 0 CA-C-O 121.23 0.538 . . . . 74.12 111.704 -178.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -135.78 140.71 34.43 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-N 114.394 -1.275 . . . . 73.24 107.955 170.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -60.87 113.92 1.93 Allowed 'Trans proline' 0 C--N 1.366 1.487 0 C-N-CA 123.212 2.608 . . . . 75.34 111.134 175.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . 0.441 ' HB3' ' HG3' ' A' ' 220' ' ' GLU . . . -99.98 -10.51 21.54 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.497 0.719 . . . . 73.41 110.848 175.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -55.52 -46.73 77.0 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.226 1.011 . . . . 74.44 111.956 -178.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 86.42 -10.73 65.73 Favored Glycine 0 C--N 1.345 1.047 0 N-CA-C 115.562 0.985 . . . . 63.14 115.562 168.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 61.9 p -151.1 14.54 0.71 Allowed 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 118.017 0.909 . . . . 71.24 111.925 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 77.95 109.19 0.18 Allowed Glycine 0 C--N 1.348 1.222 0 CA-C-O 119.338 -0.701 . . . . 55.14 111.502 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -68.92 -109.72 0.02 OUTLIER Glycine 0 C--N 1.352 1.447 0 CA-C-N 116.99 0.395 . . . . 72.25 112.862 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 12.3 t -133.8 28.45 3.89 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 109.011 -0.737 . . . . 73.41 109.011 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -69.9 94.0 0.42 Allowed Glycine 0 C--N 1.346 1.091 0 CA-C-N 115.238 -0.892 . . . . 52.21 112.817 -177.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -141.3 150.75 22.1 Favored Glycine 0 C--O 1.242 0.617 0 N-CA-C 109.57 -1.412 . . . . 64.24 109.57 171.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' SER . . . . . 0.548 ' HA ' ' HD2' ' A' ' 240' ' ' PHE . 27.4 p -75.66 79.78 2.63 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-O 121.72 0.771 . . . . 72.54 110.378 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -80.0 -29.72 45.46 Favored Glycine 0 C--N 1.343 0.959 0 CA-C-N 114.929 -1.032 . . . . 60.04 112.157 176.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 156.71 150.6 5.72 Favored Glycine 0 C--N 1.344 0.989 0 CA-C-O 119.105 -0.83 . . . . 64.31 111.225 177.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 16.7 m 58.59 103.61 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.544 1.138 . . . . 71.3 110.729 -175.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.461 ' HA ' ' HB2' ' A' ' 240' ' ' PHE . 18.2 mm100 -69.69 -24.38 63.58 Favored 'General case' 0 CA--C 1.553 1.061 0 N-CA-C 112.683 0.623 . . . . 74.04 112.683 -175.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -93.02 141.18 28.69 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.427 0.691 . . . . 71.52 110.07 -178.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 17.6 mt -123.44 148.4 46.2 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 124.971 1.308 . . . . 72.24 109.22 174.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -127.86 120.64 28.19 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.21 0.604 . . . . 75.41 109.673 177.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.425 ' O ' ' HA ' ' A' ' 251' ' ' LEU . . . -145.35 160.06 42.11 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.729 0.812 . . . . 74.15 109.939 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 11.5 m -102.55 143.79 31.8 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 108.771 -0.826 . . . . 74.1 108.771 176.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.534 HD11 HG22 ' A' ' 210' ' ' VAL . 49.0 tp -113.95 124.97 53.45 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.634 1.174 . . . . 74.01 109.858 -173.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -96.97 102.86 14.72 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.375 0.67 . . . . 73.22 109.522 175.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.517 ' HA ' HG12 ' A' ' 210' ' ' VAL . 3.2 p -104.45 125.9 32.89 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 124.093 0.957 . . . . 74.23 109.675 173.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . 0.462 ' HA ' ' HG1' ' A' ' 256' ' ' THR . 50.4 Cg_exo -56.86 148.44 66.93 Favored 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 122.698 2.265 . . . . 74.52 112.526 170.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . 0.488 ' HA ' HG22 ' A' ' 255' ' ' ILE . . . -49.38 -52.39 49.75 Favored Pre-proline 0 CA--C 1.56 1.359 0 C-N-CA 124.269 1.027 . . . . 73.43 112.452 178.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.41 ' O ' HG12 ' A' ' 206' ' ' VAL . 30.8 Cg_endo -61.28 -40.3 50.76 Favored 'Trans proline' 0 C--N 1.4 3.266 0 C-N-CA 121.752 1.635 . . . . 75.32 112.877 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 29.1 mt -68.7 -30.48 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 123.233 0.613 . . . . 74.23 110.669 -178.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.92 -42.52 73.19 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 122.827 0.451 . . . . 62.2 110.662 177.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.438 HG21 ' O ' ' A' ' 201' ' ' ALA . 61.4 t -71.05 -53.9 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 123.303 0.641 . . . . 75.33 111.438 -177.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.41 HG12 ' O ' ' A' ' 202' ' ' PRO . 7.7 p -80.09 -31.59 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 122.439 0.296 . . . . 73.11 111.787 -174.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 93.45 131.22 5.84 Favored Glycine 0 CA--C 1.532 1.105 0 N-CA-C 111.618 -0.593 . . . . 75.21 111.618 -172.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -166.72 -143.87 3.91 Favored Glycine 0 C--N 1.341 0.856 0 CA-C-O 119.339 -0.701 . . . . 74.34 111.899 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.546 ' HB2' ' HZ3' ' A' ' 209' ' ' LYS . 9.6 mtmp? -132.96 145.71 51.13 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.886 0.874 . . . . 73.31 109.704 174.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.534 HG22 HD11 ' A' ' 197' ' ' LEU . 22.1 m -139.44 158.54 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 124.385 1.074 . . . . 74.42 110.219 177.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 29.2 mtp-105 -79.76 132.87 36.27 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 122.917 0.487 . . . . 72.42 111.598 -177.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -121.12 125.21 46.67 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 125.368 1.467 . . . . 65.35 108.016 172.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.65 106.89 18.82 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 123.478 0.711 . . . . 71.02 110.124 -175.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 29.8 p -117.38 172.51 7.27 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.402 0.681 . . . . 73.21 109.928 -179.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 9.3 mt -71.54 -24.77 62.0 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 109.541 -0.541 . . . . 72.11 109.541 175.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -79.52 -18.87 50.93 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.128 0.971 . . . . 75.14 110.767 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 135.19 -175.51 20.61 Favored Glycine 0 C--N 1.353 1.495 0 CA-C-N 116.064 -0.517 . . . . 53.51 112.948 172.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -66.76 126.48 15.43 Favored 'Trans proline' 0 C--N 1.372 1.809 0 C-N-CA 122.931 2.42 . . . . 72.0 110.644 168.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 35.4 m -133.16 138.68 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 122.882 0.473 . . . . 64.44 110.67 -178.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.468 ' HB3' ' HB3' ' A' ' 209' ' ' LYS . 46.9 mt-10 -92.99 108.55 20.09 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.178 0.591 . . . . 72.13 110.777 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . 0.5 HG21 ' HB3' ' A' ' 175' ' ' TYR . 61.0 t -91.89 119.24 38.93 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 C-N-CA 124.451 1.101 . . . . 70.04 109.429 -176.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -65.04 102.61 0.64 Allowed 'General case' 0 C--O 1.239 0.534 0 O-C-N 124.309 1.005 . . . . 72.54 109.969 175.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.43 HG11 HG23 ' A' ' 199' ' ' VAL . 48.1 t -74.8 117.28 61.27 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 124.376 1.07 . . . . 70.03 109.061 172.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -59.62 156.64 35.96 Favored 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 122.32 2.013 . . . . 73.11 112.158 178.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -63.06 125.24 15.45 Favored 'Trans proline' 0 C--N 1.375 1.945 0 C-N-CA 122.389 2.059 . . . . 75.03 111.567 177.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 72.9 mtm180 68.13 83.51 0.16 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.962 1.305 . . . . 75.43 110.051 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.525 HG23 HG13 ' A' ' 253' ' ' VAL . 89.8 m -126.48 117.5 23.02 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.011 0.924 . . . . 73.01 109.464 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -85.79 158.35 20.02 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.939 0.895 . . . . 73.33 112.151 -172.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -72.54 124.33 24.99 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 114.635 -1.166 . . . . 64.45 109.951 179.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 102.28 2.85 51.07 Favored Glycine 0 C--N 1.335 0.52 0 CA-C-O 119.524 -0.598 . . . . 74.23 112.596 -176.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 87.1 mtt180 -72.66 161.27 30.98 Favored 'General case' 0 C--N 1.356 0.879 0 CA-C-O 121.264 0.554 . . . . 74.2 110.051 170.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.445 ' HG3' HG12 ' A' ' 170' ' ' VAL . 19.9 pttm -124.38 140.47 52.92 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.324 -0.853 . . . . 74.44 109.876 -179.116 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.45 HD23 ' HB1' ' A' ' 173' ' ' ALA . 61.4 mt -117.87 141.28 48.61 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 107.49 -1.3 . . . . 73.31 107.49 176.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 30.6 ttt180 -130.88 101.73 5.76 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 108.081 -1.081 . . . . 73.53 108.081 167.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 27.6 mt -71.03 87.31 0.74 Allowed 'General case' 0 C--O 1.24 0.603 0 CA-C-N 114.524 -1.216 . . . . 72.14 108.286 175.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 59.6 mtmt -68.75 122.98 19.7 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 114.272 -1.331 . . . . 75.1 111.006 -174.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 69.65 26.42 74.48 Favored Glycine 0 C--N 1.345 1.079 0 O-C-N 124.305 1.003 . . . . 72.43 112.303 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.438 ' HB3' ' CE1' ' A' ' 175' ' ' TYR . 31.3 mmtp -135.85 35.02 2.87 Favored 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 124.512 1.125 . . . . 74.21 110.985 -172.007 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -114.27 -115.36 3.14 Favored Glycine 0 N--CA 1.477 1.414 0 N-CA-C 111.952 -0.459 . . . . 73.31 111.952 177.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . 0.548 ' HD2' ' HA ' ' A' ' 187' ' ' SER . 1.8 m-85 -69.83 142.03 90.49 Favored Pre-proline 0 N--CA 1.485 1.321 0 C-N-CA 123.17 0.588 . . . . 70.32 110.946 177.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -52.44 144.12 41.9 Favored 'Trans proline' 0 C--N 1.376 1.985 0 C-N-CA 123.687 2.925 . . . . 71.01 113.602 172.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -156.8 113.31 0.56 Allowed Glycine 0 CA--C 1.531 1.063 0 CA-C-O 118.399 -1.223 . . . . 73.23 110.248 -179.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.26 -14.98 45.33 Favored 'Trans proline' 0 C--N 1.386 2.521 0 C-N-CA 123.535 2.823 . . . . 70.32 114.565 -176.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -112.6 -12.24 13.46 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 123.529 0.732 . . . . 72.34 111.594 175.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 163.03 125.68 0.78 Allowed Glycine 0 C--N 1.344 0.998 0 N-CA-C 111.123 -0.791 . . . . 75.43 111.123 -178.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 12.3 mtm180 -73.63 162.32 29.33 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.135 0.574 . . . . 72.04 110.928 -178.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -83.82 -163.72 35.78 Favored Glycine 0 C--N 1.348 1.212 0 CA-C-N 115.894 -0.594 . . . . 65.15 112.971 178.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -108.36 157.46 18.37 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.213 0.605 . . . . 74.54 110.676 -176.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 45.6 tp -132.83 110.91 10.66 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.101 0.96 . . . . 74.34 108.571 170.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 21.9 t80 -96.28 120.97 37.55 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.382 1.073 . . . . 73.42 109.326 -176.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.425 ' HA ' ' O ' ' A' ' 195' ' ' ALA . 51.5 mt -120.02 126.98 52.14 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.727 0.811 . . . . 72.24 110.862 -176.288 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.99 116.52 25.1 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 122.886 0.474 . . . . 75.03 110.434 173.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.525 HG13 HG23 ' A' ' 227' ' ' THR . 96.7 t -65.71 115.58 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 123.381 0.673 . . . . 73.13 110.511 176.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -121.12 111.62 17.67 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.015 0.926 . . . . 71.42 109.193 172.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.488 HG22 ' HA ' ' A' ' 201' ' ' ALA . 44.7 mt -76.89 121.47 29.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 108.988 -0.745 . . . . 74.02 108.988 175.18 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' THR . . . . . 0.462 ' HG1' ' HA ' ' A' ' 200' ' ' PRO . 34.6 p . . . . . 0 C--O 1.253 1.254 0 N-CA-C 108.23 -1.026 . . . . 72.02 108.23 175.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 N--CA 1.484 1.257 0 N-CA-C 111.251 0.093 . . . . 74.4 111.251 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -74.65 105.73 5.88 Favored 'General case' 0 C--N 1.35 0.593 0 N-CA-C 108.759 -0.83 . . . . 75.22 108.759 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -49.06 -53.15 21.61 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 125.719 1.608 . . . . 73.21 113.409 -176.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.414 HG21 ' HB3' ' A' ' 234' ' ' ARG . 12.9 m -90.33 -174.82 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.019 0 C-N-CA 123.542 0.737 . . . . 73.13 110.651 -175.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 10.3 tt -93.85 137.46 22.73 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.124 0 N-CA-C 108.29 -1.004 . . . . 72.21 108.29 165.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -74.84 113.39 12.08 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.438 1.095 . . . . 52.54 110.02 -175.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.459 ' HB1' HD23 ' A' ' 233' ' ' LEU . . . -111.6 178.95 4.16 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.449 0.7 . . . . 73.03 110.711 -178.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -146.76 156.5 43.2 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.572 1.149 . . . . 72.43 109.456 178.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -130.67 172.06 12.38 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.086 0.47 . . . . 75.23 110.045 168.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -134.5 140.91 37.06 Favored Pre-proline 0 N--CA 1.476 0.837 0 C-N-CA 124.585 1.154 . . . . 75.21 108.27 175.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -64.04 106.08 0.63 Allowed 'Trans proline' 0 C--N 1.363 1.342 0 C-N-CA 122.775 2.317 . . . . 74.22 111.035 175.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -63.83 -36.87 85.34 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.535 0.734 . . . . 73.23 111.826 -175.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -94.67 -41.69 9.16 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.434 0.694 . . . . 63.43 110.057 176.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 128.12 10.3 3.49 Favored Glycine 0 C--N 1.353 1.494 0 CA-C-O 119.648 -0.529 . . . . 64.51 113.603 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 21.1 t -97.41 171.57 8.31 Favored 'General case' 0 N--CA 1.486 1.325 0 CA-C-N 117.638 0.719 . . . . 72.12 110.89 -179.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 117.85 92.69 1.59 Allowed Glycine 0 C--N 1.346 1.118 0 N-CA-C 110.596 -1.002 . . . . 75.24 110.596 -174.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -175.72 -32.82 0.04 OUTLIER Glycine 0 C--N 1.35 1.358 0 CA-C-N 117.229 0.515 . . . . 61.31 114.204 -177.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 34.6 p -110.49 10.13 23.2 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 112.967 0.729 . . . . 62.35 112.967 -173.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . 0.402 ' N ' ' HG2' ' A' ' 241' ' ' PRO . . . -55.1 109.99 1.54 Allowed Glycine 0 C--N 1.348 1.23 0 O-C-N 123.502 0.501 . . . . 74.54 113.735 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -143.23 114.57 0.85 Allowed Glycine 0 C--N 1.341 0.847 0 N-CA-C 110.777 -0.929 . . . . 55.31 110.777 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 16.7 t -162.86 115.43 1.6 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.61 0.764 . . . . 72.14 109.803 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 73.93 8.03 77.11 Favored Glycine 0 C--N 1.356 1.649 0 O-C-N 123.612 0.57 . . . . 62.12 114.188 176.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 64.16 26.24 70.26 Favored Glycine 0 C--N 1.35 1.325 0 CA-C-N 116.812 0.306 . . . . 62.4 112.456 -174.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 29.0 m -83.68 156.15 22.78 Favored 'General case' 0 C--N 1.35 0.604 0 C-N-CA 123.714 0.806 . . . . 63.3 111.363 -175.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.467 ' HA ' ' HB2' ' A' ' 240' ' ' PHE . 23.9 mm-40 -114.47 -21.12 10.49 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.079 0.952 . . . . 64.34 110.084 168.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -89.6 146.92 24.22 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.031 0.932 . . . . 74.23 109.927 -170.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 13.7 mt -140.53 131.56 26.23 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 107.634 -1.247 . . . . 70.41 107.634 166.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -120.13 128.3 53.31 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 108.782 -0.822 . . . . 73.43 108.782 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -157.53 162.04 38.82 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.742 0.817 . . . . 73.25 110.157 178.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 17.2 p -91.87 149.12 21.74 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 109.033 -0.728 . . . . 70.32 109.033 170.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.61 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . 40.8 tp -113.4 115.01 27.4 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 123.622 0.769 . . . . 75.23 109.549 -175.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -80.03 100.96 8.42 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.625 0.77 . . . . 72.22 109.163 -179.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.565 ' HA ' HG12 ' A' ' 210' ' ' VAL . 40.9 t -109.84 104.39 55.38 Favored Pre-proline 0 CA--C 1.54 0.578 0 N-CA-C 108.509 -0.923 . . . . 60.54 108.509 178.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . 0.49 ' HA ' ' HG1' ' A' ' 256' ' ' THR . 77.1 Cg_exo -53.22 139.79 62.62 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 122.723 2.282 . . . . 74.43 112.07 174.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . 0.403 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -47.8 -47.84 61.78 Favored Pre-proline 0 CA--C 1.558 1.266 0 C-N-CA 124.377 1.071 . . . . 74.42 113.749 -175.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.1 -45.06 34.13 Favored 'Trans proline' 0 C--N 1.39 2.716 0 C-N-CA 121.977 1.785 . . . . 74.44 112.902 174.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 36.6 mt -66.1 -32.24 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 123.577 0.751 . . . . 64.54 110.84 -177.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -65.91 -50.64 63.75 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 122.994 0.518 . . . . 73.12 110.377 177.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 201' ' ' ALA . 81.4 t -64.3 -53.23 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 O-C-N 123.877 0.736 . . . . 74.45 111.685 -175.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 26.9 m -78.31 -26.28 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 N-CA-C 112.237 0.458 . . . . 73.33 112.237 -176.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 81.01 139.99 2.65 Favored Glycine 0 C--N 1.349 1.301 0 N-CA-C 112.147 -0.381 . . . . 74.45 112.147 -175.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -177.74 -124.27 0.84 Allowed Glycine 0 C--N 1.344 0.995 0 CA-C-N 117.202 0.501 . . . . 45.22 112.506 -178.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -136.59 153.13 51.05 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.977 0.911 . . . . 74.43 108.71 176.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.565 HG12 ' HA ' ' A' ' 199' ' ' VAL . 15.7 m -138.06 128.03 35.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 123.268 0.627 . . . . 72.5 109.381 171.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 63.6 mtm-85 -81.95 110.29 17.09 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.38 0.672 . . . . 73.35 110.796 -176.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -100.46 161.14 13.8 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.677 1.191 . . . . 74.32 109.93 178.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' MET . . . . . 0.436 ' HA ' ' HE2' ' A' ' 213' ' ' MET . 8.1 mmt -99.17 119.82 38.49 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.714 0.805 . . . . 72.32 109.889 -177.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 76.4 p -110.6 175.49 5.41 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.52 0.728 . . . . 74.24 109.113 170.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 29.1 mt -69.84 -10.43 58.41 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 112.712 0.634 . . . . 75.34 112.712 -174.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -117.43 -12.69 10.39 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.266 0.626 . . . . 73.51 112.284 -177.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 153.15 -169.62 32.05 Favored Glycine 0 C--N 1.356 1.655 0 N-CA-C 114.335 0.494 . . . . 71.42 114.335 173.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -70.22 141.23 42.85 Favored 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 123.558 2.839 . . . . 74.32 112.456 176.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 34.6 m -137.89 130.96 41.75 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 C-N-CA 123.547 0.739 . . . . 61.43 110.157 178.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -88.07 108.52 19.28 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.408 0.683 . . . . 71.34 110.173 -178.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 44.9 t -94.74 122.95 46.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 123.734 0.814 . . . . 73.24 109.682 -176.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -68.61 107.0 2.79 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.205 1.002 . . . . 73.51 111.452 -177.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 66.4 t -86.2 121.05 72.74 Favored Pre-proline 0 CA--C 1.553 1.065 0 C-N-CA 124.634 1.174 . . . . 71.44 110.047 176.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -63.52 164.38 20.98 Favored 'Trans proline' 0 C--N 1.379 2.183 0 C-N-CA 122.918 2.412 . . . . 65.42 112.527 174.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -66.28 128.35 19.25 Favored 'Trans proline' 0 C--N 1.376 2.008 0 C-N-CA 122.615 2.21 . . . . 72.3 112.184 173.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 63.3 mtm-85 62.81 70.54 0.55 Allowed 'General case' 0 C--N 1.353 0.746 0 C-N-CA 124.724 1.21 . . . . 72.3 110.846 178.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.573 HG22 HG13 ' A' ' 253' ' ' VAL . 56.8 m -101.57 114.72 29.01 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 114.829 -1.078 . . . . 63.11 109.376 -178.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 22.9 mp0 -84.79 153.03 23.25 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.271 0.628 . . . . 72.41 111.404 -174.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -73.15 127.89 33.91 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.734 -0.839 . . . . 64.13 108.734 174.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 110.08 -11.84 31.65 Favored Glycine 0 C--N 1.333 0.366 0 N-CA-C 111.533 -0.627 . . . . 55.14 111.533 -171.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.499 ' HD2' HG21 ' A' ' 227' ' ' THR . 90.7 mtt180 -66.81 156.79 34.61 Favored 'General case' 0 C--N 1.36 1.043 0 CA-C-O 121.361 0.601 . . . . 75.13 110.142 169.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 38.3 pttt -131.91 135.08 46.37 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 114.996 -1.002 . . . . 74.44 109.391 -176.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.459 HD23 ' HB1' ' A' ' 173' ' ' ALA . 75.9 mt -115.96 137.06 52.45 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 108.081 -1.081 . . . . 72.54 108.081 176.204 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . 0.414 ' HB3' HG21 ' A' ' 170' ' ' VAL . 40.8 ttm105 -119.52 120.49 36.92 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.565 -1.272 . . . . 75.5 107.565 166.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.518 ' O ' ' HA ' ' A' ' 248' ' ' ASP . 43.7 mt -101.88 78.82 1.84 Allowed 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 108.678 -0.86 . . . . 61.1 108.678 -177.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -75.95 144.15 41.17 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 122.883 0.473 . . . . 74.14 109.856 176.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 68.31 18.16 71.1 Favored Glycine 0 C--N 1.344 1.005 0 CA-C-N 115.639 -0.709 . . . . 64.43 112.336 -174.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 10.1 mmpt? -129.75 -30.58 2.04 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.352 1.061 . . . . 70.24 110.728 -175.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -66.84 -125.83 0.02 OUTLIER Glycine 0 C--N 1.36 1.863 0 N-CA-C 114.766 0.666 . . . . 64.41 114.766 -171.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . 0.467 ' HB2' ' HA ' ' A' ' 191' ' ' GLN . 1.1 m-85 -67.78 135.46 92.31 Favored Pre-proline 0 N--CA 1.482 1.15 0 CA-C-O 118.802 -0.618 . . . . 65.34 109.903 177.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.447 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 37.3 Cg_exo -42.51 138.46 3.41 Favored 'Trans proline' 0 C--N 1.378 2.101 0 C-N-CA 124.278 3.319 . . . . 74.42 114.92 175.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -164.46 113.16 0.54 Allowed Glycine 0 CA--C 1.531 1.046 0 N-CA-C 109.219 -1.552 . . . . 74.44 109.219 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -60.51 -40.13 59.43 Favored 'Trans proline' 0 C--N 1.379 2.142 0 C-N-CA 123.234 2.623 . . . . 72.11 113.296 -173.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -77.32 -25.05 50.81 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.057 0.543 . . . . 65.24 110.8 176.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 169.18 127.21 0.91 Allowed Glycine 0 C--N 1.338 0.673 0 N-CA-C 110.996 -0.842 . . . . 73.52 110.996 179.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.447 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 48.6 mtm180 -69.54 159.59 33.05 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.106 0.562 . . . . 73.33 109.874 178.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -74.08 -156.56 4.55 Favored Glycine 0 C--N 1.339 0.702 0 CA-C-N 116.069 -0.514 . . . . 75.14 112.911 175.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . 0.518 ' HA ' ' O ' ' A' ' 235' ' ' LEU . 2.6 p30 -122.7 136.46 54.88 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 122.332 -0.511 . . . . 70.25 112.018 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 32.5 tp -100.57 104.6 15.95 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 107.241 -1.392 . . . . 74.3 107.241 168.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -89.28 108.03 19.39 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.172 0.989 . . . . 72.43 109.02 -178.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.61 ' HB3' ' HB2' ' A' ' 197' ' ' LEU . 63.8 mt -110.43 110.75 21.63 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.412 1.085 . . . . 73.41 110.349 -176.069 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -80.37 110.23 15.63 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.119 0.568 . . . . 74.54 109.694 176.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.573 HG13 HG22 ' A' ' 227' ' ' THR . 89.8 t -59.49 110.76 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.417 0.687 . . . . 73.43 111.017 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 30.8 mmm180 -114.23 113.0 24.04 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 125.053 1.341 . . . . 74.53 108.45 173.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.478 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 56.9 mt -75.62 126.14 36.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 N-CA-C 109.253 -0.647 . . . . 73.42 109.253 178.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' THR . . . . . 0.49 ' HG1' ' HA ' ' A' ' 200' ' ' PRO . 45.2 p . . . . . 0 C--O 1.248 1.003 0 C-N-CA 124.167 0.987 . . . . 73.43 108.623 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.484 1.267 0 CA-C-O 121.105 0.479 . . . . 73.13 110.263 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -83.59 72.21 10.31 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.785 0.803 . . . . 70.02 109.179 175.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -80.98 -41.6 22.52 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 114.983 -1.008 . . . . 60.24 110.292 -177.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.582 HG23 ' HB3' ' A' ' 234' ' ' ARG . 34.1 m -90.01 173.06 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-N 115.158 -0.928 . . . . 74.24 110.948 178.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 15.1 tt -96.34 143.81 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 N-CA-C 108.676 -0.861 . . . . 73.03 108.676 171.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -65.81 132.16 48.03 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.3 1.04 . . . . 75.21 112.065 -173.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.466 ' HB1' HD23 ' A' ' 233' ' ' LEU . . . -146.61 164.39 32.8 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.336 1.054 . . . . 72.43 110.816 -178.333 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -160.4 154.09 22.52 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.68 1.192 . . . . 74.34 109.161 179.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.527 ' HA ' ' HA ' ' A' ' 221' ' ' VAL . 31.7 p90 -117.72 -177.21 3.19 Favored 'General case' 0 C--N 1.347 0.475 0 CA-C-O 121.575 0.703 . . . . 74.31 110.953 178.341 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -136.15 131.81 18.88 Favored Pre-proline 0 N--CA 1.468 0.456 0 N-CA-C 107.438 -1.319 . . . . 75.23 107.438 173.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -65.25 95.25 0.26 Allowed 'Trans proline' 0 CA--C 1.551 1.359 0 C-N-CA 122.149 1.899 . . . . 74.43 110.787 177.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . 0.478 ' HB2' ' HG3' ' A' ' 220' ' ' GLU . . . -70.4 -24.64 62.96 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 115.522 -0.763 . . . . 73.52 110.294 176.061 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -62.27 154.27 28.19 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 123.917 0.887 . . . . 75.14 110.191 165.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -51.94 -60.34 7.67 Favored Glycine 0 C--N 1.359 1.842 0 O-C-N 123.62 0.575 . . . . 63.33 113.123 -177.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 23.1 t -177.32 85.19 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.18 0.992 . . . . 73.41 108.501 173.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 83.03 100.33 0.51 Allowed Glycine 0 C--N 1.347 1.177 0 CA-C-N 116.187 -0.46 . . . . 54.44 112.881 176.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -72.04 -69.8 1.33 Allowed Glycine 0 C--N 1.351 1.364 0 N-CA-C 111.992 -0.443 . . . . 62.32 111.992 176.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 35.6 p -167.72 174.35 7.72 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.31 0.644 . . . . 75.04 111.316 -176.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -91.51 -146.33 17.37 Favored Glycine 0 C--N 1.349 1.3 0 CA-C-N 115.506 -0.77 . . . . 63.01 113.028 177.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -156.54 169.79 33.96 Favored Glycine 0 C--N 1.345 1.05 0 N-CA-C 111.938 -0.465 . . . . 70.31 111.938 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 36.4 p -88.39 164.95 15.27 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.136 0.575 . . . . 75.33 111.423 -175.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 72.11 -81.95 0.55 Allowed Glycine 0 C--N 1.355 1.594 0 O-C-N 123.8 0.687 . . . . 64.22 111.725 -174.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 165.94 38.63 0.02 OUTLIER Glycine 0 C--N 1.338 0.652 0 N-CA-C 110.685 -0.966 . . . . 72.3 110.685 175.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 44.8 p -66.72 93.09 0.24 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.965 0.906 . . . . 70.24 112.414 -170.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.585 ' HA ' ' HB2' ' A' ' 240' ' ' PHE . 16.8 mm100 -74.26 -46.39 41.73 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.134 0.573 . . . . 72.24 110.374 176.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.426 ' HA ' ' O ' ' A' ' 248' ' ' ASP . 8.0 p-10 -103.59 139.95 38.21 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.015 -0.539 . . . . 71.43 109.63 176.045 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 86.1 mt -118.83 150.8 39.22 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 108.632 -0.877 . . . . 74.33 108.632 -177.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -122.21 127.59 50.16 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 108.119 -1.067 . . . . 74.35 108.119 172.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -152.88 158.49 42.22 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 122.956 0.502 . . . . 72.45 110.203 -177.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 10.7 p -94.94 138.02 33.23 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 123.222 0.609 . . . . 72.14 109.917 174.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.43 HD12 HG22 ' A' ' 210' ' ' VAL . 52.0 tp -110.88 114.38 27.66 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.381 1.072 . . . . 71.2 109.543 -173.091 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -75.81 104.38 6.33 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 109.251 -0.648 . . . . 73.33 109.251 176.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.56 HG21 HG21 ' A' ' 210' ' ' VAL . 30.0 t -113.46 107.19 53.62 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 123.668 0.787 . . . . 52.44 108.936 175.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . 0.417 ' HA ' ' HG1' ' A' ' 256' ' ' THR . 74.0 Cg_exo -54.19 140.66 71.44 Favored 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.796 2.331 . . . . 73.24 112.267 172.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -47.7 -50.14 53.11 Favored Pre-proline 0 CA--C 1.571 1.752 0 N-CA-C 113.992 1.108 . . . . 74.11 113.992 -177.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -58.1 -39.25 87.13 Favored 'Trans proline' 0 C--N 1.401 3.318 0 C-N-CA 121.838 1.692 . . . . 74.24 112.806 177.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 47.5 mt -72.01 -31.31 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 123.95 0.9 . . . . 71.42 110.829 -178.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.68 -46.63 68.56 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.239 0.615 . . . . 73.25 110.944 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 83.2 t -70.54 -40.99 77.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-N 115.284 -0.871 . . . . 62.32 111.705 -176.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 8.2 p -77.45 -31.02 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 CA-C-N 116.473 -0.33 . . . . 44.52 111.404 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 80.55 69.07 1.42 Allowed Glycine 0 C--N 1.349 1.296 0 CA-C-N 116.055 -0.521 . . . . 73.24 112.344 -173.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -101.29 -150.68 24.14 Favored Glycine 0 C--N 1.346 1.106 0 CA-C-O 119.715 -0.492 . . . . 73.13 112.158 -176.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 55.0 mttp -117.39 143.39 46.04 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.229 0.612 . . . . 75.31 109.56 173.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.56 HG21 HG21 ' A' ' 199' ' ' VAL . 27.7 m -136.72 142.28 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 124.14 0.976 . . . . 74.0 109.192 174.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 88.9 mtm180 -73.72 137.9 44.3 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.127 0.489 . . . . 75.45 111.086 176.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -116.59 121.13 40.83 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.268 1.427 . . . . 73.23 107.394 172.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.0 111.6 19.85 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 109.382 -0.599 . . . . 64.22 109.382 -178.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 81.4 p -120.83 -179.88 4.14 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.457 0.703 . . . . 74.41 111.07 -176.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 12.3 mt -70.31 -22.68 62.8 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 115.466 -0.788 . . . . 73.33 110.003 175.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -87.44 -12.87 44.86 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 123.93 0.892 . . . . 72.14 110.621 177.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 117.37 -158.97 14.29 Favored Glycine 0 C--N 1.354 1.535 0 CA-C-N 116.353 -0.385 . . . . 62.04 113.109 175.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.7 127.9 14.46 Favored 'Trans proline' 0 C--N 1.367 1.533 0 C-N-CA 122.669 2.246 . . . . 74.13 111.381 175.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 29.6 m -132.39 125.03 53.02 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.827 0 N-CA-C 109.919 -0.4 . . . . 73.41 109.919 173.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.478 ' HG3' ' HB2' ' A' ' 178' ' ' ALA . 45.4 mt-10 -84.14 105.82 15.3 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.316 0.647 . . . . 70.21 110.285 -178.293 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . 0.527 ' HA ' ' HA ' ' A' ' 175' ' ' TYR . 46.5 t -90.03 116.94 32.34 Favored 'Isoleucine or valine' 0 C--O 1.243 0.717 0 C-N-CA 124.303 1.041 . . . . 74.42 108.576 -175.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -69.32 101.09 1.44 Allowed 'General case' 0 C--O 1.241 0.613 0 CA-C-N 114.873 -1.058 . . . . 75.14 109.146 176.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 47.1 t -69.18 131.55 90.47 Favored Pre-proline 0 CA--C 1.544 0.749 0 CA-C-N 114.781 -1.1 . . . . 70.42 109.05 176.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -62.81 159.49 37.37 Favored 'Trans proline' 0 CA--C 1.561 1.85 0 C-N-CA 122.06 1.84 . . . . 75.45 111.923 170.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -67.05 147.66 80.12 Favored 'Trans proline' 0 C--N 1.376 2.003 0 C-N-CA 122.159 1.906 . . . . 74.33 112.191 176.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 47.8 mtp180 53.54 54.79 9.5 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.919 1.288 . . . . 74.1 111.368 174.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.546 HG23 ' HD2' ' A' ' 231' ' ' ARG . 91.3 m -96.8 117.95 32.19 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 114.525 -1.216 . . . . 64.32 109.11 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 26.8 mp0 -90.38 161.67 15.48 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.277 0.631 . . . . 73.41 111.57 -177.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -64.42 127.62 32.27 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 114.454 -1.248 . . . . 71.43 110.239 177.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 103.85 -4.31 45.9 Favored Glycine 0 C--N 1.341 0.854 0 CA-C-O 119.374 -0.681 . . . . 73.44 113.526 -179.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.546 ' HD2' HG23 ' A' ' 227' ' ' THR . 87.5 mtt180 -68.65 162.07 26.78 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 117.741 0.771 . . . . 75.21 111.54 175.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -127.33 124.24 38.23 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 123.84 0.856 . . . . 75.42 110.679 -173.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.466 HD23 ' HB1' ' A' ' 173' ' ' ALA . 61.8 mt -113.32 100.0 8.22 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.049 0.939 . . . . 62.11 109.138 178.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . 0.582 ' HB3' HG23 ' A' ' 170' ' ' VAL . 22.6 ttt180 -85.4 102.15 13.19 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 107.966 -1.124 . . . . 70.32 107.966 169.074 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 53.5 mt -68.89 92.06 0.49 Allowed 'General case' 0 C--O 1.244 0.776 0 N-CA-C 107.808 -1.182 . . . . 75.43 107.808 172.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -71.28 114.11 9.0 Favored 'General case' 0 C--N 1.357 0.925 0 CA-C-N 114.137 -1.392 . . . . 75.13 111.813 -167.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . 0.404 ' O ' ' HD3' ' A' ' 246' ' ' ARG . . . 67.53 34.08 83.17 Favored Glycine 0 C--N 1.346 1.121 0 O-C-N 124.053 0.846 . . . . 62.34 112.056 178.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.455 ' HB3' ' CE1' ' A' ' 175' ' ' TYR . 32.9 mmtp -128.62 10.36 6.09 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.645 0.778 . . . . 74.42 111.97 -172.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -84.48 -129.14 1.82 Allowed Glycine 0 N--CA 1.47 0.948 0 N-CA-C 111.742 -0.543 . . . . 73.41 111.742 176.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . 0.585 ' HB2' ' HA ' ' A' ' 191' ' ' GLN . 3.2 m-85 -74.88 142.92 77.2 Favored Pre-proline 0 N--CA 1.48 1.072 0 C-N-CA 123.283 0.633 . . . . 74.34 110.894 175.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.672 ' HA ' ' HG3' ' A' ' 246' ' ' ARG . 21.3 Cg_exo -64.5 142.86 79.98 Favored 'Trans proline' 0 C--N 1.379 2.132 0 C-N-CA 123.003 2.469 . . . . 74.41 113.11 -176.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -157.48 118.25 0.82 Allowed Glycine 0 CA--C 1.535 1.291 0 CA-C-O 118.696 -1.058 . . . . 64.34 111.345 -179.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -64.04 -28.99 65.99 Favored 'Trans proline' 0 C--N 1.384 2.44 0 C-N-CA 123.131 2.554 . . . . 72.04 114.335 -178.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -86.61 -15.35 40.05 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.169 0.588 . . . . 61.51 111.18 176.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 163.29 118.33 0.45 Allowed Glycine 0 C--N 1.344 0.99 0 N-CA-C 110.072 -1.211 . . . . 63.24 110.072 178.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.672 ' HG3' ' HA ' ' A' ' 241' ' ' PRO . 45.4 ttt180 -69.25 140.27 54.47 Favored 'General case' 0 C--O 1.243 0.726 0 CA-C-N 117.505 0.653 . . . . 72.11 109.508 175.389 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -68.56 -169.47 5.54 Favored Glycine 0 C--N 1.351 1.4 0 O-C-N 123.563 0.539 . . . . 53.14 113.347 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . 0.426 ' O ' ' HA ' ' A' ' 192' ' ' ASP . 10.1 m-20 -122.11 169.7 10.6 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.134 0.573 . . . . 71.3 110.734 -175.286 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 43.2 tp -136.24 107.21 6.68 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 108.356 -0.979 . . . . 61.24 108.356 168.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -94.46 107.4 19.37 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 108.881 -0.785 . . . . 74.3 108.881 -174.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 66.2 mt -110.5 113.99 27.06 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.055 0.942 . . . . 75.31 110.117 -175.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -79.52 116.75 19.92 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 109.218 -0.66 . . . . 75.41 109.218 173.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.45 HG11 HG21 ' A' ' 227' ' ' THR . 69.5 t -65.45 105.42 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 CA-C-O 121.231 0.539 . . . . 75.34 110.168 177.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 15.3 mmt85 -103.17 106.75 17.33 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 108.043 -1.095 . . . . 73.15 108.043 172.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.489 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 15.3 mt -74.42 119.55 22.03 Favored 'Isoleucine or valine' 0 C--N 1.352 0.716 0 N-CA-C 109.265 -0.643 . . . . 72.4 109.265 179.388 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 256' ' ' THR . . . . . 0.417 ' HG1' ' HA ' ' A' ' 200' ' ' PRO . 23.5 p . . . . . 0 C--O 1.252 1.206 0 C-N-CA 124.736 1.214 . . . . 75.42 109.213 -176.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 23.7 mmt . . . . . 0 N--CA 1.479 1.024 0 N-CA-C 109.089 -0.708 . . . . 74.31 109.089 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -75.63 77.11 2.62 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 121.682 0.754 . . . . 61.02 109.923 177.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -60.6 -50.64 72.71 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 115.146 -0.934 . . . . 75.23 110.233 -178.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.432 HG21 ' HB3' ' A' ' 234' ' ' ARG . 25.6 m -98.13 167.86 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-N 115.083 -0.962 . . . . 74.24 110.468 175.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 16.8 tt -89.11 149.59 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.004 0 N-CA-C 108.953 -0.758 . . . . 73.32 108.953 171.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -60.56 142.44 55.4 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.77 1.228 . . . . 73.11 112.377 -175.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.476 ' HB3' HD21 ' A' ' 233' ' ' LEU . . . -159.94 155.45 25.55 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.805 1.242 . . . . 70.32 109.092 174.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -149.98 119.77 7.08 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 123.48 0.712 . . . . 75.34 110.013 177.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.54 ' HE1' ' HB3' ' A' ' 238' ' ' LYS . 17.7 p90 -93.11 164.76 13.14 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 109.451 -0.574 . . . . 75.15 109.451 174.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 46.3 mttm -138.9 143.83 38.96 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 123.519 0.728 . . . . 70.52 109.507 172.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -56.71 108.91 0.38 Allowed 'Trans proline' 0 C--N 1.382 2.312 0 C-N-CA 123.742 2.961 . . . . 72.14 112.984 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . 0.577 ' HB3' ' HG3' ' A' ' 220' ' ' GLU . . . -88.51 -19.15 26.79 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.131 0.572 . . . . 63.53 110.049 174.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -64.73 -41.92 95.59 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.338 1.055 . . . . 75.24 110.173 174.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 148.11 -54.24 0.52 Allowed Glycine 0 C--N 1.342 0.878 0 CA-C-N 115.504 -0.771 . . . . 52.24 111.535 178.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 68.3 m -149.51 106.59 3.58 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.511 0.724 . . . . 72.41 110.317 -175.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -76.35 88.06 0.91 Allowed Glycine 0 C--N 1.347 1.18 0 N-CA-C 109.896 -1.282 . . . . 73.33 109.896 169.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -59.96 126.28 41.27 Favored Glycine 0 C--N 1.353 1.521 0 O-C-N 124.258 0.622 . . . . 25.2 113.316 -173.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' SER . . . . . 0.421 ' HA ' ' HG2' ' A' ' 241' ' ' PRO . 43.3 m -85.43 125.25 32.86 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 123.464 0.706 . . . . 72.33 110.4 179.101 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -94.15 -100.81 1.64 Allowed Glycine 0 C--N 1.34 0.78 0 N-CA-C 110.727 -0.949 . . . . 54.03 110.727 172.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . 0.484 ' HA2' ' HD2' ' A' ' 243' ' ' PRO . . . -161.8 -50.65 0.02 OUTLIER Glycine 0 C--N 1.335 0.525 0 N-CA-C 110.099 -1.201 . . . . 73.51 110.099 177.413 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 14.3 t -156.49 -161.99 1.2 Allowed 'General case' 0 CA--C 1.554 1.112 0 N-CA-C 107.606 -1.257 . . . . 75.22 107.606 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -179.1 -173.66 44.57 Favored Glycine 0 C--N 1.352 1.462 0 CA-C-N 118.561 0.619 . . . . 73.53 113.752 177.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -68.69 -29.08 72.74 Favored Glycine 0 C--N 1.349 1.269 0 N-CA-C 112.087 -0.405 . . . . 54.32 112.087 172.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 23.1 m -144.51 108.9 4.83 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.735 1.214 . . . . 74.1 108.125 175.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 23.4 mp0 -75.74 -40.91 54.65 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 121.799 0.809 . . . . 74.24 109.039 176.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 19.2 p-10 -94.63 147.95 22.77 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 114.727 -1.124 . . . . 71.11 110.509 -178.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 95.6 mt -126.26 157.78 37.42 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.638 1.175 . . . . 74.14 109.667 178.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -135.31 122.95 22.2 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.911 0.884 . . . . 74.43 108.676 176.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -152.67 171.22 18.52 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.005 0.922 . . . . 73.42 109.711 178.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' THR . . . . . 0.44 HG21 ' HB2' ' A' ' 252' ' ' GLU . 11.7 p -97.96 146.31 25.61 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.335 0.654 . . . . 71.12 109.944 173.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.56 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . 39.1 tp -114.45 111.28 21.16 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.19 0.996 . . . . 71.22 109.112 178.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -87.28 101.41 13.5 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.135 0.493 . . . . 75.01 109.899 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.476 ' HA ' HG11 ' A' ' 210' ' ' VAL . 46.9 t -102.55 121.97 47.91 Favored Pre-proline 0 CA--C 1.542 0.655 0 C-N-CA 124.379 1.071 . . . . 71.14 108.904 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -56.03 142.34 85.66 Favored 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 122.809 2.339 . . . . 65.23 111.602 170.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . 0.448 ' O ' HG22 ' A' ' 205' ' ' VAL . . . -49.48 -49.4 71.82 Favored Pre-proline 0 CA--C 1.56 1.329 0 CA-C-O 118.045 -0.979 . . . . 74.3 113.496 -179.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -60.05 -40.1 64.23 Favored 'Trans proline' 0 C--N 1.394 2.973 0 C-N-CA 121.995 1.797 . . . . 63.42 112.87 178.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 34.7 mt -69.2 -33.26 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 C-N-CA 123.761 0.824 . . . . 71.24 110.6 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.63 -38.03 80.21 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.414 0.685 . . . . 73.43 111.437 178.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.448 HG22 ' O ' ' A' ' 201' ' ' ALA . 99.1 t -74.13 -55.84 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.415 0.686 . . . . 75.35 110.96 -178.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 11.5 m -81.42 -23.37 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 N-CA-C 112.171 0.434 . . . . 74.3 112.171 -171.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 88.16 134.7 4.74 Favored Glycine 0 C--N 1.347 1.16 0 N-CA-C 111.378 -0.689 . . . . 63.23 111.378 -173.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -173.13 -147.54 5.93 Favored Glycine 0 C--N 1.338 0.692 0 N-CA-C 111.644 -0.582 . . . . 71.24 111.644 -177.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -137.02 134.89 37.08 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.22 0.608 . . . . 72.01 110.15 177.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.476 HG11 ' HA ' ' A' ' 199' ' ' VAL . 29.5 m -121.96 147.31 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 123.251 0.62 . . . . 75.14 109.73 179.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -86.68 111.89 21.11 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 116.169 -0.469 . . . . 74.42 109.767 -173.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -99.98 157.68 16.37 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.249 1.02 . . . . 72.03 109.917 177.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 2.0 mmt -105.28 108.81 20.52 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 115.336 -0.847 . . . . 73.13 109.747 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 45.4 p -109.79 -177.72 3.34 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.849 0.859 . . . . 73.51 109.039 171.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 19.0 mt -72.28 -26.74 62.09 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.125 0.57 . . . . 73.14 110.452 -175.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 10.6 mp0 -80.0 -20.54 45.2 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.27 1.028 . . . . 64.23 110.397 -178.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 133.46 -154.5 21.28 Favored Glycine 0 C--N 1.351 1.396 0 CA-C-O 119.56 -0.578 . . . . 71.54 112.104 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -67.83 142.18 56.63 Favored 'Trans proline' 0 C--N 1.369 1.641 0 C-N-CA 122.829 2.353 . . . . 63.52 112.313 172.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 30.0 m -139.61 147.82 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 124.007 0.923 . . . . 74.11 109.639 175.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.577 ' HG3' ' HB3' ' A' ' 178' ' ' ALA . 42.5 mt-10 -100.78 109.24 21.22 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.131 0.572 . . . . 72.35 109.672 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 47.9 t -94.53 122.61 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 123.82 0.848 . . . . 74.44 109.734 -175.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -69.72 99.96 1.42 Allowed 'General case' 0 C--N 1.35 0.62 0 O-C-N 123.952 0.783 . . . . 52.13 110.022 177.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 57.9 t -77.82 121.01 83.54 Favored Pre-proline 0 C--O 1.243 0.728 0 CA-C-N 114.558 -1.201 . . . . 71.32 108.849 173.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -61.5 157.13 42.91 Favored 'Trans proline' 0 CA--C 1.563 1.963 0 C-N-CA 122.25 1.967 . . . . 74.54 111.97 172.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -66.31 144.15 73.13 Favored 'Trans proline' 0 C--N 1.372 1.788 0 C-N-CA 122.251 1.967 . . . . 73.41 111.448 172.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 88.6 mtt180 69.12 32.24 3.77 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 125.126 1.37 . . . . 72.3 111.367 172.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.51 HG22 ' HD2' ' A' ' 231' ' ' ARG . 97.4 m -77.32 121.6 23.96 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.451 1.1 . . . . 74.11 110.325 174.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -95.18 163.3 13.34 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 109.603 -0.517 . . . . 74.11 109.603 178.189 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -70.69 118.84 13.99 Favored 'General case' 0 C--N 1.348 0.51 0 CA-C-N 115.469 -0.787 . . . . 72.21 108.925 170.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 115.01 -1.47 22.8 Favored Glycine 0 N--CA 1.464 0.544 0 CA-C-O 119.73 -0.483 . . . . 71.34 112.518 -172.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.51 ' HD2' HG22 ' A' ' 227' ' ' THR . 38.8 mtt180 -75.55 158.52 32.4 Favored 'General case' 0 C--N 1.358 0.958 0 CA-C-O 121.451 0.643 . . . . 72.51 110.289 168.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.431 ' HG3' HG13 ' A' ' 170' ' ' VAL . 23.0 pttm -124.7 129.19 50.02 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.653 1.181 . . . . 74.22 108.731 -177.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.476 HD21 ' HB3' ' A' ' 173' ' ' ALA . 87.6 mt -117.91 104.16 10.65 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.966 0.907 . . . . 74.41 108.905 -178.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . 0.432 ' HB3' HG21 ' A' ' 170' ' ' VAL . 41.8 ttm180 -97.01 100.43 11.93 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 107.254 -1.388 . . . . 74.12 107.254 175.267 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 20.8 mt -73.4 84.22 1.46 Allowed 'General case' 0 C--O 1.24 0.555 0 N-CA-C 107.185 -1.413 . . . . 74.5 107.185 173.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 6.6 mtpm? -73.53 132.34 42.75 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 115.199 -0.91 . . . . 74.14 110.328 -172.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 69.01 23.5 76.03 Favored Glycine 0 C--N 1.342 0.897 0 O-C-N 123.899 0.749 . . . . 75.44 112.431 -176.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.54 ' HB3' ' HE1' ' A' ' 175' ' ' TYR . 60.8 mmtt -138.72 17.7 2.69 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.995 1.318 . . . . 73.13 111.136 -170.293 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . 0.465 ' HA2' ' HB2' ' A' ' 249' ' ' LEU . . . -82.18 -89.48 0.65 Allowed Glycine 0 N--CA 1.471 0.984 0 N-CA-C 110.499 -1.04 . . . . 72.24 110.499 173.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -95.85 120.62 62.84 Favored Pre-proline 0 N--CA 1.47 0.557 0 N-CA-C 108.339 -0.985 . . . . 73.12 108.339 167.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.421 ' HG2' ' HA ' ' A' ' 184' ' ' SER . 69.1 Cg_endo -77.82 132.01 11.59 Favored 'Trans proline' 0 C--N 1.372 1.808 0 C-N-CA 122.417 2.078 . . . . 75.44 111.41 175.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 168.29 146.69 5.06 Favored Glycine 0 C--N 1.345 1.073 0 CA-C-O 119.228 -0.762 . . . . 51.53 112.688 177.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . 0.484 ' HD2' ' HA2' ' A' ' 186' ' ' GLY . 57.3 Cg_endo -68.98 -18.82 40.54 Favored 'Trans proline' 0 C--N 1.376 2.001 0 C-N-CA 123.635 2.89 . . . . 73.25 114.82 -173.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -81.26 -28.96 34.51 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 118.403 0.547 . . . . 64.42 111.134 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -179.34 105.94 0.2 Allowed Glycine 0 C--N 1.346 1.094 0 O-C-N 123.478 0.486 . . . . 72.01 112.205 -178.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 61.2 mtt-85 -86.8 122.55 30.84 Favored 'General case' 0 C--N 1.349 0.577 0 N-CA-C 108.012 -1.107 . . . . 74.2 108.012 173.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -83.41 -168.12 42.82 Favored Glycine 0 N--CA 1.469 0.866 0 O-C-N 123.661 0.601 . . . . 73.41 113.945 -176.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -120.29 126.5 50.73 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 108.674 -0.862 . . . . 75.41 108.674 177.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.465 ' HB2' ' HA2' ' A' ' 239' ' ' GLY . 46.3 tp -97.77 106.3 18.59 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 106.888 -1.523 . . . . 71.33 106.888 175.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -99.25 122.39 42.35 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.311 -0.859 . . . . 74.25 109.034 -170.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.56 ' HB3' ' HB2' ' A' ' 197' ' ' LEU . 65.0 mt -123.24 122.18 37.73 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.708 0.803 . . . . 61.31 110.157 -172.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . 0.44 ' HB2' HG21 ' A' ' 196' ' ' THR . 28.2 mm-40 -90.71 109.67 20.85 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.836 0.854 . . . . 74.0 109.686 178.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.506 HG13 HG23 ' A' ' 227' ' ' THR . 84.4 t -63.48 113.74 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 CA-C-O 121.424 0.631 . . . . 73.03 111.409 -176.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 28.1 mmm180 -114.21 105.27 12.97 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.72 1.608 . . . . 75.35 108.02 173.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.421 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 39.8 mt -76.95 128.59 37.87 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 N-CA-C 110.0 -0.37 . . . . 62.53 110.0 178.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 19.2 p . . . . . 0 C--O 1.248 1.015 0 C-N-CA 124.793 1.237 . . . . 51.12 108.79 -176.735 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 25.8 ptt? . . . . . 0 N--CA 1.488 1.439 0 CA-C-O 119.61 -0.233 . . . . 71.44 111.592 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 32.6 t70 55.07 79.07 0.16 Allowed 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 124.854 1.262 . . . . 62.43 109.558 -172.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -62.81 -72.29 0.14 Allowed 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.119 -0.946 . . . . 73.54 111.878 -167.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.437 HG23 ' HB3' ' A' ' 234' ' ' ARG . 25.4 m -85.43 171.96 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 O-C-N 123.755 0.659 . . . . 72.44 110.749 -179.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.437 HG23 ' HD3' ' A' ' 231' ' ' ARG . 15.7 tt -93.05 145.69 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 N-CA-C 109.334 -0.617 . . . . 74.44 109.334 173.326 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -60.13 129.02 39.66 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.92 1.288 . . . . 73.53 111.329 -177.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.465 ' HB1' HD21 ' A' ' 233' ' ' LEU . . . -152.18 163.06 40.17 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 124.624 1.169 . . . . 61.43 109.219 175.539 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -149.17 176.68 10.29 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 108.56 -0.904 . . . . 72.34 108.56 173.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.419 ' CE1' ' HB3' ' A' ' 238' ' ' LYS . 22.8 p90 -144.07 177.23 8.72 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 118.029 0.377 . . . . 74.21 111.244 175.051 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -136.88 131.1 17.9 Favored Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 124.031 0.933 . . . . 74.04 109.52 176.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . 0.5 ' HA ' HG13 ' A' ' 219' ' ' VAL . 44.1 Cg_endo -66.07 95.39 0.3 Allowed 'Trans proline' 0 C--N 1.369 1.637 0 C-N-CA 122.927 2.418 . . . . 65.3 111.548 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . 0.538 ' HB3' ' HG3' ' A' ' 220' ' ' GLU . . . -63.84 -37.21 86.53 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.1 0.96 . . . . 72.11 111.561 -176.254 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . 0.425 ' HB2' ' HG2' ' A' ' 218' ' ' PRO . 29.0 t70 -95.95 101.35 13.01 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 109.39 -0.596 . . . . 72.54 109.39 176.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 58.82 -99.25 0.12 Allowed Glycine 0 C--N 1.351 1.389 0 O-C-N 124.469 1.106 . . . . 71.21 113.003 177.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 57.8 p -157.68 152.62 25.51 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 124.206 1.003 . . . . 75.2 108.983 179.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -74.07 135.51 20.15 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 111.059 -0.816 . . . . 72.5 111.059 171.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 176.39 35.63 0.05 OUTLIER Glycine 0 C--N 1.337 0.624 0 CA-C-O 120.199 -0.223 . . . . 63.43 112.595 179.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 42.5 t -69.97 109.61 4.61 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 109.737 -0.468 . . . . 71.45 109.737 179.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -74.38 73.88 1.32 Allowed Glycine 0 C--N 1.346 1.124 0 O-C-N 123.728 0.642 . . . . 64.31 112.707 -179.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . 0.484 ' HA3' ' HE2' ' A' ' 240' ' ' PHE . . . -102.85 150.31 17.84 Favored Glycine 0 C--N 1.342 0.89 0 N-CA-C 111.593 -0.603 . . . . 62.34 111.593 176.313 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 33.7 t -145.71 30.28 1.09 Allowed 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 123.538 0.735 . . . . 74.32 110.008 -177.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -89.59 13.2 64.69 Favored Glycine 0 C--N 1.352 1.439 0 CA-C-N 116.152 -0.476 . . . . 61.12 113.844 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 95.07 -23.9 31.14 Favored Glycine 0 C--N 1.352 1.442 0 CA-C-N 117.325 0.563 . . . . 64.31 113.233 178.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 15.2 m -73.85 89.24 1.84 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.332 0.653 . . . . 74.4 110.815 -178.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -92.91 -33.01 14.36 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 109.073 -0.714 . . . . 71.14 109.073 172.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.433 ' HA ' ' O ' ' A' ' 248' ' ' ASP . 1.2 p30 -102.61 129.39 49.17 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.292 -0.867 . . . . 63.24 109.443 175.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 68.4 mt -109.18 135.35 50.44 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 108.174 -1.047 . . . . 73.21 108.174 177.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -120.23 121.9 39.74 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 108.227 -1.027 . . . . 74.4 108.227 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -154.29 166.35 33.45 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 123.358 0.663 . . . . 74.21 110.56 -173.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 4.9 m -102.24 145.12 29.89 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 109.185 -0.672 . . . . 62.33 109.185 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.518 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . 43.0 tp -119.75 121.72 39.81 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.476 0.71 . . . . 74.43 110.183 -172.231 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -83.77 115.24 22.12 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 109.349 -0.612 . . . . 75.1 109.349 173.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.519 ' HA ' HG11 ' A' ' 210' ' ' VAL . 98.1 t -119.26 110.44 37.72 Favored Pre-proline 0 CA--C 1.537 0.478 0 C-N-CA 123.98 0.912 . . . . 75.33 109.0 177.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . 0.417 ' HA ' ' HG1' ' A' ' 256' ' ' THR . 54.5 Cg_exo -54.73 141.66 75.34 Favored 'Trans proline' 0 C--N 1.37 1.697 0 C-N-CA 122.755 2.303 . . . . 75.5 112.184 171.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . 0.409 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -48.48 -47.78 68.72 Favored Pre-proline 0 CA--C 1.563 1.447 0 CA-C-O 117.784 -1.103 . . . . 74.3 113.426 177.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.409 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 15.7 Cg_endo -54.79 -46.33 34.14 Favored 'Trans proline' 0 C--N 1.398 3.163 0 C-N-CA 122.3 2.0 . . . . 73.25 112.787 175.214 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . 0.416 HG21 HG12 ' A' ' 210' ' ' VAL . 43.9 mt -68.74 -32.35 54.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 123.768 0.827 . . . . 74.5 111.115 -176.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -65.61 -44.9 85.1 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.251 0.62 . . . . 64.51 110.829 178.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 60.3 t -71.35 -52.3 27.67 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-N 115.82 -0.627 . . . . 74.43 110.909 -178.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 14.6 m -71.49 -25.85 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 N-CA-C 111.958 0.355 . . . . 70.51 111.958 -176.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 74.15 74.5 0.84 Allowed Glycine 0 C--N 1.341 0.833 0 N-CA-C 111.674 -0.57 . . . . 74.53 111.674 -174.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -118.88 -164.16 12.72 Favored Glycine 0 N--CA 1.472 1.08 0 N-CA-C 111.75 -0.54 . . . . 34.44 111.75 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -103.16 142.46 34.11 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 117.434 0.617 . . . . 74.32 110.317 -179.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.519 HG11 ' HA ' ' A' ' 199' ' ' VAL . 22.5 m -120.73 147.15 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 124.672 1.189 . . . . 74.31 109.077 175.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 19.3 ttm180 -90.46 109.55 20.67 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 122.024 -0.423 . . . . 72.4 110.034 -178.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -100.25 158.63 15.73 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.689 1.196 . . . . 72.33 110.803 -175.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' MET . . . . . 0.434 ' HA ' ' HE2' ' A' ' 213' ' ' MET . 2.0 mmt -105.87 108.63 20.25 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.636 0.774 . . . . 75.32 110.437 -178.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 68.7 p -111.32 175.41 5.43 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 109.434 -0.58 . . . . 75.23 109.434 170.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 19.3 mt -70.61 -17.82 62.88 Favored 'General case' 0 CA--C 1.55 0.978 0 CA-C-N 115.761 -0.654 . . . . 75.04 110.468 178.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -92.44 -0.32 57.37 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.868 1.267 . . . . 74.12 110.993 178.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 108.89 -161.76 13.07 Favored Glycine 0 C--N 1.349 1.264 0 C-N-CA 123.594 0.616 . . . . 74.14 113.281 175.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . 0.425 ' HG2' ' HB2' ' A' ' 179' ' ' ASP . 59.8 Cg_endo -72.46 132.16 18.66 Favored 'Trans proline' 0 C--N 1.363 1.313 0 C-N-CA 122.719 2.28 . . . . 74.43 112.864 178.398 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.5 HG13 ' HA ' ' A' ' 177' ' ' PRO . 34.2 m -130.13 160.24 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 124.344 1.058 . . . . 73.21 109.214 177.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.538 ' HG3' ' HB3' ' A' ' 178' ' ' ALA . 46.1 mt-10 -109.26 108.27 18.81 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.461 0.704 . . . . 73.2 110.297 178.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 72.9 t -92.69 116.13 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 123.363 0.665 . . . . 75.01 109.591 -176.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -66.57 100.45 0.67 Allowed 'General case' 0 CA--C 1.543 0.706 0 O-C-N 124.022 0.827 . . . . 52.11 109.647 174.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 61.1 t -75.16 131.11 78.98 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 124.944 1.297 . . . . 72.41 109.071 176.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.89 152.56 63.34 Favored 'Trans proline' 0 CA--C 1.565 2.055 0 C-N-CA 122.318 2.012 . . . . 74.54 112.76 173.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_exo -65.49 146.44 85.06 Favored 'Trans proline' 0 C--N 1.371 1.738 0 C-N-CA 122.453 2.102 . . . . 72.33 112.88 175.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 35.1 mtp180 65.29 23.34 12.13 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 125.009 1.323 . . . . 75.04 112.207 174.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.516 HG21 ' HD2' ' A' ' 231' ' ' ARG . 4.1 m -54.81 139.13 40.75 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.612 1.165 . . . . 72.41 112.397 179.441 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -102.94 158.34 16.35 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.868 0.867 . . . . 74.11 109.816 175.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -73.83 131.26 41.33 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 108.893 -0.781 . . . . 72.13 108.893 172.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 100.2 2.22 55.81 Favored Glycine 0 N--CA 1.464 0.528 0 CA-C-O 119.197 -0.78 . . . . 71.14 112.385 -172.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.516 ' HD2' HG21 ' A' ' 227' ' ' THR . 60.5 mtt-85 -69.18 159.34 33.17 Favored 'General case' 0 C--N 1.359 1.021 0 CA-C-O 121.457 0.646 . . . . 73.03 110.338 172.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 48.9 pttt -130.86 132.93 45.48 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 114.927 -1.033 . . . . 74.31 109.727 -175.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.465 HD21 ' HB1' ' A' ' 173' ' ' ALA . 37.3 mt -121.47 127.3 50.94 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 108.213 -1.032 . . . . 74.32 108.213 178.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . 0.437 ' HB3' HG23 ' A' ' 170' ' ' VAL . 31.4 ttt180 -116.83 102.78 9.68 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 107.797 -1.186 . . . . 73.14 107.797 170.578 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.435 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 16.3 mt -83.52 84.58 7.48 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 114.948 -1.024 . . . . 75.24 109.279 -176.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -71.09 137.1 48.62 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.143 -0.935 . . . . 73.4 110.86 -178.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 67.39 16.56 67.41 Favored Glycine 0 C--N 1.352 1.425 0 O-C-N 123.987 0.804 . . . . 64.03 112.567 -177.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.419 ' HB3' ' CE1' ' A' ' 175' ' ' TYR . 31.3 mmtp -139.96 23.37 2.42 Favored 'General case' 0 C--O 1.217 -0.64 0 C-N-CA 124.54 1.136 . . . . 75.42 109.861 -175.297 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -89.37 -127.25 3.08 Favored Glycine 0 N--CA 1.468 0.829 0 O-C-N 121.869 -0.519 . . . . 54.0 111.899 171.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . 0.484 ' HE2' ' HA3' ' A' ' 186' ' ' GLY . 0.1 OUTLIER -80.52 147.06 62.65 Favored Pre-proline 0 N--CA 1.476 0.863 0 CA-C-O 118.326 -0.845 . . . . 72.03 110.434 176.491 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.421 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 86.2 Cg_exo -46.08 140.72 10.25 Favored 'Trans proline' 0 C--N 1.392 2.856 0 C-N-CA 123.837 3.025 . . . . 72.11 114.409 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -157.26 129.37 2.36 Favored Glycine 0 CA--C 1.536 1.353 0 CA-C-O 118.5 -1.167 . . . . 70.24 111.459 -179.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -62.47 -45.45 14.6 Favored 'Trans proline' 0 C--N 1.378 2.089 0 C-N-CA 123.137 2.558 . . . . 75.44 113.869 -178.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -78.21 -28.19 47.96 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-O 121.146 0.498 . . . . 72.3 110.461 177.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 169.52 145.92 4.85 Favored Glycine 0 C--N 1.334 0.471 0 CA-C-N 115.13 -0.941 . . . . 75.02 110.854 176.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.421 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 23.9 mtt180 -69.46 156.08 39.44 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.3 0.64 . . . . 75.34 110.665 177.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -73.13 -155.96 3.39 Favored Glycine 0 C--N 1.348 1.196 0 CA-C-N 116.076 -0.511 . . . . 65.11 113.218 178.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . 0.433 ' O ' ' HA ' ' A' ' 192' ' ' ASP . 21.6 m-20 -106.99 148.63 28.45 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.551 0.74 . . . . 70.34 110.479 179.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.435 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 50.0 tp -125.23 105.12 8.89 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 107.663 -1.236 . . . . 74.14 107.663 169.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -96.96 109.09 21.91 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 123.637 0.775 . . . . 74.43 109.527 -174.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.518 ' HB3' ' HB2' ' A' ' 197' ' ' LEU . 71.8 mt -112.84 116.36 29.93 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.119 0.968 . . . . 73.32 109.918 -178.272 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -86.64 113.64 22.68 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.644 0.778 . . . . 73.34 110.192 177.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 97.0 t -65.68 125.0 21.84 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.218 0 C-N-CA 123.801 0.84 . . . . 75.11 112.314 -177.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 26.3 mmm180 -118.34 108.38 15.01 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.428 1.491 . . . . 74.25 107.905 170.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.497 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 34.6 mt -76.78 119.16 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 109.696 -0.483 . . . . 71.23 109.696 177.352 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 256' ' ' THR . . . . . 0.417 ' HG1' ' HA ' ' A' ' 200' ' ' PRO . 36.0 p . . . . . 0 CA--C 1.551 0.999 0 C-N-CA 124.437 1.095 . . . . 75.01 108.903 178.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 15.5 tpt . . . . . 0 N--CA 1.481 1.086 0 N-CA-C 109.396 -0.594 . . . . 71.54 109.396 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -113.77 108.2 16.77 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.778 0.831 . . . . 74.41 109.84 -179.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -72.29 -51.89 18.77 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 121.772 0.796 . . . . 72.51 109.453 170.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.434 HG22 ' N ' ' A' ' 234' ' ' ARG . 27.1 m -107.28 -176.98 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-N 114.206 -1.361 . . . . 64.22 109.458 179.12 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 13.2 tt -84.83 139.77 17.0 Favored 'Isoleucine or valine' 0 C--O 1.246 0.891 0 N-CA-C 108.036 -1.098 . . . . 75.43 108.036 164.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -70.59 135.13 48.23 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 122.831 0.452 . . . . 75.23 110.065 177.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.441 ' HB3' HD22 ' A' ' 233' ' ' LEU . . . -138.98 175.37 9.61 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.062 0.945 . . . . 74.52 109.207 177.073 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -150.98 158.98 44.82 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 122.79 0.436 . . . . 73.04 110.337 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.48 ' CE1' ' HB3' ' A' ' 238' ' ' LYS . 9.8 p90 -140.63 176.12 9.05 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.346 0.593 . . . . 73.21 110.548 170.012 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -145.48 149.26 40.09 Favored Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 124.586 1.154 . . . . 72.25 108.614 170.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . 0.531 ' HA ' HG11 ' A' ' 219' ' ' VAL . 27.5 Cg_endo -58.24 123.79 14.42 Favored 'Trans proline' 0 C--N 1.373 1.85 0 C-N-CA 123.009 2.473 . . . . 73.21 111.99 -179.32 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . 0.532 ' HB3' ' HG3' ' A' ' 220' ' ' GLU . . . -88.22 55.29 3.37 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 108.177 -1.046 . . . . 70.12 108.177 172.428 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 32.9 t70 60.83 91.25 0.06 Allowed 'General case' 0 C--N 1.356 0.885 0 C-N-CA 124.91 1.284 . . . . 75.32 110.448 -168.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 161.31 103.58 0.18 Allowed Glycine 0 C--N 1.342 0.879 0 CA-C-N 116.048 -0.523 . . . . 42.23 112.118 -179.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' SER . . . . . 0.511 ' HA ' ' HB3' ' A' ' 216' ' ' GLU . 65.5 m -147.92 142.12 26.13 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.903 0.881 . . . . 64.51 110.115 175.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -156.84 -143.78 3.75 Favored Glycine 0 C--N 1.339 0.732 0 N-CA-C 110.48 -1.048 . . . . 64.4 110.48 -179.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 83.95 -66.99 3.8 Favored Glycine 0 C--N 1.342 0.917 0 CA-C-N 117.165 0.483 . . . . 63.22 114.061 172.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 24.9 m 77.79 -41.3 0.34 Allowed 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 125.944 1.698 . . . . 70.55 111.457 -172.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -166.07 -158.2 10.74 Favored Glycine 0 C--N 1.344 0.982 0 N-CA-C 111.521 -0.631 . . . . 60.21 111.521 172.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -166.82 23.49 0.12 Allowed Glycine 0 C--N 1.347 1.154 0 CA-C-N 116.872 0.336 . . . . 64.04 112.964 176.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 32.1 t -69.49 123.99 22.72 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.579 0.751 . . . . 71.2 110.658 -178.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 102.85 12.17 32.88 Favored Glycine 0 C--N 1.346 1.115 0 CA-C-N 116.357 -0.383 . . . . 74.11 112.505 -172.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -161.71 -179.31 36.31 Favored Glycine 0 C--N 1.344 0.983 0 N-CA-C 112.114 -0.394 . . . . 63.24 112.114 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 45.5 m -77.08 97.05 4.59 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 122.73 0.412 . . . . 74.13 110.352 -178.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.416 ' HA ' ' HB2' ' A' ' 240' ' ' PHE . 53.5 mt-30 -66.6 -20.37 65.99 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.435 0.694 . . . . 74.21 111.08 173.096 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 20.1 p-10 -85.18 126.5 33.7 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.311 0.644 . . . . 74.23 109.773 171.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 34.5 mt -108.9 145.07 35.97 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.191 1.396 . . . . 74.4 108.875 177.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -123.73 121.75 36.3 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 107.797 -1.186 . . . . 73.4 107.797 175.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.425 ' O ' ' HA ' ' A' ' 251' ' ' LEU . . . -149.51 165.59 31.71 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.065 0.946 . . . . 75.14 109.527 -171.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 10.5 m -108.77 140.72 41.81 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 109.969 -0.382 . . . . 74.3 109.969 -177.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.459 HD11 HG21 ' A' ' 210' ' ' VAL . 43.1 tp -108.79 121.52 45.24 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.748 0.819 . . . . 72.13 110.036 -176.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -93.11 103.02 15.35 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 109.161 -0.681 . . . . 62.43 109.161 172.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.505 HG22 HG11 ' A' ' 223' ' ' VAL . 2.7 p -106.57 119.52 51.4 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 123.676 0.791 . . . . 74.3 109.53 173.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -55.47 140.88 83.15 Favored 'Trans proline' 0 C--N 1.375 1.922 0 C-N-CA 122.331 2.021 . . . . 73.34 112.486 169.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -51.71 -49.17 84.72 Favored Pre-proline 0 CA--C 1.554 1.113 0 CA-C-O 118.077 -0.963 . . . . 73.55 113.451 -177.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -56.59 -39.83 88.62 Favored 'Trans proline' 0 C--N 1.39 2.724 0 C-N-CA 121.902 1.735 . . . . 73.2 112.877 176.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 28.4 mt -69.15 -34.28 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 123.259 0.624 . . . . 75.44 110.4 -178.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -66.33 -42.72 87.75 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.012 0.525 . . . . 72.0 111.073 178.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 87.1 t -71.96 -49.51 44.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 123.682 0.793 . . . . 70.24 111.282 -176.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 16.2 m -75.01 -22.75 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 CA-C-N 116.668 -0.242 . . . . 70.45 111.496 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 76.4 76.05 0.84 Allowed Glycine 0 C--N 1.346 1.106 0 N-CA-C 112.179 -0.369 . . . . 73.23 112.179 -177.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -110.69 -159.18 16.42 Favored Glycine 0 C--N 1.339 0.706 0 N-CA-C 111.699 -0.561 . . . . 73.32 111.699 -179.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 33.7 mtmm -115.13 145.45 42.34 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 108.88 -0.785 . . . . 74.14 108.88 173.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.486 HG13 ' HA ' ' A' ' 199' ' ' VAL . 19.6 m -128.06 168.17 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 123.95 0.9 . . . . 74.11 109.829 177.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 35.4 mtp-105 -99.38 117.49 33.93 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 121.218 0.532 . . . . 73.44 110.498 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -101.02 128.09 47.22 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 107.633 -1.247 . . . . 62.0 107.633 171.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.25 112.1 23.06 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 109.158 -0.682 . . . . 75.41 109.158 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 69.3 p -110.39 -177.96 3.38 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.62 0.768 . . . . 65.31 109.823 177.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 17.4 mt -67.44 -23.48 65.53 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 122.488 0.315 . . . . 75.13 111.021 178.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . 0.511 ' HB3' ' HA ' ' A' ' 181' ' ' SER . 45.3 mt-10 -86.31 -19.14 30.3 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.748 0.819 . . . . 71.23 111.895 178.283 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 127.42 -151.77 18.56 Favored Glycine 0 C--N 1.345 1.043 0 CA-C-O 119.568 -0.573 . . . . 53.11 112.594 176.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.65 135.14 17.56 Favored 'Trans proline' 0 C--N 1.372 1.799 0 C-N-CA 122.7 2.267 . . . . 74.04 111.65 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.531 HG11 ' HA ' ' A' ' 177' ' ' PRO . 33.3 m -135.41 142.07 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 123.306 0.642 . . . . 74.44 109.813 175.349 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.532 ' HG3' ' HB3' ' A' ' 178' ' ' ALA . 43.2 mt-10 -90.49 106.74 18.7 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.028 0.531 . . . . 73.02 110.281 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . 0.414 HG23 ' HB3' ' A' ' 175' ' ' TYR . 59.6 t -94.33 121.65 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 123.79 0.836 . . . . 73.33 109.423 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -71.19 107.95 4.46 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.257 0.623 . . . . 75.24 110.064 177.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.505 HG11 HG22 ' A' ' 199' ' ' VAL . 48.3 t -83.51 124.05 75.96 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 124.658 1.183 . . . . 75.05 108.897 175.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -58.97 152.49 57.97 Favored 'Trans proline' 0 CA--C 1.567 2.169 0 C-N-CA 122.675 2.25 . . . . 75.32 113.11 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -59.61 126.23 20.03 Favored 'Trans proline' 0 C--N 1.375 1.972 0 C-N-CA 122.511 2.141 . . . . 74.15 112.408 173.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 75.3 mtp180 65.52 61.58 0.69 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.97 1.308 . . . . 65.03 111.317 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.404 HG23 ' HD2' ' A' ' 231' ' ' ARG . 27.0 m -85.16 143.86 28.54 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.409 -0.814 . . . . 64.45 109.773 173.208 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -111.07 153.89 25.01 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.66 0.784 . . . . 74.35 110.863 179.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -70.46 135.82 48.98 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.576 0.75 . . . . 74.31 110.261 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.82 1.29 63.55 Favored Glycine 0 C--N 1.341 0.811 0 CA-C-O 119.689 -0.506 . . . . 72.3 113.174 -177.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.404 ' HD2' HG23 ' A' ' 227' ' ' THR . 52.4 mtt-85 -69.84 160.99 30.74 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 117.243 0.521 . . . . 74.14 110.551 171.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 20.9 pttm -126.98 135.06 50.34 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.864 -0.607 . . . . 74.01 110.603 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.441 HD22 ' HB3' ' A' ' 173' ' ' ALA . 74.4 mt -114.08 145.24 41.88 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.951 1.3 . . . . 73.2 108.173 175.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . 0.434 ' N ' HG22 ' A' ' 170' ' ' VAL . 51.7 ttt85 -136.53 102.18 4.86 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 107.952 -1.129 . . . . 74.52 107.952 166.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.415 HD11 ' HD1' ' A' ' 175' ' ' TYR . 14.8 mt -73.78 91.43 1.94 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.752 1.221 . . . . 73.32 109.433 179.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 51.9 mttp -62.29 124.74 21.7 Favored 'General case' 0 C--N 1.354 0.801 0 C-N-CA 123.437 0.695 . . . . 74.42 110.696 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 69.42 34.52 74.3 Favored Glycine 0 C--N 1.345 1.059 0 O-C-N 123.54 0.525 . . . . 72.24 113.061 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.48 ' HB3' ' CE1' ' A' ' 175' ' ' TYR . 32.8 mmtm -143.44 29.84 1.41 Allowed 'General case' 0 CA--C 1.559 1.321 0 C-N-CA 123.76 0.824 . . . . 74.4 112.616 -173.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -99.21 -111.05 3.15 Favored Glycine 0 N--CA 1.482 1.716 0 N-CA-C 111.134 -0.787 . . . . 72.43 111.134 175.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . 0.416 ' HB2' ' HA ' ' A' ' 191' ' ' GLN . 5.8 m-85 -71.19 151.88 94.57 Favored Pre-proline 0 N--CA 1.48 1.049 0 C-N-CA 123.728 0.811 . . . . 73.2 109.813 165.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.452 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 52.3 Cg_exo -57.3 155.68 28.86 Favored 'Trans proline' 0 C--N 1.373 1.838 0 C-N-CA 122.93 2.42 . . . . 73.3 112.418 165.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -162.76 125.03 1.35 Allowed Glycine 0 CA--C 1.535 1.296 0 CA-C-O 118.602 -1.11 . . . . 64.14 111.625 178.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -60.65 -49.01 9.58 Favored 'Trans proline' 0 C--N 1.381 2.237 0 C-N-CA 123.391 2.727 . . . . 74.43 112.644 177.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -76.31 -26.34 55.72 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 122.874 0.47 . . . . 75.03 110.692 178.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 165.01 145.17 4.31 Favored Glycine 0 C--N 1.344 1.005 0 CA-C-N 115.617 -0.72 . . . . 75.15 111.343 177.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.452 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 21.1 mtt180 -73.28 163.3 28.29 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.538 0.735 . . . . 73.42 111.127 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -81.55 -169.23 42.08 Favored Glycine 0 C--N 1.348 1.202 0 CA-C-N 115.824 -0.626 . . . . 74.45 111.768 170.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -107.37 152.1 24.62 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 118.003 0.902 . . . . 72.31 110.617 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 55.9 tp -120.92 106.7 11.87 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 108.706 -0.849 . . . . 74.54 108.706 173.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -91.37 123.66 34.97 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 123.806 0.843 . . . . 73.32 108.984 -177.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.425 ' HA ' ' O ' ' A' ' 195' ' ' ALA . 61.7 mt -119.53 122.37 41.48 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.374 0.67 . . . . 74.13 110.396 -176.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -81.07 114.0 19.63 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 108.975 -0.75 . . . . 71.11 108.975 172.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 88.4 t -66.92 109.52 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 122.905 0.482 . . . . 73.11 110.791 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 9.2 mmm180 -113.47 105.68 13.65 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 124.279 1.032 . . . . 75.23 108.848 173.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 28.9 mt -76.96 131.09 35.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-N 115.652 -0.703 . . . . 75.34 109.525 176.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 3.3 t . . . . . 0 CA--C 1.562 1.414 0 CA-C-O 117.849 -1.072 . . . . 71.11 108.763 -178.231 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 24.8 mmt . . . . . 0 N--CA 1.473 0.703 0 CA-C-O 121.198 0.523 . . . . 73.34 109.762 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -86.2 77.26 9.6 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 122.134 0.969 . . . . 73.34 109.159 175.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -70.33 -49.85 45.2 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 114.396 -1.274 . . . . 70.44 111.045 -178.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.462 HG13 ' HB2' ' A' ' 234' ' ' ARG . 26.2 m -93.37 177.19 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 C-N-CA 123.061 0.545 . . . . 65.2 110.637 175.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.408 HG22 ' HD3' ' A' ' 231' ' ' ARG . 13.8 tt -103.17 147.59 9.37 Favored 'Isoleucine or valine' 0 C--O 1.245 0.863 0 N-CA-C 108.418 -0.956 . . . . 72.34 108.418 173.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -64.31 142.83 58.28 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.654 0.782 . . . . 72.33 110.656 -178.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.494 ' HB2' HD22 ' A' ' 233' ' ' LEU . . . -160.0 164.48 33.23 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 123.82 0.848 . . . . 75.23 109.616 -178.264 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -157.25 157.67 34.71 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.703 0.801 . . . . 73.02 109.665 -178.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.451 ' CE1' ' HB3' ' A' ' 238' ' ' LYS . 5.5 p90 -135.97 178.01 7.38 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.232 0.539 . . . . 75.53 111.537 177.124 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . 0.516 ' HE2' ' HA ' ' A' ' 176' ' ' LYS . 7.9 mmpt? -132.7 135.31 25.87 Favored Pre-proline 0 N--CA 1.472 0.632 0 C-N-CA 124.691 1.197 . . . . 73.32 108.924 174.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . 0.511 ' HA ' HG12 ' A' ' 219' ' ' VAL . 48.1 Cg_endo -65.86 94.96 0.28 Allowed 'Trans proline' 0 C--N 1.377 2.05 0 C-N-CA 122.74 2.294 . . . . 72.02 111.127 178.037 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . 0.5 ' H ' ' HA ' ' A' ' 219' ' ' VAL . . . -67.28 -21.79 65.68 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.371 1.068 . . . . 74.11 111.543 -177.111 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . 0.509 ' HB2' ' HD2' ' A' ' 218' ' ' PRO . 15.2 t70 -63.83 -46.51 84.74 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.629 0.772 . . . . 72.02 110.014 170.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 115.54 -40.79 2.32 Favored Glycine 0 C--N 1.341 0.847 0 CA-C-N 114.883 -1.053 . . . . 71.23 111.107 -174.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 32.3 p -123.86 142.42 51.14 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.018 0.927 . . . . 75.45 109.345 179.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -150.19 108.94 0.41 Allowed Glycine 0 C--N 1.344 0.982 0 N-CA-C 111.439 -0.664 . . . . 75.32 111.439 -177.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -168.85 66.34 0.18 Allowed Glycine 0 C--N 1.349 1.262 0 CA-C-N 116.756 0.278 . . . . 60.03 112.752 -177.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 47.0 m -66.48 151.16 47.8 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.687 0.795 . . . . 65.25 110.864 171.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -69.95 130.68 22.5 Favored Glycine 0 CA--C 1.529 0.961 0 N-CA-C 110.968 -0.853 . . . . 55.23 110.968 176.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -66.6 100.89 0.58 Allowed Glycine 0 C--N 1.349 1.274 0 N-CA-C 111.732 -0.547 . . . . 62.13 111.732 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 20.2 m -55.49 -60.22 3.72 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.666 1.187 . . . . 72.12 112.276 -176.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -179.61 -130.74 1.51 Allowed Glycine 0 N--CA 1.463 0.458 0 N-CA-C 111.03 -0.828 . . . . 73.11 111.03 -178.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -81.9 61.48 4.66 Favored Glycine 0 C--N 1.344 1.023 0 N-CA-C 112.165 -0.374 . . . . 64.13 112.165 176.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 60.8 m -147.21 48.43 1.12 Allowed 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.616 1.166 . . . . 62.32 108.579 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -65.97 -24.28 66.76 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 115.239 -0.891 . . . . 74.23 111.155 178.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.405 ' HA ' ' O ' ' A' ' 248' ' ' ASP . 6.7 p-10 -91.19 151.28 21.01 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 115.673 -0.694 . . . . 73.23 109.901 175.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 79.7 mt -132.76 130.79 40.39 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.792 0.837 . . . . 71.34 109.084 173.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -96.71 125.48 41.21 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 108.337 -0.986 . . . . 74.55 108.337 174.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.46 ' O ' ' HA ' ' A' ' 251' ' ' LEU . . . -148.63 143.23 26.41 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.408 0.683 . . . . 74.25 109.336 178.026 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' THR . . . . . 0.4 HG21 ' HB2' ' A' ' 252' ' ' GLU . 2.4 p -89.92 132.36 35.35 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 109.079 -0.712 . . . . 71.52 109.079 171.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.549 HD12 ' HB1' ' A' ' 212' ' ' ALA . 62.3 tp -107.3 110.96 23.1 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.81 0.844 . . . . 74.44 108.972 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -85.08 128.46 34.66 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-O 120.962 0.411 . . . . 75.21 109.918 175.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.504 ' HA ' HG13 ' A' ' 210' ' ' VAL . 3.1 p -133.29 123.67 17.85 Favored Pre-proline 0 CA--C 1.545 0.773 0 CA-C-N 114.775 -1.102 . . . . 71.4 108.954 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -57.61 143.15 95.51 Favored 'Trans proline' 0 C--N 1.37 1.662 0 C-N-CA 122.585 2.19 . . . . 71.55 111.653 171.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . 0.403 ' O ' HG21 ' A' ' 205' ' ' VAL . . . -50.42 -46.45 84.39 Favored Pre-proline 0 CA--C 1.563 1.443 0 CA-C-O 117.782 -1.104 . . . . 70.15 112.993 -178.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -55.51 -44.62 46.67 Favored 'Trans proline' 0 C--N 1.395 2.977 0 C-N-CA 122.3 2.0 . . . . 74.22 113.088 174.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . 0.473 HG21 HG11 ' A' ' 210' ' ' VAL . 45.4 mt -68.4 -32.03 53.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 C-N-CA 123.467 0.707 . . . . 63.35 110.598 -178.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.42 -44.02 75.91 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.224 0.61 . . . . 75.55 110.957 178.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.403 HG21 ' O ' ' A' ' 201' ' ' ALA . 93.1 t -70.43 -48.19 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 123.532 0.733 . . . . 72.0 111.217 -177.601 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 7.2 p -72.47 -30.37 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 CA-C-O 120.601 0.239 . . . . 74.32 110.998 -179.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 78.76 67.57 1.59 Allowed Glycine 0 C--N 1.352 1.423 0 N-CA-C 111.637 -0.585 . . . . 43.02 111.637 -174.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -98.95 -145.71 19.1 Favored Glycine 0 C--N 1.352 1.444 0 N-CA-C 111.449 -0.66 . . . . 74.31 111.449 -177.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -120.73 146.68 46.22 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.561 0.745 . . . . 72.31 109.078 173.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.504 HG13 ' HA ' ' A' ' 199' ' ' VAL . 7.1 m -139.9 155.36 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 C-N-CA 124.679 1.192 . . . . 74.52 109.211 171.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 14.7 ttp180 -91.22 119.55 31.4 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-O 120.805 0.336 . . . . 74.52 111.126 -170.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.549 ' HB1' HD12 ' A' ' 197' ' ' LEU . . . -100.53 151.78 21.17 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.969 0.907 . . . . 44.33 108.951 172.146 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -107.15 116.46 31.97 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 123.599 0.76 . . . . 73.24 110.222 -178.052 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 24.6 p -109.72 172.24 6.97 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.21 1.004 . . . . 73.05 108.631 172.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 17.5 mt -74.02 -5.9 44.22 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 122.819 0.448 . . . . 73.13 111.958 -176.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -107.16 -9.64 16.09 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.756 1.223 . . . . 75.23 111.349 -177.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 139.65 -165.92 25.72 Favored Glycine 0 C--N 1.352 1.439 0 CA-C-O 120.151 -0.25 . . . . 70.14 113.526 175.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . 0.509 ' HD2' ' HB2' ' A' ' 179' ' ' ASP . 71.7 Cg_endo -76.66 142.65 23.22 Favored 'Trans proline' 0 C--N 1.369 1.627 0 C-N-CA 123.225 2.617 . . . . 75.25 112.466 176.02 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.511 HG12 ' HA ' ' A' ' 177' ' ' PRO . 24.8 m -137.29 143.58 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 123.849 0.86 . . . . 73.45 109.733 176.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -97.3 114.65 26.45 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 118.27 0.487 . . . . 74.54 109.78 175.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . 0.415 HG23 ' HB3' ' A' ' 175' ' ' TYR . 52.9 t -95.47 126.02 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.277 1.031 . . . . 71.31 109.679 179.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -75.46 106.3 6.94 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 123.315 0.646 . . . . 63.33 109.397 175.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 44.9 t -68.39 132.09 91.53 Favored Pre-proline 0 CA--C 1.552 1.028 0 C-N-CA 124.417 1.087 . . . . 63.52 109.525 175.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -59.78 144.86 99.37 Favored 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 122.455 2.103 . . . . 63.23 111.853 173.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_exo -62.12 129.66 27.93 Favored 'Trans proline' 0 C--N 1.375 1.961 0 C-N-CA 122.667 2.245 . . . . 71.03 111.689 176.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 62.7 mtp180 67.33 79.18 0.23 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.247 1.419 . . . . 74.11 110.086 179.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.517 ' HA ' ' HE ' ' A' ' 231' ' ' ARG . 13.3 m -107.52 141.16 39.39 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 114.231 -1.35 . . . . 74.22 110.684 -177.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -118.11 147.23 43.5 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.356 1.062 . . . . 74.22 108.382 174.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -60.26 125.2 22.78 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.123 0.969 . . . . 72.33 110.571 -178.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 113.38 4.38 23.63 Favored Glycine 0 C--N 1.34 0.805 0 CA-C-O 119.537 -0.591 . . . . 74.43 113.12 -175.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.517 ' HE ' ' HA ' ' A' ' 227' ' ' THR . 72.4 mtt-85 -65.73 148.23 52.09 Favored 'General case' 0 C--N 1.363 1.162 0 N-CA-C 109.249 -0.649 . . . . 74.3 109.249 167.316 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.4 ' O ' ' HB ' ' A' ' 170' ' ' VAL . 18.9 pttm -124.84 117.08 23.32 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.971 -1.122 . . . . 64.4 107.971 176.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.494 HD22 ' HB2' ' A' ' 173' ' ' ALA . 30.6 mt -103.89 97.42 7.42 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 108.066 -1.087 . . . . 74.31 108.066 -179.466 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . 0.462 ' HB2' HG13 ' A' ' 170' ' ' VAL . 40.6 ttt180 -93.54 101.13 13.3 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 108.823 -0.806 . . . . 75.34 108.823 177.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.474 ' HB3' ' HB2' ' A' ' 238' ' ' LYS . 21.8 mt -82.92 83.92 7.61 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.481 -1.236 . . . . 75.14 109.669 -174.133 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 55.4 mttp -62.75 137.63 58.31 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 116.098 -0.501 . . . . 71.01 110.082 177.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 64.59 23.66 68.93 Favored Glycine 0 C--N 1.347 1.151 0 O-C-N 123.679 0.612 . . . . 70.24 113.004 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.474 ' HB2' ' HB3' ' A' ' 235' ' ' LEU . 45.7 mmtm -140.51 16.86 2.37 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.308 1.043 . . . . 70.13 111.247 -176.201 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -93.47 -116.99 2.62 Favored Glycine 0 N--CA 1.467 0.741 0 N-CA-C 111.568 -0.613 . . . . 75.22 111.568 179.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -71.45 130.29 87.73 Favored Pre-proline 0 CA--C 1.546 0.817 0 CA-C-O 118.619 -0.705 . . . . 74.01 109.781 179.191 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.446 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 22.2 Cg_endo -60.41 129.16 28.58 Favored 'Trans proline' 0 C--N 1.373 1.824 0 C-N-CA 123.154 2.569 . . . . 71.5 112.533 175.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -150.81 135.44 5.16 Favored Glycine 0 CA--C 1.532 1.103 0 CA-C-O 118.651 -1.083 . . . . 73.13 110.557 179.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -61.73 -41.67 37.08 Favored 'Trans proline' 0 C--N 1.382 2.331 0 C-N-CA 123.54 2.827 . . . . 74.31 112.746 -176.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -78.01 -26.64 48.61 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.177 0.591 . . . . 73.24 111.258 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 169.24 148.11 5.69 Favored Glycine 0 C--N 1.347 1.172 0 N-CA-C 111.457 -0.657 . . . . 75.23 111.457 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.446 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 36.4 mtt-85 -86.45 161.37 18.66 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 122.769 0.428 . . . . 65.41 110.148 178.079 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -81.84 -155.86 15.99 Favored Glycine 0 C--N 1.34 0.785 0 CA-C-N 115.591 -0.732 . . . . 52.13 112.368 172.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . 0.405 ' O ' ' HA ' ' A' ' 192' ' ' ASP . 6.5 p-10 -118.45 131.53 56.26 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.442 0.697 . . . . 75.23 110.381 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 58.5 tp -98.16 106.89 19.24 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 107.76 -1.2 . . . . 75.11 107.76 173.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -89.3 108.58 19.7 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 115.496 -0.775 . . . . 74.32 109.053 -177.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.504 HD11 HD22 ' A' ' 197' ' ' LEU . 63.6 mt -103.13 139.35 38.76 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.79 0.836 . . . . 65.34 110.096 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . 0.4 ' HB2' HG21 ' A' ' 196' ' ' THR . 46.3 mt-10 -111.44 108.79 18.47 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.63 -0.878 . . . . 74.11 108.63 172.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 72.5 t -66.5 109.37 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 C-N-CA 123.922 0.889 . . . . 74.4 111.33 -178.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 31.5 mmm180 -108.52 102.95 11.99 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.381 1.472 . . . . 74.14 108.312 177.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 30.4 mt -77.14 142.78 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 N-CA-C 109.855 -0.424 . . . . 73.4 109.855 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.9 t . . . . . 0 CA--C 1.558 1.277 0 C-N-CA 124.092 0.957 . . . . 74.12 109.207 176.377 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' MET . . . . . 0.417 ' SD ' ' N ' ' A' ' 167' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.096 0 N-CA-C 109.088 -0.708 . . . . 73.3 109.088 . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -89.87 57.91 4.02 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-O 122.045 0.926 . . . . 70.02 109.365 177.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -56.69 -55.46 33.89 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 114.589 -1.187 . . . . 74.34 110.053 -179.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.44 HG21 ' HB3' ' A' ' 234' ' ' ARG . 15.4 m -97.41 161.7 2.78 Favored 'Isoleucine or valine' 0 C--O 1.247 0.942 0 CA-C-N 114.905 -1.043 . . . . 74.34 109.188 172.149 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 12.6 tt -85.63 151.96 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 N-CA-C 108.92 -0.771 . . . . 71.35 108.92 174.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -56.15 128.81 37.36 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.471 1.109 . . . . 74.33 110.961 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.445 ' HB2' HD22 ' A' ' 233' ' ' LEU . . . -158.66 143.95 16.37 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.258 1.023 . . . . 74.21 109.754 179.111 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -146.56 169.13 19.58 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 108.244 -1.021 . . . . 74.24 108.244 172.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.501 ' CE1' ' HB3' ' A' ' 238' ' ' LYS . 37.5 p90 -129.61 -177.81 4.42 Favored 'General case' 0 C--O 1.243 0.733 0 CA-C-O 121.739 0.781 . . . . 74.43 111.65 -176.166 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 11.9 mmmm -132.61 122.03 17.59 Favored Pre-proline 0 C--O 1.232 0.178 0 CA-C-N 114.368 -1.287 . . . . 75.05 107.536 174.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . 0.407 ' HA ' HG11 ' A' ' 219' ' ' VAL . 57.3 Cg_endo -66.92 93.71 0.33 Allowed 'Trans proline' 0 C--N 1.359 1.105 0 C-N-CA 122.856 2.371 . . . . 73.43 111.63 -177.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . 0.436 ' HB1' ' HG3' ' A' ' 220' ' ' GLU . . . -67.48 91.47 0.27 Allowed 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 109.45 -0.574 . . . . 72.34 109.45 179.097 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 67.59 14.94 9.69 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 124.52 1.128 . . . . 72.42 111.583 -174.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -88.3 115.04 4.32 Favored Glycine 0 C--N 1.348 1.199 0 N-CA-C 111.622 -0.591 . . . . 61.5 111.622 -178.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 22.8 t -164.24 96.78 0.79 Allowed 'General case' 0 C--O 1.242 0.697 0 N-CA-C 108.696 -0.853 . . . . 72.24 108.696 177.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -88.55 -179.01 46.56 Favored Glycine 0 C--N 1.347 1.165 0 CA-C-N 116.171 -0.468 . . . . 75.12 112.224 175.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -78.68 -97.66 0.24 Allowed Glycine 0 C--N 1.343 0.925 0 N-CA-C 112.218 -0.353 . . . . 52.34 112.218 175.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 33.1 t -150.04 162.75 39.78 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 122.946 0.498 . . . . 73.12 110.882 -177.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -100.12 -53.2 1.11 Allowed Glycine 0 C--N 1.348 1.208 0 CA-C-N 115.358 -0.837 . . . . 70.43 112.02 -179.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 64.52 -112.62 5.15 Favored Glycine 0 C--N 1.349 1.269 0 O-C-N 123.924 0.426 . . . . 71.2 112.076 -177.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 35.3 t -79.92 79.47 6.44 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.749 0.82 . . . . 74.51 108.899 172.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -138.82 94.72 0.21 Allowed Glycine 0 C--N 1.347 1.148 0 N-CA-C 111.033 -0.827 . . . . 73.54 111.033 -177.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -55.17 -43.2 83.74 Favored Glycine 0 C--N 1.352 1.446 0 O-C-N 124.39 0.7 . . . . 64.42 113.999 -175.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 18.2 m -70.11 96.65 1.09 Allowed 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 109.454 -0.573 . . . . 74.52 109.454 174.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 25.5 mm-40 -96.12 -36.41 10.99 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.025 0.53 . . . . 73.14 110.152 171.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -95.09 154.21 17.28 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 122.726 0.41 . . . . 61.15 110.74 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 33.3 mt -128.09 156.33 42.99 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.147 0.979 . . . . 70.21 109.863 175.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -130.5 121.91 26.67 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.892 0.877 . . . . 74.23 108.716 173.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -149.6 167.35 26.61 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 124.003 0.921 . . . . 61.12 109.58 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 17.7 m -112.14 137.04 50.77 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.779 -0.646 . . . . 70.0 109.4 -178.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 43.8 tp -108.92 122.13 46.57 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.181 0.992 . . . . 74.51 110.117 -170.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -87.45 104.64 16.65 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.566 0.746 . . . . 72.0 109.613 176.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.527 ' HA ' HG12 ' A' ' 210' ' ' VAL . 59.7 t -109.21 113.74 58.51 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 123.489 0.716 . . . . 74.15 109.436 174.123 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -58.56 141.84 97.72 Favored 'Trans proline' 0 C--N 1.379 2.17 0 C-N-CA 123.039 2.493 . . . . 64.2 111.937 171.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -51.6 -45.51 91.1 Favored Pre-proline 0 CA--C 1.562 1.419 0 N-CA-C 113.931 1.086 . . . . 74.32 113.931 -176.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -55.37 -47.09 27.76 Favored 'Trans proline' 0 C--N 1.391 2.775 0 C-N-CA 121.957 1.771 . . . . 73.22 113.184 173.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 56.6 mt -66.86 -29.82 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 123.641 0.776 . . . . 75.33 110.734 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.8 -46.77 67.82 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.585 0.754 . . . . 73.01 111.486 179.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 85.5 t -66.44 -54.43 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 115.937 -0.574 . . . . 73.51 110.501 -178.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 18.2 m -69.47 -30.44 45.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 N-CA-C 112.072 0.397 . . . . 73.24 112.072 -177.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 74.68 68.3 1.58 Allowed Glycine 0 C--N 1.345 1.038 0 O-C-N 123.431 0.457 . . . . 72.22 112.28 -176.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -97.58 -126.51 5.43 Favored Glycine 0 C--N 1.348 1.222 0 N-CA-C 111.74 -0.544 . . . . 44.44 111.74 -178.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 49.1 mtmt -131.55 158.93 39.64 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.741 0.816 . . . . 75.43 108.982 171.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.527 HG12 ' HA ' ' A' ' 199' ' ' VAL . 6.0 m -136.77 137.29 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 123.545 0.738 . . . . 74.3 109.917 174.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 51.1 ttt-85 -83.58 109.04 17.08 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 108.913 -0.773 . . . . 75.53 108.913 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -101.12 155.26 18.1 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.493 1.117 . . . . 73.41 110.213 -177.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' MET . . . . . 0.425 ' HA ' ' HE2' ' A' ' 213' ' ' MET . 16.1 mmt -105.62 118.45 36.61 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.022 0.929 . . . . 75.14 109.349 178.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 70.7 p -116.65 179.24 4.06 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.803 0.441 . . . . 72.02 109.825 170.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 20.8 mt -62.97 -36.15 82.52 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.752 -0.658 . . . . 74.45 111.091 -177.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -93.69 -20.14 20.44 Favored 'General case' 0 CA--C 1.554 1.1 0 CA-C-N 115.295 -0.866 . . . . 72.41 111.643 -170.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 155.56 177.73 29.09 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 120.881 -0.676 . . . . 43.44 114.183 177.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -64.5 142.11 76.68 Favored 'Trans proline' 0 C--N 1.376 1.975 0 C-N-CA 123.001 2.467 . . . . 73.4 112.513 174.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.407 HG11 ' HA ' ' A' ' 177' ' ' PRO . 34.4 m -139.3 128.49 29.34 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 C-N-CA 123.311 0.644 . . . . 74.41 109.84 179.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.436 ' HG3' ' HB1' ' A' ' 178' ' ' ALA . 36.7 mt-10 -83.42 104.02 13.24 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 109.778 -0.453 . . . . 73.23 109.778 177.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 48.1 t -93.49 118.13 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 109.121 -0.696 . . . . 74.13 109.121 -177.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -71.87 107.21 4.52 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 123.25 0.62 . . . . 73.34 110.16 -179.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 60.5 t -70.97 130.29 88.49 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 124.556 1.142 . . . . 74.52 109.709 -179.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -63.73 140.08 72.4 Favored 'Trans proline' 0 C--N 1.373 1.868 0 C-N-CA 122.387 2.058 . . . . 74.14 112.246 174.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -60.38 133.54 49.82 Favored 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 122.342 2.028 . . . . 70.43 111.758 174.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 82.1 mtt180 68.85 72.5 0.27 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.938 1.295 . . . . 74.21 109.795 -176.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.699 ' HA ' ' HE ' ' A' ' 231' ' ' ARG . 38.9 m -94.22 140.13 30.16 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 114.784 -1.098 . . . . 73.43 110.085 176.01 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -113.29 145.48 40.99 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 124.054 0.942 . . . . 73.42 108.738 174.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . 0.455 ' HB3' ' HB ' ' A' ' 255' ' ' ILE . . . -64.33 117.09 6.73 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.369 0.668 . . . . 73.33 109.587 178.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 108.47 9.74 26.64 Favored Glycine 0 CA--C 1.526 0.746 0 CA-C-O 119.426 -0.652 . . . . 63.42 112.565 -173.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.699 ' HE ' ' HA ' ' A' ' 227' ' ' THR . 57.5 mtt-85 -63.45 150.0 44.72 Favored 'General case' 0 C--N 1.361 1.072 0 N-CA-C 109.348 -0.612 . . . . 75.41 109.348 166.21 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 19.6 pttm -121.91 138.91 54.22 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 123.217 0.607 . . . . 70.43 109.762 174.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.445 HD22 ' HB2' ' A' ' 173' ' ' ALA . 57.4 mt -123.9 137.26 54.66 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.588 1.155 . . . . 75.34 108.221 177.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . 0.44 ' HB3' HG21 ' A' ' 170' ' ' VAL . 52.8 ttm-85 -128.75 102.41 6.55 Favored 'General case' 0 C--O 1.243 0.72 0 N-CA-C 108.734 -0.839 . . . . 73.31 108.734 176.114 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.424 HD11 ' CD1' ' A' ' 175' ' ' TYR . 17.0 mt -83.9 89.52 7.23 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.019 0.927 . . . . 71.44 109.361 -174.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -73.78 131.58 41.71 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.532 -0.758 . . . . 73.44 110.971 -175.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 66.81 24.82 72.98 Favored Glycine 0 C--N 1.35 1.348 0 O-C-N 123.858 0.724 . . . . 74.43 112.972 -178.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.501 ' HB3' ' CE1' ' A' ' 175' ' ' TYR . 32.1 mmtp -140.23 39.49 1.92 Allowed 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.038 0.935 . . . . 72.21 110.581 -172.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -120.85 -120.62 2.77 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-N 116.228 -0.442 . . . . 64.33 112.232 174.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -69.19 147.75 97.45 Favored Pre-proline 0 N--CA 1.49 1.557 0 C-N-CA 123.78 0.832 . . . . 74.34 111.684 178.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.436 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 22.6 Cg_endo -59.97 134.02 54.07 Favored 'Trans proline' 0 C--N 1.387 2.602 0 C-N-CA 123.329 2.686 . . . . 73.05 113.455 -179.545 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -151.04 131.74 3.62 Favored Glycine 0 CA--C 1.54 1.62 0 N-CA-C 110.287 -1.125 . . . . 62.21 110.287 179.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -65.27 -45.99 6.52 Favored 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 123.266 2.644 . . . . 75.23 113.69 -170.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -86.72 11.8 12.22 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 122.855 0.462 . . . . 73.45 111.828 -178.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 133.56 139.87 4.26 Favored Glycine 0 C--N 1.341 0.829 0 N-CA-C 109.766 -1.334 . . . . 62.1 109.766 -174.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.436 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 23.4 mtm180 -78.14 170.73 16.13 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-O 121.025 0.44 . . . . 75.55 111.248 -175.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.52 -156.93 8.45 Favored Glycine 0 C--N 1.344 1.027 0 CA-C-N 115.281 -0.872 . . . . 63.5 112.775 172.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -116.73 160.95 20.0 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.537 0.335 . . . . 73.23 111.148 -170.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 38.8 tp -140.66 106.87 5.23 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 108.258 -1.016 . . . . 74.13 108.258 173.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -94.98 116.31 28.53 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 109.277 -0.638 . . . . 74.21 109.277 -175.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 60.5 mt -116.13 117.99 31.61 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.542 0.737 . . . . 74.34 109.792 -178.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -89.74 112.4 23.67 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.65 0.78 . . . . 73.01 109.598 177.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.477 HG12 HG23 ' A' ' 227' ' ' THR . 60.2 t -71.2 118.79 16.44 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 CA-C-O 121.497 0.665 . . . . 62.22 112.059 -176.101 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 29.6 mmm180 -108.16 115.7 30.61 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 125.101 1.36 . . . . 73.33 108.293 170.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.455 ' HB ' ' HB3' ' A' ' 229' ' ' ALA . 30.5 mt -76.18 128.09 37.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 108.437 -0.949 . . . . 74.22 108.437 170.188 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 6.8 t . . . . . 0 CA--C 1.558 1.274 0 CA-C-O 117.427 -1.273 . . . . 73.2 107.927 -176.382 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 20.3 mmt . . . . . 0 N--CA 1.475 0.822 0 N-CA-C 109.592 -0.521 . . . . 75.1 109.592 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -148.1 131.16 16.3 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 107.695 -1.224 . . . . 75.24 107.695 175.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -72.32 -65.94 0.71 Allowed 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.062 -0.517 . . . . 74.55 109.743 178.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 33.3 m -109.67 -175.74 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 C-N-CA 124.586 1.155 . . . . 72.15 110.472 179.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 14.9 tt -91.94 144.7 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 N-CA-C 107.873 -1.158 . . . . 74.44 107.873 165.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -63.36 140.27 58.86 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.463 0.705 . . . . 70.44 112.745 -172.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -153.29 153.55 32.86 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.876 1.27 . . . . 75.31 108.494 171.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -147.42 156.5 42.93 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 108.244 -1.021 . . . . 62.23 108.244 172.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.433 ' CZ ' ' HB3' ' A' ' 238' ' ' LYS . 12.4 p90 -136.7 168.28 19.82 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.585 0.587 . . . . 74.03 112.585 179.078 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -140.25 150.11 60.33 Favored Pre-proline 0 N--CA 1.477 0.901 0 C-N-CA 125.042 1.337 . . . . 74.1 108.158 176.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . 0.535 ' HA ' HG12 ' A' ' 219' ' ' VAL . 38.8 Cg_endo -65.21 109.35 1.32 Allowed 'Trans proline' 0 C--N 1.374 1.885 0 C-N-CA 122.174 1.916 . . . . 72.44 110.909 179.395 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -58.88 -44.11 91.06 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.302 1.041 . . . . 71.31 111.382 -175.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -80.02 -30.09 39.46 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 114.759 -1.109 . . . . 74.11 110.729 177.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 90.73 35.64 7.18 Favored Glycine 0 C--N 1.348 1.2 0 CA-C-N 115.988 -0.551 . . . . 71.11 113.281 176.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 29.6 t -121.11 170.19 9.79 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 122.999 0.52 . . . . 65.11 109.6 171.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -137.11 99.67 0.3 Allowed Glycine 0 C--N 1.345 1.028 0 N-CA-C 111.785 -0.526 . . . . 71.52 111.785 -177.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -73.89 75.25 1.1 Allowed Glycine 0 C--N 1.353 1.482 0 N-CA-C 111.722 -0.551 . . . . 65.12 111.722 176.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' SER . . . . . 0.465 ' HA ' ' HG3' ' A' ' 241' ' ' PRO . 4.4 p -96.94 89.81 4.98 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.077 0.951 . . . . 73.11 111.131 -172.041 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -74.19 131.36 13.49 Favored Glycine 0 C--N 1.35 1.331 0 CA-C-N 115.224 -0.898 . . . . 43.51 112.961 175.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -78.59 100.12 1.67 Allowed Glycine 0 C--N 1.35 1.316 0 CA-C-O 119.761 -0.466 . . . . 62.43 112.336 -177.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 26.3 m 65.81 79.59 0.24 Allowed 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 125.095 1.358 . . . . 64.42 110.354 -179.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -95.98 28.83 11.25 Favored Glycine 0 C--N 1.347 1.194 0 CA-C-N 115.412 -0.813 . . . . 71.04 113.306 -175.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.5 -57.68 4.46 Favored Glycine 0 C--N 1.347 1.143 0 CA-C-N 116.635 0.218 . . . . 64.34 112.722 176.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 49.9 m -131.13 154.28 48.49 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.938 0.895 . . . . 75.52 109.829 -179.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.5 ' HB3' ' HA3' ' A' ' 247' ' ' GLY . 39.7 mt-30 -94.08 -21.47 19.11 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.531 0.733 . . . . 72.32 111.006 176.009 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -80.69 152.05 28.61 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.494 0.717 . . . . 73.41 111.107 177.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 13.5 mt -132.57 143.12 49.49 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.744 1.218 . . . . 75.22 108.707 168.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -111.8 135.39 52.48 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 106.474 -1.676 . . . . 73.25 106.474 166.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -159.73 171.61 19.22 Favored 'General case' 0 C--N 1.327 -0.382 0 O-C-N 123.696 0.622 . . . . 75.41 109.746 179.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 26.5 m -113.31 142.35 45.94 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.453 -0.943 . . . . 71.3 108.453 179.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.44 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . 51.2 tp -109.31 121.66 45.66 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 109.339 -0.615 . . . . 72.53 109.339 179.504 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -82.6 134.26 35.18 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 109.001 -0.74 . . . . 63.41 109.001 167.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.425 ' HA ' HG11 ' A' ' 210' ' ' VAL . 4.2 p -143.03 121.27 7.2 Favored Pre-proline 0 CA--C 1.539 0.553 0 N-CA-C 108.429 -0.952 . . . . 73.35 108.429 175.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . 0.539 ' HA ' ' HG1' ' A' ' 256' ' ' THR . 50.4 Cg_exo -56.22 142.29 87.36 Favored 'Trans proline' 0 C--N 1.366 1.48 0 C-N-CA 122.58 2.186 . . . . 74.13 112.12 175.051 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -49.4 -45.87 77.43 Favored Pre-proline 0 CA--C 1.558 1.259 0 C-N-CA 123.729 0.812 . . . . 74.4 113.065 178.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -53.9 -55.16 3.73 Favored 'Trans proline' 0 C--N 1.397 3.103 0 C-N-CA 122.273 1.982 . . . . 75.42 113.109 171.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 52.3 mt -63.66 -30.45 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 C-N-CA 123.304 0.642 . . . . 75.11 111.779 -177.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.73 -42.41 74.01 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 122.949 0.5 . . . . 73.12 111.443 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 97.2 t -73.66 -54.48 15.16 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 C-N-CA 123.138 0.575 . . . . 73.14 111.107 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 14.8 m -76.74 -22.03 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 N-CA-C 112.03 0.382 . . . . 73.43 112.03 -174.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 86.67 170.59 47.02 Favored Glycine 0 C--N 1.348 1.239 0 N-CA-C 112.047 -0.421 . . . . 64.45 112.047 -174.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 145.96 -129.14 3.29 Favored Glycine 0 C--N 1.333 0.397 0 N-CA-C 111.071 -0.812 . . . . 64.15 111.071 175.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -139.73 158.51 43.98 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.883 0.873 . . . . 75.13 109.709 176.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.425 HG11 ' HA ' ' A' ' 199' ' ' VAL . 18.7 m -138.51 155.43 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 123.722 0.809 . . . . 73.45 109.535 171.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 48.2 mtm180 -82.72 127.85 33.81 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 109.353 -0.61 . . . . 73.33 109.353 173.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -116.36 146.38 42.51 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 124.373 1.069 . . . . 74.55 109.156 179.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' MET . . . . . 0.448 ' HA ' ' HE2' ' A' ' 213' ' ' MET . 5.2 mmt -94.81 110.05 21.96 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 109.321 -0.622 . . . . 74.12 109.321 177.588 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 38.4 p -119.63 174.93 6.11 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 123.838 0.855 . . . . 71.13 109.416 174.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . 0.404 HD11 ' CE1' ' A' ' 240' ' ' PHE . 15.5 mt -78.72 -2.1 37.72 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 116.298 -0.41 . . . . 73.54 111.681 -177.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -100.67 -4.8 27.61 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.868 0.867 . . . . 73.23 110.936 171.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 114.67 -160.53 13.15 Favored Glycine 0 C--N 1.356 1.686 0 C-N-CA 123.611 0.624 . . . . 62.44 112.806 178.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.33 131.8 19.7 Favored 'Trans proline' 0 C--N 1.375 1.924 0 C-N-CA 122.771 2.314 . . . . 63.21 112.503 175.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.535 HG12 ' HA ' ' A' ' 177' ' ' PRO . 31.6 m -134.81 139.84 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 123.586 0.754 . . . . 75.21 110.484 -178.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -87.04 105.69 17.33 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 122.66 0.384 . . . . 75.2 110.139 178.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 76.8 t -92.5 117.66 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 N-CA-C 108.543 -0.91 . . . . 74.43 108.543 179.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -65.6 101.65 0.63 Allowed 'General case' 0 C--O 1.24 0.569 0 O-C-N 124.322 1.014 . . . . 74.54 110.254 178.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 63.0 t -77.84 117.98 69.26 Favored Pre-proline 0 CA--C 1.543 0.682 0 O-C-N 124.613 1.196 . . . . 73.52 108.823 174.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -65.31 151.62 84.68 Favored 'Trans proline' 0 CA--C 1.559 1.769 0 C-N-CA 122.033 1.822 . . . . 74.33 111.602 170.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_exo -63.62 141.53 80.07 Favored 'Trans proline' 0 C--N 1.373 1.867 0 C-N-CA 122.555 2.17 . . . . 74.4 112.357 178.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 51.7 mtm180 62.93 49.07 3.67 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.786 1.234 . . . . 71.51 110.638 176.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.495 HG23 HG12 ' A' ' 253' ' ' VAL . 55.3 m -98.85 109.2 22.0 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 114.271 -1.331 . . . . 65.23 109.244 173.287 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -85.47 161.49 19.37 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.606 -0.725 . . . . 71.21 111.773 -175.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -69.15 124.43 23.79 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.765 0.826 . . . . 74.31 110.084 177.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 111.43 -9.82 28.5 Favored Glycine 0 N--CA 1.471 0.992 0 O-C-N 123.306 0.378 . . . . 74.23 112.411 -175.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 66.0 mtt180 -70.15 162.69 27.84 Favored 'General case' 0 C--N 1.35 0.622 0 CA-C-O 121.532 0.682 . . . . 72.55 111.046 170.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 18.7 pttm -121.58 143.53 49.25 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 114.957 -1.02 . . . . 75.33 110.305 -177.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 93.1 mt -125.35 142.66 51.37 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.748 1.219 . . . . 74.24 108.325 174.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 65.8 ttt180 -133.18 124.27 27.14 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 108.22 -1.03 . . . . 74.4 108.22 -179.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.444 ' HB3' ' HG3' ' A' ' 238' ' ' LYS . 26.6 mt -120.88 84.04 2.17 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.671 0.788 . . . . 72.22 109.455 -166.117 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -79.32 140.01 37.66 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.875 0.87 . . . . 70.1 110.726 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 70.27 26.98 73.45 Favored Glycine 0 C--N 1.347 1.174 0 O-C-N 123.828 0.705 . . . . 45.02 112.336 -176.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.444 ' HG3' ' HB3' ' A' ' 235' ' ' LEU . 8.0 mmpt? -128.75 -48.34 1.25 Allowed 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.982 0.913 . . . . 60.31 111.583 -172.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -55.39 -102.42 0.01 OUTLIER Glycine 0 CA--C 1.549 2.162 0 N-CA-C 116.25 1.26 . . . . 53.54 116.25 -164.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . 0.404 ' CE1' HD11 ' A' ' 215' ' ' LEU . 0.7 OUTLIER -84.17 153.41 62.88 Favored Pre-proline 0 N--CA 1.485 1.292 0 C-N-CA 123.098 0.559 . . . . 72.51 110.181 177.301 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.477 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 18.2 Cg_endo -56.28 154.27 29.81 Favored 'Trans proline' 0 C--N 1.373 1.86 0 C-N-CA 123.813 3.009 . . . . 73.34 114.076 170.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -165.23 143.55 8.56 Favored Glycine 0 CA--C 1.535 1.34 0 CA-C-O 119.017 -0.88 . . . . 62.14 111.974 175.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -63.7 -45.13 11.73 Favored 'Trans proline' 0 C--N 1.382 2.323 0 C-N-CA 123.372 2.715 . . . . 64.2 113.096 179.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -80.38 -26.18 38.73 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 122.747 0.419 . . . . 75.44 110.946 -179.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 166.73 160.02 13.29 Favored Glycine 0 C--N 1.336 0.536 0 N-CA-C 111.029 -0.828 . . . . 61.43 111.029 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.477 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 23.9 mtm180 -78.81 160.67 27.26 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 122.547 0.339 . . . . 72.43 110.682 -179.337 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . 0.5 ' HA3' ' HB3' ' A' ' 191' ' ' GLN . . . -88.02 -155.82 29.6 Favored Glycine 0 C--N 1.344 0.98 0 CA-C-N 115.833 -0.621 . . . . 65.31 113.529 -175.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -102.47 155.59 18.16 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.125 0.57 . . . . 74.34 109.826 -175.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 36.6 tp -136.73 115.75 12.37 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 107.829 -1.175 . . . . 74.54 107.829 168.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -100.04 107.96 20.03 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.009 -0.737 . . . . 71.51 109.009 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.44 ' HB3' ' HB2' ' A' ' 197' ' ' LEU . 43.0 mt -102.33 121.06 41.54 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.61 0.764 . . . . 73.12 110.225 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -91.23 115.52 28.09 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 109.361 -0.607 . . . . 74.12 109.361 174.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.495 HG12 HG23 ' A' ' 227' ' ' THR . 85.2 t -62.42 127.94 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.533 1.133 . . . . 55.52 111.751 -176.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -131.39 116.21 17.24 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.717 1.207 . . . . 75.54 107.942 172.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 34.9 mt -77.51 126.61 38.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 O-C-N 123.769 0.668 . . . . 75.23 109.653 176.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 256' ' ' THR . . . . . 0.539 ' HG1' ' HA ' ' A' ' 200' ' ' PRO . 25.7 p . . . . . 0 C--O 1.254 1.313 0 N-CA-C 108.314 -0.995 . . . . 75.44 108.314 173.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 66.0 mtm . . . . . 0 N--CA 1.478 0.95 0 N-CA-C 108.695 -0.854 . . . . 73.33 108.695 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 25.3 t70 67.86 106.23 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.577 1.151 . . . . 74.4 110.354 -175.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -97.84 -63.89 1.09 Allowed 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.675 0.79 . . . . 65.33 110.285 -176.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.437 HG11 ' HB2' ' A' ' 234' ' ' ARG . 14.0 m -95.99 176.43 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 123.49 0.716 . . . . 73.11 111.037 -178.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 17.7 tt -96.35 138.32 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 N-CA-C 107.611 -1.255 . . . . 74.24 107.611 162.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -71.87 145.64 48.43 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.761 0.824 . . . . 75.22 111.268 -174.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.401 ' HB2' HD22 ' A' ' 233' ' ' LEU . . . -155.58 178.16 10.56 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.587 1.155 . . . . 73.42 109.74 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -156.32 152.16 27.3 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.751 0.82 . . . . 72.12 109.962 178.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.437 ' CD1' HD13 ' A' ' 235' ' ' LEU . 33.0 p90 -129.04 168.01 16.68 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 121.139 0.495 . . . . 72.42 110.863 175.003 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -145.26 150.45 44.89 Favored Pre-proline 0 CA--C 1.548 0.885 0 CA-C-N 114.635 -1.166 . . . . 75.31 109.078 176.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -57.78 110.59 0.65 Allowed 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 123.604 2.869 . . . . 72.2 112.91 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . 0.429 ' HB2' ' HG3' ' A' ' 220' ' ' GLU . . . -71.12 -25.32 62.53 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.581 0.753 . . . . 52.23 111.236 -178.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -64.77 -29.52 70.49 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 115.64 -0.709 . . . . 73.44 111.24 174.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 140.02 -80.47 0.27 Allowed Glycine 0 C--N 1.342 0.874 0 N-CA-C 110.464 -1.054 . . . . 75.02 110.464 -178.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 35.2 t -117.18 153.79 32.22 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 123.516 0.726 . . . . 44.32 109.193 175.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -113.11 128.18 8.27 Favored Glycine 0 C--N 1.343 0.952 0 N-CA-C 110.818 -0.913 . . . . 62.52 110.818 179.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -86.13 128.27 8.75 Favored Glycine 0 C--N 1.348 1.21 0 N-CA-C 111.374 -0.69 . . . . 75.14 111.374 178.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 57.8 m -70.47 88.64 0.67 Allowed 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 121.389 0.614 . . . . 72.11 110.446 178.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -146.13 123.97 1.95 Allowed Glycine 0 C--N 1.337 0.627 0 CA-C-N 115.084 -0.962 . . . . 75.24 110.738 177.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -77.28 72.06 2.18 Favored Glycine 0 C--N 1.35 1.324 0 N-CA-C 112.166 -0.374 . . . . 74.33 112.166 -179.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 23.0 m -75.84 81.08 2.76 Favored 'General case' 0 C--N 1.352 0.692 0 C-N-CA 123.967 0.907 . . . . 72.53 109.577 -179.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 123.18 144.47 6.62 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.84 -0.904 . . . . 70.4 110.84 -175.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -84.07 74.07 2.56 Favored Glycine 0 C--N 1.348 1.234 0 CA-C-N 116.893 0.346 . . . . 70.14 112.667 -176.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 67.5 m -152.03 164.88 36.29 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.231 1.013 . . . . 71.11 109.763 177.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.498 ' HA ' ' HB2' ' A' ' 240' ' ' PHE . 83.5 mm-40 -120.32 -51.89 2.18 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.434 -0.951 . . . . 73.05 108.434 167.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -93.63 158.65 15.59 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 115.992 -0.549 . . . . 74.34 110.046 174.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 93.8 mt -136.25 149.97 48.75 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.03 0.932 . . . . 71.41 109.024 176.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -123.68 123.38 40.41 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.746 0.818 . . . . 74.23 108.819 173.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -157.44 170.92 21.35 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.19 0.596 . . . . 75.41 110.653 179.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 19.3 p -96.3 152.44 18.58 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.719 0.808 . . . . 74.11 109.822 174.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.688 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . 34.6 tp -116.77 114.42 23.95 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.392 0.677 . . . . 75.42 109.978 -176.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -74.97 100.74 4.23 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 109.366 -0.605 . . . . 74.41 109.366 176.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.481 ' HA ' HG13 ' A' ' 210' ' ' VAL . 54.8 t -110.6 110.5 57.56 Favored Pre-proline 0 N--CA 1.473 0.677 0 N-CA-C 108.807 -0.812 . . . . 73.13 108.807 177.011 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -53.33 138.35 64.67 Favored 'Trans proline' 0 C--N 1.379 2.133 0 C-N-CA 122.741 2.294 . . . . 74.14 111.626 173.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -46.13 -47.97 43.53 Favored Pre-proline 0 CA--C 1.569 1.679 0 N-CA-C 113.798 1.036 . . . . 72.12 113.798 -178.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -54.3 -46.16 35.59 Favored 'Trans proline' 0 C--N 1.4 3.249 0 C-N-CA 122.627 2.218 . . . . 74.01 112.557 174.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 49.9 mt -68.88 -30.12 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 124.148 0.979 . . . . 73.42 111.063 -176.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.55 -39.85 80.89 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 122.956 0.503 . . . . 64.34 111.197 177.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 88.3 t -70.96 -52.63 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 123.489 0.716 . . . . 74.33 111.089 179.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 18.5 m -80.0 -29.68 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 CA-C-N 116.046 -0.525 . . . . 63.03 112.379 -172.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 83.95 103.8 0.56 Allowed Glycine 0 C--N 1.345 1.079 0 O-C-N 123.554 0.533 . . . . 70.12 112.772 -176.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -158.7 178.43 34.91 Favored Glycine 0 C--N 1.342 0.896 0 N-CA-C 112.175 -0.37 . . . . 64.3 112.175 -178.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.542 ' HB3' ' HB3' ' A' ' 220' ' ' GLU . 34.6 mtmm -82.79 148.51 27.76 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 122.917 0.487 . . . . 75.22 111.364 -178.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.481 HG13 ' HA ' ' A' ' 199' ' ' VAL . 32.8 m -136.6 147.86 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 C-N-CA 123.93 0.892 . . . . 71.5 110.156 176.314 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 11.3 mtm180 -82.02 111.47 18.21 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-O 121.216 0.531 . . . . 75.11 111.521 -178.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -102.0 142.69 32.89 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 125.005 1.322 . . . . 65.23 109.167 171.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 34.2 tpp -100.88 116.3 32.42 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 122.763 0.425 . . . . 75.55 109.854 176.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 81.0 p -110.69 -178.59 3.52 Favored 'General case' 0 C--O 1.247 0.926 0 C-N-CA 124.101 0.96 . . . . 73.31 109.424 177.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 14.9 mt -77.32 -5.53 49.87 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 122.924 0.49 . . . . 75.3 110.609 -177.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -102.31 -19.23 15.09 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.332 1.053 . . . . 75.33 110.65 177.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 133.07 -160.35 23.86 Favored Glycine 0 C--N 1.356 1.69 0 CA-C-O 119.954 -0.359 . . . . 72.33 113.305 176.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -78.09 126.64 7.96 Favored 'Trans proline' 0 C--N 1.376 1.998 0 C-N-CA 123.172 2.581 . . . . 73.31 111.772 -179.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.419 ' HA ' ' H ' ' A' ' 178' ' ' ALA . 28.1 m -132.54 143.49 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 124.123 0.969 . . . . 74.42 109.489 -178.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.542 ' HB3' ' HB3' ' A' ' 209' ' ' LYS . 35.0 mt-10 -101.82 115.77 31.26 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.901 0.481 . . . . 75.3 110.484 176.166 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 24.1 t -95.64 116.46 37.33 Favored 'Isoleucine or valine' 0 C--N 1.346 0.413 0 C-N-CA 124.507 1.123 . . . . 73.15 109.138 -177.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -64.51 100.79 0.39 Allowed 'General case' 0 C--O 1.239 0.544 0 O-C-N 124.156 0.91 . . . . 74.32 110.109 174.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 21.3 t -82.73 127.73 68.96 Favored Pre-proline 0 N--CA 1.47 0.531 0 CA-C-N 114.927 -1.033 . . . . 74.51 108.652 177.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -61.46 156.79 44.65 Favored 'Trans proline' 0 CA--C 1.559 1.766 0 C-N-CA 122.277 1.985 . . . . 75.33 112.418 173.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -70.45 161.53 45.7 Favored 'Trans proline' 0 C--N 1.373 1.865 0 C-N-CA 122.388 2.058 . . . . 71.24 112.136 173.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 72.5 mtm-85 58.25 33.54 23.24 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.38 1.072 . . . . 74.25 111.782 175.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.586 HG21 ' HD2' ' A' ' 231' ' ' ARG . 25.5 m -92.72 126.57 37.87 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.397 1.079 . . . . 75.42 110.154 -178.382 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -93.8 162.18 14.03 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.361 0.664 . . . . 72.2 111.158 -178.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . 0.451 ' HB3' ' HB ' ' A' ' 255' ' ' ILE . . . -71.82 119.22 15.68 Favored 'General case' 0 C--N 1.35 0.613 0 CA-C-N 115.177 -0.919 . . . . 64.12 109.324 174.075 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 114.82 -2.7 23.01 Favored Glycine 0 C--N 1.333 0.366 0 CA-C-O 119.527 -0.596 . . . . 72.51 112.414 -174.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.586 ' HD2' HG21 ' A' ' 227' ' ' THR . 91.3 mtt180 -74.81 161.15 29.85 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-N 117.45 0.625 . . . . 75.24 110.209 170.343 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.465 ' HD2' ' OH ' ' A' ' 250' ' ' TYR . 20.8 pttm -129.06 134.53 48.14 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.875 0.87 . . . . 74.54 109.768 -176.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.401 HD22 ' HB2' ' A' ' 173' ' ' ALA . 73.8 mt -111.5 126.79 55.35 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.065 -1.087 . . . . 74.5 108.065 175.06 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . 0.437 ' HB2' HG11 ' A' ' 170' ' ' VAL . 54.3 ttm-85 -108.37 102.91 11.98 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 107.324 -1.361 . . . . 73.23 107.324 170.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.437 HD13 ' CD1' ' A' ' 175' ' ' TYR . 20.3 mt -79.1 91.06 4.87 Favored 'General case' 0 C--O 1.245 0.835 0 N-CA-C 108.104 -1.073 . . . . 74.21 108.104 179.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.425 ' HA ' ' OD2' ' A' ' 248' ' ' ASP . 90.8 mttt -72.97 122.97 22.57 Favored 'General case' 0 C--O 1.243 0.762 0 CA-C-N 113.711 -1.586 . . . . 75.43 111.771 -170.059 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 64.87 27.4 72.09 Favored Glycine 0 C--N 1.346 1.094 0 O-C-N 123.864 0.727 . . . . 72.51 111.658 -176.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.428 ' HB3' ' CE1' ' A' ' 175' ' ' TYR . 30.5 mmtp -140.65 59.35 1.55 Allowed 'General case' 0 C--O 1.22 -0.481 0 C-N-CA 124.858 1.263 . . . . 71.11 108.083 -175.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -120.39 -131.47 4.11 Favored Glycine 0 N--CA 1.467 0.725 0 N-CA-C 109.914 -1.274 . . . . 73.04 109.914 165.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . 0.498 ' HB2' ' HA ' ' A' ' 191' ' ' GLN . 4.3 m-85 -60.17 146.23 83.77 Favored Pre-proline 0 N--CA 1.484 1.245 0 C-N-CA 123.408 0.683 . . . . 74.02 111.537 173.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.556 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 37.5 Cg_endo -63.13 132.02 34.83 Favored 'Trans proline' 0 C--N 1.381 2.284 0 C-N-CA 123.146 2.564 . . . . 72.22 112.435 179.327 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -141.94 136.11 7.13 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-O 118.329 -1.261 . . . . 74.51 110.523 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -57.2 -53.86 4.3 Favored 'Trans proline' 0 C--N 1.378 2.105 0 C-N-CA 123.493 2.795 . . . . 72.31 113.762 -176.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -81.97 -26.44 33.92 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 122.964 0.505 . . . . 64.51 111.362 -178.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -177.63 140.47 4.77 Favored Glycine 0 C--N 1.341 0.812 0 N-CA-C 111.352 -0.699 . . . . 52.31 111.352 -177.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.556 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 57.4 mtm180 -78.87 169.46 18.19 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.221 0.609 . . . . 74.43 110.536 177.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -78.55 -159.7 14.61 Favored Glycine 0 C--N 1.339 0.718 0 CA-C-N 116.137 -0.483 . . . . 60.24 112.299 175.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . 0.425 ' OD2' ' HA ' ' A' ' 236' ' ' LYS . 27.7 m-20 -125.69 127.5 46.33 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 109.836 -0.431 . . . . 74.05 109.836 178.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 58.3 tp -100.74 109.63 21.67 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 108.159 -1.052 . . . . 72.11 108.159 177.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . 0.465 ' OH ' ' HD2' ' A' ' 232' ' ' LYS . 33.9 t80 -98.07 108.38 21.08 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.497 -0.774 . . . . 74.13 109.082 -174.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.688 ' HB3' ' HB2' ' A' ' 197' ' ' LEU . 69.9 mt -121.3 106.71 11.73 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.85 0.86 . . . . 74.25 110.336 -174.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . 0.411 ' HA ' ' HA ' ' A' ' 232' ' ' LYS . 53.5 mt-10 -80.29 110.99 16.25 Favored 'General case' 0 C--O 1.241 0.605 0 CA-C-N 115.177 -0.92 . . . . 70.22 110.365 178.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.405 HG13 HG22 ' A' ' 227' ' ' THR . 95.2 t -57.58 113.58 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 124.048 0.939 . . . . 70.15 111.363 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 28.7 mmm180 -113.22 116.18 29.37 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 107.241 -1.392 . . . . 70.4 107.241 169.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.451 ' HB ' ' HB3' ' A' ' 229' ' ' ALA . 58.1 mt -76.24 123.19 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 122.988 0.515 . . . . 74.32 109.78 -179.434 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.2 t . . . . . 0 CA--C 1.559 1.318 0 N-CA-C 107.802 -1.185 . . . . 75.13 107.802 175.031 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 26.0 mmt . . . . . 0 N--CA 1.476 0.855 0 N-CA-C 109.786 -0.45 . . . . 74.41 109.786 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -86.23 64.23 8.44 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-O 122.067 0.937 . . . . 75.02 108.504 175.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -90.65 -56.33 3.23 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.176 -0.92 . . . . 72.42 110.438 -170.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.415 HG23 ' HB3' ' A' ' 234' ' ' ARG . 35.5 m -79.04 155.61 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 109.72 -0.474 . . . . 71.11 109.72 173.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 12.7 tt -81.59 141.51 15.01 Favored 'Isoleucine or valine' 0 C--O 1.243 0.756 0 N-CA-C 108.99 -0.744 . . . . 73.4 108.99 173.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -62.97 133.17 54.21 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.208 1.003 . . . . 72.23 111.524 -172.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.461 ' HB3' HD22 ' A' ' 233' ' ' LEU . . . -147.52 171.33 15.72 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 124.594 1.158 . . . . 73.32 110.038 177.17 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -157.75 151.85 24.43 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.4 1.08 . . . . 75.05 108.374 176.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.402 ' HD1' HD12 ' A' ' 235' ' ' LEU . 6.4 p90 -128.3 167.02 17.51 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 109.898 -0.408 . . . . 72.33 109.898 172.375 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -140.67 136.41 16.43 Favored Pre-proline 0 N--CA 1.471 0.599 0 C-N-CA 123.281 0.632 . . . . 72.23 109.859 169.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . 0.524 ' HA ' HG13 ' A' ' 219' ' ' VAL . 13.7 Cg_endo -55.07 113.16 1.27 Allowed 'Trans proline' 0 C--N 1.378 2.088 0 C-N-CA 123.646 2.897 . . . . 74.21 112.881 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . 0.527 ' HB1' ' HG3' ' A' ' 220' ' ' GLU . . . -87.0 -10.64 52.64 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.735 0.814 . . . . 73.2 112.007 -175.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -109.53 -75.69 0.62 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.311 0.644 . . . . 75.21 109.591 178.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -126.58 -104.35 1.35 Allowed Glycine 0 C--N 1.347 1.143 0 N-CA-C 110.441 -1.064 . . . . 61.23 110.441 -178.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 74.0 m -157.64 160.46 38.06 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.612 1.165 . . . . 73.13 109.732 174.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -66.77 124.1 23.31 Favored Glycine 0 C--N 1.345 1.036 0 N-CA-C 111.343 -0.703 . . . . 62.01 111.343 171.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -84.42 154.63 30.14 Favored Glycine 0 C--N 1.343 0.953 0 N-CA-C 111.972 -0.451 . . . . 65.31 111.972 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' SER . . . . . 0.481 ' HB2' ' HB2' ' A' ' 241' ' ' PRO . 39.2 t -123.88 108.67 12.7 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.685 0.794 . . . . 71.23 109.008 179.489 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -99.92 52.97 0.99 Allowed Glycine 0 C--N 1.342 0.9 0 N-CA-C 111.494 -0.642 . . . . 72.43 111.494 177.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 103.76 -132.32 11.0 Favored Glycine 0 N--CA 1.468 0.828 0 N-CA-C 110.814 -0.914 . . . . 61.25 110.814 -172.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 29.5 p -77.58 -2.21 34.6 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 123.703 0.801 . . . . 75.22 112.053 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 95.92 -6.56 67.0 Favored Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.611 -0.549 . . . . 74.32 113.342 176.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 67.42 -84.3 0.14 Allowed Glycine 0 C--N 1.359 1.822 0 N-CA-C 111.731 -0.548 . . . . 72.12 111.731 -177.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 50.6 m -113.13 98.48 7.17 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 108.162 -1.051 . . . . 74.23 108.162 169.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.488 ' HA ' ' HB3' ' A' ' 240' ' ' PHE . 77.1 mt-30 -68.42 -25.28 64.95 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.298 0.639 . . . . 75.14 111.507 179.203 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.506 ' HB3' ' HE1' ' A' ' 194' ' ' TYR . 4.1 m-20 -79.77 114.79 18.96 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 114.654 -1.157 . . . . 55.53 109.718 -179.434 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 69.0 mt -112.27 135.97 52.29 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 108.808 -0.812 . . . . 74.41 108.808 172.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . 0.506 ' HE1' ' HB3' ' A' ' 192' ' ' ASP . 46.3 m-85 -129.05 122.99 31.14 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 108.648 -0.871 . . . . 70.42 108.648 -178.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -154.78 162.91 40.93 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 121.57 0.7 . . . . 74.51 110.333 -176.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 19.8 p -97.47 141.16 30.87 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-N 115.436 -0.802 . . . . 74.24 109.188 174.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.58 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . 45.7 tp -108.48 113.15 25.95 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.613 -0.721 . . . . 71.25 110.044 -175.345 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -79.32 99.89 7.32 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 109.22 -0.659 . . . . 64.43 109.22 178.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 43.1 t -106.86 118.43 54.21 Favored Pre-proline 0 N--CA 1.467 0.42 0 CA-C-N 115.334 -0.848 . . . . 74.4 108.721 176.03 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -54.74 143.25 70.96 Favored 'Trans proline' 0 C--N 1.371 1.747 0 C-N-CA 122.415 2.076 . . . . 74.24 111.796 169.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . 0.412 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -53.75 -44.41 97.92 Favored Pre-proline 0 CA--C 1.562 1.413 0 CA-C-O 118.03 -0.986 . . . . 64.13 112.454 179.012 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.412 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 13.7 Cg_endo -55.7 -47.17 26.71 Favored 'Trans proline' 0 C--N 1.403 3.412 0 C-N-CA 122.543 2.162 . . . . 73.54 111.97 172.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 33.2 mt -70.82 -24.73 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 C-N-CA 123.291 0.636 . . . . 73.01 111.238 -176.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -73.48 -41.72 62.78 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.169 0.588 . . . . 75.24 110.513 178.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 98.0 t -69.3 -55.24 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 123.616 0.767 . . . . 73.34 110.985 178.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 8.8 p -73.18 -31.62 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 C-N-CA 122.767 0.427 . . . . 74.34 111.507 -175.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 78.9 95.03 0.28 Allowed Glycine 0 C--N 1.345 1.062 0 N-CA-C 112.131 -0.388 . . . . 52.54 112.131 -175.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -141.21 -177.76 16.76 Favored Glycine 0 N--CA 1.467 0.765 0 N-CA-C 111.544 -0.622 . . . . 71.04 111.544 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.445 ' HD2' ' HB3' ' A' ' 220' ' ' GLU . 46.0 mtmt -84.17 137.09 33.7 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 109.443 -0.577 . . . . 74.31 109.443 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 26.8 m -119.75 157.51 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 123.775 0.83 . . . . 74.31 109.082 170.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 78.4 mtm180 -86.41 119.46 26.7 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 109.667 -0.494 . . . . 74.43 109.667 172.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -101.47 140.01 36.35 Favored 'General case' 0 C--O 1.245 0.848 0 C-N-CA 124.311 1.044 . . . . 73.14 108.273 174.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.66 103.23 15.15 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.435 -0.95 . . . . 72.0 108.435 -178.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 47.5 p -111.73 177.76 4.54 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.997 0.919 . . . . 74.12 109.86 -179.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 11.2 mt -67.67 -27.76 67.12 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 122.973 0.509 . . . . 72.44 110.916 -176.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -82.66 -18.92 39.33 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.994 0.918 . . . . 72.3 111.408 179.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 129.08 -154.28 20.2 Favored Glycine 0 C--N 1.353 1.489 0 CA-C-O 119.501 -0.61 . . . . 61.15 112.746 178.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -73.32 133.86 19.94 Favored 'Trans proline' 0 C--N 1.374 1.887 0 C-N-CA 122.722 2.281 . . . . 75.32 111.78 175.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.524 HG13 ' HA ' ' A' ' 177' ' ' PRO . 26.9 m -133.29 147.61 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 123.581 0.752 . . . . 75.34 110.164 177.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.527 ' HG3' ' HB1' ' A' ' 178' ' ' ALA . 48.3 mt-10 -90.73 106.02 18.22 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.143 0.577 . . . . 61.42 110.028 178.685 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 61.6 t -94.72 113.71 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 N-CA-C 109.096 -0.705 . . . . 63.35 109.096 176.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -68.02 100.04 0.94 Allowed 'General case' 0 C--O 1.242 0.658 0 O-C-N 124.028 0.83 . . . . 73.11 109.229 173.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.402 HG13 HG11 ' A' ' 199' ' ' VAL . 25.5 t -79.7 124.53 83.52 Favored Pre-proline 0 C--O 1.24 0.591 0 C-N-CA 123.884 0.874 . . . . 74.14 109.046 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -55.83 146.49 66.92 Favored 'Trans proline' 0 C--N 1.374 1.9 0 C-N-CA 122.485 2.124 . . . . 72.33 112.574 174.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -67.4 150.68 80.84 Favored 'Trans proline' 0 C--N 1.373 1.862 0 C-N-CA 122.144 1.896 . . . . 71.05 112.62 175.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 61.58 37.74 16.02 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 124.904 1.281 . . . . 75.21 111.705 177.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 45.5 m -96.96 116.01 28.45 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.816 0.846 . . . . 75.25 110.622 -178.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 24.1 mp0 -86.18 165.7 16.33 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.771 0.828 . . . . 63.43 111.287 -178.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -70.49 133.67 47.03 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 114.799 -1.091 . . . . 72.21 109.46 176.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 112.68 -24.95 12.51 Favored Glycine 0 C--N 1.334 0.461 0 N-CA-C 111.441 -0.664 . . . . 53.15 111.441 -176.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 60.6 mtt180 -63.82 160.65 16.93 Favored 'General case' 0 C--N 1.36 1.038 0 C-N-CA 123.504 0.722 . . . . 74.03 111.526 178.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 16.1 pttm -130.21 134.42 47.26 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.202 1.001 . . . . 74.51 110.145 -171.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.461 HD22 ' HB3' ' A' ' 173' ' ' ALA . 58.5 mt -120.0 100.24 7.1 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.648 1.179 . . . . 75.34 108.524 179.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . 0.415 ' HB3' HG23 ' A' ' 170' ' ' VAL . 67.8 ttt180 -93.92 101.1 13.16 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 108.5 -0.926 . . . . 75.55 108.5 177.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.476 HD11 HD11 ' A' ' 251' ' ' LEU . 21.3 mt -79.14 83.35 5.21 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.187 0.995 . . . . 71.51 109.343 -178.448 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -79.3 140.97 37.41 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.529 0.732 . . . . 73.34 110.628 -177.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 65.41 24.82 71.02 Favored Glycine 0 C--N 1.349 1.26 0 O-C-N 124.045 0.841 . . . . 72.14 111.65 -174.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -130.33 -26.01 2.37 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.713 0.805 . . . . 75.2 110.859 -174.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -67.96 -145.53 0.12 Allowed Glycine 0 C--N 1.358 1.751 0 O-C-N 123.653 0.596 . . . . 62.14 113.718 -175.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . 0.488 ' HB3' ' HA ' ' A' ' 191' ' ' GLN . 0.1 OUTLIER -67.06 120.68 73.8 Favored Pre-proline 0 CA--C 1.552 1.055 0 O-C-N 122.369 -0.489 . . . . 74.21 110.912 -173.21 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.58 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 15.7 Cg_exo -70.67 160.19 50.25 Favored 'Trans proline' 0 C--N 1.385 2.499 0 C-N-CA 123.746 2.964 . . . . 70.43 115.499 -173.518 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -159.43 164.26 33.89 Favored Glycine 0 CA--C 1.532 1.095 0 CA-C-N 113.188 -1.824 . . . . 70.52 110.43 175.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -70.51 -23.31 27.53 Favored 'Trans proline' 0 C--N 1.37 1.685 0 C-N-CA 122.945 2.43 . . . . 74.41 113.291 -177.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -89.42 -27.08 20.65 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.227 0.611 . . . . 72.43 110.783 177.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 166.95 -170.12 41.21 Favored Glycine 0 C--N 1.349 1.269 0 N-CA-C 112.183 -0.367 . . . . 61.21 112.183 -178.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.58 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 26.6 mtm180 -117.92 155.36 30.34 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.875 0.87 . . . . 74.21 110.412 -177.382 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . 0.485 ' HA3' ' HB3' ' A' ' 191' ' ' GLN . . . -86.84 -156.13 28.59 Favored Glycine 0 C--N 1.343 0.951 0 CA-C-N 115.706 -0.679 . . . . 75.11 111.952 171.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -122.56 154.26 38.16 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 121.287 0.565 . . . . 62.31 110.894 176.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.42 ' HG ' ' HG ' ' A' ' 251' ' ' LEU . 41.4 tp -116.77 107.28 14.45 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 107.485 -1.302 . . . . 72.34 107.485 170.143 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -90.75 105.75 18.04 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.77 0.828 . . . . 75.42 108.773 -176.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.58 ' HB3' ' HB2' ' A' ' 197' ' ' LEU . 49.5 mt -109.71 106.73 16.49 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.498 1.119 . . . . 55.03 110.654 -177.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -82.81 115.63 21.79 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 109.62 -0.511 . . . . 74.31 109.62 176.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 61.6 t -60.03 104.55 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 124.425 1.09 . . . . 73.55 111.455 -177.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 21.3 mmm180 -101.56 107.13 18.32 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 125.115 1.366 . . . . 72.31 107.997 171.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.469 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 48.3 mt -77.43 132.39 32.8 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 CA-C-O 120.913 0.387 . . . . 74.21 110.512 178.58 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 3.1 t . . . . . 0 C--O 1.251 1.16 0 C-N-CA 124.766 1.226 . . . . 72.35 109.294 177.805 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 25.7 ptt? . . . . . 0 N--CA 1.472 0.667 0 N-CA-C 109.752 -0.462 . . . . 61.25 109.752 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 60.04 98.08 0.03 OUTLIER 'General case' 0 C--N 1.359 1.009 0 C-N-CA 125.404 1.482 . . . . 72.2 111.031 178.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . 0.49 ' O ' ' HE3' ' A' ' 232' ' ' LYS . 23.1 t70 -53.94 -50.6 66.11 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.435 0.694 . . . . 75.44 110.08 -179.347 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 29.3 m -113.04 157.92 13.57 Favored 'Isoleucine or valine' 0 C--O 1.244 0.797 0 C-N-CA 123.752 0.821 . . . . 71.11 110.491 178.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 15.5 tt -81.15 147.03 6.58 Favored 'Isoleucine or valine' 0 C--O 1.248 0.979 0 N-CA-C 107.398 -1.334 . . . . 73.32 107.398 166.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -57.58 123.82 16.91 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.196 0.598 . . . . 75.31 110.761 -178.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.472 ' HB3' HD23 ' A' ' 233' ' ' LEU . . . -146.64 159.05 43.94 Favored 'General case' 0 C--O 1.244 0.789 0 CA-C-N 115.102 -0.954 . . . . 75.05 109.649 177.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -158.95 163.03 36.87 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.037 -0.983 . . . . 71.52 108.964 179.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.494 ' HD1' HD12 ' A' ' 235' ' ' LEU . 16.8 p90 -135.21 170.89 15.23 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-O 121.402 0.62 . . . . 74.25 111.406 176.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -137.27 141.15 33.06 Favored Pre-proline 0 CA--C 1.542 0.671 0 CA-C-N 113.584 -1.643 . . . . 75.4 107.734 173.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . 0.463 ' HA ' HG12 ' A' ' 219' ' ' VAL . 32.1 Cg_exo -59.13 117.55 4.3 Favored 'Trans proline' 0 CA--C 1.551 1.372 0 C-N-CA 123.196 2.597 . . . . 74.24 111.707 179.502 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . 0.468 ' HB3' ' HG3' ' A' ' 220' ' ' GLU . . . -65.67 -46.28 79.73 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.85 0.833 . . . . 73.22 109.662 -177.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -88.44 158.21 18.43 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 114.096 -1.411 . . . . 73.45 109.153 170.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -76.34 66.81 2.57 Favored Glycine 0 C--N 1.349 1.304 0 N-CA-C 111.285 -0.726 . . . . 61.33 111.285 172.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 11.6 t -139.91 134.35 31.48 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 107.868 -1.16 . . . . 75.11 107.868 -176.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 169.24 84.18 0.05 OUTLIER Glycine 0 C--N 1.333 0.404 0 N-CA-C 110.499 -1.04 . . . . 73.41 110.499 -176.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -70.09 -176.91 19.27 Favored Glycine 0 C--N 1.343 0.939 0 N-CA-C 112.158 -0.377 . . . . 75.41 112.158 173.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 51.2 m -144.89 145.88 31.78 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 117.405 0.602 . . . . 61.23 110.533 -176.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -163.57 -87.32 0.06 OUTLIER Glycine 0 C--N 1.337 0.599 0 N-CA-C 110.354 -1.099 . . . . 73.22 110.354 179.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 59.27 40.37 95.8 Favored Glycine 0 C--N 1.352 1.439 0 O-C-N 123.883 0.402 . . . . 71.43 113.554 -178.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 28.6 p -72.7 -49.02 34.11 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.691 0.796 . . . . 74.41 112.085 -174.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 158.19 4.38 0.07 OUTLIER Glycine 0 N--CA 1.469 0.887 0 CA-C-N 115.973 -0.558 . . . . 51.3 113.061 -178.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -78.85 -157.19 10.61 Favored Glycine 0 C--N 1.352 1.456 0 CA-C-N 117.071 0.436 . . . . 75.21 112.889 175.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 22.5 p -69.33 86.46 0.42 Allowed 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 123.759 0.824 . . . . 75.25 110.587 177.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.42 ' HA ' ' HB2' ' A' ' 240' ' ' PHE . 77.2 mt-30 -84.74 -27.23 27.1 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.478 1.111 . . . . 74.32 111.036 177.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -76.06 129.65 37.16 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 115.216 -0.902 . . . . 74.41 108.951 174.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 42.5 mt -116.94 147.1 42.54 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.731 1.212 . . . . 74.3 108.72 173.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -139.81 122.25 16.13 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.086 0.955 . . . . 73.31 108.92 -175.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -163.1 169.03 20.05 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.009 0.524 . . . . 65.42 111.002 -175.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 8.7 p -95.56 149.74 21.1 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.54 0.736 . . . . 71.54 109.782 171.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.551 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . 38.4 tp -112.85 113.69 25.88 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.657 0.783 . . . . 75.14 109.926 -178.312 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -73.79 109.26 7.16 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 123.37 0.668 . . . . 74.13 109.76 174.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.449 ' HA ' HG13 ' A' ' 210' ' ' VAL . 89.5 t -118.83 120.37 31.55 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 108.716 -0.846 . . . . 74.55 108.716 175.61 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_exo -55.96 142.81 84.42 Favored 'Trans proline' 0 C--N 1.368 1.561 0 C-N-CA 123.147 2.565 . . . . 71.31 112.06 169.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -52.04 -46.18 93.15 Favored Pre-proline 0 CA--C 1.556 1.205 0 C-N-CA 124.512 1.125 . . . . 33.23 113.847 -179.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.456 ' O ' HG12 ' A' ' 206' ' ' VAL . 12.7 Cg_endo -55.0 -50.43 13.25 Favored 'Trans proline' 0 C--N 1.394 2.923 0 C-N-CA 122.147 1.898 . . . . 71.25 112.835 173.543 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 36.6 mt -63.55 -30.43 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 123.842 0.857 . . . . 70.04 111.443 -177.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.44 -48.24 61.53 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.212 0.605 . . . . 71.32 111.407 177.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 86.5 t -67.04 -52.57 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 C-N-CA 123.461 0.704 . . . . 74.41 111.605 -175.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.456 HG12 ' O ' ' A' ' 202' ' ' PRO . 12.9 p -82.54 -30.13 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 C-N-CA 122.613 0.365 . . . . 72.4 111.466 -176.339 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 89.13 126.58 2.85 Favored Glycine 0 C--N 1.349 1.297 0 N-CA-C 111.76 -0.536 . . . . 72.23 111.76 -175.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -159.65 -141.97 3.27 Favored Glycine 0 C--N 1.341 0.831 0 CA-C-O 119.997 -0.335 . . . . 73.12 112.425 -177.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm -134.68 134.2 40.86 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 108.555 -0.906 . . . . 75.14 108.555 175.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.449 HG13 ' HA ' ' A' ' 199' ' ' VAL . 35.1 m -119.5 163.07 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 C-N-CA 123.994 0.918 . . . . 54.55 108.823 173.255 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 80.2 mtm180 -98.79 123.65 43.17 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 121.324 0.583 . . . . 74.23 110.459 175.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -100.71 137.28 39.32 Favored 'General case' 0 C--O 1.246 0.899 0 CA-C-N 114.934 -1.03 . . . . 72.25 108.77 179.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' MET . . . . . 0.471 ' HA ' ' HE2' ' A' ' 213' ' ' MET . 18.9 mmt -83.02 108.52 16.39 Favored 'General case' 0 C--O 1.238 0.465 0 O-C-N 124.179 0.925 . . . . 73.32 108.682 176.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 80.4 p -108.98 177.08 4.87 Favored 'General case' 0 C--O 1.244 0.768 0 N-CA-C 108.307 -0.997 . . . . 75.33 108.307 174.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 11.2 mt -66.78 -23.26 66.05 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 116.404 -0.362 . . . . 73.33 110.135 177.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -92.33 -19.61 21.95 Favored 'General case' 0 CA--C 1.558 1.259 0 C-N-CA 124.082 0.953 . . . . 74.45 111.509 -179.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 129.16 -149.56 18.59 Favored Glycine 0 C--N 1.355 1.589 0 CA-C-O 119.561 -0.577 . . . . 72.43 114.1 173.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -76.36 127.73 9.97 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 123.194 2.596 . . . . 74.04 112.066 -178.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.463 HG12 ' HA ' ' A' ' 177' ' ' PRO . 33.8 m -130.4 131.47 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 122.989 0.516 . . . . 72.4 110.524 176.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.468 ' HG3' ' HB3' ' A' ' 178' ' ' ALA . 40.0 mt-10 -77.41 104.2 7.78 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 122.944 0.498 . . . . 64.04 109.963 178.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 59.7 t -92.7 122.4 44.14 Favored 'Isoleucine or valine' 0 C--O 1.245 0.821 0 N-CA-C 108.149 -1.056 . . . . 73.33 108.149 178.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -68.65 99.72 1.04 Allowed 'General case' 0 C--O 1.24 0.605 0 O-C-N 124.215 0.947 . . . . 63.12 109.379 177.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 69.4 t -77.39 120.37 81.24 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-N 115.152 -0.931 . . . . 70.52 108.596 174.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -64.06 156.5 58.49 Favored 'Trans proline' 0 C--N 1.377 2.053 0 C-N-CA 122.72 2.28 . . . . 73.51 112.241 177.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -65.11 143.43 78.19 Favored 'Trans proline' 0 C--N 1.372 1.809 0 C-N-CA 122.349 2.032 . . . . 74.12 111.332 170.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 71.6 mtm180 65.42 66.14 0.54 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.675 1.19 . . . . 74.2 110.339 178.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.594 HG23 ' HD2' ' A' ' 231' ' ' ARG . 97.1 m -107.77 134.31 50.91 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.062 -0.972 . . . . 72.35 110.038 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -108.33 157.7 18.15 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.958 0.903 . . . . 71.44 110.264 176.539 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -72.49 118.81 15.86 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.126 0.97 . . . . 62.3 109.277 173.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 114.54 -6.5 22.68 Favored Glycine 0 CA--C 1.521 0.467 0 CA-C-O 119.295 -0.725 . . . . 61.54 112.014 -171.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.594 ' HD2' HG23 ' A' ' 227' ' ' THR . 49.8 mtt-85 -67.15 157.93 32.49 Favored 'General case' 0 C--N 1.364 1.21 0 CA-C-N 117.941 0.87 . . . . 74.51 110.286 169.343 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.49 ' HE3' ' O ' ' A' ' 169' ' ' ASP . 32.7 pttt -130.23 138.31 50.49 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 123.756 0.822 . . . . 73.43 109.348 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.472 HD23 ' HB3' ' A' ' 173' ' ' ALA . 59.8 mt -127.3 100.52 6.09 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.032 1.333 . . . . 74.45 108.212 -178.103 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 22.6 ttp180 -90.64 102.0 14.74 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.162 -1.051 . . . . 75.34 108.162 176.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.494 HD12 ' HD1' ' A' ' 175' ' ' TYR . 14.5 mt -76.41 83.28 3.14 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 114.188 -1.369 . . . . 73.43 108.271 -179.556 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -66.62 134.96 53.38 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 114.465 -1.243 . . . . 74.21 111.234 -173.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 69.57 10.21 63.17 Favored Glycine 0 CA--C 1.538 1.526 0 O-C-N 123.73 0.644 . . . . 75.05 112.782 -178.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.451 ' HB3' ' CE1' ' A' ' 175' ' ' TYR . 33.4 mmtp -134.03 42.54 2.91 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 125.126 1.371 . . . . 74.12 110.523 -171.072 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -100.97 -102.4 2.55 Favored Glycine 0 N--CA 1.472 1.044 0 N-CA-C 109.714 -1.354 . . . . 74.15 109.714 165.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . 0.42 ' HB2' ' HA ' ' A' ' 191' ' ' GLN . 8.8 m-85 -82.08 126.33 75.02 Favored Pre-proline 0 N--CA 1.475 0.795 0 C-N-CA 123.076 0.55 . . . . 73.43 109.667 167.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.471 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 12.9 Cg_exo -71.79 158.3 53.39 Favored 'Trans proline' 0 C--N 1.37 1.684 0 C-N-CA 122.901 2.401 . . . . 72.44 111.928 175.057 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -178.64 151.93 10.9 Favored Glycine 0 CA--C 1.529 0.916 0 CA-C-O 119.17 -0.794 . . . . 75.13 112.004 -178.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -71.36 -28.82 17.69 Favored 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 123.149 2.566 . . . . 74.3 113.671 179.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -121.42 -26.49 4.98 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.49 0.716 . . . . 74.3 112.215 -178.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -134.38 117.74 1.87 Allowed Glycine 0 C--N 1.345 1.058 0 N-CA-C 111.434 -0.666 . . . . 61.14 111.434 -174.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.471 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 70.5 mtt180 -127.29 126.83 43.33 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 108.666 -0.864 . . . . 75.22 108.666 178.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -80.69 -161.37 25.35 Favored Glycine 0 C--N 1.351 1.401 0 O-C-N 123.354 0.409 . . . . 72.12 112.843 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -130.74 156.64 44.62 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.227 0.611 . . . . 71.53 110.314 175.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.471 ' HG ' ' HG ' ' A' ' 251' ' ' LEU . 36.9 tp -114.33 109.92 19.1 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 108.811 -0.811 . . . . 72.34 108.811 172.112 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -93.01 107.79 19.5 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.915 0.886 . . . . 75.1 108.971 -176.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.551 ' HB3' ' HB2' ' A' ' 197' ' ' LEU . 48.3 mt -113.31 116.95 30.52 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.101 0.96 . . . . 74.12 111.455 -173.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -86.99 108.48 18.86 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 109.166 -0.679 . . . . 73.25 109.166 173.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 53.8 t -60.99 120.15 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 123.512 0.725 . . . . 73.52 110.68 179.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 26.2 mmm180 -117.21 113.53 22.36 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 106.898 -1.519 . . . . 73.24 106.898 173.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 55.5 mt -79.15 127.19 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 123.312 0.645 . . . . 73.14 110.906 -177.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 20.1 p . . . . . 0 C--O 1.25 1.096 0 C-N-CA 124.742 1.217 . . . . 73.32 108.304 177.447 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 26.9 t70 . . . . . 0 N--CA 1.475 0.802 0 N-CA-C 107.984 -1.117 . . . . 71.519999999999996 107.984 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.47 HG21 ' HB3' ' A' ' 234' ' ' ARG . 17.1 m -85.99 143.02 12.35 Favored 'Isoleucine or valine' 0 C--O 1.245 0.835 0 N-CA-C 108.016 -1.105 . . . . 63.210000000000001 108.016 167.481 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 15.2 tt -73.83 141.26 16.43 Favored 'Isoleucine or valine' 0 C--O 1.246 0.876 0 N-CA-C 108.701 -0.852 . . . . 41.32 108.701 174.01 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -63.93 118.57 8.61 Favored 'General case' 0 C--N 1.349 0.554 0 O-C-N 123.903 0.752 . . . . 73.129999999999995 110.906 -173.158 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.454 ' HB2' HD22 ' A' ' 233' ' ' LEU . . . -124.02 160.66 27.16 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.267 1.027 . . . . 72.450000000000003 109.813 -174.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -149.08 163.75 36.65 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.488 0.715 . . . . 74.349999999999994 109.75 -178.014 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.442 ' HD1' HD13 ' A' ' 235' ' ' LEU . 7.9 p90 -150.08 178.76 8.65 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 122.899 0.479 . . . . 74.219999999999999 110.773 174.669 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 41.4 mmtm -141.67 132.33 13.05 Favored Pre-proline 0 N--CA 1.483 1.222 0 C-N-CA 124.73 1.212 . . . . 75.040000000000006 109.007 175.037 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' PRO . . . . . 0.423 ' HA ' HG12 ' A' ' 219' ' ' VAL . 55.7 Cg_endo -67.54 105.54 1.09 Allowed 'Trans proline' 0 C--N 1.384 2.415 0 C-N-CA 122.946 2.431 . . . . 70.140000000000001 111.866 -177.562 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 178' ' ' ALA . . . . . 0.494 ' HB2' ' HG3' ' A' ' 220' ' ' GLU . . . . . . . . 0 CA--C 1.537 0.48 0 C-N-CA 123.46 0.704 . . . . 50.149999999999999 109.235 178.165 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 121.708 0.766 . . . . 34.009999999999998 110.314 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.485 ' HA ' ' O ' ' A' ' 248' ' ' ASP . 3.7 p-10 -88.17 145.57 25.85 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 114.653 -1.158 . . . . 61.310000000000002 110.153 171.007 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 67.9 mt -127.11 140.43 52.28 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.682 0.793 . . . . 63.450000000000003 108.954 172.344 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -107.21 120.87 43.31 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 108.919 -0.771 . . . . 75.319999999999993 108.919 175.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -143.81 161.62 38.17 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.836 0.854 . . . . 74.349999999999994 109.452 -177.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 2.7 m -112.97 141.27 47.0 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 109.072 -0.714 . . . . 74.540000000000006 109.072 -178.093 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.52 HD11 HG23 ' A' ' 210' ' ' VAL . 37.6 tp -113.22 117.93 33.26 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.281 0.632 . . . . 74.25 111.052 -168.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -82.34 101.18 10.41 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.91 -0.774 . . . . 74.319999999999993 108.91 168.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.544 ' HA ' HG11 ' A' ' 210' ' ' VAL . 2.6 p -115.31 112.71 43.73 Favored Pre-proline 0 CA--C 1.546 0.79 0 N-CA-C 109.218 -0.66 . . . . 74.109999999999999 109.218 173.446 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -54.08 146.1 50.02 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 123.349 2.699 . . . . 55.149999999999999 113.029 175.361 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -49.38 -49.32 71.69 Favored Pre-proline 0 CA--C 1.561 1.383 0 O-C-N 124.356 1.035 . . . . 25.300000000000001 113.489 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -60.19 -42.13 45.47 Favored 'Trans proline' 0 C--N 1.393 2.91 0 C-N-CA 121.919 1.746 . . . . 61.200000000000003 112.528 177.195 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 43.0 mt -70.92 -27.33 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 123.602 0.761 . . . . 62.149999999999999 110.932 -177.162 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.05 -48.13 63.6 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.069 0.548 . . . . 52.219999999999999 110.709 175.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 88.6 t -68.12 -46.17 81.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 123.742 0.817 . . . . 63.530000000000001 111.591 -176.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 17.0 m -73.65 -33.13 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 CA-C-N 116.691 -0.231 . . . . 73.549999999999997 111.109 178.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 74.66 77.17 0.68 Allowed Glycine 0 C--N 1.349 1.268 0 CA-C-N 115.987 -0.551 . . . . 72.140000000000001 112.243 -173.507 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -107.58 -133.64 7.21 Favored Glycine 0 C--N 1.344 1.025 0 N-CA-C 111.566 -0.614 . . . . 75.5 111.566 178.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm -131.49 147.24 52.53 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.858 0.863 . . . . 70.040000000000006 109.633 171.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.544 HG11 ' HA ' ' A' ' 199' ' ' VAL . 17.4 m -133.62 143.57 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 124.401 1.08 . . . . 74.340000000000003 109.278 174.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 211' ' ' ARG . . . . . 0.432 ' HA ' ' O ' ' A' ' 219' ' ' VAL . 14.8 ttm180 -85.56 116.31 23.78 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 122.486 0.314 . . . . 73.450000000000003 110.882 -175.714 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -100.68 141.36 33.66 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.454 1.102 . . . . 73.319999999999993 110.113 177.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 2.2 mmt -88.23 125.03 34.43 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 123.881 0.873 . . . . 70.140000000000001 110.051 176.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 41.3 p -134.42 177.75 7.52 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.791 0.836 . . . . 54.130000000000003 110.605 178.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 215' ' ' LEU . . . . . 0.415 HD12 ' HE1' ' A' ' 240' ' ' PHE . 20.1 mt -69.19 -26.28 64.75 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 122.811 0.445 . . . . 73.439999999999998 110.503 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -79.84 -19.38 48.55 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.483 0.713 . . . . 73.209999999999994 110.967 178.498 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 127.47 -157.28 20.82 Favored Glycine 0 C--N 1.352 1.438 0 CA-C-O 119.797 -0.446 . . . . 71.409999999999997 112.653 178.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 218' ' ' PRO . . . . . 0.448 ' HG2' ' O ' ' A' ' 178' ' ' ALA . 58.7 Cg_endo -76.37 134.06 15.22 Favored 'Trans proline' 0 C--N 1.369 1.657 0 C-N-CA 122.744 2.296 . . . . 55.140000000000001 111.655 175.204 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' A' ' 211' ' ' ARG . 19.7 m -135.34 145.41 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 123.722 0.809 . . . . 74.340000000000003 109.106 -178.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.494 ' HG3' ' HB2' ' A' ' 178' ' ' ALA . 56.0 mt-10 -105.32 110.66 23.1 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 118.942 0.792 . . . . 73.299999999999997 109.545 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 45.5 t -97.06 122.43 48.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 124.975 1.31 . . . . 65.450000000000003 111.021 -170.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -65.25 105.31 1.08 Allowed 'General case' 0 C--O 1.241 0.641 0 C-N-CA 124.28 1.032 . . . . 54.409999999999997 110.94 175.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 51.5 t -76.8 128.14 82.36 Favored Pre-proline 0 CA--C 1.548 0.866 0 CA-C-N 114.741 -1.118 . . . . 65.209999999999994 109.008 173.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.48 141.99 96.86 Favored 'Trans proline' 0 CA--C 1.561 1.84 0 C-N-CA 122.504 2.136 . . . . 60.43 112.445 174.13 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -59.41 126.61 21.25 Favored 'Trans proline' 0 C--N 1.375 1.97 0 C-N-CA 122.696 2.264 . . . . 50.130000000000003 112.771 173.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 86.6 mtt-85 70.74 71.47 0.19 Allowed 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 125.638 1.575 . . . . 73.109999999999999 110.065 179.096 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.619 HG23 ' HD2' ' A' ' 231' ' ' ARG . 15.9 m -103.45 136.8 42.52 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 114.264 -1.335 . . . . 65.510000000000005 110.622 -177.067 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 22.3 mp0 -103.91 158.04 16.68 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.209 1.004 . . . . 64.329999999999998 109.764 177.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -74.47 144.97 43.97 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 109.424 -0.584 . . . . 63.43 109.424 173.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 89.89 2.0 75.77 Favored Glycine 0 C--N 1.341 0.86 0 CA-C-O 120.112 -0.271 . . . . 75.049999999999997 112.687 -175.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.619 ' HD2' HG23 ' A' ' 227' ' ' THR . 83.1 mtt180 -70.13 160.83 31.33 Favored 'General case' 0 C--N 1.356 0.848 0 CA-C-O 121.528 0.68 . . . . 60.340000000000003 110.179 170.245 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 16.1 pttp -130.53 138.42 50.2 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 114.863 -1.062 . . . . 74.140000000000001 108.885 175.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.454 HD22 ' HB2' ' A' ' 173' ' ' ALA . 67.0 mt -119.89 141.41 49.61 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.564 1.146 . . . . 74.230000000000004 107.925 178.186 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 234' ' ' ARG . . . . . 0.47 ' HB3' HG21 ' A' ' 170' ' ' VAL . 33.8 ttt180 -129.53 107.98 9.89 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.452 -0.944 . . . . 74.219999999999999 108.452 171.085 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.442 HD13 ' HD1' ' A' ' 175' ' ' TYR . 19.6 mt -81.08 83.99 6.62 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.833 1.253 . . . . 71.310000000000002 109.099 -177.649 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -69.75 134.43 48.6 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.108 0.963 . . . . 61.350000000000001 111.123 -175.026 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 65.18 21.95 68.59 Favored Glycine 0 C--N 1.35 1.338 0 O-C-N 123.892 0.745 . . . . 70.310000000000002 112.826 -176.25 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.439 ' HD3' HH21 ' A' ' 246' ' ' ARG . 29.5 mmtp -138.32 19.87 2.76 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.028 0.931 . . . . 74.200000000000003 110.899 -174.548 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -92.83 -133.25 6.35 Favored Glycine 0 N--CA 1.466 0.657 0 N-CA-C 111.919 -0.472 . . . . 72.150000000000006 111.919 174.482 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 240' ' ' PHE . . . . . 0.415 ' HE1' HD12 ' A' ' 215' ' ' LEU . 0.1 OUTLIER -61.35 138.72 94.75 Favored Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 123.888 0.875 . . . . 74.109999999999999 110.133 177.746 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_exo -48.12 146.18 9.81 Favored 'Trans proline' 0 C--N 1.377 2.045 0 C-N-CA 123.9 3.066 . . . . 74.230000000000004 115.107 177.1 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -159.79 138.67 5.71 Favored Glycine 0 CA--C 1.534 1.238 0 CA-C-O 118.559 -1.134 . . . . 72.5 110.469 177.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -65.82 -40.21 17.63 Favored 'Trans proline' 0 C--N 1.378 2.12 0 C-N-CA 123.274 2.649 . . . . 61.140000000000001 113.551 -171.123 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -97.55 -18.44 18.97 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.59 0.756 . . . . 32.100000000000001 111.454 -177.63 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 175.67 148.51 6.89 Favored Glycine 0 C--N 1.341 0.847 0 N-CA-C 110.76 -0.936 . . . . 71.340000000000003 110.76 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.439 HH21 ' HD3' ' A' ' 238' ' ' LYS . 21.0 mtm180 -90.12 170.53 10.24 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 117.18 0.49 . . . . 75.430000000000007 110.425 -176.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -78.27 -153.6 6.73 Favored Glycine 0 C--N 1.343 0.954 0 CA-C-N 115.862 -0.608 . . . . 64.409999999999997 112.19 173.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 248' ' ' ASP . . . . . 0.485 ' O ' ' HA ' ' A' ' 192' ' ' ASP . 4.6 p30 -122.92 155.78 36.03 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 117.617 0.708 . . . . 73.209999999999994 110.849 176.383 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 55.2 tp -121.76 108.41 13.48 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 108.907 -0.775 . . . . 74.409999999999997 108.907 174.046 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 42.7 t80 -90.45 108.69 19.94 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 115.099 -0.955 . . . . 74.120000000000005 110.105 -175.497 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 62.9 mt -105.91 121.93 45.09 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.721 0.808 . . . . 62.420000000000002 110.517 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -84.16 110.63 18.66 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 122.935 0.494 . . . . 71.430000000000007 109.795 172.032 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 57.6 t -64.84 119.27 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 123.83 0.852 . . . . 52.520000000000003 111.763 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 21.7 mmt180 -119.66 117.78 29.21 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 108.011 -1.107 . . . . 55.5 108.011 171.133 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 17.5 mt -75.53 117.38 19.84 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 N-CA-C 109.037 -0.727 . . . . 54.100000000000001 109.037 175.233 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 27.2 m . . . . . 0 C--O 1.25 1.115 0 C-N-CA 124.931 1.292 . . . . 74.439999999999998 108.848 -175.57 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 35.7 t70 . . . . . 0 N--CA 1.477 0.894 0 CA-C-O 121.398 0.618 . . . . 74.099999999999994 110.256 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.49 HG12 ' HG3' ' A' ' 232' ' ' LYS . 13.9 m -91.71 162.41 2.42 Favored 'Isoleucine or valine' 0 C--O 1.244 0.782 0 CA-C-N 115.043 -0.98 . . . . 75.299999999999997 109.377 173.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 16.7 tt -79.38 135.35 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 N-CA-C 107.694 -1.225 . . . . 74.129999999999995 107.694 166.285 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -70.92 142.89 51.08 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.365 0.666 . . . . 74.219999999999999 110.737 -172.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.442 ' HB2' HD22 ' A' ' 233' ' ' LEU . . . -149.17 162.14 40.58 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.418 0.687 . . . . 71.040000000000006 110.127 -178.195 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -136.51 156.63 48.32 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 123.795 0.838 . . . . 74.430000000000007 110.024 -177.18 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.494 ' H ' ' HD3' ' A' ' 238' ' ' LYS . 7.3 p90 -150.3 171.92 16.19 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.084 0.553 . . . . 53.329999999999998 111.486 167.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' LYS . . . . . 0.43 ' HE2' ' HD2' ' A' ' 177' ' ' PRO . 12.6 mmmm -137.79 140.41 29.57 Favored Pre-proline 0 C--O 1.241 0.629 0 C-N-CA 124.291 1.036 . . . . 72.420000000000002 108.564 173.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' PRO . . . . . 0.552 ' HA ' HG12 ' A' ' 219' ' ' VAL . 18.2 Cg_endo -61.29 109.05 0.66 Allowed 'Trans proline' 0 C--N 1.368 1.553 0 C-N-CA 122.486 2.124 . . . . 61.140000000000001 111.104 172.567 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' ALA . . . . . 0.551 ' HB2' ' HG3' ' A' ' 220' ' ' GLU . . . . . . . . 0 N--CA 1.475 0.795 0 C-N-CA 123.711 0.804 . . . . 60.119999999999997 110.691 177.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.449 ' HA ' ' HB2' ' A' ' 240' ' ' PHE . 91.5 mm-40 . . . . . 0 C--O 1.248 1.013 0 CA-C-O 120.929 0.395 . . . . 64.340000000000003 110.848 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -82.74 120.87 26.15 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.113 -0.949 . . . . 73.310000000000002 110.012 175.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 81.3 mt -110.49 147.8 33.38 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.916 0.886 . . . . 74.329999999999998 108.697 171.422 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -130.08 122.77 28.97 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.543 0.737 . . . . 74.019999999999996 109.664 -177.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.409 ' O ' ' HA ' ' A' ' 251' ' ' LEU . . . -160.68 169.9 21.9 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.584 0.754 . . . . 74.049999999999997 110.27 -178.13 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 196' ' ' THR . . . . . 0.551 HG22 ' HB2' ' A' ' 252' ' ' GLU . 8.9 p -101.83 145.84 28.63 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.365 0.666 . . . . 75.120000000000005 109.783 174.406 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.575 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . 51.8 tp -113.75 113.72 25.35 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.276 1.031 . . . . 72.439999999999998 110.09 -174.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -75.51 101.81 5.0 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 109.557 -0.534 . . . . 71.310000000000002 109.557 173.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.522 ' HA ' HG11 ' A' ' 210' ' ' VAL . 44.7 t -104.92 118.84 55.19 Favored Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 108.404 -0.961 . . . . 75.329999999999998 108.404 174.131 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -55.23 140.28 81.29 Favored 'Trans proline' 0 C--N 1.372 1.799 0 C-N-CA 122.727 2.285 . . . . 65.25 111.514 169.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -51.75 -47.87 89.05 Favored Pre-proline 0 CA--C 1.559 1.308 0 N-CA-C 114.432 1.271 . . . . 74.219999999999999 114.432 -175.23 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 202' ' ' PRO . . . . . 0.441 ' O ' HG12 ' A' ' 206' ' ' VAL . 16.3 Cg_endo -55.93 -45.43 38.73 Favored 'Trans proline' 0 C--N 1.385 2.469 0 C-N-CA 122.218 1.945 . . . . 53.219999999999999 112.743 174.087 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 47.5 mt -65.83 -31.07 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 123.714 0.806 . . . . 63.43 110.902 -178.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' ALA . . . . . 0.419 ' HB1' ' O ' ' A' ' 227' ' ' THR . . . -70.91 -40.21 72.28 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.29 0.636 . . . . 73.430000000000007 111.415 177.667 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 64.8 t -72.47 -54.98 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 123.858 0.863 . . . . 73.310000000000002 111.512 -177.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.441 HG12 ' O ' ' A' ' 202' ' ' PRO . 8.3 p -86.97 -16.73 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 C-N-CA 122.492 0.317 . . . . 71.349999999999994 111.831 -174.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 83.02 162.18 32.03 Favored Glycine 0 C--N 1.349 1.251 0 N-CA-C 111.234 -0.746 . . . . 74.109999999999999 111.234 -173.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 161.47 -134.12 3.42 Favored Glycine 0 N--CA 1.464 0.533 0 CA-C-N 117.429 0.615 . . . . 73.450000000000003 112.326 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.452 ' HD3' ' HB3' ' A' ' 220' ' ' GLU . 92.8 mttt -134.69 144.83 48.01 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.875 0.87 . . . . 71.409999999999997 109.963 175.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.522 HG11 ' HA ' ' A' ' 199' ' ' VAL . 22.3 m -129.29 144.61 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 N-CA-C 108.451 -0.944 . . . . 74.019999999999996 108.451 168.188 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 36.3 ttp180 -86.63 110.91 20.16 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 109.612 -0.514 . . . . 73.310000000000002 109.612 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -101.89 151.71 21.77 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.176 0.591 . . . . 53.140000000000001 110.203 179.306 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -98.29 117.94 33.82 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 123.078 0.551 . . . . 75.329999999999998 109.724 178.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 43.6 p -111.84 179.02 4.13 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.387 0.675 . . . . 73.120000000000005 109.417 171.248 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 215' ' ' LEU . . . . . 0.415 HD12 ' HE1' ' A' ' 240' ' ' PHE . 20.7 mt -81.81 -7.49 59.61 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.075 0.55 . . . . 73.420000000000002 112.102 -173.105 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -98.9 -19.83 17.14 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.335 1.054 . . . . 75.030000000000001 110.859 178.099 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 144.36 -165.69 27.4 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-N 115.911 -0.586 . . . . 64.420000000000002 111.842 -177.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -74.78 147.45 34.99 Favored 'Trans proline' 0 C--N 1.367 1.501 0 C-N-CA 122.935 2.423 . . . . 74.510000000000005 112.224 176.156 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.552 HG12 ' HA ' ' A' ' 177' ' ' PRO . 14.1 m -135.56 157.15 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 123.762 0.825 . . . . 74.129999999999995 109.524 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.551 ' HG3' ' HB2' ' A' ' 178' ' ' ALA . 51.9 mt-10 -108.06 106.19 16.3 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 109.349 -0.612 . . . . 71.349999999999994 109.349 176.216 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 56.1 t -92.96 112.21 25.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 109.19 -0.67 . . . . 71.230000000000004 109.19 -177.56 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -65.06 101.09 0.48 Allowed 'General case' 0 CA--C 1.539 0.545 0 O-C-N 123.999 0.812 . . . . 72.340000000000003 109.436 173.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 64.7 t -73.46 127.39 88.93 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-N 115.018 -0.992 . . . . 75.120000000000005 109.231 174.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.94 157.57 57.73 Favored 'Trans proline' 0 CA--C 1.559 1.75 0 C-N-CA 121.491 1.461 . . . . 73.439999999999998 110.824 171.089 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -70.05 164.28 35.42 Favored 'Trans proline' 0 C--N 1.366 1.455 0 C-N-CA 122.064 1.843 . . . . 72.120000000000005 111.942 176.069 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 75.7 mtm180 59.32 25.8 14.53 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 124.834 1.254 . . . . 73.120000000000005 112.146 174.429 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.544 HG23 ' HD2' ' A' ' 231' ' ' ARG . 96.7 m -90.85 99.6 12.61 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.943 0.897 . . . . 75.439999999999998 110.064 -176.577 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 19.7 mp0 -84.76 166.78 16.69 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 121.318 0.58 . . . . 60.119999999999997 111.542 -176.023 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 229' ' ' ALA . . . . . 0.532 ' HB2' ' HB ' ' A' ' 255' ' ' ILE . . . -66.98 124.2 22.36 Favored 'General case' 0 C--N 1.346 0.455 0 CA-C-N 114.549 -1.205 . . . . 62.299999999999997 109.699 177.348 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 114.05 -12.46 22.16 Favored Glycine 0 C--N 1.335 0.518 0 CA-C-O 119.401 -0.666 . . . . 74.319999999999993 112.645 -174.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.544 ' HD2' HG23 ' A' ' 227' ' ' THR . 42.6 mtt180 -71.62 162.88 28.75 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.738 0.78 . . . . 72.049999999999997 111.459 172.782 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.49 ' HG3' HG12 ' A' ' 170' ' ' VAL . 20.4 pttm -129.04 136.23 50.0 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.84 1.256 . . . . 72.5 109.294 -178.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.442 HD22 ' HB2' ' A' ' 173' ' ' ALA . 96.1 mt -116.83 113.95 23.24 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.011 0.924 . . . . 60.32 108.749 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 234' ' ' ARG . . . . . 0.448 ' H ' HG21 ' A' ' 170' ' ' VAL . 19.9 ttt180 -96.45 101.02 12.58 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 107.381 -1.34 . . . . 73.409999999999997 107.381 170.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.437 HD13 ' CD1' ' A' ' 175' ' ' TYR . 22.2 mt -78.86 84.26 4.92 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 114.714 -1.13 . . . . 73.019999999999996 107.992 178.344 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 10.2 mtmp? -72.38 123.81 23.84 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 113.752 -1.567 . . . . 63.409999999999997 111.093 -172.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 67.28 32.05 78.77 Favored Glycine 0 C--N 1.346 1.133 0 O-C-N 123.733 0.646 . . . . 73.120000000000005 112.391 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.494 ' HD3' ' H ' ' A' ' 175' ' ' TYR . 10.3 mmpt? -125.3 -31.58 3.03 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.313 1.045 . . . . 73.040000000000006 112.248 -174.34 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -59.22 -112.09 0.01 OUTLIER Glycine 0 C--N 1.357 1.704 0 N-CA-C 116.092 1.197 . . . . 55.130000000000003 116.092 -168.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 240' ' ' PHE . . . . . 0.449 ' HB2' ' HA ' ' A' ' 191' ' ' GLN . 0.2 OUTLIER -71.54 136.16 83.62 Favored Pre-proline 0 N--CA 1.485 1.278 0 CA-C-N 117.393 0.596 . . . . 75.340000000000003 110.334 -178.805 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.58 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 13.7 Cg_exo -67.48 127.07 15.83 Favored 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.409 2.073 . . . . 73.019999999999996 111.981 -179.079 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -137.23 145.05 16.75 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-O 118.963 -0.91 . . . . 72.109999999999999 111.447 -179.264 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.6 -32.65 30.51 Favored 'Trans proline' 0 C--N 1.374 1.89 0 C-N-CA 123.215 2.61 . . . . 62.200000000000003 113.627 -174.21 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -91.96 -18.94 22.98 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.143 0.577 . . . . 74.409999999999997 110.935 178.584 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 163.26 151.87 6.6 Favored Glycine 0 C--N 1.343 0.948 0 N-CA-C 111.521 -0.631 . . . . 54.109999999999999 111.521 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.58 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 37.2 mtt-85 -78.52 164.05 25.04 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.371 0.669 . . . . 70.409999999999997 111.195 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 247' ' ' GLY . . . . . 0.407 ' HA3' ' HB3' ' A' ' 191' ' ' GLN . . . -83.17 -154.72 17.39 Favored Glycine 0 C--N 1.342 0.879 0 CA-C-N 115.249 -0.887 . . . . 74.219999999999999 113.078 178.7 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -119.25 127.02 52.86 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 117.122 0.461 . . . . 40.25 110.011 177.325 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.501 ' HG ' ' HG ' ' A' ' 251' ' ' LEU . 60.6 tp -100.22 108.01 20.0 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 107.547 -1.279 . . . . 73.430000000000007 107.547 170.559 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 250' ' ' TYR . . . . . 0.442 ' OH ' ' HD2' ' A' ' 232' ' ' LYS . 23.0 t80 -97.14 108.18 20.85 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.754 -0.832 . . . . 74.430000000000007 108.754 -175.725 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.575 ' HB3' ' HB2' ' A' ' 197' ' ' LEU . 55.3 mt -115.7 120.42 39.29 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.931 0.892 . . . . 74.209999999999994 110.894 -173.422 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 252' ' ' GLU . . . . . 0.551 ' HB2' HG22 ' A' ' 196' ' ' THR . 3.6 mp0 -84.76 115.13 22.54 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.15 0.58 . . . . 74.439999999999998 109.93 175.738 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.512 HG11 HG22 ' A' ' 227' ' ' THR . 61.5 t -65.84 109.05 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 C-N-CA 123.497 0.719 . . . . 73.329999999999998 111.744 -176.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -104.77 107.99 19.24 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.891 1.277 . . . . 74.400000000000006 108.322 171.163 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.532 ' HB ' ' HB2' ' A' ' 229' ' ' ALA . 16.2 mt -75.69 132.77 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 122.907 0.483 . . . . 73.310000000000002 109.782 177.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 20.7 p . . . . . 0 CA--C 1.557 1.226 0 C-N-CA 124.435 1.094 . . . . 64.310000000000002 108.924 -177.885 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 32.9 t70 . . . . . 0 N--CA 1.478 0.966 0 CA-C-O 120.627 0.251 . . . . 62.119999999999997 110.873 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.441 HG12 ' HG3' ' A' ' 232' ' ' LYS . 31.9 m -108.97 168.64 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 123.37 0.668 . . . . 73.439999999999998 110.688 177.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 10.4 tt -89.3 150.32 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.976 0 N-CA-C 108.489 -0.93 . . . . 53.149999999999999 108.489 167.467 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -58.07 142.36 47.16 Favored 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 124.75 1.22 . . . . 72.010000000000005 111.888 178.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -164.76 149.43 9.43 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.317 1.447 . . . . 62.420000000000002 108.394 176.547 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -146.43 154.85 42.08 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 123.346 0.658 . . . . 73.340000000000003 109.825 175.116 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.423 ' CD1' HD13 ' A' ' 235' ' ' LEU . 44.4 p90 -118.17 177.34 4.83 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.249 0.62 . . . . 73.450000000000003 111.052 -177.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -145.32 145.79 27.8 Favored Pre-proline 0 N--CA 1.472 0.667 0 CA-C-N 114.325 -1.307 . . . . 73.129999999999995 108.569 168.592 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' PRO . . . . . 0.461 ' HA ' HG12 ' A' ' 219' ' ' VAL . 20.9 Cg_endo -59.26 127.53 24.31 Favored 'Trans proline' 0 C--N 1.376 2.023 0 C-N-CA 122.747 2.298 . . . . 75.099999999999994 111.545 174.376 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.164 0 C-N-CA 124.133 0.973 . . . . 74.439999999999998 111.489 -178.704 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 . . . . . 0 C--O 1.24 0.58 0 CA-C-O 120.838 0.352 . . . . 74.530000000000001 110.387 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -91.16 127.5 36.61 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.81 0.844 . . . . 65.219999999999999 109.599 -176.136 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 76.8 mt -109.6 146.9 33.95 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.279 1.032 . . . . 64.209999999999994 108.978 177.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -128.02 123.29 34.32 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 108.22 -1.03 . . . . 74.310000000000002 108.22 177.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -152.28 162.0 41.78 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.768 0.827 . . . . 43.140000000000001 110.329 -178.231 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 196' ' ' THR . . . . . 0.511 HG22 ' HE ' ' A' ' 254' ' ' ARG . 13.0 p -85.35 149.61 25.33 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.896 0.878 . . . . 71.439999999999998 110.691 174.491 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.582 HD13 HD13 ' A' ' 251' ' ' LEU . 43.7 tp -115.29 114.47 25.22 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.928 0.891 . . . . 70.140000000000001 109.017 179.068 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -88.83 101.2 13.8 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.254 0.622 . . . . 73.420000000000002 109.873 -177.067 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.566 ' HA ' HG11 ' A' ' 210' ' ' VAL . 7.4 p -118.39 123.12 29.54 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 123.784 0.834 . . . . 71.099999999999994 110.299 -177.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -57.73 146.3 85.98 Favored 'Trans proline' 0 C--N 1.372 1.796 0 C-N-CA 122.694 2.263 . . . . 63.240000000000002 112.311 168.004 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -51.77 -46.91 91.69 Favored Pre-proline 0 CA--C 1.559 1.319 0 N-CA-C 113.725 1.009 . . . . 64.310000000000002 113.725 179.207 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 202' ' ' PRO . . . . . 0.418 ' O ' HG22 ' A' ' 206' ' ' VAL . 11.3 Cg_endo -53.6 -48.75 20.18 Favored 'Trans proline' 0 C--N 1.398 3.159 0 C-N-CA 122.327 2.018 . . . . 62.299999999999997 112.995 173.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 31.4 mt -66.36 -31.3 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 123.778 0.831 . . . . 74.109999999999999 111.359 -177.008 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.52 -41.23 76.29 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 122.708 0.403 . . . . 73.450000000000003 111.515 178.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 84.8 t -72.87 -51.41 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 122.96 0.504 . . . . 63.530000000000001 111.433 -178.203 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.418 HG22 ' O ' ' A' ' 202' ' ' PRO . 19.3 m -85.73 -20.15 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 N-CA-C 112.497 0.554 . . . . 75.239999999999995 112.497 -174.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 90.98 162.65 38.34 Favored Glycine 0 N--CA 1.476 1.323 0 N-CA-C 111.249 -0.74 . . . . 63.109999999999999 111.249 -171.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 161.92 -147.93 14.75 Favored Glycine 0 N--CA 1.467 0.722 0 CA-C-N 117.635 0.718 . . . . 63.539999999999999 111.918 178.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 33.2 mtmm -133.13 139.52 47.13 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.239 0.616 . . . . 62.240000000000002 109.759 175.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.566 HG11 ' HA ' ' A' ' 199' ' ' VAL . 27.1 m -135.83 144.85 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 123.649 0.78 . . . . 73.420000000000002 109.404 175.152 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 25.1 ttm180 -85.8 116.42 24.04 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 123.196 0.598 . . . . 74.219999999999999 111.227 -171.216 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -102.81 164.66 11.5 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.564 1.146 . . . . 61.399999999999999 110.158 173.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -105.4 123.19 47.46 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.896 0.878 . . . . 71.349999999999994 110.183 -178.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 81.1 p -124.52 177.94 5.66 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.131 0.973 . . . . 72.010000000000005 109.936 175.535 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 14.7 mt -78.9 -9.7 59.57 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.058 0.543 . . . . 72.430000000000007 111.739 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -94.34 -18.65 21.39 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.699 0.8 . . . . 73.019999999999996 110.569 176.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 137.64 -164.21 25.45 Favored Glycine 0 C--N 1.349 1.292 0 CA-C-N 116.057 -0.52 . . . . 45.5 112.174 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -74.1 134.05 18.9 Favored 'Trans proline' 0 C--N 1.365 1.43 0 C-N-CA 122.439 2.093 . . . . 71.340000000000003 111.304 171.094 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.461 HG12 ' HA ' ' A' ' 177' ' ' PRO . 33.2 m -133.42 132.68 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 123.782 0.833 . . . . 75.310000000000002 109.071 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -91.72 116.47 28.91 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 122.028 -0.42 . . . . 73.109999999999999 110.014 179.262 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 36.9 t -96.54 127.22 48.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 C-N-CA 124.961 1.304 . . . . 73.019999999999996 109.995 -173.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -69.22 99.69 1.19 Allowed 'General case' 0 CA--C 1.54 0.589 0 O-C-N 123.959 0.787 . . . . 64.010000000000005 109.92 175.093 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 58.9 t -72.63 121.75 85.72 Favored Pre-proline 0 C--O 1.239 0.551 0 C-N-CA 124.583 1.153 . . . . 73.409999999999997 108.917 174.466 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -61.12 152.43 71.67 Favored 'Trans proline' 0 C--N 1.375 1.93 0 C-N-CA 122.297 1.998 . . . . 62.140000000000001 111.474 172.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_exo -64.57 157.4 55.53 Favored 'Trans proline' 0 C--N 1.37 1.66 0 C-N-CA 122.255 1.97 . . . . 63.200000000000003 111.87 171.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 62.41 33.42 16.26 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.925 1.29 . . . . 64.420000000000002 110.894 174.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.498 HG23 ' HD2' ' A' ' 231' ' ' ARG . 21.1 m -88.52 126.32 35.2 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.917 0.887 . . . . 73.420000000000002 110.477 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 -94.2 163.73 13.33 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.218 1.007 . . . . 72.200000000000003 111.361 -176.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -69.14 114.76 7.7 Favored 'General case' 0 C--N 1.348 0.528 0 CA-C-N 115.029 -0.987 . . . . 70.510000000000005 109.289 173.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 105.38 4.6 40.59 Favored Glycine 0 C--N 1.338 0.648 0 O-C-N 123.756 0.66 . . . . 63.219999999999999 112.799 -179.313 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.498 ' HD2' HG23 ' A' ' 227' ' ' THR . 28.3 mtt180 -63.68 152.9 37.81 Favored 'General case' 0 C--N 1.359 0.989 0 CA-C-N 117.404 0.602 . . . . 74.099999999999994 110.466 171.553 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.441 ' HG3' HG12 ' A' ' 170' ' ' VAL . 20.8 pttm -115.63 130.52 56.89 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 123.575 0.75 . . . . 65.319999999999993 109.877 -179.208 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 89.1 mt -120.44 132.67 55.33 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 107.766 -1.198 . . . . 63.32 107.766 176.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 234' ' ' ARG . . . . . 0.413 ' H ' HG21 ' A' ' 170' ' ' VAL . 35.5 ttm-85 -121.92 106.89 11.65 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 108.149 -1.056 . . . . 73.129999999999995 108.149 170.721 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.423 HD13 ' CD1' ' A' ' 175' ' ' TYR . 15.4 mt -76.06 82.57 2.91 Favored 'General case' 0 C--O 1.243 0.715 0 N-CA-C 107.375 -1.342 . . . . 51.409999999999997 107.375 174.105 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -71.28 133.04 45.77 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-N 115.318 -0.855 . . . . 72.400000000000006 110.746 -173.291 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 65.14 26.3 71.44 Favored Glycine 0 C--N 1.345 1.029 0 O-C-N 124.083 0.864 . . . . 61.109999999999999 112.563 -177.013 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -142.82 36.93 1.43 Allowed 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 124.008 0.923 . . . . 75.349999999999994 111.11 -177.197 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -100.97 -111.66 3.43 Favored Glycine 0 N--CA 1.478 1.498 0 CA-C-O 119.579 -0.567 . . . . 45.229999999999997 112.26 175.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -62.92 133.89 95.46 Favored Pre-proline 0 N--CA 1.487 1.411 0 CA-C-O 118.178 -0.915 . . . . 71.230000000000004 110.557 173.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -62.45 130.41 29.98 Favored 'Trans proline' 0 C--N 1.38 2.233 0 C-N-CA 123.119 2.546 . . . . 70.439999999999998 112.159 178.042 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -166.02 124.27 1.22 Allowed Glycine 0 CA--C 1.533 1.184 0 CA-C-O 118.71 -1.05 . . . . 61.409999999999997 111.42 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -68.68 -26.95 32.65 Favored 'Trans proline' 0 C--N 1.382 2.337 0 C-N-CA 123.528 2.819 . . . . 63.520000000000003 113.273 -176.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -80.97 -25.64 37.19 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.356 0.662 . . . . 71.0 111.083 178.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 161.79 117.78 0.44 Allowed Glycine 0 C--N 1.342 0.906 0 N-CA-C 111.232 -0.747 . . . . 70.519999999999996 111.232 -178.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 29.8 mtt-85 -69.58 164.99 22.04 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.668 0.787 . . . . 75.409999999999997 110.518 176.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -80.09 -158.21 16.1 Favored Glycine 0 N--CA 1.472 1.038 0 CA-C-N 115.886 -0.597 . . . . 74.319999999999993 112.387 172.269 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -115.39 153.57 30.8 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 108.998 -0.742 . . . . 75.510000000000005 108.998 173.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 46.7 tp -123.42 107.63 11.81 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 108.124 -1.065 . . . . 63.049999999999997 108.124 171.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 24.6 t80 -96.67 107.74 20.24 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 115.331 -0.85 . . . . 71.150000000000006 108.978 -172.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.582 HD13 HD13 ' A' ' 197' ' ' LEU . 76.5 mt -103.96 120.65 41.48 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 123.77 0.828 . . . . 73.019999999999996 110.639 -176.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -89.6 103.51 16.15 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.093 0.957 . . . . 73.450000000000003 108.448 177.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.479 HG11 HG22 ' A' ' 227' ' ' THR . 72.6 t -58.1 116.68 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 123.69 0.796 . . . . 73.510000000000005 111.179 -179.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 254' ' ' ARG . . . . . 0.511 ' HE ' HG22 ' A' ' 196' ' ' THR . 20.4 mmt180 -117.07 107.27 14.31 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 107.801 -1.185 . . . . 72.319999999999993 107.801 173.019 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 40.6 mt -75.95 135.47 26.9 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.929 0 N-CA-C 109.464 -0.569 . . . . 64.219999999999999 109.464 175.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 14.5 t . . . . . 0 C--O 1.26 1.607 0 C-N-CA 124.673 1.189 . . . . 62.409999999999997 109.718 -176.568 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 169' ' ' ASP . . . . . 0.402 ' O ' ' HE2' ' A' ' 232' ' ' LYS . 28.1 t70 . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 121.132 0.492 . . . . 65.409999999999997 110.038 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.6 HG21 ' HB3' ' A' ' 234' ' ' ARG . 33.2 m -106.93 162.15 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 CA-C-N 115.146 -0.934 . . . . 74.439999999999998 109.232 172.439 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 10.0 tt -83.38 147.8 5.56 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.08 0 N-CA-C 109.781 -0.451 . . . . 75.349999999999994 109.781 175.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -62.69 139.94 58.68 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.383 1.073 . . . . 72.420000000000002 111.941 -178.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.512 ' HB2' HD22 ' A' ' 233' ' ' LEU . . . -156.78 166.56 33.03 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 114.833 -1.076 . . . . 54.25 109.853 178.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -154.53 158.78 40.36 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 124.882 1.273 . . . . 73.299999999999997 108.268 173.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.646 ' HE1' ' HB3' ' A' ' 238' ' ' LYS . 45.6 p90 -118.52 -177.49 3.31 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 122.753 0.421 . . . . 63.310000000000002 110.102 173.581 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -144.21 129.27 9.5 Favored Pre-proline 0 N--CA 1.475 0.796 0 N-CA-C 107.61 -1.256 . . . . 64.519999999999996 107.61 170.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' PRO . . . . . 0.49 ' HA ' HG12 ' A' ' 219' ' ' VAL . 32.7 Cg_endo -62.81 111.63 1.42 Allowed 'Trans proline' 0 C--N 1.371 1.731 0 C-N-CA 122.823 2.349 . . . . 54.509999999999998 111.094 -179.074 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.068 0 C-N-CA 123.77 0.828 . . . . 55.439999999999998 111.179 -177.848 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 . . . . . 0 CA--C 1.544 0.713 0 N-CA-C 108.312 -0.996 . . . . 64.420000000000002 108.312 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.401 ' HA ' ' O ' ' A' ' 248' ' ' ASP . 21.3 t70 -98.98 155.56 17.36 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.143 0.977 . . . . 62.32 110.326 -177.128 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 48.0 mt -142.53 134.77 27.54 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.599 1.16 . . . . 63.119999999999997 109.128 169.423 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -106.5 122.44 46.3 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 108.479 -0.934 . . . . 75.420000000000002 108.479 171.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.463 ' O ' ' HA ' ' A' ' 251' ' ' LEU . . . -145.96 140.52 26.96 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 109.388 -0.597 . . . . 55.329999999999998 109.388 178.174 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 9.4 p -81.33 137.53 35.74 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 109.459 -0.571 . . . . 72.310000000000002 109.459 173.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.421 HD11 HG23 ' A' ' 210' ' ' VAL . 51.4 tp -106.76 111.5 24.05 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 108.39 -0.966 . . . . 73.510000000000005 108.39 -176.624 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -81.86 99.47 9.05 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 108.678 -0.86 . . . . 74.340000000000003 108.678 178.574 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.479 ' HA ' HG11 ' A' ' 210' ' ' VAL . 3.2 p -106.34 116.89 58.5 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 123.713 0.805 . . . . 52.229999999999997 109.321 178.49 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -54.94 140.05 79.18 Favored 'Trans proline' 0 C--N 1.367 1.534 0 C-N-CA 122.422 2.082 . . . . 73.420000000000002 112.206 172.671 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.409 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -49.04 -44.92 73.92 Favored Pre-proline 0 CA--C 1.559 1.311 0 N-CA-C 114.184 1.179 . . . . 55.539999999999999 114.184 179.274 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 202' ' ' PRO . . . . . 0.409 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 18.6 Cg_endo -57.4 -48.72 16.2 Favored 'Trans proline' 0 C--N 1.388 2.628 0 C-N-CA 121.838 1.692 . . . . 54.43 112.764 174.037 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 53.3 mt -65.79 -31.63 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 C-N-CA 123.781 0.833 . . . . 75.019999999999996 111.074 -178.04 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -64.1 -52.09 60.86 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.287 0.635 . . . . 74.099999999999994 110.746 177.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 91.8 t -67.63 -51.96 45.77 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-N 115.567 -0.742 . . . . 75.120000000000005 111.385 -176.342 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 15.5 m -79.68 -22.74 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 112.591 0.589 . . . . 74.019999999999996 112.591 -174.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 82.1 154.39 13.66 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 112.126 -0.39 . . . . 75.030000000000001 112.126 -171.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 164.58 -135.16 3.62 Favored Glycine 0 C--N 1.337 0.629 0 N-CA-C 111.74 -0.544 . . . . 51.520000000000003 111.74 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 9.4 mtmp? -133.87 153.19 51.92 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 124.12 0.968 . . . . 62.240000000000002 109.247 173.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.479 HG11 ' HA ' ' A' ' 199' ' ' VAL . 15.6 m -134.8 141.03 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 124.106 0.962 . . . . 40.210000000000001 108.817 172.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -81.7 114.16 20.17 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.175 0.59 . . . . 74.120000000000005 109.705 -177.224 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -106.51 154.83 20.29 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.583 1.153 . . . . 74.340000000000003 110.351 178.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.71 126.03 52.55 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.461 0.704 . . . . 50.210000000000001 109.9 173.044 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 65.2 p -126.62 -178.72 4.47 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.354 1.062 . . . . 62.409999999999997 109.539 177.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 10.3 mt -73.12 -20.42 60.94 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-O 120.721 0.296 . . . . 71.439999999999998 110.602 176.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -78.67 -19.78 51.73 Favored 'General case' 0 CA--C 1.561 1.376 0 C-N-CA 124.05 0.94 . . . . 72.540000000000006 110.827 173.334 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 120.05 -158.06 15.46 Favored Glycine 0 C--N 1.35 1.327 0 CA-C-O 119.614 -0.548 . . . . 55.520000000000003 112.294 178.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.78 126.87 11.75 Favored 'Trans proline' 0 C--N 1.369 1.649 0 C-N-CA 122.275 1.983 . . . . 63.310000000000002 111.294 178.113 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.49 HG12 ' HA ' ' A' ' 177' ' ' PRO . 28.7 m -136.72 128.02 42.38 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.977 0 C-N-CA 123.879 0.872 . . . . 72.430000000000007 109.325 178.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -85.01 113.45 21.45 Favored 'General case' 0 N--CA 1.482 1.128 0 O-C-N 121.972 -0.455 . . . . 73.129999999999995 110.405 177.354 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.506 ' HA ' ' HA ' ' A' ' 175' ' ' TYR . 58.7 t -93.51 120.77 43.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 C-N-CA 123.267 0.627 . . . . 71.400000000000006 109.648 -177.269 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -63.57 101.51 0.35 Allowed 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.054 0.942 . . . . 75.400000000000006 110.566 176.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 62.5 t -70.03 121.04 81.65 Favored Pre-proline 0 CA--C 1.544 0.74 0 CA-C-N 114.663 -1.153 . . . . 65.129999999999995 108.79 172.413 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -63.92 157.52 52.17 Favored 'Trans proline' 0 CA--C 1.571 2.338 0 C-N-CA 122.029 1.819 . . . . 51.549999999999997 111.674 174.173 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -66.79 127.0 16.24 Favored 'Trans proline' 0 C--N 1.368 1.579 0 C-N-CA 122.868 2.378 . . . . 71.5 112.243 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 38.5 mtm180 64.61 79.21 0.26 Allowed 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.984 1.314 . . . . 74.120000000000005 110.459 -175.172 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.557 HG22 HG11 ' A' ' 253' ' ' VAL . 99.3 m -117.12 106.81 13.75 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.11 0.964 . . . . 74.319999999999993 109.006 177.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 24.2 mp0 -88.54 153.47 21.11 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.838 -0.619 . . . . 65.150000000000006 110.787 -173.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -62.9 138.69 58.61 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.108 0.963 . . . . 44.240000000000002 111.115 -178.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 89.94 10.66 64.4 Favored Glycine 0 C--N 1.338 0.646 0 CA-C-N 115.713 -0.676 . . . . 71.340000000000003 112.689 -174.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.486 ' HD2' HG23 ' A' ' 227' ' ' THR . 78.0 mtt180 -78.15 162.49 26.59 Favored 'General case' 0 C--O 1.244 0.778 0 CA-C-O 121.591 0.71 . . . . 73.109999999999999 110.429 169.032 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.402 ' HE2' ' O ' ' A' ' 169' ' ' ASP . 19.6 pttm -127.52 129.11 46.8 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 114.739 -1.119 . . . . 70.439999999999998 109.869 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.512 HD22 ' HB2' ' A' ' 173' ' ' ALA . 66.2 mt -110.45 134.09 52.67 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 107.517 -1.29 . . . . 72.150000000000006 107.517 172.249 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 234' ' ' ARG . . . . . 0.6 ' HB3' HG21 ' A' ' 170' ' ' VAL . 42.3 ttm105 -123.28 98.95 6.1 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 107.044 -1.465 . . . . 71.209999999999994 107.044 167.45 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.517 ' HB3' ' HB2' ' A' ' 238' ' ' LYS . 65.8 mt -74.43 82.93 1.95 Allowed 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 114.213 -1.358 . . . . 53.119999999999997 108.526 177.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -75.8 137.68 40.68 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 122.664 0.386 . . . . 71.25 110.434 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 69.86 24.48 76.37 Favored Glycine 0 C--N 1.339 0.724 0 O-C-N 124.066 0.854 . . . . 64.400000000000006 111.973 -175.407 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.646 ' HB3' ' HE1' ' A' ' 175' ' ' TYR . 73.8 mmtt -138.87 -9.35 1.36 Allowed 'General case' 0 CA--C 1.561 1.37 0 C-N-CA 124.171 0.988 . . . . 72.340000000000003 111.88 -170.252 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -80.8 -120.81 0.46 Allowed Glycine 0 N--CA 1.478 1.494 0 CA-C-O 119.93 -0.372 . . . . 72.530000000000001 113.8 -175.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.31 119.02 49.26 Favored Pre-proline 0 N--CA 1.485 1.315 0 CA-C-O 118.472 -0.775 . . . . 72.540000000000006 109.251 175.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.744 ' HA ' ' HG3' ' A' ' 246' ' ' ARG . 25.1 Cg_exo -59.45 128.59 27.81 Favored 'Trans proline' 0 C--N 1.38 2.215 0 C-N-CA 122.824 2.349 . . . . 52.409999999999997 111.747 -176.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -141.14 123.91 2.42 Favored Glycine 0 CA--C 1.534 1.222 0 CA-C-O 118.798 -1.001 . . . . 65.219999999999999 111.641 -176.047 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -70.76 -15.05 33.35 Favored 'Trans proline' 0 C--N 1.385 2.452 0 C-N-CA 123.09 2.527 . . . . 75.450000000000003 113.18 178.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -97.56 -6.45 33.48 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.211 0.604 . . . . 72.150000000000006 111.155 173.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 142.77 115.61 1.11 Allowed Glycine 0 C--N 1.344 0.988 0 N-CA-C 111.005 -0.838 . . . . 61.549999999999997 111.005 -177.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.744 ' HG3' ' HA ' ' A' ' 241' ' ' PRO . 8.0 ttm180 -65.64 139.85 58.45 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.226 1.011 . . . . 71.129999999999995 110.744 176.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -73.17 -155.14 3.03 Favored Glycine 0 C--N 1.347 1.179 0 O-C-N 123.459 0.475 . . . . 61.210000000000001 113.501 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 248' ' ' ASP . . . . . 0.401 ' O ' ' HA ' ' A' ' 192' ' ' ASP . 10.7 p-10 -126.51 132.89 51.29 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 117.738 0.769 . . . . 73.019999999999996 112.667 -176.437 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 51.9 tp -101.24 107.08 18.37 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.14 0.976 . . . . 61.219999999999999 108.949 175.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -89.6 108.24 19.55 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.313 0.645 . . . . 63.539999999999999 109.604 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.463 ' HA ' ' O ' ' A' ' 195' ' ' ALA . 68.1 mt -101.46 112.11 24.54 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 123.752 0.821 . . . . 73.230000000000004 110.597 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -79.77 103.38 9.63 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.589 0.756 . . . . 75.549999999999997 109.47 174.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.557 HG11 HG22 ' A' ' 227' ' ' THR . 75.0 t -61.66 114.59 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.306 1.042 . . . . 73.209999999999994 111.223 -177.197 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 67.4 mmt-85 -123.19 112.08 17.26 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.672 1.189 . . . . 74.099999999999994 108.565 175.477 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 48.8 mt -76.48 126.58 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 123.152 0.581 . . . . 75.510000000000005 109.91 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 24.0 p . . . . . 0 C--O 1.255 1.394 0 C-N-CA 124.99 1.316 . . . . 71.200000000000003 108.411 179.258 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 28.5 t70 . . . . . 0 N--CA 1.469 0.522 0 CA-C-O 121.468 0.651 . . . . 71.019999999999996 111.181 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.751 HG21 ' HB3' ' A' ' 234' ' ' ARG . 19.7 m -79.69 174.47 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 CA-C-N 114.587 -1.188 . . . . 53.530000000000001 110.218 175.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 14.8 tt -82.72 139.82 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 N-CA-C 108.467 -0.938 . . . . 74.340000000000003 108.467 167.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -70.12 93.32 0.8 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.535 0.734 . . . . 75.120000000000005 109.37 -179.055 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.411 ' HB2' HD22 ' A' ' 233' ' ' LEU . . . -98.37 152.23 19.69 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.838 -0.619 . . . . 64.129999999999995 110.113 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -140.84 149.28 41.8 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.285 0.634 . . . . 73.120000000000005 109.996 175.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.427 ' CD1' HD13 ' A' ' 235' ' ' LEU . 9.5 p90 -122.43 172.11 8.59 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 123.281 0.633 . . . . 72.030000000000001 110.554 176.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -138.04 121.88 11.61 Favored Pre-proline 0 N--CA 1.468 0.445 0 N-CA-C 107.268 -1.382 . . . . 72.219999999999999 107.268 175.07 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -64.51 141.41 73.56 Favored 'Trans proline' 0 C--N 1.367 1.544 0 C-N-CA 122.768 2.312 . . . . 70.540000000000006 110.801 -175.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.714 0 CA-C-O 121.586 0.708 . . . . 73.25 109.743 -178.167 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.562 ' HA ' ' HB2' ' A' ' 240' ' ' PHE . 10.7 mm100 . . . . . 0 C--O 1.244 0.782 0 CA-C-O 121.128 0.489 . . . . 70.120000000000005 110.358 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -86.17 135.64 33.51 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 114.959 -1.019 . . . . 72.109999999999999 108.374 172.14 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 94.6 mt -134.01 155.98 49.02 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.81 0.844 . . . . 75.140000000000001 109.817 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -130.08 136.81 49.75 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 108.008 -1.108 . . . . 72.120000000000005 108.008 173.172 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -160.42 171.34 19.23 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.211 0.529 . . . . 64.239999999999995 110.917 -177.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 17.6 p -104.83 151.62 23.59 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.6 0.76 . . . . 74.25 109.829 173.308 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.533 HD11 HG23 ' A' ' 210' ' ' VAL . 47.6 tp -123.13 118.3 27.37 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 123.863 0.865 . . . . 73.129999999999995 109.195 -175.004 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -82.61 100.11 9.96 Favored 'General case' 0 C--O 1.241 0.627 0 C-N-CA 123.329 0.652 . . . . 44.119999999999997 109.549 -178.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.533 HG22 HG21 ' A' ' 210' ' ' VAL . 23.6 t -110.06 109.02 59.12 Favored Pre-proline 0 CA--C 1.538 0.509 0 N-CA-C 108.489 -0.93 . . . . 73.239999999999995 108.489 176.365 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -54.2 138.46 71.92 Favored 'Trans proline' 0 C--N 1.377 2.062 0 C-N-CA 122.777 2.318 . . . . 61.409999999999997 112.008 172.434 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -48.41 -47.56 68.44 Favored Pre-proline 0 CA--C 1.564 1.504 0 N-CA-C 113.772 1.027 . . . . 62.039999999999999 113.772 -177.575 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -56.07 -45.52 37.77 Favored 'Trans proline' 0 C--N 1.391 2.785 0 C-N-CA 121.845 1.697 . . . . 61.399999999999999 112.775 173.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 45.3 mt -69.93 -27.89 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 123.917 0.887 . . . . 62.229999999999997 111.181 -176.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.88 -48.9 64.77 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.075 0.55 . . . . 63.509999999999998 110.59 177.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 61.9 t -67.34 -48.42 77.86 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 CA-C-N 115.488 -0.778 . . . . 72.299999999999997 111.701 -177.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 11.8 p -75.44 -34.05 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 C-N-CA 122.391 0.277 . . . . 45.350000000000001 111.459 -178.297 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 83.7 141.02 4.47 Favored Glycine 0 C--N 1.344 0.982 0 N-CA-C 112.119 -0.392 . . . . 65.549999999999997 112.119 -172.234 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -178.07 -129.66 1.3 Allowed Glycine 0 C--N 1.34 0.777 0 N-CA-C 111.417 -0.673 . . . . 74.420000000000002 111.417 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 60.5 mttm -137.98 144.86 41.34 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.246 0.619 . . . . 64.310000000000002 109.771 173.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.533 HG23 HD11 ' A' ' 197' ' ' LEU . 31.1 m -134.87 155.57 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 124.333 1.053 . . . . 63.039999999999999 108.506 171.333 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 35.0 mtm-85 -97.47 126.36 42.7 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 121.015 0.436 . . . . 74.519999999999996 111.718 -176.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 212' ' ' ALA . . . . . 0.53 ' HB2' HD13 ' A' ' 197' ' ' LEU . . . -101.47 133.87 45.44 Favored 'General case' 0 C--O 1.241 0.628 0 C-N-CA 124.687 1.195 . . . . 53.240000000000002 109.14 173.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.56 112.77 21.88 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 108.793 -0.817 . . . . 73.439999999999998 108.793 175.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 68.3 p -111.39 177.1 4.77 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.393 0.677 . . . . 64.340000000000003 109.192 175.098 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 26.5 mt -62.9 -39.02 93.22 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 122.831 0.453 . . . . 71.219999999999999 111.487 -172.01 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -86.0 -18.22 33.16 Favored 'General case' 0 CA--C 1.551 1.003 0 CA-C-N 115.824 -0.625 . . . . 74.299999999999997 111.364 -175.515 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 153.53 -166.06 31.63 Favored Glycine 0 C--N 1.352 1.444 0 N-CA-C 114.37 0.508 . . . . 74.120000000000005 114.37 174.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -77.8 142.9 20.53 Favored 'Trans proline' 0 C--N 1.376 1.988 0 C-N-CA 123.088 2.525 . . . . 62.030000000000001 111.858 176.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.406 ' HB ' ' CD2' ' A' ' 175' ' ' TYR . 11.7 m -135.91 140.44 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 N-CA-C 109.237 -0.653 . . . . 64.150000000000006 109.237 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -96.96 108.1 20.75 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 122.819 0.448 . . . . 64.010000000000005 110.123 -178.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 22.3 t -95.08 135.12 30.12 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 C-N-CA 124.404 1.082 . . . . 62.049999999999997 109.815 -175.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -77.38 109.2 11.1 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 123.305 0.642 . . . . 72.230000000000004 110.666 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 57.3 t -79.11 117.7 68.37 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 123.681 0.793 . . . . 65.200000000000003 109.07 173.105 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -60.69 158.02 34.72 Favored 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 122.458 2.105 . . . . 74.129999999999995 112.371 174.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -71.26 133.45 22.85 Favored 'Trans proline' 0 C--N 1.368 1.582 0 C-N-CA 121.5 1.467 . . . . 65.450000000000003 110.563 171.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 67.82 67.21 0.36 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.81 1.244 . . . . 71.040000000000006 110.141 -176.49 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.501 HG22 HG11 ' A' ' 253' ' ' VAL . 72.9 m -103.02 132.89 48.96 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.188 0.995 . . . . 55.219999999999999 109.595 176.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -110.7 155.48 22.38 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.632 0.773 . . . . 75.400000000000006 110.555 -177.102 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 229' ' ' ALA . . . . . 0.507 ' HB2' ' HB ' ' A' ' 255' ' ' ILE . . . -69.22 121.58 17.1 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.981 0.912 . . . . 71.120000000000005 110.225 -178.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 111.64 -7.6 28.02 Favored Glycine 0 C--N 1.333 0.398 0 CA-C-O 119.222 -0.765 . . . . 54.520000000000003 112.555 -176.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.478 ' HD2' HG23 ' A' ' 227' ' ' THR . 58.7 mtt180 -61.24 145.77 50.12 Favored 'General case' 0 C--N 1.361 1.097 0 CA-C-N 117.326 0.563 . . . . 61.409999999999997 109.915 174.414 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.47 ' HG3' HG12 ' A' ' 170' ' ' VAL . 20.1 pttm -117.06 104.35 11.16 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.282 -0.872 . . . . 72.239999999999995 109.215 -175.365 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.411 HD22 ' HB2' ' A' ' 173' ' ' ALA . 82.8 mt -90.11 97.35 11.14 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 108.723 -0.844 . . . . 64.409999999999997 108.723 176.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 234' ' ' ARG . . . . . 0.751 ' HB3' HG21 ' A' ' 170' ' ' VAL . 64.7 ttt180 -88.07 107.18 18.62 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 108.676 -0.861 . . . . 64.120000000000005 108.676 171.413 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.427 HD13 ' CD1' ' A' ' 175' ' ' TYR . 16.0 mt -77.67 84.23 4.02 Favored 'General case' 0 C--O 1.248 0.989 0 N-CA-C 107.659 -1.237 . . . . 70.530000000000001 107.659 174.025 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 10.5 mtmp? -71.43 118.49 14.31 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 113.835 -1.529 . . . . 73.209999999999994 111.988 -169.09 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 64.14 28.82 73.44 Favored Glycine 0 C--N 1.348 1.212 0 O-C-N 124.044 0.84 . . . . 34.539999999999999 112.803 179.174 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 30.8 mmtp -125.47 -6.92 6.94 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 118.278 -0.868 . . . . 73.409999999999997 112.774 -173.135 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -62.57 -108.17 0.01 OUTLIER Glycine 0 C--N 1.354 1.538 0 O-C-N 123.827 0.704 . . . . 53.32 114.731 -171.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 240' ' ' PHE . . . . . 0.562 ' HB2' ' HA ' ' A' ' 191' ' ' GLN . 0.1 OUTLIER -75.97 140.02 69.96 Favored Pre-proline 0 N--CA 1.477 0.91 0 CA-C-O 118.574 -0.727 . . . . 70.519999999999996 109.811 177.72 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.516 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 53.1 Cg_exo -57.37 149.07 67.63 Favored 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 122.587 2.192 . . . . 72.310000000000002 113.293 175.057 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -164.81 123.58 1.18 Allowed Glycine 0 CA--C 1.538 1.512 0 CA-C-O 118.414 -1.215 . . . . 62.420000000000002 111.661 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -57.54 -46.16 29.14 Favored 'Trans proline' 0 C--N 1.386 2.521 0 C-N-CA 123.806 3.004 . . . . 70.25 113.646 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -78.87 -24.13 44.47 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 122.756 0.422 . . . . 72.439999999999998 110.81 178.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 168.19 142.0 3.36 Favored Glycine 0 C--N 1.345 1.057 0 CA-C-N 115.782 -0.645 . . . . 75.409999999999997 111.798 178.208 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.516 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 27.3 mtt-85 -73.63 166.54 23.08 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.495 0.718 . . . . 70.140000000000001 110.969 178.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -85.23 -156.99 27.35 Favored Glycine 0 C--N 1.336 0.579 0 CA-C-N 115.391 -0.822 . . . . 53.43 111.463 168.451 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -131.61 157.99 42.19 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 109.077 -0.712 . . . . 74.430000000000007 109.077 -176.317 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 42.4 tp -141.42 112.18 7.15 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 109.652 -0.499 . . . . 51.340000000000003 109.652 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -102.77 109.36 20.91 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.759 0.824 . . . . 74.409999999999997 109.838 -176.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 65.9 mt -104.92 136.09 45.05 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.727 0.811 . . . . 72.200000000000003 110.156 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -97.69 116.56 30.15 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.691 0.796 . . . . 70.510000000000005 109.303 170.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.501 HG11 HG22 ' A' ' 227' ' ' THR . 94.1 t -61.33 106.38 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-O 121.506 0.67 . . . . 74.109999999999999 110.465 172.379 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 17.0 mmt85 -104.37 102.49 12.16 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-N 114.67 -1.15 . . . . 74.319999999999993 108.065 173.043 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.507 ' HB ' ' HB2' ' A' ' 229' ' ' ALA . 24.1 mt -76.36 119.0 23.68 Favored 'Isoleucine or valine' 0 C--O 1.245 0.83 0 C-N-CA 122.901 0.481 . . . . 63.350000000000001 109.767 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.5 t . . . . . 0 CA--C 1.558 1.288 0 N-CA-C 108.682 -0.858 . . . . 72.310000000000002 108.682 175.99 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 32.9 t70 . . . . . 0 N--CA 1.482 1.158 0 CA-C-O 121.638 0.733 . . . . 73.329999999999998 110.501 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.62 HG12 ' HG3' ' A' ' 232' ' ' LYS . 27.6 m -111.43 164.57 7.25 Favored 'Isoleucine or valine' 0 C--O 1.243 0.76 0 CA-C-N 114.305 -1.316 . . . . 65.549999999999997 109.16 175.035 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 17.6 tt -89.51 145.71 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 N-CA-C 108.236 -1.024 . . . . 75.0 108.236 168.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -58.75 122.21 12.98 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.671 0.788 . . . . 74.450000000000003 110.879 -179.034 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.454 ' HB2' HD22 ' A' ' 233' ' ' LEU . . . -135.99 154.78 50.97 Favored 'General case' 0 C--O 1.243 0.729 0 C-N-CA 124.5 1.12 . . . . 62.149999999999999 108.449 174.722 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -152.88 151.22 30.13 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.938 0.895 . . . . 71.420000000000002 109.404 -178.151 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.442 ' CD1' HD13 ' A' ' 235' ' ' LEU . 2.6 p90 -130.14 173.93 10.28 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-O 121.39 0.614 . . . . 71.409999999999997 111.025 176.206 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 78.2 mttt -139.23 144.39 40.26 Favored Pre-proline 0 C--O 1.243 0.746 0 CA-C-N 114.692 -1.14 . . . . 73.439999999999998 109.203 174.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -55.1 103.9 0.11 Allowed 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 123.279 2.652 . . . . 71.310000000000002 112.105 178.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' ALA . . . . . 0.502 ' HB2' ' HG3' ' A' ' 220' ' ' GLU . . . . . . . . 0 N--CA 1.478 0.948 0 C-N-CA 123.834 0.854 . . . . 74.409999999999997 111.345 -178.204 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 . . . . . 0 N--CA 1.479 1.017 0 N-CA-C 108.745 -0.835 . . . . 75.129999999999995 108.745 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -76.79 150.38 36.17 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 114.296 -1.32 . . . . 70.530000000000001 110.613 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 36.6 mt -133.92 139.31 46.06 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 124.89 1.276 . . . . 74.129999999999995 107.639 171.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -128.21 125.01 38.15 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.204 0.602 . . . . 73.5 109.498 -176.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -161.85 171.51 17.63 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 123.736 0.815 . . . . 45.43 110.756 -175.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 15.6 p -105.89 149.86 26.16 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.633 0.773 . . . . 55.229999999999997 109.967 173.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.552 HD13 HD13 ' A' ' 251' ' ' LEU . 51.7 tp -115.01 118.72 34.22 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.999 0.92 . . . . 61.100000000000001 109.875 -175.735 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -83.39 119.62 24.86 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 109.319 -0.623 . . . . 74.310000000000002 109.319 175.307 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.515 ' HA ' HG11 ' A' ' 210' ' ' VAL . 3.5 p -133.7 123.24 17.16 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 123.638 0.775 . . . . 75.239999999999995 109.675 178.042 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -59.02 139.61 91.58 Favored 'Trans proline' 0 C--N 1.375 1.968 0 C-N-CA 122.725 2.283 . . . . 73.140000000000001 111.447 171.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.454 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -49.11 -47.58 75.12 Favored Pre-proline 0 CA--C 1.557 1.232 0 CA-C-O 117.792 -1.099 . . . . 64.439999999999998 113.022 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -55.93 -45.28 39.81 Favored 'Trans proline' 0 C--N 1.395 2.978 0 C-N-CA 122.206 1.938 . . . . 65.120000000000005 113.019 175.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 39.9 mt -65.93 -31.98 56.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 123.458 0.703 . . . . 65.430000000000007 111.02 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -71.84 -37.86 70.23 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.269 0.628 . . . . 71.239999999999995 111.48 179.096 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 201' ' ' ALA . 98.9 t -74.54 -53.69 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 123.647 0.779 . . . . 62.219999999999999 111.359 -178.735 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 7.1 p -73.03 -31.03 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 122.627 0.371 . . . . 54.439999999999998 111.11 -178.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 84.94 117.43 0.8 Allowed Glycine 0 C--N 1.344 0.979 0 N-CA-C 111.357 -0.697 . . . . 55.329999999999998 111.357 -172.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -151.8 -136.88 2.51 Favored Glycine 0 C--N 1.34 0.789 0 N-CA-C 111.564 -0.614 . . . . 74.329999999999998 111.564 -178.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 34.3 mtmm -136.95 146.09 45.01 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.003 0.921 . . . . 75.230000000000004 109.383 175.419 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.515 HG11 ' HA ' ' A' ' 199' ' ' VAL . 24.2 m -133.05 142.3 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 123.855 0.862 . . . . 63.509999999999998 109.22 172.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 211' ' ' ARG . . . . . 0.433 ' NH1' ' HB1' ' A' ' 178' ' ' ALA . 24.1 ttm-85 -87.7 110.45 20.44 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 122.817 0.447 . . . . 64.510000000000005 110.15 -170.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -101.8 164.47 11.71 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.656 1.182 . . . . 72.209999999999994 110.634 -178.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 10.1 mmt -105.92 123.23 47.65 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.862 0.865 . . . . 74.109999999999999 110.784 -179.174 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 214' ' ' THR . . . . . 0.467 HG22 HD22 ' A' ' 249' ' ' LEU . 47.5 p -114.63 171.29 7.73 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.304 1.042 . . . . 75.5 109.211 170.734 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 13.2 mt -72.28 -9.33 58.34 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 112.091 0.404 . . . . 73.129999999999995 112.091 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -99.97 -19.45 16.57 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 123.127 0.571 . . . . 63.219999999999999 111.772 175.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 143.58 -155.02 25.91 Favored Glycine 0 C--N 1.36 1.901 0 CA-C-O 119.695 -0.503 . . . . 53.329999999999998 113.995 174.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -76.64 136.33 17.07 Favored 'Trans proline' 0 C--N 1.379 2.14 0 C-N-CA 123.442 2.761 . . . . 75.200000000000003 113.229 178.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.479 ' HA ' ' H ' ' A' ' 178' ' ' ALA . 27.0 m -136.5 145.5 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 124.177 0.991 . . . . 74.439999999999998 109.293 177.327 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.502 ' HG3' ' HB2' ' A' ' 178' ' ' ALA . 37.4 mt-10 -102.3 112.11 24.68 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 109.52 -0.548 . . . . 62.439999999999998 109.52 178.24 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 46.7 t -94.7 118.09 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 124.41 1.084 . . . . 62.520000000000003 109.527 -174.096 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -66.96 102.19 0.94 Allowed 'General case' 0 C--O 1.24 0.561 0 C-N-CA 123.958 0.903 . . . . 71.219999999999999 110.427 176.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.458 HG11 HG21 ' A' ' 199' ' ' VAL . 64.6 t -80.24 120.88 80.89 Favored Pre-proline 0 CA--C 1.546 0.801 0 CA-C-N 115.162 -0.926 . . . . 74.530000000000001 108.969 174.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -60.6 162.38 18.26 Favored 'Trans proline' 0 CA--C 1.566 2.097 0 C-N-CA 122.904 2.403 . . . . 45.539999999999999 113.219 176.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -76.25 135.39 16.78 Favored 'Trans proline' 0 C--N 1.374 1.88 0 C-N-CA 122.622 2.215 . . . . 72.109999999999999 112.271 175.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 20.0 mtm180 66.54 57.25 0.71 Allowed 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 125.129 1.371 . . . . 73.540000000000006 110.631 -176.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.608 HG22 HG11 ' A' ' 253' ' ' VAL . 60.5 m -106.81 107.34 18.31 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.851 0.86 . . . . 52.329999999999998 109.381 178.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 22.5 mp0 -85.7 160.26 19.59 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.297 0.639 . . . . 73.239999999999995 111.678 -172.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -70.35 130.18 41.28 Favored 'General case' 0 C--N 1.352 0.682 0 N-CA-C 108.867 -0.79 . . . . 74.540000000000006 108.867 175.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 114.47 -19.08 17.16 Favored Glycine 0 N--CA 1.466 0.634 0 CA-C-O 119.636 -0.536 . . . . 71.409999999999997 111.897 -173.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.501 ' HD2' HG23 ' A' ' 227' ' ' THR . 81.2 mtt180 -67.19 161.85 23.84 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-O 121.579 0.704 . . . . 74.340000000000003 111.877 175.287 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.62 ' HG3' HG12 ' A' ' 170' ' ' VAL . 19.5 pttm -130.19 142.11 50.6 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.344 1.058 . . . . 60.5 109.42 177.754 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.454 HD22 ' HB2' ' A' ' 173' ' ' ALA . 75.2 mt -120.61 129.02 53.56 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 107.89 -1.152 . . . . 52.520000000000003 107.89 178.455 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 40.4 ttt180 -113.7 102.14 9.97 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 108.816 -0.809 . . . . 73.209999999999994 108.816 171.066 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.625 ' HB3' ' HB2' ' A' ' 238' ' ' LYS . 21.3 mt -76.19 84.01 3.01 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 114.246 -1.343 . . . . 62.310000000000002 108.632 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -72.65 127.37 32.35 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.641 -0.709 . . . . 61.43 110.67 -173.215 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 69.48 20.52 75.51 Favored Glycine 0 C--N 1.342 0.901 0 O-C-N 123.764 0.665 . . . . 65.540000000000006 112.053 -175.279 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.625 ' HB2' ' HB3' ' A' ' 235' ' ' LEU . 22.3 mmtp -136.37 58.05 1.75 Allowed 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.581 1.152 . . . . 71.409999999999997 108.54 -176.414 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -139.9 -113.48 1.08 Allowed Glycine 0 N--CA 1.472 1.093 0 CA-C-O 119.226 -0.764 . . . . 71.400000000000006 111.74 175.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -64.11 146.32 97.54 Favored Pre-proline 0 N--CA 1.484 1.254 0 CA-C-O 118.47 -0.776 . . . . 71.109999999999999 110.699 175.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -54.79 160.0 8.23 Favored 'Trans proline' 0 C--N 1.38 2.204 0 C-N-CA 123.488 2.792 . . . . 71.109999999999999 112.871 176.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -169.85 136.43 4.0 Favored Glycine 0 CA--C 1.525 0.702 0 CA-C-O 118.742 -1.032 . . . . 52.5 112.024 -178.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -70.23 -41.54 3.6 Favored 'Trans proline' 0 C--N 1.378 2.091 0 C-N-CA 123.184 2.59 . . . . 65.329999999999998 113.305 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -102.11 -18.79 15.41 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.702 0.801 . . . . 64.209999999999994 111.222 -177.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 175.66 145.68 5.57 Favored Glycine 0 C--N 1.341 0.847 0 N-CA-C 111.262 -0.735 . . . . 72.439999999999998 111.262 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 21.1 mtm180 -88.19 165.32 15.15 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.088 0.555 . . . . 74.239999999999995 110.589 -176.066 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -74.14 -168.07 17.54 Favored Glycine 0 C--N 1.35 1.312 0 N-CA-C 111.486 -0.646 . . . . 74.099999999999994 111.486 168.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -118.27 151.84 36.89 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 118.406 1.103 . . . . 71.219999999999999 111.247 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.467 HD22 HG22 ' A' ' 214' ' ' THR . 35.9 tp -113.75 118.21 33.66 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 108.559 -0.904 . . . . 71.010000000000005 108.559 171.779 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 250' ' ' TYR . . . . . 0.539 ' OH ' ' HD2' ' A' ' 232' ' ' LYS . 2.7 t80 -96.4 115.9 28.17 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.84 -1.17 . . . . 74.400000000000006 107.84 -178.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.552 HD13 HD13 ' A' ' 197' ' ' LEU . 57.6 mt -118.93 117.22 28.23 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.79 0.836 . . . . 70.019999999999996 110.38 -177.323 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -77.32 116.07 17.62 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 108.997 -0.742 . . . . 54.140000000000001 108.997 171.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.608 HG11 HG22 ' A' ' 227' ' ' THR . 94.8 t -62.09 104.27 0.3 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.934 0 CA-C-O 121.322 0.582 . . . . 71.040000000000006 110.433 176.542 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 19.6 mmm180 -110.15 106.37 15.79 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 107.952 -1.129 . . . . 62.229999999999997 107.952 175.454 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.447 HD11 ' O ' ' A' ' 227' ' ' THR . 45.0 mt -77.77 143.8 12.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 122.898 0.479 . . . . 73.340000000000003 110.483 178.507 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 4.9 t . . . . . 0 C--O 1.261 1.68 0 C-N-CA 124.48 1.112 . . . . 64.430000000000007 108.721 174.739 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 33.1 t70 . . . . . 0 CA--C 1.543 0.692 0 CA-C-O 120.296 0.093 . . . . 63.119999999999997 111.082 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 33.0 m -89.82 157.15 3.01 Favored 'Isoleucine or valine' 0 C--O 1.243 0.75 0 C-N-CA 122.835 0.454 . . . . 74.25 110.054 176.041 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.429 HG21 ' HD3' ' A' ' 231' ' ' ARG . 15.1 tt -83.09 146.73 6.59 Favored 'Isoleucine or valine' 0 C--O 1.249 1.057 0 N-CA-C 108.496 -0.927 . . . . 52.420000000000002 108.496 172.434 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -58.06 136.08 57.1 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.718 0.807 . . . . 70.219999999999999 111.52 -176.179 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.539 ' HB2' HD22 ' A' ' 233' ' ' LEU . . . -158.31 158.18 33.87 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 124.885 1.274 . . . . 74.540000000000006 109.337 173.086 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -164.27 149.42 10.25 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.924 0.89 . . . . 75.540000000000006 109.221 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.538 ' HB3' HG22 ' A' ' 221' ' ' VAL . 1.6 p90 -122.39 175.93 6.16 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 121.807 0.813 . . . . 74.430000000000007 112.34 177.517 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -138.22 129.31 15.64 Favored Pre-proline 0 C--O 1.241 0.629 0 CA-C-N 113.639 -1.619 . . . . 73.450000000000003 107.575 167.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' PRO . . . . . 0.434 ' HA ' HG12 ' A' ' 219' ' ' VAL . 35.7 Cg_exo -54.37 128.25 29.29 Favored 'Trans proline' 0 C--N 1.369 1.657 0 C-N-CA 123.486 2.791 . . . . 64.099999999999994 111.639 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.927 0 O-C-N 123.737 0.648 . . . . 75.329999999999998 110.429 -175.86 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 120.949 0.404 . . . . 74.230000000000004 111.145 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -85.59 153.51 22.35 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.574 0.75 . . . . 74.400000000000006 109.965 178.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 58.4 mt -131.81 152.93 50.64 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.546 0.738 . . . . 73.209999999999994 109.251 176.267 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -119.18 132.41 55.96 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 108.489 -0.93 . . . . 72.420000000000002 108.489 170.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -157.79 164.46 37.01 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.22 0.608 . . . . 53.240000000000002 110.022 178.036 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 99.4 m -96.03 146.67 24.44 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 115.647 -0.706 . . . . 74.230000000000004 109.64 175.05 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.506 HD11 HG23 ' A' ' 210' ' ' VAL . 42.7 tp -113.85 117.87 32.64 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.713 0.805 . . . . 71.200000000000003 109.288 175.242 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -89.26 100.71 13.44 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 123.783 0.833 . . . . 74.439999999999998 108.917 175.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.495 ' HA ' HG11 ' A' ' 210' ' ' VAL . 7.1 p -113.04 116.74 46.87 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 123.496 0.718 . . . . 74.519999999999996 109.839 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -56.18 145.91 73.91 Favored 'Trans proline' 0 C--N 1.374 1.904 0 C-N-CA 122.839 2.359 . . . . 54.299999999999997 112.4 173.03 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -50.28 -49.48 76.28 Favored Pre-proline 0 CA--C 1.558 1.285 0 O-C-N 124.542 1.151 . . . . 72.5 112.987 -179.026 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -55.06 -46.71 31.08 Favored 'Trans proline' 0 C--N 1.401 3.315 0 C-N-CA 122.484 2.123 . . . . 72.230000000000004 112.735 175.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.522 HG21 HG13 ' A' ' 210' ' ' VAL . 42.1 mt -68.73 -32.54 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 123.664 0.786 . . . . 74.530000000000001 110.798 -176.226 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.59 -44.9 73.37 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.62 0.768 . . . . 52.409999999999997 110.459 179.165 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 95.4 t -64.64 -55.82 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 122.999 0.519 . . . . 64.409999999999997 110.602 178.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 17.0 m -69.49 -30.31 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 O-C-N 123.531 0.52 . . . . 75.319999999999993 112.171 -173.217 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 78.3 69.96 1.35 Allowed Glycine 0 C--N 1.348 1.222 0 N-CA-C 111.648 -0.581 . . . . 60.140000000000001 111.648 -172.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -104.13 -136.84 9.02 Favored Glycine 0 C--N 1.348 1.247 0 N-CA-C 111.657 -0.577 . . . . 60.439999999999998 111.657 -177.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 35.1 mtmm -133.03 137.04 46.33 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.432 0.693 . . . . 74.109999999999999 109.31 176.211 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.522 HG13 HG21 ' A' ' 203' ' ' ILE . 14.9 m -127.9 142.32 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 123.645 0.778 . . . . 63.539999999999999 109.731 174.566 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 61.5 ttp180 -83.68 117.12 23.0 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 116.13 -0.486 . . . . 53.200000000000003 110.049 -178.179 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -100.79 156.72 17.19 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.685 0.794 . . . . 72.25 109.194 174.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 76.1 mmm -107.18 121.29 44.23 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 122.729 0.412 . . . . 54.299999999999997 110.159 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 36.2 p -108.86 173.51 6.29 Favored 'General case' 0 C--O 1.243 0.726 0 C-N-CA 124.351 1.06 . . . . 61.229999999999997 108.62 170.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 13.3 mt -67.4 -24.38 65.66 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 122.625 0.37 . . . . 71.450000000000003 111.472 -175.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -87.55 -20.59 26.25 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.431 0.693 . . . . 65.200000000000003 111.498 -178.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 149.66 -160.68 28.58 Favored Glycine 0 C--N 1.35 1.318 0 CA-C-O 119.772 -0.46 . . . . 72.230000000000004 113.135 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -84.65 147.56 10.94 Favored 'Trans proline' 0 C--N 1.364 1.344 0 C-N-CA 123.061 2.507 . . . . 72.099999999999994 112.583 178.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.434 HG12 ' HA ' ' A' ' 177' ' ' PRO . 21.3 m -137.07 147.24 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 108.499 -0.926 . . . . 73.140000000000001 108.499 178.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -103.01 108.4 19.56 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 109.044 -0.724 . . . . 72.400000000000006 109.044 179.09 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.538 HG22 ' HB3' ' A' ' 175' ' ' TYR . 49.1 t -94.49 120.5 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.565 1.146 . . . . 73.0 109.888 -174.392 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -71.95 107.55 4.75 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 109.662 -0.495 . . . . 70.329999999999998 109.662 174.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 41.8 t -71.65 129.88 87.92 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 124.152 0.981 . . . . 60.329999999999998 109.166 174.79 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -63.45 157.18 52.15 Favored 'Trans proline' 0 CA--C 1.56 1.797 0 C-N-CA 122.047 1.831 . . . . 74.099999999999994 111.799 170.215 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.7 151.1 85.47 Favored 'Trans proline' 0 C--N 1.366 1.491 0 C-N-CA 122.095 1.863 . . . . 73.430000000000007 111.646 173.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 73.3 mtt85 55.65 57.97 4.88 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.166 0.986 . . . . 71.409999999999997 111.661 177.642 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.557 HG23 ' HD2' ' A' ' 231' ' ' ARG . 28.1 m -98.85 113.94 26.3 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 114.719 -1.128 . . . . 64.319999999999993 110.476 -179.149 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 22.1 mp0 -92.11 157.87 16.51 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.47 0.708 . . . . 73.219999999999999 110.03 177.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 229' ' ' ALA . . . . . 0.454 ' HB2' ' HB ' ' A' ' 255' ' ' ILE . . . -66.74 134.85 53.03 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 108.708 -0.849 . . . . 52.310000000000002 108.708 169.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 100.6 -3.06 56.11 Favored Glycine 0 C--O 1.241 0.585 0 O-C-N 123.53 0.519 . . . . 62.140000000000001 112.604 -173.693 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.557 ' HD2' HG23 ' A' ' 227' ' ' THR . 63.2 mtt-85 -69.61 159.65 33.01 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-O 121.382 0.611 . . . . 73.129999999999995 110.367 171.583 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 48.2 pttt -131.01 137.49 49.23 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.432 -0.804 . . . . 71.129999999999995 110.374 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.539 HD22 ' HB2' ' A' ' 173' ' ' ALA . 29.6 mt -123.52 135.14 53.87 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 108.156 -1.054 . . . . 74.239999999999995 108.156 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 18.9 ttt85 -122.4 101.59 7.59 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.364 -0.976 . . . . 73.530000000000001 108.364 167.132 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.533 HD13 ' HD1' ' A' ' 175' ' ' TYR . 13.3 mt -75.33 85.3 2.49 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 125.278 1.431 . . . . 60.399999999999999 109.441 -176.592 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.705 ' HA ' ' HB3' ' A' ' 248' ' ' ASP . 59.2 mttm -66.78 129.44 39.89 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.174 -0.921 . . . . 75.239999999999995 111.19 -176.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 75.89 12.43 83.94 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 123.811 0.695 . . . . 50.219999999999999 113.025 -178.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -137.21 49.97 2.0 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.588 1.155 . . . . 70.129999999999995 109.366 -176.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -113.68 -119.76 3.53 Favored Glycine 0 N--CA 1.473 1.157 0 N-CA-C 111.217 -0.753 . . . . 52.119999999999997 111.217 173.306 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -76.63 140.84 68.3 Favored Pre-proline 0 N--CA 1.48 1.058 0 C-N-CA 123.516 0.727 . . . . 63.399999999999999 109.853 176.532 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -66.88 128.1 18.18 Favored 'Trans proline' 0 C--N 1.376 2.004 0 C-N-CA 122.636 2.224 . . . . 71.140000000000001 111.3 170.216 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -129.09 161.16 22.6 Favored Glycine 0 N--CA 1.476 1.332 0 CA-C-O 119.548 -0.585 . . . . 43.109999999999999 112.196 176.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -68.5 -33.01 23.79 Favored 'Trans proline' 0 C--N 1.37 1.69 0 C-N-CA 122.457 2.105 . . . . 65.349999999999994 113.083 -177.28 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -99.03 -2.08 38.12 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.146 0.578 . . . . 65.420000000000002 112.298 -177.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 157.9 -151.07 22.23 Favored Glycine 0 C--N 1.344 0.981 0 N-CA-C 111.143 -0.783 . . . . 75.420000000000002 111.143 -177.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 29.8 mtt-85 -129.43 163.17 26.42 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 117.889 0.845 . . . . 71.430000000000007 111.019 174.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -87.61 -156.99 30.86 Favored Glycine 0 C--N 1.345 1.058 0 CA-C-N 115.051 -0.977 . . . . 53.149999999999999 111.641 167.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 248' ' ' ASP . . . . . 0.705 ' HB3' ' HA ' ' A' ' 236' ' ' LYS . 1.0 OUTLIER -130.07 135.6 48.42 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 122.935 0.494 . . . . 71.120000000000005 112.035 -177.78 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 34.5 tp -98.59 116.97 31.99 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.354 0.661 . . . . 72.349999999999994 109.586 178.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -91.01 107.8 19.44 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.69 0.796 . . . . 73.420000000000002 109.335 178.563 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 48.8 mt -97.23 141.85 29.85 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.201 0.6 . . . . 73.329999999999998 111.255 178.197 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -101.53 108.13 19.61 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.084 -0.962 . . . . 72.239999999999995 108.882 175.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 69.0 t -66.09 116.24 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-O 121.119 0.485 . . . . 64.129999999999995 111.025 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 36.7 mmm-85 -121.55 115.05 22.09 Favored 'General case' 0 C--O 1.242 0.677 0 N-CA-C 107.594 -1.261 . . . . 75.010000000000005 107.594 173.301 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.454 ' HB ' ' HB2' ' A' ' 229' ' ' ALA . 21.9 mt -75.07 129.03 37.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 N-CA-C 109.513 -0.551 . . . . 72.010000000000005 109.513 175.26 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 8.3 t . . . . . 0 CA--C 1.562 1.407 0 CA-C-O 117.418 -1.277 . . . . 70.450000000000003 108.3 178.439 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 37.4 t70 . . . . . 0 N--CA 1.475 0.815 0 N-CA-C 107.456 -1.313 . . . . 63.140000000000001 107.456 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.526 HG21 ' HB3' ' A' ' 234' ' ' ARG . 16.2 m -88.22 161.59 2.74 Favored 'Isoleucine or valine' 0 C--O 1.244 0.78 0 N-CA-C 108.249 -1.019 . . . . 72.430000000000007 108.249 161.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 16.2 tt -91.02 133.18 33.55 Favored 'Isoleucine or valine' 0 C--O 1.243 0.721 0 N-CA-C 107.07 -1.456 . . . . 73.519999999999996 107.07 164.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -68.57 117.89 10.9 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 123.659 0.784 . . . . 74.230000000000004 110.152 -170.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.467 ' HB2' HD22 ' A' ' 233' ' ' LEU . . . -123.57 172.61 8.64 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.662 1.185 . . . . 73.400000000000006 108.834 178.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -152.81 158.25 41.95 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.386 0.674 . . . . 71.129999999999995 109.659 177.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -141.21 168.39 19.9 Favored 'General case' 0 C--N 1.35 0.59 0 C-N-CA 122.731 0.412 . . . . 73.310000000000002 110.761 177.183 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -142.78 149.23 49.23 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 124.95 1.3 . . . . 72.209999999999994 108.705 173.04 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' PRO . . . . . 0.547 ' HA ' HG12 ' A' ' 219' ' ' VAL . 20.4 Cg_endo -58.76 123.78 14.29 Favored 'Trans proline' 0 C--N 1.377 2.051 0 C-N-CA 122.931 2.42 . . . . 61.109999999999999 111.757 176.356 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' ALA . . . . . 0.562 ' HB2' ' HG3' ' A' ' 220' ' ' GLU . . . . . . . . 0 N--CA 1.477 0.912 0 C-N-CA 123.694 0.798 . . . . 62.520000000000003 109.827 179.201 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.417 ' O ' ' HA3' ' A' ' 247' ' ' GLY . 25.0 mm-40 . . . . . 0 N--CA 1.477 0.913 0 CA-C-O 120.938 0.399 . . . . 73.099999999999994 111.423 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -93.41 157.72 16.08 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.462 0.705 . . . . 75.219999999999999 110.047 175.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 43.1 mt -136.24 143.35 44.25 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.323 1.049 . . . . 75.030000000000001 108.282 171.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -129.61 120.76 25.79 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 123.791 0.836 . . . . 72.329999999999998 109.079 -178.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -159.37 165.18 33.82 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 121.47 0.653 . . . . 74.510000000000005 110.931 -177.417 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 2.9 p -93.25 138.3 31.76 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.798 0.839 . . . . 70.209999999999994 109.56 173.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.56 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . 57.9 tp -108.6 119.34 39.22 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.597 1.159 . . . . 71.299999999999997 109.497 -177.218 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -82.2 103.2 11.63 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 109.562 -0.533 . . . . 72.019999999999996 109.562 176.415 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.515 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 47.5 t -106.21 111.17 64.36 Favored Pre-proline 0 CA--C 1.542 0.643 0 N-CA-C 108.195 -1.039 . . . . 71.549999999999997 108.195 175.468 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 200' ' ' PRO . . . . . 0.424 ' HD2' HD12 ' A' ' 203' ' ' ILE . 50.5 Cg_exo -57.38 142.1 94.98 Favored 'Trans proline' 0 C--N 1.373 1.862 0 C-N-CA 122.498 2.132 . . . . 72.150000000000006 111.874 172.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.404 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -50.66 -47.5 84.87 Favored Pre-proline 0 CA--C 1.559 1.298 0 CA-C-O 117.793 -1.099 . . . . 62.299999999999997 112.985 -177.751 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -55.49 -41.93 73.05 Favored 'Trans proline' 0 C--N 1.398 3.178 0 C-N-CA 122.095 1.863 . . . . 64.230000000000004 112.891 176.021 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.424 HD12 ' HD2' ' A' ' 200' ' ' PRO . 34.5 mt -69.71 -36.2 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 C-N-CA 123.379 0.671 . . . . 74.450000000000003 110.894 -177.592 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.24 -38.32 78.44 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.227 0.611 . . . . 64.420000000000002 111.651 -178.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 201' ' ' ALA . 89.3 t -72.7 -56.29 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 CA-C-N 115.689 -0.687 . . . . 74.340000000000003 110.82 -178.674 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 9.4 m -80.39 -24.69 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 CA-C-N 116.294 -0.412 . . . . 73.510000000000005 111.985 -172.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 82.47 136.92 2.56 Favored Glycine 0 C--N 1.349 1.254 0 O-C-N 123.433 0.458 . . . . 44.100000000000001 112.622 -175.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 179.49 -124.91 0.93 Allowed Glycine 0 C--N 1.341 0.844 0 N-CA-C 111.776 -0.529 . . . . 62.140000000000001 111.776 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.514 ' HD2' ' HB3' ' A' ' 220' ' ' GLU . 46.9 mtmt -137.63 153.02 49.93 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.654 0.781 . . . . 42.43 109.817 176.044 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.491 HG11 ' HA ' ' A' ' 199' ' ' VAL . 27.3 m -128.84 168.23 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.578 1.151 . . . . 72.319999999999993 108.707 170.361 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 45.9 ttp180 -94.78 141.48 28.58 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 109.761 -0.459 . . . . 70.129999999999995 109.761 173.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -129.77 154.78 46.87 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.02 0.928 . . . . 75.340000000000003 109.036 173.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -103.66 114.45 28.72 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 109.218 -0.66 . . . . 73.129999999999995 109.218 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 64.4 p -114.57 175.62 5.41 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.246 0.618 . . . . 64.310000000000002 109.439 174.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 11.8 mt -81.12 -3.17 51.14 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 116.109 -0.496 . . . . 55.350000000000001 110.283 173.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -91.54 -20.34 21.8 Favored 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 123.862 0.865 . . . . 72.239999999999995 110.403 170.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 133.23 -163.64 24.3 Favored Glycine 0 C--N 1.352 1.446 0 CA-C-O 119.752 -0.471 . . . . 62.140000000000001 112.595 177.104 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -74.93 131.03 13.91 Favored 'Trans proline' 0 C--N 1.37 1.705 0 C-N-CA 123.042 2.495 . . . . 75.129999999999995 110.278 172.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.547 HG12 ' HA ' ' A' ' 177' ' ' PRO . 17.9 m -131.19 161.83 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 123.538 0.735 . . . . 61.020000000000003 110.478 -173.098 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.562 ' HG3' ' HB2' ' A' ' 178' ' ' ALA . 35.4 mt-10 -112.18 113.25 25.4 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.645 0.778 . . . . 74.510000000000005 109.681 178.454 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 57.5 t -95.46 118.99 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.229 1.011 . . . . 54.409999999999997 109.059 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -67.54 100.13 0.84 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.777 0.831 . . . . 70.430000000000007 110.149 176.508 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 91.7 t -81.77 121.02 79.09 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 124.562 1.145 . . . . 72.129999999999995 109.858 176.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -65.56 155.27 69.84 Favored 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 122.22 1.947 . . . . 70.439999999999998 111.482 173.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -66.77 156.23 66.91 Favored 'Trans proline' 0 C--N 1.37 1.702 0 C-N-CA 122.322 2.015 . . . . 74.140000000000001 111.731 172.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 49.0 mtm-85 63.34 31.53 15.2 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.19 0.996 . . . . 73.129999999999995 111.151 172.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.429 HG23 ' HD2' ' A' ' 231' ' ' ARG . 92.1 m -86.84 122.62 30.97 Favored 'General case' 0 C--N 1.344 0.367 0 C-N-CA 123.58 0.752 . . . . 65.030000000000001 109.256 176.617 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -94.35 167.79 11.3 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.499 0.719 . . . . 75.040000000000006 110.715 177.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -78.71 149.21 32.81 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-N 114.936 -1.029 . . . . 74.120000000000005 109.816 177.376 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 87.34 1.43 83.88 Favored Glycine 0 C--N 1.339 0.716 0 CA-C-N 115.681 -0.69 . . . . 75.129999999999995 111.963 -173.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.429 ' HD2' HG23 ' A' ' 227' ' ' THR . 54.3 mtt-85 -79.25 163.05 25.27 Favored 'General case' 0 C--N 1.353 0.76 0 CA-C-O 121.419 0.628 . . . . 71.209999999999994 110.103 170.767 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 15.9 pttm -128.41 139.97 52.08 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 124.344 1.058 . . . . 72.25 109.491 -178.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.467 HD22 ' HB2' ' A' ' 173' ' ' ALA . 90.0 mt -120.29 105.95 11.42 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.25 1.02 . . . . 64.239999999999995 108.906 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 234' ' ' ARG . . . . . 0.526 ' HB3' HG21 ' A' ' 170' ' ' VAL . 71.4 ttt180 -90.49 101.45 14.19 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 107.278 -1.378 . . . . 64.340000000000003 107.278 170.674 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 22.8 mt -77.13 83.41 3.62 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 107.718 -1.215 . . . . 71.409999999999997 107.718 174.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -68.68 129.0 38.67 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-N 113.049 -1.887 . . . . 74.430000000000007 111.861 -169.55 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 60.62 32.2 77.61 Favored Glycine 0 C--N 1.347 1.188 0 O-C-N 124.738 1.274 . . . . 61.409999999999997 112.473 177.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -136.79 -2.92 2.09 Favored 'General case' 0 C--N 1.358 0.964 0 N-CA-C 113.641 0.978 . . . . 74.25 113.641 -176.034 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 239' ' ' GLY . . . . . 0.415 ' HA2' ' HB2' ' A' ' 249' ' ' LEU . . . -61.69 -107.33 0.01 OUTLIER Glycine 0 N--CA 1.485 1.965 0 N-CA-C 114.603 0.601 . . . . 71.519999999999996 114.603 -178.152 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -67.81 136.31 92.38 Favored Pre-proline 0 N--CA 1.486 1.351 0 CA-C-O 118.328 -0.844 . . . . 72.340000000000003 109.523 171.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.507 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 37.8 Cg_exo -60.88 135.65 60.93 Favored 'Trans proline' 0 C--N 1.371 1.75 0 C-N-CA 122.648 2.232 . . . . 52.25 112.532 175.302 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -164.86 120.56 0.94 Allowed Glycine 0 CA--C 1.54 1.613 0 CA-C-O 118.556 -1.136 . . . . 73.219999999999999 111.99 -177.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -72.25 -20.13 24.95 Favored 'Trans proline' 0 C--N 1.387 2.554 0 C-N-CA 123.506 2.804 . . . . 72.219999999999999 112.811 176.315 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -93.29 12.64 23.91 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.231 0.612 . . . . 62.450000000000003 110.695 175.207 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 118.97 120.24 2.91 Favored Glycine 0 C--N 1.353 1.477 0 N-CA-C 110.592 -1.003 . . . . 70.230000000000004 110.592 -177.507 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.507 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 28.0 mtt180 -72.29 162.67 29.15 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.291 0.636 . . . . 73.239999999999995 109.71 174.623 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 247' ' ' GLY . . . . . 0.417 ' HA3' ' O ' ' A' ' 191' ' ' GLN . . . -80.56 -157.86 16.77 Favored Glycine 0 C--N 1.348 1.234 0 N-CA-C 112.435 -0.266 . . . . 73.129999999999995 112.435 174.484 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -121.43 128.85 52.58 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 117.407 0.603 . . . . 61.5 109.786 177.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.415 ' HB2' ' HA2' ' A' ' 239' ' ' GLY . 50.2 tp -100.19 108.18 20.22 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 108.263 -1.014 . . . . 71.450000000000003 108.263 173.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -98.69 116.43 30.91 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 108.522 -0.918 . . . . 70.420000000000002 108.522 -174.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.56 ' HB3' ' HB2' ' A' ' 197' ' ' LEU . 49.1 mt -127.22 119.17 25.78 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.024 0.93 . . . . 74.310000000000002 110.271 -173.24 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -83.57 121.33 27.09 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 122.979 0.511 . . . . 75.430000000000007 110.192 176.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 61.2 t -66.87 105.49 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 C-N-CA 123.691 0.796 . . . . 75.129999999999995 110.46 179.28 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 47.6 mmm-85 -107.25 100.02 9.51 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 107.703 -1.221 . . . . 74.040000000000006 107.703 173.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.515 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 39.8 mt -76.94 119.37 25.21 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 CA-C-N 116.063 -0.517 . . . . 72.239999999999995 110.422 -178.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 29.5 p . . . . . 0 C--O 1.249 1.06 0 N-CA-C 108.393 -0.965 . . . . 44.020000000000003 108.393 175.614 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 20.3 t70 . . . . . 0 N--CA 1.474 0.76 0 CA-C-O 121.299 0.571 . . . . 63.530000000000001 109.707 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.44 HG12 ' HG3' ' A' ' 232' ' ' LYS . 33.5 m -92.03 156.09 3.05 Favored 'Isoleucine or valine' 0 C--O 1.244 0.784 0 CA-C-N 114.87 -1.059 . . . . 51.450000000000003 109.147 171.542 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 16.6 tt -83.3 143.43 11.95 Favored 'Isoleucine or valine' 0 C--O 1.245 0.863 0 N-CA-C 108.703 -0.851 . . . . 60.520000000000003 108.703 171.299 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -59.92 137.96 57.94 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.301 1.041 . . . . 74.319999999999993 110.787 -176.279 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.466 ' HB2' HD22 ' A' ' 233' ' ' LEU . . . -157.69 159.34 36.81 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.319 1.048 . . . . 53.340000000000003 109.537 -178.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -160.42 152.22 19.93 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.604 0.762 . . . . 65.430000000000007 109.742 174.22 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.546 ' HB3' HG22 ' A' ' 221' ' ' VAL . 34.6 p90 -113.7 -178.67 3.43 Favored 'General case' 0 C--N 1.349 0.561 0 CA-C-O 121.23 0.538 . . . . 70.5 111.704 -178.274 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -135.78 140.71 34.43 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-N 114.394 -1.275 . . . . 64.420000000000002 107.955 170.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -60.87 113.92 1.93 Allowed 'Trans proline' 0 C--N 1.366 1.487 0 C-N-CA 123.212 2.608 . . . . 75.340000000000003 111.134 175.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' ALA . . . . . 0.439 ' HB2' ' HG3' ' A' ' 220' ' ' GLU . . . . . . . . 0 N--CA 1.48 1.039 0 C-N-CA 123.497 0.719 . . . . 73.409999999999997 110.848 175.599 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.496 ' HA ' ' HB2' ' A' ' 240' ' ' PHE . 18.2 mm100 . . . . . 0 CA--C 1.553 1.061 0 N-CA-C 112.683 0.623 . . . . 55.219999999999999 112.683 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -93.02 141.18 28.69 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.427 0.691 . . . . 71.519999999999996 110.07 -178.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 17.6 mt -123.44 148.4 46.2 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 124.971 1.308 . . . . 72.239999999999995 109.22 174.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -127.86 120.64 28.19 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.21 0.604 . . . . 73.209999999999994 109.673 177.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.431 ' O ' ' HA ' ' A' ' 251' ' ' LEU . . . -145.35 160.06 42.11 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.729 0.812 . . . . 60.329999999999998 109.939 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 11.5 m -102.55 143.79 31.8 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 108.771 -0.826 . . . . 44.399999999999999 108.771 176.411 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.569 HD11 HG23 ' A' ' 210' ' ' VAL . 49.0 tp -113.95 124.97 53.45 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.634 1.174 . . . . 64.109999999999999 109.858 -173.573 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -96.97 102.86 14.72 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.375 0.67 . . . . 73.219999999999999 109.522 175.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.532 ' HA ' HG11 ' A' ' 210' ' ' VAL . 3.2 p -104.45 125.9 32.89 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 124.093 0.957 . . . . 71.319999999999993 109.675 173.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.86 148.44 66.93 Favored 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 122.698 2.265 . . . . 74.519999999999996 112.526 170.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.459 ' HA ' HG23 ' A' ' 255' ' ' ILE . . . -49.38 -52.39 49.75 Favored Pre-proline 0 CA--C 1.56 1.359 0 C-N-CA 124.269 1.027 . . . . 72.049999999999997 112.452 178.45 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 202' ' ' PRO . . . . . 0.436 ' O ' HG12 ' A' ' 206' ' ' VAL . 30.8 Cg_endo -61.28 -40.3 50.76 Favored 'Trans proline' 0 C--N 1.4 3.266 0 C-N-CA 121.752 1.635 . . . . 75.319999999999993 112.877 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 29.1 mt -68.7 -30.48 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 123.233 0.613 . . . . 73.040000000000006 110.669 -178.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.92 -42.52 73.19 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 122.827 0.451 . . . . 45.109999999999999 110.662 177.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 201' ' ' ALA . 61.4 t -71.05 -53.9 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 123.303 0.641 . . . . 75.329999999999998 111.438 -177.72 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.436 HG12 ' O ' ' A' ' 202' ' ' PRO . 7.7 p -80.09 -31.59 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 122.439 0.296 . . . . 73.109999999999999 111.787 -174.728 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 93.45 131.22 5.84 Favored Glycine 0 CA--C 1.532 1.105 0 N-CA-C 111.618 -0.593 . . . . 72.150000000000006 111.618 -172.334 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -166.72 -143.87 3.91 Favored Glycine 0 C--N 1.341 0.856 0 CA-C-O 119.339 -0.701 . . . . 62.43 111.899 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.466 ' HB3' ' HB3' ' A' ' 220' ' ' GLU . 9.6 mtmp? -132.96 145.71 51.13 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.886 0.874 . . . . 73.310000000000002 109.704 174.477 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.569 HG23 HD11 ' A' ' 197' ' ' LEU . 22.1 m -139.44 158.54 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 124.385 1.074 . . . . 74.420000000000002 110.219 177.741 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 29.2 mtp-105 -79.76 132.87 36.27 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 122.917 0.487 . . . . 71.0 111.598 -177.681 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -121.12 125.21 46.67 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 125.368 1.467 . . . . 65.349999999999994 108.016 172.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.65 106.89 18.82 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 123.478 0.711 . . . . 71.019999999999996 110.124 -175.474 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 29.8 p -117.38 172.51 7.27 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.402 0.681 . . . . 73.209999999999994 109.928 -179.149 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 9.3 mt -71.54 -24.77 62.0 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 109.541 -0.541 . . . . 72.109999999999999 109.541 175.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -79.52 -18.87 50.93 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.128 0.971 . . . . 75.140000000000001 110.767 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 135.19 -175.51 20.61 Favored Glycine 0 C--N 1.353 1.495 0 CA-C-N 116.064 -0.517 . . . . 53.509999999999998 112.948 172.053 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -66.76 126.48 15.43 Favored 'Trans proline' 0 C--N 1.372 1.809 0 C-N-CA 122.931 2.42 . . . . 53.310000000000002 110.644 168.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 35.4 m -133.16 138.68 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 122.882 0.473 . . . . 64.439999999999998 110.67 -178.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.466 ' HB3' ' HB3' ' A' ' 209' ' ' LYS . 46.9 mt-10 -92.99 108.55 20.09 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.178 0.591 . . . . 72.129999999999995 110.777 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.546 HG22 ' HB3' ' A' ' 175' ' ' TYR . 61.0 t -91.89 119.24 38.93 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 C-N-CA 124.451 1.101 . . . . 70.040000000000006 109.429 -176.296 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -65.04 102.61 0.64 Allowed 'General case' 0 C--O 1.239 0.534 0 O-C-N 124.309 1.005 . . . . 64.420000000000002 109.969 175.244 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.471 HG11 HG21 ' A' ' 199' ' ' VAL . 48.1 t -74.8 117.28 61.27 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 124.376 1.07 . . . . 70.030000000000001 109.061 172.205 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -59.62 156.64 35.96 Favored 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 122.32 2.013 . . . . 73.109999999999999 112.158 178.182 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -63.06 125.24 15.45 Favored 'Trans proline' 0 C--N 1.375 1.945 0 C-N-CA 122.389 2.059 . . . . 75.030000000000001 111.567 177.35 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 72.9 mtm180 68.13 83.51 0.16 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.962 1.305 . . . . 74.510000000000005 110.051 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.585 HG22 HG11 ' A' ' 253' ' ' VAL . 89.8 m -126.48 117.5 23.02 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.011 0.924 . . . . 73.010000000000005 109.464 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -85.79 158.35 20.02 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.939 0.895 . . . . 71.430000000000007 112.151 -172.402 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -72.54 124.33 24.99 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 114.635 -1.166 . . . . 60.299999999999997 109.951 179.241 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 102.28 2.85 51.07 Favored Glycine 0 C--N 1.335 0.52 0 CA-C-O 119.524 -0.598 . . . . 45.0 112.596 -176.23 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 87.1 mtt180 -72.66 161.27 30.98 Favored 'General case' 0 C--N 1.356 0.879 0 CA-C-O 121.264 0.554 . . . . 74.200000000000003 110.051 170.335 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.44 ' HG3' HG12 ' A' ' 170' ' ' VAL . 19.9 pttm -124.38 140.47 52.92 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.324 -0.853 . . . . 74.439999999999998 109.876 -179.116 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.466 HD22 ' HB2' ' A' ' 173' ' ' ALA . 61.4 mt -117.87 141.28 48.61 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 107.49 -1.3 . . . . 73.310000000000002 107.49 176.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 30.6 ttt180 -130.88 101.73 5.76 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 108.081 -1.081 . . . . 72.150000000000006 108.081 167.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.455 HD13 ' HD1' ' A' ' 175' ' ' TYR . 27.6 mt -71.03 87.31 0.74 Allowed 'General case' 0 C--O 1.24 0.603 0 CA-C-N 114.524 -1.216 . . . . 70.420000000000002 108.286 175.136 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 59.6 mtmt -68.75 122.98 19.7 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 114.272 -1.331 . . . . 75.099999999999994 111.006 -174.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 69.65 26.42 74.48 Favored Glycine 0 C--N 1.345 1.079 0 O-C-N 124.305 1.003 . . . . 71.150000000000006 112.303 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.447 ' HB3' ' CE1' ' A' ' 175' ' ' TYR . 31.3 mmtp -135.85 35.02 2.87 Favored 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 124.512 1.125 . . . . 71.239999999999995 110.985 -172.007 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -114.27 -115.36 3.14 Favored Glycine 0 N--CA 1.477 1.414 0 N-CA-C 111.952 -0.459 . . . . 51.039999999999999 111.952 177.579 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 240' ' ' PHE . . . . . 0.496 ' HB2' ' HA ' ' A' ' 191' ' ' GLN . 1.8 m-85 -69.83 142.03 90.49 Favored Pre-proline 0 N--CA 1.485 1.321 0 C-N-CA 123.17 0.588 . . . . 65.319999999999993 110.946 177.607 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -52.44 144.12 41.9 Favored 'Trans proline' 0 C--N 1.376 1.985 0 C-N-CA 123.687 2.925 . . . . 65.010000000000005 113.602 172.162 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -156.8 113.31 0.56 Allowed Glycine 0 CA--C 1.531 1.063 0 CA-C-O 118.399 -1.223 . . . . 73.230000000000004 110.248 -179.436 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.26 -14.98 45.33 Favored 'Trans proline' 0 C--N 1.386 2.521 0 C-N-CA 123.535 2.823 . . . . 61.530000000000001 114.565 -176.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -112.6 -12.24 13.46 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 123.529 0.732 . . . . 72.340000000000003 111.594 175.07 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 163.03 125.68 0.78 Allowed Glycine 0 C--N 1.344 0.998 0 N-CA-C 111.123 -0.791 . . . . 63.119999999999997 111.123 -178.183 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 12.3 mtm180 -73.63 162.32 29.33 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.135 0.574 . . . . 72.040000000000006 110.928 -178.355 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -83.82 -163.72 35.78 Favored Glycine 0 C--N 1.348 1.212 0 CA-C-N 115.894 -0.594 . . . . 65.150000000000006 112.971 178.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -108.36 157.46 18.37 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.213 0.605 . . . . 74.540000000000006 110.676 -176.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 45.6 tp -132.83 110.91 10.66 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.101 0.96 . . . . 74.340000000000003 108.571 170.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 21.9 t80 -96.28 120.97 37.55 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.382 1.073 . . . . 62.119999999999997 109.326 -176.444 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.431 ' HA ' ' O ' ' A' ' 195' ' ' ALA . 51.5 mt -120.02 126.98 52.14 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.727 0.811 . . . . 72.239999999999995 110.862 -176.288 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.99 116.52 25.1 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 122.886 0.474 . . . . 72.340000000000003 110.434 173.228 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.585 HG11 HG22 ' A' ' 227' ' ' THR . 96.7 t -65.71 115.58 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 123.381 0.673 . . . . 73.129999999999995 110.511 176.518 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -121.12 111.62 17.67 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.015 0.926 . . . . 71.420000000000002 109.193 172.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.459 HG23 ' HA ' ' A' ' 201' ' ' ALA . 44.7 mt -76.89 121.47 29.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 108.988 -0.745 . . . . 74.019999999999996 108.988 175.18 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 34.6 p . . . . . 0 C--O 1.253 1.254 0 N-CA-C 108.23 -1.026 . . . . 51.140000000000001 108.23 175.908 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 29.7 t70 . . . . . 0 N--CA 1.483 1.186 0 N-CA-C 113.409 0.892 . . . . 73.209999999999994 113.409 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.444 HG21 ' HB3' ' A' ' 234' ' ' ARG . 12.9 m -90.33 -174.82 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.019 0 C-N-CA 123.542 0.737 . . . . 73.129999999999995 110.651 -175.401 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 10.3 tt -93.85 137.46 22.73 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.124 0 N-CA-C 108.29 -1.004 . . . . 71.530000000000001 108.29 165.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -74.84 113.39 12.08 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.438 1.095 . . . . 52.539999999999999 110.02 -175.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.453 ' HB2' HD22 ' A' ' 233' ' ' LEU . . . -111.6 178.95 4.16 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.449 0.7 . . . . 70.420000000000002 110.711 -178.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -146.76 156.5 43.2 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.572 1.149 . . . . 72.430000000000007 109.456 178.349 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.403 ' HD1' HD13 ' A' ' 235' ' ' LEU . 2.5 p90 -130.67 172.06 12.38 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.086 0.47 . . . . 74.030000000000001 110.045 168.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -134.5 140.91 37.06 Favored Pre-proline 0 N--CA 1.476 0.837 0 C-N-CA 124.585 1.154 . . . . 52.539999999999999 108.27 175.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -64.04 106.08 0.63 Allowed 'Trans proline' 0 C--N 1.363 1.342 0 C-N-CA 122.775 2.317 . . . . 74.219999999999999 111.035 175.152 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.336 0 C-N-CA 123.535 0.734 . . . . 32.109999999999999 111.826 -175.652 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.482 ' HA ' ' HB2' ' A' ' 240' ' ' PHE . 23.9 mm-40 . . . . . 0 N--CA 1.477 0.904 0 CA-C-O 121.191 0.52 . . . . 51.420000000000002 110.084 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -89.6 146.92 24.22 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.031 0.932 . . . . 74.230000000000004 109.927 -170.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.424 HD23 ' HA ' ' A' ' 193' ' ' LEU . 13.7 mt -140.53 131.56 26.23 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 107.634 -1.247 . . . . 70.409999999999997 107.634 166.648 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -120.13 128.3 53.31 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 108.782 -0.822 . . . . 65.540000000000006 108.782 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -157.53 162.04 38.82 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.742 0.817 . . . . 52.210000000000001 110.157 178.139 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 17.2 p -91.87 149.12 21.74 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 109.033 -0.728 . . . . 64.409999999999997 109.033 170.23 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.619 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . 40.8 tp -113.4 115.01 27.4 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 123.622 0.769 . . . . 75.230000000000004 109.549 -175.307 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -80.03 100.96 8.42 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.625 0.77 . . . . 72.219999999999999 109.163 -179.006 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.578 ' HA ' HG11 ' A' ' 210' ' ' VAL . 40.9 t -109.84 104.39 55.38 Favored Pre-proline 0 CA--C 1.54 0.578 0 N-CA-C 108.509 -0.923 . . . . 60.539999999999999 108.509 178.238 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -53.22 139.79 62.62 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 122.723 2.282 . . . . 74.430000000000007 112.07 174.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.428 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -47.8 -47.84 61.78 Favored Pre-proline 0 CA--C 1.558 1.266 0 C-N-CA 124.377 1.071 . . . . 74.230000000000004 113.749 -175.769 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.1 -45.06 34.13 Favored 'Trans proline' 0 C--N 1.39 2.716 0 C-N-CA 121.977 1.785 . . . . 73.420000000000002 112.902 174.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 36.6 mt -66.1 -32.24 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 123.577 0.751 . . . . 64.430000000000007 110.84 -177.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -65.91 -50.64 63.75 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 122.994 0.518 . . . . 73.120000000000005 110.377 177.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 201' ' ' ALA . 81.4 t -64.3 -53.23 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 O-C-N 123.877 0.736 . . . . 73.510000000000005 111.685 -175.77 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 26.9 m -78.31 -26.28 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 N-CA-C 112.237 0.458 . . . . 73.329999999999998 112.237 -176.398 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 81.01 139.99 2.65 Favored Glycine 0 C--N 1.349 1.301 0 N-CA-C 112.147 -0.381 . . . . 74.030000000000001 112.147 -175.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -177.74 -124.27 0.84 Allowed Glycine 0 C--N 1.344 0.995 0 CA-C-N 117.202 0.501 . . . . 31.120000000000001 112.506 -178.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -136.59 153.13 51.05 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.977 0.911 . . . . 72.109999999999999 108.71 176.07 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.578 HG11 ' HA ' ' A' ' 199' ' ' VAL . 15.7 m -138.06 128.03 35.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 123.268 0.627 . . . . 72.5 109.381 171.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 211' ' ' ARG . . . . . 0.418 ' HG2' ' HG2' ' A' ' 220' ' ' GLU . 63.6 mtm-85 -81.95 110.29 17.09 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.38 0.672 . . . . 62.43 110.796 -176.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -100.46 161.14 13.8 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.677 1.191 . . . . 74.310000000000002 109.93 178.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 8.1 mmt -99.17 119.82 38.49 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.714 0.805 . . . . 70.0 109.889 -177.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 76.4 p -110.6 175.49 5.41 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.52 0.728 . . . . 60.109999999999999 109.113 170.053 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 29.1 mt -69.84 -10.43 58.41 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 112.712 0.634 . . . . 74.400000000000006 112.712 -174.04 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -117.43 -12.69 10.39 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.266 0.626 . . . . 51.350000000000001 112.284 -177.27 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 153.15 -169.62 32.05 Favored Glycine 0 C--N 1.356 1.655 0 N-CA-C 114.335 0.494 . . . . 71.340000000000003 114.335 173.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -70.22 141.23 42.85 Favored 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 123.558 2.839 . . . . 72.420000000000002 112.456 176.032 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 34.6 m -137.89 130.96 41.75 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 C-N-CA 123.547 0.739 . . . . 52.350000000000001 110.157 178.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.418 ' HG2' ' HG2' ' A' ' 211' ' ' ARG . 14.3 mt-10 -88.07 108.52 19.28 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.408 0.683 . . . . 71.340000000000003 110.173 -178.133 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 44.9 t -94.74 122.95 46.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 123.734 0.814 . . . . 73.239999999999995 109.682 -176.408 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -68.61 107.0 2.79 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.205 1.002 . . . . 73.510000000000005 111.452 -177.352 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 66.4 t -86.2 121.05 72.74 Favored Pre-proline 0 CA--C 1.553 1.065 0 C-N-CA 124.634 1.174 . . . . 71.120000000000005 110.047 176.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -63.52 164.38 20.98 Favored 'Trans proline' 0 C--N 1.379 2.183 0 C-N-CA 122.918 2.412 . . . . 65.420000000000002 112.527 174.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -66.28 128.35 19.25 Favored 'Trans proline' 0 C--N 1.376 2.008 0 C-N-CA 122.615 2.21 . . . . 72.299999999999997 112.184 173.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 63.3 mtm-85 62.81 70.54 0.55 Allowed 'General case' 0 C--N 1.353 0.746 0 C-N-CA 124.724 1.21 . . . . 72.299999999999997 110.846 178.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.631 HG22 HG11 ' A' ' 253' ' ' VAL . 56.8 m -101.57 114.72 29.01 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 114.829 -1.078 . . . . 63.109999999999999 109.376 -178.699 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 22.9 mp0 -84.79 153.03 23.25 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.271 0.628 . . . . 62.140000000000001 111.404 -174.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -73.15 127.89 33.91 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.734 -0.839 . . . . 64.129999999999995 108.734 174.309 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 110.08 -11.84 31.65 Favored Glycine 0 C--N 1.333 0.366 0 N-CA-C 111.533 -0.627 . . . . 55.140000000000001 111.533 -171.329 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.575 ' HD2' HG23 ' A' ' 227' ' ' THR . 90.7 mtt180 -66.81 156.79 34.61 Favored 'General case' 0 C--N 1.36 1.043 0 CA-C-O 121.361 0.601 . . . . 60.229999999999997 110.142 169.108 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 38.3 pttt -131.91 135.08 46.37 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 114.996 -1.002 . . . . 74.439999999999998 109.391 -176.308 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.453 HD22 ' HB2' ' A' ' 173' ' ' ALA . 75.9 mt -115.96 137.06 52.45 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 108.081 -1.081 . . . . 62.299999999999997 108.081 176.204 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 234' ' ' ARG . . . . . 0.444 ' HB3' HG21 ' A' ' 170' ' ' VAL . 40.8 ttm105 -119.52 120.49 36.92 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.565 -1.272 . . . . 75.5 107.565 166.65 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.514 ' O ' ' HA ' ' A' ' 248' ' ' ASP . 43.7 mt -101.88 78.82 1.84 Allowed 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 108.678 -0.86 . . . . 61.100000000000001 108.678 -177.48 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -75.95 144.15 41.17 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 122.883 0.473 . . . . 74.120000000000005 109.856 176.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 68.31 18.16 71.1 Favored Glycine 0 C--N 1.344 1.005 0 CA-C-N 115.639 -0.709 . . . . 63.109999999999999 112.336 -174.231 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 10.1 mmpt? -129.75 -30.58 2.04 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.352 1.061 . . . . 70.239999999999995 110.728 -175.076 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -66.84 -125.83 0.02 OUTLIER Glycine 0 C--N 1.36 1.863 0 N-CA-C 114.766 0.666 . . . . 64.409999999999997 114.766 -171.323 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 240' ' ' PHE . . . . . 0.482 ' HB2' ' HA ' ' A' ' 191' ' ' GLN . 1.1 m-85 -67.78 135.46 92.31 Favored Pre-proline 0 N--CA 1.482 1.15 0 CA-C-O 118.802 -0.618 . . . . 64.310000000000002 109.903 177.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.56 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 37.3 Cg_exo -42.51 138.46 3.41 Favored 'Trans proline' 0 C--N 1.378 2.101 0 C-N-CA 124.278 3.319 . . . . 74.420000000000002 114.92 175.7 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -164.46 113.16 0.54 Allowed Glycine 0 CA--C 1.531 1.046 0 N-CA-C 109.219 -1.552 . . . . 74.439999999999998 109.219 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -60.51 -40.13 59.43 Favored 'Trans proline' 0 C--N 1.379 2.142 0 C-N-CA 123.234 2.623 . . . . 72.109999999999999 113.296 -173.19 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -77.32 -25.05 50.81 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.057 0.543 . . . . 61.420000000000002 110.8 176.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 169.18 127.21 0.91 Allowed Glycine 0 C--N 1.338 0.673 0 N-CA-C 110.996 -0.842 . . . . 71.310000000000002 110.996 179.243 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.56 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 48.6 mtm180 -69.54 159.59 33.05 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.106 0.562 . . . . 73.329999999999998 109.874 178.556 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 247' ' ' GLY . . . . . 0.426 ' HA3' ' HB3' ' A' ' 191' ' ' GLN . . . -74.08 -156.56 4.55 Favored Glycine 0 C--N 1.339 0.702 0 CA-C-N 116.069 -0.514 . . . . 75.140000000000001 112.911 175.697 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 248' ' ' ASP . . . . . 0.514 ' HA ' ' O ' ' A' ' 235' ' ' LEU . 2.6 p30 -122.7 136.46 54.88 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 122.332 -0.511 . . . . 70.25 112.018 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 32.5 tp -100.57 104.6 15.95 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 107.241 -1.392 . . . . 74.299999999999997 107.241 168.029 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -89.28 108.03 19.39 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.172 0.989 . . . . 72.430000000000007 109.02 -178.055 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.619 ' HB3' ' HB2' ' A' ' 197' ' ' LEU . 63.8 mt -110.43 110.75 21.63 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.412 1.085 . . . . 73.409999999999997 110.349 -176.069 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -80.37 110.23 15.63 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.119 0.568 . . . . 74.540000000000006 109.694 176.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.631 HG11 HG22 ' A' ' 227' ' ' THR . 89.8 t -59.49 110.76 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.417 0.687 . . . . 71.010000000000005 111.017 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 30.8 mmm180 -114.23 113.0 24.04 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 125.053 1.341 . . . . 74.530000000000001 108.45 173.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.477 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 56.9 mt -75.62 126.14 36.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 N-CA-C 109.253 -0.647 . . . . 73.420000000000002 109.253 178.42 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 45.2 p . . . . . 0 C--O 1.248 1.003 0 C-N-CA 124.167 0.987 . . . . 73.430000000000007 108.623 -179.635 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 37.7 t70 . . . . . 0 N--CA 1.476 0.849 0 CA-C-O 121.283 0.563 . . . . 60.240000000000002 110.292 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.638 HG21 ' HB3' ' A' ' 234' ' ' ARG . 34.1 m -90.01 173.06 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-N 115.158 -0.928 . . . . 71.040000000000006 110.948 178.369 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 15.1 tt -96.34 143.81 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 N-CA-C 108.676 -0.861 . . . . 63.409999999999997 108.676 171.333 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -65.81 132.16 48.03 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.3 1.04 . . . . 74.200000000000003 112.065 -173.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.485 ' HB2' HD22 ' A' ' 233' ' ' LEU . . . -146.61 164.39 32.8 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.336 1.054 . . . . 40.109999999999999 110.816 -178.333 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -160.4 154.09 22.52 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.68 1.192 . . . . 74.340000000000003 109.161 179.321 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.533 ' HA ' ' HA ' ' A' ' 221' ' ' VAL . 31.7 p90 -117.72 -177.21 3.19 Favored 'General case' 0 C--N 1.347 0.475 0 CA-C-O 121.575 0.703 . . . . 74.310000000000002 110.953 178.341 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -136.15 131.81 18.88 Favored Pre-proline 0 N--CA 1.468 0.456 0 N-CA-C 107.438 -1.319 . . . . 71.230000000000004 107.438 173.178 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -65.25 95.25 0.26 Allowed 'Trans proline' 0 CA--C 1.551 1.359 0 C-N-CA 122.149 1.899 . . . . 52.509999999999998 110.787 177.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' ALA . . . . . 0.477 ' HB2' ' HG3' ' A' ' 220' ' ' GLU . . . . . . . . 0 N--CA 1.482 1.137 0 CA-C-N 115.522 -0.763 . . . . 73.519999999999996 110.294 176.061 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.614 ' HA ' ' HB2' ' A' ' 240' ' ' PHE . 16.8 mm100 . . . . . 0 N--CA 1.475 0.776 0 CA-C-O 121.15 0.5 . . . . 72.239999999999995 110.374 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.425 ' HA ' ' O ' ' A' ' 248' ' ' ASP . 8.0 p-10 -103.59 139.95 38.21 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.015 -0.539 . . . . 71.430000000000007 109.63 176.045 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 86.1 mt -118.83 150.8 39.22 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 108.632 -0.877 . . . . 74.109999999999999 108.632 -177.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -122.21 127.59 50.16 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 108.119 -1.067 . . . . 72.420000000000002 108.119 172.16 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -152.88 158.49 42.22 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 122.956 0.502 . . . . 72.450000000000003 110.203 -177.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 10.7 p -94.94 138.02 33.23 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 123.222 0.609 . . . . 72.129999999999995 109.917 174.456 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.456 HD11 HG23 ' A' ' 210' ' ' VAL . 52.0 tp -110.88 114.38 27.66 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.381 1.072 . . . . 63.439999999999998 109.543 -173.091 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -75.81 104.38 6.33 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 109.251 -0.648 . . . . 73.329999999999998 109.251 176.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.587 HG22 HG21 ' A' ' 210' ' ' VAL . 30.0 t -113.46 107.19 53.62 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 123.668 0.787 . . . . 51.149999999999999 108.936 175.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -54.19 140.66 71.44 Favored 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.796 2.331 . . . . 73.239999999999995 112.267 172.703 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -47.7 -50.14 53.11 Favored Pre-proline 0 CA--C 1.571 1.752 0 N-CA-C 113.992 1.108 . . . . 63.119999999999997 113.992 -177.626 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -58.1 -39.25 87.13 Favored 'Trans proline' 0 C--N 1.401 3.318 0 C-N-CA 121.838 1.692 . . . . 53.43 112.806 177.074 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 47.5 mt -72.01 -31.31 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 123.95 0.9 . . . . 71.420000000000002 110.829 -178.286 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.68 -46.63 68.56 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.239 0.615 . . . . 73.25 110.944 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 83.2 t -70.54 -40.99 77.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-N 115.284 -0.871 . . . . 62.32 111.705 -176.748 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 8.2 p -77.45 -31.02 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 CA-C-N 116.473 -0.33 . . . . 44.520000000000003 111.404 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 80.55 69.07 1.42 Allowed Glycine 0 C--N 1.349 1.296 0 CA-C-N 116.055 -0.521 . . . . 73.239999999999995 112.344 -173.748 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -101.29 -150.68 24.14 Favored Glycine 0 C--N 1.346 1.106 0 CA-C-O 119.715 -0.492 . . . . 71.120000000000005 112.158 -176.025 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 55.0 mttp -117.39 143.39 46.04 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.229 0.612 . . . . 71.219999999999999 109.56 173.179 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.587 HG21 HG22 ' A' ' 199' ' ' VAL . 27.7 m -136.72 142.28 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 124.14 0.976 . . . . 55.340000000000003 109.192 174.569 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 88.9 mtm180 -73.72 137.9 44.3 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.127 0.489 . . . . 75.450000000000003 111.086 176.126 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -116.59 121.13 40.83 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.268 1.427 . . . . 72.340000000000003 107.394 172.149 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.0 111.6 19.85 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 109.382 -0.599 . . . . 63.109999999999999 109.382 -178.819 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 81.4 p -120.83 -179.88 4.14 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.457 0.703 . . . . 55.43 111.07 -176.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 12.3 mt -70.31 -22.68 62.8 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 115.466 -0.788 . . . . 72.0 110.003 175.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -87.44 -12.87 44.86 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 123.93 0.892 . . . . 72.140000000000001 110.621 177.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 117.37 -158.97 14.29 Favored Glycine 0 C--N 1.354 1.535 0 CA-C-N 116.353 -0.385 . . . . 51.140000000000001 113.109 175.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.7 127.9 14.46 Favored 'Trans proline' 0 C--N 1.367 1.533 0 C-N-CA 122.669 2.246 . . . . 74.129999999999995 111.381 175.255 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 29.6 m -132.39 125.03 53.02 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.827 0 N-CA-C 109.919 -0.4 . . . . 63.420000000000002 109.919 173.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.477 ' HG3' ' HB2' ' A' ' 178' ' ' ALA . 45.4 mt-10 -84.14 105.82 15.3 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.316 0.647 . . . . 70.209999999999994 110.285 -178.293 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.533 ' HA ' ' HA ' ' A' ' 175' ' ' TYR . 46.5 t -90.03 116.94 32.34 Favored 'Isoleucine or valine' 0 C--O 1.243 0.717 0 C-N-CA 124.303 1.041 . . . . 73.25 108.576 -175.539 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -69.32 101.09 1.44 Allowed 'General case' 0 C--O 1.241 0.613 0 CA-C-N 114.873 -1.058 . . . . 52.530000000000001 109.146 176.091 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 47.1 t -69.18 131.55 90.47 Favored Pre-proline 0 CA--C 1.544 0.749 0 CA-C-N 114.781 -1.1 . . . . 64.420000000000002 109.05 176.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -62.81 159.49 37.37 Favored 'Trans proline' 0 CA--C 1.561 1.85 0 C-N-CA 122.06 1.84 . . . . 71.030000000000001 111.923 170.34 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -67.05 147.66 80.12 Favored 'Trans proline' 0 C--N 1.376 2.003 0 C-N-CA 122.159 1.906 . . . . 74.329999999999998 112.191 176.683 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 47.8 mtp180 53.54 54.79 9.5 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.919 1.288 . . . . 73.450000000000003 111.368 174.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.615 HG23 ' HD2' ' A' ' 231' ' ' ARG . 91.3 m -96.8 117.95 32.19 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 114.525 -1.216 . . . . 64.319999999999993 109.11 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 26.8 mp0 -90.38 161.67 15.48 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.277 0.631 . . . . 73.409999999999997 111.57 -177.068 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -64.42 127.62 32.27 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 114.454 -1.248 . . . . 55.539999999999999 110.239 177.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 103.85 -4.31 45.9 Favored Glycine 0 C--N 1.341 0.854 0 CA-C-O 119.374 -0.681 . . . . 73.439999999999998 113.526 -179.444 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.615 ' HD2' HG23 ' A' ' 227' ' ' THR . 87.5 mtt180 -68.65 162.07 26.78 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 117.741 0.771 . . . . 71.420000000000002 111.54 175.57 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -127.33 124.24 38.23 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 123.84 0.856 . . . . 75.420000000000002 110.679 -173.228 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.485 HD22 ' HB2' ' A' ' 173' ' ' ALA . 61.8 mt -113.32 100.0 8.22 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.049 0.939 . . . . 62.109999999999999 109.138 178.58 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 234' ' ' ARG . . . . . 0.638 ' HB3' HG21 ' A' ' 170' ' ' VAL . 22.6 ttt180 -85.4 102.15 13.19 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 107.966 -1.124 . . . . 65.209999999999994 107.966 169.074 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.414 HD13 ' HD1' ' A' ' 175' ' ' TYR . 53.5 mt -68.89 92.06 0.49 Allowed 'General case' 0 C--O 1.244 0.776 0 N-CA-C 107.808 -1.182 . . . . 75.430000000000007 107.808 172.854 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -71.28 114.11 9.0 Favored 'General case' 0 C--N 1.357 0.925 0 CA-C-N 114.137 -1.392 . . . . 74.409999999999997 111.813 -167.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 237' ' ' GLY . . . . . 0.405 ' O ' ' HD3' ' A' ' 246' ' ' ARG . . . 67.53 34.08 83.17 Favored Glycine 0 C--N 1.346 1.121 0 O-C-N 124.053 0.846 . . . . 44.32 112.056 178.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.461 ' HB3' ' CE1' ' A' ' 175' ' ' TYR . 32.9 mmtp -128.62 10.36 6.09 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.645 0.778 . . . . 74.420000000000002 111.97 -172.733 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -84.48 -129.14 1.82 Allowed Glycine 0 N--CA 1.47 0.948 0 N-CA-C 111.742 -0.543 . . . . 60.229999999999997 111.742 176.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 240' ' ' PHE . . . . . 0.614 ' HB2' ' HA ' ' A' ' 191' ' ' GLN . 3.2 m-85 -74.88 142.92 77.2 Favored Pre-proline 0 N--CA 1.48 1.072 0 C-N-CA 123.283 0.633 . . . . 74.120000000000005 110.894 175.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.723 ' HA ' ' HG3' ' A' ' 246' ' ' ARG . 21.3 Cg_exo -64.5 142.86 79.98 Favored 'Trans proline' 0 C--N 1.379 2.132 0 C-N-CA 123.003 2.469 . . . . 74.409999999999997 113.11 -176.578 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -157.48 118.25 0.82 Allowed Glycine 0 CA--C 1.535 1.291 0 CA-C-O 118.696 -1.058 . . . . 44.039999999999999 111.345 -179.409 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -64.04 -28.99 65.99 Favored 'Trans proline' 0 C--N 1.384 2.44 0 C-N-CA 123.131 2.554 . . . . 72.040000000000006 114.335 -178.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -86.61 -15.35 40.05 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.169 0.588 . . . . 61.509999999999998 111.18 176.495 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 163.29 118.33 0.45 Allowed Glycine 0 C--N 1.344 0.99 0 N-CA-C 110.072 -1.211 . . . . 63.240000000000002 110.072 178.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.723 ' HG3' ' HA ' ' A' ' 241' ' ' PRO . 45.4 ttt180 -69.25 140.27 54.47 Favored 'General case' 0 C--O 1.243 0.726 0 CA-C-N 117.505 0.653 . . . . 72.109999999999999 109.508 175.389 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -68.56 -169.47 5.54 Favored Glycine 0 C--N 1.351 1.4 0 O-C-N 123.563 0.539 . . . . 53.140000000000001 113.347 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 248' ' ' ASP . . . . . 0.425 ' O ' ' HA ' ' A' ' 192' ' ' ASP . 10.1 m-20 -122.11 169.7 10.6 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.134 0.573 . . . . 71.299999999999997 110.734 -175.286 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 43.2 tp -136.24 107.21 6.68 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 108.356 -0.979 . . . . 61.240000000000002 108.356 168.432 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -94.46 107.4 19.37 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 108.881 -0.785 . . . . 74.299999999999997 108.881 -174.443 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.401 HD12 HD11 ' A' ' 235' ' ' LEU . 66.2 mt -110.5 113.99 27.06 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.055 0.942 . . . . 75.040000000000006 110.117 -175.335 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -79.52 116.75 19.92 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 109.218 -0.66 . . . . 72.049999999999997 109.218 173.624 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.508 HG11 HG22 ' A' ' 227' ' ' THR . 69.5 t -65.45 105.42 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 CA-C-O 121.231 0.539 . . . . 75.129999999999995 110.168 177.637 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 15.3 mmt85 -103.17 106.75 17.33 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 108.043 -1.095 . . . . 62.109999999999999 108.043 172.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.48 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 15.3 mt -74.42 119.55 22.03 Favored 'Isoleucine or valine' 0 C--N 1.352 0.716 0 N-CA-C 109.265 -0.643 . . . . 64.040000000000006 109.265 179.388 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 23.5 p . . . . . 0 C--O 1.252 1.206 0 C-N-CA 124.736 1.214 . . . . 75.420000000000002 109.213 -176.141 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 27.5 t70 . . . . . 0 N--CA 1.477 0.885 0 CA-C-O 120.835 0.35 . . . . 75.230000000000004 110.233 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.466 HG21 ' HB3' ' A' ' 234' ' ' ARG . 25.6 m -98.13 167.86 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-N 115.083 -0.962 . . . . 72.230000000000004 110.468 175.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 16.8 tt -89.11 149.59 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.004 0 N-CA-C 108.953 -0.758 . . . . 72.109999999999999 108.953 171.127 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -60.56 142.44 55.4 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.77 1.228 . . . . 72.329999999999998 112.377 -175.641 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.514 ' HB2' HD22 ' A' ' 233' ' ' LEU . . . -159.94 155.45 25.55 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.805 1.242 . . . . 70.319999999999993 109.092 174.84 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -149.98 119.77 7.08 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 123.48 0.712 . . . . 75.340000000000003 110.013 177.255 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.557 ' HE1' ' HB3' ' A' ' 238' ' ' LYS . 17.7 p90 -93.11 164.76 13.14 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 109.451 -0.574 . . . . 75.150000000000006 109.451 174.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 46.3 mttm -138.9 143.83 38.96 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 123.519 0.728 . . . . 70.519999999999996 109.507 172.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -56.71 108.91 0.38 Allowed 'Trans proline' 0 C--N 1.382 2.312 0 C-N-CA 123.742 2.961 . . . . 61.420000000000002 112.984 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' ALA . . . . . 0.653 ' HB2' ' HG3' ' A' ' 220' ' ' GLU . . . . . . . . 0 N--CA 1.483 1.201 0 C-N-CA 123.131 0.572 . . . . 54.420000000000002 110.049 174.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 23.4 mp0 . . . . . 0 N--CA 1.478 0.953 0 CA-C-O 121.799 0.809 . . . . 74.239999999999995 109.039 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 19.2 p-10 -94.63 147.95 22.77 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 114.727 -1.124 . . . . 71.109999999999999 110.509 -178.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 95.6 mt -126.26 157.78 37.42 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.638 1.175 . . . . 73.0 109.667 178.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -135.31 122.95 22.2 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.911 0.884 . . . . 70.230000000000004 108.676 176.639 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -152.67 171.22 18.52 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.005 0.922 . . . . 73.420000000000002 109.711 178.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 196' ' ' THR . . . . . 0.461 HG22 ' HB2' ' A' ' 252' ' ' GLU . 11.7 p -97.96 146.31 25.61 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.335 0.654 . . . . 71.120000000000005 109.944 173.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.561 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . 39.1 tp -114.45 111.28 21.16 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.19 0.996 . . . . 71.219999999999999 109.112 178.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -87.28 101.41 13.5 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.135 0.493 . . . . 75.010000000000005 109.899 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.481 ' HA ' HG11 ' A' ' 210' ' ' VAL . 46.9 t -102.55 121.97 47.91 Favored Pre-proline 0 CA--C 1.542 0.655 0 C-N-CA 124.379 1.071 . . . . 63.140000000000001 108.904 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -56.03 142.34 85.66 Favored 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 122.809 2.339 . . . . 65.230000000000004 111.602 170.01 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.467 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -49.48 -49.4 71.82 Favored Pre-proline 0 CA--C 1.56 1.329 0 CA-C-O 118.045 -0.979 . . . . 64.310000000000002 113.496 -179.176 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -60.05 -40.1 64.23 Favored 'Trans proline' 0 C--N 1.394 2.973 0 C-N-CA 121.995 1.797 . . . . 63.420000000000002 112.87 178.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 34.7 mt -69.2 -33.26 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 C-N-CA 123.761 0.824 . . . . 62.210000000000001 110.6 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.63 -38.03 80.21 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.414 0.685 . . . . 72.530000000000001 111.437 178.419 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 201' ' ' ALA . 99.1 t -74.13 -55.84 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.415 0.686 . . . . 74.209999999999994 110.96 -178.858 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 11.5 m -81.42 -23.37 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 N-CA-C 112.171 0.434 . . . . 74.019999999999996 112.171 -171.724 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 88.16 134.7 4.74 Favored Glycine 0 C--N 1.347 1.16 0 N-CA-C 111.378 -0.689 . . . . 63.229999999999997 111.378 -173.239 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -173.13 -147.54 5.93 Favored Glycine 0 C--N 1.338 0.692 0 N-CA-C 111.644 -0.582 . . . . 71.239999999999995 111.644 -177.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -137.02 134.89 37.08 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.22 0.608 . . . . 71.109999999999999 110.15 177.118 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.481 HG11 ' HA ' ' A' ' 199' ' ' VAL . 29.5 m -121.96 147.31 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 123.251 0.62 . . . . 75.140000000000001 109.73 179.403 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -86.68 111.89 21.11 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 116.169 -0.469 . . . . 62.340000000000003 109.767 -173.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -99.98 157.68 16.37 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.249 1.02 . . . . 63.299999999999997 109.917 177.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 2.0 mmt -105.28 108.81 20.52 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 115.336 -0.847 . . . . 65.099999999999994 109.747 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 45.4 p -109.79 -177.72 3.34 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.849 0.859 . . . . 61.329999999999998 109.039 171.614 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 19.0 mt -72.28 -26.74 62.09 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.125 0.57 . . . . 70.239999999999995 110.452 -175.679 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 10.6 mp0 -80.0 -20.54 45.2 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.27 1.028 . . . . 64.230000000000004 110.397 -178.226 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 133.46 -154.5 21.28 Favored Glycine 0 C--N 1.351 1.396 0 CA-C-O 119.56 -0.578 . . . . 53.229999999999997 112.104 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -67.83 142.18 56.63 Favored 'Trans proline' 0 C--N 1.369 1.641 0 C-N-CA 122.829 2.353 . . . . 63.520000000000003 112.313 172.221 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.435 ' HA ' ' H ' ' A' ' 178' ' ' ALA . 30.0 m -139.61 147.82 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 124.007 0.923 . . . . 74.109999999999999 109.639 175.369 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.653 ' HG3' ' HB2' ' A' ' 178' ' ' ALA . 42.5 mt-10 -100.78 109.24 21.22 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.131 0.572 . . . . 72.349999999999994 109.672 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.414 ' HA ' ' HA ' ' A' ' 175' ' ' TYR . 47.9 t -94.53 122.61 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 123.82 0.848 . . . . 74.310000000000002 109.734 -175.362 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -69.72 99.96 1.42 Allowed 'General case' 0 C--N 1.35 0.62 0 O-C-N 123.952 0.783 . . . . 52.130000000000003 110.022 177.713 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.468 HG11 HG11 ' A' ' 199' ' ' VAL . 57.9 t -77.82 121.01 83.54 Favored Pre-proline 0 C--O 1.243 0.728 0 CA-C-N 114.558 -1.201 . . . . 71.319999999999993 108.849 173.76 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -61.5 157.13 42.91 Favored 'Trans proline' 0 CA--C 1.563 1.963 0 C-N-CA 122.25 1.967 . . . . 73.540000000000006 111.97 172.693 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -66.31 144.15 73.13 Favored 'Trans proline' 0 C--N 1.372 1.788 0 C-N-CA 122.251 1.967 . . . . 53.549999999999997 111.448 172.154 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 88.6 mtt180 69.12 32.24 3.77 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 125.126 1.37 . . . . 71.099999999999994 111.367 172.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.547 HG23 ' HD2' ' A' ' 231' ' ' ARG . 97.4 m -77.32 121.6 23.96 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.451 1.1 . . . . 74.109999999999999 110.325 174.692 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -95.18 163.3 13.34 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 109.603 -0.517 . . . . 74.109999999999999 109.603 178.189 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -70.69 118.84 13.99 Favored 'General case' 0 C--N 1.348 0.51 0 CA-C-N 115.469 -0.787 . . . . 72.209999999999994 108.925 170.658 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 115.01 -1.47 22.8 Favored Glycine 0 N--CA 1.464 0.544 0 CA-C-O 119.73 -0.483 . . . . 71.340000000000003 112.518 -172.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.547 ' HD2' HG23 ' A' ' 227' ' ' THR . 38.8 mtt180 -75.55 158.52 32.4 Favored 'General case' 0 C--N 1.358 0.958 0 CA-C-O 121.451 0.643 . . . . 62.130000000000003 110.289 168.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.437 ' HG3' HG12 ' A' ' 170' ' ' VAL . 23.0 pttm -124.7 129.19 50.02 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.653 1.181 . . . . 74.219999999999999 108.731 -177.513 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.514 HD22 ' HB2' ' A' ' 173' ' ' ALA . 87.6 mt -117.91 104.16 10.65 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.966 0.907 . . . . 70.129999999999995 108.905 -178.813 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 234' ' ' ARG . . . . . 0.466 ' HB3' HG21 ' A' ' 170' ' ' VAL . 41.8 ttm180 -97.01 100.43 11.93 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 107.254 -1.388 . . . . 73.340000000000003 107.254 175.267 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 20.8 mt -73.4 84.22 1.46 Allowed 'General case' 0 C--O 1.24 0.555 0 N-CA-C 107.185 -1.413 . . . . 74.239999999999995 107.185 173.715 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 6.6 mtpm? -73.53 132.34 42.75 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 115.199 -0.91 . . . . 74.140000000000001 110.328 -172.795 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 69.01 23.5 76.03 Favored Glycine 0 C--N 1.342 0.897 0 O-C-N 123.899 0.749 . . . . 75.129999999999995 112.431 -176.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.557 ' HB3' ' HE1' ' A' ' 175' ' ' TYR . 60.8 mmtt -138.72 17.7 2.69 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.995 1.318 . . . . 73.129999999999995 111.136 -170.293 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 239' ' ' GLY . . . . . 0.464 ' HA2' ' HB2' ' A' ' 249' ' ' LEU . . . -82.18 -89.48 0.65 Allowed Glycine 0 N--CA 1.471 0.984 0 N-CA-C 110.499 -1.04 . . . . 72.239999999999995 110.499 173.78 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -95.85 120.62 62.84 Favored Pre-proline 0 N--CA 1.47 0.557 0 N-CA-C 108.339 -0.985 . . . . 73.120000000000005 108.339 167.548 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -77.82 132.01 11.59 Favored 'Trans proline' 0 C--N 1.372 1.808 0 C-N-CA 122.417 2.078 . . . . 74.450000000000003 111.41 175.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 168.29 146.69 5.06 Favored Glycine 0 C--N 1.345 1.073 0 CA-C-O 119.228 -0.762 . . . . 44.009999999999998 112.688 177.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -68.98 -18.82 40.54 Favored 'Trans proline' 0 C--N 1.376 2.001 0 C-N-CA 123.635 2.89 . . . . 61.210000000000001 114.82 -173.52 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -81.26 -28.96 34.51 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 118.403 0.547 . . . . 64.420000000000002 111.134 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -179.34 105.94 0.2 Allowed Glycine 0 C--N 1.346 1.094 0 O-C-N 123.478 0.486 . . . . 72.010000000000005 112.205 -178.562 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 61.2 mtt-85 -86.8 122.55 30.84 Favored 'General case' 0 C--N 1.349 0.577 0 N-CA-C 108.012 -1.107 . . . . 72.200000000000003 108.012 173.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -83.41 -168.12 42.82 Favored Glycine 0 N--CA 1.469 0.866 0 O-C-N 123.661 0.601 . . . . 64.409999999999997 113.945 -176.088 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -120.29 126.5 50.73 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 108.674 -0.862 . . . . 65.450000000000003 108.674 177.152 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.464 ' HB2' ' HA2' ' A' ' 239' ' ' GLY . 46.3 tp -97.77 106.3 18.59 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 106.888 -1.523 . . . . 71.329999999999998 106.888 175.684 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -99.25 122.39 42.35 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.311 -0.859 . . . . 74.25 109.034 -170.076 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.561 ' HB3' ' HB2' ' A' ' 197' ' ' LEU . 65.0 mt -123.24 122.18 37.73 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.708 0.803 . . . . 61.310000000000002 110.157 -172.268 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 252' ' ' GLU . . . . . 0.461 ' HB2' HG22 ' A' ' 196' ' ' THR . 28.2 mm-40 -90.71 109.67 20.85 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.836 0.854 . . . . 74.0 109.686 178.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.542 HG11 HG22 ' A' ' 227' ' ' THR . 84.4 t -63.48 113.74 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 CA-C-O 121.424 0.631 . . . . 63.409999999999997 111.409 -176.606 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 28.1 mmm180 -114.21 105.27 12.97 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.72 1.608 . . . . 75.349999999999994 108.02 173.411 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.405 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 39.8 mt -76.95 128.59 37.87 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 N-CA-C 110.0 -0.37 . . . . 52.439999999999998 110.0 178.671 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 19.2 p . . . . . 0 C--O 1.248 1.015 0 C-N-CA 124.793 1.237 . . . . 51.119999999999997 108.79 -176.735 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 24.7 t70 . . . . . 0 N--CA 1.472 0.672 0 N-CA-C 111.878 0.325 . . . . 73.540000000000006 111.878 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.491 HG21 ' HB3' ' A' ' 234' ' ' ARG . 25.4 m -85.43 171.96 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 O-C-N 123.755 0.659 . . . . 72.439999999999998 110.749 -179.188 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.431 HG21 ' HD3' ' A' ' 231' ' ' ARG . 15.7 tt -93.05 145.69 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 N-CA-C 109.334 -0.617 . . . . 72.230000000000004 109.334 173.326 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -60.13 129.02 39.66 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.92 1.288 . . . . 73.530000000000001 111.329 -177.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.487 ' HB2' HD22 ' A' ' 233' ' ' LEU . . . -152.18 163.06 40.17 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 124.624 1.169 . . . . 61.43 109.219 175.539 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -149.17 176.68 10.29 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 108.56 -0.904 . . . . 64.200000000000003 108.56 173.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.429 ' CE1' ' HB3' ' A' ' 238' ' ' LYS . 22.8 p90 -144.07 177.23 8.72 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 118.029 0.377 . . . . 74.209999999999994 111.244 175.051 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -136.88 131.1 17.9 Favored Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 124.031 0.933 . . . . 74.040000000000006 109.52 176.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' PRO . . . . . 0.511 ' HA ' HG12 ' A' ' 219' ' ' VAL . 44.1 Cg_endo -66.07 95.39 0.3 Allowed 'Trans proline' 0 C--N 1.369 1.637 0 C-N-CA 122.927 2.418 . . . . 65.299999999999997 111.548 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 178' ' ' ALA . . . . . 0.586 ' HB2' ' HG3' ' A' ' 220' ' ' GLU . . . . . . . . 0 N--CA 1.479 1.005 0 C-N-CA 124.1 0.96 . . . . 64.349999999999994 111.561 -176.254 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 . . . . . 0 N--CA 1.477 0.888 0 N-CA-C 109.073 -0.714 . . . . 64.209999999999994 109.073 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.44 ' HA ' ' O ' ' A' ' 248' ' ' ASP . 1.2 p30 -102.61 129.39 49.17 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.292 -0.867 . . . . 63.240000000000002 109.443 175.703 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 68.4 mt -109.18 135.35 50.44 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 108.174 -1.047 . . . . 72.099999999999994 108.174 177.299 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -120.23 121.9 39.74 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 108.227 -1.027 . . . . 72.549999999999997 108.227 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -154.29 166.35 33.45 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 123.358 0.663 . . . . 40.030000000000001 110.56 -173.202 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 4.9 m -102.24 145.12 29.89 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 109.185 -0.672 . . . . 62.329999999999998 109.185 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.529 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . 43.0 tp -119.75 121.72 39.81 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.476 0.71 . . . . 72.140000000000001 110.183 -172.231 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -83.77 115.24 22.12 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 109.349 -0.612 . . . . 75.099999999999994 109.349 173.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.532 ' HA ' HG11 ' A' ' 210' ' ' VAL . 98.1 t -119.26 110.44 37.72 Favored Pre-proline 0 CA--C 1.537 0.478 0 C-N-CA 123.98 0.912 . . . . 75.329999999999998 109.0 177.501 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -54.73 141.66 75.34 Favored 'Trans proline' 0 C--N 1.37 1.697 0 C-N-CA 122.755 2.303 . . . . 70.400000000000006 112.184 171.631 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.406 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -48.48 -47.78 68.72 Favored Pre-proline 0 CA--C 1.563 1.447 0 CA-C-O 117.784 -1.103 . . . . 74.109999999999999 113.426 177.772 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 202' ' ' PRO . . . . . 0.406 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 15.7 Cg_endo -54.79 -46.33 34.14 Favored 'Trans proline' 0 C--N 1.398 3.163 0 C-N-CA 122.3 2.0 . . . . 72.219999999999999 112.787 175.214 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.419 HG21 HG13 ' A' ' 210' ' ' VAL . 43.9 mt -68.74 -32.35 54.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 123.768 0.827 . . . . 74.5 111.115 -176.818 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -65.61 -44.9 85.1 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.251 0.62 . . . . 64.510000000000005 110.829 178.462 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 201' ' ' ALA . 60.3 t -71.35 -52.3 27.67 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-N 115.82 -0.627 . . . . 74.430000000000007 110.909 -178.35 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 14.6 m -71.49 -25.85 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 N-CA-C 111.958 0.355 . . . . 70.510000000000005 111.958 -176.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 74.15 74.5 0.84 Allowed Glycine 0 C--N 1.341 0.833 0 N-CA-C 111.674 -0.57 . . . . 62.450000000000003 111.674 -174.329 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -118.88 -164.16 12.72 Favored Glycine 0 N--CA 1.472 1.08 0 N-CA-C 111.75 -0.54 . . . . 34.439999999999998 111.75 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -103.16 142.46 34.11 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 117.434 0.617 . . . . 74.319999999999993 110.317 -179.129 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.532 HG11 ' HA ' ' A' ' 199' ' ' VAL . 22.5 m -120.73 147.15 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 124.672 1.189 . . . . 65.219999999999999 109.077 175.205 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 19.3 ttm180 -90.46 109.55 20.67 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 122.024 -0.423 . . . . 72.400000000000006 110.034 -178.07 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -100.25 158.63 15.73 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.689 1.196 . . . . 71.430000000000007 110.803 -175.508 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 2.0 mmt -105.87 108.63 20.25 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.636 0.774 . . . . 75.319999999999993 110.437 -178.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 68.7 p -111.32 175.41 5.43 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 109.434 -0.58 . . . . 75.230000000000004 109.434 170.591 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 19.3 mt -70.61 -17.82 62.88 Favored 'General case' 0 CA--C 1.55 0.978 0 CA-C-N 115.761 -0.654 . . . . 64.019999999999996 110.468 178.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -92.44 -0.32 57.37 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.868 1.267 . . . . 71.310000000000002 110.993 178.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 108.89 -161.76 13.07 Favored Glycine 0 C--N 1.349 1.264 0 C-N-CA 123.594 0.616 . . . . 74.140000000000001 113.281 175.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.46 132.16 18.66 Favored 'Trans proline' 0 C--N 1.363 1.313 0 C-N-CA 122.719 2.28 . . . . 74.430000000000007 112.864 178.398 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.511 HG12 ' HA ' ' A' ' 177' ' ' PRO . 34.2 m -130.13 160.24 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 124.344 1.058 . . . . 73.120000000000005 109.214 177.508 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.586 ' HG3' ' HB2' ' A' ' 178' ' ' ALA . 46.1 mt-10 -109.26 108.27 18.81 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.461 0.704 . . . . 73.200000000000003 110.297 178.458 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 72.9 t -92.69 116.13 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 123.363 0.665 . . . . 52.310000000000002 109.591 -176.398 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -66.57 100.45 0.67 Allowed 'General case' 0 CA--C 1.543 0.706 0 O-C-N 124.022 0.827 . . . . 52.109999999999999 109.647 174.394 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 61.1 t -75.16 131.11 78.98 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 124.944 1.297 . . . . 53.299999999999997 109.071 176.231 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 224' ' ' PRO . . . . . 0.41 ' HA ' ' HD3' ' A' ' 225' ' ' PRO . 18.4 Cg_endo -59.89 152.56 63.34 Favored 'Trans proline' 0 CA--C 1.565 2.055 0 C-N-CA 122.318 2.012 . . . . 73.430000000000007 112.76 173.575 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 225' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 224' ' ' PRO . 29.6 Cg_exo -65.49 146.44 85.06 Favored 'Trans proline' 0 C--N 1.371 1.738 0 C-N-CA 122.453 2.102 . . . . 72.329999999999998 112.88 175.623 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 35.1 mtp180 65.29 23.34 12.13 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 125.009 1.323 . . . . 75.040000000000006 112.207 174.563 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.528 HG23 ' HD2' ' A' ' 231' ' ' ARG . 4.1 m -54.81 139.13 40.75 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.612 1.165 . . . . 72.409999999999997 112.397 179.441 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -102.94 158.34 16.35 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.868 0.867 . . . . 63.539999999999999 109.816 175.368 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -73.83 131.26 41.33 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 108.893 -0.781 . . . . 72.129999999999995 108.893 172.396 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 100.2 2.22 55.81 Favored Glycine 0 N--CA 1.464 0.528 0 CA-C-O 119.197 -0.78 . . . . 71.140000000000001 112.385 -172.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.528 ' HD2' HG23 ' A' ' 227' ' ' THR . 60.5 mtt-85 -69.18 159.34 33.17 Favored 'General case' 0 C--N 1.359 1.021 0 CA-C-O 121.457 0.646 . . . . 73.030000000000001 110.338 172.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 48.9 pttt -130.86 132.93 45.48 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 114.927 -1.033 . . . . 73.120000000000005 109.727 -175.28 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.487 HD22 ' HB2' ' A' ' 173' ' ' ALA . 37.3 mt -121.47 127.3 50.94 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 108.213 -1.032 . . . . 65.409999999999997 108.213 178.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 234' ' ' ARG . . . . . 0.491 ' HB3' HG21 ' A' ' 170' ' ' VAL . 31.4 ttt180 -116.83 102.78 9.68 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 107.797 -1.186 . . . . 71.239999999999995 107.797 170.578 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.444 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 16.3 mt -83.52 84.58 7.48 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 114.948 -1.024 . . . . 75.239999999999995 109.279 -176.503 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -71.09 137.1 48.62 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.143 -0.935 . . . . 73.400000000000006 110.86 -178.325 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 67.39 16.56 67.41 Favored Glycine 0 C--N 1.352 1.425 0 O-C-N 123.987 0.804 . . . . 61.539999999999999 112.567 -177.356 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.429 ' HB3' ' CE1' ' A' ' 175' ' ' TYR . 31.3 mmtp -139.96 23.37 2.42 Favored 'General case' 0 C--O 1.217 -0.64 0 C-N-CA 124.54 1.136 . . . . 74.340000000000003 109.861 -175.297 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -89.37 -127.25 3.08 Favored Glycine 0 N--CA 1.468 0.829 0 O-C-N 121.869 -0.519 . . . . 54.0 111.899 171.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.52 147.06 62.65 Favored Pre-proline 0 N--CA 1.476 0.863 0 CA-C-O 118.326 -0.845 . . . . 71.430000000000007 110.434 176.491 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.503 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 86.2 Cg_exo -46.08 140.72 10.25 Favored 'Trans proline' 0 C--N 1.392 2.856 0 C-N-CA 123.837 3.025 . . . . 61.520000000000003 114.409 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -157.26 129.37 2.36 Favored Glycine 0 CA--C 1.536 1.353 0 CA-C-O 118.5 -1.167 . . . . 61.149999999999999 111.459 -179.192 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -62.47 -45.45 14.6 Favored 'Trans proline' 0 C--N 1.378 2.089 0 C-N-CA 123.137 2.558 . . . . 75.439999999999998 113.869 -178.381 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -78.21 -28.19 47.96 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-O 121.146 0.498 . . . . 22.149999999999999 110.461 177.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 169.52 145.92 4.85 Favored Glycine 0 C--N 1.334 0.471 0 CA-C-N 115.13 -0.941 . . . . 75.019999999999996 110.854 176.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.503 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 23.9 mtt180 -69.46 156.08 39.44 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.3 0.64 . . . . 75.340000000000003 110.665 177.737 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -73.13 -155.96 3.39 Favored Glycine 0 C--N 1.348 1.196 0 CA-C-N 116.076 -0.511 . . . . 65.109999999999999 113.218 178.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 248' ' ' ASP . . . . . 0.44 ' O ' ' HA ' ' A' ' 192' ' ' ASP . 21.6 m-20 -106.99 148.63 28.45 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.551 0.74 . . . . 61.240000000000002 110.479 179.58 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.444 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 50.0 tp -125.23 105.12 8.89 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 107.663 -1.236 . . . . 74.140000000000001 107.663 169.601 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -96.96 109.09 21.91 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 123.637 0.775 . . . . 73.109999999999999 109.527 -174.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.529 ' HB3' ' HB2' ' A' ' 197' ' ' LEU . 71.8 mt -112.84 116.36 29.93 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.119 0.968 . . . . 71.219999999999999 109.918 -178.272 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -86.64 113.64 22.68 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.644 0.778 . . . . 73.340000000000003 110.192 177.154 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.402 HG11 ' CG2' ' A' ' 227' ' ' THR . 97.0 t -65.68 125.0 21.84 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.218 0 C-N-CA 123.801 0.84 . . . . 62.32 112.314 -177.157 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 26.3 mmm180 -118.34 108.38 15.01 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.428 1.491 . . . . 74.25 107.905 170.246 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.491 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 34.6 mt -76.78 119.16 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 109.696 -0.483 . . . . 70.319999999999993 109.696 177.352 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 36.0 p . . . . . 0 CA--C 1.551 0.999 0 C-N-CA 124.437 1.095 . . . . 74.120000000000005 108.903 178.924 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 25.9 t70 . . . . . 0 N--CA 1.48 1.032 0 CA-C-O 121.772 0.796 . . . . 72.510000000000005 109.453 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.426 HG21 ' N ' ' A' ' 234' ' ' ARG . 27.1 m -107.28 -176.98 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-N 114.206 -1.361 . . . . 62.240000000000002 109.458 179.12 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 13.2 tt -84.83 139.77 17.0 Favored 'Isoleucine or valine' 0 C--O 1.246 0.891 0 N-CA-C 108.036 -1.098 . . . . 75.430000000000007 108.036 164.517 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -70.59 135.13 48.23 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 122.831 0.452 . . . . 75.230000000000004 110.065 177.348 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.452 ' HB2' HD22 ' A' ' 233' ' ' LEU . . . -138.98 175.37 9.61 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.062 0.945 . . . . 74.319999999999993 109.207 177.073 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -150.98 158.98 44.82 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 122.79 0.436 . . . . 64.219999999999999 110.337 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.532 ' HD1' HD13 ' A' ' 235' ' ' LEU . 9.8 p90 -140.63 176.12 9.05 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.346 0.593 . . . . 73.150000000000006 110.548 170.012 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -145.48 149.26 40.09 Favored Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 124.586 1.154 . . . . 71.209999999999994 108.614 170.559 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' PRO . . . . . 0.519 ' HA ' HG12 ' A' ' 219' ' ' VAL . 27.5 Cg_endo -58.24 123.79 14.42 Favored 'Trans proline' 0 C--N 1.373 1.85 0 C-N-CA 123.009 2.473 . . . . 73.209999999999994 111.99 -179.32 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 178' ' ' ALA . . . . . 0.579 ' HB2' ' HG3' ' A' ' 220' ' ' GLU . . . . . . . . 0 N--CA 1.476 0.846 0 N-CA-C 108.177 -1.046 . . . . 70.120000000000005 108.177 172.428 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.415 ' HA ' ' HB2' ' A' ' 240' ' ' PHE . 53.5 mt-30 . . . . . 0 N--CA 1.474 0.731 0 CA-C-O 120.989 0.423 . . . . 73.129999999999995 111.08 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 20.1 p-10 -85.18 126.5 33.7 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.311 0.644 . . . . 73.299999999999997 109.773 171.559 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 34.5 mt -108.9 145.07 35.97 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.191 1.396 . . . . 52.32 108.875 177.563 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -123.73 121.75 36.3 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 107.797 -1.186 . . . . 73.400000000000006 107.797 175.295 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.426 ' O ' ' HA ' ' A' ' 251' ' ' LEU . . . -149.51 165.59 31.71 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.065 0.946 . . . . 74.310000000000002 109.527 -171.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 10.5 m -108.77 140.72 41.81 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 109.969 -0.382 . . . . 74.299999999999997 109.969 -177.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.476 HD11 HG23 ' A' ' 210' ' ' VAL . 43.1 tp -108.79 121.52 45.24 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.748 0.819 . . . . 65.209999999999994 110.036 -176.319 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -93.11 103.02 15.35 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 109.161 -0.681 . . . . 62.43 109.161 172.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.56 HG21 HG11 ' A' ' 223' ' ' VAL . 2.7 p -106.57 119.52 51.4 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 123.676 0.791 . . . . 74.299999999999997 109.53 173.729 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -55.47 140.88 83.15 Favored 'Trans proline' 0 C--N 1.375 1.922 0 C-N-CA 122.331 2.021 . . . . 54.399999999999999 112.486 169.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.405 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -51.71 -49.17 84.72 Favored Pre-proline 0 CA--C 1.554 1.113 0 CA-C-O 118.077 -0.963 . . . . 73.549999999999997 113.451 -177.657 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -56.59 -39.83 88.62 Favored 'Trans proline' 0 C--N 1.39 2.724 0 C-N-CA 121.902 1.735 . . . . 54.350000000000001 112.877 176.097 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 28.4 mt -69.15 -34.28 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 123.259 0.624 . . . . 62.149999999999999 110.4 -178.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -66.33 -42.72 87.75 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.012 0.525 . . . . 72.0 111.073 178.061 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 201' ' ' ALA . 87.1 t -71.96 -49.51 44.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 123.682 0.793 . . . . 64.030000000000001 111.282 -176.24 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 16.2 m -75.01 -22.75 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 CA-C-N 116.668 -0.242 . . . . 70.450000000000003 111.496 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 76.4 76.05 0.84 Allowed Glycine 0 C--N 1.346 1.106 0 N-CA-C 112.179 -0.369 . . . . 61.520000000000003 112.179 -177.535 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -110.69 -159.18 16.42 Favored Glycine 0 C--N 1.339 0.706 0 N-CA-C 111.699 -0.561 . . . . 73.319999999999993 111.699 -179.218 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 33.7 mtmm -115.13 145.45 42.34 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 108.88 -0.785 . . . . 63.439999999999998 108.88 173.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.49 HG11 ' HA ' ' A' ' 199' ' ' VAL . 19.6 m -128.06 168.17 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 123.95 0.9 . . . . 73.109999999999999 109.829 177.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 35.4 mtp-105 -99.38 117.49 33.93 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 121.218 0.532 . . . . 73.439999999999998 110.498 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -101.02 128.09 47.22 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 107.633 -1.247 . . . . 24.449999999999999 107.633 171.671 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.25 112.1 23.06 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 109.158 -0.682 . . . . 75.409999999999997 109.158 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 69.3 p -110.39 -177.96 3.38 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.62 0.768 . . . . 65.310000000000002 109.823 177.017 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 17.4 mt -67.44 -23.48 65.53 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 122.488 0.315 . . . . 61.5 111.021 178.578 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -86.31 -19.14 30.3 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.748 0.819 . . . . 71.230000000000004 111.895 178.283 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 127.42 -151.77 18.56 Favored Glycine 0 C--N 1.345 1.043 0 CA-C-O 119.568 -0.573 . . . . 53.109999999999999 112.594 176.073 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.65 135.14 17.56 Favored 'Trans proline' 0 C--N 1.372 1.799 0 C-N-CA 122.7 2.267 . . . . 74.040000000000006 111.65 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.519 HG12 ' HA ' ' A' ' 177' ' ' PRO . 33.3 m -135.41 142.07 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 123.306 0.642 . . . . 73.030000000000001 109.813 175.349 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.579 ' HG3' ' HB2' ' A' ' 178' ' ' ALA . 43.2 mt-10 -90.49 106.74 18.7 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.028 0.531 . . . . 73.019999999999996 110.281 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.435 HG22 ' HB3' ' A' ' 175' ' ' TYR . 59.6 t -94.33 121.65 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 123.79 0.836 . . . . 60.450000000000003 109.423 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -71.19 107.95 4.46 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.257 0.623 . . . . 75.239999999999995 110.064 177.137 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.56 HG11 HG21 ' A' ' 199' ' ' VAL . 48.3 t -83.51 124.05 75.96 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 124.658 1.183 . . . . 75.049999999999997 108.897 175.703 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -58.97 152.49 57.97 Favored 'Trans proline' 0 CA--C 1.567 2.169 0 C-N-CA 122.675 2.25 . . . . 75.319999999999993 113.11 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -59.61 126.23 20.03 Favored 'Trans proline' 0 C--N 1.375 1.972 0 C-N-CA 122.511 2.141 . . . . 74.150000000000006 112.408 173.553 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 75.3 mtp180 65.52 61.58 0.69 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.97 1.308 . . . . 65.030000000000001 111.317 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.468 HG23 ' HD2' ' A' ' 231' ' ' ARG . 27.0 m -85.16 143.86 28.54 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.409 -0.814 . . . . 64.450000000000003 109.773 173.208 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -111.07 153.89 25.01 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.66 0.784 . . . . 74.349999999999994 110.863 179.384 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -70.46 135.82 48.98 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.576 0.75 . . . . 74.310000000000002 110.261 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.82 1.29 63.55 Favored Glycine 0 C--N 1.341 0.811 0 CA-C-O 119.689 -0.506 . . . . 71.310000000000002 113.174 -177.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.468 ' HD2' HG23 ' A' ' 227' ' ' THR . 52.4 mtt-85 -69.84 160.99 30.74 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 117.243 0.521 . . . . 63.420000000000002 110.551 171.705 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 20.9 pttm -126.98 135.06 50.34 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.864 -0.607 . . . . 73.510000000000005 110.603 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.452 HD22 ' HB2' ' A' ' 173' ' ' ALA . 74.4 mt -114.08 145.24 41.88 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.951 1.3 . . . . 63.399999999999999 108.173 175.77 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 234' ' ' ARG . . . . . 0.426 ' N ' HG21 ' A' ' 170' ' ' VAL . 51.7 ttt85 -136.53 102.18 4.86 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 107.952 -1.129 . . . . 74.519999999999996 107.952 166.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.532 HD13 ' HD1' ' A' ' 175' ' ' TYR . 14.8 mt -73.78 91.43 1.94 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.752 1.221 . . . . 63.32 109.433 179.368 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 51.9 mttp -62.29 124.74 21.7 Favored 'General case' 0 C--N 1.354 0.801 0 C-N-CA 123.437 0.695 . . . . 74.420000000000002 110.696 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 69.42 34.52 74.3 Favored Glycine 0 C--N 1.345 1.059 0 O-C-N 123.54 0.525 . . . . 51.340000000000003 113.061 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.487 ' HB3' ' CE1' ' A' ' 175' ' ' TYR . 32.8 mmtm -143.44 29.84 1.41 Allowed 'General case' 0 CA--C 1.559 1.321 0 C-N-CA 123.76 0.824 . . . . 74.400000000000006 112.616 -173.741 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -99.21 -111.05 3.15 Favored Glycine 0 N--CA 1.482 1.716 0 N-CA-C 111.134 -0.787 . . . . 52.119999999999997 111.134 175.739 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 240' ' ' PHE . . . . . 0.415 ' HB2' ' HA ' ' A' ' 191' ' ' GLN . 5.8 m-85 -71.19 151.88 94.57 Favored Pre-proline 0 N--CA 1.48 1.049 0 C-N-CA 123.728 0.811 . . . . 71.140000000000001 109.813 165.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.525 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 52.3 Cg_exo -57.3 155.68 28.86 Favored 'Trans proline' 0 C--N 1.373 1.838 0 C-N-CA 122.93 2.42 . . . . 54.420000000000002 112.418 165.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -162.76 125.03 1.35 Allowed Glycine 0 CA--C 1.535 1.296 0 CA-C-O 118.602 -1.11 . . . . 64.140000000000001 111.625 178.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -60.65 -49.01 9.58 Favored 'Trans proline' 0 C--N 1.381 2.237 0 C-N-CA 123.391 2.727 . . . . 74.430000000000007 112.644 177.185 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -76.31 -26.34 55.72 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 122.874 0.47 . . . . 64.519999999999996 110.692 178.091 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 165.01 145.17 4.31 Favored Glycine 0 C--N 1.344 1.005 0 CA-C-N 115.617 -0.72 . . . . 75.150000000000006 111.343 177.523 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.525 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 21.1 mtt180 -73.28 163.3 28.29 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.538 0.735 . . . . 73.099999999999994 111.127 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -81.55 -169.23 42.08 Favored Glycine 0 C--N 1.348 1.202 0 CA-C-N 115.824 -0.626 . . . . 74.450000000000003 111.768 170.424 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -107.37 152.1 24.62 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 118.003 0.902 . . . . 72.310000000000002 110.617 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 55.9 tp -120.92 106.7 11.87 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 108.706 -0.849 . . . . 61.039999999999999 108.706 173.116 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -91.37 123.66 34.97 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 123.806 0.843 . . . . 63.420000000000002 108.984 -177.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.426 ' HA ' ' O ' ' A' ' 195' ' ' ALA . 61.7 mt -119.53 122.37 41.48 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.374 0.67 . . . . 74.129999999999995 110.396 -176.846 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -81.07 114.0 19.63 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 108.975 -0.75 . . . . 71.109999999999999 108.975 172.013 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 88.4 t -66.92 109.52 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 122.905 0.482 . . . . 73.109999999999999 110.791 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 9.2 mmm180 -113.47 105.68 13.65 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 124.279 1.032 . . . . 73.209999999999994 108.848 173.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 28.9 mt -76.96 131.09 35.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-N 115.652 -0.703 . . . . 73.209999999999994 109.525 176.218 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 3.3 t . . . . . 0 CA--C 1.562 1.414 0 CA-C-O 117.849 -1.072 . . . . 62.450000000000003 108.763 -178.231 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 21.1 t70 . . . . . 0 N--CA 1.476 0.827 0 CA-C-O 120.976 0.417 . . . . 70.439999999999998 111.045 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.498 HG11 ' HB2' ' A' ' 234' ' ' ARG . 26.2 m -93.37 177.19 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 C-N-CA 123.061 0.545 . . . . 65.200000000000003 110.637 175.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.405 HG21 ' HD3' ' A' ' 231' ' ' ARG . 13.8 tt -103.17 147.59 9.37 Favored 'Isoleucine or valine' 0 C--O 1.245 0.863 0 N-CA-C 108.418 -0.956 . . . . 72.340000000000003 108.418 173.747 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -64.31 142.83 58.28 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.654 0.782 . . . . 52.439999999999998 110.656 -178.362 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.529 ' HB2' HD22 ' A' ' 233' ' ' LEU . . . -160.0 164.48 33.23 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 123.82 0.848 . . . . 53.450000000000003 109.616 -178.264 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -157.25 157.67 34.71 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.703 0.801 . . . . 73.019999999999996 109.665 -178.357 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.489 ' HD1' HD13 ' A' ' 235' ' ' LEU . 5.5 p90 -135.97 178.01 7.38 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.232 0.539 . . . . 75.530000000000001 111.537 177.124 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 176' ' ' LYS . . . . . 0.555 ' HE2' ' HA ' ' A' ' 176' ' ' LYS . 7.9 mmpt? -132.7 135.31 25.87 Favored Pre-proline 0 N--CA 1.472 0.632 0 C-N-CA 124.691 1.197 . . . . 73.219999999999999 108.924 174.757 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 177' ' ' PRO . . . . . 0.519 ' HA ' HG12 ' A' ' 219' ' ' VAL . 48.1 Cg_endo -65.86 94.96 0.28 Allowed 'Trans proline' 0 C--N 1.377 2.05 0 C-N-CA 122.74 2.294 . . . . 72.019999999999996 111.127 178.037 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 178' ' ' ALA . . . . . 0.58 ' H ' ' HA ' ' A' ' 219' ' ' VAL . . . . . . . . 0 N--CA 1.479 1.004 0 C-N-CA 124.371 1.068 . . . . 74.109999999999999 111.543 -177.111 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 . . . . . 0 N--CA 1.48 1.062 0 CA-C-O 121.184 0.516 . . . . 61.439999999999998 111.155 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.407 ' HA ' ' O ' ' A' ' 248' ' ' ASP . 6.7 p-10 -91.19 151.28 21.01 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 115.673 -0.694 . . . . 73.230000000000004 109.901 175.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 79.7 mt -132.76 130.79 40.39 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.792 0.837 . . . . 71.340000000000003 109.084 173.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -96.71 125.48 41.21 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 108.337 -0.986 . . . . 74.549999999999997 108.337 174.296 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.458 ' O ' ' HA ' ' A' ' 251' ' ' LEU . . . -148.63 143.23 26.41 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.408 0.683 . . . . 74.25 109.336 178.026 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 2.4 p -89.92 132.36 35.35 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 109.079 -0.712 . . . . 71.519999999999996 109.079 171.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.575 HD13 ' HB2' ' A' ' 212' ' ' ALA . 62.3 tp -107.3 110.96 23.1 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.81 0.844 . . . . 74.439999999999998 108.972 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -85.08 128.46 34.66 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-O 120.962 0.411 . . . . 75.209999999999994 109.918 175.472 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.514 ' HA ' HG11 ' A' ' 210' ' ' VAL . 3.1 p -133.29 123.67 17.85 Favored Pre-proline 0 CA--C 1.545 0.773 0 CA-C-N 114.775 -1.102 . . . . 71.129999999999995 108.954 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -57.61 143.15 95.51 Favored 'Trans proline' 0 C--N 1.37 1.662 0 C-N-CA 122.585 2.19 . . . . 71.549999999999997 111.653 171.166 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.431 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -50.42 -46.45 84.39 Favored Pre-proline 0 CA--C 1.563 1.443 0 CA-C-O 117.782 -1.104 . . . . 70.150000000000006 112.993 -178.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -55.51 -44.62 46.67 Favored 'Trans proline' 0 C--N 1.395 2.977 0 C-N-CA 122.3 2.0 . . . . 74.219999999999999 113.088 174.55 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.473 HG21 HG13 ' A' ' 210' ' ' VAL . 45.4 mt -68.4 -32.03 53.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 C-N-CA 123.467 0.707 . . . . 61.210000000000001 110.598 -178.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.42 -44.02 75.91 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.224 0.61 . . . . 74.349999999999994 110.957 178.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 201' ' ' ALA . 93.1 t -70.43 -48.19 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 123.532 0.733 . . . . 72.0 111.217 -177.601 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 7.2 p -72.47 -30.37 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 CA-C-O 120.601 0.239 . . . . 74.319999999999993 110.998 -179.121 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 78.76 67.57 1.59 Allowed Glycine 0 C--N 1.352 1.423 0 N-CA-C 111.637 -0.585 . . . . 43.020000000000003 111.637 -174.776 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -98.95 -145.71 19.1 Favored Glycine 0 C--N 1.352 1.444 0 N-CA-C 111.449 -0.66 . . . . 74.310000000000002 111.449 -177.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -120.73 146.68 46.22 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.561 0.745 . . . . 63.32 109.078 173.731 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.514 HG11 ' HA ' ' A' ' 199' ' ' VAL . 7.1 m -139.9 155.36 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 C-N-CA 124.679 1.192 . . . . 53.439999999999998 109.211 171.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 14.7 ttp180 -91.22 119.55 31.4 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-O 120.805 0.336 . . . . 72.109999999999999 111.126 -170.395 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 212' ' ' ALA . . . . . 0.575 ' HB2' HD13 ' A' ' 197' ' ' LEU . . . -100.53 151.78 21.17 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.969 0.907 . . . . 43.310000000000002 108.951 172.146 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -107.15 116.46 31.97 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 123.599 0.76 . . . . 73.239999999999995 110.222 -178.052 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 24.6 p -109.72 172.24 6.97 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.21 1.004 . . . . 72.409999999999997 108.631 172.417 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 17.5 mt -74.02 -5.9 44.22 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 122.819 0.448 . . . . 62.32 111.958 -176.062 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 216' ' ' GLU . . . . . 0.409 ' H ' ' HG2' ' A' ' 216' ' ' GLU . 6.2 pt-20 -107.16 -9.64 16.09 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.756 1.223 . . . . 75.230000000000004 111.349 -177.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 139.65 -165.92 25.72 Favored Glycine 0 C--N 1.352 1.439 0 CA-C-O 120.151 -0.25 . . . . 34.32 113.526 175.045 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.66 142.65 23.22 Favored 'Trans proline' 0 C--N 1.369 1.627 0 C-N-CA 123.225 2.617 . . . . 75.25 112.466 176.02 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.58 ' HA ' ' H ' ' A' ' 178' ' ' ALA . 24.8 m -137.29 143.58 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 123.849 0.86 . . . . 73.450000000000003 109.733 176.583 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.407 ' HG3' ' HB2' ' A' ' 178' ' ' ALA . 46.4 mt-10 -97.3 114.65 26.45 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 118.27 0.487 . . . . 74.540000000000006 109.78 175.653 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.446 HG22 ' HB3' ' A' ' 175' ' ' TYR . 52.9 t -95.47 126.02 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.277 1.031 . . . . 71.310000000000002 109.679 179.674 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -75.46 106.3 6.94 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 123.315 0.646 . . . . 53.340000000000003 109.397 175.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 44.9 t -68.39 132.09 91.53 Favored Pre-proline 0 CA--C 1.552 1.028 0 C-N-CA 124.417 1.087 . . . . 63.520000000000003 109.525 175.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -59.78 144.86 99.37 Favored 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 122.455 2.103 . . . . 63.229999999999997 111.853 173.132 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_exo -62.12 129.66 27.93 Favored 'Trans proline' 0 C--N 1.375 1.961 0 C-N-CA 122.667 2.245 . . . . 52.329999999999998 111.689 176.371 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 62.7 mtp180 67.33 79.18 0.23 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.247 1.419 . . . . 72.349999999999994 110.086 179.44 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.566 ' HA ' ' HE ' ' A' ' 231' ' ' ARG . 13.3 m -107.52 141.16 39.39 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 114.231 -1.35 . . . . 74.219999999999999 110.684 -177.663 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 24.5 mp0 -118.11 147.23 43.5 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.356 1.062 . . . . 74.219999999999999 108.382 174.214 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -60.26 125.2 22.78 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.123 0.969 . . . . 72.329999999999998 110.571 -178.321 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 113.38 4.38 23.63 Favored Glycine 0 C--N 1.34 0.805 0 CA-C-O 119.537 -0.591 . . . . 74.430000000000007 113.12 -175.203 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.566 ' HE ' ' HA ' ' A' ' 227' ' ' THR . 72.4 mtt-85 -65.73 148.23 52.09 Favored 'General case' 0 C--N 1.363 1.162 0 N-CA-C 109.249 -0.649 . . . . 73.239999999999995 109.249 167.316 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 18.9 pttm -124.84 117.08 23.32 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.971 -1.122 . . . . 63.420000000000002 107.971 176.687 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.529 HD22 ' HB2' ' A' ' 173' ' ' ALA . 30.6 mt -103.89 97.42 7.42 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 108.066 -1.087 . . . . 71.030000000000001 108.066 -179.466 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 234' ' ' ARG . . . . . 0.498 ' HB2' HG11 ' A' ' 170' ' ' VAL . 40.6 ttt180 -93.54 101.13 13.3 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 108.823 -0.806 . . . . 75.230000000000004 108.823 177.82 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.492 ' HB3' ' HB2' ' A' ' 238' ' ' LYS . 21.8 mt -82.92 83.92 7.61 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.481 -1.236 . . . . 64.200000000000003 109.669 -174.133 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 55.4 mttp -62.75 137.63 58.31 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 116.098 -0.501 . . . . 60.420000000000002 110.082 177.272 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 64.59 23.66 68.93 Favored Glycine 0 C--N 1.347 1.151 0 O-C-N 123.679 0.612 . . . . 64.319999999999993 113.004 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.492 ' HB2' ' HB3' ' A' ' 235' ' ' LEU . 45.7 mmtm -140.51 16.86 2.37 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.308 1.043 . . . . 63.0 111.247 -176.201 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -93.47 -116.99 2.62 Favored Glycine 0 N--CA 1.467 0.741 0 N-CA-C 111.568 -0.613 . . . . 70.420000000000002 111.568 179.119 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -71.45 130.29 87.73 Favored Pre-proline 0 CA--C 1.546 0.817 0 CA-C-O 118.619 -0.705 . . . . 72.439999999999998 109.781 179.191 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.479 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 22.2 Cg_endo -60.41 129.16 28.58 Favored 'Trans proline' 0 C--N 1.373 1.824 0 C-N-CA 123.154 2.569 . . . . 71.5 112.533 175.616 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -150.81 135.44 5.16 Favored Glycine 0 CA--C 1.532 1.103 0 CA-C-O 118.651 -1.083 . . . . 71.439999999999998 110.557 179.395 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -61.73 -41.67 37.08 Favored 'Trans proline' 0 C--N 1.382 2.331 0 C-N-CA 123.54 2.827 . . . . 53.219999999999999 112.746 -176.595 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -78.01 -26.64 48.61 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.177 0.591 . . . . 73.239999999999995 111.258 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 169.24 148.11 5.69 Favored Glycine 0 C--N 1.347 1.172 0 N-CA-C 111.457 -0.657 . . . . 63.219999999999999 111.457 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.479 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 36.4 mtt-85 -86.45 161.37 18.66 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 122.769 0.428 . . . . 65.409999999999997 110.148 178.079 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -81.84 -155.86 15.99 Favored Glycine 0 C--N 1.34 0.785 0 CA-C-N 115.591 -0.732 . . . . 51.299999999999997 112.368 172.641 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 248' ' ' ASP . . . . . 0.407 ' O ' ' HA ' ' A' ' 192' ' ' ASP . 6.5 p-10 -118.45 131.53 56.26 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.442 0.697 . . . . 75.230000000000004 110.381 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 58.5 tp -98.16 106.89 19.24 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 107.76 -1.2 . . . . 53.43 107.76 173.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -89.3 108.58 19.7 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 115.496 -0.775 . . . . 74.319999999999993 109.053 -177.136 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.558 HD13 HD22 ' A' ' 197' ' ' LEU . 63.6 mt -103.13 139.35 38.76 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.79 0.836 . . . . 65.340000000000003 110.096 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -111.44 108.79 18.47 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.63 -0.878 . . . . 72.340000000000003 108.63 172.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 72.5 t -66.5 109.37 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 C-N-CA 123.922 0.889 . . . . 74.400000000000006 111.33 -178.609 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 31.5 mmm180 -108.52 102.95 11.99 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.381 1.472 . . . . 63.450000000000003 108.312 177.069 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 30.4 mt -77.14 142.78 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 N-CA-C 109.855 -0.424 . . . . 64.439999999999998 109.855 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.9 t . . . . . 0 CA--C 1.558 1.277 0 C-N-CA 124.092 0.957 . . . . 70.049999999999997 109.207 176.377 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 25.5 t70 . . . . . 0 N--CA 1.474 0.758 0 CA-C-O 121.069 0.461 . . . . 71.329999999999998 110.053 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.492 HG21 ' HB3' ' A' ' 234' ' ' ARG . 15.4 m -97.41 161.7 2.78 Favored 'Isoleucine or valine' 0 C--O 1.247 0.942 0 CA-C-N 114.905 -1.043 . . . . 74.340000000000003 109.188 172.149 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 12.6 tt -85.63 151.96 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 N-CA-C 108.92 -0.771 . . . . 63.329999999999998 108.92 174.006 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -56.15 128.81 37.36 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.471 1.109 . . . . 74.329999999999998 110.961 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.466 ' HB2' HD22 ' A' ' 233' ' ' LEU . . . -158.66 143.95 16.37 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.258 1.023 . . . . 74.209999999999994 109.754 179.111 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -146.56 169.13 19.58 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 108.244 -1.021 . . . . 74.239999999999995 108.244 172.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.511 ' CE1' ' HB3' ' A' ' 238' ' ' LYS . 37.5 p90 -129.61 -177.81 4.42 Favored 'General case' 0 C--O 1.243 0.733 0 CA-C-O 121.739 0.781 . . . . 74.430000000000007 111.65 -176.166 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 11.9 mmmm -132.61 122.03 17.59 Favored Pre-proline 0 C--O 1.232 0.178 0 CA-C-N 114.368 -1.287 . . . . 74.400000000000006 107.536 174.424 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' PRO . . . . . 0.411 ' HA ' HG12 ' A' ' 219' ' ' VAL . 57.3 Cg_endo -66.92 93.71 0.33 Allowed 'Trans proline' 0 C--N 1.359 1.105 0 C-N-CA 122.856 2.371 . . . . 73.430000000000007 111.63 -177.816 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 178' ' ' ALA . . . . . 0.452 ' HB2' ' HG3' ' A' ' 220' ' ' GLU . . . . . . . . 0 CA--C 1.542 0.658 0 N-CA-C 109.45 -0.574 . . . . 54.039999999999999 109.45 179.097 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.401 ' HA ' ' HB2' ' A' ' 240' ' ' PHE . 25.5 mm-40 . . . . . 0 N--CA 1.478 0.927 0 N-CA-C 110.152 -0.314 . . . . 64.040000000000006 110.152 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -95.09 154.21 17.28 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 122.726 0.41 . . . . 61.149999999999999 110.74 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 33.3 mt -128.09 156.33 42.99 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.147 0.979 . . . . 70.209999999999994 109.863 175.324 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -130.5 121.91 26.67 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.892 0.877 . . . . 74.230000000000004 108.716 173.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -149.6 167.35 26.61 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 124.003 0.921 . . . . 53.130000000000003 109.58 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 17.7 m -112.14 137.04 50.77 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.779 -0.646 . . . . 70.0 109.4 -178.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 43.8 tp -108.92 122.13 46.57 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.181 0.992 . . . . 74.510000000000005 110.117 -170.77 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -87.45 104.64 16.65 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.566 0.746 . . . . 72.0 109.613 176.665 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.537 ' HA ' HG11 ' A' ' 210' ' ' VAL . 59.7 t -109.21 113.74 58.51 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 123.489 0.716 . . . . 72.5 109.436 174.123 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -58.56 141.84 97.72 Favored 'Trans proline' 0 C--N 1.379 2.17 0 C-N-CA 123.039 2.493 . . . . 64.200000000000003 111.937 171.047 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -51.6 -45.51 91.1 Favored Pre-proline 0 CA--C 1.562 1.419 0 N-CA-C 113.931 1.086 . . . . 31.0 113.931 -176.054 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -55.37 -47.09 27.76 Favored 'Trans proline' 0 C--N 1.391 2.775 0 C-N-CA 121.957 1.771 . . . . 70.319999999999993 113.184 173.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 56.6 mt -66.86 -29.82 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 123.641 0.776 . . . . 75.329999999999998 110.734 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.8 -46.77 67.82 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.585 0.754 . . . . 71.109999999999999 111.486 179.376 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 85.5 t -66.44 -54.43 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 115.937 -0.574 . . . . 63.240000000000002 110.501 -178.78 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 18.2 m -69.47 -30.44 45.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 N-CA-C 112.072 0.397 . . . . 73.239999999999995 112.072 -177.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 74.68 68.3 1.58 Allowed Glycine 0 C--N 1.345 1.038 0 O-C-N 123.431 0.457 . . . . 71.439999999999998 112.28 -176.165 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -97.58 -126.51 5.43 Favored Glycine 0 C--N 1.348 1.222 0 N-CA-C 111.74 -0.544 . . . . 44.439999999999998 111.74 -178.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 49.1 mtmt -131.55 158.93 39.64 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.741 0.816 . . . . 71.319999999999993 108.982 171.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.537 HG11 ' HA ' ' A' ' 199' ' ' VAL . 6.0 m -136.77 137.29 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 123.545 0.738 . . . . 43.219999999999999 109.917 174.542 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 51.1 ttt-85 -83.58 109.04 17.08 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 108.913 -0.773 . . . . 73.010000000000005 108.913 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -101.12 155.26 18.1 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.493 1.117 . . . . 64.349999999999994 110.213 -177.012 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 16.1 mmt -105.62 118.45 36.61 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.022 0.929 . . . . 51.240000000000002 109.349 178.766 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 70.7 p -116.65 179.24 4.06 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.803 0.441 . . . . 72.019999999999996 109.825 170.584 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 20.8 mt -62.97 -36.15 82.52 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.752 -0.658 . . . . 71.129999999999995 111.091 -177.587 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -93.69 -20.14 20.44 Favored 'General case' 0 CA--C 1.554 1.1 0 CA-C-N 115.295 -0.866 . . . . 72.409999999999997 111.643 -170.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 155.56 177.73 29.09 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 120.881 -0.676 . . . . 43.439999999999998 114.183 177.55 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -64.5 142.11 76.68 Favored 'Trans proline' 0 C--N 1.376 1.975 0 C-N-CA 123.001 2.467 . . . . 73.120000000000005 112.513 174.5 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.411 HG12 ' HA ' ' A' ' 177' ' ' PRO . 34.4 m -139.3 128.49 29.34 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 C-N-CA 123.311 0.644 . . . . 74.409999999999997 109.84 179.405 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.452 ' HG3' ' HB2' ' A' ' 178' ' ' ALA . 36.7 mt-10 -83.42 104.02 13.24 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 109.778 -0.453 . . . . 72.5 109.778 177.808 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 48.1 t -93.49 118.13 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 109.121 -0.696 . . . . 74.129999999999995 109.121 -177.592 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -71.87 107.21 4.52 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 123.25 0.62 . . . . 72.109999999999999 110.16 -179.555 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 60.5 t -70.97 130.29 88.49 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 124.556 1.142 . . . . 74.519999999999996 109.709 -179.429 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -63.73 140.08 72.4 Favored 'Trans proline' 0 C--N 1.373 1.868 0 C-N-CA 122.387 2.058 . . . . 62.25 112.246 174.037 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -60.38 133.54 49.82 Favored 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 122.342 2.028 . . . . 70.430000000000007 111.758 174.393 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 82.1 mtt180 68.85 72.5 0.27 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.938 1.295 . . . . 73.049999999999997 109.795 -176.157 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.735 ' HA ' ' HE ' ' A' ' 231' ' ' ARG . 38.9 m -94.22 140.13 30.16 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 114.784 -1.098 . . . . 73.200000000000003 110.085 176.01 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 24.2 mp0 -113.29 145.48 40.99 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 124.054 0.942 . . . . 73.420000000000002 108.738 174.272 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 229' ' ' ALA . . . . . 0.474 ' HB2' ' HB ' ' A' ' 255' ' ' ILE . . . -64.33 117.09 6.73 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.369 0.668 . . . . 62.530000000000001 109.587 178.435 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 108.47 9.74 26.64 Favored Glycine 0 CA--C 1.526 0.746 0 CA-C-O 119.426 -0.652 . . . . 55.409999999999997 112.565 -173.305 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.735 ' HE ' ' HA ' ' A' ' 227' ' ' THR . 57.5 mtt-85 -63.45 150.0 44.72 Favored 'General case' 0 C--N 1.361 1.072 0 N-CA-C 109.348 -0.612 . . . . 74.319999999999993 109.348 166.21 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 19.6 pttm -121.91 138.91 54.22 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 123.217 0.607 . . . . 65.409999999999997 109.762 174.283 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.466 HD22 ' HB2' ' A' ' 173' ' ' ALA . 57.4 mt -123.9 137.26 54.66 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.588 1.155 . . . . 65.340000000000003 108.221 177.814 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 234' ' ' ARG . . . . . 0.492 ' HB3' HG21 ' A' ' 170' ' ' VAL . 52.8 ttm-85 -128.75 102.41 6.55 Favored 'General case' 0 C--O 1.243 0.72 0 N-CA-C 108.734 -0.839 . . . . 73.310000000000002 108.734 176.114 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.44 HD13 ' CD1' ' A' ' 175' ' ' TYR . 17.0 mt -83.9 89.52 7.23 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.019 0.927 . . . . 71.409999999999997 109.361 -174.678 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -73.78 131.58 41.71 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.532 -0.758 . . . . 73.439999999999998 110.971 -175.281 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 66.81 24.82 72.98 Favored Glycine 0 C--N 1.35 1.348 0 O-C-N 123.858 0.724 . . . . 74.430000000000007 112.972 -178.333 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.511 ' HB3' ' CE1' ' A' ' 175' ' ' TYR . 32.1 mmtp -140.23 39.49 1.92 Allowed 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.038 0.935 . . . . 70.25 110.581 -172.521 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -120.85 -120.62 2.77 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-N 116.228 -0.442 . . . . 64.329999999999998 112.232 174.164 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 240' ' ' PHE . . . . . 0.401 ' HB2' ' HA ' ' A' ' 191' ' ' GLN . 2.9 m-85 -69.19 147.75 97.45 Favored Pre-proline 0 N--CA 1.49 1.557 0 C-N-CA 123.78 0.832 . . . . 74.340000000000003 111.684 178.417 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.504 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 22.6 Cg_endo -59.97 134.02 54.07 Favored 'Trans proline' 0 C--N 1.387 2.602 0 C-N-CA 123.329 2.686 . . . . 73.049999999999997 113.455 -179.545 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -151.04 131.74 3.62 Favored Glycine 0 CA--C 1.54 1.62 0 N-CA-C 110.287 -1.125 . . . . 62.210000000000001 110.287 179.389 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -65.27 -45.99 6.52 Favored 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 123.266 2.644 . . . . 74.530000000000001 113.69 -170.55 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -86.72 11.8 12.22 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 122.855 0.462 . . . . 73.450000000000003 111.828 -178.676 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 133.56 139.87 4.26 Favored Glycine 0 C--N 1.341 0.829 0 N-CA-C 109.766 -1.334 . . . . 62.100000000000001 109.766 -174.138 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.504 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 23.4 mtm180 -78.14 170.73 16.13 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-O 121.025 0.44 . . . . 71.030000000000001 111.248 -175.641 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.52 -156.93 8.45 Favored Glycine 0 C--N 1.344 1.027 0 CA-C-N 115.281 -0.872 . . . . 63.5 112.775 172.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -116.73 160.95 20.0 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.537 0.335 . . . . 73.230000000000004 111.148 -170.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 38.8 tp -140.66 106.87 5.23 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 108.258 -1.016 . . . . 73.540000000000006 108.258 173.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -94.98 116.31 28.53 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 109.277 -0.638 . . . . 74.209999999999994 109.277 -175.781 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 60.5 mt -116.13 117.99 31.61 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.542 0.737 . . . . 74.340000000000003 109.792 -178.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -89.74 112.4 23.67 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.65 0.78 . . . . 73.010000000000005 109.598 177.143 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.487 HG11 HG21 ' A' ' 227' ' ' THR . 60.2 t -71.2 118.79 16.44 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 CA-C-O 121.497 0.665 . . . . 50.420000000000002 112.059 -176.101 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 29.6 mmm180 -108.16 115.7 30.61 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 125.101 1.36 . . . . 73.329999999999998 108.293 170.247 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.474 ' HB ' ' HB2' ' A' ' 229' ' ' ALA . 30.5 mt -76.18 128.09 37.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 108.437 -0.949 . . . . 60.340000000000003 108.437 170.188 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 6.8 t . . . . . 0 CA--C 1.558 1.274 0 CA-C-O 117.427 -1.273 . . . . 64.040000000000006 107.927 -176.382 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 36.1 t70 . . . . . 0 N--CA 1.471 0.623 0 N-CA-C 109.743 -0.466 . . . . 73.329999999999998 109.743 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 33.3 m -109.67 -175.74 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 C-N-CA 124.586 1.155 . . . . 71.310000000000002 110.472 179.012 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 14.9 tt -91.94 144.7 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 N-CA-C 107.873 -1.158 . . . . 54.439999999999998 107.873 165.128 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -63.36 140.27 58.86 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.463 0.705 . . . . 60.119999999999997 112.745 -172.094 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.401 ' HB2' HD22 ' A' ' 233' ' ' LEU . . . -153.29 153.55 32.86 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.876 1.27 . . . . 74.219999999999999 108.494 171.607 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -147.42 156.5 42.93 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 108.244 -1.021 . . . . 62.229999999999997 108.244 172.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.442 ' CZ ' ' HB3' ' A' ' 238' ' ' LYS . 12.4 p90 -136.7 168.28 19.82 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.585 0.587 . . . . 74.030000000000001 112.585 179.078 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -140.25 150.11 60.33 Favored Pre-proline 0 N--CA 1.477 0.901 0 C-N-CA 125.042 1.337 . . . . 73.409999999999997 108.158 176.87 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 177' ' ' PRO . . . . . 0.492 ' HA ' HG12 ' A' ' 219' ' ' VAL . 38.8 Cg_endo -65.21 109.35 1.32 Allowed 'Trans proline' 0 C--N 1.374 1.885 0 C-N-CA 122.174 1.916 . . . . 72.439999999999998 110.909 179.395 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.03 0 C-N-CA 124.302 1.041 . . . . 52.310000000000002 111.382 -175.089 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.532 ' HB3' ' HA3' ' A' ' 247' ' ' GLY . 39.7 mt-30 . . . . . 0 N--CA 1.476 0.858 0 CA-C-O 120.527 0.204 . . . . 72.319999999999993 111.006 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -80.69 152.05 28.61 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.494 0.717 . . . . 63.229999999999997 111.107 177.108 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 13.5 mt -132.57 143.12 49.49 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.744 1.218 . . . . 73.230000000000004 108.707 168.307 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -111.8 135.39 52.48 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 106.474 -1.676 . . . . 65.239999999999995 106.474 166.081 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -159.73 171.61 19.22 Favored 'General case' 0 C--N 1.327 -0.382 0 O-C-N 123.696 0.622 . . . . 55.109999999999999 109.746 179.046 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 26.5 m -113.31 142.35 45.94 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.453 -0.943 . . . . 71.299999999999997 108.453 179.079 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.438 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . 51.2 tp -109.31 121.66 45.66 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 109.339 -0.615 . . . . 62.219999999999999 109.339 179.504 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -82.6 134.26 35.18 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 109.001 -0.74 . . . . 63.140000000000001 109.001 167.462 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.44 ' HA ' HG11 ' A' ' 210' ' ' VAL . 4.2 p -143.03 121.27 7.2 Favored Pre-proline 0 CA--C 1.539 0.553 0 N-CA-C 108.429 -0.952 . . . . 65.150000000000006 108.429 175.812 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.22 142.29 87.36 Favored 'Trans proline' 0 C--N 1.366 1.48 0 C-N-CA 122.58 2.186 . . . . 74.129999999999995 112.12 175.051 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -49.4 -45.87 77.43 Favored Pre-proline 0 CA--C 1.558 1.259 0 C-N-CA 123.729 0.812 . . . . 62.219999999999999 113.065 178.444 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -53.9 -55.16 3.73 Favored 'Trans proline' 0 C--N 1.397 3.103 0 C-N-CA 122.273 1.982 . . . . 75.420000000000002 113.109 171.724 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 52.3 mt -63.66 -30.45 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 C-N-CA 123.304 0.642 . . . . 74.409999999999997 111.779 -177.178 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.73 -42.41 74.01 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 122.949 0.5 . . . . 53.340000000000003 111.443 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 97.2 t -73.66 -54.48 15.16 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 C-N-CA 123.138 0.575 . . . . 73.109999999999999 111.107 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 14.8 m -76.74 -22.03 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 N-CA-C 112.03 0.382 . . . . 73.430000000000007 112.03 -174.242 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 86.67 170.59 47.02 Favored Glycine 0 C--N 1.348 1.239 0 N-CA-C 112.047 -0.421 . . . . 41.530000000000001 112.047 -174.082 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 145.96 -129.14 3.29 Favored Glycine 0 C--N 1.333 0.397 0 N-CA-C 111.071 -0.812 . . . . 35.5 111.071 175.094 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -139.73 158.51 43.98 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.883 0.873 . . . . 74.340000000000003 109.709 176.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.44 HG11 ' HA ' ' A' ' 199' ' ' VAL . 18.7 m -138.51 155.43 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 123.722 0.809 . . . . 73.450000000000003 109.535 171.466 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 48.2 mtm180 -82.72 127.85 33.81 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 109.353 -0.61 . . . . 54.520000000000003 109.353 173.849 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -116.36 146.38 42.51 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 124.373 1.069 . . . . 72.420000000000002 109.156 179.043 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 5.2 mmt -94.81 110.05 21.96 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 109.321 -0.622 . . . . 62.219999999999999 109.321 177.588 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 38.4 p -119.63 174.93 6.11 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 123.838 0.855 . . . . 71.129999999999995 109.416 174.302 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 215' ' ' LEU . . . . . 0.433 HD12 ' CE1' ' A' ' 240' ' ' PHE . 15.5 mt -78.72 -2.1 37.72 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 116.298 -0.41 . . . . 73.540000000000006 111.681 -177.241 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -100.67 -4.8 27.61 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.868 0.867 . . . . 73.230000000000004 110.936 171.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 114.67 -160.53 13.15 Favored Glycine 0 C--N 1.356 1.686 0 C-N-CA 123.611 0.624 . . . . 62.439999999999998 112.806 178.121 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.33 131.8 19.7 Favored 'Trans proline' 0 C--N 1.375 1.924 0 C-N-CA 122.771 2.314 . . . . 63.210000000000001 112.503 175.58 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.492 HG12 ' HA ' ' A' ' 177' ' ' PRO . 31.6 m -134.81 139.84 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 123.586 0.754 . . . . 52.229999999999997 110.484 -178.46 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -87.04 105.69 17.33 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 122.66 0.384 . . . . 75.200000000000003 110.139 178.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 76.8 t -92.5 117.66 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 N-CA-C 108.543 -0.91 . . . . 62.219999999999999 108.543 179.091 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -65.6 101.65 0.63 Allowed 'General case' 0 C--O 1.24 0.569 0 O-C-N 124.322 1.014 . . . . 74.540000000000006 110.254 178.48 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 63.0 t -77.84 117.98 69.26 Favored Pre-proline 0 CA--C 1.543 0.682 0 O-C-N 124.613 1.196 . . . . 64.329999999999998 108.823 174.604 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -65.31 151.62 84.68 Favored 'Trans proline' 0 CA--C 1.559 1.769 0 C-N-CA 122.033 1.822 . . . . 74.329999999999998 111.602 170.387 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_exo -63.62 141.53 80.07 Favored 'Trans proline' 0 C--N 1.373 1.867 0 C-N-CA 122.555 2.17 . . . . 70.329999999999998 112.357 178.331 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 51.7 mtm180 62.93 49.07 3.67 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.786 1.234 . . . . 71.439999999999998 110.638 176.485 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.536 HG22 HG11 ' A' ' 253' ' ' VAL . 55.3 m -98.85 109.2 22.0 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 114.271 -1.331 . . . . 65.230000000000004 109.244 173.287 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -85.47 161.49 19.37 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.606 -0.725 . . . . 64.219999999999999 111.773 -175.003 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -69.15 124.43 23.79 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.765 0.826 . . . . 74.310000000000002 110.084 177.398 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 111.43 -9.82 28.5 Favored Glycine 0 N--CA 1.471 0.992 0 O-C-N 123.306 0.378 . . . . 74.230000000000004 112.411 -175.133 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 66.0 mtt180 -70.15 162.69 27.84 Favored 'General case' 0 C--N 1.35 0.622 0 CA-C-O 121.532 0.682 . . . . 72.549999999999997 111.046 170.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 18.7 pttm -121.58 143.53 49.25 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 114.957 -1.02 . . . . 74.239999999999995 110.305 -177.109 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.401 HD22 ' HB2' ' A' ' 173' ' ' ALA . 93.1 mt -125.35 142.66 51.37 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.748 1.219 . . . . 74.239999999999995 108.325 174.277 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 65.8 ttt180 -133.18 124.27 27.14 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 108.22 -1.03 . . . . 72.109999999999999 108.22 -179.473 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.435 ' HB3' ' HG3' ' A' ' 238' ' ' LYS . 26.6 mt -120.88 84.04 2.17 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.671 0.788 . . . . 72.219999999999999 109.455 -166.117 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -79.32 140.01 37.66 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.875 0.87 . . . . 62.399999999999999 110.726 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 70.27 26.98 73.45 Favored Glycine 0 C--N 1.347 1.174 0 O-C-N 123.828 0.705 . . . . 45.020000000000003 112.336 -176.437 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.442 ' HB3' ' CZ ' ' A' ' 175' ' ' TYR . 8.0 mmpt? -128.75 -48.34 1.25 Allowed 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.982 0.913 . . . . 60.0 111.583 -172.122 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -55.39 -102.42 0.01 OUTLIER Glycine 0 CA--C 1.549 2.162 0 N-CA-C 116.25 1.26 . . . . 53.539999999999999 116.25 -164.376 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 240' ' ' PHE . . . . . 0.433 ' CE1' HD12 ' A' ' 215' ' ' LEU . 0.7 OUTLIER -84.17 153.41 62.88 Favored Pre-proline 0 N--CA 1.485 1.292 0 C-N-CA 123.098 0.559 . . . . 72.510000000000005 110.181 177.301 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.546 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 18.2 Cg_endo -56.28 154.27 29.81 Favored 'Trans proline' 0 C--N 1.373 1.86 0 C-N-CA 123.813 3.009 . . . . 73.230000000000004 114.076 170.851 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -165.23 143.55 8.56 Favored Glycine 0 CA--C 1.535 1.34 0 CA-C-O 119.017 -0.88 . . . . 62.140000000000001 111.974 175.497 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -63.7 -45.13 11.73 Favored 'Trans proline' 0 C--N 1.382 2.323 0 C-N-CA 123.372 2.715 . . . . 63.119999999999997 113.096 179.71 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -80.38 -26.18 38.73 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 122.747 0.419 . . . . 72.219999999999999 110.946 -179.508 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 166.73 160.02 13.29 Favored Glycine 0 C--N 1.336 0.536 0 N-CA-C 111.029 -0.828 . . . . 61.43 111.029 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.546 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 23.9 mtm180 -78.81 160.67 27.26 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 122.547 0.339 . . . . 61.229999999999997 110.682 -179.337 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 247' ' ' GLY . . . . . 0.532 ' HA3' ' HB3' ' A' ' 191' ' ' GLN . . . -88.02 -155.82 29.6 Favored Glycine 0 C--N 1.344 0.98 0 CA-C-N 115.833 -0.621 . . . . 65.310000000000002 113.529 -175.522 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -102.47 155.59 18.16 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.125 0.57 . . . . 72.510000000000005 109.826 -175.427 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 36.6 tp -136.73 115.75 12.37 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 107.829 -1.175 . . . . 74.150000000000006 107.829 168.355 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -100.04 107.96 20.03 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.009 -0.737 . . . . 62.340000000000003 109.009 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.438 ' HB3' ' HB2' ' A' ' 197' ' ' LEU . 43.0 mt -102.33 121.06 41.54 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.61 0.764 . . . . 55.539999999999999 110.225 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -91.23 115.52 28.09 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 109.361 -0.607 . . . . 74.120000000000005 109.361 174.108 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.536 HG11 HG22 ' A' ' 227' ' ' THR . 85.2 t -62.42 127.94 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.533 1.133 . . . . 52.310000000000002 111.751 -176.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -131.39 116.21 17.24 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.717 1.207 . . . . 75.540000000000006 107.942 172.532 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 34.9 mt -77.51 126.61 38.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 O-C-N 123.769 0.668 . . . . 75.230000000000004 109.653 176.483 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 25.7 p . . . . . 0 C--O 1.254 1.313 0 N-CA-C 108.314 -0.995 . . . . 72.310000000000002 108.314 173.083 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 34.7 t70 . . . . . 0 N--CA 1.478 0.927 0 N-CA-C 110.285 -0.265 . . . . 54.240000000000002 110.285 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.48 HG21 ' HB3' ' A' ' 234' ' ' ARG . 14.0 m -95.99 176.43 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 123.49 0.716 . . . . 73.109999999999999 111.037 -178.647 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 17.7 tt -96.35 138.32 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 N-CA-C 107.611 -1.255 . . . . 72.239999999999995 107.611 162.398 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -71.87 145.64 48.43 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.761 0.824 . . . . 71.340000000000003 111.268 -174.005 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.411 ' HB2' HD22 ' A' ' 233' ' ' LEU . . . -155.58 178.16 10.56 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.587 1.155 . . . . 73.420000000000002 109.74 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -156.32 152.16 27.3 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.751 0.82 . . . . 34.030000000000001 109.962 178.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.438 ' CD1' HD13 ' A' ' 235' ' ' LEU . 33.0 p90 -129.04 168.01 16.68 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 121.139 0.495 . . . . 72.420000000000002 110.863 175.003 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -145.26 150.45 44.89 Favored Pre-proline 0 CA--C 1.548 0.885 0 CA-C-N 114.635 -1.166 . . . . 75.310000000000002 109.078 176.556 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -57.78 110.59 0.65 Allowed 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 123.604 2.869 . . . . 71.019999999999996 112.91 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 178' ' ' ALA . . . . . 0.46 ' HB2' ' HG3' ' A' ' 220' ' ' GLU . . . . . . . . 0 N--CA 1.482 1.134 0 C-N-CA 123.581 0.753 . . . . 52.229999999999997 111.236 -178.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.479 ' HA ' ' HB2' ' A' ' 240' ' ' PHE . 83.5 mm-40 . . . . . 0 N--CA 1.47 0.531 0 N-CA-C 108.434 -0.951 . . . . 55.030000000000001 108.434 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -93.63 158.65 15.59 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 115.992 -0.549 . . . . 74.340000000000003 110.046 174.263 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 93.8 mt -136.25 149.97 48.75 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.03 0.932 . . . . 71.409999999999997 109.024 176.15 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -123.68 123.38 40.41 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.746 0.818 . . . . 73.329999999999998 108.819 173.583 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -157.44 170.92 21.35 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.19 0.596 . . . . 75.409999999999997 110.653 179.155 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 19.3 p -96.3 152.44 18.58 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.719 0.808 . . . . 74.109999999999999 109.822 174.686 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.696 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . 34.6 tp -116.77 114.42 23.95 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.392 0.677 . . . . 75.420000000000002 109.978 -176.69 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -74.97 100.74 4.23 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 109.366 -0.605 . . . . 73.540000000000006 109.366 176.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.485 ' HA ' HG11 ' A' ' 210' ' ' VAL . 54.8 t -110.6 110.5 57.56 Favored Pre-proline 0 N--CA 1.473 0.677 0 N-CA-C 108.807 -0.812 . . . . 62.420000000000002 108.807 177.011 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -53.33 138.35 64.67 Favored 'Trans proline' 0 C--N 1.379 2.133 0 C-N-CA 122.741 2.294 . . . . 74.140000000000001 111.626 173.182 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -46.13 -47.97 43.53 Favored Pre-proline 0 CA--C 1.569 1.679 0 N-CA-C 113.798 1.036 . . . . 61.409999999999997 113.798 -178.052 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -54.3 -46.16 35.59 Favored 'Trans proline' 0 C--N 1.4 3.249 0 C-N-CA 122.627 2.218 . . . . 70.120000000000005 112.557 174.492 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 49.9 mt -68.88 -30.12 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 124.148 0.979 . . . . 73.049999999999997 111.063 -176.036 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.55 -39.85 80.89 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 122.956 0.503 . . . . 64.340000000000003 111.197 177.264 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 88.3 t -70.96 -52.63 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 123.489 0.716 . . . . 74.329999999999998 111.089 179.154 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 18.5 m -80.0 -29.68 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 CA-C-N 116.046 -0.525 . . . . 60.25 112.379 -172.46 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 83.95 103.8 0.56 Allowed Glycine 0 C--N 1.345 1.079 0 O-C-N 123.554 0.533 . . . . 70.120000000000005 112.772 -176.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -158.7 178.43 34.91 Favored Glycine 0 C--N 1.342 0.896 0 N-CA-C 112.175 -0.37 . . . . 64.299999999999997 112.175 -178.797 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.535 ' HB3' ' HB3' ' A' ' 220' ' ' GLU . 34.6 mtmm -82.79 148.51 27.76 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 122.917 0.487 . . . . 41.520000000000003 111.364 -178.499 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.485 HG11 ' HA ' ' A' ' 199' ' ' VAL . 32.8 m -136.6 147.86 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 C-N-CA 123.93 0.892 . . . . 52.439999999999998 110.156 176.314 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 11.3 mtm180 -82.02 111.47 18.21 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-O 121.216 0.531 . . . . 75.109999999999999 111.521 -178.439 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -102.0 142.69 32.89 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 125.005 1.322 . . . . 64.120000000000005 109.167 171.045 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 34.2 tpp -100.88 116.3 32.42 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 122.763 0.425 . . . . 75.549999999999997 109.854 176.363 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 81.0 p -110.69 -178.59 3.52 Favored 'General case' 0 C--O 1.247 0.926 0 C-N-CA 124.101 0.96 . . . . 42.140000000000001 109.424 177.403 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 14.9 mt -77.32 -5.53 49.87 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 122.924 0.49 . . . . 60.119999999999997 110.609 -177.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -102.31 -19.23 15.09 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.332 1.053 . . . . 74.129999999999995 110.65 177.59 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 133.07 -160.35 23.86 Favored Glycine 0 C--N 1.356 1.69 0 CA-C-O 119.954 -0.359 . . . . 72.329999999999998 113.305 176.349 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -78.09 126.64 7.96 Favored 'Trans proline' 0 C--N 1.376 1.998 0 C-N-CA 123.172 2.581 . . . . 71.409999999999997 111.772 -179.551 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.455 ' HA ' ' H ' ' A' ' 178' ' ' ALA . 28.1 m -132.54 143.49 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 124.123 0.969 . . . . 73.150000000000006 109.489 -178.723 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.535 ' HB3' ' HB3' ' A' ' 209' ' ' LYS . 35.0 mt-10 -101.82 115.77 31.26 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.901 0.481 . . . . 75.299999999999997 110.484 176.166 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 24.1 t -95.64 116.46 37.33 Favored 'Isoleucine or valine' 0 C--N 1.346 0.413 0 C-N-CA 124.507 1.123 . . . . 65.519999999999996 109.138 -177.756 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -64.51 100.79 0.39 Allowed 'General case' 0 C--O 1.239 0.544 0 O-C-N 124.156 0.91 . . . . 72.409999999999997 110.109 174.534 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.403 HG11 HG11 ' A' ' 199' ' ' VAL . 21.3 t -82.73 127.73 68.96 Favored Pre-proline 0 N--CA 1.47 0.531 0 CA-C-N 114.927 -1.033 . . . . 74.510000000000005 108.652 177.283 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -61.46 156.79 44.65 Favored 'Trans proline' 0 CA--C 1.559 1.766 0 C-N-CA 122.277 1.985 . . . . 64.299999999999997 112.418 173.182 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -70.45 161.53 45.7 Favored 'Trans proline' 0 C--N 1.373 1.865 0 C-N-CA 122.388 2.058 . . . . 71.239999999999995 112.136 173.581 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 72.5 mtm-85 58.25 33.54 23.24 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.38 1.072 . . . . 74.25 111.782 175.15 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.638 HG23 ' HD2' ' A' ' 231' ' ' ARG . 25.5 m -92.72 126.57 37.87 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.397 1.079 . . . . 75.420000000000002 110.154 -178.382 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -93.8 162.18 14.03 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.361 0.664 . . . . 63.530000000000001 111.158 -178.309 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 229' ' ' ALA . . . . . 0.474 ' HB2' ' HB ' ' A' ' 255' ' ' ILE . . . -71.82 119.22 15.68 Favored 'General case' 0 C--N 1.35 0.613 0 CA-C-N 115.177 -0.919 . . . . 64.120000000000005 109.324 174.075 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 114.82 -2.7 23.01 Favored Glycine 0 C--N 1.333 0.366 0 CA-C-O 119.527 -0.596 . . . . 50.119999999999997 112.414 -174.505 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.638 ' HD2' HG23 ' A' ' 227' ' ' THR . 91.3 mtt180 -74.81 161.15 29.85 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-N 117.45 0.625 . . . . 73.219999999999999 110.209 170.343 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.483 ' HD2' ' OH ' ' A' ' 250' ' ' TYR . 20.8 pttm -129.06 134.53 48.14 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.875 0.87 . . . . 74.540000000000006 109.768 -176.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.411 HD22 ' HB2' ' A' ' 173' ' ' ALA . 73.8 mt -111.5 126.79 55.35 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.065 -1.087 . . . . 74.5 108.065 175.06 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 234' ' ' ARG . . . . . 0.48 ' HB3' HG21 ' A' ' 170' ' ' VAL . 54.3 ttm-85 -108.37 102.91 11.98 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 107.324 -1.361 . . . . 72.439999999999998 107.324 170.368 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.438 HD13 ' CD1' ' A' ' 175' ' ' TYR . 20.3 mt -79.1 91.06 4.87 Favored 'General case' 0 C--O 1.245 0.835 0 N-CA-C 108.104 -1.073 . . . . 74.019999999999996 108.104 179.457 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.438 ' HA ' ' OD2' ' A' ' 248' ' ' ASP . 90.8 mttt -72.97 122.97 22.57 Favored 'General case' 0 C--O 1.243 0.762 0 CA-C-N 113.711 -1.586 . . . . 72.420000000000002 111.771 -170.059 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 64.87 27.4 72.09 Favored Glycine 0 C--N 1.346 1.094 0 O-C-N 123.864 0.727 . . . . 72.510000000000005 111.658 -176.074 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.438 ' HB3' ' CE1' ' A' ' 175' ' ' TYR . 30.5 mmtp -140.65 59.35 1.55 Allowed 'General case' 0 C--O 1.22 -0.481 0 C-N-CA 124.858 1.263 . . . . 71.109999999999999 108.083 -175.528 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -120.39 -131.47 4.11 Favored Glycine 0 N--CA 1.467 0.725 0 N-CA-C 109.914 -1.274 . . . . 42.329999999999998 109.914 165.772 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 240' ' ' PHE . . . . . 0.479 ' HB2' ' HA ' ' A' ' 191' ' ' GLN . 4.3 m-85 -60.17 146.23 83.77 Favored Pre-proline 0 N--CA 1.484 1.245 0 C-N-CA 123.408 0.683 . . . . 74.019999999999996 111.537 173.602 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.597 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 37.5 Cg_endo -63.13 132.02 34.83 Favored 'Trans proline' 0 C--N 1.381 2.284 0 C-N-CA 123.146 2.564 . . . . 72.219999999999999 112.435 179.327 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -141.94 136.11 7.13 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-O 118.329 -1.261 . . . . 74.510000000000005 110.523 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -57.2 -53.86 4.3 Favored 'Trans proline' 0 C--N 1.378 2.105 0 C-N-CA 123.493 2.795 . . . . 72.310000000000002 113.762 -176.55 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -81.97 -26.44 33.92 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 122.964 0.505 . . . . 64.129999999999995 111.362 -178.685 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -177.63 140.47 4.77 Favored Glycine 0 C--N 1.341 0.812 0 N-CA-C 111.352 -0.699 . . . . 44.130000000000003 111.352 -177.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.597 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 57.4 mtm180 -78.87 169.46 18.19 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.221 0.609 . . . . 74.340000000000003 110.536 177.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -78.55 -159.7 14.61 Favored Glycine 0 C--N 1.339 0.718 0 CA-C-N 116.137 -0.483 . . . . 60.240000000000002 112.299 175.56 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 248' ' ' ASP . . . . . 0.438 ' OD2' ' HA ' ' A' ' 236' ' ' LYS . 27.7 m-20 -125.69 127.5 46.33 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 109.836 -0.431 . . . . 74.049999999999997 109.836 178.624 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 58.3 tp -100.74 109.63 21.67 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 108.159 -1.052 . . . . 40.409999999999997 108.159 177.013 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 250' ' ' TYR . . . . . 0.483 ' OH ' ' HD2' ' A' ' 232' ' ' LYS . 33.9 t80 -98.07 108.38 21.08 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.497 -0.774 . . . . 74.129999999999995 109.082 -174.371 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.696 ' HB3' ' HB2' ' A' ' 197' ' ' LEU . 69.9 mt -121.3 106.71 11.73 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.85 0.86 . . . . 60.409999999999997 110.336 -174.732 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 252' ' ' GLU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 232' ' ' LYS . 53.5 mt-10 -80.29 110.99 16.25 Favored 'General case' 0 C--O 1.241 0.605 0 CA-C-N 115.177 -0.92 . . . . 63.32 110.365 178.441 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.475 HG11 HG22 ' A' ' 227' ' ' THR . 95.2 t -57.58 113.58 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 124.048 0.939 . . . . 53.43 111.363 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 28.7 mmm180 -113.22 116.18 29.37 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 107.241 -1.392 . . . . 70.400000000000006 107.241 169.749 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.474 ' HB ' ' HB2' ' A' ' 229' ' ' ALA . 58.1 mt -76.24 123.19 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 122.988 0.515 . . . . 74.319999999999993 109.78 -179.434 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.2 t . . . . . 0 CA--C 1.559 1.318 0 N-CA-C 107.802 -1.185 . . . . 75.129999999999995 107.802 175.031 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 29.0 t70 . . . . . 0 N--CA 1.475 0.781 0 CA-C-O 120.851 0.358 . . . . 72.420000000000002 110.438 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.446 HG21 ' HB3' ' A' ' 234' ' ' ARG . 35.5 m -79.04 155.61 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 109.72 -0.474 . . . . 71.109999999999999 109.72 173.823 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 12.7 tt -81.59 141.51 15.01 Favored 'Isoleucine or valine' 0 C--O 1.243 0.756 0 N-CA-C 108.99 -0.744 . . . . 71.319999999999993 108.99 173.039 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -62.97 133.17 54.21 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.208 1.003 . . . . 72.230000000000004 111.524 -172.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.499 ' HB2' HD22 ' A' ' 233' ' ' LEU . . . -147.52 171.33 15.72 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 124.594 1.158 . . . . 73.040000000000006 110.038 177.17 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -157.75 151.85 24.43 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.4 1.08 . . . . 75.049999999999997 108.374 176.386 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.43 ' HD1' HD13 ' A' ' 235' ' ' LEU . 6.4 p90 -128.3 167.02 17.51 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 109.898 -0.408 . . . . 70.25 109.898 172.375 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -140.67 136.41 16.43 Favored Pre-proline 0 N--CA 1.471 0.599 0 C-N-CA 123.281 0.632 . . . . 72.230000000000004 109.859 169.265 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 177' ' ' PRO . . . . . 0.534 ' HA ' HG12 ' A' ' 219' ' ' VAL . 13.7 Cg_endo -55.07 113.16 1.27 Allowed 'Trans proline' 0 C--N 1.378 2.088 0 C-N-CA 123.646 2.897 . . . . 73.430000000000007 112.881 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 178' ' ' ALA . . . . . 0.635 ' HB2' ' HG3' ' A' ' 220' ' ' GLU . . . . . . . . 0 N--CA 1.478 0.97 0 C-N-CA 123.735 0.814 . . . . 64.219999999999999 112.007 -175.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.501 ' HB3' ' HA3' ' A' ' 247' ' ' GLY . 77.1 mt-30 . . . . . 0 N--CA 1.479 0.99 0 CA-C-O 121.052 0.453 . . . . 75.140000000000001 111.507 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.517 ' HB3' ' HE1' ' A' ' 194' ' ' TYR . 4.1 m-20 -79.77 114.79 18.96 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 114.654 -1.157 . . . . 55.530000000000001 109.718 -179.434 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 69.0 mt -112.27 135.97 52.29 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 108.808 -0.812 . . . . 73.349999999999994 108.808 172.803 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 194' ' ' TYR . . . . . 0.517 ' HE1' ' HB3' ' A' ' 192' ' ' ASP . 46.3 m-85 -129.05 122.99 31.14 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 108.648 -0.871 . . . . 62.439999999999998 108.648 -178.718 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.408 ' O ' ' HA ' ' A' ' 251' ' ' LEU . . . -154.78 162.91 40.93 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 121.57 0.7 . . . . 55.200000000000003 110.333 -176.674 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 19.8 p -97.47 141.16 30.87 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-N 115.436 -0.802 . . . . 60.109999999999999 109.188 174.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.585 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . 45.7 tp -108.48 113.15 25.95 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.613 -0.721 . . . . 70.030000000000001 110.044 -175.345 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -79.32 99.89 7.32 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 109.22 -0.659 . . . . 62.539999999999999 109.22 178.451 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 43.1 t -106.86 118.43 54.21 Favored Pre-proline 0 N--CA 1.467 0.42 0 CA-C-N 115.334 -0.848 . . . . 71.109999999999999 108.721 176.03 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -54.74 143.25 70.96 Favored 'Trans proline' 0 C--N 1.371 1.747 0 C-N-CA 122.415 2.076 . . . . 74.239999999999995 111.796 169.422 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.413 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -53.75 -44.41 97.92 Favored Pre-proline 0 CA--C 1.562 1.413 0 CA-C-O 118.03 -0.986 . . . . 54.039999999999999 112.454 179.012 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 202' ' ' PRO . . . . . 0.413 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 13.7 Cg_endo -55.7 -47.17 26.71 Favored 'Trans proline' 0 C--N 1.403 3.412 0 C-N-CA 122.543 2.162 . . . . 73.540000000000006 111.97 172.712 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 33.2 mt -70.82 -24.73 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 C-N-CA 123.291 0.636 . . . . 73.010000000000005 111.238 -176.846 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -73.48 -41.72 62.78 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.169 0.588 . . . . 75.239999999999995 110.513 178.054 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 98.0 t -69.3 -55.24 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 123.616 0.767 . . . . 73.340000000000003 110.985 178.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 8.8 p -73.18 -31.62 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 C-N-CA 122.767 0.427 . . . . 74.340000000000003 111.507 -175.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 78.9 95.03 0.28 Allowed Glycine 0 C--N 1.345 1.062 0 N-CA-C 112.131 -0.388 . . . . 52.539999999999999 112.131 -175.449 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -141.21 -177.76 16.76 Favored Glycine 0 N--CA 1.467 0.765 0 N-CA-C 111.544 -0.622 . . . . 54.130000000000003 111.544 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.45 ' HD2' ' HB3' ' A' ' 220' ' ' GLU . 46.0 mtmt -84.17 137.09 33.7 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 109.443 -0.577 . . . . 74.310000000000002 109.443 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 26.8 m -119.75 157.51 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 123.775 0.83 . . . . 60.329999999999998 109.082 170.183 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 78.4 mtm180 -86.41 119.46 26.7 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 109.667 -0.494 . . . . 72.140000000000001 109.667 172.428 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -101.47 140.01 36.35 Favored 'General case' 0 C--O 1.245 0.848 0 C-N-CA 124.311 1.044 . . . . 73.140000000000001 108.273 174.351 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.66 103.23 15.15 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.435 -0.95 . . . . 71.219999999999999 108.435 -178.694 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 47.5 p -111.73 177.76 4.54 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.997 0.919 . . . . 71.519999999999996 109.86 -179.624 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 11.2 mt -67.67 -27.76 67.12 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 122.973 0.509 . . . . 72.439999999999998 110.916 -176.29 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -82.66 -18.92 39.33 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.994 0.918 . . . . 72.299999999999997 111.408 179.285 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 129.08 -154.28 20.2 Favored Glycine 0 C--N 1.353 1.489 0 CA-C-O 119.501 -0.61 . . . . 54.5 112.746 178.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -73.32 133.86 19.94 Favored 'Trans proline' 0 C--N 1.374 1.887 0 C-N-CA 122.722 2.281 . . . . 74.329999999999998 111.78 175.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.534 HG12 ' HA ' ' A' ' 177' ' ' PRO . 26.9 m -133.29 147.61 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 123.581 0.752 . . . . 75.340000000000003 110.164 177.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.635 ' HG3' ' HB2' ' A' ' 178' ' ' ALA . 48.3 mt-10 -90.73 106.02 18.22 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.143 0.577 . . . . 61.420000000000002 110.028 178.685 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 61.6 t -94.72 113.71 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 N-CA-C 109.096 -0.705 . . . . 63.350000000000001 109.096 176.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -68.02 100.04 0.94 Allowed 'General case' 0 C--O 1.242 0.658 0 O-C-N 124.028 0.83 . . . . 73.109999999999999 109.229 173.594 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.462 HG11 HG11 ' A' ' 199' ' ' VAL . 25.5 t -79.7 124.53 83.52 Favored Pre-proline 0 C--O 1.24 0.591 0 C-N-CA 123.884 0.874 . . . . 63.119999999999997 109.046 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -55.83 146.49 66.92 Favored 'Trans proline' 0 C--N 1.374 1.9 0 C-N-CA 122.485 2.124 . . . . 70.219999999999999 112.574 174.569 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -67.4 150.68 80.84 Favored 'Trans proline' 0 C--N 1.373 1.862 0 C-N-CA 122.144 1.896 . . . . 71.049999999999997 112.62 175.758 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 61.58 37.74 16.02 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 124.904 1.281 . . . . 75.209999999999994 111.705 177.238 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 45.5 m -96.96 116.01 28.45 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.816 0.846 . . . . 60.420000000000002 110.622 -178.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 24.1 mp0 -86.18 165.7 16.33 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.771 0.828 . . . . 63.43 111.287 -178.32 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -70.49 133.67 47.03 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 114.799 -1.091 . . . . 72.209999999999994 109.46 176.253 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 112.68 -24.95 12.51 Favored Glycine 0 C--N 1.334 0.461 0 N-CA-C 111.441 -0.664 . . . . 53.149999999999999 111.441 -176.519 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 60.6 mtt180 -63.82 160.65 16.93 Favored 'General case' 0 C--N 1.36 1.038 0 C-N-CA 123.504 0.722 . . . . 72.400000000000006 111.526 178.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 16.1 pttm -130.21 134.42 47.26 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.202 1.001 . . . . 71.230000000000004 110.145 -171.716 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.499 HD22 ' HB2' ' A' ' 173' ' ' ALA . 58.5 mt -120.0 100.24 7.1 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.648 1.179 . . . . 64.129999999999995 108.524 179.663 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 234' ' ' ARG . . . . . 0.446 ' HB3' HG21 ' A' ' 170' ' ' VAL . 67.8 ttt180 -93.92 101.1 13.16 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 108.5 -0.926 . . . . 52.530000000000001 108.5 177.831 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.463 HD11 HD12 ' A' ' 251' ' ' LEU . 21.3 mt -79.14 83.35 5.21 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.187 0.995 . . . . 54.0 109.343 -178.448 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -79.3 140.97 37.41 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.529 0.732 . . . . 73.340000000000003 110.628 -177.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 65.41 24.82 71.02 Favored Glycine 0 C--N 1.349 1.26 0 O-C-N 124.045 0.841 . . . . 34.420000000000002 111.65 -174.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -130.33 -26.01 2.37 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.713 0.805 . . . . 75.200000000000003 110.859 -174.213 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -67.96 -145.53 0.12 Allowed Glycine 0 C--N 1.358 1.751 0 O-C-N 123.653 0.596 . . . . 62.140000000000001 113.718 -175.052 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 240' ' ' PHE . . . . . 0.494 ' HB3' ' HA ' ' A' ' 191' ' ' GLN . 0.1 OUTLIER -67.06 120.68 73.8 Favored Pre-proline 0 CA--C 1.552 1.055 0 O-C-N 122.369 -0.489 . . . . 74.209999999999994 110.912 -173.21 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.564 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 15.7 Cg_exo -70.67 160.19 50.25 Favored 'Trans proline' 0 C--N 1.385 2.499 0 C-N-CA 123.746 2.964 . . . . 63.130000000000003 115.499 -173.518 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -159.43 164.26 33.89 Favored Glycine 0 CA--C 1.532 1.095 0 CA-C-N 113.188 -1.824 . . . . 70.519999999999996 110.43 175.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -70.51 -23.31 27.53 Favored 'Trans proline' 0 C--N 1.37 1.685 0 C-N-CA 122.945 2.43 . . . . 70.409999999999997 113.291 -177.422 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -89.42 -27.08 20.65 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.227 0.611 . . . . 72.430000000000007 110.783 177.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 166.95 -170.12 41.21 Favored Glycine 0 C--N 1.349 1.269 0 N-CA-C 112.183 -0.367 . . . . 22.109999999999999 112.183 -178.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.564 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 26.6 mtm180 -117.92 155.36 30.34 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.875 0.87 . . . . 71.400000000000006 110.412 -177.382 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 247' ' ' GLY . . . . . 0.501 ' HA3' ' HB3' ' A' ' 191' ' ' GLN . . . -86.84 -156.13 28.59 Favored Glycine 0 C--N 1.343 0.951 0 CA-C-N 115.706 -0.679 . . . . 75.109999999999999 111.952 171.674 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -122.56 154.26 38.16 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 121.287 0.565 . . . . 60.219999999999999 110.894 176.575 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.404 ' HG ' ' HG ' ' A' ' 251' ' ' LEU . 41.4 tp -116.77 107.28 14.45 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 107.485 -1.302 . . . . 64.209999999999994 107.485 170.143 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -90.75 105.75 18.04 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.77 0.828 . . . . 75.420000000000002 108.773 -176.771 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.585 ' HB3' ' HB2' ' A' ' 197' ' ' LEU . 49.5 mt -109.71 106.73 16.49 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.498 1.119 . . . . 55.030000000000001 110.654 -177.726 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -82.81 115.63 21.79 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 109.62 -0.511 . . . . 74.310000000000002 109.62 176.402 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 61.6 t -60.03 104.55 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 124.425 1.09 . . . . 64.140000000000001 111.455 -177.49 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 21.3 mmm180 -101.56 107.13 18.32 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 125.115 1.366 . . . . 60.310000000000002 107.997 171.68 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.469 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 48.3 mt -77.43 132.39 32.8 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 CA-C-O 120.913 0.387 . . . . 45.399999999999999 110.512 178.58 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 3.1 t . . . . . 0 C--O 1.251 1.16 0 C-N-CA 124.766 1.226 . . . . 65.409999999999997 109.294 177.805 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 169' ' ' ASP . . . . . 0.498 ' O ' ' HE3' ' A' ' 232' ' ' LYS . 23.1 t70 . . . . . 0 N--CA 1.479 1.007 0 N-CA-C 110.08 -0.341 . . . . 75.439999999999998 110.08 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 29.3 m -113.04 157.92 13.57 Favored 'Isoleucine or valine' 0 C--O 1.244 0.797 0 C-N-CA 123.752 0.821 . . . . 63.420000000000002 110.491 178.129 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 15.5 tt -81.15 147.03 6.58 Favored 'Isoleucine or valine' 0 C--O 1.248 0.979 0 N-CA-C 107.398 -1.334 . . . . 73.319999999999993 107.398 166.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -57.58 123.82 16.91 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.196 0.598 . . . . 75.310000000000002 110.761 -178.542 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.491 ' HB2' HD22 ' A' ' 233' ' ' LEU . . . -146.64 159.05 43.94 Favored 'General case' 0 C--O 1.244 0.789 0 CA-C-N 115.102 -0.954 . . . . 75.049999999999997 109.649 177.334 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -158.95 163.03 36.87 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.037 -0.983 . . . . 71.519999999999996 108.964 179.196 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.539 ' HD1' HD13 ' A' ' 235' ' ' LEU . 16.8 p90 -135.21 170.89 15.23 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-O 121.402 0.62 . . . . 71.319999999999993 111.406 176.557 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -137.27 141.15 33.06 Favored Pre-proline 0 CA--C 1.542 0.671 0 CA-C-N 113.584 -1.643 . . . . 72.030000000000001 107.734 173.099 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 177' ' ' PRO . . . . . 0.431 ' HA ' HG12 ' A' ' 219' ' ' VAL . 32.1 Cg_exo -59.13 117.55 4.3 Favored 'Trans proline' 0 CA--C 1.551 1.372 0 C-N-CA 123.196 2.597 . . . . 62.530000000000001 111.707 179.502 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 178' ' ' ALA . . . . . 0.507 ' HB2' ' HG3' ' A' ' 220' ' ' GLU . . . . . . . . 0 N--CA 1.488 1.459 0 CA-C-O 121.85 0.833 . . . . 73.219999999999999 109.662 -177.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.412 ' HA ' ' HB2' ' A' ' 240' ' ' PHE . 77.2 mt-30 . . . . . 0 N--CA 1.481 1.082 0 CA-C-O 120.94 0.4 . . . . 60.399999999999999 111.036 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -76.06 129.65 37.16 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 115.216 -0.902 . . . . 74.409999999999997 108.951 174.503 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 42.5 mt -116.94 147.1 42.54 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.731 1.212 . . . . 74.299999999999997 108.72 173.337 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -139.81 122.25 16.13 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.086 0.955 . . . . 73.219999999999999 108.92 -175.182 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.403 ' O ' ' HA ' ' A' ' 251' ' ' LEU . . . -163.1 169.03 20.05 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.009 0.524 . . . . 50.210000000000001 111.002 -175.778 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 8.7 p -95.56 149.74 21.1 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.54 0.736 . . . . 71.540000000000006 109.782 171.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.552 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . 38.4 tp -112.85 113.69 25.88 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.657 0.783 . . . . 64.019999999999996 109.926 -178.312 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -73.79 109.26 7.16 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 123.37 0.668 . . . . 74.129999999999995 109.76 174.057 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.451 ' HA ' HG11 ' A' ' 210' ' ' VAL . 89.5 t -118.83 120.37 31.55 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 108.716 -0.846 . . . . 74.549999999999997 108.716 175.61 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_exo -55.96 142.81 84.42 Favored 'Trans proline' 0 C--N 1.368 1.561 0 C-N-CA 123.147 2.565 . . . . 65.230000000000004 112.06 169.431 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.404 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -52.04 -46.18 93.15 Favored Pre-proline 0 CA--C 1.556 1.205 0 C-N-CA 124.512 1.125 . . . . 25.530000000000001 113.847 -179.149 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 202' ' ' PRO . . . . . 0.468 ' O ' HG12 ' A' ' 206' ' ' VAL . 12.7 Cg_endo -55.0 -50.43 13.25 Favored 'Trans proline' 0 C--N 1.394 2.923 0 C-N-CA 122.147 1.898 . . . . 70.109999999999999 112.835 173.543 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 36.6 mt -63.55 -30.43 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 123.842 0.857 . . . . 64.420000000000002 111.443 -177.505 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.44 -48.24 61.53 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.212 0.605 . . . . 71.319999999999993 111.407 177.564 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 201' ' ' ALA . 86.5 t -67.04 -52.57 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 C-N-CA 123.461 0.704 . . . . 71.129999999999995 111.605 -175.547 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.468 HG12 ' O ' ' A' ' 202' ' ' PRO . 12.9 p -82.54 -30.13 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 C-N-CA 122.613 0.365 . . . . 72.400000000000006 111.466 -176.339 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 89.13 126.58 2.85 Favored Glycine 0 C--N 1.349 1.297 0 N-CA-C 111.76 -0.536 . . . . 72.230000000000004 111.76 -175.342 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -159.65 -141.97 3.27 Favored Glycine 0 C--N 1.341 0.831 0 CA-C-O 119.997 -0.335 . . . . 73.120000000000005 112.425 -177.175 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm -134.68 134.2 40.86 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 108.555 -0.906 . . . . 63.009999999999998 108.555 175.578 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.451 HG11 ' HA ' ' A' ' 199' ' ' VAL . 35.1 m -119.5 163.07 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 C-N-CA 123.994 0.918 . . . . 52.409999999999997 108.823 173.255 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 80.2 mtm180 -98.79 123.65 43.17 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 121.324 0.583 . . . . 64.239999999999995 110.459 175.39 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -100.71 137.28 39.32 Favored 'General case' 0 C--O 1.246 0.899 0 CA-C-N 114.934 -1.03 . . . . 72.25 108.77 179.279 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 18.9 mmt -83.02 108.52 16.39 Favored 'General case' 0 C--O 1.238 0.465 0 O-C-N 124.179 0.925 . . . . 73.319999999999993 108.682 176.653 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 80.4 p -108.98 177.08 4.87 Favored 'General case' 0 C--O 1.244 0.768 0 N-CA-C 108.307 -0.997 . . . . 72.120000000000005 108.307 174.736 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 11.2 mt -66.78 -23.26 66.05 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 116.404 -0.362 . . . . 71.010000000000005 110.135 177.469 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -92.33 -19.61 21.95 Favored 'General case' 0 CA--C 1.558 1.259 0 C-N-CA 124.082 0.953 . . . . 74.450000000000003 111.509 -179.415 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 129.16 -149.56 18.59 Favored Glycine 0 C--N 1.355 1.589 0 CA-C-O 119.561 -0.577 . . . . 72.430000000000007 114.1 173.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -76.36 127.73 9.97 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 123.194 2.596 . . . . 61.030000000000001 112.066 -178.204 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.468 ' HA ' ' H ' ' A' ' 178' ' ' ALA . 33.8 m -130.4 131.47 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 122.989 0.516 . . . . 72.400000000000006 110.524 176.471 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.507 ' HG3' ' HB2' ' A' ' 178' ' ' ALA . 40.0 mt-10 -77.41 104.2 7.78 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 122.944 0.498 . . . . 64.040000000000006 109.963 178.834 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 59.7 t -92.7 122.4 44.14 Favored 'Isoleucine or valine' 0 C--O 1.245 0.821 0 N-CA-C 108.149 -1.056 . . . . 73.329999999999998 108.149 178.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -68.65 99.72 1.04 Allowed 'General case' 0 C--O 1.24 0.605 0 O-C-N 124.215 0.947 . . . . 63.119999999999997 109.379 177.671 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 69.4 t -77.39 120.37 81.24 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-N 115.152 -0.931 . . . . 70.519999999999996 108.596 174.748 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -64.06 156.5 58.49 Favored 'Trans proline' 0 C--N 1.377 2.053 0 C-N-CA 122.72 2.28 . . . . 73.510000000000005 112.241 177.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -65.11 143.43 78.19 Favored 'Trans proline' 0 C--N 1.372 1.809 0 C-N-CA 122.349 2.032 . . . . 74.120000000000005 111.332 170.428 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 71.6 mtm180 65.42 66.14 0.54 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.675 1.19 . . . . 73.319999999999993 110.339 178.61 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.613 HG23 ' HD2' ' A' ' 231' ' ' ARG . 97.1 m -107.77 134.31 50.91 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.062 -0.972 . . . . 72.349999999999994 110.038 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -108.33 157.7 18.15 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.958 0.903 . . . . 64.340000000000003 110.264 176.539 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -72.49 118.81 15.86 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.126 0.97 . . . . 61.32 109.277 173.337 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 114.54 -6.5 22.68 Favored Glycine 0 CA--C 1.521 0.467 0 CA-C-O 119.295 -0.725 . . . . 61.539999999999999 112.014 -171.71 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.613 ' HD2' HG23 ' A' ' 227' ' ' THR . 49.8 mtt-85 -67.15 157.93 32.49 Favored 'General case' 0 C--N 1.364 1.21 0 CA-C-N 117.941 0.87 . . . . 74.510000000000005 110.286 169.343 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.498 ' HE3' ' O ' ' A' ' 169' ' ' ASP . 32.7 pttt -130.23 138.31 50.49 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 123.756 0.822 . . . . 73.430000000000007 109.348 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.491 HD22 ' HB2' ' A' ' 173' ' ' ALA . 59.8 mt -127.3 100.52 6.09 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.032 1.333 . . . . 62.310000000000002 108.212 -178.103 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 22.6 ttp180 -90.64 102.0 14.74 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.162 -1.051 . . . . 75.340000000000003 108.162 176.117 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.539 HD13 ' HD1' ' A' ' 175' ' ' TYR . 14.5 mt -76.41 83.28 3.14 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 114.188 -1.369 . . . . 73.430000000000007 108.271 -179.556 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -66.62 134.96 53.38 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 114.465 -1.243 . . . . 74.209999999999994 111.234 -173.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 69.57 10.21 63.17 Favored Glycine 0 CA--C 1.538 1.526 0 O-C-N 123.73 0.644 . . . . 73.109999999999999 112.782 -178.798 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.458 ' HB3' ' CE1' ' A' ' 175' ' ' TYR . 33.4 mmtp -134.03 42.54 2.91 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 125.126 1.371 . . . . 74.120000000000005 110.523 -171.072 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -100.97 -102.4 2.55 Favored Glycine 0 N--CA 1.472 1.044 0 N-CA-C 109.714 -1.354 . . . . 65.439999999999998 109.714 165.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 240' ' ' PHE . . . . . 0.412 ' HB2' ' HA ' ' A' ' 191' ' ' GLN . 8.8 m-85 -82.08 126.33 75.02 Favored Pre-proline 0 N--CA 1.475 0.795 0 C-N-CA 123.076 0.55 . . . . 73.430000000000007 109.667 167.837 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.522 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 12.9 Cg_exo -71.79 158.3 53.39 Favored 'Trans proline' 0 C--N 1.37 1.684 0 C-N-CA 122.901 2.401 . . . . 72.439999999999998 111.928 175.057 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -178.64 151.93 10.9 Favored Glycine 0 CA--C 1.529 0.916 0 CA-C-O 119.17 -0.794 . . . . 75.129999999999995 112.004 -178.021 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -71.36 -28.82 17.69 Favored 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 123.149 2.566 . . . . 74.299999999999997 113.671 179.333 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -121.42 -26.49 4.98 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.49 0.716 . . . . 74.299999999999997 112.215 -178.241 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -134.38 117.74 1.87 Allowed Glycine 0 C--N 1.345 1.058 0 N-CA-C 111.434 -0.666 . . . . 54.409999999999997 111.434 -174.225 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.522 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 70.5 mtt180 -127.29 126.83 43.33 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 108.666 -0.864 . . . . 73.0 108.666 178.372 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -80.69 -161.37 25.35 Favored Glycine 0 C--N 1.351 1.401 0 O-C-N 123.354 0.409 . . . . 72.120000000000005 112.843 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -130.74 156.64 44.62 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.227 0.611 . . . . 71.25 110.314 175.091 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.459 ' HG ' ' HG ' ' A' ' 251' ' ' LEU . 36.9 tp -114.33 109.92 19.1 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 108.811 -0.811 . . . . 72.299999999999997 108.811 172.112 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -93.01 107.79 19.5 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.915 0.886 . . . . 73.430000000000007 108.971 -176.721 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.552 ' HB3' ' HB2' ' A' ' 197' ' ' LEU . 48.3 mt -113.31 116.95 30.52 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.101 0.96 . . . . 73.129999999999995 111.455 -173.597 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -86.99 108.48 18.86 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 109.166 -0.679 . . . . 73.25 109.166 173.315 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.407 HG11 ' CG2' ' A' ' 227' ' ' THR . 53.8 t -60.99 120.15 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 123.512 0.725 . . . . 73.519999999999996 110.68 179.198 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 26.2 mmm180 -117.21 113.53 22.36 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 106.898 -1.519 . . . . 73.239999999999995 106.898 173.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 55.5 mt -79.15 127.19 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 123.312 0.645 . . . . 62.420000000000002 110.906 -177.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 20.1 p . . . . . 0 C--O 1.25 1.096 0 C-N-CA 124.742 1.217 . . . . 73.319999999999993 108.304 177.447 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 64.5 mtt . . . . . 0 N--CA 1.476 0.862 0 N-CA-C 109.709 -0.478 . . . . 72.409999999999997 109.709 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -77.25 89.63 3.71 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 108.382 -0.97 . . . . 75.109999999999999 108.382 171.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -75.8 -77.68 0.13 Allowed 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 107.984 -1.117 . . . . 71.519999999999996 107.984 171.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.47 HG21 ' HB3' ' A' ' 234' ' ' ARG . 17.1 m -85.99 143.02 12.35 Favored 'Isoleucine or valine' 0 C--O 1.245 0.835 0 N-CA-C 108.016 -1.105 . . . . 63.210000000000001 108.016 167.481 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 15.2 tt -73.83 141.26 16.43 Favored 'Isoleucine or valine' 0 C--O 1.246 0.876 0 N-CA-C 108.701 -0.852 . . . . 41.32 108.701 174.01 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -63.93 118.57 8.61 Favored 'General case' 0 C--N 1.349 0.554 0 O-C-N 123.903 0.752 . . . . 73.129999999999995 110.906 -173.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.454 ' HB2' HD22 ' A' ' 233' ' ' LEU . . . -124.02 160.66 27.16 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.267 1.027 . . . . 72.450000000000003 109.813 -174.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -149.08 163.75 36.65 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.488 0.715 . . . . 74.349999999999994 109.75 -178.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.442 ' HD1' HD13 ' A' ' 235' ' ' LEU . 7.9 p90 -150.08 178.76 8.65 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 122.899 0.479 . . . . 74.219999999999999 110.773 174.669 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 41.4 mmtm -141.67 132.33 13.05 Favored Pre-proline 0 N--CA 1.483 1.222 0 C-N-CA 124.73 1.212 . . . . 75.040000000000006 109.007 175.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' PRO . . . . . 0.423 ' HA ' HG12 ' A' ' 219' ' ' VAL . 55.7 Cg_endo -67.54 105.54 1.09 Allowed 'Trans proline' 0 C--N 1.384 2.415 0 C-N-CA 122.946 2.431 . . . . 70.140000000000001 111.866 -177.562 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' ALA . . . . . 0.494 ' HB2' ' HG3' ' A' ' 220' ' ' GLU . . . -77.59 86.44 3.91 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.46 0.704 . . . . 50.149999999999999 109.235 178.165 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 68.18 13.47 9.08 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.883 1.273 . . . . 71.540000000000006 111.683 -174.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -69.12 149.67 49.31 Favored Glycine 0 C--N 1.36 1.888 0 CA-C-O 119.708 -0.496 . . . . 71.420000000000002 111.955 177.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 34.8 t -124.19 101.55 7.26 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 117.506 0.653 . . . . 74.129999999999995 110.413 -172.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -93.52 -146.2 19.26 Favored Glycine 0 CA--C 1.536 1.358 0 CA-C-N 115.945 -0.571 . . . . 71.409999999999997 112.503 176.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' GLY . . . . . 0.41 ' O ' ' HB3' ' A' ' 241' ' ' PRO . . . 166.66 -179.78 40.34 Favored Glycine 0 C--N 1.344 0.979 0 N-CA-C 110.619 -0.992 . . . . 52.240000000000002 110.619 -179.366 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 32.6 p -78.64 88.13 4.56 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 109.114 -0.699 . . . . 61.399999999999999 109.114 173.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -80.42 -122.81 0.49 Allowed Glycine 0 C--N 1.349 1.271 0 CA-C-N 115.619 -0.719 . . . . 45.229999999999997 113.172 -177.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 76.5 11.92 84.76 Favored Glycine 0 C--N 1.349 1.305 0 C-N-CA 122.752 0.215 . . . . 41.329999999999998 112.883 -177.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 34.1 p -81.76 -4.11 55.52 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.102 0.961 . . . . 74.519999999999996 111.57 -178.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 96.95 -118.36 6.03 Favored Glycine 0 C--N 1.349 1.286 0 N-CA-C 111.334 -0.707 . . . . 74.549999999999997 111.334 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 70.75 -88.51 0.37 Allowed Glycine 0 C--N 1.345 1.072 0 N-CA-C 110.911 -0.875 . . . . 64.219999999999999 110.911 -176.34 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 66.9 m -156.24 94.74 1.53 Allowed 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.534 1.133 . . . . 73.329999999999998 108.365 175.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -57.53 -44.26 84.99 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-O 121.708 0.766 . . . . 34.009999999999998 110.314 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.485 ' HA ' ' O ' ' A' ' 248' ' ' ASP . 3.7 p-10 -88.17 145.57 25.85 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 114.653 -1.158 . . . . 61.310000000000002 110.153 171.007 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 67.9 mt -127.11 140.43 52.28 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.682 0.793 . . . . 63.450000000000003 108.954 172.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -107.21 120.87 43.31 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 108.919 -0.771 . . . . 75.319999999999993 108.919 175.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -143.81 161.62 38.17 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.836 0.854 . . . . 74.349999999999994 109.452 -177.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 2.7 m -112.97 141.27 47.0 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 109.072 -0.714 . . . . 74.540000000000006 109.072 -178.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.52 HD11 HG23 ' A' ' 210' ' ' VAL . 37.6 tp -113.22 117.93 33.26 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.281 0.632 . . . . 74.25 111.052 -168.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -82.34 101.18 10.41 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.91 -0.774 . . . . 74.319999999999993 108.91 168.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.544 ' HA ' HG11 ' A' ' 210' ' ' VAL . 2.6 p -115.31 112.71 43.73 Favored Pre-proline 0 CA--C 1.546 0.79 0 N-CA-C 109.218 -0.66 . . . . 74.109999999999999 109.218 173.446 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -54.08 146.1 50.02 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 123.349 2.699 . . . . 55.149999999999999 113.029 175.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -49.38 -49.32 71.69 Favored Pre-proline 0 CA--C 1.561 1.383 0 O-C-N 124.356 1.035 . . . . 25.300000000000001 113.489 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -60.19 -42.13 45.47 Favored 'Trans proline' 0 C--N 1.393 2.91 0 C-N-CA 121.919 1.746 . . . . 61.200000000000003 112.528 177.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 43.0 mt -70.92 -27.33 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 123.602 0.761 . . . . 62.149999999999999 110.932 -177.162 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.05 -48.13 63.6 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.069 0.548 . . . . 52.219999999999999 110.709 175.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 88.6 t -68.12 -46.17 81.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 123.742 0.817 . . . . 63.530000000000001 111.591 -176.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 17.0 m -73.65 -33.13 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 CA-C-N 116.691 -0.231 . . . . 73.549999999999997 111.109 178.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 74.66 77.17 0.68 Allowed Glycine 0 C--N 1.349 1.268 0 CA-C-N 115.987 -0.551 . . . . 72.140000000000001 112.243 -173.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -107.58 -133.64 7.21 Favored Glycine 0 C--N 1.344 1.025 0 N-CA-C 111.566 -0.614 . . . . 75.5 111.566 178.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm -131.49 147.24 52.53 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.858 0.863 . . . . 70.040000000000006 109.633 171.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.544 HG11 ' HA ' ' A' ' 199' ' ' VAL . 17.4 m -133.62 143.57 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 124.401 1.08 . . . . 74.340000000000003 109.278 174.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 211' ' ' ARG . . . . . 0.432 ' HA ' ' O ' ' A' ' 219' ' ' VAL . 14.8 ttm180 -85.56 116.31 23.78 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 122.486 0.314 . . . . 73.450000000000003 110.882 -175.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -100.68 141.36 33.66 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.454 1.102 . . . . 73.319999999999993 110.113 177.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 2.2 mmt -88.23 125.03 34.43 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 123.881 0.873 . . . . 70.140000000000001 110.051 176.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 41.3 p -134.42 177.75 7.52 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.791 0.836 . . . . 54.130000000000003 110.605 178.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.415 HD12 ' HE1' ' A' ' 240' ' ' PHE . 20.1 mt -69.19 -26.28 64.75 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 122.811 0.445 . . . . 73.439999999999998 110.503 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -79.84 -19.38 48.55 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.483 0.713 . . . . 73.209999999999994 110.967 178.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 127.47 -157.28 20.82 Favored Glycine 0 C--N 1.352 1.438 0 CA-C-O 119.797 -0.446 . . . . 71.409999999999997 112.653 178.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' PRO . . . . . 0.448 ' HG2' ' O ' ' A' ' 178' ' ' ALA . 58.7 Cg_endo -76.37 134.06 15.22 Favored 'Trans proline' 0 C--N 1.369 1.657 0 C-N-CA 122.744 2.296 . . . . 55.140000000000001 111.655 175.204 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' A' ' 211' ' ' ARG . 19.7 m -135.34 145.41 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 123.722 0.809 . . . . 74.340000000000003 109.106 -178.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.494 ' HG3' ' HB2' ' A' ' 178' ' ' ALA . 56.0 mt-10 -105.32 110.66 23.1 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 118.942 0.792 . . . . 73.299999999999997 109.545 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 45.5 t -97.06 122.43 48.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 124.975 1.31 . . . . 65.450000000000003 111.021 -170.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -65.25 105.31 1.08 Allowed 'General case' 0 C--O 1.241 0.641 0 C-N-CA 124.28 1.032 . . . . 54.409999999999997 110.94 175.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 51.5 t -76.8 128.14 82.36 Favored Pre-proline 0 CA--C 1.548 0.866 0 CA-C-N 114.741 -1.118 . . . . 65.209999999999994 109.008 173.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.48 141.99 96.86 Favored 'Trans proline' 0 CA--C 1.561 1.84 0 C-N-CA 122.504 2.136 . . . . 60.43 112.445 174.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -59.41 126.61 21.25 Favored 'Trans proline' 0 C--N 1.375 1.97 0 C-N-CA 122.696 2.264 . . . . 50.130000000000003 112.771 173.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 86.6 mtt-85 70.74 71.47 0.19 Allowed 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 125.638 1.575 . . . . 73.109999999999999 110.065 179.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.619 HG23 ' HD2' ' A' ' 231' ' ' ARG . 15.9 m -103.45 136.8 42.52 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 114.264 -1.335 . . . . 65.510000000000005 110.622 -177.067 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 22.3 mp0 -103.91 158.04 16.68 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.209 1.004 . . . . 64.329999999999998 109.764 177.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -74.47 144.97 43.97 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 109.424 -0.584 . . . . 63.43 109.424 173.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 89.89 2.0 75.77 Favored Glycine 0 C--N 1.341 0.86 0 CA-C-O 120.112 -0.271 . . . . 75.049999999999997 112.687 -175.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.619 ' HD2' HG23 ' A' ' 227' ' ' THR . 83.1 mtt180 -70.13 160.83 31.33 Favored 'General case' 0 C--N 1.356 0.848 0 CA-C-O 121.528 0.68 . . . . 60.340000000000003 110.179 170.245 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 16.1 pttp -130.53 138.42 50.2 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 114.863 -1.062 . . . . 74.140000000000001 108.885 175.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.454 HD22 ' HB2' ' A' ' 173' ' ' ALA . 67.0 mt -119.89 141.41 49.61 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.564 1.146 . . . . 74.230000000000004 107.925 178.186 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 234' ' ' ARG . . . . . 0.47 ' HB3' HG21 ' A' ' 170' ' ' VAL . 33.8 ttt180 -129.53 107.98 9.89 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.452 -0.944 . . . . 74.219999999999999 108.452 171.085 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.442 HD13 ' HD1' ' A' ' 175' ' ' TYR . 19.6 mt -81.08 83.99 6.62 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.833 1.253 . . . . 71.310000000000002 109.099 -177.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -69.75 134.43 48.6 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.108 0.963 . . . . 61.350000000000001 111.123 -175.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 65.18 21.95 68.59 Favored Glycine 0 C--N 1.35 1.338 0 O-C-N 123.892 0.745 . . . . 70.310000000000002 112.826 -176.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.439 ' HD3' HH21 ' A' ' 246' ' ' ARG . 29.5 mmtp -138.32 19.87 2.76 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.028 0.931 . . . . 74.200000000000003 110.899 -174.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -92.83 -133.25 6.35 Favored Glycine 0 N--CA 1.466 0.657 0 N-CA-C 111.919 -0.472 . . . . 72.150000000000006 111.919 174.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' PHE . . . . . 0.415 ' HE1' HD12 ' A' ' 215' ' ' LEU . 0.1 OUTLIER -61.35 138.72 94.75 Favored Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 123.888 0.875 . . . . 74.109999999999999 110.133 177.746 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.41 ' HB3' ' O ' ' A' ' 183' ' ' GLY . 97.1 Cg_exo -48.12 146.18 9.81 Favored 'Trans proline' 0 C--N 1.377 2.045 0 C-N-CA 123.9 3.066 . . . . 74.230000000000004 115.107 177.1 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -159.79 138.67 5.71 Favored Glycine 0 CA--C 1.534 1.238 0 CA-C-O 118.559 -1.134 . . . . 72.5 110.469 177.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -65.82 -40.21 17.63 Favored 'Trans proline' 0 C--N 1.378 2.12 0 C-N-CA 123.274 2.649 . . . . 61.140000000000001 113.551 -171.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -97.55 -18.44 18.97 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.59 0.756 . . . . 32.100000000000001 111.454 -177.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 175.67 148.51 6.89 Favored Glycine 0 C--N 1.341 0.847 0 N-CA-C 110.76 -0.936 . . . . 71.340000000000003 110.76 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.439 HH21 ' HD3' ' A' ' 238' ' ' LYS . 21.0 mtm180 -90.12 170.53 10.24 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 117.18 0.49 . . . . 75.430000000000007 110.425 -176.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -78.27 -153.6 6.73 Favored Glycine 0 C--N 1.343 0.954 0 CA-C-N 115.862 -0.608 . . . . 64.409999999999997 112.19 173.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 248' ' ' ASP . . . . . 0.485 ' O ' ' HA ' ' A' ' 192' ' ' ASP . 4.6 p30 -122.92 155.78 36.03 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 117.617 0.708 . . . . 73.209999999999994 110.849 176.383 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 55.2 tp -121.76 108.41 13.48 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 108.907 -0.775 . . . . 74.409999999999997 108.907 174.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 42.7 t80 -90.45 108.69 19.94 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 115.099 -0.955 . . . . 74.120000000000005 110.105 -175.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 62.9 mt -105.91 121.93 45.09 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.721 0.808 . . . . 62.420000000000002 110.517 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -84.16 110.63 18.66 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 122.935 0.494 . . . . 71.430000000000007 109.795 172.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 57.6 t -64.84 119.27 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 123.83 0.852 . . . . 52.520000000000003 111.763 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 21.7 mmt180 -119.66 117.78 29.21 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 108.011 -1.107 . . . . 55.5 108.011 171.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 17.5 mt -75.53 117.38 19.84 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 N-CA-C 109.037 -0.727 . . . . 54.100000000000001 109.037 175.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 27.2 m . . . . . 0 C--O 1.25 1.115 0 C-N-CA 124.931 1.292 . . . . 74.439999999999998 108.848 -175.57 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 59.8 mtt . . . . . 0 N--CA 1.483 1.218 0 N-CA-C 108.847 -0.797 . . . . 71.540000000000006 108.847 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -82.1 69.36 8.8 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-O 122.608 1.194 . . . . 74.129999999999995 110.633 -174.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -87.59 -51.44 5.89 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 114.855 -1.066 . . . . 74.099999999999994 110.256 -175.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.49 HG12 ' HG3' ' A' ' 232' ' ' LYS . 13.9 m -91.71 162.41 2.42 Favored 'Isoleucine or valine' 0 C--O 1.244 0.782 0 CA-C-N 115.043 -0.98 . . . . 75.299999999999997 109.377 173.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 16.7 tt -79.38 135.35 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 N-CA-C 107.694 -1.225 . . . . 74.129999999999995 107.694 166.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -70.92 142.89 51.08 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.365 0.666 . . . . 74.219999999999999 110.737 -172.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.442 ' HB2' HD22 ' A' ' 233' ' ' LEU . . . -149.17 162.14 40.58 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.418 0.687 . . . . 71.040000000000006 110.127 -178.195 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -136.51 156.63 48.32 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 123.795 0.838 . . . . 74.430000000000007 110.024 -177.18 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.494 ' H ' ' HD3' ' A' ' 238' ' ' LYS . 7.3 p90 -150.3 171.92 16.19 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.084 0.553 . . . . 53.329999999999998 111.486 167.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.43 ' HE2' ' HD2' ' A' ' 177' ' ' PRO . 12.6 mmmm -137.79 140.41 29.57 Favored Pre-proline 0 C--O 1.241 0.629 0 C-N-CA 124.291 1.036 . . . . 72.420000000000002 108.564 173.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' PRO . . . . . 0.552 ' HA ' HG12 ' A' ' 219' ' ' VAL . 18.2 Cg_endo -61.29 109.05 0.66 Allowed 'Trans proline' 0 C--N 1.368 1.553 0 C-N-CA 122.486 2.124 . . . . 61.140000000000001 111.104 172.567 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' ALA . . . . . 0.551 ' HB2' ' HG3' ' A' ' 220' ' ' GLU . . . -74.51 -12.52 60.5 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.711 0.804 . . . . 60.119999999999997 110.691 177.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -67.35 138.93 57.14 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.221 1.008 . . . . 64.400000000000006 111.779 178.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -71.21 -20.64 78.21 Favored Glycine 0 C--N 1.353 1.5 0 CA-C-O 119.465 -0.631 . . . . 54.450000000000003 114.307 -173.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 13.1 m -70.54 -14.48 62.53 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 117.365 0.583 . . . . 71.450000000000003 110.741 175.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 82.55 7.18 87.84 Favored Glycine 0 C--N 1.353 1.493 0 C-N-CA 123.558 0.599 . . . . 75.030000000000001 114.131 173.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 65.49 64.46 3.45 Favored Glycine 0 C--N 1.344 0.994 0 N-CA-C 112.014 -0.434 . . . . 51.539999999999999 112.014 -174.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 31.7 m -84.74 107.93 17.18 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 123.359 0.663 . . . . 73.019999999999996 109.591 175.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -92.75 -155.71 32.18 Favored Glycine 0 C--N 1.347 1.146 0 CA-C-N 116.537 -0.301 . . . . 43.210000000000001 113.029 179.055 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 136.07 -51.19 0.82 Allowed Glycine 0 C--N 1.338 0.681 0 N-CA-C 110.784 -0.926 . . . . 63.420000000000002 110.784 -177.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 57.9 p -102.67 130.62 49.64 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.628 0.771 . . . . 54.210000000000001 109.921 177.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 123.47 98.02 1.32 Allowed Glycine 0 C--N 1.346 1.128 0 N-CA-C 111.713 -0.555 . . . . 74.209999999999994 111.713 178.102 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -71.17 -24.18 77.3 Favored Glycine 0 C--N 1.349 1.267 0 C-N-CA 122.639 0.161 . . . . 55.350000000000001 113.265 177.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 35.5 m -75.78 87.19 2.8 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.373 0.669 . . . . 53.409999999999997 110.302 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.449 ' HA ' ' HB2' ' A' ' 240' ' ' PHE . 91.5 mm-40 -76.43 -33.52 58.79 Favored 'General case' 0 C--O 1.248 1.013 0 CA-C-N 114.752 -1.113 . . . . 64.340000000000003 110.848 -178.4 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -82.74 120.87 26.15 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.113 -0.949 . . . . 73.310000000000002 110.012 175.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 81.3 mt -110.49 147.8 33.38 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.916 0.886 . . . . 74.329999999999998 108.697 171.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -130.08 122.77 28.97 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.543 0.737 . . . . 74.019999999999996 109.664 -177.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.409 ' O ' ' HA ' ' A' ' 251' ' ' LEU . . . -160.68 169.9 21.9 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.584 0.754 . . . . 74.049999999999997 110.27 -178.13 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 196' ' ' THR . . . . . 0.551 HG22 ' HB2' ' A' ' 252' ' ' GLU . 8.9 p -101.83 145.84 28.63 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.365 0.666 . . . . 75.120000000000005 109.783 174.406 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.575 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . 51.8 tp -113.75 113.72 25.35 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.276 1.031 . . . . 72.439999999999998 110.09 -174.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -75.51 101.81 5.0 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 109.557 -0.534 . . . . 71.310000000000002 109.557 173.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.522 ' HA ' HG11 ' A' ' 210' ' ' VAL . 44.7 t -104.92 118.84 55.19 Favored Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 108.404 -0.961 . . . . 75.329999999999998 108.404 174.131 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -55.23 140.28 81.29 Favored 'Trans proline' 0 C--N 1.372 1.799 0 C-N-CA 122.727 2.285 . . . . 65.25 111.514 169.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -51.75 -47.87 89.05 Favored Pre-proline 0 CA--C 1.559 1.308 0 N-CA-C 114.432 1.271 . . . . 74.219999999999999 114.432 -175.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.441 ' O ' HG12 ' A' ' 206' ' ' VAL . 16.3 Cg_endo -55.93 -45.43 38.73 Favored 'Trans proline' 0 C--N 1.385 2.469 0 C-N-CA 122.218 1.945 . . . . 53.219999999999999 112.743 174.087 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 47.5 mt -65.83 -31.07 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 123.714 0.806 . . . . 63.43 110.902 -178.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' ALA . . . . . 0.419 ' HB1' ' O ' ' A' ' 227' ' ' THR . . . -70.91 -40.21 72.28 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.29 0.636 . . . . 73.430000000000007 111.415 177.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 64.8 t -72.47 -54.98 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 123.858 0.863 . . . . 73.310000000000002 111.512 -177.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.441 HG12 ' O ' ' A' ' 202' ' ' PRO . 8.3 p -86.97 -16.73 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 C-N-CA 122.492 0.317 . . . . 71.349999999999994 111.831 -174.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 83.02 162.18 32.03 Favored Glycine 0 C--N 1.349 1.251 0 N-CA-C 111.234 -0.746 . . . . 74.109999999999999 111.234 -173.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 161.47 -134.12 3.42 Favored Glycine 0 N--CA 1.464 0.533 0 CA-C-N 117.429 0.615 . . . . 73.450000000000003 112.326 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.452 ' HD3' ' HB3' ' A' ' 220' ' ' GLU . 92.8 mttt -134.69 144.83 48.01 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.875 0.87 . . . . 71.409999999999997 109.963 175.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.522 HG11 ' HA ' ' A' ' 199' ' ' VAL . 22.3 m -129.29 144.61 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 N-CA-C 108.451 -0.944 . . . . 74.019999999999996 108.451 168.188 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 36.3 ttp180 -86.63 110.91 20.16 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 109.612 -0.514 . . . . 73.310000000000002 109.612 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -101.89 151.71 21.77 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.176 0.591 . . . . 53.140000000000001 110.203 179.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -98.29 117.94 33.82 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 123.078 0.551 . . . . 75.329999999999998 109.724 178.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 43.6 p -111.84 179.02 4.13 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.387 0.675 . . . . 73.120000000000005 109.417 171.248 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.415 HD12 ' HE1' ' A' ' 240' ' ' PHE . 20.7 mt -81.81 -7.49 59.61 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.075 0.55 . . . . 73.420000000000002 112.102 -173.105 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -98.9 -19.83 17.14 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.335 1.054 . . . . 75.030000000000001 110.859 178.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 144.36 -165.69 27.4 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-N 115.911 -0.586 . . . . 64.420000000000002 111.842 -177.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -74.78 147.45 34.99 Favored 'Trans proline' 0 C--N 1.367 1.501 0 C-N-CA 122.935 2.423 . . . . 74.510000000000005 112.224 176.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.552 HG12 ' HA ' ' A' ' 177' ' ' PRO . 14.1 m -135.56 157.15 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 123.762 0.825 . . . . 74.129999999999995 109.524 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.551 ' HG3' ' HB2' ' A' ' 178' ' ' ALA . 51.9 mt-10 -108.06 106.19 16.3 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 109.349 -0.612 . . . . 71.349999999999994 109.349 176.216 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 56.1 t -92.96 112.21 25.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 109.19 -0.67 . . . . 71.230000000000004 109.19 -177.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -65.06 101.09 0.48 Allowed 'General case' 0 CA--C 1.539 0.545 0 O-C-N 123.999 0.812 . . . . 72.340000000000003 109.436 173.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 64.7 t -73.46 127.39 88.93 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-N 115.018 -0.992 . . . . 75.120000000000005 109.231 174.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.94 157.57 57.73 Favored 'Trans proline' 0 CA--C 1.559 1.75 0 C-N-CA 121.491 1.461 . . . . 73.439999999999998 110.824 171.089 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -70.05 164.28 35.42 Favored 'Trans proline' 0 C--N 1.366 1.455 0 C-N-CA 122.064 1.843 . . . . 72.120000000000005 111.942 176.069 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 75.7 mtm180 59.32 25.8 14.53 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 124.834 1.254 . . . . 73.120000000000005 112.146 174.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.544 HG23 ' HD2' ' A' ' 231' ' ' ARG . 96.7 m -90.85 99.6 12.61 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.943 0.897 . . . . 75.439999999999998 110.064 -176.577 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 19.7 mp0 -84.76 166.78 16.69 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 121.318 0.58 . . . . 60.119999999999997 111.542 -176.023 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' ALA . . . . . 0.532 ' HB2' ' HB ' ' A' ' 255' ' ' ILE . . . -66.98 124.2 22.36 Favored 'General case' 0 C--N 1.346 0.455 0 CA-C-N 114.549 -1.205 . . . . 62.299999999999997 109.699 177.348 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 114.05 -12.46 22.16 Favored Glycine 0 C--N 1.335 0.518 0 CA-C-O 119.401 -0.666 . . . . 74.319999999999993 112.645 -174.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.544 ' HD2' HG23 ' A' ' 227' ' ' THR . 42.6 mtt180 -71.62 162.88 28.75 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.738 0.78 . . . . 72.049999999999997 111.459 172.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.49 ' HG3' HG12 ' A' ' 170' ' ' VAL . 20.4 pttm -129.04 136.23 50.0 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.84 1.256 . . . . 72.5 109.294 -178.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.442 HD22 ' HB2' ' A' ' 173' ' ' ALA . 96.1 mt -116.83 113.95 23.24 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.011 0.924 . . . . 60.32 108.749 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 234' ' ' ARG . . . . . 0.448 ' H ' HG21 ' A' ' 170' ' ' VAL . 19.9 ttt180 -96.45 101.02 12.58 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 107.381 -1.34 . . . . 73.409999999999997 107.381 170.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.437 HD13 ' CD1' ' A' ' 175' ' ' TYR . 22.2 mt -78.86 84.26 4.92 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 114.714 -1.13 . . . . 73.019999999999996 107.992 178.344 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 10.2 mtmp? -72.38 123.81 23.84 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 113.752 -1.567 . . . . 63.409999999999997 111.093 -172.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 67.28 32.05 78.77 Favored Glycine 0 C--N 1.346 1.133 0 O-C-N 123.733 0.646 . . . . 73.120000000000005 112.391 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.494 ' HD3' ' H ' ' A' ' 175' ' ' TYR . 10.3 mmpt? -125.3 -31.58 3.03 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.313 1.045 . . . . 73.040000000000006 112.248 -174.34 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -59.22 -112.09 0.01 OUTLIER Glycine 0 C--N 1.357 1.704 0 N-CA-C 116.092 1.197 . . . . 55.130000000000003 116.092 -168.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 240' ' ' PHE . . . . . 0.449 ' HB2' ' HA ' ' A' ' 191' ' ' GLN . 0.2 OUTLIER -71.54 136.16 83.62 Favored Pre-proline 0 N--CA 1.485 1.278 0 CA-C-N 117.393 0.596 . . . . 75.340000000000003 110.334 -178.805 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.58 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 13.7 Cg_exo -67.48 127.07 15.83 Favored 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.409 2.073 . . . . 73.019999999999996 111.981 -179.079 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -137.23 145.05 16.75 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-O 118.963 -0.91 . . . . 72.109999999999999 111.447 -179.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.6 -32.65 30.51 Favored 'Trans proline' 0 C--N 1.374 1.89 0 C-N-CA 123.215 2.61 . . . . 62.200000000000003 113.627 -174.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -91.96 -18.94 22.98 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.143 0.577 . . . . 74.409999999999997 110.935 178.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 163.26 151.87 6.6 Favored Glycine 0 C--N 1.343 0.948 0 N-CA-C 111.521 -0.631 . . . . 54.109999999999999 111.521 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.58 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 37.2 mtt-85 -78.52 164.05 25.04 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.371 0.669 . . . . 70.409999999999997 111.195 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.407 ' HA3' ' HB3' ' A' ' 191' ' ' GLN . . . -83.17 -154.72 17.39 Favored Glycine 0 C--N 1.342 0.879 0 CA-C-N 115.249 -0.887 . . . . 74.219999999999999 113.078 178.7 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -119.25 127.02 52.86 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 117.122 0.461 . . . . 40.25 110.011 177.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.501 ' HG ' ' HG ' ' A' ' 251' ' ' LEU . 60.6 tp -100.22 108.01 20.0 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 107.547 -1.279 . . . . 73.430000000000007 107.547 170.559 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 250' ' ' TYR . . . . . 0.442 ' OH ' ' HD2' ' A' ' 232' ' ' LYS . 23.0 t80 -97.14 108.18 20.85 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.754 -0.832 . . . . 74.430000000000007 108.754 -175.725 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.575 ' HB3' ' HB2' ' A' ' 197' ' ' LEU . 55.3 mt -115.7 120.42 39.29 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.931 0.892 . . . . 74.209999999999994 110.894 -173.422 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 252' ' ' GLU . . . . . 0.551 ' HB2' HG22 ' A' ' 196' ' ' THR . 3.6 mp0 -84.76 115.13 22.54 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.15 0.58 . . . . 74.439999999999998 109.93 175.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.512 HG11 HG22 ' A' ' 227' ' ' THR . 61.5 t -65.84 109.05 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 C-N-CA 123.497 0.719 . . . . 73.329999999999998 111.744 -176.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -104.77 107.99 19.24 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.891 1.277 . . . . 74.400000000000006 108.322 171.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.532 ' HB ' ' HB2' ' A' ' 229' ' ' ALA . 16.2 mt -75.69 132.77 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 122.907 0.483 . . . . 73.310000000000002 109.782 177.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 20.7 p . . . . . 0 CA--C 1.557 1.226 0 C-N-CA 124.435 1.094 . . . . 64.310000000000002 108.924 -177.885 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 167' ' ' MET . . . . . 0.452 ' SD ' ' N ' ' A' ' 167' ' ' MET . 1.3 mpt? . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.152 0.025 . . . . 73.510000000000005 111.042 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -78.39 91.59 4.49 Favored 'General case' 0 C--N 1.355 0.833 0 N-CA-C 108.546 -0.909 . . . . 55.200000000000003 108.546 174.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -64.15 -60.04 3.7 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 115.792 -0.64 . . . . 62.119999999999997 110.873 -179.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.441 HG12 ' HG3' ' A' ' 232' ' ' LYS . 31.9 m -108.97 168.64 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 123.37 0.668 . . . . 73.439999999999998 110.688 177.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 10.4 tt -89.3 150.32 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.976 0 N-CA-C 108.489 -0.93 . . . . 53.149999999999999 108.489 167.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -58.07 142.36 47.16 Favored 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 124.75 1.22 . . . . 72.010000000000005 111.888 178.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -164.76 149.43 9.43 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.317 1.447 . . . . 62.420000000000002 108.394 176.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -146.43 154.85 42.08 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 123.346 0.658 . . . . 73.340000000000003 109.825 175.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.423 ' CD1' HD13 ' A' ' 235' ' ' LEU . 44.4 p90 -118.17 177.34 4.83 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.249 0.62 . . . . 73.450000000000003 111.052 -177.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -145.32 145.79 27.8 Favored Pre-proline 0 N--CA 1.472 0.667 0 CA-C-N 114.325 -1.307 . . . . 73.129999999999995 108.569 168.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' PRO . . . . . 0.461 ' HA ' HG12 ' A' ' 219' ' ' VAL . 20.9 Cg_endo -59.26 127.53 24.31 Favored 'Trans proline' 0 C--N 1.376 2.023 0 C-N-CA 122.747 2.298 . . . . 75.099999999999994 111.545 174.376 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.33 -32.7 72.58 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.133 0.973 . . . . 74.439999999999998 111.489 -178.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -131.5 -161.93 1.18 Allowed 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.501 1.12 . . . . 51.420000000000002 108.257 176.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -76.36 67.38 2.51 Favored Glycine 0 C--N 1.348 1.243 0 N-CA-C 110.757 -0.937 . . . . 61.210000000000001 110.757 168.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 16.8 m -71.7 95.53 1.48 Allowed 'General case' 0 C--N 1.351 0.662 0 C-N-CA 123.979 0.912 . . . . 70.209999999999994 110.496 -172.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -124.67 33.19 3.83 Favored Glycine 0 C--N 1.339 0.743 0 CA-C-N 115.392 -0.822 . . . . 62.43 111.387 177.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -66.32 133.03 33.2 Favored Glycine 0 C--N 1.352 1.457 0 N-CA-C 111.044 -0.823 . . . . 71.340000000000003 111.044 175.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 70.1 p -62.1 121.6 13.46 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.668 0.787 . . . . 71.129999999999995 110.527 -177.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -61.68 121.67 26.64 Favored Glycine 0 C--N 1.354 1.532 0 O-C-N 123.896 0.748 . . . . 25.329999999999998 112.319 178.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -64.58 162.48 37.58 Favored Glycine 0 C--N 1.351 1.383 0 C-N-CA 123.123 0.392 . . . . 64.310000000000002 113.552 -177.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 50.8 m -63.66 123.48 18.97 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.103 0.961 . . . . 73.329999999999998 111.966 -175.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -169.41 127.85 1.57 Allowed Glycine 0 C--N 1.338 0.692 0 N-CA-C 111.246 -0.742 . . . . 44.240000000000002 111.246 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -84.62 50.66 4.44 Favored Glycine 0 C--N 1.35 1.36 0 N-CA-C 111.667 -0.573 . . . . 62.329999999999998 111.667 176.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 38.3 t -158.34 131.14 7.21 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 124.429 1.092 . . . . 63.039999999999999 108.089 179.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -81.3 -21.08 39.56 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 123.571 0.748 . . . . 74.530000000000001 110.387 173.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -91.16 127.5 36.61 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.81 0.844 . . . . 65.219999999999999 109.599 -176.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 76.8 mt -109.6 146.9 33.95 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.279 1.032 . . . . 64.209999999999994 108.978 177.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -128.02 123.29 34.32 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 108.22 -1.03 . . . . 74.310000000000002 108.22 177.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -152.28 162.0 41.78 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.768 0.827 . . . . 43.140000000000001 110.329 -178.231 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' THR . . . . . 0.511 HG22 ' HE ' ' A' ' 254' ' ' ARG . 13.0 p -85.35 149.61 25.33 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.896 0.878 . . . . 71.439999999999998 110.691 174.491 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.582 HD13 HD13 ' A' ' 251' ' ' LEU . 43.7 tp -115.29 114.47 25.22 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.928 0.891 . . . . 70.140000000000001 109.017 179.068 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -88.83 101.2 13.8 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.254 0.622 . . . . 73.420000000000002 109.873 -177.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.566 ' HA ' HG11 ' A' ' 210' ' ' VAL . 7.4 p -118.39 123.12 29.54 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 123.784 0.834 . . . . 71.099999999999994 110.299 -177.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -57.73 146.3 85.98 Favored 'Trans proline' 0 C--N 1.372 1.796 0 C-N-CA 122.694 2.263 . . . . 63.240000000000002 112.311 168.004 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -51.77 -46.91 91.69 Favored Pre-proline 0 CA--C 1.559 1.319 0 N-CA-C 113.725 1.009 . . . . 64.310000000000002 113.725 179.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.418 ' O ' HG22 ' A' ' 206' ' ' VAL . 11.3 Cg_endo -53.6 -48.75 20.18 Favored 'Trans proline' 0 C--N 1.398 3.159 0 C-N-CA 122.327 2.018 . . . . 62.299999999999997 112.995 173.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 31.4 mt -66.36 -31.3 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 123.778 0.831 . . . . 74.109999999999999 111.359 -177.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.52 -41.23 76.29 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 122.708 0.403 . . . . 73.450000000000003 111.515 178.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 84.8 t -72.87 -51.41 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 122.96 0.504 . . . . 63.530000000000001 111.433 -178.203 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.418 HG22 ' O ' ' A' ' 202' ' ' PRO . 19.3 m -85.73 -20.15 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 N-CA-C 112.497 0.554 . . . . 75.239999999999995 112.497 -174.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 90.98 162.65 38.34 Favored Glycine 0 N--CA 1.476 1.323 0 N-CA-C 111.249 -0.74 . . . . 63.109999999999999 111.249 -171.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 161.92 -147.93 14.75 Favored Glycine 0 N--CA 1.467 0.722 0 CA-C-N 117.635 0.718 . . . . 63.539999999999999 111.918 178.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 33.2 mtmm -133.13 139.52 47.13 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.239 0.616 . . . . 62.240000000000002 109.759 175.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.566 HG11 ' HA ' ' A' ' 199' ' ' VAL . 27.1 m -135.83 144.85 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 123.649 0.78 . . . . 73.420000000000002 109.404 175.152 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 25.1 ttm180 -85.8 116.42 24.04 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 123.196 0.598 . . . . 74.219999999999999 111.227 -171.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -102.81 164.66 11.5 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.564 1.146 . . . . 61.399999999999999 110.158 173.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -105.4 123.19 47.46 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.896 0.878 . . . . 71.349999999999994 110.183 -178.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 81.1 p -124.52 177.94 5.66 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.131 0.973 . . . . 72.010000000000005 109.936 175.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 14.7 mt -78.9 -9.7 59.57 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.058 0.543 . . . . 72.430000000000007 111.739 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -94.34 -18.65 21.39 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.699 0.8 . . . . 73.019999999999996 110.569 176.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 137.64 -164.21 25.45 Favored Glycine 0 C--N 1.349 1.292 0 CA-C-N 116.057 -0.52 . . . . 45.5 112.174 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -74.1 134.05 18.9 Favored 'Trans proline' 0 C--N 1.365 1.43 0 C-N-CA 122.439 2.093 . . . . 71.340000000000003 111.304 171.094 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.461 HG12 ' HA ' ' A' ' 177' ' ' PRO . 33.2 m -133.42 132.68 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 123.782 0.833 . . . . 75.310000000000002 109.071 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -91.72 116.47 28.91 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 122.028 -0.42 . . . . 73.109999999999999 110.014 179.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 36.9 t -96.54 127.22 48.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 C-N-CA 124.961 1.304 . . . . 73.019999999999996 109.995 -173.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -69.22 99.69 1.19 Allowed 'General case' 0 CA--C 1.54 0.589 0 O-C-N 123.959 0.787 . . . . 64.010000000000005 109.92 175.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 58.9 t -72.63 121.75 85.72 Favored Pre-proline 0 C--O 1.239 0.551 0 C-N-CA 124.583 1.153 . . . . 73.409999999999997 108.917 174.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -61.12 152.43 71.67 Favored 'Trans proline' 0 C--N 1.375 1.93 0 C-N-CA 122.297 1.998 . . . . 62.140000000000001 111.474 172.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_exo -64.57 157.4 55.53 Favored 'Trans proline' 0 C--N 1.37 1.66 0 C-N-CA 122.255 1.97 . . . . 63.200000000000003 111.87 171.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 62.41 33.42 16.26 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.925 1.29 . . . . 64.420000000000002 110.894 174.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.498 HG23 ' HD2' ' A' ' 231' ' ' ARG . 21.1 m -88.52 126.32 35.2 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.917 0.887 . . . . 73.420000000000002 110.477 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 -94.2 163.73 13.33 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.218 1.007 . . . . 72.200000000000003 111.361 -176.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -69.14 114.76 7.7 Favored 'General case' 0 C--N 1.348 0.528 0 CA-C-N 115.029 -0.987 . . . . 70.510000000000005 109.289 173.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 105.38 4.6 40.59 Favored Glycine 0 C--N 1.338 0.648 0 O-C-N 123.756 0.66 . . . . 63.219999999999999 112.799 -179.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.498 ' HD2' HG23 ' A' ' 227' ' ' THR . 28.3 mtt180 -63.68 152.9 37.81 Favored 'General case' 0 C--N 1.359 0.989 0 CA-C-N 117.404 0.602 . . . . 74.099999999999994 110.466 171.553 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.441 ' HG3' HG12 ' A' ' 170' ' ' VAL . 20.8 pttm -115.63 130.52 56.89 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 123.575 0.75 . . . . 65.319999999999993 109.877 -179.208 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 89.1 mt -120.44 132.67 55.33 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 107.766 -1.198 . . . . 63.32 107.766 176.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 234' ' ' ARG . . . . . 0.413 ' H ' HG21 ' A' ' 170' ' ' VAL . 35.5 ttm-85 -121.92 106.89 11.65 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 108.149 -1.056 . . . . 73.129999999999995 108.149 170.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.423 HD13 ' CD1' ' A' ' 175' ' ' TYR . 15.4 mt -76.06 82.57 2.91 Favored 'General case' 0 C--O 1.243 0.715 0 N-CA-C 107.375 -1.342 . . . . 51.409999999999997 107.375 174.105 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -71.28 133.04 45.77 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-N 115.318 -0.855 . . . . 72.400000000000006 110.746 -173.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 65.14 26.3 71.44 Favored Glycine 0 C--N 1.345 1.029 0 O-C-N 124.083 0.864 . . . . 61.109999999999999 112.563 -177.013 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -142.82 36.93 1.43 Allowed 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 124.008 0.923 . . . . 75.349999999999994 111.11 -177.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -100.97 -111.66 3.43 Favored Glycine 0 N--CA 1.478 1.498 0 CA-C-O 119.579 -0.567 . . . . 45.229999999999997 112.26 175.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -62.92 133.89 95.46 Favored Pre-proline 0 N--CA 1.487 1.411 0 CA-C-O 118.178 -0.915 . . . . 71.230000000000004 110.557 173.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -62.45 130.41 29.98 Favored 'Trans proline' 0 C--N 1.38 2.233 0 C-N-CA 123.119 2.546 . . . . 70.439999999999998 112.159 178.042 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -166.02 124.27 1.22 Allowed Glycine 0 CA--C 1.533 1.184 0 CA-C-O 118.71 -1.05 . . . . 61.409999999999997 111.42 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -68.68 -26.95 32.65 Favored 'Trans proline' 0 C--N 1.382 2.337 0 C-N-CA 123.528 2.819 . . . . 63.520000000000003 113.273 -176.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -80.97 -25.64 37.19 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.356 0.662 . . . . 71.0 111.083 178.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 161.79 117.78 0.44 Allowed Glycine 0 C--N 1.342 0.906 0 N-CA-C 111.232 -0.747 . . . . 70.519999999999996 111.232 -178.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 29.8 mtt-85 -69.58 164.99 22.04 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.668 0.787 . . . . 75.409999999999997 110.518 176.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -80.09 -158.21 16.1 Favored Glycine 0 N--CA 1.472 1.038 0 CA-C-N 115.886 -0.597 . . . . 74.319999999999993 112.387 172.269 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -115.39 153.57 30.8 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 108.998 -0.742 . . . . 75.510000000000005 108.998 173.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 46.7 tp -123.42 107.63 11.81 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 108.124 -1.065 . . . . 63.049999999999997 108.124 171.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 24.6 t80 -96.67 107.74 20.24 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 115.331 -0.85 . . . . 71.150000000000006 108.978 -172.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.582 HD13 HD13 ' A' ' 197' ' ' LEU . 76.5 mt -103.96 120.65 41.48 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 123.77 0.828 . . . . 73.019999999999996 110.639 -176.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -89.6 103.51 16.15 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.093 0.957 . . . . 73.450000000000003 108.448 177.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.479 HG11 HG22 ' A' ' 227' ' ' THR . 72.6 t -58.1 116.68 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 123.69 0.796 . . . . 73.510000000000005 111.179 -179.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 254' ' ' ARG . . . . . 0.511 ' HE ' HG22 ' A' ' 196' ' ' THR . 20.4 mmt180 -117.07 107.27 14.31 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 107.801 -1.185 . . . . 72.319999999999993 107.801 173.019 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 40.6 mt -75.95 135.47 26.9 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.929 0 N-CA-C 109.464 -0.569 . . . . 64.219999999999999 109.464 175.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 14.5 t . . . . . 0 C--O 1.26 1.607 0 C-N-CA 124.673 1.189 . . . . 62.409999999999997 109.718 -176.568 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 90.4 mtp . . . . . 0 N--CA 1.477 0.888 0 N-CA-C 109.854 -0.424 . . . . 53.5 109.854 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -104.01 -37.64 7.29 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.185 0.594 . . . . 52.32 110.904 -178.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' ASP . . . . . 0.402 ' O ' ' HE2' ' A' ' 232' ' ' LYS . 28.1 t70 -59.8 -57.78 11.43 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.652 0.781 . . . . 65.409999999999997 110.038 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.6 HG21 ' HB3' ' A' ' 234' ' ' ARG . 33.2 m -106.93 162.15 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 CA-C-N 115.146 -0.934 . . . . 74.439999999999998 109.232 172.439 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 10.0 tt -83.38 147.8 5.56 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.08 0 N-CA-C 109.781 -0.451 . . . . 75.349999999999994 109.781 175.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -62.69 139.94 58.68 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.383 1.073 . . . . 72.420000000000002 111.941 -178.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.512 ' HB2' HD22 ' A' ' 233' ' ' LEU . . . -156.78 166.56 33.03 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 114.833 -1.076 . . . . 54.25 109.853 178.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -154.53 158.78 40.36 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 124.882 1.273 . . . . 73.299999999999997 108.268 173.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.646 ' HE1' ' HB3' ' A' ' 238' ' ' LYS . 45.6 p90 -118.52 -177.49 3.31 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 122.753 0.421 . . . . 63.310000000000002 110.102 173.581 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -144.21 129.27 9.5 Favored Pre-proline 0 N--CA 1.475 0.796 0 N-CA-C 107.61 -1.256 . . . . 64.519999999999996 107.61 170.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' PRO . . . . . 0.49 ' HA ' HG12 ' A' ' 219' ' ' VAL . 32.7 Cg_endo -62.81 111.63 1.42 Allowed 'Trans proline' 0 C--N 1.371 1.731 0 C-N-CA 122.823 2.349 . . . . 54.509999999999998 111.094 -179.074 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -72.1 76.97 0.95 Allowed 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 123.77 0.828 . . . . 55.439999999999998 111.179 -177.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 21.3 t70 64.74 2.58 1.73 Allowed 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 125.36 1.464 . . . . 65.530000000000001 112.609 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -141.71 131.19 4.68 Favored Glycine 0 C--N 1.346 1.11 0 N-CA-C 111.794 -0.522 . . . . 44.229999999999997 111.794 -173.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 21.0 t -144.87 162.4 36.93 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.7 0.8 . . . . 71.120000000000005 109.381 -178.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' GLY . . . . . 0.485 ' N ' ' HG3' ' A' ' 216' ' ' GLU . . . -88.01 -83.05 1.23 Allowed Glycine 0 C--N 1.344 1.009 0 O-C-N 123.5 0.5 . . . . 72.420000000000002 112.947 -173.417 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 157.73 -95.86 0.15 Allowed Glycine 0 C--N 1.343 0.926 0 N-CA-C 111.73 -0.548 . . . . 64.209999999999994 111.73 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 73.8 m -146.88 157.15 43.57 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.169 0.988 . . . . 62.439999999999998 110.033 178.07 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 170.99 -133.41 2.77 Favored Glycine 0 C--N 1.343 0.931 0 N-CA-C 110.762 -0.935 . . . . 73.109999999999999 110.762 -177.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 79.69 96.49 0.32 Allowed Glycine 0 C--N 1.351 1.383 0 N-CA-C 111.745 -0.542 . . . . 73.230000000000004 111.745 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 27.7 m -85.88 -175.2 5.49 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.035 0.534 . . . . 64.549999999999997 110.557 178.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -79.9 66.4 3.58 Favored Glycine 0 C--N 1.348 1.237 0 N-CA-C 112.154 -0.378 . . . . 54.200000000000003 112.154 177.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 153.85 -55.36 0.43 Allowed Glycine 0 C--N 1.34 0.78 0 N-CA-C 110.977 -0.849 . . . . 74.329999999999998 110.977 -177.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 35.6 p -80.89 75.9 7.83 Favored 'General case' 0 C--N 1.351 0.646 0 CA-C-O 121.918 0.866 . . . . 70.120000000000005 110.35 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -117.8 -19.63 9.18 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 114.29 -1.323 . . . . 64.420000000000002 108.312 168.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.401 ' HA ' ' O ' ' A' ' 248' ' ' ASP . 21.3 t70 -98.98 155.56 17.36 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.143 0.977 . . . . 62.32 110.326 -177.128 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 48.0 mt -142.53 134.77 27.54 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.599 1.16 . . . . 63.119999999999997 109.128 169.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -106.5 122.44 46.3 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 108.479 -0.934 . . . . 75.420000000000002 108.479 171.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.463 ' O ' ' HA ' ' A' ' 251' ' ' LEU . . . -145.96 140.52 26.96 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 109.388 -0.597 . . . . 55.329999999999998 109.388 178.174 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 9.4 p -81.33 137.53 35.74 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 109.459 -0.571 . . . . 72.310000000000002 109.459 173.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.421 HD11 HG23 ' A' ' 210' ' ' VAL . 51.4 tp -106.76 111.5 24.05 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 108.39 -0.966 . . . . 73.510000000000005 108.39 -176.624 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -81.86 99.47 9.05 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 108.678 -0.86 . . . . 74.340000000000003 108.678 178.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.479 ' HA ' HG11 ' A' ' 210' ' ' VAL . 3.2 p -106.34 116.89 58.5 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 123.713 0.805 . . . . 52.229999999999997 109.321 178.49 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -54.94 140.05 79.18 Favored 'Trans proline' 0 C--N 1.367 1.534 0 C-N-CA 122.422 2.082 . . . . 73.420000000000002 112.206 172.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.409 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -49.04 -44.92 73.92 Favored Pre-proline 0 CA--C 1.559 1.311 0 N-CA-C 114.184 1.179 . . . . 55.539999999999999 114.184 179.274 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.409 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 18.6 Cg_endo -57.4 -48.72 16.2 Favored 'Trans proline' 0 C--N 1.388 2.628 0 C-N-CA 121.838 1.692 . . . . 54.43 112.764 174.037 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 53.3 mt -65.79 -31.63 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 C-N-CA 123.781 0.833 . . . . 75.019999999999996 111.074 -178.04 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -64.1 -52.09 60.86 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.287 0.635 . . . . 74.099999999999994 110.746 177.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 91.8 t -67.63 -51.96 45.77 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-N 115.567 -0.742 . . . . 75.120000000000005 111.385 -176.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 15.5 m -79.68 -22.74 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 112.591 0.589 . . . . 74.019999999999996 112.591 -174.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 82.1 154.39 13.66 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 112.126 -0.39 . . . . 75.030000000000001 112.126 -171.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 164.58 -135.16 3.62 Favored Glycine 0 C--N 1.337 0.629 0 N-CA-C 111.74 -0.544 . . . . 51.520000000000003 111.74 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 9.4 mtmp? -133.87 153.19 51.92 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 124.12 0.968 . . . . 62.240000000000002 109.247 173.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.479 HG11 ' HA ' ' A' ' 199' ' ' VAL . 15.6 m -134.8 141.03 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 124.106 0.962 . . . . 40.210000000000001 108.817 172.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -81.7 114.16 20.17 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.175 0.59 . . . . 74.120000000000005 109.705 -177.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -106.51 154.83 20.29 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.583 1.153 . . . . 74.340000000000003 110.351 178.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.71 126.03 52.55 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.461 0.704 . . . . 50.210000000000001 109.9 173.044 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 65.2 p -126.62 -178.72 4.47 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.354 1.062 . . . . 62.409999999999997 109.539 177.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 10.3 mt -73.12 -20.42 60.94 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-O 120.721 0.296 . . . . 71.439999999999998 110.602 176.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' GLU . . . . . 0.485 ' HG3' ' N ' ' A' ' 182' ' ' GLY . 27.0 tt0 -78.67 -19.78 51.73 Favored 'General case' 0 CA--C 1.561 1.376 0 C-N-CA 124.05 0.94 . . . . 72.540000000000006 110.827 173.334 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 120.05 -158.06 15.46 Favored Glycine 0 C--N 1.35 1.327 0 CA-C-O 119.614 -0.548 . . . . 55.520000000000003 112.294 178.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.78 126.87 11.75 Favored 'Trans proline' 0 C--N 1.369 1.649 0 C-N-CA 122.275 1.983 . . . . 63.310000000000002 111.294 178.113 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.49 HG12 ' HA ' ' A' ' 177' ' ' PRO . 28.7 m -136.72 128.02 42.38 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.977 0 C-N-CA 123.879 0.872 . . . . 72.430000000000007 109.325 178.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -85.01 113.45 21.45 Favored 'General case' 0 N--CA 1.482 1.128 0 O-C-N 121.972 -0.455 . . . . 73.129999999999995 110.405 177.354 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.506 ' HA ' ' HA ' ' A' ' 175' ' ' TYR . 58.7 t -93.51 120.77 43.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 C-N-CA 123.267 0.627 . . . . 71.400000000000006 109.648 -177.269 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -63.57 101.51 0.35 Allowed 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.054 0.942 . . . . 75.400000000000006 110.566 176.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 62.5 t -70.03 121.04 81.65 Favored Pre-proline 0 CA--C 1.544 0.74 0 CA-C-N 114.663 -1.153 . . . . 65.129999999999995 108.79 172.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -63.92 157.52 52.17 Favored 'Trans proline' 0 CA--C 1.571 2.338 0 C-N-CA 122.029 1.819 . . . . 51.549999999999997 111.674 174.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -66.79 127.0 16.24 Favored 'Trans proline' 0 C--N 1.368 1.579 0 C-N-CA 122.868 2.378 . . . . 71.5 112.243 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 38.5 mtm180 64.61 79.21 0.26 Allowed 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.984 1.314 . . . . 74.120000000000005 110.459 -175.172 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.557 HG22 HG11 ' A' ' 253' ' ' VAL . 99.3 m -117.12 106.81 13.75 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.11 0.964 . . . . 74.319999999999993 109.006 177.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 24.2 mp0 -88.54 153.47 21.11 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.838 -0.619 . . . . 65.150000000000006 110.787 -173.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -62.9 138.69 58.61 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.108 0.963 . . . . 44.240000000000002 111.115 -178.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 89.94 10.66 64.4 Favored Glycine 0 C--N 1.338 0.646 0 CA-C-N 115.713 -0.676 . . . . 71.340000000000003 112.689 -174.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.486 ' HD2' HG23 ' A' ' 227' ' ' THR . 78.0 mtt180 -78.15 162.49 26.59 Favored 'General case' 0 C--O 1.244 0.778 0 CA-C-O 121.591 0.71 . . . . 73.109999999999999 110.429 169.032 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.402 ' HE2' ' O ' ' A' ' 169' ' ' ASP . 19.6 pttm -127.52 129.11 46.8 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 114.739 -1.119 . . . . 70.439999999999998 109.869 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.512 HD22 ' HB2' ' A' ' 173' ' ' ALA . 66.2 mt -110.45 134.09 52.67 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 107.517 -1.29 . . . . 72.150000000000006 107.517 172.249 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 234' ' ' ARG . . . . . 0.6 ' HB3' HG21 ' A' ' 170' ' ' VAL . 42.3 ttm105 -123.28 98.95 6.1 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 107.044 -1.465 . . . . 71.209999999999994 107.044 167.45 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.517 ' HB3' ' HB2' ' A' ' 238' ' ' LYS . 65.8 mt -74.43 82.93 1.95 Allowed 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 114.213 -1.358 . . . . 53.119999999999997 108.526 177.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -75.8 137.68 40.68 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 122.664 0.386 . . . . 71.25 110.434 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 69.86 24.48 76.37 Favored Glycine 0 C--N 1.339 0.724 0 O-C-N 124.066 0.854 . . . . 64.400000000000006 111.973 -175.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.646 ' HB3' ' HE1' ' A' ' 175' ' ' TYR . 73.8 mmtt -138.87 -9.35 1.36 Allowed 'General case' 0 CA--C 1.561 1.37 0 C-N-CA 124.171 0.988 . . . . 72.340000000000003 111.88 -170.252 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -80.8 -120.81 0.46 Allowed Glycine 0 N--CA 1.478 1.494 0 CA-C-O 119.93 -0.372 . . . . 72.530000000000001 113.8 -175.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.31 119.02 49.26 Favored Pre-proline 0 N--CA 1.485 1.315 0 CA-C-O 118.472 -0.775 . . . . 72.540000000000006 109.251 175.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.744 ' HA ' ' HG3' ' A' ' 246' ' ' ARG . 25.1 Cg_exo -59.45 128.59 27.81 Favored 'Trans proline' 0 C--N 1.38 2.215 0 C-N-CA 122.824 2.349 . . . . 52.409999999999997 111.747 -176.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -141.14 123.91 2.42 Favored Glycine 0 CA--C 1.534 1.222 0 CA-C-O 118.798 -1.001 . . . . 65.219999999999999 111.641 -176.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -70.76 -15.05 33.35 Favored 'Trans proline' 0 C--N 1.385 2.452 0 C-N-CA 123.09 2.527 . . . . 75.450000000000003 113.18 178.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -97.56 -6.45 33.48 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.211 0.604 . . . . 72.150000000000006 111.155 173.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 142.77 115.61 1.11 Allowed Glycine 0 C--N 1.344 0.988 0 N-CA-C 111.005 -0.838 . . . . 61.549999999999997 111.005 -177.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.744 ' HG3' ' HA ' ' A' ' 241' ' ' PRO . 8.0 ttm180 -65.64 139.85 58.45 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.226 1.011 . . . . 71.129999999999995 110.744 176.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -73.17 -155.14 3.03 Favored Glycine 0 C--N 1.347 1.179 0 O-C-N 123.459 0.475 . . . . 61.210000000000001 113.501 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 248' ' ' ASP . . . . . 0.401 ' O ' ' HA ' ' A' ' 192' ' ' ASP . 10.7 p-10 -126.51 132.89 51.29 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 117.738 0.769 . . . . 73.019999999999996 112.667 -176.437 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 51.9 tp -101.24 107.08 18.37 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.14 0.976 . . . . 61.219999999999999 108.949 175.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -89.6 108.24 19.55 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.313 0.645 . . . . 63.539999999999999 109.604 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.463 ' HA ' ' O ' ' A' ' 195' ' ' ALA . 68.1 mt -101.46 112.11 24.54 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 123.752 0.821 . . . . 73.230000000000004 110.597 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -79.77 103.38 9.63 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.589 0.756 . . . . 75.549999999999997 109.47 174.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.557 HG11 HG22 ' A' ' 227' ' ' THR . 75.0 t -61.66 114.59 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.306 1.042 . . . . 73.209999999999994 111.223 -177.197 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 67.4 mmt-85 -123.19 112.08 17.26 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.672 1.189 . . . . 74.099999999999994 108.565 175.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 48.8 mt -76.48 126.58 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 123.152 0.581 . . . . 75.510000000000005 109.91 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 24.0 p . . . . . 0 C--O 1.255 1.394 0 C-N-CA 124.99 1.316 . . . . 71.200000000000003 108.411 179.258 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 22.5 ptp . . . . . 0 N--CA 1.484 1.231 0 CA-C-O 120.84 0.352 . . . . 74.200000000000003 110.411 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -102.06 49.31 0.86 Allowed 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 107.586 -1.265 . . . . 74.209999999999994 107.586 173.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -65.66 -52.92 47.91 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 114.047 -1.433 . . . . 71.019999999999996 111.181 -176.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.751 HG21 ' HB3' ' A' ' 234' ' ' ARG . 19.7 m -79.69 174.47 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 CA-C-N 114.587 -1.188 . . . . 53.530000000000001 110.218 175.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 14.8 tt -82.72 139.82 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 N-CA-C 108.467 -0.938 . . . . 74.340000000000003 108.467 167.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -70.12 93.32 0.8 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.535 0.734 . . . . 75.120000000000005 109.37 -179.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.411 ' HB2' HD22 ' A' ' 233' ' ' LEU . . . -98.37 152.23 19.69 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.838 -0.619 . . . . 64.129999999999995 110.113 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -140.84 149.28 41.8 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.285 0.634 . . . . 73.120000000000005 109.996 175.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.427 ' CD1' HD13 ' A' ' 235' ' ' LEU . 9.5 p90 -122.43 172.11 8.59 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 123.281 0.633 . . . . 72.030000000000001 110.554 176.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -138.04 121.88 11.61 Favored Pre-proline 0 N--CA 1.468 0.445 0 N-CA-C 107.268 -1.382 . . . . 72.219999999999999 107.268 175.07 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -64.51 141.41 73.56 Favored 'Trans proline' 0 C--N 1.367 1.544 0 C-N-CA 122.768 2.312 . . . . 70.540000000000006 110.801 -175.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -65.33 94.27 0.16 Allowed 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 121.586 0.708 . . . . 73.25 109.743 -178.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -80.91 142.32 33.67 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 114.398 -1.274 . . . . 74.129999999999995 111.811 -169.265 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -122.5 -57.3 0.2 Allowed Glycine 0 C--N 1.338 0.685 0 N-CA-C 110.592 -1.003 . . . . 14.23 110.592 173.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 66.6 m -129.87 -8.23 4.46 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.725 0.81 . . . . 55.450000000000003 111.622 177.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 89.86 158.8 34.81 Favored Glycine 0 C--N 1.348 1.239 0 N-CA-C 112.658 -0.177 . . . . 34.229999999999997 112.658 -171.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 144.22 112.91 0.85 Allowed Glycine 0 C--N 1.338 0.685 0 CA-C-O 119.526 -0.597 . . . . 74.25 111.682 176.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 42.6 p -167.72 102.07 0.48 Allowed 'General case' 0 C--O 1.242 0.701 0 C-N-CA 124.299 1.04 . . . . 74.329999999999998 109.407 175.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -89.34 -62.97 1.31 Allowed Glycine 0 C--N 1.344 0.973 0 N-CA-C 112.328 -0.309 . . . . 75.049999999999997 112.328 -178.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 153.77 77.33 0.02 OUTLIER Glycine 0 C--N 1.334 0.452 0 N-CA-C 111.42 -0.672 . . . . 63.219999999999999 111.42 -177.36 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 56.6 m -77.07 156.26 31.87 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.043 0.537 . . . . 41.310000000000002 110.277 178.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -127.5 147.37 17.06 Favored Glycine 0 C--N 1.343 0.921 0 O-C-N 123.231 0.332 . . . . 63.240000000000002 112.404 -175.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 157.13 -55.34 0.39 Allowed Glycine 0 C--N 1.341 0.816 0 N-CA-C 110.432 -1.067 . . . . 74.540000000000006 110.432 178.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 51.0 p -150.97 96.76 2.37 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 108.392 -0.966 . . . . 52.32 108.392 173.049 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.562 ' HA ' ' HB2' ' A' ' 240' ' ' PHE . 10.7 mm100 -75.49 -40.14 57.66 Favored 'General case' 0 C--O 1.244 0.782 0 CA-C-N 115.876 -0.602 . . . . 70.120000000000005 110.358 -177.274 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -86.17 135.64 33.51 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 114.959 -1.019 . . . . 72.109999999999999 108.374 172.14 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 94.6 mt -134.01 155.98 49.02 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.81 0.844 . . . . 75.140000000000001 109.817 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -130.08 136.81 49.75 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 108.008 -1.108 . . . . 72.120000000000005 108.008 173.172 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -160.42 171.34 19.23 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.211 0.529 . . . . 64.239999999999995 110.917 -177.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 17.6 p -104.83 151.62 23.59 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.6 0.76 . . . . 74.25 109.829 173.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.533 HD11 HG23 ' A' ' 210' ' ' VAL . 47.6 tp -123.13 118.3 27.37 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 123.863 0.865 . . . . 73.129999999999995 109.195 -175.004 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -82.61 100.11 9.96 Favored 'General case' 0 C--O 1.241 0.627 0 C-N-CA 123.329 0.652 . . . . 44.119999999999997 109.549 -178.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.533 HG22 HG21 ' A' ' 210' ' ' VAL . 23.6 t -110.06 109.02 59.12 Favored Pre-proline 0 CA--C 1.538 0.509 0 N-CA-C 108.489 -0.93 . . . . 73.239999999999995 108.489 176.365 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -54.2 138.46 71.92 Favored 'Trans proline' 0 C--N 1.377 2.062 0 C-N-CA 122.777 2.318 . . . . 61.409999999999997 112.008 172.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -48.41 -47.56 68.44 Favored Pre-proline 0 CA--C 1.564 1.504 0 N-CA-C 113.772 1.027 . . . . 62.039999999999999 113.772 -177.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -56.07 -45.52 37.77 Favored 'Trans proline' 0 C--N 1.391 2.785 0 C-N-CA 121.845 1.697 . . . . 61.399999999999999 112.775 173.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 45.3 mt -69.93 -27.89 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 123.917 0.887 . . . . 62.229999999999997 111.181 -176.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.88 -48.9 64.77 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.075 0.55 . . . . 63.509999999999998 110.59 177.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 61.9 t -67.34 -48.42 77.86 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 CA-C-N 115.488 -0.778 . . . . 72.299999999999997 111.701 -177.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 11.8 p -75.44 -34.05 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 C-N-CA 122.391 0.277 . . . . 45.350000000000001 111.459 -178.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 83.7 141.02 4.47 Favored Glycine 0 C--N 1.344 0.982 0 N-CA-C 112.119 -0.392 . . . . 65.549999999999997 112.119 -172.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -178.07 -129.66 1.3 Allowed Glycine 0 C--N 1.34 0.777 0 N-CA-C 111.417 -0.673 . . . . 74.420000000000002 111.417 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 60.5 mttm -137.98 144.86 41.34 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.246 0.619 . . . . 64.310000000000002 109.771 173.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.533 HG23 HD11 ' A' ' 197' ' ' LEU . 31.1 m -134.87 155.57 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 124.333 1.053 . . . . 63.039999999999999 108.506 171.333 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 35.0 mtm-85 -97.47 126.36 42.7 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 121.015 0.436 . . . . 74.519999999999996 111.718 -176.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.53 ' HB2' HD13 ' A' ' 197' ' ' LEU . . . -101.47 133.87 45.44 Favored 'General case' 0 C--O 1.241 0.628 0 C-N-CA 124.687 1.195 . . . . 53.240000000000002 109.14 173.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.56 112.77 21.88 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 108.793 -0.817 . . . . 73.439999999999998 108.793 175.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 68.3 p -111.39 177.1 4.77 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.393 0.677 . . . . 64.340000000000003 109.192 175.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 26.5 mt -62.9 -39.02 93.22 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 122.831 0.453 . . . . 71.219999999999999 111.487 -172.01 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -86.0 -18.22 33.16 Favored 'General case' 0 CA--C 1.551 1.003 0 CA-C-N 115.824 -0.625 . . . . 74.299999999999997 111.364 -175.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 153.53 -166.06 31.63 Favored Glycine 0 C--N 1.352 1.444 0 N-CA-C 114.37 0.508 . . . . 74.120000000000005 114.37 174.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -77.8 142.9 20.53 Favored 'Trans proline' 0 C--N 1.376 1.988 0 C-N-CA 123.088 2.525 . . . . 62.030000000000001 111.858 176.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.406 ' HB ' ' CD2' ' A' ' 175' ' ' TYR . 11.7 m -135.91 140.44 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 N-CA-C 109.237 -0.653 . . . . 64.150000000000006 109.237 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -96.96 108.1 20.75 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 122.819 0.448 . . . . 64.010000000000005 110.123 -178.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 22.3 t -95.08 135.12 30.12 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 C-N-CA 124.404 1.082 . . . . 62.049999999999997 109.815 -175.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -77.38 109.2 11.1 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 123.305 0.642 . . . . 72.230000000000004 110.666 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 57.3 t -79.11 117.7 68.37 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 123.681 0.793 . . . . 65.200000000000003 109.07 173.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -60.69 158.02 34.72 Favored 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 122.458 2.105 . . . . 74.129999999999995 112.371 174.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -71.26 133.45 22.85 Favored 'Trans proline' 0 C--N 1.368 1.582 0 C-N-CA 121.5 1.467 . . . . 65.450000000000003 110.563 171.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 67.82 67.21 0.36 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.81 1.244 . . . . 71.040000000000006 110.141 -176.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.501 HG22 HG11 ' A' ' 253' ' ' VAL . 72.9 m -103.02 132.89 48.96 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.188 0.995 . . . . 55.219999999999999 109.595 176.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -110.7 155.48 22.38 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.632 0.773 . . . . 75.400000000000006 110.555 -177.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' ALA . . . . . 0.507 ' HB2' ' HB ' ' A' ' 255' ' ' ILE . . . -69.22 121.58 17.1 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.981 0.912 . . . . 71.120000000000005 110.225 -178.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 111.64 -7.6 28.02 Favored Glycine 0 C--N 1.333 0.398 0 CA-C-O 119.222 -0.765 . . . . 54.520000000000003 112.555 -176.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.478 ' HD2' HG23 ' A' ' 227' ' ' THR . 58.7 mtt180 -61.24 145.77 50.12 Favored 'General case' 0 C--N 1.361 1.097 0 CA-C-N 117.326 0.563 . . . . 61.409999999999997 109.915 174.414 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.47 ' HG3' HG12 ' A' ' 170' ' ' VAL . 20.1 pttm -117.06 104.35 11.16 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.282 -0.872 . . . . 72.239999999999995 109.215 -175.365 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.411 HD22 ' HB2' ' A' ' 173' ' ' ALA . 82.8 mt -90.11 97.35 11.14 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 108.723 -0.844 . . . . 64.409999999999997 108.723 176.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 234' ' ' ARG . . . . . 0.751 ' HB3' HG21 ' A' ' 170' ' ' VAL . 64.7 ttt180 -88.07 107.18 18.62 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 108.676 -0.861 . . . . 64.120000000000005 108.676 171.413 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.427 HD13 ' CD1' ' A' ' 175' ' ' TYR . 16.0 mt -77.67 84.23 4.02 Favored 'General case' 0 C--O 1.248 0.989 0 N-CA-C 107.659 -1.237 . . . . 70.530000000000001 107.659 174.025 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 10.5 mtmp? -71.43 118.49 14.31 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 113.835 -1.529 . . . . 73.209999999999994 111.988 -169.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 64.14 28.82 73.44 Favored Glycine 0 C--N 1.348 1.212 0 O-C-N 124.044 0.84 . . . . 34.539999999999999 112.803 179.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 30.8 mmtp -125.47 -6.92 6.94 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 118.278 -0.868 . . . . 73.409999999999997 112.774 -173.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -62.57 -108.17 0.01 OUTLIER Glycine 0 C--N 1.354 1.538 0 O-C-N 123.827 0.704 . . . . 53.32 114.731 -171.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 240' ' ' PHE . . . . . 0.562 ' HB2' ' HA ' ' A' ' 191' ' ' GLN . 0.1 OUTLIER -75.97 140.02 69.96 Favored Pre-proline 0 N--CA 1.477 0.91 0 CA-C-O 118.574 -0.727 . . . . 70.519999999999996 109.811 177.72 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.516 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 53.1 Cg_exo -57.37 149.07 67.63 Favored 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 122.587 2.192 . . . . 72.310000000000002 113.293 175.057 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -164.81 123.58 1.18 Allowed Glycine 0 CA--C 1.538 1.512 0 CA-C-O 118.414 -1.215 . . . . 62.420000000000002 111.661 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -57.54 -46.16 29.14 Favored 'Trans proline' 0 C--N 1.386 2.521 0 C-N-CA 123.806 3.004 . . . . 70.25 113.646 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -78.87 -24.13 44.47 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 122.756 0.422 . . . . 72.439999999999998 110.81 178.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 168.19 142.0 3.36 Favored Glycine 0 C--N 1.345 1.057 0 CA-C-N 115.782 -0.645 . . . . 75.409999999999997 111.798 178.208 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.516 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 27.3 mtt-85 -73.63 166.54 23.08 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.495 0.718 . . . . 70.140000000000001 110.969 178.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -85.23 -156.99 27.35 Favored Glycine 0 C--N 1.336 0.579 0 CA-C-N 115.391 -0.822 . . . . 53.43 111.463 168.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -131.61 157.99 42.19 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 109.077 -0.712 . . . . 74.430000000000007 109.077 -176.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 42.4 tp -141.42 112.18 7.15 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 109.652 -0.499 . . . . 51.340000000000003 109.652 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -102.77 109.36 20.91 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.759 0.824 . . . . 74.409999999999997 109.838 -176.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 65.9 mt -104.92 136.09 45.05 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.727 0.811 . . . . 72.200000000000003 110.156 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -97.69 116.56 30.15 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.691 0.796 . . . . 70.510000000000005 109.303 170.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.501 HG11 HG22 ' A' ' 227' ' ' THR . 94.1 t -61.33 106.38 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-O 121.506 0.67 . . . . 74.109999999999999 110.465 172.379 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 17.0 mmt85 -104.37 102.49 12.16 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-N 114.67 -1.15 . . . . 74.319999999999993 108.065 173.043 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.507 ' HB ' ' HB2' ' A' ' 229' ' ' ALA . 24.1 mt -76.36 119.0 23.68 Favored 'Isoleucine or valine' 0 C--O 1.245 0.83 0 C-N-CA 122.901 0.481 . . . . 63.350000000000001 109.767 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.5 t . . . . . 0 CA--C 1.558 1.288 0 N-CA-C 108.682 -0.858 . . . . 72.310000000000002 108.682 175.99 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 64.0 mtt . . . . . 0 N--CA 1.478 0.927 0 N-CA-C 109.462 -0.57 . . . . 74.219999999999999 109.462 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -85.94 71.99 10.54 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 122.029 0.919 . . . . 72.5 109.401 176.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -65.47 -44.63 86.54 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 115.243 -0.89 . . . . 73.329999999999998 110.501 177.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.62 HG12 ' HG3' ' A' ' 232' ' ' LYS . 27.6 m -111.43 164.57 7.25 Favored 'Isoleucine or valine' 0 C--O 1.243 0.76 0 CA-C-N 114.305 -1.316 . . . . 65.549999999999997 109.16 175.035 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 17.6 tt -89.51 145.71 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 N-CA-C 108.236 -1.024 . . . . 75.0 108.236 168.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -58.75 122.21 12.98 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.671 0.788 . . . . 74.450000000000003 110.879 -179.034 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.454 ' HB2' HD22 ' A' ' 233' ' ' LEU . . . -135.99 154.78 50.97 Favored 'General case' 0 C--O 1.243 0.729 0 C-N-CA 124.5 1.12 . . . . 62.149999999999999 108.449 174.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -152.88 151.22 30.13 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.938 0.895 . . . . 71.420000000000002 109.404 -178.151 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.442 ' CD1' HD13 ' A' ' 235' ' ' LEU . 2.6 p90 -130.14 173.93 10.28 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-O 121.39 0.614 . . . . 71.409999999999997 111.025 176.206 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 78.2 mttt -139.23 144.39 40.26 Favored Pre-proline 0 C--O 1.243 0.746 0 CA-C-N 114.692 -1.14 . . . . 73.439999999999998 109.203 174.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -55.1 103.9 0.11 Allowed 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 123.279 2.652 . . . . 71.310000000000002 112.105 178.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' ALA . . . . . 0.502 ' HB2' ' HG3' ' A' ' 220' ' ' GLU . . . -68.41 -22.68 64.6 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.834 0.854 . . . . 74.409999999999997 111.345 -178.204 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -68.34 -38.24 81.32 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.883 0.873 . . . . 54.399999999999999 110.564 171.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 111.54 -22.91 18.96 Favored Glycine 0 C--N 1.353 1.517 0 CA-C-O 119.746 -0.474 . . . . 73.109999999999999 113.892 175.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 49.2 m -88.04 -64.41 1.15 Allowed 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 117.662 0.731 . . . . 72.409999999999997 109.997 178.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 81.36 -177.65 54.12 Favored Glycine 0 C--N 1.353 1.483 0 CA-C-N 116.528 -0.305 . . . . 51.43 112.994 -175.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -138.47 155.03 23.33 Favored Glycine 0 C--N 1.341 0.834 0 C-N-CA 122.58 0.133 . . . . 65.430000000000007 112.943 178.032 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 47.3 p -160.15 25.61 0.17 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.035 0.934 . . . . 75.420000000000002 110.667 -175.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -62.32 -87.59 0.04 OUTLIER Glycine 0 C--N 1.354 1.544 0 CA-C-N 115.594 -0.73 . . . . 64.0 114.219 -177.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -174.64 134.26 2.73 Favored Glycine 0 C--N 1.346 1.126 0 N-CA-C 112.052 -0.419 . . . . 45.329999999999998 112.052 -178.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 23.9 p -71.3 94.12 1.18 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.639 0.776 . . . . 71.129999999999995 110.289 178.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -80.74 79.34 1.78 Allowed Glycine 0 C--N 1.345 1.036 0 CA-C-N 115.726 -0.67 . . . . 71.319999999999993 112.781 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 85.16 -59.63 4.85 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 112.03 -0.428 . . . . 74.219999999999999 112.03 -179.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 48.8 m -80.46 139.22 36.53 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.073 0.549 . . . . 71.129999999999995 110.369 174.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -129.88 -49.29 1.13 Allowed 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.366 1.066 . . . . 75.129999999999995 108.745 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -76.79 150.38 36.17 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 114.296 -1.32 . . . . 70.530000000000001 110.613 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 36.6 mt -133.92 139.31 46.06 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 124.89 1.276 . . . . 74.129999999999995 107.639 171.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -128.21 125.01 38.15 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.204 0.602 . . . . 73.5 109.498 -176.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -161.85 171.51 17.63 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 123.736 0.815 . . . . 45.43 110.756 -175.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 15.6 p -105.89 149.86 26.16 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.633 0.773 . . . . 55.229999999999997 109.967 173.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.552 HD13 HD13 ' A' ' 251' ' ' LEU . 51.7 tp -115.01 118.72 34.22 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.999 0.92 . . . . 61.100000000000001 109.875 -175.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -83.39 119.62 24.86 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 109.319 -0.623 . . . . 74.310000000000002 109.319 175.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.515 ' HA ' HG11 ' A' ' 210' ' ' VAL . 3.5 p -133.7 123.24 17.16 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 123.638 0.775 . . . . 75.239999999999995 109.675 178.042 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -59.02 139.61 91.58 Favored 'Trans proline' 0 C--N 1.375 1.968 0 C-N-CA 122.725 2.283 . . . . 73.140000000000001 111.447 171.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.454 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -49.11 -47.58 75.12 Favored Pre-proline 0 CA--C 1.557 1.232 0 CA-C-O 117.792 -1.099 . . . . 64.439999999999998 113.022 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -55.93 -45.28 39.81 Favored 'Trans proline' 0 C--N 1.395 2.978 0 C-N-CA 122.206 1.938 . . . . 65.120000000000005 113.019 175.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 39.9 mt -65.93 -31.98 56.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 123.458 0.703 . . . . 65.430000000000007 111.02 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -71.84 -37.86 70.23 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.269 0.628 . . . . 71.239999999999995 111.48 179.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 201' ' ' ALA . 98.9 t -74.54 -53.69 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 123.647 0.779 . . . . 62.219999999999999 111.359 -178.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 7.1 p -73.03 -31.03 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 122.627 0.371 . . . . 54.439999999999998 111.11 -178.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 84.94 117.43 0.8 Allowed Glycine 0 C--N 1.344 0.979 0 N-CA-C 111.357 -0.697 . . . . 55.329999999999998 111.357 -172.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -151.8 -136.88 2.51 Favored Glycine 0 C--N 1.34 0.789 0 N-CA-C 111.564 -0.614 . . . . 74.329999999999998 111.564 -178.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 34.3 mtmm -136.95 146.09 45.01 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.003 0.921 . . . . 75.230000000000004 109.383 175.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.515 HG11 ' HA ' ' A' ' 199' ' ' VAL . 24.2 m -133.05 142.3 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 123.855 0.862 . . . . 63.509999999999998 109.22 172.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 211' ' ' ARG . . . . . 0.433 ' NH1' ' HB1' ' A' ' 178' ' ' ALA . 24.1 ttm-85 -87.7 110.45 20.44 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 122.817 0.447 . . . . 64.510000000000005 110.15 -170.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -101.8 164.47 11.71 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.656 1.182 . . . . 72.209999999999994 110.634 -178.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 10.1 mmt -105.92 123.23 47.65 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.862 0.865 . . . . 74.109999999999999 110.784 -179.174 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' THR . . . . . 0.467 HG22 HD22 ' A' ' 249' ' ' LEU . 47.5 p -114.63 171.29 7.73 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.304 1.042 . . . . 75.5 109.211 170.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 13.2 mt -72.28 -9.33 58.34 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 112.091 0.404 . . . . 73.129999999999995 112.091 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -99.97 -19.45 16.57 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 123.127 0.571 . . . . 63.219999999999999 111.772 175.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 143.58 -155.02 25.91 Favored Glycine 0 C--N 1.36 1.901 0 CA-C-O 119.695 -0.503 . . . . 53.329999999999998 113.995 174.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -76.64 136.33 17.07 Favored 'Trans proline' 0 C--N 1.379 2.14 0 C-N-CA 123.442 2.761 . . . . 75.200000000000003 113.229 178.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.479 ' HA ' ' H ' ' A' ' 178' ' ' ALA . 27.0 m -136.5 145.5 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 124.177 0.991 . . . . 74.439999999999998 109.293 177.327 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.502 ' HG3' ' HB2' ' A' ' 178' ' ' ALA . 37.4 mt-10 -102.3 112.11 24.68 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 109.52 -0.548 . . . . 62.439999999999998 109.52 178.24 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 46.7 t -94.7 118.09 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 124.41 1.084 . . . . 62.520000000000003 109.527 -174.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -66.96 102.19 0.94 Allowed 'General case' 0 C--O 1.24 0.561 0 C-N-CA 123.958 0.903 . . . . 71.219999999999999 110.427 176.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.458 HG11 HG21 ' A' ' 199' ' ' VAL . 64.6 t -80.24 120.88 80.89 Favored Pre-proline 0 CA--C 1.546 0.801 0 CA-C-N 115.162 -0.926 . . . . 74.530000000000001 108.969 174.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -60.6 162.38 18.26 Favored 'Trans proline' 0 CA--C 1.566 2.097 0 C-N-CA 122.904 2.403 . . . . 45.539999999999999 113.219 176.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -76.25 135.39 16.78 Favored 'Trans proline' 0 C--N 1.374 1.88 0 C-N-CA 122.622 2.215 . . . . 72.109999999999999 112.271 175.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 20.0 mtm180 66.54 57.25 0.71 Allowed 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 125.129 1.371 . . . . 73.540000000000006 110.631 -176.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.608 HG22 HG11 ' A' ' 253' ' ' VAL . 60.5 m -106.81 107.34 18.31 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.851 0.86 . . . . 52.329999999999998 109.381 178.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 22.5 mp0 -85.7 160.26 19.59 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.297 0.639 . . . . 73.239999999999995 111.678 -172.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -70.35 130.18 41.28 Favored 'General case' 0 C--N 1.352 0.682 0 N-CA-C 108.867 -0.79 . . . . 74.540000000000006 108.867 175.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 114.47 -19.08 17.16 Favored Glycine 0 N--CA 1.466 0.634 0 CA-C-O 119.636 -0.536 . . . . 71.409999999999997 111.897 -173.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.501 ' HD2' HG23 ' A' ' 227' ' ' THR . 81.2 mtt180 -67.19 161.85 23.84 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-O 121.579 0.704 . . . . 74.340000000000003 111.877 175.287 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.62 ' HG3' HG12 ' A' ' 170' ' ' VAL . 19.5 pttm -130.19 142.11 50.6 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.344 1.058 . . . . 60.5 109.42 177.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.454 HD22 ' HB2' ' A' ' 173' ' ' ALA . 75.2 mt -120.61 129.02 53.56 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 107.89 -1.152 . . . . 52.520000000000003 107.89 178.455 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 40.4 ttt180 -113.7 102.14 9.97 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 108.816 -0.809 . . . . 73.209999999999994 108.816 171.066 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.625 ' HB3' ' HB2' ' A' ' 238' ' ' LYS . 21.3 mt -76.19 84.01 3.01 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 114.246 -1.343 . . . . 62.310000000000002 108.632 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -72.65 127.37 32.35 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.641 -0.709 . . . . 61.43 110.67 -173.215 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 69.48 20.52 75.51 Favored Glycine 0 C--N 1.342 0.901 0 O-C-N 123.764 0.665 . . . . 65.540000000000006 112.053 -175.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.625 ' HB2' ' HB3' ' A' ' 235' ' ' LEU . 22.3 mmtp -136.37 58.05 1.75 Allowed 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.581 1.152 . . . . 71.409999999999997 108.54 -176.414 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -139.9 -113.48 1.08 Allowed Glycine 0 N--CA 1.472 1.093 0 CA-C-O 119.226 -0.764 . . . . 71.400000000000006 111.74 175.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -64.11 146.32 97.54 Favored Pre-proline 0 N--CA 1.484 1.254 0 CA-C-O 118.47 -0.776 . . . . 71.109999999999999 110.699 175.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -54.79 160.0 8.23 Favored 'Trans proline' 0 C--N 1.38 2.204 0 C-N-CA 123.488 2.792 . . . . 71.109999999999999 112.871 176.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -169.85 136.43 4.0 Favored Glycine 0 CA--C 1.525 0.702 0 CA-C-O 118.742 -1.032 . . . . 52.5 112.024 -178.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -70.23 -41.54 3.6 Favored 'Trans proline' 0 C--N 1.378 2.091 0 C-N-CA 123.184 2.59 . . . . 65.329999999999998 113.305 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -102.11 -18.79 15.41 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.702 0.801 . . . . 64.209999999999994 111.222 -177.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 175.66 145.68 5.57 Favored Glycine 0 C--N 1.341 0.847 0 N-CA-C 111.262 -0.735 . . . . 72.439999999999998 111.262 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 21.1 mtm180 -88.19 165.32 15.15 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.088 0.555 . . . . 74.239999999999995 110.589 -176.066 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -74.14 -168.07 17.54 Favored Glycine 0 C--N 1.35 1.312 0 N-CA-C 111.486 -0.646 . . . . 74.099999999999994 111.486 168.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -118.27 151.84 36.89 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 118.406 1.103 . . . . 71.219999999999999 111.247 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.467 HD22 HG22 ' A' ' 214' ' ' THR . 35.9 tp -113.75 118.21 33.66 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 108.559 -0.904 . . . . 71.010000000000005 108.559 171.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 250' ' ' TYR . . . . . 0.539 ' OH ' ' HD2' ' A' ' 232' ' ' LYS . 2.7 t80 -96.4 115.9 28.17 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.84 -1.17 . . . . 74.400000000000006 107.84 -178.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.552 HD13 HD13 ' A' ' 197' ' ' LEU . 57.6 mt -118.93 117.22 28.23 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.79 0.836 . . . . 70.019999999999996 110.38 -177.323 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -77.32 116.07 17.62 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 108.997 -0.742 . . . . 54.140000000000001 108.997 171.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.608 HG11 HG22 ' A' ' 227' ' ' THR . 94.8 t -62.09 104.27 0.3 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.934 0 CA-C-O 121.322 0.582 . . . . 71.040000000000006 110.433 176.542 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 19.6 mmm180 -110.15 106.37 15.79 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 107.952 -1.129 . . . . 62.229999999999997 107.952 175.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.447 HD11 ' O ' ' A' ' 227' ' ' THR . 45.0 mt -77.77 143.8 12.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 122.898 0.479 . . . . 73.340000000000003 110.483 178.507 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 4.9 t . . . . . 0 C--O 1.261 1.68 0 C-N-CA 124.48 1.112 . . . . 64.430000000000007 108.721 174.739 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 167' ' ' MET . . . . . 0.562 ' SD ' ' HE3' ' A' ' 236' ' ' LYS . 26.1 ptt? . . . . . 0 N--CA 1.488 1.458 0 CA-C-O 121.344 0.593 . . . . 72.439999999999998 110.243 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -78.61 6.79 7.96 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.653 1.181 . . . . 73.319999999999993 112.566 -175.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -56.74 -61.47 2.4 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.007 0.923 . . . . 63.119999999999997 111.082 178.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 33.0 m -89.82 157.15 3.01 Favored 'Isoleucine or valine' 0 C--O 1.243 0.75 0 C-N-CA 122.835 0.454 . . . . 74.25 110.054 176.041 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.429 HG21 ' HD3' ' A' ' 231' ' ' ARG . 15.1 tt -83.09 146.73 6.59 Favored 'Isoleucine or valine' 0 C--O 1.249 1.057 0 N-CA-C 108.496 -0.927 . . . . 52.420000000000002 108.496 172.434 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -58.06 136.08 57.1 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.718 0.807 . . . . 70.219999999999999 111.52 -176.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.539 ' HB2' HD22 ' A' ' 233' ' ' LEU . . . -158.31 158.18 33.87 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 124.885 1.274 . . . . 74.540000000000006 109.337 173.086 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -164.27 149.42 10.25 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.924 0.89 . . . . 75.540000000000006 109.221 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.538 ' HB3' HG22 ' A' ' 221' ' ' VAL . 1.6 p90 -122.39 175.93 6.16 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 121.807 0.813 . . . . 74.430000000000007 112.34 177.517 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -138.22 129.31 15.64 Favored Pre-proline 0 C--O 1.241 0.629 0 CA-C-N 113.639 -1.619 . . . . 73.450000000000003 107.575 167.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' PRO . . . . . 0.434 ' HA ' HG12 ' A' ' 219' ' ' VAL . 35.7 Cg_exo -54.37 128.25 29.29 Favored 'Trans proline' 0 C--N 1.369 1.657 0 C-N-CA 123.486 2.791 . . . . 64.099999999999994 111.639 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -63.99 99.26 0.25 Allowed 'General case' 0 CA--C 1.549 0.927 0 O-C-N 123.737 0.648 . . . . 75.329999999999998 110.429 -175.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 35.4 t70 70.25 15.0 7.54 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 125.801 1.64 . . . . 64.129999999999995 111.701 -178.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -114.17 165.14 12.03 Favored Glycine 0 C--N 1.346 1.133 0 C-N-CA 123.344 0.497 . . . . 54.0 112.516 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 24.9 p -90.63 132.86 35.51 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.353 0.661 . . . . 70.439999999999998 110.095 177.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -168.99 60.45 0.2 Allowed Glycine 0 C--N 1.338 0.682 0 N-CA-C 111.084 -0.806 . . . . 52.399999999999999 111.084 -177.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -95.57 81.51 0.83 Allowed Glycine 0 C--N 1.339 0.75 0 N-CA-C 111.515 -0.634 . . . . 60.200000000000003 111.515 176.209 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 49.4 m -137.35 156.06 48.67 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.286 0.634 . . . . 63.299999999999997 110.601 -178.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -139.76 -170.36 11.93 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 110.976 -0.85 . . . . 55.109999999999999 110.976 175.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 88.55 -151.2 22.32 Favored Glycine 0 C--N 1.343 0.96 0 CA-C-N 117.031 0.416 . . . . 62.350000000000001 112.661 -178.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 68.5 m -158.2 -172.65 3.97 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.268 1.027 . . . . 45.420000000000002 109.755 -177.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -178.25 135.78 2.77 Favored Glycine 0 C--N 1.34 0.76 0 CA-C-O 119.695 -0.503 . . . . 32.409999999999997 111.994 171.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -63.51 -22.16 65.48 Favored Glycine 0 C--N 1.358 1.8 0 CA-C-O 121.423 0.457 . . . . 64.549999999999997 112.257 172.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 50.3 m -115.55 173.75 6.37 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.703 1.201 . . . . 65.540000000000006 108.915 168.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 67.54 14.92 9.72 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 124.49 1.116 . . . . 74.230000000000004 111.145 -172.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -85.59 153.51 22.35 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.574 0.75 . . . . 74.400000000000006 109.965 178.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 58.4 mt -131.81 152.93 50.64 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.546 0.738 . . . . 73.209999999999994 109.251 176.267 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -119.18 132.41 55.96 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 108.489 -0.93 . . . . 72.420000000000002 108.489 170.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -157.79 164.46 37.01 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.22 0.608 . . . . 53.240000000000002 110.022 178.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 99.4 m -96.03 146.67 24.44 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 115.647 -0.706 . . . . 74.230000000000004 109.64 175.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.506 HD11 HG23 ' A' ' 210' ' ' VAL . 42.7 tp -113.85 117.87 32.64 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.713 0.805 . . . . 71.200000000000003 109.288 175.242 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -89.26 100.71 13.44 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 123.783 0.833 . . . . 74.439999999999998 108.917 175.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.495 ' HA ' HG11 ' A' ' 210' ' ' VAL . 7.1 p -113.04 116.74 46.87 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 123.496 0.718 . . . . 74.519999999999996 109.839 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -56.18 145.91 73.91 Favored 'Trans proline' 0 C--N 1.374 1.904 0 C-N-CA 122.839 2.359 . . . . 54.299999999999997 112.4 173.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -50.28 -49.48 76.28 Favored Pre-proline 0 CA--C 1.558 1.285 0 O-C-N 124.542 1.151 . . . . 72.5 112.987 -179.026 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -55.06 -46.71 31.08 Favored 'Trans proline' 0 C--N 1.401 3.315 0 C-N-CA 122.484 2.123 . . . . 72.230000000000004 112.735 175.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.522 HG21 HG13 ' A' ' 210' ' ' VAL . 42.1 mt -68.73 -32.54 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 123.664 0.786 . . . . 74.530000000000001 110.798 -176.226 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.59 -44.9 73.37 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.62 0.768 . . . . 52.409999999999997 110.459 179.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 95.4 t -64.64 -55.82 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 122.999 0.519 . . . . 64.409999999999997 110.602 178.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 17.0 m -69.49 -30.31 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 O-C-N 123.531 0.52 . . . . 75.319999999999993 112.171 -173.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 78.3 69.96 1.35 Allowed Glycine 0 C--N 1.348 1.222 0 N-CA-C 111.648 -0.581 . . . . 60.140000000000001 111.648 -172.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -104.13 -136.84 9.02 Favored Glycine 0 C--N 1.348 1.247 0 N-CA-C 111.657 -0.577 . . . . 60.439999999999998 111.657 -177.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 35.1 mtmm -133.03 137.04 46.33 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.432 0.693 . . . . 74.109999999999999 109.31 176.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.522 HG13 HG21 ' A' ' 203' ' ' ILE . 14.9 m -127.9 142.32 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 123.645 0.778 . . . . 63.539999999999999 109.731 174.566 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 61.5 ttp180 -83.68 117.12 23.0 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 116.13 -0.486 . . . . 53.200000000000003 110.049 -178.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -100.79 156.72 17.19 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.685 0.794 . . . . 72.25 109.194 174.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 76.1 mmm -107.18 121.29 44.23 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 122.729 0.412 . . . . 54.299999999999997 110.159 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 36.2 p -108.86 173.51 6.29 Favored 'General case' 0 C--O 1.243 0.726 0 C-N-CA 124.351 1.06 . . . . 61.229999999999997 108.62 170.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 13.3 mt -67.4 -24.38 65.66 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 122.625 0.37 . . . . 71.450000000000003 111.472 -175.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -87.55 -20.59 26.25 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.431 0.693 . . . . 65.200000000000003 111.498 -178.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 149.66 -160.68 28.58 Favored Glycine 0 C--N 1.35 1.318 0 CA-C-O 119.772 -0.46 . . . . 72.230000000000004 113.135 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -84.65 147.56 10.94 Favored 'Trans proline' 0 C--N 1.364 1.344 0 C-N-CA 123.061 2.507 . . . . 72.099999999999994 112.583 178.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.434 HG12 ' HA ' ' A' ' 177' ' ' PRO . 21.3 m -137.07 147.24 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 108.499 -0.926 . . . . 73.140000000000001 108.499 178.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -103.01 108.4 19.56 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 109.044 -0.724 . . . . 72.400000000000006 109.044 179.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.538 HG22 ' HB3' ' A' ' 175' ' ' TYR . 49.1 t -94.49 120.5 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.565 1.146 . . . . 73.0 109.888 -174.392 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -71.95 107.55 4.75 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 109.662 -0.495 . . . . 70.329999999999998 109.662 174.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 41.8 t -71.65 129.88 87.92 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 124.152 0.981 . . . . 60.329999999999998 109.166 174.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -63.45 157.18 52.15 Favored 'Trans proline' 0 CA--C 1.56 1.797 0 C-N-CA 122.047 1.831 . . . . 74.099999999999994 111.799 170.215 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.7 151.1 85.47 Favored 'Trans proline' 0 C--N 1.366 1.491 0 C-N-CA 122.095 1.863 . . . . 73.430000000000007 111.646 173.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 73.3 mtt85 55.65 57.97 4.88 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.166 0.986 . . . . 71.409999999999997 111.661 177.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.557 HG23 ' HD2' ' A' ' 231' ' ' ARG . 28.1 m -98.85 113.94 26.3 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 114.719 -1.128 . . . . 64.319999999999993 110.476 -179.149 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 22.1 mp0 -92.11 157.87 16.51 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.47 0.708 . . . . 73.219999999999999 110.03 177.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' ALA . . . . . 0.454 ' HB2' ' HB ' ' A' ' 255' ' ' ILE . . . -66.74 134.85 53.03 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 108.708 -0.849 . . . . 52.310000000000002 108.708 169.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 100.6 -3.06 56.11 Favored Glycine 0 C--O 1.241 0.585 0 O-C-N 123.53 0.519 . . . . 62.140000000000001 112.604 -173.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.557 ' HD2' HG23 ' A' ' 227' ' ' THR . 63.2 mtt-85 -69.61 159.65 33.01 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-O 121.382 0.611 . . . . 73.129999999999995 110.367 171.583 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 48.2 pttt -131.01 137.49 49.23 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.432 -0.804 . . . . 71.129999999999995 110.374 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.539 HD22 ' HB2' ' A' ' 173' ' ' ALA . 29.6 mt -123.52 135.14 53.87 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 108.156 -1.054 . . . . 74.239999999999995 108.156 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 18.9 ttt85 -122.4 101.59 7.59 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.364 -0.976 . . . . 73.530000000000001 108.364 167.132 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.533 HD13 ' HD1' ' A' ' 175' ' ' TYR . 13.3 mt -75.33 85.3 2.49 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 125.278 1.431 . . . . 60.399999999999999 109.441 -176.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.705 ' HA ' ' HB3' ' A' ' 248' ' ' ASP . 59.2 mttm -66.78 129.44 39.89 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.174 -0.921 . . . . 75.239999999999995 111.19 -176.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 75.89 12.43 83.94 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 123.811 0.695 . . . . 50.219999999999999 113.025 -178.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -137.21 49.97 2.0 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.588 1.155 . . . . 70.129999999999995 109.366 -176.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -113.68 -119.76 3.53 Favored Glycine 0 N--CA 1.473 1.157 0 N-CA-C 111.217 -0.753 . . . . 52.119999999999997 111.217 173.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -76.63 140.84 68.3 Favored Pre-proline 0 N--CA 1.48 1.058 0 C-N-CA 123.516 0.727 . . . . 63.399999999999999 109.853 176.532 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -66.88 128.1 18.18 Favored 'Trans proline' 0 C--N 1.376 2.004 0 C-N-CA 122.636 2.224 . . . . 71.140000000000001 111.3 170.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -129.09 161.16 22.6 Favored Glycine 0 N--CA 1.476 1.332 0 CA-C-O 119.548 -0.585 . . . . 43.109999999999999 112.196 176.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -68.5 -33.01 23.79 Favored 'Trans proline' 0 C--N 1.37 1.69 0 C-N-CA 122.457 2.105 . . . . 65.349999999999994 113.083 -177.28 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -99.03 -2.08 38.12 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.146 0.578 . . . . 65.420000000000002 112.298 -177.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 157.9 -151.07 22.23 Favored Glycine 0 C--N 1.344 0.981 0 N-CA-C 111.143 -0.783 . . . . 75.420000000000002 111.143 -177.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 29.8 mtt-85 -129.43 163.17 26.42 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 117.889 0.845 . . . . 71.430000000000007 111.019 174.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -87.61 -156.99 30.86 Favored Glycine 0 C--N 1.345 1.058 0 CA-C-N 115.051 -0.977 . . . . 53.149999999999999 111.641 167.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 248' ' ' ASP . . . . . 0.705 ' HB3' ' HA ' ' A' ' 236' ' ' LYS . 1.0 OUTLIER -130.07 135.6 48.42 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 122.935 0.494 . . . . 71.120000000000005 112.035 -177.78 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 34.5 tp -98.59 116.97 31.99 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.354 0.661 . . . . 72.349999999999994 109.586 178.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -91.01 107.8 19.44 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.69 0.796 . . . . 73.420000000000002 109.335 178.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 48.8 mt -97.23 141.85 29.85 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.201 0.6 . . . . 73.329999999999998 111.255 178.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -101.53 108.13 19.61 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.084 -0.962 . . . . 72.239999999999995 108.882 175.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 69.0 t -66.09 116.24 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-O 121.119 0.485 . . . . 64.129999999999995 111.025 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 36.7 mmm-85 -121.55 115.05 22.09 Favored 'General case' 0 C--O 1.242 0.677 0 N-CA-C 107.594 -1.261 . . . . 75.010000000000005 107.594 173.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.454 ' HB ' ' HB2' ' A' ' 229' ' ' ALA . 21.9 mt -75.07 129.03 37.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 N-CA-C 109.513 -0.551 . . . . 72.010000000000005 109.513 175.26 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 8.3 t . . . . . 0 CA--C 1.562 1.407 0 CA-C-O 117.418 -1.277 . . . . 70.450000000000003 108.3 178.439 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 53.3 tpp . . . . . 0 N--CA 1.475 0.824 0 N-CA-C 109.733 -0.469 . . . . 71.530000000000001 109.733 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 19.9 t70 63.89 88.84 0.1 Allowed 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.774 1.23 . . . . 74.340000000000003 111.202 178.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -152.78 -63.84 0.16 Allowed 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 107.456 -1.313 . . . . 63.140000000000001 107.456 175.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.526 HG21 ' HB3' ' A' ' 234' ' ' ARG . 16.2 m -88.22 161.59 2.74 Favored 'Isoleucine or valine' 0 C--O 1.244 0.78 0 N-CA-C 108.249 -1.019 . . . . 72.430000000000007 108.249 161.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 16.2 tt -91.02 133.18 33.55 Favored 'Isoleucine or valine' 0 C--O 1.243 0.721 0 N-CA-C 107.07 -1.456 . . . . 73.519999999999996 107.07 164.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -68.57 117.89 10.9 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 123.659 0.784 . . . . 74.230000000000004 110.152 -170.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.467 ' HB2' HD22 ' A' ' 233' ' ' LEU . . . -123.57 172.61 8.64 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.662 1.185 . . . . 73.400000000000006 108.834 178.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -152.81 158.25 41.95 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.386 0.674 . . . . 71.129999999999995 109.659 177.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -141.21 168.39 19.9 Favored 'General case' 0 C--N 1.35 0.59 0 C-N-CA 122.731 0.412 . . . . 73.310000000000002 110.761 177.183 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -142.78 149.23 49.23 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 124.95 1.3 . . . . 72.209999999999994 108.705 173.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' PRO . . . . . 0.547 ' HA ' HG12 ' A' ' 219' ' ' VAL . 20.4 Cg_endo -58.76 123.78 14.29 Favored 'Trans proline' 0 C--N 1.377 2.051 0 C-N-CA 122.931 2.42 . . . . 61.109999999999999 111.757 176.356 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' ALA . . . . . 0.562 ' HB2' ' HG3' ' A' ' 220' ' ' GLU . . . -77.98 -38.98 43.83 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.694 0.798 . . . . 62.520000000000003 109.827 179.201 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -93.34 152.74 18.95 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 114.637 -1.165 . . . . 74.230000000000004 109.58 175.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -74.7 85.2 0.76 Allowed Glycine 0 C--N 1.35 1.316 0 N-CA-C 111.312 -0.715 . . . . 73.129999999999995 111.312 177.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 29.3 p -78.23 130.79 36.7 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.885 0.874 . . . . 74.340000000000003 110.904 -178.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -101.89 -21.82 10.74 Favored Glycine 0 C--N 1.348 1.243 0 CA-C-N 116.317 -0.401 . . . . 71.099999999999994 113.011 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -92.93 37.88 3.29 Favored Glycine 0 C--N 1.348 1.248 0 C-N-CA 123.029 0.347 . . . . 65.329999999999998 112.503 -177.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 20.6 p -79.62 84.71 5.43 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.616 0.767 . . . . 72.150000000000006 110.698 -178.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 176.94 135.39 2.17 Favored Glycine 0 C--N 1.347 1.163 0 CA-C-N 115.428 -0.806 . . . . 53.409999999999997 111.722 176.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -110.21 -150.93 12.94 Favored Glycine 0 C--N 1.351 1.415 0 C-N-CA 123.557 0.598 . . . . 71.409999999999997 111.763 176.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 70.8 m -155.16 -50.6 0.09 Allowed 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.205 0.602 . . . . 74.430000000000007 110.146 177.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 177.22 -157.22 21.89 Favored Glycine 0 C--N 1.342 0.886 0 CA-C-N 116.234 -0.439 . . . . 70.340000000000003 112.013 -177.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 76.48 -124.72 7.3 Favored Glycine 0 C--N 1.346 1.132 0 N-CA-C 111.775 -0.53 . . . . 71.25 111.775 -179.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 49.5 m -104.43 94.02 5.11 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.387 0.675 . . . . 70.439999999999998 109.645 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.417 ' O ' ' HA3' ' A' ' 247' ' ' GLY . 25.0 mm-40 -85.61 5.4 31.96 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 115.317 -0.856 . . . . 73.099999999999994 111.423 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -93.41 157.72 16.08 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.462 0.705 . . . . 75.219999999999999 110.047 175.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 43.1 mt -136.24 143.35 44.25 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.323 1.049 . . . . 75.030000000000001 108.282 171.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -129.61 120.76 25.79 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 123.791 0.836 . . . . 72.329999999999998 109.079 -178.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -159.37 165.18 33.82 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 121.47 0.653 . . . . 74.510000000000005 110.931 -177.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 2.9 p -93.25 138.3 31.76 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.798 0.839 . . . . 70.209999999999994 109.56 173.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.56 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . 57.9 tp -108.6 119.34 39.22 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.597 1.159 . . . . 71.299999999999997 109.497 -177.218 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -82.2 103.2 11.63 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 109.562 -0.533 . . . . 72.019999999999996 109.562 176.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.515 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 47.5 t -106.21 111.17 64.36 Favored Pre-proline 0 CA--C 1.542 0.643 0 N-CA-C 108.195 -1.039 . . . . 71.549999999999997 108.195 175.468 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 200' ' ' PRO . . . . . 0.424 ' HD2' HD12 ' A' ' 203' ' ' ILE . 50.5 Cg_exo -57.38 142.1 94.98 Favored 'Trans proline' 0 C--N 1.373 1.862 0 C-N-CA 122.498 2.132 . . . . 72.150000000000006 111.874 172.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.404 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -50.66 -47.5 84.87 Favored Pre-proline 0 CA--C 1.559 1.298 0 CA-C-O 117.793 -1.099 . . . . 62.299999999999997 112.985 -177.751 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -55.49 -41.93 73.05 Favored 'Trans proline' 0 C--N 1.398 3.178 0 C-N-CA 122.095 1.863 . . . . 64.230000000000004 112.891 176.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.424 HD12 ' HD2' ' A' ' 200' ' ' PRO . 34.5 mt -69.71 -36.2 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 C-N-CA 123.379 0.671 . . . . 74.450000000000003 110.894 -177.592 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.24 -38.32 78.44 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.227 0.611 . . . . 64.420000000000002 111.651 -178.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 201' ' ' ALA . 89.3 t -72.7 -56.29 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 CA-C-N 115.689 -0.687 . . . . 74.340000000000003 110.82 -178.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 9.4 m -80.39 -24.69 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 CA-C-N 116.294 -0.412 . . . . 73.510000000000005 111.985 -172.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 82.47 136.92 2.56 Favored Glycine 0 C--N 1.349 1.254 0 O-C-N 123.433 0.458 . . . . 44.100000000000001 112.622 -175.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 179.49 -124.91 0.93 Allowed Glycine 0 C--N 1.341 0.844 0 N-CA-C 111.776 -0.529 . . . . 62.140000000000001 111.776 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.514 ' HD2' ' HB3' ' A' ' 220' ' ' GLU . 46.9 mtmt -137.63 153.02 49.93 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.654 0.781 . . . . 42.43 109.817 176.044 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.491 HG11 ' HA ' ' A' ' 199' ' ' VAL . 27.3 m -128.84 168.23 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.578 1.151 . . . . 72.319999999999993 108.707 170.361 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 45.9 ttp180 -94.78 141.48 28.58 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 109.761 -0.459 . . . . 70.129999999999995 109.761 173.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -129.77 154.78 46.87 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.02 0.928 . . . . 75.340000000000003 109.036 173.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -103.66 114.45 28.72 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 109.218 -0.66 . . . . 73.129999999999995 109.218 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 64.4 p -114.57 175.62 5.41 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.246 0.618 . . . . 64.310000000000002 109.439 174.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 11.8 mt -81.12 -3.17 51.14 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 116.109 -0.496 . . . . 55.350000000000001 110.283 173.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -91.54 -20.34 21.8 Favored 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 123.862 0.865 . . . . 72.239999999999995 110.403 170.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 133.23 -163.64 24.3 Favored Glycine 0 C--N 1.352 1.446 0 CA-C-O 119.752 -0.471 . . . . 62.140000000000001 112.595 177.104 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -74.93 131.03 13.91 Favored 'Trans proline' 0 C--N 1.37 1.705 0 C-N-CA 123.042 2.495 . . . . 75.129999999999995 110.278 172.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.547 HG12 ' HA ' ' A' ' 177' ' ' PRO . 17.9 m -131.19 161.83 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 123.538 0.735 . . . . 61.020000000000003 110.478 -173.098 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.562 ' HG3' ' HB2' ' A' ' 178' ' ' ALA . 35.4 mt-10 -112.18 113.25 25.4 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.645 0.778 . . . . 74.510000000000005 109.681 178.454 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 57.5 t -95.46 118.99 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.229 1.011 . . . . 54.409999999999997 109.059 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -67.54 100.13 0.84 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.777 0.831 . . . . 70.430000000000007 110.149 176.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 91.7 t -81.77 121.02 79.09 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 124.562 1.145 . . . . 72.129999999999995 109.858 176.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -65.56 155.27 69.84 Favored 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 122.22 1.947 . . . . 70.439999999999998 111.482 173.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -66.77 156.23 66.91 Favored 'Trans proline' 0 C--N 1.37 1.702 0 C-N-CA 122.322 2.015 . . . . 74.140000000000001 111.731 172.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 49.0 mtm-85 63.34 31.53 15.2 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.19 0.996 . . . . 73.129999999999995 111.151 172.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.429 HG23 ' HD2' ' A' ' 231' ' ' ARG . 92.1 m -86.84 122.62 30.97 Favored 'General case' 0 C--N 1.344 0.367 0 C-N-CA 123.58 0.752 . . . . 65.030000000000001 109.256 176.617 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -94.35 167.79 11.3 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.499 0.719 . . . . 75.040000000000006 110.715 177.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -78.71 149.21 32.81 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-N 114.936 -1.029 . . . . 74.120000000000005 109.816 177.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 87.34 1.43 83.88 Favored Glycine 0 C--N 1.339 0.716 0 CA-C-N 115.681 -0.69 . . . . 75.129999999999995 111.963 -173.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.429 ' HD2' HG23 ' A' ' 227' ' ' THR . 54.3 mtt-85 -79.25 163.05 25.27 Favored 'General case' 0 C--N 1.353 0.76 0 CA-C-O 121.419 0.628 . . . . 71.209999999999994 110.103 170.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 15.9 pttm -128.41 139.97 52.08 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 124.344 1.058 . . . . 72.25 109.491 -178.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.467 HD22 ' HB2' ' A' ' 173' ' ' ALA . 90.0 mt -120.29 105.95 11.42 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.25 1.02 . . . . 64.239999999999995 108.906 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 234' ' ' ARG . . . . . 0.526 ' HB3' HG21 ' A' ' 170' ' ' VAL . 71.4 ttt180 -90.49 101.45 14.19 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 107.278 -1.378 . . . . 64.340000000000003 107.278 170.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 22.8 mt -77.13 83.41 3.62 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 107.718 -1.215 . . . . 71.409999999999997 107.718 174.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -68.68 129.0 38.67 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-N 113.049 -1.887 . . . . 74.430000000000007 111.861 -169.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 60.62 32.2 77.61 Favored Glycine 0 C--N 1.347 1.188 0 O-C-N 124.738 1.274 . . . . 61.409999999999997 112.473 177.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -136.79 -2.92 2.09 Favored 'General case' 0 C--N 1.358 0.964 0 N-CA-C 113.641 0.978 . . . . 74.25 113.641 -176.034 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 239' ' ' GLY . . . . . 0.415 ' HA2' ' HB2' ' A' ' 249' ' ' LEU . . . -61.69 -107.33 0.01 OUTLIER Glycine 0 N--CA 1.485 1.965 0 N-CA-C 114.603 0.601 . . . . 71.519999999999996 114.603 -178.152 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -67.81 136.31 92.38 Favored Pre-proline 0 N--CA 1.486 1.351 0 CA-C-O 118.328 -0.844 . . . . 72.340000000000003 109.523 171.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.507 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 37.8 Cg_exo -60.88 135.65 60.93 Favored 'Trans proline' 0 C--N 1.371 1.75 0 C-N-CA 122.648 2.232 . . . . 52.25 112.532 175.302 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -164.86 120.56 0.94 Allowed Glycine 0 CA--C 1.54 1.613 0 CA-C-O 118.556 -1.136 . . . . 73.219999999999999 111.99 -177.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -72.25 -20.13 24.95 Favored 'Trans proline' 0 C--N 1.387 2.554 0 C-N-CA 123.506 2.804 . . . . 72.219999999999999 112.811 176.315 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -93.29 12.64 23.91 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.231 0.612 . . . . 62.450000000000003 110.695 175.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 118.97 120.24 2.91 Favored Glycine 0 C--N 1.353 1.477 0 N-CA-C 110.592 -1.003 . . . . 70.230000000000004 110.592 -177.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.507 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 28.0 mtt180 -72.29 162.67 29.15 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.291 0.636 . . . . 73.239999999999995 109.71 174.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.417 ' HA3' ' O ' ' A' ' 191' ' ' GLN . . . -80.56 -157.86 16.77 Favored Glycine 0 C--N 1.348 1.234 0 N-CA-C 112.435 -0.266 . . . . 73.129999999999995 112.435 174.484 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -121.43 128.85 52.58 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 117.407 0.603 . . . . 61.5 109.786 177.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.415 ' HB2' ' HA2' ' A' ' 239' ' ' GLY . 50.2 tp -100.19 108.18 20.22 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 108.263 -1.014 . . . . 71.450000000000003 108.263 173.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -98.69 116.43 30.91 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 108.522 -0.918 . . . . 70.420000000000002 108.522 -174.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.56 ' HB3' ' HB2' ' A' ' 197' ' ' LEU . 49.1 mt -127.22 119.17 25.78 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.024 0.93 . . . . 74.310000000000002 110.271 -173.24 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -83.57 121.33 27.09 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 122.979 0.511 . . . . 75.430000000000007 110.192 176.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 61.2 t -66.87 105.49 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 C-N-CA 123.691 0.796 . . . . 75.129999999999995 110.46 179.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 47.6 mmm-85 -107.25 100.02 9.51 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 107.703 -1.221 . . . . 74.040000000000006 107.703 173.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.515 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 39.8 mt -76.94 119.37 25.21 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 CA-C-N 116.063 -0.517 . . . . 72.239999999999995 110.422 -178.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 29.5 p . . . . . 0 C--O 1.249 1.06 0 N-CA-C 108.393 -0.965 . . . . 44.020000000000003 108.393 175.614 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 67.2 mtm . . . . . 0 N--CA 1.48 1.072 0 N-CA-C 109.752 -0.462 . . . . 74.340000000000003 109.752 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -89.21 48.33 1.6 Allowed 'General case' 0 N--CA 1.48 1.074 0 CA-C-O 121.89 0.853 . . . . 62.409999999999997 110.148 177.198 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -58.14 -55.64 32.38 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 114.757 -1.111 . . . . 63.530000000000001 109.707 174.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.44 HG12 ' HG3' ' A' ' 232' ' ' LYS . 33.5 m -92.03 156.09 3.05 Favored 'Isoleucine or valine' 0 C--O 1.244 0.784 0 CA-C-N 114.87 -1.059 . . . . 51.450000000000003 109.147 171.542 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 16.6 tt -83.3 143.43 11.95 Favored 'Isoleucine or valine' 0 C--O 1.245 0.863 0 N-CA-C 108.703 -0.851 . . . . 60.520000000000003 108.703 171.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -59.92 137.96 57.94 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.301 1.041 . . . . 74.319999999999993 110.787 -176.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.466 ' HB2' HD22 ' A' ' 233' ' ' LEU . . . -157.69 159.34 36.81 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.319 1.048 . . . . 53.340000000000003 109.537 -178.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -160.42 152.22 19.93 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.604 0.762 . . . . 65.430000000000007 109.742 174.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.546 ' HB3' HG22 ' A' ' 221' ' ' VAL . 34.6 p90 -113.7 -178.67 3.43 Favored 'General case' 0 C--N 1.349 0.561 0 CA-C-O 121.23 0.538 . . . . 70.5 111.704 -178.274 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -135.78 140.71 34.43 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-N 114.394 -1.275 . . . . 64.420000000000002 107.955 170.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -60.87 113.92 1.93 Allowed 'Trans proline' 0 C--N 1.366 1.487 0 C-N-CA 123.212 2.608 . . . . 75.340000000000003 111.134 175.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' ALA . . . . . 0.439 ' HB2' ' HG3' ' A' ' 220' ' ' GLU . . . -99.98 -10.51 21.54 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.497 0.719 . . . . 73.409999999999997 110.848 175.599 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -55.52 -46.73 77.0 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.226 1.011 . . . . 74.439999999999998 111.956 -178.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 86.42 -10.73 65.73 Favored Glycine 0 C--N 1.345 1.047 0 N-CA-C 115.562 0.985 . . . . 63.140000000000001 115.562 168.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 61.9 p -151.1 14.54 0.71 Allowed 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 118.017 0.909 . . . . 71.239999999999995 111.925 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 77.95 109.19 0.18 Allowed Glycine 0 C--N 1.348 1.222 0 CA-C-O 119.338 -0.701 . . . . 55.140000000000001 111.502 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -68.92 -109.72 0.02 OUTLIER Glycine 0 C--N 1.352 1.447 0 CA-C-N 116.99 0.395 . . . . 53.439999999999998 112.862 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 12.3 t -133.8 28.45 3.89 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 109.011 -0.737 . . . . 73.140000000000001 109.011 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -69.9 94.0 0.42 Allowed Glycine 0 C--N 1.346 1.091 0 CA-C-N 115.238 -0.892 . . . . 33.32 112.817 -177.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -141.3 150.75 22.1 Favored Glycine 0 C--O 1.242 0.617 0 N-CA-C 109.57 -1.412 . . . . 64.239999999999995 109.57 171.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.551 ' HA ' ' HD2' ' A' ' 240' ' ' PHE . 27.4 p -75.66 79.78 2.63 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-O 121.72 0.771 . . . . 71.049999999999997 110.378 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -80.0 -29.72 45.46 Favored Glycine 0 C--N 1.343 0.959 0 CA-C-N 114.929 -1.032 . . . . 60.039999999999999 112.157 176.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 156.71 150.6 5.72 Favored Glycine 0 C--N 1.344 0.989 0 CA-C-O 119.105 -0.83 . . . . 64.310000000000002 111.225 177.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 16.7 m 58.59 103.61 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.544 1.138 . . . . 71.299999999999997 110.729 -175.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.496 ' HA ' ' HB2' ' A' ' 240' ' ' PHE . 18.2 mm100 -69.69 -24.38 63.58 Favored 'General case' 0 CA--C 1.553 1.061 0 N-CA-C 112.683 0.623 . . . . 55.219999999999999 112.683 -175.445 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -93.02 141.18 28.69 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.427 0.691 . . . . 71.519999999999996 110.07 -178.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 17.6 mt -123.44 148.4 46.2 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 124.971 1.308 . . . . 72.239999999999995 109.22 174.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -127.86 120.64 28.19 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.21 0.604 . . . . 73.209999999999994 109.673 177.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.431 ' O ' ' HA ' ' A' ' 251' ' ' LEU . . . -145.35 160.06 42.11 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.729 0.812 . . . . 60.329999999999998 109.939 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 11.5 m -102.55 143.79 31.8 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 108.771 -0.826 . . . . 44.399999999999999 108.771 176.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.569 HD11 HG23 ' A' ' 210' ' ' VAL . 49.0 tp -113.95 124.97 53.45 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.634 1.174 . . . . 64.109999999999999 109.858 -173.573 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -96.97 102.86 14.72 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.375 0.67 . . . . 73.219999999999999 109.522 175.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.532 ' HA ' HG11 ' A' ' 210' ' ' VAL . 3.2 p -104.45 125.9 32.89 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 124.093 0.957 . . . . 71.319999999999993 109.675 173.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.86 148.44 66.93 Favored 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 122.698 2.265 . . . . 74.519999999999996 112.526 170.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.459 ' HA ' HG23 ' A' ' 255' ' ' ILE . . . -49.38 -52.39 49.75 Favored Pre-proline 0 CA--C 1.56 1.359 0 C-N-CA 124.269 1.027 . . . . 72.049999999999997 112.452 178.45 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.436 ' O ' HG12 ' A' ' 206' ' ' VAL . 30.8 Cg_endo -61.28 -40.3 50.76 Favored 'Trans proline' 0 C--N 1.4 3.266 0 C-N-CA 121.752 1.635 . . . . 75.319999999999993 112.877 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 29.1 mt -68.7 -30.48 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 123.233 0.613 . . . . 73.040000000000006 110.669 -178.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.92 -42.52 73.19 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 122.827 0.451 . . . . 45.109999999999999 110.662 177.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 201' ' ' ALA . 61.4 t -71.05 -53.9 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 123.303 0.641 . . . . 75.329999999999998 111.438 -177.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.436 HG12 ' O ' ' A' ' 202' ' ' PRO . 7.7 p -80.09 -31.59 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 122.439 0.296 . . . . 73.109999999999999 111.787 -174.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 93.45 131.22 5.84 Favored Glycine 0 CA--C 1.532 1.105 0 N-CA-C 111.618 -0.593 . . . . 72.150000000000006 111.618 -172.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -166.72 -143.87 3.91 Favored Glycine 0 C--N 1.341 0.856 0 CA-C-O 119.339 -0.701 . . . . 62.43 111.899 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.466 ' HB3' ' HB3' ' A' ' 220' ' ' GLU . 9.6 mtmp? -132.96 145.71 51.13 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.886 0.874 . . . . 73.310000000000002 109.704 174.477 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.569 HG23 HD11 ' A' ' 197' ' ' LEU . 22.1 m -139.44 158.54 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 124.385 1.074 . . . . 74.420000000000002 110.219 177.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 29.2 mtp-105 -79.76 132.87 36.27 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 122.917 0.487 . . . . 71.0 111.598 -177.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -121.12 125.21 46.67 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 125.368 1.467 . . . . 65.349999999999994 108.016 172.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.65 106.89 18.82 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 123.478 0.711 . . . . 71.019999999999996 110.124 -175.474 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 29.8 p -117.38 172.51 7.27 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.402 0.681 . . . . 73.209999999999994 109.928 -179.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 9.3 mt -71.54 -24.77 62.0 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 109.541 -0.541 . . . . 72.109999999999999 109.541 175.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -79.52 -18.87 50.93 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.128 0.971 . . . . 75.140000000000001 110.767 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 135.19 -175.51 20.61 Favored Glycine 0 C--N 1.353 1.495 0 CA-C-N 116.064 -0.517 . . . . 53.509999999999998 112.948 172.053 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -66.76 126.48 15.43 Favored 'Trans proline' 0 C--N 1.372 1.809 0 C-N-CA 122.931 2.42 . . . . 53.310000000000002 110.644 168.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 35.4 m -133.16 138.68 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 122.882 0.473 . . . . 64.439999999999998 110.67 -178.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.466 ' HB3' ' HB3' ' A' ' 209' ' ' LYS . 46.9 mt-10 -92.99 108.55 20.09 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.178 0.591 . . . . 72.129999999999995 110.777 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.546 HG22 ' HB3' ' A' ' 175' ' ' TYR . 61.0 t -91.89 119.24 38.93 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 C-N-CA 124.451 1.101 . . . . 70.040000000000006 109.429 -176.296 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -65.04 102.61 0.64 Allowed 'General case' 0 C--O 1.239 0.534 0 O-C-N 124.309 1.005 . . . . 64.420000000000002 109.969 175.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.471 HG11 HG21 ' A' ' 199' ' ' VAL . 48.1 t -74.8 117.28 61.27 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 124.376 1.07 . . . . 70.030000000000001 109.061 172.205 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -59.62 156.64 35.96 Favored 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 122.32 2.013 . . . . 73.109999999999999 112.158 178.182 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -63.06 125.24 15.45 Favored 'Trans proline' 0 C--N 1.375 1.945 0 C-N-CA 122.389 2.059 . . . . 75.030000000000001 111.567 177.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 72.9 mtm180 68.13 83.51 0.16 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.962 1.305 . . . . 74.510000000000005 110.051 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.585 HG22 HG11 ' A' ' 253' ' ' VAL . 89.8 m -126.48 117.5 23.02 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.011 0.924 . . . . 73.010000000000005 109.464 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -85.79 158.35 20.02 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.939 0.895 . . . . 71.430000000000007 112.151 -172.402 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -72.54 124.33 24.99 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 114.635 -1.166 . . . . 60.299999999999997 109.951 179.241 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 102.28 2.85 51.07 Favored Glycine 0 C--N 1.335 0.52 0 CA-C-O 119.524 -0.598 . . . . 45.0 112.596 -176.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 87.1 mtt180 -72.66 161.27 30.98 Favored 'General case' 0 C--N 1.356 0.879 0 CA-C-O 121.264 0.554 . . . . 74.200000000000003 110.051 170.335 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.44 ' HG3' HG12 ' A' ' 170' ' ' VAL . 19.9 pttm -124.38 140.47 52.92 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.324 -0.853 . . . . 74.439999999999998 109.876 -179.116 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.466 HD22 ' HB2' ' A' ' 173' ' ' ALA . 61.4 mt -117.87 141.28 48.61 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 107.49 -1.3 . . . . 73.310000000000002 107.49 176.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 30.6 ttt180 -130.88 101.73 5.76 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 108.081 -1.081 . . . . 72.150000000000006 108.081 167.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.455 HD13 ' HD1' ' A' ' 175' ' ' TYR . 27.6 mt -71.03 87.31 0.74 Allowed 'General case' 0 C--O 1.24 0.603 0 CA-C-N 114.524 -1.216 . . . . 70.420000000000002 108.286 175.136 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 59.6 mtmt -68.75 122.98 19.7 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 114.272 -1.331 . . . . 75.099999999999994 111.006 -174.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 69.65 26.42 74.48 Favored Glycine 0 C--N 1.345 1.079 0 O-C-N 124.305 1.003 . . . . 71.150000000000006 112.303 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.447 ' HB3' ' CE1' ' A' ' 175' ' ' TYR . 31.3 mmtp -135.85 35.02 2.87 Favored 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 124.512 1.125 . . . . 71.239999999999995 110.985 -172.007 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -114.27 -115.36 3.14 Favored Glycine 0 N--CA 1.477 1.414 0 N-CA-C 111.952 -0.459 . . . . 51.039999999999999 111.952 177.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 240' ' ' PHE . . . . . 0.551 ' HD2' ' HA ' ' A' ' 187' ' ' SER . 1.8 m-85 -69.83 142.03 90.49 Favored Pre-proline 0 N--CA 1.485 1.321 0 C-N-CA 123.17 0.588 . . . . 65.319999999999993 110.946 177.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.404 ' O ' ' HB3' ' A' ' 187' ' ' SER . 81.1 Cg_exo -52.44 144.12 41.9 Favored 'Trans proline' 0 C--N 1.376 1.985 0 C-N-CA 123.687 2.925 . . . . 65.010000000000005 113.602 172.162 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -156.8 113.31 0.56 Allowed Glycine 0 CA--C 1.531 1.063 0 CA-C-O 118.399 -1.223 . . . . 73.230000000000004 110.248 -179.436 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.26 -14.98 45.33 Favored 'Trans proline' 0 C--N 1.386 2.521 0 C-N-CA 123.535 2.823 . . . . 61.530000000000001 114.565 -176.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -112.6 -12.24 13.46 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 123.529 0.732 . . . . 72.340000000000003 111.594 175.07 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 163.03 125.68 0.78 Allowed Glycine 0 C--N 1.344 0.998 0 N-CA-C 111.123 -0.791 . . . . 63.119999999999997 111.123 -178.183 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 12.3 mtm180 -73.63 162.32 29.33 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.135 0.574 . . . . 72.040000000000006 110.928 -178.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -83.82 -163.72 35.78 Favored Glycine 0 C--N 1.348 1.212 0 CA-C-N 115.894 -0.594 . . . . 65.150000000000006 112.971 178.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -108.36 157.46 18.37 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.213 0.605 . . . . 74.540000000000006 110.676 -176.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 45.6 tp -132.83 110.91 10.66 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.101 0.96 . . . . 74.340000000000003 108.571 170.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 21.9 t80 -96.28 120.97 37.55 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.382 1.073 . . . . 62.119999999999997 109.326 -176.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.431 ' HA ' ' O ' ' A' ' 195' ' ' ALA . 51.5 mt -120.02 126.98 52.14 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.727 0.811 . . . . 72.239999999999995 110.862 -176.288 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.99 116.52 25.1 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 122.886 0.474 . . . . 72.340000000000003 110.434 173.228 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.585 HG11 HG22 ' A' ' 227' ' ' THR . 96.7 t -65.71 115.58 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 123.381 0.673 . . . . 73.129999999999995 110.511 176.518 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -121.12 111.62 17.67 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.015 0.926 . . . . 71.420000000000002 109.193 172.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.459 HG23 ' HA ' ' A' ' 201' ' ' ALA . 44.7 mt -76.89 121.47 29.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 108.988 -0.745 . . . . 74.019999999999996 108.988 175.18 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 34.6 p . . . . . 0 C--O 1.253 1.254 0 N-CA-C 108.23 -1.026 . . . . 51.140000000000001 108.23 175.908 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 N--CA 1.484 1.257 0 N-CA-C 111.251 0.093 . . . . 72.040000000000006 111.251 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -74.65 105.73 5.88 Favored 'General case' 0 C--N 1.35 0.593 0 N-CA-C 108.759 -0.83 . . . . 75.219999999999999 108.759 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -49.06 -53.15 21.61 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 125.719 1.608 . . . . 73.209999999999994 113.409 -176.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.444 HG21 ' HB3' ' A' ' 234' ' ' ARG . 12.9 m -90.33 -174.82 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.019 0 C-N-CA 123.542 0.737 . . . . 73.129999999999995 110.651 -175.401 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 10.3 tt -93.85 137.46 22.73 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.124 0 N-CA-C 108.29 -1.004 . . . . 71.530000000000001 108.29 165.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -74.84 113.39 12.08 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.438 1.095 . . . . 52.539999999999999 110.02 -175.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.453 ' HB2' HD22 ' A' ' 233' ' ' LEU . . . -111.6 178.95 4.16 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.449 0.7 . . . . 70.420000000000002 110.711 -178.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -146.76 156.5 43.2 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.572 1.149 . . . . 72.430000000000007 109.456 178.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.403 ' HD1' HD13 ' A' ' 235' ' ' LEU . 2.5 p90 -130.67 172.06 12.38 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.086 0.47 . . . . 74.030000000000001 110.045 168.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -134.5 140.91 37.06 Favored Pre-proline 0 N--CA 1.476 0.837 0 C-N-CA 124.585 1.154 . . . . 52.539999999999999 108.27 175.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -64.04 106.08 0.63 Allowed 'Trans proline' 0 C--N 1.363 1.342 0 C-N-CA 122.775 2.317 . . . . 74.219999999999999 111.035 175.152 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -63.83 -36.87 85.34 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.535 0.734 . . . . 32.109999999999999 111.826 -175.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -94.67 -41.69 9.16 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.434 0.694 . . . . 62.030000000000001 110.057 176.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 128.12 10.3 3.49 Favored Glycine 0 C--N 1.353 1.494 0 CA-C-O 119.648 -0.529 . . . . 52.399999999999999 113.603 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 21.1 t -97.41 171.57 8.31 Favored 'General case' 0 N--CA 1.486 1.325 0 CA-C-N 117.638 0.719 . . . . 72.120000000000005 110.89 -179.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 117.85 92.69 1.59 Allowed Glycine 0 C--N 1.346 1.118 0 N-CA-C 110.596 -1.002 . . . . 75.239999999999995 110.596 -174.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -175.72 -32.82 0.04 OUTLIER Glycine 0 C--N 1.35 1.358 0 CA-C-N 117.229 0.515 . . . . 61.310000000000002 114.204 -177.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 34.6 p -110.49 10.13 23.2 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 112.967 0.729 . . . . 41.409999999999997 112.967 -173.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 0.41 ' N ' ' HG2' ' A' ' 241' ' ' PRO . . . -55.1 109.99 1.54 Allowed Glycine 0 C--N 1.348 1.23 0 O-C-N 123.502 0.501 . . . . 74.540000000000006 113.735 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -143.23 114.57 0.85 Allowed Glycine 0 C--N 1.341 0.847 0 N-CA-C 110.777 -0.929 . . . . 40.539999999999999 110.777 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 16.7 t -162.86 115.43 1.6 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.61 0.764 . . . . 63.25 109.803 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 73.93 8.03 77.11 Favored Glycine 0 C--N 1.356 1.649 0 O-C-N 123.612 0.57 . . . . 62.119999999999997 114.188 176.307 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 64.16 26.24 70.26 Favored Glycine 0 C--N 1.35 1.325 0 CA-C-N 116.812 0.306 . . . . 62.399999999999999 112.456 -174.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 29.0 m -83.68 156.15 22.78 Favored 'General case' 0 C--N 1.35 0.604 0 C-N-CA 123.714 0.806 . . . . 63.299999999999997 111.363 -175.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.482 ' HA ' ' HB2' ' A' ' 240' ' ' PHE . 23.9 mm-40 -114.47 -21.12 10.49 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.079 0.952 . . . . 51.420000000000002 110.084 168.452 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -89.6 146.92 24.22 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.031 0.932 . . . . 74.230000000000004 109.927 -170.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.424 HD23 ' HA ' ' A' ' 193' ' ' LEU . 13.7 mt -140.53 131.56 26.23 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 107.634 -1.247 . . . . 70.409999999999997 107.634 166.648 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -120.13 128.3 53.31 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 108.782 -0.822 . . . . 65.540000000000006 108.782 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -157.53 162.04 38.82 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.742 0.817 . . . . 52.210000000000001 110.157 178.139 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 17.2 p -91.87 149.12 21.74 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 109.033 -0.728 . . . . 64.409999999999997 109.033 170.23 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.619 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . 40.8 tp -113.4 115.01 27.4 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 123.622 0.769 . . . . 75.230000000000004 109.549 -175.307 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -80.03 100.96 8.42 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.625 0.77 . . . . 72.219999999999999 109.163 -179.006 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.578 ' HA ' HG11 ' A' ' 210' ' ' VAL . 40.9 t -109.84 104.39 55.38 Favored Pre-proline 0 CA--C 1.54 0.578 0 N-CA-C 108.509 -0.923 . . . . 60.539999999999999 108.509 178.238 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -53.22 139.79 62.62 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 122.723 2.282 . . . . 74.430000000000007 112.07 174.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.428 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -47.8 -47.84 61.78 Favored Pre-proline 0 CA--C 1.558 1.266 0 C-N-CA 124.377 1.071 . . . . 74.230000000000004 113.749 -175.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.1 -45.06 34.13 Favored 'Trans proline' 0 C--N 1.39 2.716 0 C-N-CA 121.977 1.785 . . . . 73.420000000000002 112.902 174.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 36.6 mt -66.1 -32.24 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 123.577 0.751 . . . . 64.430000000000007 110.84 -177.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -65.91 -50.64 63.75 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 122.994 0.518 . . . . 73.120000000000005 110.377 177.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 201' ' ' ALA . 81.4 t -64.3 -53.23 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 O-C-N 123.877 0.736 . . . . 73.510000000000005 111.685 -175.77 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 26.9 m -78.31 -26.28 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 N-CA-C 112.237 0.458 . . . . 73.329999999999998 112.237 -176.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 81.01 139.99 2.65 Favored Glycine 0 C--N 1.349 1.301 0 N-CA-C 112.147 -0.381 . . . . 74.030000000000001 112.147 -175.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -177.74 -124.27 0.84 Allowed Glycine 0 C--N 1.344 0.995 0 CA-C-N 117.202 0.501 . . . . 31.120000000000001 112.506 -178.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -136.59 153.13 51.05 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.977 0.911 . . . . 72.109999999999999 108.71 176.07 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.578 HG11 ' HA ' ' A' ' 199' ' ' VAL . 15.7 m -138.06 128.03 35.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 123.268 0.627 . . . . 72.5 109.381 171.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 211' ' ' ARG . . . . . 0.418 ' HG2' ' HG2' ' A' ' 220' ' ' GLU . 63.6 mtm-85 -81.95 110.29 17.09 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.38 0.672 . . . . 62.43 110.796 -176.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -100.46 161.14 13.8 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.677 1.191 . . . . 74.310000000000002 109.93 178.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 8.1 mmt -99.17 119.82 38.49 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.714 0.805 . . . . 70.0 109.889 -177.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 76.4 p -110.6 175.49 5.41 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.52 0.728 . . . . 60.109999999999999 109.113 170.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 29.1 mt -69.84 -10.43 58.41 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 112.712 0.634 . . . . 74.400000000000006 112.712 -174.04 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -117.43 -12.69 10.39 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.266 0.626 . . . . 51.350000000000001 112.284 -177.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 153.15 -169.62 32.05 Favored Glycine 0 C--N 1.356 1.655 0 N-CA-C 114.335 0.494 . . . . 71.340000000000003 114.335 173.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -70.22 141.23 42.85 Favored 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 123.558 2.839 . . . . 72.420000000000002 112.456 176.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 34.6 m -137.89 130.96 41.75 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 C-N-CA 123.547 0.739 . . . . 52.350000000000001 110.157 178.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.418 ' HG2' ' HG2' ' A' ' 211' ' ' ARG . 14.3 mt-10 -88.07 108.52 19.28 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.408 0.683 . . . . 71.340000000000003 110.173 -178.133 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 44.9 t -94.74 122.95 46.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 123.734 0.814 . . . . 73.239999999999995 109.682 -176.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -68.61 107.0 2.79 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.205 1.002 . . . . 73.510000000000005 111.452 -177.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 66.4 t -86.2 121.05 72.74 Favored Pre-proline 0 CA--C 1.553 1.065 0 C-N-CA 124.634 1.174 . . . . 71.120000000000005 110.047 176.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -63.52 164.38 20.98 Favored 'Trans proline' 0 C--N 1.379 2.183 0 C-N-CA 122.918 2.412 . . . . 65.420000000000002 112.527 174.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -66.28 128.35 19.25 Favored 'Trans proline' 0 C--N 1.376 2.008 0 C-N-CA 122.615 2.21 . . . . 72.299999999999997 112.184 173.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 63.3 mtm-85 62.81 70.54 0.55 Allowed 'General case' 0 C--N 1.353 0.746 0 C-N-CA 124.724 1.21 . . . . 72.299999999999997 110.846 178.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.631 HG22 HG11 ' A' ' 253' ' ' VAL . 56.8 m -101.57 114.72 29.01 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 114.829 -1.078 . . . . 63.109999999999999 109.376 -178.699 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 22.9 mp0 -84.79 153.03 23.25 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.271 0.628 . . . . 62.140000000000001 111.404 -174.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -73.15 127.89 33.91 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.734 -0.839 . . . . 64.129999999999995 108.734 174.309 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 110.08 -11.84 31.65 Favored Glycine 0 C--N 1.333 0.366 0 N-CA-C 111.533 -0.627 . . . . 55.140000000000001 111.533 -171.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.575 ' HD2' HG23 ' A' ' 227' ' ' THR . 90.7 mtt180 -66.81 156.79 34.61 Favored 'General case' 0 C--N 1.36 1.043 0 CA-C-O 121.361 0.601 . . . . 60.229999999999997 110.142 169.108 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 38.3 pttt -131.91 135.08 46.37 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 114.996 -1.002 . . . . 74.439999999999998 109.391 -176.308 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.453 HD22 ' HB2' ' A' ' 173' ' ' ALA . 75.9 mt -115.96 137.06 52.45 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 108.081 -1.081 . . . . 62.299999999999997 108.081 176.204 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 234' ' ' ARG . . . . . 0.444 ' HB3' HG21 ' A' ' 170' ' ' VAL . 40.8 ttm105 -119.52 120.49 36.92 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.565 -1.272 . . . . 75.5 107.565 166.65 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.514 ' O ' ' HA ' ' A' ' 248' ' ' ASP . 43.7 mt -101.88 78.82 1.84 Allowed 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 108.678 -0.86 . . . . 61.100000000000001 108.678 -177.48 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -75.95 144.15 41.17 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 122.883 0.473 . . . . 74.120000000000005 109.856 176.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 68.31 18.16 71.1 Favored Glycine 0 C--N 1.344 1.005 0 CA-C-N 115.639 -0.709 . . . . 63.109999999999999 112.336 -174.231 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 10.1 mmpt? -129.75 -30.58 2.04 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.352 1.061 . . . . 70.239999999999995 110.728 -175.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -66.84 -125.83 0.02 OUTLIER Glycine 0 C--N 1.36 1.863 0 N-CA-C 114.766 0.666 . . . . 64.409999999999997 114.766 -171.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 240' ' ' PHE . . . . . 0.482 ' HB2' ' HA ' ' A' ' 191' ' ' GLN . 1.1 m-85 -67.78 135.46 92.31 Favored Pre-proline 0 N--CA 1.482 1.15 0 CA-C-O 118.802 -0.618 . . . . 64.310000000000002 109.903 177.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.56 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 37.3 Cg_exo -42.51 138.46 3.41 Favored 'Trans proline' 0 C--N 1.378 2.101 0 C-N-CA 124.278 3.319 . . . . 74.420000000000002 114.92 175.7 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -164.46 113.16 0.54 Allowed Glycine 0 CA--C 1.531 1.046 0 N-CA-C 109.219 -1.552 . . . . 74.439999999999998 109.219 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -60.51 -40.13 59.43 Favored 'Trans proline' 0 C--N 1.379 2.142 0 C-N-CA 123.234 2.623 . . . . 72.109999999999999 113.296 -173.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -77.32 -25.05 50.81 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.057 0.543 . . . . 61.420000000000002 110.8 176.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 169.18 127.21 0.91 Allowed Glycine 0 C--N 1.338 0.673 0 N-CA-C 110.996 -0.842 . . . . 71.310000000000002 110.996 179.243 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.56 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 48.6 mtm180 -69.54 159.59 33.05 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.106 0.562 . . . . 73.329999999999998 109.874 178.556 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.426 ' HA3' ' HB3' ' A' ' 191' ' ' GLN . . . -74.08 -156.56 4.55 Favored Glycine 0 C--N 1.339 0.702 0 CA-C-N 116.069 -0.514 . . . . 75.140000000000001 112.911 175.697 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 248' ' ' ASP . . . . . 0.514 ' HA ' ' O ' ' A' ' 235' ' ' LEU . 2.6 p30 -122.7 136.46 54.88 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 122.332 -0.511 . . . . 70.25 112.018 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 32.5 tp -100.57 104.6 15.95 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 107.241 -1.392 . . . . 74.299999999999997 107.241 168.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -89.28 108.03 19.39 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.172 0.989 . . . . 72.430000000000007 109.02 -178.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.619 ' HB3' ' HB2' ' A' ' 197' ' ' LEU . 63.8 mt -110.43 110.75 21.63 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.412 1.085 . . . . 73.409999999999997 110.349 -176.069 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -80.37 110.23 15.63 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.119 0.568 . . . . 74.540000000000006 109.694 176.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.631 HG11 HG22 ' A' ' 227' ' ' THR . 89.8 t -59.49 110.76 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.417 0.687 . . . . 71.010000000000005 111.017 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 30.8 mmm180 -114.23 113.0 24.04 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 125.053 1.341 . . . . 74.530000000000001 108.45 173.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.477 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 56.9 mt -75.62 126.14 36.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 N-CA-C 109.253 -0.647 . . . . 73.420000000000002 109.253 178.42 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 45.2 p . . . . . 0 C--O 1.248 1.003 0 C-N-CA 124.167 0.987 . . . . 73.430000000000007 108.623 -179.635 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.484 1.267 0 CA-C-O 121.105 0.479 . . . . 70.400000000000006 110.263 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -83.59 72.21 10.31 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.785 0.803 . . . . 70.019999999999996 109.179 175.01 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -80.98 -41.6 22.52 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 114.983 -1.008 . . . . 60.240000000000002 110.292 -177.236 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.638 HG21 ' HB3' ' A' ' 234' ' ' ARG . 34.1 m -90.01 173.06 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-N 115.158 -0.928 . . . . 71.040000000000006 110.948 178.369 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 15.1 tt -96.34 143.81 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 N-CA-C 108.676 -0.861 . . . . 63.409999999999997 108.676 171.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -65.81 132.16 48.03 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.3 1.04 . . . . 74.200000000000003 112.065 -173.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.485 ' HB2' HD22 ' A' ' 233' ' ' LEU . . . -146.61 164.39 32.8 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.336 1.054 . . . . 40.109999999999999 110.816 -178.333 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -160.4 154.09 22.52 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.68 1.192 . . . . 74.340000000000003 109.161 179.321 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.533 ' HA ' ' HA ' ' A' ' 221' ' ' VAL . 31.7 p90 -117.72 -177.21 3.19 Favored 'General case' 0 C--N 1.347 0.475 0 CA-C-O 121.575 0.703 . . . . 74.310000000000002 110.953 178.341 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -136.15 131.81 18.88 Favored Pre-proline 0 N--CA 1.468 0.456 0 N-CA-C 107.438 -1.319 . . . . 71.230000000000004 107.438 173.178 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -65.25 95.25 0.26 Allowed 'Trans proline' 0 CA--C 1.551 1.359 0 C-N-CA 122.149 1.899 . . . . 52.509999999999998 110.787 177.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' ALA . . . . . 0.477 ' HB2' ' HG3' ' A' ' 220' ' ' GLU . . . -70.4 -24.64 62.96 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 115.522 -0.763 . . . . 73.519999999999996 110.294 176.061 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -62.27 154.27 28.19 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 123.917 0.887 . . . . 73.409999999999997 110.191 165.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -51.94 -60.34 7.67 Favored Glycine 0 C--N 1.359 1.842 0 O-C-N 123.62 0.575 . . . . 63.329999999999998 113.123 -177.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 23.1 t -177.32 85.19 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.18 0.992 . . . . 44.409999999999997 108.501 173.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 83.03 100.33 0.51 Allowed Glycine 0 C--N 1.347 1.177 0 CA-C-N 116.187 -0.46 . . . . 42.409999999999997 112.881 176.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -72.04 -69.8 1.33 Allowed Glycine 0 C--N 1.351 1.364 0 N-CA-C 111.992 -0.443 . . . . 62.32 111.992 176.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 35.6 p -167.72 174.35 7.72 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.31 0.644 . . . . 75.040000000000006 111.316 -176.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -91.51 -146.33 17.37 Favored Glycine 0 C--N 1.349 1.3 0 CA-C-N 115.506 -0.77 . . . . 62.299999999999997 113.028 177.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -156.54 169.79 33.96 Favored Glycine 0 C--N 1.345 1.05 0 N-CA-C 111.938 -0.465 . . . . 70.310000000000002 111.938 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 36.4 p -88.39 164.95 15.27 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.136 0.575 . . . . 75.329999999999998 111.423 -175.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 72.11 -81.95 0.55 Allowed Glycine 0 C--N 1.355 1.594 0 O-C-N 123.8 0.687 . . . . 61.140000000000001 111.725 -174.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 165.94 38.63 0.02 OUTLIER Glycine 0 C--N 1.338 0.652 0 N-CA-C 110.685 -0.966 . . . . 65.340000000000003 110.685 175.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 44.8 p -66.72 93.09 0.24 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.965 0.906 . . . . 44.329999999999998 112.414 -170.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.614 ' HA ' ' HB2' ' A' ' 240' ' ' PHE . 16.8 mm100 -74.26 -46.39 41.73 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.134 0.573 . . . . 72.239999999999995 110.374 176.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.425 ' HA ' ' O ' ' A' ' 248' ' ' ASP . 8.0 p-10 -103.59 139.95 38.21 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.015 -0.539 . . . . 71.430000000000007 109.63 176.045 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 86.1 mt -118.83 150.8 39.22 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 108.632 -0.877 . . . . 74.109999999999999 108.632 -177.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -122.21 127.59 50.16 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 108.119 -1.067 . . . . 72.420000000000002 108.119 172.16 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -152.88 158.49 42.22 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 122.956 0.502 . . . . 72.450000000000003 110.203 -177.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 10.7 p -94.94 138.02 33.23 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 123.222 0.609 . . . . 72.129999999999995 109.917 174.456 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.456 HD11 HG23 ' A' ' 210' ' ' VAL . 52.0 tp -110.88 114.38 27.66 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.381 1.072 . . . . 63.439999999999998 109.543 -173.091 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -75.81 104.38 6.33 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 109.251 -0.648 . . . . 73.329999999999998 109.251 176.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.587 HG22 HG21 ' A' ' 210' ' ' VAL . 30.0 t -113.46 107.19 53.62 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 123.668 0.787 . . . . 51.149999999999999 108.936 175.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -54.19 140.66 71.44 Favored 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.796 2.331 . . . . 73.239999999999995 112.267 172.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -47.7 -50.14 53.11 Favored Pre-proline 0 CA--C 1.571 1.752 0 N-CA-C 113.992 1.108 . . . . 63.119999999999997 113.992 -177.626 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -58.1 -39.25 87.13 Favored 'Trans proline' 0 C--N 1.401 3.318 0 C-N-CA 121.838 1.692 . . . . 53.43 112.806 177.074 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 47.5 mt -72.01 -31.31 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 123.95 0.9 . . . . 71.420000000000002 110.829 -178.286 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.68 -46.63 68.56 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.239 0.615 . . . . 73.25 110.944 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 83.2 t -70.54 -40.99 77.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-N 115.284 -0.871 . . . . 62.32 111.705 -176.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 8.2 p -77.45 -31.02 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 CA-C-N 116.473 -0.33 . . . . 44.520000000000003 111.404 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 80.55 69.07 1.42 Allowed Glycine 0 C--N 1.349 1.296 0 CA-C-N 116.055 -0.521 . . . . 73.239999999999995 112.344 -173.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -101.29 -150.68 24.14 Favored Glycine 0 C--N 1.346 1.106 0 CA-C-O 119.715 -0.492 . . . . 71.120000000000005 112.158 -176.025 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 55.0 mttp -117.39 143.39 46.04 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.229 0.612 . . . . 71.219999999999999 109.56 173.179 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.587 HG21 HG22 ' A' ' 199' ' ' VAL . 27.7 m -136.72 142.28 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 124.14 0.976 . . . . 55.340000000000003 109.192 174.569 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 88.9 mtm180 -73.72 137.9 44.3 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.127 0.489 . . . . 75.450000000000003 111.086 176.126 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -116.59 121.13 40.83 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.268 1.427 . . . . 72.340000000000003 107.394 172.149 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.0 111.6 19.85 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 109.382 -0.599 . . . . 63.109999999999999 109.382 -178.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 81.4 p -120.83 -179.88 4.14 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.457 0.703 . . . . 55.43 111.07 -176.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 12.3 mt -70.31 -22.68 62.8 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 115.466 -0.788 . . . . 72.0 110.003 175.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -87.44 -12.87 44.86 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 123.93 0.892 . . . . 72.140000000000001 110.621 177.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 117.37 -158.97 14.29 Favored Glycine 0 C--N 1.354 1.535 0 CA-C-N 116.353 -0.385 . . . . 51.140000000000001 113.109 175.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.7 127.9 14.46 Favored 'Trans proline' 0 C--N 1.367 1.533 0 C-N-CA 122.669 2.246 . . . . 74.129999999999995 111.381 175.255 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 29.6 m -132.39 125.03 53.02 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.827 0 N-CA-C 109.919 -0.4 . . . . 63.420000000000002 109.919 173.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.477 ' HG3' ' HB2' ' A' ' 178' ' ' ALA . 45.4 mt-10 -84.14 105.82 15.3 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.316 0.647 . . . . 70.209999999999994 110.285 -178.293 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.533 ' HA ' ' HA ' ' A' ' 175' ' ' TYR . 46.5 t -90.03 116.94 32.34 Favored 'Isoleucine or valine' 0 C--O 1.243 0.717 0 C-N-CA 124.303 1.041 . . . . 73.25 108.576 -175.539 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -69.32 101.09 1.44 Allowed 'General case' 0 C--O 1.241 0.613 0 CA-C-N 114.873 -1.058 . . . . 52.530000000000001 109.146 176.091 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 47.1 t -69.18 131.55 90.47 Favored Pre-proline 0 CA--C 1.544 0.749 0 CA-C-N 114.781 -1.1 . . . . 64.420000000000002 109.05 176.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -62.81 159.49 37.37 Favored 'Trans proline' 0 CA--C 1.561 1.85 0 C-N-CA 122.06 1.84 . . . . 71.030000000000001 111.923 170.34 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -67.05 147.66 80.12 Favored 'Trans proline' 0 C--N 1.376 2.003 0 C-N-CA 122.159 1.906 . . . . 74.329999999999998 112.191 176.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 47.8 mtp180 53.54 54.79 9.5 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.919 1.288 . . . . 73.450000000000003 111.368 174.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.615 HG23 ' HD2' ' A' ' 231' ' ' ARG . 91.3 m -96.8 117.95 32.19 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 114.525 -1.216 . . . . 64.319999999999993 109.11 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 26.8 mp0 -90.38 161.67 15.48 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.277 0.631 . . . . 73.409999999999997 111.57 -177.068 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -64.42 127.62 32.27 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 114.454 -1.248 . . . . 55.539999999999999 110.239 177.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 103.85 -4.31 45.9 Favored Glycine 0 C--N 1.341 0.854 0 CA-C-O 119.374 -0.681 . . . . 73.439999999999998 113.526 -179.444 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.615 ' HD2' HG23 ' A' ' 227' ' ' THR . 87.5 mtt180 -68.65 162.07 26.78 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 117.741 0.771 . . . . 71.420000000000002 111.54 175.57 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -127.33 124.24 38.23 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 123.84 0.856 . . . . 75.420000000000002 110.679 -173.228 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.485 HD22 ' HB2' ' A' ' 173' ' ' ALA . 61.8 mt -113.32 100.0 8.22 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.049 0.939 . . . . 62.109999999999999 109.138 178.58 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 234' ' ' ARG . . . . . 0.638 ' HB3' HG21 ' A' ' 170' ' ' VAL . 22.6 ttt180 -85.4 102.15 13.19 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 107.966 -1.124 . . . . 65.209999999999994 107.966 169.074 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.414 HD13 ' HD1' ' A' ' 175' ' ' TYR . 53.5 mt -68.89 92.06 0.49 Allowed 'General case' 0 C--O 1.244 0.776 0 N-CA-C 107.808 -1.182 . . . . 75.430000000000007 107.808 172.854 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -71.28 114.11 9.0 Favored 'General case' 0 C--N 1.357 0.925 0 CA-C-N 114.137 -1.392 . . . . 74.409999999999997 111.813 -167.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 237' ' ' GLY . . . . . 0.405 ' O ' ' HD3' ' A' ' 246' ' ' ARG . . . 67.53 34.08 83.17 Favored Glycine 0 C--N 1.346 1.121 0 O-C-N 124.053 0.846 . . . . 44.32 112.056 178.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.461 ' HB3' ' CE1' ' A' ' 175' ' ' TYR . 32.9 mmtp -128.62 10.36 6.09 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.645 0.778 . . . . 74.420000000000002 111.97 -172.733 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -84.48 -129.14 1.82 Allowed Glycine 0 N--CA 1.47 0.948 0 N-CA-C 111.742 -0.543 . . . . 60.229999999999997 111.742 176.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 240' ' ' PHE . . . . . 0.614 ' HB2' ' HA ' ' A' ' 191' ' ' GLN . 3.2 m-85 -74.88 142.92 77.2 Favored Pre-proline 0 N--CA 1.48 1.072 0 C-N-CA 123.283 0.633 . . . . 74.120000000000005 110.894 175.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.723 ' HA ' ' HG3' ' A' ' 246' ' ' ARG . 21.3 Cg_exo -64.5 142.86 79.98 Favored 'Trans proline' 0 C--N 1.379 2.132 0 C-N-CA 123.003 2.469 . . . . 74.409999999999997 113.11 -176.578 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -157.48 118.25 0.82 Allowed Glycine 0 CA--C 1.535 1.291 0 CA-C-O 118.696 -1.058 . . . . 44.039999999999999 111.345 -179.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -64.04 -28.99 65.99 Favored 'Trans proline' 0 C--N 1.384 2.44 0 C-N-CA 123.131 2.554 . . . . 72.040000000000006 114.335 -178.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -86.61 -15.35 40.05 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.169 0.588 . . . . 61.509999999999998 111.18 176.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 163.29 118.33 0.45 Allowed Glycine 0 C--N 1.344 0.99 0 N-CA-C 110.072 -1.211 . . . . 63.240000000000002 110.072 178.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.723 ' HG3' ' HA ' ' A' ' 241' ' ' PRO . 45.4 ttt180 -69.25 140.27 54.47 Favored 'General case' 0 C--O 1.243 0.726 0 CA-C-N 117.505 0.653 . . . . 72.109999999999999 109.508 175.389 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -68.56 -169.47 5.54 Favored Glycine 0 C--N 1.351 1.4 0 O-C-N 123.563 0.539 . . . . 53.140000000000001 113.347 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 248' ' ' ASP . . . . . 0.425 ' O ' ' HA ' ' A' ' 192' ' ' ASP . 10.1 m-20 -122.11 169.7 10.6 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.134 0.573 . . . . 71.299999999999997 110.734 -175.286 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 43.2 tp -136.24 107.21 6.68 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 108.356 -0.979 . . . . 61.240000000000002 108.356 168.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -94.46 107.4 19.37 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 108.881 -0.785 . . . . 74.299999999999997 108.881 -174.443 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.401 HD12 HD11 ' A' ' 235' ' ' LEU . 66.2 mt -110.5 113.99 27.06 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.055 0.942 . . . . 75.040000000000006 110.117 -175.335 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -79.52 116.75 19.92 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 109.218 -0.66 . . . . 72.049999999999997 109.218 173.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.508 HG11 HG22 ' A' ' 227' ' ' THR . 69.5 t -65.45 105.42 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 CA-C-O 121.231 0.539 . . . . 75.129999999999995 110.168 177.637 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 15.3 mmt85 -103.17 106.75 17.33 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 108.043 -1.095 . . . . 62.109999999999999 108.043 172.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.48 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 15.3 mt -74.42 119.55 22.03 Favored 'Isoleucine or valine' 0 C--N 1.352 0.716 0 N-CA-C 109.265 -0.643 . . . . 64.040000000000006 109.265 179.388 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 23.5 p . . . . . 0 C--O 1.252 1.206 0 C-N-CA 124.736 1.214 . . . . 75.420000000000002 109.213 -176.141 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 23.7 mmt . . . . . 0 N--CA 1.479 1.024 0 N-CA-C 109.089 -0.708 . . . . 74.109999999999999 109.089 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -75.63 77.11 2.62 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 121.682 0.754 . . . . 61.020000000000003 109.923 177.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -60.6 -50.64 72.71 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 115.146 -0.934 . . . . 75.230000000000004 110.233 -178.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.466 HG21 ' HB3' ' A' ' 234' ' ' ARG . 25.6 m -98.13 167.86 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-N 115.083 -0.962 . . . . 72.230000000000004 110.468 175.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 16.8 tt -89.11 149.59 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.004 0 N-CA-C 108.953 -0.758 . . . . 72.109999999999999 108.953 171.127 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -60.56 142.44 55.4 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.77 1.228 . . . . 72.329999999999998 112.377 -175.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.514 ' HB2' HD22 ' A' ' 233' ' ' LEU . . . -159.94 155.45 25.55 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.805 1.242 . . . . 70.319999999999993 109.092 174.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -149.98 119.77 7.08 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 123.48 0.712 . . . . 75.340000000000003 110.013 177.255 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.557 ' HE1' ' HB3' ' A' ' 238' ' ' LYS . 17.7 p90 -93.11 164.76 13.14 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 109.451 -0.574 . . . . 75.150000000000006 109.451 174.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 46.3 mttm -138.9 143.83 38.96 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 123.519 0.728 . . . . 70.519999999999996 109.507 172.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -56.71 108.91 0.38 Allowed 'Trans proline' 0 C--N 1.382 2.312 0 C-N-CA 123.742 2.961 . . . . 61.420000000000002 112.984 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' ALA . . . . . 0.653 ' HB2' ' HG3' ' A' ' 220' ' ' GLU . . . -88.51 -19.15 26.79 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.131 0.572 . . . . 54.420000000000002 110.049 174.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -64.73 -41.92 95.59 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.338 1.055 . . . . 74.519999999999996 110.173 174.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 148.11 -54.24 0.52 Allowed Glycine 0 C--N 1.342 0.878 0 CA-C-N 115.504 -0.771 . . . . 52.240000000000002 111.535 178.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 68.3 m -149.51 106.59 3.58 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.511 0.724 . . . . 72.409999999999997 110.317 -175.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -76.35 88.06 0.91 Allowed Glycine 0 C--N 1.347 1.18 0 N-CA-C 109.896 -1.282 . . . . 73.329999999999998 109.896 169.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -59.96 126.28 41.27 Favored Glycine 0 C--N 1.353 1.521 0 O-C-N 124.258 0.622 . . . . 25.199999999999999 113.316 -173.264 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 43.3 m -85.43 125.25 32.86 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 123.464 0.706 . . . . 52.310000000000002 110.4 179.101 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -94.15 -100.81 1.64 Allowed Glycine 0 C--N 1.34 0.78 0 N-CA-C 110.727 -0.949 . . . . 53.210000000000001 110.727 172.133 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' GLY . . . . . 0.484 ' HA2' ' HD2' ' A' ' 243' ' ' PRO . . . -161.8 -50.65 0.02 OUTLIER Glycine 0 C--N 1.335 0.525 0 N-CA-C 110.099 -1.201 . . . . 73.510000000000005 110.099 177.413 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 14.3 t -156.49 -161.99 1.2 Allowed 'General case' 0 CA--C 1.554 1.112 0 N-CA-C 107.606 -1.257 . . . . 71.519999999999996 107.606 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -179.1 -173.66 44.57 Favored Glycine 0 C--N 1.352 1.462 0 CA-C-N 118.561 0.619 . . . . 73.530000000000001 113.752 177.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -68.69 -29.08 72.74 Favored Glycine 0 C--N 1.349 1.269 0 N-CA-C 112.087 -0.405 . . . . 54.32 112.087 172.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 23.1 m -144.51 108.9 4.83 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.735 1.214 . . . . 74.099999999999994 108.125 175.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 23.4 mp0 -75.74 -40.91 54.65 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 121.799 0.809 . . . . 74.239999999999995 109.039 176.116 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 19.2 p-10 -94.63 147.95 22.77 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 114.727 -1.124 . . . . 71.109999999999999 110.509 -178.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 95.6 mt -126.26 157.78 37.42 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.638 1.175 . . . . 73.0 109.667 178.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -135.31 122.95 22.2 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.911 0.884 . . . . 70.230000000000004 108.676 176.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -152.67 171.22 18.52 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.005 0.922 . . . . 73.420000000000002 109.711 178.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 196' ' ' THR . . . . . 0.461 HG22 ' HB2' ' A' ' 252' ' ' GLU . 11.7 p -97.96 146.31 25.61 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.335 0.654 . . . . 71.120000000000005 109.944 173.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.561 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . 39.1 tp -114.45 111.28 21.16 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.19 0.996 . . . . 71.219999999999999 109.112 178.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -87.28 101.41 13.5 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.135 0.493 . . . . 75.010000000000005 109.899 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.481 ' HA ' HG11 ' A' ' 210' ' ' VAL . 46.9 t -102.55 121.97 47.91 Favored Pre-proline 0 CA--C 1.542 0.655 0 C-N-CA 124.379 1.071 . . . . 63.140000000000001 108.904 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -56.03 142.34 85.66 Favored 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 122.809 2.339 . . . . 65.230000000000004 111.602 170.01 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.467 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -49.48 -49.4 71.82 Favored Pre-proline 0 CA--C 1.56 1.329 0 CA-C-O 118.045 -0.979 . . . . 64.310000000000002 113.496 -179.176 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -60.05 -40.1 64.23 Favored 'Trans proline' 0 C--N 1.394 2.973 0 C-N-CA 121.995 1.797 . . . . 63.420000000000002 112.87 178.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 34.7 mt -69.2 -33.26 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 C-N-CA 123.761 0.824 . . . . 62.210000000000001 110.6 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.63 -38.03 80.21 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.414 0.685 . . . . 72.530000000000001 111.437 178.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 201' ' ' ALA . 99.1 t -74.13 -55.84 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.415 0.686 . . . . 74.209999999999994 110.96 -178.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 11.5 m -81.42 -23.37 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 N-CA-C 112.171 0.434 . . . . 74.019999999999996 112.171 -171.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 88.16 134.7 4.74 Favored Glycine 0 C--N 1.347 1.16 0 N-CA-C 111.378 -0.689 . . . . 63.229999999999997 111.378 -173.239 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -173.13 -147.54 5.93 Favored Glycine 0 C--N 1.338 0.692 0 N-CA-C 111.644 -0.582 . . . . 71.239999999999995 111.644 -177.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -137.02 134.89 37.08 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.22 0.608 . . . . 71.109999999999999 110.15 177.118 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.481 HG11 ' HA ' ' A' ' 199' ' ' VAL . 29.5 m -121.96 147.31 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 123.251 0.62 . . . . 75.140000000000001 109.73 179.403 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -86.68 111.89 21.11 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 116.169 -0.469 . . . . 62.340000000000003 109.767 -173.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -99.98 157.68 16.37 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.249 1.02 . . . . 63.299999999999997 109.917 177.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 2.0 mmt -105.28 108.81 20.52 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 115.336 -0.847 . . . . 65.099999999999994 109.747 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 45.4 p -109.79 -177.72 3.34 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.849 0.859 . . . . 61.329999999999998 109.039 171.614 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 19.0 mt -72.28 -26.74 62.09 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.125 0.57 . . . . 70.239999999999995 110.452 -175.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 10.6 mp0 -80.0 -20.54 45.2 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.27 1.028 . . . . 64.230000000000004 110.397 -178.226 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 133.46 -154.5 21.28 Favored Glycine 0 C--N 1.351 1.396 0 CA-C-O 119.56 -0.578 . . . . 53.229999999999997 112.104 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -67.83 142.18 56.63 Favored 'Trans proline' 0 C--N 1.369 1.641 0 C-N-CA 122.829 2.353 . . . . 63.520000000000003 112.313 172.221 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.435 ' HA ' ' H ' ' A' ' 178' ' ' ALA . 30.0 m -139.61 147.82 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 124.007 0.923 . . . . 74.109999999999999 109.639 175.369 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.653 ' HG3' ' HB2' ' A' ' 178' ' ' ALA . 42.5 mt-10 -100.78 109.24 21.22 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.131 0.572 . . . . 72.349999999999994 109.672 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.414 ' HA ' ' HA ' ' A' ' 175' ' ' TYR . 47.9 t -94.53 122.61 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 123.82 0.848 . . . . 74.310000000000002 109.734 -175.362 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -69.72 99.96 1.42 Allowed 'General case' 0 C--N 1.35 0.62 0 O-C-N 123.952 0.783 . . . . 52.130000000000003 110.022 177.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.468 HG11 HG11 ' A' ' 199' ' ' VAL . 57.9 t -77.82 121.01 83.54 Favored Pre-proline 0 C--O 1.243 0.728 0 CA-C-N 114.558 -1.201 . . . . 71.319999999999993 108.849 173.76 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -61.5 157.13 42.91 Favored 'Trans proline' 0 CA--C 1.563 1.963 0 C-N-CA 122.25 1.967 . . . . 73.540000000000006 111.97 172.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -66.31 144.15 73.13 Favored 'Trans proline' 0 C--N 1.372 1.788 0 C-N-CA 122.251 1.967 . . . . 53.549999999999997 111.448 172.154 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 88.6 mtt180 69.12 32.24 3.77 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 125.126 1.37 . . . . 71.099999999999994 111.367 172.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.547 HG23 ' HD2' ' A' ' 231' ' ' ARG . 97.4 m -77.32 121.6 23.96 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.451 1.1 . . . . 74.109999999999999 110.325 174.692 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -95.18 163.3 13.34 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 109.603 -0.517 . . . . 74.109999999999999 109.603 178.189 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -70.69 118.84 13.99 Favored 'General case' 0 C--N 1.348 0.51 0 CA-C-N 115.469 -0.787 . . . . 72.209999999999994 108.925 170.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 115.01 -1.47 22.8 Favored Glycine 0 N--CA 1.464 0.544 0 CA-C-O 119.73 -0.483 . . . . 71.340000000000003 112.518 -172.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.547 ' HD2' HG23 ' A' ' 227' ' ' THR . 38.8 mtt180 -75.55 158.52 32.4 Favored 'General case' 0 C--N 1.358 0.958 0 CA-C-O 121.451 0.643 . . . . 62.130000000000003 110.289 168.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.437 ' HG3' HG12 ' A' ' 170' ' ' VAL . 23.0 pttm -124.7 129.19 50.02 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.653 1.181 . . . . 74.219999999999999 108.731 -177.513 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.514 HD22 ' HB2' ' A' ' 173' ' ' ALA . 87.6 mt -117.91 104.16 10.65 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.966 0.907 . . . . 70.129999999999995 108.905 -178.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 234' ' ' ARG . . . . . 0.466 ' HB3' HG21 ' A' ' 170' ' ' VAL . 41.8 ttm180 -97.01 100.43 11.93 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 107.254 -1.388 . . . . 73.340000000000003 107.254 175.267 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 20.8 mt -73.4 84.22 1.46 Allowed 'General case' 0 C--O 1.24 0.555 0 N-CA-C 107.185 -1.413 . . . . 74.239999999999995 107.185 173.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 6.6 mtpm? -73.53 132.34 42.75 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 115.199 -0.91 . . . . 74.140000000000001 110.328 -172.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 69.01 23.5 76.03 Favored Glycine 0 C--N 1.342 0.897 0 O-C-N 123.899 0.749 . . . . 75.129999999999995 112.431 -176.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.557 ' HB3' ' HE1' ' A' ' 175' ' ' TYR . 60.8 mmtt -138.72 17.7 2.69 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.995 1.318 . . . . 73.129999999999995 111.136 -170.293 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 239' ' ' GLY . . . . . 0.464 ' HA2' ' HB2' ' A' ' 249' ' ' LEU . . . -82.18 -89.48 0.65 Allowed Glycine 0 N--CA 1.471 0.984 0 N-CA-C 110.499 -1.04 . . . . 72.239999999999995 110.499 173.78 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -95.85 120.62 62.84 Favored Pre-proline 0 N--CA 1.47 0.557 0 N-CA-C 108.339 -0.985 . . . . 73.120000000000005 108.339 167.548 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -77.82 132.01 11.59 Favored 'Trans proline' 0 C--N 1.372 1.808 0 C-N-CA 122.417 2.078 . . . . 74.450000000000003 111.41 175.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 168.29 146.69 5.06 Favored Glycine 0 C--N 1.345 1.073 0 CA-C-O 119.228 -0.762 . . . . 44.009999999999998 112.688 177.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 243' ' ' PRO . . . . . 0.484 ' HD2' ' HA2' ' A' ' 186' ' ' GLY . 57.3 Cg_endo -68.98 -18.82 40.54 Favored 'Trans proline' 0 C--N 1.376 2.001 0 C-N-CA 123.635 2.89 . . . . 61.210000000000001 114.82 -173.52 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -81.26 -28.96 34.51 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 118.403 0.547 . . . . 64.420000000000002 111.134 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -179.34 105.94 0.2 Allowed Glycine 0 C--N 1.346 1.094 0 O-C-N 123.478 0.486 . . . . 72.010000000000005 112.205 -178.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 61.2 mtt-85 -86.8 122.55 30.84 Favored 'General case' 0 C--N 1.349 0.577 0 N-CA-C 108.012 -1.107 . . . . 72.200000000000003 108.012 173.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -83.41 -168.12 42.82 Favored Glycine 0 N--CA 1.469 0.866 0 O-C-N 123.661 0.601 . . . . 64.409999999999997 113.945 -176.088 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -120.29 126.5 50.73 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 108.674 -0.862 . . . . 65.450000000000003 108.674 177.152 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.464 ' HB2' ' HA2' ' A' ' 239' ' ' GLY . 46.3 tp -97.77 106.3 18.59 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 106.888 -1.523 . . . . 71.329999999999998 106.888 175.684 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -99.25 122.39 42.35 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.311 -0.859 . . . . 74.25 109.034 -170.076 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.561 ' HB3' ' HB2' ' A' ' 197' ' ' LEU . 65.0 mt -123.24 122.18 37.73 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.708 0.803 . . . . 61.310000000000002 110.157 -172.268 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 252' ' ' GLU . . . . . 0.461 ' HB2' HG22 ' A' ' 196' ' ' THR . 28.2 mm-40 -90.71 109.67 20.85 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.836 0.854 . . . . 74.0 109.686 178.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.542 HG11 HG22 ' A' ' 227' ' ' THR . 84.4 t -63.48 113.74 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 CA-C-O 121.424 0.631 . . . . 63.409999999999997 111.409 -176.606 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 28.1 mmm180 -114.21 105.27 12.97 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.72 1.608 . . . . 75.349999999999994 108.02 173.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.405 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 39.8 mt -76.95 128.59 37.87 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 N-CA-C 110.0 -0.37 . . . . 52.439999999999998 110.0 178.671 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 19.2 p . . . . . 0 C--O 1.248 1.015 0 C-N-CA 124.793 1.237 . . . . 51.119999999999997 108.79 -176.735 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 25.8 ptt? . . . . . 0 N--CA 1.488 1.439 0 CA-C-O 119.61 -0.233 . . . . 71.439999999999998 111.592 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 32.6 t70 55.07 79.07 0.16 Allowed 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 124.854 1.262 . . . . 62.43 109.558 -172.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -62.81 -72.29 0.14 Allowed 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.119 -0.946 . . . . 73.540000000000006 111.878 -167.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.491 HG21 ' HB3' ' A' ' 234' ' ' ARG . 25.4 m -85.43 171.96 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 O-C-N 123.755 0.659 . . . . 72.439999999999998 110.749 -179.188 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.431 HG21 ' HD3' ' A' ' 231' ' ' ARG . 15.7 tt -93.05 145.69 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 N-CA-C 109.334 -0.617 . . . . 72.230000000000004 109.334 173.326 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -60.13 129.02 39.66 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.92 1.288 . . . . 73.530000000000001 111.329 -177.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.487 ' HB2' HD22 ' A' ' 233' ' ' LEU . . . -152.18 163.06 40.17 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 124.624 1.169 . . . . 61.43 109.219 175.539 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -149.17 176.68 10.29 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 108.56 -0.904 . . . . 64.200000000000003 108.56 173.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.429 ' CE1' ' HB3' ' A' ' 238' ' ' LYS . 22.8 p90 -144.07 177.23 8.72 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 118.029 0.377 . . . . 74.209999999999994 111.244 175.051 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -136.88 131.1 17.9 Favored Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 124.031 0.933 . . . . 74.040000000000006 109.52 176.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' PRO . . . . . 0.511 ' HA ' HG12 ' A' ' 219' ' ' VAL . 44.1 Cg_endo -66.07 95.39 0.3 Allowed 'Trans proline' 0 C--N 1.369 1.637 0 C-N-CA 122.927 2.418 . . . . 65.299999999999997 111.548 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 178' ' ' ALA . . . . . 0.586 ' HB2' ' HG3' ' A' ' 220' ' ' GLU . . . -63.84 -37.21 86.53 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.1 0.96 . . . . 64.349999999999994 111.561 -176.254 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.429 ' HB2' ' HG2' ' A' ' 218' ' ' PRO . 29.0 t70 -95.95 101.35 13.01 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 109.39 -0.596 . . . . 62.100000000000001 109.39 176.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 58.82 -99.25 0.12 Allowed Glycine 0 C--N 1.351 1.389 0 O-C-N 124.469 1.106 . . . . 71.209999999999994 113.003 177.329 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 57.8 p -157.68 152.62 25.51 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 124.206 1.003 . . . . 75.200000000000003 108.983 179.357 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -74.07 135.51 20.15 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 111.059 -0.816 . . . . 72.5 111.059 171.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 176.39 35.63 0.05 OUTLIER Glycine 0 C--N 1.337 0.624 0 CA-C-O 120.199 -0.223 . . . . 63.43 112.595 179.161 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 42.5 t -69.97 109.61 4.61 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 109.737 -0.468 . . . . 71.450000000000003 109.737 179.279 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -74.38 73.88 1.32 Allowed Glycine 0 C--N 1.346 1.124 0 O-C-N 123.728 0.642 . . . . 52.0 112.707 -179.133 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' GLY . . . . . 0.465 ' HA3' ' HE2' ' A' ' 240' ' ' PHE . . . -102.85 150.31 17.84 Favored Glycine 0 C--N 1.342 0.89 0 N-CA-C 111.593 -0.603 . . . . 62.340000000000003 111.593 176.313 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 33.7 t -145.71 30.28 1.09 Allowed 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 123.538 0.735 . . . . 74.319999999999993 110.008 -177.053 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -89.59 13.2 64.69 Favored Glycine 0 C--N 1.352 1.439 0 CA-C-N 116.152 -0.476 . . . . 61.119999999999997 113.844 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 95.07 -23.9 31.14 Favored Glycine 0 C--N 1.352 1.442 0 CA-C-N 117.325 0.563 . . . . 64.310000000000002 113.233 178.004 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 15.2 m -73.85 89.24 1.84 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.332 0.653 . . . . 64.129999999999995 110.815 -178.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -92.91 -33.01 14.36 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 109.073 -0.714 . . . . 64.209999999999994 109.073 172.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.44 ' HA ' ' O ' ' A' ' 248' ' ' ASP . 1.2 p30 -102.61 129.39 49.17 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.292 -0.867 . . . . 63.240000000000002 109.443 175.703 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 68.4 mt -109.18 135.35 50.44 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 108.174 -1.047 . . . . 72.099999999999994 108.174 177.299 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -120.23 121.9 39.74 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 108.227 -1.027 . . . . 72.549999999999997 108.227 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -154.29 166.35 33.45 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 123.358 0.663 . . . . 40.030000000000001 110.56 -173.202 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 4.9 m -102.24 145.12 29.89 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 109.185 -0.672 . . . . 62.329999999999998 109.185 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.529 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . 43.0 tp -119.75 121.72 39.81 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.476 0.71 . . . . 72.140000000000001 110.183 -172.231 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -83.77 115.24 22.12 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 109.349 -0.612 . . . . 75.099999999999994 109.349 173.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.532 ' HA ' HG11 ' A' ' 210' ' ' VAL . 98.1 t -119.26 110.44 37.72 Favored Pre-proline 0 CA--C 1.537 0.478 0 C-N-CA 123.98 0.912 . . . . 75.329999999999998 109.0 177.501 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -54.73 141.66 75.34 Favored 'Trans proline' 0 C--N 1.37 1.697 0 C-N-CA 122.755 2.303 . . . . 70.400000000000006 112.184 171.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.406 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -48.48 -47.78 68.72 Favored Pre-proline 0 CA--C 1.563 1.447 0 CA-C-O 117.784 -1.103 . . . . 74.109999999999999 113.426 177.772 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.406 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 15.7 Cg_endo -54.79 -46.33 34.14 Favored 'Trans proline' 0 C--N 1.398 3.163 0 C-N-CA 122.3 2.0 . . . . 72.219999999999999 112.787 175.214 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.419 HG21 HG13 ' A' ' 210' ' ' VAL . 43.9 mt -68.74 -32.35 54.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 123.768 0.827 . . . . 74.5 111.115 -176.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -65.61 -44.9 85.1 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.251 0.62 . . . . 64.510000000000005 110.829 178.462 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 201' ' ' ALA . 60.3 t -71.35 -52.3 27.67 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-N 115.82 -0.627 . . . . 74.430000000000007 110.909 -178.35 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 14.6 m -71.49 -25.85 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 N-CA-C 111.958 0.355 . . . . 70.510000000000005 111.958 -176.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 74.15 74.5 0.84 Allowed Glycine 0 C--N 1.341 0.833 0 N-CA-C 111.674 -0.57 . . . . 62.450000000000003 111.674 -174.329 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -118.88 -164.16 12.72 Favored Glycine 0 N--CA 1.472 1.08 0 N-CA-C 111.75 -0.54 . . . . 34.439999999999998 111.75 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -103.16 142.46 34.11 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 117.434 0.617 . . . . 74.319999999999993 110.317 -179.129 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.532 HG11 ' HA ' ' A' ' 199' ' ' VAL . 22.5 m -120.73 147.15 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 124.672 1.189 . . . . 65.219999999999999 109.077 175.205 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 19.3 ttm180 -90.46 109.55 20.67 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 122.024 -0.423 . . . . 72.400000000000006 110.034 -178.07 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -100.25 158.63 15.73 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.689 1.196 . . . . 71.430000000000007 110.803 -175.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 2.0 mmt -105.87 108.63 20.25 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.636 0.774 . . . . 75.319999999999993 110.437 -178.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 68.7 p -111.32 175.41 5.43 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 109.434 -0.58 . . . . 75.230000000000004 109.434 170.591 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 19.3 mt -70.61 -17.82 62.88 Favored 'General case' 0 CA--C 1.55 0.978 0 CA-C-N 115.761 -0.654 . . . . 64.019999999999996 110.468 178.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -92.44 -0.32 57.37 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.868 1.267 . . . . 71.310000000000002 110.993 178.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 108.89 -161.76 13.07 Favored Glycine 0 C--N 1.349 1.264 0 C-N-CA 123.594 0.616 . . . . 74.140000000000001 113.281 175.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 218' ' ' PRO . . . . . 0.429 ' HG2' ' HB2' ' A' ' 179' ' ' ASP . 59.8 Cg_endo -72.46 132.16 18.66 Favored 'Trans proline' 0 C--N 1.363 1.313 0 C-N-CA 122.719 2.28 . . . . 74.430000000000007 112.864 178.398 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.511 HG12 ' HA ' ' A' ' 177' ' ' PRO . 34.2 m -130.13 160.24 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 124.344 1.058 . . . . 73.120000000000005 109.214 177.508 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.586 ' HG3' ' HB2' ' A' ' 178' ' ' ALA . 46.1 mt-10 -109.26 108.27 18.81 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.461 0.704 . . . . 73.200000000000003 110.297 178.458 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 72.9 t -92.69 116.13 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 123.363 0.665 . . . . 52.310000000000002 109.591 -176.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -66.57 100.45 0.67 Allowed 'General case' 0 CA--C 1.543 0.706 0 O-C-N 124.022 0.827 . . . . 52.109999999999999 109.647 174.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 61.1 t -75.16 131.11 78.98 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 124.944 1.297 . . . . 53.299999999999997 109.071 176.231 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 224' ' ' PRO . . . . . 0.41 ' HA ' ' HD3' ' A' ' 225' ' ' PRO . 18.4 Cg_endo -59.89 152.56 63.34 Favored 'Trans proline' 0 CA--C 1.565 2.055 0 C-N-CA 122.318 2.012 . . . . 73.430000000000007 112.76 173.575 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 225' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 224' ' ' PRO . 29.6 Cg_exo -65.49 146.44 85.06 Favored 'Trans proline' 0 C--N 1.371 1.738 0 C-N-CA 122.453 2.102 . . . . 72.329999999999998 112.88 175.623 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 35.1 mtp180 65.29 23.34 12.13 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 125.009 1.323 . . . . 75.040000000000006 112.207 174.563 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.528 HG23 ' HD2' ' A' ' 231' ' ' ARG . 4.1 m -54.81 139.13 40.75 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.612 1.165 . . . . 72.409999999999997 112.397 179.441 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -102.94 158.34 16.35 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.868 0.867 . . . . 63.539999999999999 109.816 175.368 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -73.83 131.26 41.33 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 108.893 -0.781 . . . . 72.129999999999995 108.893 172.396 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 100.2 2.22 55.81 Favored Glycine 0 N--CA 1.464 0.528 0 CA-C-O 119.197 -0.78 . . . . 71.140000000000001 112.385 -172.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.528 ' HD2' HG23 ' A' ' 227' ' ' THR . 60.5 mtt-85 -69.18 159.34 33.17 Favored 'General case' 0 C--N 1.359 1.021 0 CA-C-O 121.457 0.646 . . . . 73.030000000000001 110.338 172.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 48.9 pttt -130.86 132.93 45.48 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 114.927 -1.033 . . . . 73.120000000000005 109.727 -175.28 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.487 HD22 ' HB2' ' A' ' 173' ' ' ALA . 37.3 mt -121.47 127.3 50.94 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 108.213 -1.032 . . . . 65.409999999999997 108.213 178.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 234' ' ' ARG . . . . . 0.491 ' HB3' HG21 ' A' ' 170' ' ' VAL . 31.4 ttt180 -116.83 102.78 9.68 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 107.797 -1.186 . . . . 71.239999999999995 107.797 170.578 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.444 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 16.3 mt -83.52 84.58 7.48 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 114.948 -1.024 . . . . 75.239999999999995 109.279 -176.503 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -71.09 137.1 48.62 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.143 -0.935 . . . . 73.400000000000006 110.86 -178.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 67.39 16.56 67.41 Favored Glycine 0 C--N 1.352 1.425 0 O-C-N 123.987 0.804 . . . . 61.539999999999999 112.567 -177.356 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.429 ' HB3' ' CE1' ' A' ' 175' ' ' TYR . 31.3 mmtp -139.96 23.37 2.42 Favored 'General case' 0 C--O 1.217 -0.64 0 C-N-CA 124.54 1.136 . . . . 74.340000000000003 109.861 -175.297 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -89.37 -127.25 3.08 Favored Glycine 0 N--CA 1.468 0.829 0 O-C-N 121.869 -0.519 . . . . 54.0 111.899 171.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 240' ' ' PHE . . . . . 0.465 ' HE2' ' HA3' ' A' ' 186' ' ' GLY . 0.1 OUTLIER -80.52 147.06 62.65 Favored Pre-proline 0 N--CA 1.476 0.863 0 CA-C-O 118.326 -0.845 . . . . 71.430000000000007 110.434 176.491 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.503 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 86.2 Cg_exo -46.08 140.72 10.25 Favored 'Trans proline' 0 C--N 1.392 2.856 0 C-N-CA 123.837 3.025 . . . . 61.520000000000003 114.409 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -157.26 129.37 2.36 Favored Glycine 0 CA--C 1.536 1.353 0 CA-C-O 118.5 -1.167 . . . . 61.149999999999999 111.459 -179.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -62.47 -45.45 14.6 Favored 'Trans proline' 0 C--N 1.378 2.089 0 C-N-CA 123.137 2.558 . . . . 75.439999999999998 113.869 -178.381 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -78.21 -28.19 47.96 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-O 121.146 0.498 . . . . 22.149999999999999 110.461 177.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 169.52 145.92 4.85 Favored Glycine 0 C--N 1.334 0.471 0 CA-C-N 115.13 -0.941 . . . . 75.019999999999996 110.854 176.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.503 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 23.9 mtt180 -69.46 156.08 39.44 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.3 0.64 . . . . 75.340000000000003 110.665 177.737 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -73.13 -155.96 3.39 Favored Glycine 0 C--N 1.348 1.196 0 CA-C-N 116.076 -0.511 . . . . 65.109999999999999 113.218 178.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 248' ' ' ASP . . . . . 0.44 ' O ' ' HA ' ' A' ' 192' ' ' ASP . 21.6 m-20 -106.99 148.63 28.45 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.551 0.74 . . . . 61.240000000000002 110.479 179.58 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.444 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 50.0 tp -125.23 105.12 8.89 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 107.663 -1.236 . . . . 74.140000000000001 107.663 169.601 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -96.96 109.09 21.91 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 123.637 0.775 . . . . 73.109999999999999 109.527 -174.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.529 ' HB3' ' HB2' ' A' ' 197' ' ' LEU . 71.8 mt -112.84 116.36 29.93 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.119 0.968 . . . . 71.219999999999999 109.918 -178.272 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -86.64 113.64 22.68 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.644 0.778 . . . . 73.340000000000003 110.192 177.154 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.402 HG11 ' CG2' ' A' ' 227' ' ' THR . 97.0 t -65.68 125.0 21.84 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.218 0 C-N-CA 123.801 0.84 . . . . 62.32 112.314 -177.157 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 26.3 mmm180 -118.34 108.38 15.01 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.428 1.491 . . . . 74.25 107.905 170.246 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.491 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 34.6 mt -76.78 119.16 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 109.696 -0.483 . . . . 70.319999999999993 109.696 177.352 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 36.0 p . . . . . 0 CA--C 1.551 0.999 0 C-N-CA 124.437 1.095 . . . . 74.120000000000005 108.903 178.924 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 15.5 tpt . . . . . 0 N--CA 1.481 1.086 0 N-CA-C 109.396 -0.594 . . . . 71.319999999999993 109.396 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -113.77 108.2 16.77 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.778 0.831 . . . . 74.409999999999997 109.84 -179.35 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -72.29 -51.89 18.77 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 121.772 0.796 . . . . 72.510000000000005 109.453 170.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.426 HG21 ' N ' ' A' ' 234' ' ' ARG . 27.1 m -107.28 -176.98 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-N 114.206 -1.361 . . . . 62.240000000000002 109.458 179.12 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 13.2 tt -84.83 139.77 17.0 Favored 'Isoleucine or valine' 0 C--O 1.246 0.891 0 N-CA-C 108.036 -1.098 . . . . 75.430000000000007 108.036 164.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -70.59 135.13 48.23 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 122.831 0.452 . . . . 75.230000000000004 110.065 177.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.452 ' HB2' HD22 ' A' ' 233' ' ' LEU . . . -138.98 175.37 9.61 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.062 0.945 . . . . 74.319999999999993 109.207 177.073 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -150.98 158.98 44.82 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 122.79 0.436 . . . . 64.219999999999999 110.337 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.532 ' HD1' HD13 ' A' ' 235' ' ' LEU . 9.8 p90 -140.63 176.12 9.05 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.346 0.593 . . . . 73.150000000000006 110.548 170.012 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -145.48 149.26 40.09 Favored Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 124.586 1.154 . . . . 71.209999999999994 108.614 170.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' PRO . . . . . 0.519 ' HA ' HG12 ' A' ' 219' ' ' VAL . 27.5 Cg_endo -58.24 123.79 14.42 Favored 'Trans proline' 0 C--N 1.373 1.85 0 C-N-CA 123.009 2.473 . . . . 73.209999999999994 111.99 -179.32 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 178' ' ' ALA . . . . . 0.579 ' HB2' ' HG3' ' A' ' 220' ' ' GLU . . . -88.22 55.29 3.37 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 108.177 -1.046 . . . . 70.120000000000005 108.177 172.428 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 32.9 t70 60.83 91.25 0.06 Allowed 'General case' 0 C--N 1.356 0.885 0 C-N-CA 124.91 1.284 . . . . 71.430000000000007 110.448 -168.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 161.31 103.58 0.18 Allowed Glycine 0 C--N 1.342 0.879 0 CA-C-N 116.048 -0.523 . . . . 42.229999999999997 112.118 -179.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' SER . . . . . 0.5 ' HA ' ' HB3' ' A' ' 216' ' ' GLU . 65.5 m -147.92 142.12 26.13 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.903 0.881 . . . . 64.510000000000005 110.115 175.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -156.84 -143.78 3.75 Favored Glycine 0 C--N 1.339 0.732 0 N-CA-C 110.48 -1.048 . . . . 55.509999999999998 110.48 -179.5 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 83.95 -66.99 3.8 Favored Glycine 0 C--N 1.342 0.917 0 CA-C-N 117.165 0.483 . . . . 63.219999999999999 114.061 172.32 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 24.9 m 77.79 -41.3 0.34 Allowed 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 125.944 1.698 . . . . 70.549999999999997 111.457 -172.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -166.07 -158.2 10.74 Favored Glycine 0 C--N 1.344 0.982 0 N-CA-C 111.521 -0.631 . . . . 50.030000000000001 111.521 172.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -166.82 23.49 0.12 Allowed Glycine 0 C--N 1.347 1.154 0 CA-C-N 116.872 0.336 . . . . 53.340000000000003 112.964 176.453 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 32.1 t -69.49 123.99 22.72 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.579 0.751 . . . . 53.299999999999997 110.658 -178.231 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 102.85 12.17 32.88 Favored Glycine 0 C--N 1.346 1.115 0 CA-C-N 116.357 -0.383 . . . . 54.219999999999999 112.505 -172.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -161.71 -179.31 36.31 Favored Glycine 0 C--N 1.344 0.983 0 N-CA-C 112.114 -0.394 . . . . 62.130000000000003 112.114 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 45.5 m -77.08 97.05 4.59 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 122.73 0.412 . . . . 74.129999999999995 110.352 -178.013 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.415 ' HA ' ' HB2' ' A' ' 240' ' ' PHE . 53.5 mt-30 -66.6 -20.37 65.99 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.435 0.694 . . . . 73.129999999999995 111.08 173.096 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 20.1 p-10 -85.18 126.5 33.7 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.311 0.644 . . . . 73.299999999999997 109.773 171.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 34.5 mt -108.9 145.07 35.97 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.191 1.396 . . . . 52.32 108.875 177.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -123.73 121.75 36.3 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 107.797 -1.186 . . . . 73.400000000000006 107.797 175.295 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.426 ' O ' ' HA ' ' A' ' 251' ' ' LEU . . . -149.51 165.59 31.71 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.065 0.946 . . . . 74.310000000000002 109.527 -171.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 10.5 m -108.77 140.72 41.81 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 109.969 -0.382 . . . . 74.299999999999997 109.969 -177.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.476 HD11 HG23 ' A' ' 210' ' ' VAL . 43.1 tp -108.79 121.52 45.24 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.748 0.819 . . . . 65.209999999999994 110.036 -176.319 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -93.11 103.02 15.35 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 109.161 -0.681 . . . . 62.43 109.161 172.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.56 HG21 HG11 ' A' ' 223' ' ' VAL . 2.7 p -106.57 119.52 51.4 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 123.676 0.791 . . . . 74.299999999999997 109.53 173.729 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -55.47 140.88 83.15 Favored 'Trans proline' 0 C--N 1.375 1.922 0 C-N-CA 122.331 2.021 . . . . 54.399999999999999 112.486 169.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.405 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -51.71 -49.17 84.72 Favored Pre-proline 0 CA--C 1.554 1.113 0 CA-C-O 118.077 -0.963 . . . . 73.549999999999997 113.451 -177.657 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -56.59 -39.83 88.62 Favored 'Trans proline' 0 C--N 1.39 2.724 0 C-N-CA 121.902 1.735 . . . . 54.350000000000001 112.877 176.097 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 28.4 mt -69.15 -34.28 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 123.259 0.624 . . . . 62.149999999999999 110.4 -178.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -66.33 -42.72 87.75 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.012 0.525 . . . . 72.0 111.073 178.061 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 201' ' ' ALA . 87.1 t -71.96 -49.51 44.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 123.682 0.793 . . . . 64.030000000000001 111.282 -176.24 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 16.2 m -75.01 -22.75 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 CA-C-N 116.668 -0.242 . . . . 70.450000000000003 111.496 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 76.4 76.05 0.84 Allowed Glycine 0 C--N 1.346 1.106 0 N-CA-C 112.179 -0.369 . . . . 61.520000000000003 112.179 -177.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -110.69 -159.18 16.42 Favored Glycine 0 C--N 1.339 0.706 0 N-CA-C 111.699 -0.561 . . . . 73.319999999999993 111.699 -179.218 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 33.7 mtmm -115.13 145.45 42.34 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 108.88 -0.785 . . . . 63.439999999999998 108.88 173.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.49 HG11 ' HA ' ' A' ' 199' ' ' VAL . 19.6 m -128.06 168.17 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 123.95 0.9 . . . . 73.109999999999999 109.829 177.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 35.4 mtp-105 -99.38 117.49 33.93 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 121.218 0.532 . . . . 73.439999999999998 110.498 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -101.02 128.09 47.22 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 107.633 -1.247 . . . . 24.449999999999999 107.633 171.671 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.25 112.1 23.06 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 109.158 -0.682 . . . . 75.409999999999997 109.158 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 69.3 p -110.39 -177.96 3.38 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.62 0.768 . . . . 65.310000000000002 109.823 177.017 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 17.4 mt -67.44 -23.48 65.53 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 122.488 0.315 . . . . 61.5 111.021 178.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 216' ' ' GLU . . . . . 0.5 ' HB3' ' HA ' ' A' ' 181' ' ' SER . 45.3 mt-10 -86.31 -19.14 30.3 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.748 0.819 . . . . 71.230000000000004 111.895 178.283 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 127.42 -151.77 18.56 Favored Glycine 0 C--N 1.345 1.043 0 CA-C-O 119.568 -0.573 . . . . 53.109999999999999 112.594 176.073 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.65 135.14 17.56 Favored 'Trans proline' 0 C--N 1.372 1.799 0 C-N-CA 122.7 2.267 . . . . 74.040000000000006 111.65 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.519 HG12 ' HA ' ' A' ' 177' ' ' PRO . 33.3 m -135.41 142.07 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 123.306 0.642 . . . . 73.030000000000001 109.813 175.349 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.579 ' HG3' ' HB2' ' A' ' 178' ' ' ALA . 43.2 mt-10 -90.49 106.74 18.7 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.028 0.531 . . . . 73.019999999999996 110.281 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.435 HG22 ' HB3' ' A' ' 175' ' ' TYR . 59.6 t -94.33 121.65 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 123.79 0.836 . . . . 60.450000000000003 109.423 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -71.19 107.95 4.46 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.257 0.623 . . . . 75.239999999999995 110.064 177.137 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.56 HG11 HG21 ' A' ' 199' ' ' VAL . 48.3 t -83.51 124.05 75.96 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 124.658 1.183 . . . . 75.049999999999997 108.897 175.703 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -58.97 152.49 57.97 Favored 'Trans proline' 0 CA--C 1.567 2.169 0 C-N-CA 122.675 2.25 . . . . 75.319999999999993 113.11 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -59.61 126.23 20.03 Favored 'Trans proline' 0 C--N 1.375 1.972 0 C-N-CA 122.511 2.141 . . . . 74.150000000000006 112.408 173.553 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 75.3 mtp180 65.52 61.58 0.69 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.97 1.308 . . . . 65.030000000000001 111.317 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.468 HG23 ' HD2' ' A' ' 231' ' ' ARG . 27.0 m -85.16 143.86 28.54 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.409 -0.814 . . . . 64.450000000000003 109.773 173.208 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -111.07 153.89 25.01 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.66 0.784 . . . . 74.349999999999994 110.863 179.384 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -70.46 135.82 48.98 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.576 0.75 . . . . 74.310000000000002 110.261 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.82 1.29 63.55 Favored Glycine 0 C--N 1.341 0.811 0 CA-C-O 119.689 -0.506 . . . . 71.310000000000002 113.174 -177.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.468 ' HD2' HG23 ' A' ' 227' ' ' THR . 52.4 mtt-85 -69.84 160.99 30.74 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 117.243 0.521 . . . . 63.420000000000002 110.551 171.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 20.9 pttm -126.98 135.06 50.34 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.864 -0.607 . . . . 73.510000000000005 110.603 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.452 HD22 ' HB2' ' A' ' 173' ' ' ALA . 74.4 mt -114.08 145.24 41.88 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.951 1.3 . . . . 63.399999999999999 108.173 175.77 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 234' ' ' ARG . . . . . 0.426 ' N ' HG21 ' A' ' 170' ' ' VAL . 51.7 ttt85 -136.53 102.18 4.86 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 107.952 -1.129 . . . . 74.519999999999996 107.952 166.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.532 HD13 ' HD1' ' A' ' 175' ' ' TYR . 14.8 mt -73.78 91.43 1.94 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.752 1.221 . . . . 63.32 109.433 179.368 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 51.9 mttp -62.29 124.74 21.7 Favored 'General case' 0 C--N 1.354 0.801 0 C-N-CA 123.437 0.695 . . . . 74.420000000000002 110.696 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 69.42 34.52 74.3 Favored Glycine 0 C--N 1.345 1.059 0 O-C-N 123.54 0.525 . . . . 51.340000000000003 113.061 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.487 ' HB3' ' CE1' ' A' ' 175' ' ' TYR . 32.8 mmtm -143.44 29.84 1.41 Allowed 'General case' 0 CA--C 1.559 1.321 0 C-N-CA 123.76 0.824 . . . . 74.400000000000006 112.616 -173.741 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -99.21 -111.05 3.15 Favored Glycine 0 N--CA 1.482 1.716 0 N-CA-C 111.134 -0.787 . . . . 52.119999999999997 111.134 175.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 240' ' ' PHE . . . . . 0.415 ' HB2' ' HA ' ' A' ' 191' ' ' GLN . 5.8 m-85 -71.19 151.88 94.57 Favored Pre-proline 0 N--CA 1.48 1.049 0 C-N-CA 123.728 0.811 . . . . 71.140000000000001 109.813 165.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.525 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 52.3 Cg_exo -57.3 155.68 28.86 Favored 'Trans proline' 0 C--N 1.373 1.838 0 C-N-CA 122.93 2.42 . . . . 54.420000000000002 112.418 165.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -162.76 125.03 1.35 Allowed Glycine 0 CA--C 1.535 1.296 0 CA-C-O 118.602 -1.11 . . . . 64.140000000000001 111.625 178.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -60.65 -49.01 9.58 Favored 'Trans proline' 0 C--N 1.381 2.237 0 C-N-CA 123.391 2.727 . . . . 74.430000000000007 112.644 177.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -76.31 -26.34 55.72 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 122.874 0.47 . . . . 64.519999999999996 110.692 178.091 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 165.01 145.17 4.31 Favored Glycine 0 C--N 1.344 1.005 0 CA-C-N 115.617 -0.72 . . . . 75.150000000000006 111.343 177.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.525 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 21.1 mtt180 -73.28 163.3 28.29 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.538 0.735 . . . . 73.099999999999994 111.127 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -81.55 -169.23 42.08 Favored Glycine 0 C--N 1.348 1.202 0 CA-C-N 115.824 -0.626 . . . . 74.450000000000003 111.768 170.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -107.37 152.1 24.62 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 118.003 0.902 . . . . 72.310000000000002 110.617 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 55.9 tp -120.92 106.7 11.87 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 108.706 -0.849 . . . . 61.039999999999999 108.706 173.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -91.37 123.66 34.97 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 123.806 0.843 . . . . 63.420000000000002 108.984 -177.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.426 ' HA ' ' O ' ' A' ' 195' ' ' ALA . 61.7 mt -119.53 122.37 41.48 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.374 0.67 . . . . 74.129999999999995 110.396 -176.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -81.07 114.0 19.63 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 108.975 -0.75 . . . . 71.109999999999999 108.975 172.013 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 88.4 t -66.92 109.52 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 122.905 0.482 . . . . 73.109999999999999 110.791 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 9.2 mmm180 -113.47 105.68 13.65 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 124.279 1.032 . . . . 73.209999999999994 108.848 173.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 28.9 mt -76.96 131.09 35.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-N 115.652 -0.703 . . . . 73.209999999999994 109.525 176.218 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 3.3 t . . . . . 0 CA--C 1.562 1.414 0 CA-C-O 117.849 -1.072 . . . . 62.450000000000003 108.763 -178.231 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 24.8 mmt . . . . . 0 N--CA 1.473 0.703 0 CA-C-O 121.198 0.523 . . . . 64.140000000000001 109.762 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -86.2 77.26 9.6 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 122.134 0.969 . . . . 73.340000000000003 109.159 175.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -70.33 -49.85 45.2 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 114.396 -1.274 . . . . 70.439999999999998 111.045 -178.238 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.498 HG11 ' HB2' ' A' ' 234' ' ' ARG . 26.2 m -93.37 177.19 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 C-N-CA 123.061 0.545 . . . . 65.200000000000003 110.637 175.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.405 HG21 ' HD3' ' A' ' 231' ' ' ARG . 13.8 tt -103.17 147.59 9.37 Favored 'Isoleucine or valine' 0 C--O 1.245 0.863 0 N-CA-C 108.418 -0.956 . . . . 72.340000000000003 108.418 173.747 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -64.31 142.83 58.28 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.654 0.782 . . . . 52.439999999999998 110.656 -178.362 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.529 ' HB2' HD22 ' A' ' 233' ' ' LEU . . . -160.0 164.48 33.23 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 123.82 0.848 . . . . 53.450000000000003 109.616 -178.264 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -157.25 157.67 34.71 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.703 0.801 . . . . 73.019999999999996 109.665 -178.357 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.489 ' HD1' HD13 ' A' ' 235' ' ' LEU . 5.5 p90 -135.97 178.01 7.38 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.232 0.539 . . . . 75.530000000000001 111.537 177.124 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.555 ' HE2' ' HA ' ' A' ' 176' ' ' LYS . 7.9 mmpt? -132.7 135.31 25.87 Favored Pre-proline 0 N--CA 1.472 0.632 0 C-N-CA 124.691 1.197 . . . . 73.219999999999999 108.924 174.757 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' PRO . . . . . 0.519 ' HA ' HG12 ' A' ' 219' ' ' VAL . 48.1 Cg_endo -65.86 94.96 0.28 Allowed 'Trans proline' 0 C--N 1.377 2.05 0 C-N-CA 122.74 2.294 . . . . 72.019999999999996 111.127 178.037 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 178' ' ' ALA . . . . . 0.58 ' H ' ' HA ' ' A' ' 219' ' ' VAL . . . -67.28 -21.79 65.68 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.371 1.068 . . . . 74.109999999999999 111.543 -177.111 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.48 ' HB2' ' HD2' ' A' ' 218' ' ' PRO . 15.2 t70 -63.83 -46.51 84.74 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.629 0.772 . . . . 72.019999999999996 110.014 170.505 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 115.54 -40.79 2.32 Favored Glycine 0 C--N 1.341 0.847 0 CA-C-N 114.883 -1.053 . . . . 63.219999999999999 111.107 -174.462 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 32.3 p -123.86 142.42 51.14 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.018 0.927 . . . . 74.109999999999999 109.345 179.325 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -150.19 108.94 0.41 Allowed Glycine 0 C--N 1.344 0.982 0 N-CA-C 111.439 -0.664 . . . . 75.319999999999993 111.439 -177.543 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -168.85 66.34 0.18 Allowed Glycine 0 C--N 1.349 1.262 0 CA-C-N 116.756 0.278 . . . . 60.030000000000001 112.752 -177.094 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.411 ' H ' ' HG3' ' A' ' 241' ' ' PRO . 47.0 m -66.48 151.16 47.8 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.687 0.795 . . . . 65.25 110.864 171.186 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -69.95 130.68 22.5 Favored Glycine 0 CA--C 1.529 0.961 0 N-CA-C 110.968 -0.853 . . . . 55.229999999999997 110.968 176.369 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -66.6 100.89 0.58 Allowed Glycine 0 C--N 1.349 1.274 0 N-CA-C 111.732 -0.547 . . . . 62.130000000000003 111.732 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 20.2 m -55.49 -60.22 3.72 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.666 1.187 . . . . 72.120000000000005 112.276 -176.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -179.61 -130.74 1.51 Allowed Glycine 0 N--CA 1.463 0.458 0 N-CA-C 111.03 -0.828 . . . . 65.540000000000006 111.03 -178.339 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -81.9 61.48 4.66 Favored Glycine 0 C--N 1.344 1.023 0 N-CA-C 112.165 -0.374 . . . . 64.129999999999995 112.165 176.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 60.8 m -147.21 48.43 1.12 Allowed 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.616 1.166 . . . . 41.109999999999999 108.579 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -65.97 -24.28 66.76 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 115.239 -0.891 . . . . 61.439999999999998 111.155 178.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.407 ' HA ' ' O ' ' A' ' 248' ' ' ASP . 6.7 p-10 -91.19 151.28 21.01 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 115.673 -0.694 . . . . 73.230000000000004 109.901 175.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 79.7 mt -132.76 130.79 40.39 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.792 0.837 . . . . 71.340000000000003 109.084 173.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -96.71 125.48 41.21 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 108.337 -0.986 . . . . 74.549999999999997 108.337 174.296 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.458 ' O ' ' HA ' ' A' ' 251' ' ' LEU . . . -148.63 143.23 26.41 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.408 0.683 . . . . 74.25 109.336 178.026 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 2.4 p -89.92 132.36 35.35 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 109.079 -0.712 . . . . 71.519999999999996 109.079 171.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.575 HD13 ' HB2' ' A' ' 212' ' ' ALA . 62.3 tp -107.3 110.96 23.1 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.81 0.844 . . . . 74.439999999999998 108.972 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -85.08 128.46 34.66 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-O 120.962 0.411 . . . . 75.209999999999994 109.918 175.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.514 ' HA ' HG11 ' A' ' 210' ' ' VAL . 3.1 p -133.29 123.67 17.85 Favored Pre-proline 0 CA--C 1.545 0.773 0 CA-C-N 114.775 -1.102 . . . . 71.129999999999995 108.954 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -57.61 143.15 95.51 Favored 'Trans proline' 0 C--N 1.37 1.662 0 C-N-CA 122.585 2.19 . . . . 71.549999999999997 111.653 171.166 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.431 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -50.42 -46.45 84.39 Favored Pre-proline 0 CA--C 1.563 1.443 0 CA-C-O 117.782 -1.104 . . . . 70.150000000000006 112.993 -178.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -55.51 -44.62 46.67 Favored 'Trans proline' 0 C--N 1.395 2.977 0 C-N-CA 122.3 2.0 . . . . 74.219999999999999 113.088 174.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.473 HG21 HG13 ' A' ' 210' ' ' VAL . 45.4 mt -68.4 -32.03 53.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 C-N-CA 123.467 0.707 . . . . 61.210000000000001 110.598 -178.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.42 -44.02 75.91 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.224 0.61 . . . . 74.349999999999994 110.957 178.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 201' ' ' ALA . 93.1 t -70.43 -48.19 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 123.532 0.733 . . . . 72.0 111.217 -177.601 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 7.2 p -72.47 -30.37 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 CA-C-O 120.601 0.239 . . . . 74.319999999999993 110.998 -179.121 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 78.76 67.57 1.59 Allowed Glycine 0 C--N 1.352 1.423 0 N-CA-C 111.637 -0.585 . . . . 43.020000000000003 111.637 -174.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -98.95 -145.71 19.1 Favored Glycine 0 C--N 1.352 1.444 0 N-CA-C 111.449 -0.66 . . . . 74.310000000000002 111.449 -177.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -120.73 146.68 46.22 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.561 0.745 . . . . 63.32 109.078 173.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.514 HG11 ' HA ' ' A' ' 199' ' ' VAL . 7.1 m -139.9 155.36 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 C-N-CA 124.679 1.192 . . . . 53.439999999999998 109.211 171.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 14.7 ttp180 -91.22 119.55 31.4 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-O 120.805 0.336 . . . . 72.109999999999999 111.126 -170.395 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.575 ' HB2' HD13 ' A' ' 197' ' ' LEU . . . -100.53 151.78 21.17 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.969 0.907 . . . . 43.310000000000002 108.951 172.146 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -107.15 116.46 31.97 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 123.599 0.76 . . . . 73.239999999999995 110.222 -178.052 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 24.6 p -109.72 172.24 6.97 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.21 1.004 . . . . 72.409999999999997 108.631 172.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 17.5 mt -74.02 -5.9 44.22 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 122.819 0.448 . . . . 62.32 111.958 -176.062 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 216' ' ' GLU . . . . . 0.409 ' H ' ' HG2' ' A' ' 216' ' ' GLU . 6.2 pt-20 -107.16 -9.64 16.09 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.756 1.223 . . . . 75.230000000000004 111.349 -177.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 139.65 -165.92 25.72 Favored Glycine 0 C--N 1.352 1.439 0 CA-C-O 120.151 -0.25 . . . . 34.32 113.526 175.045 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 218' ' ' PRO . . . . . 0.48 ' HD2' ' HB2' ' A' ' 179' ' ' ASP . 71.7 Cg_endo -76.66 142.65 23.22 Favored 'Trans proline' 0 C--N 1.369 1.627 0 C-N-CA 123.225 2.617 . . . . 75.25 112.466 176.02 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.58 ' HA ' ' H ' ' A' ' 178' ' ' ALA . 24.8 m -137.29 143.58 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 123.849 0.86 . . . . 73.450000000000003 109.733 176.583 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.407 ' HG3' ' HB2' ' A' ' 178' ' ' ALA . 46.4 mt-10 -97.3 114.65 26.45 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 118.27 0.487 . . . . 74.540000000000006 109.78 175.653 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.446 HG22 ' HB3' ' A' ' 175' ' ' TYR . 52.9 t -95.47 126.02 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.277 1.031 . . . . 71.310000000000002 109.679 179.674 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -75.46 106.3 6.94 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 123.315 0.646 . . . . 53.340000000000003 109.397 175.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 44.9 t -68.39 132.09 91.53 Favored Pre-proline 0 CA--C 1.552 1.028 0 C-N-CA 124.417 1.087 . . . . 63.520000000000003 109.525 175.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -59.78 144.86 99.37 Favored 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 122.455 2.103 . . . . 63.229999999999997 111.853 173.132 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_exo -62.12 129.66 27.93 Favored 'Trans proline' 0 C--N 1.375 1.961 0 C-N-CA 122.667 2.245 . . . . 52.329999999999998 111.689 176.371 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 62.7 mtp180 67.33 79.18 0.23 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.247 1.419 . . . . 72.349999999999994 110.086 179.44 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.566 ' HA ' ' HE ' ' A' ' 231' ' ' ARG . 13.3 m -107.52 141.16 39.39 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 114.231 -1.35 . . . . 74.219999999999999 110.684 -177.663 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 24.5 mp0 -118.11 147.23 43.5 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.356 1.062 . . . . 74.219999999999999 108.382 174.214 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -60.26 125.2 22.78 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.123 0.969 . . . . 72.329999999999998 110.571 -178.321 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 113.38 4.38 23.63 Favored Glycine 0 C--N 1.34 0.805 0 CA-C-O 119.537 -0.591 . . . . 74.430000000000007 113.12 -175.203 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.566 ' HE ' ' HA ' ' A' ' 227' ' ' THR . 72.4 mtt-85 -65.73 148.23 52.09 Favored 'General case' 0 C--N 1.363 1.162 0 N-CA-C 109.249 -0.649 . . . . 73.239999999999995 109.249 167.316 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 18.9 pttm -124.84 117.08 23.32 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.971 -1.122 . . . . 63.420000000000002 107.971 176.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.529 HD22 ' HB2' ' A' ' 173' ' ' ALA . 30.6 mt -103.89 97.42 7.42 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 108.066 -1.087 . . . . 71.030000000000001 108.066 -179.466 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 234' ' ' ARG . . . . . 0.498 ' HB2' HG11 ' A' ' 170' ' ' VAL . 40.6 ttt180 -93.54 101.13 13.3 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 108.823 -0.806 . . . . 75.230000000000004 108.823 177.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.492 ' HB3' ' HB2' ' A' ' 238' ' ' LYS . 21.8 mt -82.92 83.92 7.61 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.481 -1.236 . . . . 64.200000000000003 109.669 -174.133 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 55.4 mttp -62.75 137.63 58.31 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 116.098 -0.501 . . . . 60.420000000000002 110.082 177.272 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 64.59 23.66 68.93 Favored Glycine 0 C--N 1.347 1.151 0 O-C-N 123.679 0.612 . . . . 64.319999999999993 113.004 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.492 ' HB2' ' HB3' ' A' ' 235' ' ' LEU . 45.7 mmtm -140.51 16.86 2.37 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.308 1.043 . . . . 63.0 111.247 -176.201 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -93.47 -116.99 2.62 Favored Glycine 0 N--CA 1.467 0.741 0 N-CA-C 111.568 -0.613 . . . . 70.420000000000002 111.568 179.119 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -71.45 130.29 87.73 Favored Pre-proline 0 CA--C 1.546 0.817 0 CA-C-O 118.619 -0.705 . . . . 72.439999999999998 109.781 179.191 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.479 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 22.2 Cg_endo -60.41 129.16 28.58 Favored 'Trans proline' 0 C--N 1.373 1.824 0 C-N-CA 123.154 2.569 . . . . 71.5 112.533 175.616 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -150.81 135.44 5.16 Favored Glycine 0 CA--C 1.532 1.103 0 CA-C-O 118.651 -1.083 . . . . 71.439999999999998 110.557 179.395 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -61.73 -41.67 37.08 Favored 'Trans proline' 0 C--N 1.382 2.331 0 C-N-CA 123.54 2.827 . . . . 53.219999999999999 112.746 -176.595 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -78.01 -26.64 48.61 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.177 0.591 . . . . 73.239999999999995 111.258 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 169.24 148.11 5.69 Favored Glycine 0 C--N 1.347 1.172 0 N-CA-C 111.457 -0.657 . . . . 63.219999999999999 111.457 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.479 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 36.4 mtt-85 -86.45 161.37 18.66 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 122.769 0.428 . . . . 65.409999999999997 110.148 178.079 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -81.84 -155.86 15.99 Favored Glycine 0 C--N 1.34 0.785 0 CA-C-N 115.591 -0.732 . . . . 51.299999999999997 112.368 172.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 248' ' ' ASP . . . . . 0.407 ' O ' ' HA ' ' A' ' 192' ' ' ASP . 6.5 p-10 -118.45 131.53 56.26 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.442 0.697 . . . . 75.230000000000004 110.381 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 58.5 tp -98.16 106.89 19.24 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 107.76 -1.2 . . . . 53.43 107.76 173.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -89.3 108.58 19.7 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 115.496 -0.775 . . . . 74.319999999999993 109.053 -177.136 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.558 HD13 HD22 ' A' ' 197' ' ' LEU . 63.6 mt -103.13 139.35 38.76 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.79 0.836 . . . . 65.340000000000003 110.096 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -111.44 108.79 18.47 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.63 -0.878 . . . . 72.340000000000003 108.63 172.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 72.5 t -66.5 109.37 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 C-N-CA 123.922 0.889 . . . . 74.400000000000006 111.33 -178.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 31.5 mmm180 -108.52 102.95 11.99 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.381 1.472 . . . . 63.450000000000003 108.312 177.069 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 30.4 mt -77.14 142.78 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 N-CA-C 109.855 -0.424 . . . . 64.439999999999998 109.855 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.9 t . . . . . 0 CA--C 1.558 1.277 0 C-N-CA 124.092 0.957 . . . . 70.049999999999997 109.207 176.377 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 167' ' ' MET . . . . . 0.417 ' SD ' ' N ' ' A' ' 167' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.096 0 N-CA-C 109.088 -0.708 . . . . 73.299999999999997 109.088 . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -89.87 57.91 4.02 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-O 122.045 0.926 . . . . 70.019999999999996 109.365 177.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -56.69 -55.46 33.89 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 114.589 -1.187 . . . . 71.329999999999998 110.053 -179.515 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.492 HG21 ' HB3' ' A' ' 234' ' ' ARG . 15.4 m -97.41 161.7 2.78 Favored 'Isoleucine or valine' 0 C--O 1.247 0.942 0 CA-C-N 114.905 -1.043 . . . . 74.340000000000003 109.188 172.149 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 12.6 tt -85.63 151.96 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 N-CA-C 108.92 -0.771 . . . . 63.329999999999998 108.92 174.006 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -56.15 128.81 37.36 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.471 1.109 . . . . 74.329999999999998 110.961 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.466 ' HB2' HD22 ' A' ' 233' ' ' LEU . . . -158.66 143.95 16.37 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.258 1.023 . . . . 74.209999999999994 109.754 179.111 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -146.56 169.13 19.58 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 108.244 -1.021 . . . . 74.239999999999995 108.244 172.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.511 ' CE1' ' HB3' ' A' ' 238' ' ' LYS . 37.5 p90 -129.61 -177.81 4.42 Favored 'General case' 0 C--O 1.243 0.733 0 CA-C-O 121.739 0.781 . . . . 74.430000000000007 111.65 -176.166 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 11.9 mmmm -132.61 122.03 17.59 Favored Pre-proline 0 C--O 1.232 0.178 0 CA-C-N 114.368 -1.287 . . . . 74.400000000000006 107.536 174.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' PRO . . . . . 0.411 ' HA ' HG12 ' A' ' 219' ' ' VAL . 57.3 Cg_endo -66.92 93.71 0.33 Allowed 'Trans proline' 0 C--N 1.359 1.105 0 C-N-CA 122.856 2.371 . . . . 73.430000000000007 111.63 -177.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 178' ' ' ALA . . . . . 0.452 ' HB2' ' HG3' ' A' ' 220' ' ' GLU . . . -67.48 91.47 0.27 Allowed 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 109.45 -0.574 . . . . 54.039999999999999 109.45 179.097 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 67.59 14.94 9.69 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 124.52 1.128 . . . . 61.310000000000002 111.583 -174.006 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -88.3 115.04 4.32 Favored Glycine 0 C--N 1.348 1.199 0 N-CA-C 111.622 -0.591 . . . . 42.119999999999997 111.622 -178.339 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 22.8 t -164.24 96.78 0.79 Allowed 'General case' 0 C--O 1.242 0.697 0 N-CA-C 108.696 -0.853 . . . . 72.239999999999995 108.696 177.045 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -88.55 -179.01 46.56 Favored Glycine 0 C--N 1.347 1.165 0 CA-C-N 116.171 -0.468 . . . . 54.140000000000001 112.224 175.495 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -78.68 -97.66 0.24 Allowed Glycine 0 C--N 1.343 0.925 0 N-CA-C 112.218 -0.353 . . . . 52.340000000000003 112.218 175.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 33.1 t -150.04 162.75 39.78 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 122.946 0.498 . . . . 62.130000000000003 110.882 -177.35 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -100.12 -53.2 1.11 Allowed Glycine 0 C--N 1.348 1.208 0 CA-C-N 115.358 -0.837 . . . . 70.430000000000007 112.02 -179.216 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 64.52 -112.62 5.15 Favored Glycine 0 C--N 1.349 1.269 0 O-C-N 123.924 0.426 . . . . 71.200000000000003 112.076 -177.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 35.3 t -79.92 79.47 6.44 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.749 0.82 . . . . 74.510000000000005 108.899 172.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -138.82 94.72 0.21 Allowed Glycine 0 C--N 1.347 1.148 0 N-CA-C 111.033 -0.827 . . . . 61.350000000000001 111.033 -177.552 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -55.17 -43.2 83.74 Favored Glycine 0 C--N 1.352 1.446 0 O-C-N 124.39 0.7 . . . . 63.210000000000001 113.999 -175.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 18.2 m -70.11 96.65 1.09 Allowed 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 109.454 -0.573 . . . . 53.530000000000001 109.454 174.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.401 ' HA ' ' HB2' ' A' ' 240' ' ' PHE . 25.5 mm-40 -96.12 -36.41 10.99 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.025 0.53 . . . . 64.040000000000006 110.152 171.515 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -95.09 154.21 17.28 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 122.726 0.41 . . . . 61.149999999999999 110.74 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 33.3 mt -128.09 156.33 42.99 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.147 0.979 . . . . 70.209999999999994 109.863 175.324 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -130.5 121.91 26.67 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.892 0.877 . . . . 74.230000000000004 108.716 173.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -149.6 167.35 26.61 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 124.003 0.921 . . . . 53.130000000000003 109.58 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 17.7 m -112.14 137.04 50.77 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.779 -0.646 . . . . 70.0 109.4 -178.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 43.8 tp -108.92 122.13 46.57 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.181 0.992 . . . . 74.510000000000005 110.117 -170.77 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -87.45 104.64 16.65 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.566 0.746 . . . . 72.0 109.613 176.665 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.537 ' HA ' HG11 ' A' ' 210' ' ' VAL . 59.7 t -109.21 113.74 58.51 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 123.489 0.716 . . . . 72.5 109.436 174.123 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -58.56 141.84 97.72 Favored 'Trans proline' 0 C--N 1.379 2.17 0 C-N-CA 123.039 2.493 . . . . 64.200000000000003 111.937 171.047 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -51.6 -45.51 91.1 Favored Pre-proline 0 CA--C 1.562 1.419 0 N-CA-C 113.931 1.086 . . . . 31.0 113.931 -176.054 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -55.37 -47.09 27.76 Favored 'Trans proline' 0 C--N 1.391 2.775 0 C-N-CA 121.957 1.771 . . . . 70.319999999999993 113.184 173.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 56.6 mt -66.86 -29.82 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 123.641 0.776 . . . . 75.329999999999998 110.734 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.8 -46.77 67.82 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.585 0.754 . . . . 71.109999999999999 111.486 179.376 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 85.5 t -66.44 -54.43 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 115.937 -0.574 . . . . 63.240000000000002 110.501 -178.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 18.2 m -69.47 -30.44 45.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 N-CA-C 112.072 0.397 . . . . 73.239999999999995 112.072 -177.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 74.68 68.3 1.58 Allowed Glycine 0 C--N 1.345 1.038 0 O-C-N 123.431 0.457 . . . . 71.439999999999998 112.28 -176.165 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -97.58 -126.51 5.43 Favored Glycine 0 C--N 1.348 1.222 0 N-CA-C 111.74 -0.544 . . . . 44.439999999999998 111.74 -178.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 49.1 mtmt -131.55 158.93 39.64 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.741 0.816 . . . . 71.319999999999993 108.982 171.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.537 HG11 ' HA ' ' A' ' 199' ' ' VAL . 6.0 m -136.77 137.29 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 123.545 0.738 . . . . 43.219999999999999 109.917 174.542 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 51.1 ttt-85 -83.58 109.04 17.08 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 108.913 -0.773 . . . . 73.010000000000005 108.913 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -101.12 155.26 18.1 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.493 1.117 . . . . 64.349999999999994 110.213 -177.012 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 16.1 mmt -105.62 118.45 36.61 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.022 0.929 . . . . 51.240000000000002 109.349 178.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 70.7 p -116.65 179.24 4.06 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.803 0.441 . . . . 72.019999999999996 109.825 170.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 20.8 mt -62.97 -36.15 82.52 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.752 -0.658 . . . . 71.129999999999995 111.091 -177.587 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -93.69 -20.14 20.44 Favored 'General case' 0 CA--C 1.554 1.1 0 CA-C-N 115.295 -0.866 . . . . 72.409999999999997 111.643 -170.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 155.56 177.73 29.09 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 120.881 -0.676 . . . . 43.439999999999998 114.183 177.55 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -64.5 142.11 76.68 Favored 'Trans proline' 0 C--N 1.376 1.975 0 C-N-CA 123.001 2.467 . . . . 73.120000000000005 112.513 174.5 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.411 HG12 ' HA ' ' A' ' 177' ' ' PRO . 34.4 m -139.3 128.49 29.34 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 C-N-CA 123.311 0.644 . . . . 74.409999999999997 109.84 179.405 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.452 ' HG3' ' HB2' ' A' ' 178' ' ' ALA . 36.7 mt-10 -83.42 104.02 13.24 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 109.778 -0.453 . . . . 72.5 109.778 177.808 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 48.1 t -93.49 118.13 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 109.121 -0.696 . . . . 74.129999999999995 109.121 -177.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -71.87 107.21 4.52 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 123.25 0.62 . . . . 72.109999999999999 110.16 -179.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 60.5 t -70.97 130.29 88.49 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 124.556 1.142 . . . . 74.519999999999996 109.709 -179.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -63.73 140.08 72.4 Favored 'Trans proline' 0 C--N 1.373 1.868 0 C-N-CA 122.387 2.058 . . . . 62.25 112.246 174.037 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -60.38 133.54 49.82 Favored 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 122.342 2.028 . . . . 70.430000000000007 111.758 174.393 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 82.1 mtt180 68.85 72.5 0.27 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.938 1.295 . . . . 73.049999999999997 109.795 -176.157 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.735 ' HA ' ' HE ' ' A' ' 231' ' ' ARG . 38.9 m -94.22 140.13 30.16 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 114.784 -1.098 . . . . 73.200000000000003 110.085 176.01 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 24.2 mp0 -113.29 145.48 40.99 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 124.054 0.942 . . . . 73.420000000000002 108.738 174.272 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 229' ' ' ALA . . . . . 0.474 ' HB2' ' HB ' ' A' ' 255' ' ' ILE . . . -64.33 117.09 6.73 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.369 0.668 . . . . 62.530000000000001 109.587 178.435 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 108.47 9.74 26.64 Favored Glycine 0 CA--C 1.526 0.746 0 CA-C-O 119.426 -0.652 . . . . 55.409999999999997 112.565 -173.305 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.735 ' HE ' ' HA ' ' A' ' 227' ' ' THR . 57.5 mtt-85 -63.45 150.0 44.72 Favored 'General case' 0 C--N 1.361 1.072 0 N-CA-C 109.348 -0.612 . . . . 74.319999999999993 109.348 166.21 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 19.6 pttm -121.91 138.91 54.22 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 123.217 0.607 . . . . 65.409999999999997 109.762 174.283 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.466 HD22 ' HB2' ' A' ' 173' ' ' ALA . 57.4 mt -123.9 137.26 54.66 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.588 1.155 . . . . 65.340000000000003 108.221 177.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 234' ' ' ARG . . . . . 0.492 ' HB3' HG21 ' A' ' 170' ' ' VAL . 52.8 ttm-85 -128.75 102.41 6.55 Favored 'General case' 0 C--O 1.243 0.72 0 N-CA-C 108.734 -0.839 . . . . 73.310000000000002 108.734 176.114 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.44 HD13 ' CD1' ' A' ' 175' ' ' TYR . 17.0 mt -83.9 89.52 7.23 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.019 0.927 . . . . 71.409999999999997 109.361 -174.678 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -73.78 131.58 41.71 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.532 -0.758 . . . . 73.439999999999998 110.971 -175.281 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 66.81 24.82 72.98 Favored Glycine 0 C--N 1.35 1.348 0 O-C-N 123.858 0.724 . . . . 74.430000000000007 112.972 -178.333 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.511 ' HB3' ' CE1' ' A' ' 175' ' ' TYR . 32.1 mmtp -140.23 39.49 1.92 Allowed 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.038 0.935 . . . . 70.25 110.581 -172.521 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -120.85 -120.62 2.77 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-N 116.228 -0.442 . . . . 64.329999999999998 112.232 174.164 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 240' ' ' PHE . . . . . 0.401 ' HB2' ' HA ' ' A' ' 191' ' ' GLN . 2.9 m-85 -69.19 147.75 97.45 Favored Pre-proline 0 N--CA 1.49 1.557 0 C-N-CA 123.78 0.832 . . . . 74.340000000000003 111.684 178.417 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.504 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 22.6 Cg_endo -59.97 134.02 54.07 Favored 'Trans proline' 0 C--N 1.387 2.602 0 C-N-CA 123.329 2.686 . . . . 73.049999999999997 113.455 -179.545 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -151.04 131.74 3.62 Favored Glycine 0 CA--C 1.54 1.62 0 N-CA-C 110.287 -1.125 . . . . 62.210000000000001 110.287 179.389 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -65.27 -45.99 6.52 Favored 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 123.266 2.644 . . . . 74.530000000000001 113.69 -170.55 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -86.72 11.8 12.22 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 122.855 0.462 . . . . 73.450000000000003 111.828 -178.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 133.56 139.87 4.26 Favored Glycine 0 C--N 1.341 0.829 0 N-CA-C 109.766 -1.334 . . . . 62.100000000000001 109.766 -174.138 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.504 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 23.4 mtm180 -78.14 170.73 16.13 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-O 121.025 0.44 . . . . 71.030000000000001 111.248 -175.641 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.52 -156.93 8.45 Favored Glycine 0 C--N 1.344 1.027 0 CA-C-N 115.281 -0.872 . . . . 63.5 112.775 172.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -116.73 160.95 20.0 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.537 0.335 . . . . 73.230000000000004 111.148 -170.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 38.8 tp -140.66 106.87 5.23 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 108.258 -1.016 . . . . 73.540000000000006 108.258 173.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -94.98 116.31 28.53 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 109.277 -0.638 . . . . 74.209999999999994 109.277 -175.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 60.5 mt -116.13 117.99 31.61 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.542 0.737 . . . . 74.340000000000003 109.792 -178.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -89.74 112.4 23.67 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.65 0.78 . . . . 73.010000000000005 109.598 177.143 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.487 HG11 HG21 ' A' ' 227' ' ' THR . 60.2 t -71.2 118.79 16.44 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 CA-C-O 121.497 0.665 . . . . 50.420000000000002 112.059 -176.101 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 29.6 mmm180 -108.16 115.7 30.61 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 125.101 1.36 . . . . 73.329999999999998 108.293 170.247 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.474 ' HB ' ' HB2' ' A' ' 229' ' ' ALA . 30.5 mt -76.18 128.09 37.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 108.437 -0.949 . . . . 60.340000000000003 108.437 170.188 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 6.8 t . . . . . 0 CA--C 1.558 1.274 0 CA-C-O 117.427 -1.273 . . . . 64.040000000000006 107.927 -176.382 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 20.3 mmt . . . . . 0 N--CA 1.475 0.822 0 N-CA-C 109.592 -0.521 . . . . 75.099999999999994 109.592 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -148.1 131.16 16.3 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 107.695 -1.224 . . . . 75.239999999999995 107.695 175.131 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -72.32 -65.94 0.71 Allowed 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.062 -0.517 . . . . 73.329999999999998 109.743 178.226 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 33.3 m -109.67 -175.74 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 C-N-CA 124.586 1.155 . . . . 71.310000000000002 110.472 179.012 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 14.9 tt -91.94 144.7 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 N-CA-C 107.873 -1.158 . . . . 54.439999999999998 107.873 165.128 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -63.36 140.27 58.86 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.463 0.705 . . . . 60.119999999999997 112.745 -172.094 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.401 ' HB2' HD22 ' A' ' 233' ' ' LEU . . . -153.29 153.55 32.86 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.876 1.27 . . . . 74.219999999999999 108.494 171.607 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -147.42 156.5 42.93 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 108.244 -1.021 . . . . 62.229999999999997 108.244 172.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.442 ' CZ ' ' HB3' ' A' ' 238' ' ' LYS . 12.4 p90 -136.7 168.28 19.82 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.585 0.587 . . . . 74.030000000000001 112.585 179.078 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -140.25 150.11 60.33 Favored Pre-proline 0 N--CA 1.477 0.901 0 C-N-CA 125.042 1.337 . . . . 73.409999999999997 108.158 176.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' PRO . . . . . 0.492 ' HA ' HG12 ' A' ' 219' ' ' VAL . 38.8 Cg_endo -65.21 109.35 1.32 Allowed 'Trans proline' 0 C--N 1.374 1.885 0 C-N-CA 122.174 1.916 . . . . 72.439999999999998 110.909 179.395 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -58.88 -44.11 91.06 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.302 1.041 . . . . 52.310000000000002 111.382 -175.089 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -80.02 -30.09 39.46 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 114.759 -1.109 . . . . 74.109999999999999 110.729 177.583 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 90.73 35.64 7.18 Favored Glycine 0 C--N 1.348 1.2 0 CA-C-N 115.988 -0.551 . . . . 55.439999999999998 113.281 176.508 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 29.6 t -121.11 170.19 9.79 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 122.999 0.52 . . . . 65.109999999999999 109.6 171.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -137.11 99.67 0.3 Allowed Glycine 0 C--N 1.345 1.028 0 N-CA-C 111.785 -0.526 . . . . 62.0 111.785 -177.453 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -73.89 75.25 1.1 Allowed Glycine 0 C--N 1.353 1.482 0 N-CA-C 111.722 -0.551 . . . . 65.120000000000005 111.722 176.31 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.486 ' HA ' ' HG3' ' A' ' 241' ' ' PRO . 4.4 p -96.94 89.81 4.98 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.077 0.951 . . . . 63.200000000000003 111.131 -172.041 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -74.19 131.36 13.49 Favored Glycine 0 C--N 1.35 1.331 0 CA-C-N 115.224 -0.898 . . . . 43.509999999999998 112.961 175.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -78.59 100.12 1.67 Allowed Glycine 0 C--N 1.35 1.316 0 CA-C-O 119.761 -0.466 . . . . 54.100000000000001 112.336 -177.167 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 26.3 m 65.81 79.59 0.24 Allowed 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 125.095 1.358 . . . . 54.210000000000001 110.354 -179.25 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -95.98 28.83 11.25 Favored Glycine 0 C--N 1.347 1.194 0 CA-C-N 115.412 -0.813 . . . . 71.040000000000006 113.306 -175.203 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.5 -57.68 4.46 Favored Glycine 0 C--N 1.347 1.143 0 CA-C-N 116.635 0.218 . . . . 64.340000000000003 112.722 176.254 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 49.9 m -131.13 154.28 48.49 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.938 0.895 . . . . 75.519999999999996 109.829 -179.533 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.532 ' HB3' ' HA3' ' A' ' 247' ' ' GLY . 39.7 mt-30 -94.08 -21.47 19.11 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.531 0.733 . . . . 72.319999999999993 111.006 176.009 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -80.69 152.05 28.61 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.494 0.717 . . . . 63.229999999999997 111.107 177.108 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 13.5 mt -132.57 143.12 49.49 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.744 1.218 . . . . 73.230000000000004 108.707 168.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -111.8 135.39 52.48 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 106.474 -1.676 . . . . 65.239999999999995 106.474 166.081 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -159.73 171.61 19.22 Favored 'General case' 0 C--N 1.327 -0.382 0 O-C-N 123.696 0.622 . . . . 55.109999999999999 109.746 179.046 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 26.5 m -113.31 142.35 45.94 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.453 -0.943 . . . . 71.299999999999997 108.453 179.079 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.438 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . 51.2 tp -109.31 121.66 45.66 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 109.339 -0.615 . . . . 62.219999999999999 109.339 179.504 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -82.6 134.26 35.18 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 109.001 -0.74 . . . . 63.140000000000001 109.001 167.462 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.44 ' HA ' HG11 ' A' ' 210' ' ' VAL . 4.2 p -143.03 121.27 7.2 Favored Pre-proline 0 CA--C 1.539 0.553 0 N-CA-C 108.429 -0.952 . . . . 65.150000000000006 108.429 175.812 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.22 142.29 87.36 Favored 'Trans proline' 0 C--N 1.366 1.48 0 C-N-CA 122.58 2.186 . . . . 74.129999999999995 112.12 175.051 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -49.4 -45.87 77.43 Favored Pre-proline 0 CA--C 1.558 1.259 0 C-N-CA 123.729 0.812 . . . . 62.219999999999999 113.065 178.444 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -53.9 -55.16 3.73 Favored 'Trans proline' 0 C--N 1.397 3.103 0 C-N-CA 122.273 1.982 . . . . 75.420000000000002 113.109 171.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 52.3 mt -63.66 -30.45 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 C-N-CA 123.304 0.642 . . . . 74.409999999999997 111.779 -177.178 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.73 -42.41 74.01 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 122.949 0.5 . . . . 53.340000000000003 111.443 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 97.2 t -73.66 -54.48 15.16 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 C-N-CA 123.138 0.575 . . . . 73.109999999999999 111.107 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 14.8 m -76.74 -22.03 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 N-CA-C 112.03 0.382 . . . . 73.430000000000007 112.03 -174.242 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 86.67 170.59 47.02 Favored Glycine 0 C--N 1.348 1.239 0 N-CA-C 112.047 -0.421 . . . . 41.530000000000001 112.047 -174.082 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 145.96 -129.14 3.29 Favored Glycine 0 C--N 1.333 0.397 0 N-CA-C 111.071 -0.812 . . . . 35.5 111.071 175.094 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -139.73 158.51 43.98 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.883 0.873 . . . . 74.340000000000003 109.709 176.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.44 HG11 ' HA ' ' A' ' 199' ' ' VAL . 18.7 m -138.51 155.43 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 123.722 0.809 . . . . 73.450000000000003 109.535 171.466 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 48.2 mtm180 -82.72 127.85 33.81 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 109.353 -0.61 . . . . 54.520000000000003 109.353 173.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -116.36 146.38 42.51 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 124.373 1.069 . . . . 72.420000000000002 109.156 179.043 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 5.2 mmt -94.81 110.05 21.96 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 109.321 -0.622 . . . . 62.219999999999999 109.321 177.588 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 38.4 p -119.63 174.93 6.11 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 123.838 0.855 . . . . 71.129999999999995 109.416 174.302 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.433 HD12 ' CE1' ' A' ' 240' ' ' PHE . 15.5 mt -78.72 -2.1 37.72 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 116.298 -0.41 . . . . 73.540000000000006 111.681 -177.241 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -100.67 -4.8 27.61 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.868 0.867 . . . . 73.230000000000004 110.936 171.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 114.67 -160.53 13.15 Favored Glycine 0 C--N 1.356 1.686 0 C-N-CA 123.611 0.624 . . . . 62.439999999999998 112.806 178.121 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.33 131.8 19.7 Favored 'Trans proline' 0 C--N 1.375 1.924 0 C-N-CA 122.771 2.314 . . . . 63.210000000000001 112.503 175.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.492 HG12 ' HA ' ' A' ' 177' ' ' PRO . 31.6 m -134.81 139.84 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 123.586 0.754 . . . . 52.229999999999997 110.484 -178.46 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -87.04 105.69 17.33 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 122.66 0.384 . . . . 75.200000000000003 110.139 178.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 76.8 t -92.5 117.66 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 N-CA-C 108.543 -0.91 . . . . 62.219999999999999 108.543 179.091 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -65.6 101.65 0.63 Allowed 'General case' 0 C--O 1.24 0.569 0 O-C-N 124.322 1.014 . . . . 74.540000000000006 110.254 178.48 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 63.0 t -77.84 117.98 69.26 Favored Pre-proline 0 CA--C 1.543 0.682 0 O-C-N 124.613 1.196 . . . . 64.329999999999998 108.823 174.604 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -65.31 151.62 84.68 Favored 'Trans proline' 0 CA--C 1.559 1.769 0 C-N-CA 122.033 1.822 . . . . 74.329999999999998 111.602 170.387 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_exo -63.62 141.53 80.07 Favored 'Trans proline' 0 C--N 1.373 1.867 0 C-N-CA 122.555 2.17 . . . . 70.329999999999998 112.357 178.331 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 51.7 mtm180 62.93 49.07 3.67 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.786 1.234 . . . . 71.439999999999998 110.638 176.485 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.536 HG22 HG11 ' A' ' 253' ' ' VAL . 55.3 m -98.85 109.2 22.0 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 114.271 -1.331 . . . . 65.230000000000004 109.244 173.287 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -85.47 161.49 19.37 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.606 -0.725 . . . . 64.219999999999999 111.773 -175.003 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -69.15 124.43 23.79 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.765 0.826 . . . . 74.310000000000002 110.084 177.398 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 111.43 -9.82 28.5 Favored Glycine 0 N--CA 1.471 0.992 0 O-C-N 123.306 0.378 . . . . 74.230000000000004 112.411 -175.133 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 66.0 mtt180 -70.15 162.69 27.84 Favored 'General case' 0 C--N 1.35 0.622 0 CA-C-O 121.532 0.682 . . . . 72.549999999999997 111.046 170.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 18.7 pttm -121.58 143.53 49.25 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 114.957 -1.02 . . . . 74.239999999999995 110.305 -177.109 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.401 HD22 ' HB2' ' A' ' 173' ' ' ALA . 93.1 mt -125.35 142.66 51.37 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.748 1.219 . . . . 74.239999999999995 108.325 174.277 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 65.8 ttt180 -133.18 124.27 27.14 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 108.22 -1.03 . . . . 72.109999999999999 108.22 -179.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.435 ' HB3' ' HG3' ' A' ' 238' ' ' LYS . 26.6 mt -120.88 84.04 2.17 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.671 0.788 . . . . 72.219999999999999 109.455 -166.117 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -79.32 140.01 37.66 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.875 0.87 . . . . 62.399999999999999 110.726 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 70.27 26.98 73.45 Favored Glycine 0 C--N 1.347 1.174 0 O-C-N 123.828 0.705 . . . . 45.020000000000003 112.336 -176.437 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.442 ' HB3' ' CZ ' ' A' ' 175' ' ' TYR . 8.0 mmpt? -128.75 -48.34 1.25 Allowed 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.982 0.913 . . . . 60.0 111.583 -172.122 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -55.39 -102.42 0.01 OUTLIER Glycine 0 CA--C 1.549 2.162 0 N-CA-C 116.25 1.26 . . . . 53.539999999999999 116.25 -164.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 240' ' ' PHE . . . . . 0.433 ' CE1' HD12 ' A' ' 215' ' ' LEU . 0.7 OUTLIER -84.17 153.41 62.88 Favored Pre-proline 0 N--CA 1.485 1.292 0 C-N-CA 123.098 0.559 . . . . 72.510000000000005 110.181 177.301 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.546 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 18.2 Cg_endo -56.28 154.27 29.81 Favored 'Trans proline' 0 C--N 1.373 1.86 0 C-N-CA 123.813 3.009 . . . . 73.230000000000004 114.076 170.851 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -165.23 143.55 8.56 Favored Glycine 0 CA--C 1.535 1.34 0 CA-C-O 119.017 -0.88 . . . . 62.140000000000001 111.974 175.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -63.7 -45.13 11.73 Favored 'Trans proline' 0 C--N 1.382 2.323 0 C-N-CA 123.372 2.715 . . . . 63.119999999999997 113.096 179.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -80.38 -26.18 38.73 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 122.747 0.419 . . . . 72.219999999999999 110.946 -179.508 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 166.73 160.02 13.29 Favored Glycine 0 C--N 1.336 0.536 0 N-CA-C 111.029 -0.828 . . . . 61.43 111.029 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.546 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 23.9 mtm180 -78.81 160.67 27.26 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 122.547 0.339 . . . . 61.229999999999997 110.682 -179.337 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.532 ' HA3' ' HB3' ' A' ' 191' ' ' GLN . . . -88.02 -155.82 29.6 Favored Glycine 0 C--N 1.344 0.98 0 CA-C-N 115.833 -0.621 . . . . 65.310000000000002 113.529 -175.522 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -102.47 155.59 18.16 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.125 0.57 . . . . 72.510000000000005 109.826 -175.427 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 36.6 tp -136.73 115.75 12.37 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 107.829 -1.175 . . . . 74.150000000000006 107.829 168.355 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -100.04 107.96 20.03 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.009 -0.737 . . . . 62.340000000000003 109.009 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.438 ' HB3' ' HB2' ' A' ' 197' ' ' LEU . 43.0 mt -102.33 121.06 41.54 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.61 0.764 . . . . 55.539999999999999 110.225 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -91.23 115.52 28.09 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 109.361 -0.607 . . . . 74.120000000000005 109.361 174.108 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.536 HG11 HG22 ' A' ' 227' ' ' THR . 85.2 t -62.42 127.94 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.533 1.133 . . . . 52.310000000000002 111.751 -176.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -131.39 116.21 17.24 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.717 1.207 . . . . 75.540000000000006 107.942 172.532 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 34.9 mt -77.51 126.61 38.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 O-C-N 123.769 0.668 . . . . 75.230000000000004 109.653 176.483 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 25.7 p . . . . . 0 C--O 1.254 1.313 0 N-CA-C 108.314 -0.995 . . . . 72.310000000000002 108.314 173.083 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 66.0 mtm . . . . . 0 N--CA 1.478 0.95 0 N-CA-C 108.695 -0.854 . . . . 61.340000000000003 108.695 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 25.3 t70 67.86 106.23 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.577 1.151 . . . . 74.400000000000006 110.354 -175.248 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -97.84 -63.89 1.09 Allowed 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.675 0.79 . . . . 54.240000000000002 110.285 -176.273 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.48 HG21 ' HB3' ' A' ' 234' ' ' ARG . 14.0 m -95.99 176.43 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 123.49 0.716 . . . . 73.109999999999999 111.037 -178.647 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 17.7 tt -96.35 138.32 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 N-CA-C 107.611 -1.255 . . . . 72.239999999999995 107.611 162.398 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -71.87 145.64 48.43 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.761 0.824 . . . . 71.340000000000003 111.268 -174.005 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.411 ' HB2' HD22 ' A' ' 233' ' ' LEU . . . -155.58 178.16 10.56 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.587 1.155 . . . . 73.420000000000002 109.74 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -156.32 152.16 27.3 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.751 0.82 . . . . 34.030000000000001 109.962 178.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.438 ' CD1' HD13 ' A' ' 235' ' ' LEU . 33.0 p90 -129.04 168.01 16.68 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 121.139 0.495 . . . . 72.420000000000002 110.863 175.003 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -145.26 150.45 44.89 Favored Pre-proline 0 CA--C 1.548 0.885 0 CA-C-N 114.635 -1.166 . . . . 75.310000000000002 109.078 176.556 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -57.78 110.59 0.65 Allowed 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 123.604 2.869 . . . . 71.019999999999996 112.91 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' ALA . . . . . 0.46 ' HB2' ' HG3' ' A' ' 220' ' ' GLU . . . -71.12 -25.32 62.53 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.581 0.753 . . . . 52.229999999999997 111.236 -178.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -64.77 -29.52 70.49 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 115.64 -0.709 . . . . 73.439999999999998 111.24 174.21 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 140.02 -80.47 0.27 Allowed Glycine 0 C--N 1.342 0.874 0 N-CA-C 110.464 -1.054 . . . . 75.019999999999996 110.464 -178.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 35.2 t -117.18 153.79 32.22 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 123.516 0.726 . . . . 42.219999999999999 109.193 175.43 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -113.11 128.18 8.27 Favored Glycine 0 C--N 1.343 0.952 0 N-CA-C 110.818 -0.913 . . . . 62.520000000000003 110.818 179.198 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -86.13 128.27 8.75 Favored Glycine 0 C--N 1.348 1.21 0 N-CA-C 111.374 -0.69 . . . . 55.409999999999997 111.374 178.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 57.8 m -70.47 88.64 0.67 Allowed 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 121.389 0.614 . . . . 72.109999999999999 110.446 178.573 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -146.13 123.97 1.95 Allowed Glycine 0 C--N 1.337 0.627 0 CA-C-N 115.084 -0.962 . . . . 75.239999999999995 110.738 177.41 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -77.28 72.06 2.18 Favored Glycine 0 C--N 1.35 1.324 0 N-CA-C 112.166 -0.374 . . . . 74.329999999999998 112.166 -179.012 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 23.0 m -75.84 81.08 2.76 Favored 'General case' 0 C--N 1.352 0.692 0 C-N-CA 123.967 0.907 . . . . 72.530000000000001 109.577 -179.142 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 123.18 144.47 6.62 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.84 -0.904 . . . . 44.240000000000002 110.84 -175.034 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -84.07 74.07 2.56 Favored Glycine 0 C--N 1.348 1.234 0 CA-C-N 116.893 0.346 . . . . 62.229999999999997 112.667 -176.139 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 67.5 m -152.03 164.88 36.29 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.231 1.013 . . . . 62.109999999999999 109.763 177.299 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.479 ' HA ' ' HB2' ' A' ' 240' ' ' PHE . 83.5 mm-40 -120.32 -51.89 2.18 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.434 -0.951 . . . . 55.030000000000001 108.434 167.687 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -93.63 158.65 15.59 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 115.992 -0.549 . . . . 74.340000000000003 110.046 174.263 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 93.8 mt -136.25 149.97 48.75 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.03 0.932 . . . . 71.409999999999997 109.024 176.15 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -123.68 123.38 40.41 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.746 0.818 . . . . 73.329999999999998 108.819 173.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -157.44 170.92 21.35 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.19 0.596 . . . . 75.409999999999997 110.653 179.155 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 19.3 p -96.3 152.44 18.58 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.719 0.808 . . . . 74.109999999999999 109.822 174.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.696 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . 34.6 tp -116.77 114.42 23.95 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.392 0.677 . . . . 75.420000000000002 109.978 -176.69 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -74.97 100.74 4.23 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 109.366 -0.605 . . . . 73.540000000000006 109.366 176.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.485 ' HA ' HG11 ' A' ' 210' ' ' VAL . 54.8 t -110.6 110.5 57.56 Favored Pre-proline 0 N--CA 1.473 0.677 0 N-CA-C 108.807 -0.812 . . . . 62.420000000000002 108.807 177.011 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -53.33 138.35 64.67 Favored 'Trans proline' 0 C--N 1.379 2.133 0 C-N-CA 122.741 2.294 . . . . 74.140000000000001 111.626 173.182 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -46.13 -47.97 43.53 Favored Pre-proline 0 CA--C 1.569 1.679 0 N-CA-C 113.798 1.036 . . . . 61.409999999999997 113.798 -178.052 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -54.3 -46.16 35.59 Favored 'Trans proline' 0 C--N 1.4 3.249 0 C-N-CA 122.627 2.218 . . . . 70.120000000000005 112.557 174.492 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 49.9 mt -68.88 -30.12 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 124.148 0.979 . . . . 73.049999999999997 111.063 -176.036 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.55 -39.85 80.89 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 122.956 0.503 . . . . 64.340000000000003 111.197 177.264 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 88.3 t -70.96 -52.63 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 123.489 0.716 . . . . 74.329999999999998 111.089 179.154 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 18.5 m -80.0 -29.68 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 CA-C-N 116.046 -0.525 . . . . 60.25 112.379 -172.46 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 83.95 103.8 0.56 Allowed Glycine 0 C--N 1.345 1.079 0 O-C-N 123.554 0.533 . . . . 70.120000000000005 112.772 -176.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -158.7 178.43 34.91 Favored Glycine 0 C--N 1.342 0.896 0 N-CA-C 112.175 -0.37 . . . . 64.299999999999997 112.175 -178.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.535 ' HB3' ' HB3' ' A' ' 220' ' ' GLU . 34.6 mtmm -82.79 148.51 27.76 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 122.917 0.487 . . . . 41.520000000000003 111.364 -178.499 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.485 HG11 ' HA ' ' A' ' 199' ' ' VAL . 32.8 m -136.6 147.86 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 C-N-CA 123.93 0.892 . . . . 52.439999999999998 110.156 176.314 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 11.3 mtm180 -82.02 111.47 18.21 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-O 121.216 0.531 . . . . 75.109999999999999 111.521 -178.439 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -102.0 142.69 32.89 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 125.005 1.322 . . . . 64.120000000000005 109.167 171.045 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 34.2 tpp -100.88 116.3 32.42 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 122.763 0.425 . . . . 75.549999999999997 109.854 176.363 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 81.0 p -110.69 -178.59 3.52 Favored 'General case' 0 C--O 1.247 0.926 0 C-N-CA 124.101 0.96 . . . . 42.140000000000001 109.424 177.403 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 14.9 mt -77.32 -5.53 49.87 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 122.924 0.49 . . . . 60.119999999999997 110.609 -177.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -102.31 -19.23 15.09 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.332 1.053 . . . . 74.129999999999995 110.65 177.59 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 133.07 -160.35 23.86 Favored Glycine 0 C--N 1.356 1.69 0 CA-C-O 119.954 -0.359 . . . . 72.329999999999998 113.305 176.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -78.09 126.64 7.96 Favored 'Trans proline' 0 C--N 1.376 1.998 0 C-N-CA 123.172 2.581 . . . . 71.409999999999997 111.772 -179.551 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.455 ' HA ' ' H ' ' A' ' 178' ' ' ALA . 28.1 m -132.54 143.49 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 124.123 0.969 . . . . 73.150000000000006 109.489 -178.723 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.535 ' HB3' ' HB3' ' A' ' 209' ' ' LYS . 35.0 mt-10 -101.82 115.77 31.26 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.901 0.481 . . . . 75.299999999999997 110.484 176.166 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 24.1 t -95.64 116.46 37.33 Favored 'Isoleucine or valine' 0 C--N 1.346 0.413 0 C-N-CA 124.507 1.123 . . . . 65.519999999999996 109.138 -177.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -64.51 100.79 0.39 Allowed 'General case' 0 C--O 1.239 0.544 0 O-C-N 124.156 0.91 . . . . 72.409999999999997 110.109 174.534 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.403 HG11 HG11 ' A' ' 199' ' ' VAL . 21.3 t -82.73 127.73 68.96 Favored Pre-proline 0 N--CA 1.47 0.531 0 CA-C-N 114.927 -1.033 . . . . 74.510000000000005 108.652 177.283 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -61.46 156.79 44.65 Favored 'Trans proline' 0 CA--C 1.559 1.766 0 C-N-CA 122.277 1.985 . . . . 64.299999999999997 112.418 173.182 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -70.45 161.53 45.7 Favored 'Trans proline' 0 C--N 1.373 1.865 0 C-N-CA 122.388 2.058 . . . . 71.239999999999995 112.136 173.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 72.5 mtm-85 58.25 33.54 23.24 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.38 1.072 . . . . 74.25 111.782 175.15 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.638 HG23 ' HD2' ' A' ' 231' ' ' ARG . 25.5 m -92.72 126.57 37.87 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.397 1.079 . . . . 75.420000000000002 110.154 -178.382 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -93.8 162.18 14.03 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.361 0.664 . . . . 63.530000000000001 111.158 -178.309 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 229' ' ' ALA . . . . . 0.474 ' HB2' ' HB ' ' A' ' 255' ' ' ILE . . . -71.82 119.22 15.68 Favored 'General case' 0 C--N 1.35 0.613 0 CA-C-N 115.177 -0.919 . . . . 64.120000000000005 109.324 174.075 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 114.82 -2.7 23.01 Favored Glycine 0 C--N 1.333 0.366 0 CA-C-O 119.527 -0.596 . . . . 50.119999999999997 112.414 -174.505 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.638 ' HD2' HG23 ' A' ' 227' ' ' THR . 91.3 mtt180 -74.81 161.15 29.85 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-N 117.45 0.625 . . . . 73.219999999999999 110.209 170.343 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.483 ' HD2' ' OH ' ' A' ' 250' ' ' TYR . 20.8 pttm -129.06 134.53 48.14 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.875 0.87 . . . . 74.540000000000006 109.768 -176.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.411 HD22 ' HB2' ' A' ' 173' ' ' ALA . 73.8 mt -111.5 126.79 55.35 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.065 -1.087 . . . . 74.5 108.065 175.06 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 234' ' ' ARG . . . . . 0.48 ' HB3' HG21 ' A' ' 170' ' ' VAL . 54.3 ttm-85 -108.37 102.91 11.98 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 107.324 -1.361 . . . . 72.439999999999998 107.324 170.368 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.438 HD13 ' CD1' ' A' ' 175' ' ' TYR . 20.3 mt -79.1 91.06 4.87 Favored 'General case' 0 C--O 1.245 0.835 0 N-CA-C 108.104 -1.073 . . . . 74.019999999999996 108.104 179.457 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.438 ' HA ' ' OD2' ' A' ' 248' ' ' ASP . 90.8 mttt -72.97 122.97 22.57 Favored 'General case' 0 C--O 1.243 0.762 0 CA-C-N 113.711 -1.586 . . . . 72.420000000000002 111.771 -170.059 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 64.87 27.4 72.09 Favored Glycine 0 C--N 1.346 1.094 0 O-C-N 123.864 0.727 . . . . 72.510000000000005 111.658 -176.074 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.438 ' HB3' ' CE1' ' A' ' 175' ' ' TYR . 30.5 mmtp -140.65 59.35 1.55 Allowed 'General case' 0 C--O 1.22 -0.481 0 C-N-CA 124.858 1.263 . . . . 71.109999999999999 108.083 -175.528 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -120.39 -131.47 4.11 Favored Glycine 0 N--CA 1.467 0.725 0 N-CA-C 109.914 -1.274 . . . . 42.329999999999998 109.914 165.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 240' ' ' PHE . . . . . 0.479 ' HB2' ' HA ' ' A' ' 191' ' ' GLN . 4.3 m-85 -60.17 146.23 83.77 Favored Pre-proline 0 N--CA 1.484 1.245 0 C-N-CA 123.408 0.683 . . . . 74.019999999999996 111.537 173.602 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.597 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 37.5 Cg_endo -63.13 132.02 34.83 Favored 'Trans proline' 0 C--N 1.381 2.284 0 C-N-CA 123.146 2.564 . . . . 72.219999999999999 112.435 179.327 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -141.94 136.11 7.13 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-O 118.329 -1.261 . . . . 74.510000000000005 110.523 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -57.2 -53.86 4.3 Favored 'Trans proline' 0 C--N 1.378 2.105 0 C-N-CA 123.493 2.795 . . . . 72.310000000000002 113.762 -176.55 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -81.97 -26.44 33.92 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 122.964 0.505 . . . . 64.129999999999995 111.362 -178.685 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -177.63 140.47 4.77 Favored Glycine 0 C--N 1.341 0.812 0 N-CA-C 111.352 -0.699 . . . . 44.130000000000003 111.352 -177.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.597 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 57.4 mtm180 -78.87 169.46 18.19 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.221 0.609 . . . . 74.340000000000003 110.536 177.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -78.55 -159.7 14.61 Favored Glycine 0 C--N 1.339 0.718 0 CA-C-N 116.137 -0.483 . . . . 60.240000000000002 112.299 175.56 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 248' ' ' ASP . . . . . 0.438 ' OD2' ' HA ' ' A' ' 236' ' ' LYS . 27.7 m-20 -125.69 127.5 46.33 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 109.836 -0.431 . . . . 74.049999999999997 109.836 178.624 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 58.3 tp -100.74 109.63 21.67 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 108.159 -1.052 . . . . 40.409999999999997 108.159 177.013 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 250' ' ' TYR . . . . . 0.483 ' OH ' ' HD2' ' A' ' 232' ' ' LYS . 33.9 t80 -98.07 108.38 21.08 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.497 -0.774 . . . . 74.129999999999995 109.082 -174.371 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.696 ' HB3' ' HB2' ' A' ' 197' ' ' LEU . 69.9 mt -121.3 106.71 11.73 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.85 0.86 . . . . 60.409999999999997 110.336 -174.732 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 252' ' ' GLU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 232' ' ' LYS . 53.5 mt-10 -80.29 110.99 16.25 Favored 'General case' 0 C--O 1.241 0.605 0 CA-C-N 115.177 -0.92 . . . . 63.32 110.365 178.441 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.475 HG11 HG22 ' A' ' 227' ' ' THR . 95.2 t -57.58 113.58 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 124.048 0.939 . . . . 53.43 111.363 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 28.7 mmm180 -113.22 116.18 29.37 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 107.241 -1.392 . . . . 70.400000000000006 107.241 169.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.474 ' HB ' ' HB2' ' A' ' 229' ' ' ALA . 58.1 mt -76.24 123.19 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 122.988 0.515 . . . . 74.319999999999993 109.78 -179.434 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.2 t . . . . . 0 CA--C 1.559 1.318 0 N-CA-C 107.802 -1.185 . . . . 75.129999999999995 107.802 175.031 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 26.0 mmt . . . . . 0 N--CA 1.476 0.855 0 N-CA-C 109.786 -0.45 . . . . 74.409999999999997 109.786 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -86.23 64.23 8.44 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-O 122.067 0.937 . . . . 75.019999999999996 108.504 175.608 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -90.65 -56.33 3.23 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.176 -0.92 . . . . 72.420000000000002 110.438 -170.565 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.446 HG21 ' HB3' ' A' ' 234' ' ' ARG . 35.5 m -79.04 155.61 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 109.72 -0.474 . . . . 71.109999999999999 109.72 173.823 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 12.7 tt -81.59 141.51 15.01 Favored 'Isoleucine or valine' 0 C--O 1.243 0.756 0 N-CA-C 108.99 -0.744 . . . . 71.319999999999993 108.99 173.039 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -62.97 133.17 54.21 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.208 1.003 . . . . 72.230000000000004 111.524 -172.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.499 ' HB2' HD22 ' A' ' 233' ' ' LEU . . . -147.52 171.33 15.72 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 124.594 1.158 . . . . 73.040000000000006 110.038 177.17 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -157.75 151.85 24.43 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.4 1.08 . . . . 75.049999999999997 108.374 176.386 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.43 ' HD1' HD13 ' A' ' 235' ' ' LEU . 6.4 p90 -128.3 167.02 17.51 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 109.898 -0.408 . . . . 70.25 109.898 172.375 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -140.67 136.41 16.43 Favored Pre-proline 0 N--CA 1.471 0.599 0 C-N-CA 123.281 0.632 . . . . 72.230000000000004 109.859 169.265 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' PRO . . . . . 0.534 ' HA ' HG12 ' A' ' 219' ' ' VAL . 13.7 Cg_endo -55.07 113.16 1.27 Allowed 'Trans proline' 0 C--N 1.378 2.088 0 C-N-CA 123.646 2.897 . . . . 73.430000000000007 112.881 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 178' ' ' ALA . . . . . 0.635 ' HB2' ' HG3' ' A' ' 220' ' ' GLU . . . -87.0 -10.64 52.64 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.735 0.814 . . . . 64.219999999999999 112.007 -175.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -109.53 -75.69 0.62 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.311 0.644 . . . . 75.209999999999994 109.591 178.028 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -126.58 -104.35 1.35 Allowed Glycine 0 C--N 1.347 1.143 0 N-CA-C 110.441 -1.064 . . . . 61.229999999999997 110.441 -178.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 74.0 m -157.64 160.46 38.06 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.612 1.165 . . . . 73.129999999999995 109.732 174.538 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -66.77 124.1 23.31 Favored Glycine 0 C--N 1.345 1.036 0 N-CA-C 111.343 -0.703 . . . . 61.340000000000003 111.343 171.433 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -84.42 154.63 30.14 Favored Glycine 0 C--N 1.343 0.953 0 N-CA-C 111.972 -0.451 . . . . 64.310000000000002 111.972 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.483 ' HB2' ' HB2' ' A' ' 241' ' ' PRO . 39.2 t -123.88 108.67 12.7 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.685 0.794 . . . . 35.210000000000001 109.008 179.489 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -99.92 52.97 0.99 Allowed Glycine 0 C--N 1.342 0.9 0 N-CA-C 111.494 -0.642 . . . . 54.409999999999997 111.494 177.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 103.76 -132.32 11.0 Favored Glycine 0 N--CA 1.468 0.828 0 N-CA-C 110.814 -0.914 . . . . 60.329999999999998 110.814 -172.055 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 29.5 p -77.58 -2.21 34.6 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 123.703 0.801 . . . . 75.219999999999999 112.053 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 95.92 -6.56 67.0 Favored Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.611 -0.549 . . . . 64.140000000000001 113.342 176.178 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 67.42 -84.3 0.14 Allowed Glycine 0 C--N 1.359 1.822 0 N-CA-C 111.731 -0.548 . . . . 44.109999999999999 111.731 -177.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 50.6 m -113.13 98.48 7.17 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 108.162 -1.051 . . . . 74.230000000000004 108.162 169.26 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.501 ' HB3' ' HA3' ' A' ' 247' ' ' GLY . 77.1 mt-30 -68.42 -25.28 64.95 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.298 0.639 . . . . 75.140000000000001 111.507 179.203 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.517 ' HB3' ' HE1' ' A' ' 194' ' ' TYR . 4.1 m-20 -79.77 114.79 18.96 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 114.654 -1.157 . . . . 55.530000000000001 109.718 -179.434 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 69.0 mt -112.27 135.97 52.29 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 108.808 -0.812 . . . . 73.349999999999994 108.808 172.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 194' ' ' TYR . . . . . 0.517 ' HE1' ' HB3' ' A' ' 192' ' ' ASP . 46.3 m-85 -129.05 122.99 31.14 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 108.648 -0.871 . . . . 62.439999999999998 108.648 -178.718 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.408 ' O ' ' HA ' ' A' ' 251' ' ' LEU . . . -154.78 162.91 40.93 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 121.57 0.7 . . . . 55.200000000000003 110.333 -176.674 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 19.8 p -97.47 141.16 30.87 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-N 115.436 -0.802 . . . . 60.109999999999999 109.188 174.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.585 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . 45.7 tp -108.48 113.15 25.95 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.613 -0.721 . . . . 70.030000000000001 110.044 -175.345 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -79.32 99.89 7.32 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 109.22 -0.659 . . . . 62.539999999999999 109.22 178.451 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 43.1 t -106.86 118.43 54.21 Favored Pre-proline 0 N--CA 1.467 0.42 0 CA-C-N 115.334 -0.848 . . . . 71.109999999999999 108.721 176.03 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -54.74 143.25 70.96 Favored 'Trans proline' 0 C--N 1.371 1.747 0 C-N-CA 122.415 2.076 . . . . 74.239999999999995 111.796 169.422 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.413 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -53.75 -44.41 97.92 Favored Pre-proline 0 CA--C 1.562 1.413 0 CA-C-O 118.03 -0.986 . . . . 54.039999999999999 112.454 179.012 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.413 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 13.7 Cg_endo -55.7 -47.17 26.71 Favored 'Trans proline' 0 C--N 1.403 3.412 0 C-N-CA 122.543 2.162 . . . . 73.540000000000006 111.97 172.712 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 33.2 mt -70.82 -24.73 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 C-N-CA 123.291 0.636 . . . . 73.010000000000005 111.238 -176.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -73.48 -41.72 62.78 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.169 0.588 . . . . 75.239999999999995 110.513 178.054 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 98.0 t -69.3 -55.24 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 123.616 0.767 . . . . 73.340000000000003 110.985 178.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 8.8 p -73.18 -31.62 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 C-N-CA 122.767 0.427 . . . . 74.340000000000003 111.507 -175.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 78.9 95.03 0.28 Allowed Glycine 0 C--N 1.345 1.062 0 N-CA-C 112.131 -0.388 . . . . 52.539999999999999 112.131 -175.449 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -141.21 -177.76 16.76 Favored Glycine 0 N--CA 1.467 0.765 0 N-CA-C 111.544 -0.622 . . . . 54.130000000000003 111.544 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.45 ' HD2' ' HB3' ' A' ' 220' ' ' GLU . 46.0 mtmt -84.17 137.09 33.7 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 109.443 -0.577 . . . . 74.310000000000002 109.443 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 26.8 m -119.75 157.51 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 123.775 0.83 . . . . 60.329999999999998 109.082 170.183 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 78.4 mtm180 -86.41 119.46 26.7 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 109.667 -0.494 . . . . 72.140000000000001 109.667 172.428 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -101.47 140.01 36.35 Favored 'General case' 0 C--O 1.245 0.848 0 C-N-CA 124.311 1.044 . . . . 73.140000000000001 108.273 174.351 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.66 103.23 15.15 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.435 -0.95 . . . . 71.219999999999999 108.435 -178.694 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 47.5 p -111.73 177.76 4.54 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.997 0.919 . . . . 71.519999999999996 109.86 -179.624 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 11.2 mt -67.67 -27.76 67.12 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 122.973 0.509 . . . . 72.439999999999998 110.916 -176.29 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -82.66 -18.92 39.33 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.994 0.918 . . . . 72.299999999999997 111.408 179.285 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 129.08 -154.28 20.2 Favored Glycine 0 C--N 1.353 1.489 0 CA-C-O 119.501 -0.61 . . . . 54.5 112.746 178.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -73.32 133.86 19.94 Favored 'Trans proline' 0 C--N 1.374 1.887 0 C-N-CA 122.722 2.281 . . . . 74.329999999999998 111.78 175.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.534 HG12 ' HA ' ' A' ' 177' ' ' PRO . 26.9 m -133.29 147.61 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 123.581 0.752 . . . . 75.340000000000003 110.164 177.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.635 ' HG3' ' HB2' ' A' ' 178' ' ' ALA . 48.3 mt-10 -90.73 106.02 18.22 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.143 0.577 . . . . 61.420000000000002 110.028 178.685 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 61.6 t -94.72 113.71 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 N-CA-C 109.096 -0.705 . . . . 63.350000000000001 109.096 176.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -68.02 100.04 0.94 Allowed 'General case' 0 C--O 1.242 0.658 0 O-C-N 124.028 0.83 . . . . 73.109999999999999 109.229 173.594 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.462 HG11 HG11 ' A' ' 199' ' ' VAL . 25.5 t -79.7 124.53 83.52 Favored Pre-proline 0 C--O 1.24 0.591 0 C-N-CA 123.884 0.874 . . . . 63.119999999999997 109.046 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -55.83 146.49 66.92 Favored 'Trans proline' 0 C--N 1.374 1.9 0 C-N-CA 122.485 2.124 . . . . 70.219999999999999 112.574 174.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -67.4 150.68 80.84 Favored 'Trans proline' 0 C--N 1.373 1.862 0 C-N-CA 122.144 1.896 . . . . 71.049999999999997 112.62 175.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 61.58 37.74 16.02 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 124.904 1.281 . . . . 75.209999999999994 111.705 177.238 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 45.5 m -96.96 116.01 28.45 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.816 0.846 . . . . 60.420000000000002 110.622 -178.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 24.1 mp0 -86.18 165.7 16.33 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.771 0.828 . . . . 63.43 111.287 -178.32 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -70.49 133.67 47.03 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 114.799 -1.091 . . . . 72.209999999999994 109.46 176.253 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 112.68 -24.95 12.51 Favored Glycine 0 C--N 1.334 0.461 0 N-CA-C 111.441 -0.664 . . . . 53.149999999999999 111.441 -176.519 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 60.6 mtt180 -63.82 160.65 16.93 Favored 'General case' 0 C--N 1.36 1.038 0 C-N-CA 123.504 0.722 . . . . 72.400000000000006 111.526 178.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 16.1 pttm -130.21 134.42 47.26 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.202 1.001 . . . . 71.230000000000004 110.145 -171.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.499 HD22 ' HB2' ' A' ' 173' ' ' ALA . 58.5 mt -120.0 100.24 7.1 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.648 1.179 . . . . 64.129999999999995 108.524 179.663 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 234' ' ' ARG . . . . . 0.446 ' HB3' HG21 ' A' ' 170' ' ' VAL . 67.8 ttt180 -93.92 101.1 13.16 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 108.5 -0.926 . . . . 52.530000000000001 108.5 177.831 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.463 HD11 HD12 ' A' ' 251' ' ' LEU . 21.3 mt -79.14 83.35 5.21 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.187 0.995 . . . . 54.0 109.343 -178.448 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -79.3 140.97 37.41 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.529 0.732 . . . . 73.340000000000003 110.628 -177.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 65.41 24.82 71.02 Favored Glycine 0 C--N 1.349 1.26 0 O-C-N 124.045 0.841 . . . . 34.420000000000002 111.65 -174.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -130.33 -26.01 2.37 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.713 0.805 . . . . 75.200000000000003 110.859 -174.213 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -67.96 -145.53 0.12 Allowed Glycine 0 C--N 1.358 1.751 0 O-C-N 123.653 0.596 . . . . 62.140000000000001 113.718 -175.052 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 240' ' ' PHE . . . . . 0.494 ' HB3' ' HA ' ' A' ' 191' ' ' GLN . 0.1 OUTLIER -67.06 120.68 73.8 Favored Pre-proline 0 CA--C 1.552 1.055 0 O-C-N 122.369 -0.489 . . . . 74.209999999999994 110.912 -173.21 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.564 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 15.7 Cg_exo -70.67 160.19 50.25 Favored 'Trans proline' 0 C--N 1.385 2.499 0 C-N-CA 123.746 2.964 . . . . 63.130000000000003 115.499 -173.518 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -159.43 164.26 33.89 Favored Glycine 0 CA--C 1.532 1.095 0 CA-C-N 113.188 -1.824 . . . . 70.519999999999996 110.43 175.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -70.51 -23.31 27.53 Favored 'Trans proline' 0 C--N 1.37 1.685 0 C-N-CA 122.945 2.43 . . . . 70.409999999999997 113.291 -177.422 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -89.42 -27.08 20.65 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.227 0.611 . . . . 72.430000000000007 110.783 177.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 166.95 -170.12 41.21 Favored Glycine 0 C--N 1.349 1.269 0 N-CA-C 112.183 -0.367 . . . . 22.109999999999999 112.183 -178.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.564 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 26.6 mtm180 -117.92 155.36 30.34 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.875 0.87 . . . . 71.400000000000006 110.412 -177.382 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.501 ' HA3' ' HB3' ' A' ' 191' ' ' GLN . . . -86.84 -156.13 28.59 Favored Glycine 0 C--N 1.343 0.951 0 CA-C-N 115.706 -0.679 . . . . 75.109999999999999 111.952 171.674 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -122.56 154.26 38.16 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 121.287 0.565 . . . . 60.219999999999999 110.894 176.575 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.404 ' HG ' ' HG ' ' A' ' 251' ' ' LEU . 41.4 tp -116.77 107.28 14.45 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 107.485 -1.302 . . . . 64.209999999999994 107.485 170.143 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -90.75 105.75 18.04 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.77 0.828 . . . . 75.420000000000002 108.773 -176.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.585 ' HB3' ' HB2' ' A' ' 197' ' ' LEU . 49.5 mt -109.71 106.73 16.49 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.498 1.119 . . . . 55.030000000000001 110.654 -177.726 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -82.81 115.63 21.79 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 109.62 -0.511 . . . . 74.310000000000002 109.62 176.402 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 61.6 t -60.03 104.55 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 124.425 1.09 . . . . 64.140000000000001 111.455 -177.49 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 21.3 mmm180 -101.56 107.13 18.32 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 125.115 1.366 . . . . 60.310000000000002 107.997 171.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.469 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 48.3 mt -77.43 132.39 32.8 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 CA-C-O 120.913 0.387 . . . . 45.399999999999999 110.512 178.58 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 3.1 t . . . . . 0 C--O 1.251 1.16 0 C-N-CA 124.766 1.226 . . . . 65.409999999999997 109.294 177.805 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 25.7 ptt? . . . . . 0 N--CA 1.472 0.667 0 N-CA-C 109.752 -0.462 . . . . 52.149999999999999 109.752 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 60.04 98.08 0.03 OUTLIER 'General case' 0 C--N 1.359 1.009 0 C-N-CA 125.404 1.482 . . . . 72.200000000000003 111.031 178.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' ASP . . . . . 0.498 ' O ' ' HE3' ' A' ' 232' ' ' LYS . 23.1 t70 -53.94 -50.6 66.11 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.435 0.694 . . . . 75.439999999999998 110.08 -179.347 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 29.3 m -113.04 157.92 13.57 Favored 'Isoleucine or valine' 0 C--O 1.244 0.797 0 C-N-CA 123.752 0.821 . . . . 63.420000000000002 110.491 178.129 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 15.5 tt -81.15 147.03 6.58 Favored 'Isoleucine or valine' 0 C--O 1.248 0.979 0 N-CA-C 107.398 -1.334 . . . . 73.319999999999993 107.398 166.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -57.58 123.82 16.91 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.196 0.598 . . . . 75.310000000000002 110.761 -178.542 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.491 ' HB2' HD22 ' A' ' 233' ' ' LEU . . . -146.64 159.05 43.94 Favored 'General case' 0 C--O 1.244 0.789 0 CA-C-N 115.102 -0.954 . . . . 75.049999999999997 109.649 177.334 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -158.95 163.03 36.87 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.037 -0.983 . . . . 71.519999999999996 108.964 179.196 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.539 ' HD1' HD13 ' A' ' 235' ' ' LEU . 16.8 p90 -135.21 170.89 15.23 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-O 121.402 0.62 . . . . 71.319999999999993 111.406 176.557 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -137.27 141.15 33.06 Favored Pre-proline 0 CA--C 1.542 0.671 0 CA-C-N 113.584 -1.643 . . . . 72.030000000000001 107.734 173.099 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' PRO . . . . . 0.431 ' HA ' HG12 ' A' ' 219' ' ' VAL . 32.1 Cg_exo -59.13 117.55 4.3 Favored 'Trans proline' 0 CA--C 1.551 1.372 0 C-N-CA 123.196 2.597 . . . . 62.530000000000001 111.707 179.502 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 178' ' ' ALA . . . . . 0.507 ' HB2' ' HG3' ' A' ' 220' ' ' GLU . . . -65.67 -46.28 79.73 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.85 0.833 . . . . 73.219999999999999 109.662 -177.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -88.44 158.21 18.43 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 114.096 -1.411 . . . . 73.450000000000003 109.153 170.658 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -76.34 66.81 2.57 Favored Glycine 0 C--N 1.349 1.304 0 N-CA-C 111.285 -0.726 . . . . 52.439999999999998 111.285 172.01 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 11.6 t -139.91 134.35 31.48 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 107.868 -1.16 . . . . 75.109999999999999 107.868 -176.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 169.24 84.18 0.05 OUTLIER Glycine 0 C--N 1.333 0.404 0 N-CA-C 110.499 -1.04 . . . . 73.409999999999997 110.499 -176.335 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -70.09 -176.91 19.27 Favored Glycine 0 C--N 1.343 0.939 0 N-CA-C 112.158 -0.377 . . . . 75.409999999999997 112.158 173.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 51.2 m -144.89 145.88 31.78 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 117.405 0.602 . . . . 61.229999999999997 110.533 -176.509 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -163.57 -87.32 0.06 OUTLIER Glycine 0 C--N 1.337 0.599 0 N-CA-C 110.354 -1.099 . . . . 22.420000000000002 110.354 179.214 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 59.27 40.37 95.8 Favored Glycine 0 C--N 1.352 1.439 0 O-C-N 123.883 0.402 . . . . 71.430000000000007 113.554 -178.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 28.6 p -72.7 -49.02 34.11 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.691 0.796 . . . . 74.219999999999999 112.085 -174.006 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 158.19 4.38 0.07 OUTLIER Glycine 0 N--CA 1.469 0.887 0 CA-C-N 115.973 -0.558 . . . . 34.240000000000002 113.061 -178.114 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -78.85 -157.19 10.61 Favored Glycine 0 C--N 1.352 1.456 0 CA-C-N 117.071 0.436 . . . . 61.43 112.889 175.179 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 22.5 p -69.33 86.46 0.42 Allowed 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 123.759 0.824 . . . . 75.239999999999995 110.587 177.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.412 ' HA ' ' HB2' ' A' ' 240' ' ' PHE . 77.2 mt-30 -84.74 -27.23 27.1 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.478 1.111 . . . . 60.399999999999999 111.036 177.471 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -76.06 129.65 37.16 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 115.216 -0.902 . . . . 74.409999999999997 108.951 174.503 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 42.5 mt -116.94 147.1 42.54 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.731 1.212 . . . . 74.299999999999997 108.72 173.337 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -139.81 122.25 16.13 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.086 0.955 . . . . 73.219999999999999 108.92 -175.182 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.403 ' O ' ' HA ' ' A' ' 251' ' ' LEU . . . -163.1 169.03 20.05 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.009 0.524 . . . . 50.210000000000001 111.002 -175.778 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 8.7 p -95.56 149.74 21.1 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.54 0.736 . . . . 71.540000000000006 109.782 171.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.552 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . 38.4 tp -112.85 113.69 25.88 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.657 0.783 . . . . 64.019999999999996 109.926 -178.312 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -73.79 109.26 7.16 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 123.37 0.668 . . . . 74.129999999999995 109.76 174.057 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.451 ' HA ' HG11 ' A' ' 210' ' ' VAL . 89.5 t -118.83 120.37 31.55 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 108.716 -0.846 . . . . 74.549999999999997 108.716 175.61 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_exo -55.96 142.81 84.42 Favored 'Trans proline' 0 C--N 1.368 1.561 0 C-N-CA 123.147 2.565 . . . . 65.230000000000004 112.06 169.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.404 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -52.04 -46.18 93.15 Favored Pre-proline 0 CA--C 1.556 1.205 0 C-N-CA 124.512 1.125 . . . . 25.530000000000001 113.847 -179.149 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.468 ' O ' HG12 ' A' ' 206' ' ' VAL . 12.7 Cg_endo -55.0 -50.43 13.25 Favored 'Trans proline' 0 C--N 1.394 2.923 0 C-N-CA 122.147 1.898 . . . . 70.109999999999999 112.835 173.543 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 36.6 mt -63.55 -30.43 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 123.842 0.857 . . . . 64.420000000000002 111.443 -177.505 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.44 -48.24 61.53 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.212 0.605 . . . . 71.319999999999993 111.407 177.564 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 201' ' ' ALA . 86.5 t -67.04 -52.57 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 C-N-CA 123.461 0.704 . . . . 71.129999999999995 111.605 -175.547 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.468 HG12 ' O ' ' A' ' 202' ' ' PRO . 12.9 p -82.54 -30.13 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 C-N-CA 122.613 0.365 . . . . 72.400000000000006 111.466 -176.339 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 89.13 126.58 2.85 Favored Glycine 0 C--N 1.349 1.297 0 N-CA-C 111.76 -0.536 . . . . 72.230000000000004 111.76 -175.342 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -159.65 -141.97 3.27 Favored Glycine 0 C--N 1.341 0.831 0 CA-C-O 119.997 -0.335 . . . . 73.120000000000005 112.425 -177.175 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm -134.68 134.2 40.86 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 108.555 -0.906 . . . . 63.009999999999998 108.555 175.578 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.451 HG11 ' HA ' ' A' ' 199' ' ' VAL . 35.1 m -119.5 163.07 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 C-N-CA 123.994 0.918 . . . . 52.409999999999997 108.823 173.255 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 80.2 mtm180 -98.79 123.65 43.17 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 121.324 0.583 . . . . 64.239999999999995 110.459 175.39 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -100.71 137.28 39.32 Favored 'General case' 0 C--O 1.246 0.899 0 CA-C-N 114.934 -1.03 . . . . 72.25 108.77 179.279 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 18.9 mmt -83.02 108.52 16.39 Favored 'General case' 0 C--O 1.238 0.465 0 O-C-N 124.179 0.925 . . . . 73.319999999999993 108.682 176.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 80.4 p -108.98 177.08 4.87 Favored 'General case' 0 C--O 1.244 0.768 0 N-CA-C 108.307 -0.997 . . . . 72.120000000000005 108.307 174.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 11.2 mt -66.78 -23.26 66.05 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 116.404 -0.362 . . . . 71.010000000000005 110.135 177.469 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -92.33 -19.61 21.95 Favored 'General case' 0 CA--C 1.558 1.259 0 C-N-CA 124.082 0.953 . . . . 74.450000000000003 111.509 -179.415 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 129.16 -149.56 18.59 Favored Glycine 0 C--N 1.355 1.589 0 CA-C-O 119.561 -0.577 . . . . 72.430000000000007 114.1 173.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -76.36 127.73 9.97 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 123.194 2.596 . . . . 61.030000000000001 112.066 -178.204 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.468 ' HA ' ' H ' ' A' ' 178' ' ' ALA . 33.8 m -130.4 131.47 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 122.989 0.516 . . . . 72.400000000000006 110.524 176.471 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.507 ' HG3' ' HB2' ' A' ' 178' ' ' ALA . 40.0 mt-10 -77.41 104.2 7.78 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 122.944 0.498 . . . . 64.040000000000006 109.963 178.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 59.7 t -92.7 122.4 44.14 Favored 'Isoleucine or valine' 0 C--O 1.245 0.821 0 N-CA-C 108.149 -1.056 . . . . 73.329999999999998 108.149 178.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -68.65 99.72 1.04 Allowed 'General case' 0 C--O 1.24 0.605 0 O-C-N 124.215 0.947 . . . . 63.119999999999997 109.379 177.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 69.4 t -77.39 120.37 81.24 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-N 115.152 -0.931 . . . . 70.519999999999996 108.596 174.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -64.06 156.5 58.49 Favored 'Trans proline' 0 C--N 1.377 2.053 0 C-N-CA 122.72 2.28 . . . . 73.510000000000005 112.241 177.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -65.11 143.43 78.19 Favored 'Trans proline' 0 C--N 1.372 1.809 0 C-N-CA 122.349 2.032 . . . . 74.120000000000005 111.332 170.428 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 71.6 mtm180 65.42 66.14 0.54 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.675 1.19 . . . . 73.319999999999993 110.339 178.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.613 HG23 ' HD2' ' A' ' 231' ' ' ARG . 97.1 m -107.77 134.31 50.91 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.062 -0.972 . . . . 72.349999999999994 110.038 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -108.33 157.7 18.15 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.958 0.903 . . . . 64.340000000000003 110.264 176.539 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -72.49 118.81 15.86 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.126 0.97 . . . . 61.32 109.277 173.337 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 114.54 -6.5 22.68 Favored Glycine 0 CA--C 1.521 0.467 0 CA-C-O 119.295 -0.725 . . . . 61.539999999999999 112.014 -171.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.613 ' HD2' HG23 ' A' ' 227' ' ' THR . 49.8 mtt-85 -67.15 157.93 32.49 Favored 'General case' 0 C--N 1.364 1.21 0 CA-C-N 117.941 0.87 . . . . 74.510000000000005 110.286 169.343 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.498 ' HE3' ' O ' ' A' ' 169' ' ' ASP . 32.7 pttt -130.23 138.31 50.49 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 123.756 0.822 . . . . 73.430000000000007 109.348 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.491 HD22 ' HB2' ' A' ' 173' ' ' ALA . 59.8 mt -127.3 100.52 6.09 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.032 1.333 . . . . 62.310000000000002 108.212 -178.103 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 22.6 ttp180 -90.64 102.0 14.74 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.162 -1.051 . . . . 75.340000000000003 108.162 176.117 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.539 HD13 ' HD1' ' A' ' 175' ' ' TYR . 14.5 mt -76.41 83.28 3.14 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 114.188 -1.369 . . . . 73.430000000000007 108.271 -179.556 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -66.62 134.96 53.38 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 114.465 -1.243 . . . . 74.209999999999994 111.234 -173.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 69.57 10.21 63.17 Favored Glycine 0 CA--C 1.538 1.526 0 O-C-N 123.73 0.644 . . . . 73.109999999999999 112.782 -178.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.458 ' HB3' ' CE1' ' A' ' 175' ' ' TYR . 33.4 mmtp -134.03 42.54 2.91 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 125.126 1.371 . . . . 74.120000000000005 110.523 -171.072 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -100.97 -102.4 2.55 Favored Glycine 0 N--CA 1.472 1.044 0 N-CA-C 109.714 -1.354 . . . . 65.439999999999998 109.714 165.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 240' ' ' PHE . . . . . 0.412 ' HB2' ' HA ' ' A' ' 191' ' ' GLN . 8.8 m-85 -82.08 126.33 75.02 Favored Pre-proline 0 N--CA 1.475 0.795 0 C-N-CA 123.076 0.55 . . . . 73.430000000000007 109.667 167.837 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.522 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 12.9 Cg_exo -71.79 158.3 53.39 Favored 'Trans proline' 0 C--N 1.37 1.684 0 C-N-CA 122.901 2.401 . . . . 72.439999999999998 111.928 175.057 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -178.64 151.93 10.9 Favored Glycine 0 CA--C 1.529 0.916 0 CA-C-O 119.17 -0.794 . . . . 75.129999999999995 112.004 -178.021 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -71.36 -28.82 17.69 Favored 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 123.149 2.566 . . . . 74.299999999999997 113.671 179.333 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -121.42 -26.49 4.98 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.49 0.716 . . . . 74.299999999999997 112.215 -178.241 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -134.38 117.74 1.87 Allowed Glycine 0 C--N 1.345 1.058 0 N-CA-C 111.434 -0.666 . . . . 54.409999999999997 111.434 -174.225 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.522 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 70.5 mtt180 -127.29 126.83 43.33 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 108.666 -0.864 . . . . 73.0 108.666 178.372 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -80.69 -161.37 25.35 Favored Glycine 0 C--N 1.351 1.401 0 O-C-N 123.354 0.409 . . . . 72.120000000000005 112.843 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -130.74 156.64 44.62 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.227 0.611 . . . . 71.25 110.314 175.091 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.459 ' HG ' ' HG ' ' A' ' 251' ' ' LEU . 36.9 tp -114.33 109.92 19.1 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 108.811 -0.811 . . . . 72.299999999999997 108.811 172.112 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -93.01 107.79 19.5 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.915 0.886 . . . . 73.430000000000007 108.971 -176.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.552 ' HB3' ' HB2' ' A' ' 197' ' ' LEU . 48.3 mt -113.31 116.95 30.52 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.101 0.96 . . . . 73.129999999999995 111.455 -173.597 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -86.99 108.48 18.86 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 109.166 -0.679 . . . . 73.25 109.166 173.315 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.407 HG11 ' CG2' ' A' ' 227' ' ' THR . 53.8 t -60.99 120.15 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 123.512 0.725 . . . . 73.519999999999996 110.68 179.198 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 26.2 mmm180 -117.21 113.53 22.36 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 106.898 -1.519 . . . . 73.239999999999995 106.898 173.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 55.5 mt -79.15 127.19 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 123.312 0.645 . . . . 62.420000000000002 110.906 -177.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 20.1 p . . . . . 0 C--O 1.25 1.096 0 C-N-CA 124.742 1.217 . . . . 73.319999999999993 108.304 177.447 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 26.9 t70 . . . . . 0 N--CA 1.475 0.802 0 N-CA-C 107.984 -1.117 . . . . 71.52 107.984 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.47 HG21 ' HB3' ' A' ' 234' ' ' ARG . 17.1 m -85.99 143.02 12.35 Favored 'Isoleucine or valine' 0 C--O 1.245 0.835 0 N-CA-C 108.016 -1.105 . . . . 63.21 108.016 167.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 15.2 tt -73.83 141.26 16.43 Favored 'Isoleucine or valine' 0 C--O 1.246 0.876 0 N-CA-C 108.701 -0.852 . . . . 41.32 108.701 174.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -63.93 118.57 8.61 Favored 'General case' 0 C--N 1.349 0.554 0 O-C-N 123.903 0.752 . . . . 73.13 110.906 -173.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.454 ' HB2' HD22 ' A' ' 233' ' ' LEU . . . -124.02 160.66 27.16 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.267 1.027 . . . . 72.45 109.813 -174.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -149.08 163.75 36.65 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.488 0.715 . . . . 74.35 109.75 -178.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.442 ' HD1' HD13 ' A' ' 235' ' ' LEU . 7.9 p90 -150.08 178.76 8.65 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 122.899 0.479 . . . . 74.22 110.773 174.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 41.4 mmtm -141.67 132.33 13.05 Favored Pre-proline 0 N--CA 1.483 1.222 0 C-N-CA 124.73 1.212 . . . . 75.04 109.007 175.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . 0.423 ' HA ' HG12 ' A' ' 219' ' ' VAL . 55.7 Cg_endo -67.54 105.54 1.09 Allowed 'Trans proline' 0 C--N 1.384 2.415 0 C-N-CA 122.946 2.431 . . . . 70.14 111.866 -177.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . 0.494 ' HB2' ' HG3' ' A' ' 220' ' ' GLU . . . . . . . . 0 CA--C 1.537 0.48 0 C-N-CA 123.46 0.704 . . . . 50.15 109.235 178.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 121.708 0.766 . . . . 34.01 110.314 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.485 ' HA ' ' O ' ' A' ' 248' ' ' ASP . 3.7 p-10 -88.17 145.57 25.85 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 114.653 -1.158 . . . . 61.31 110.153 171.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 67.9 mt -127.11 140.43 52.28 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.682 0.793 . . . . 63.45 108.954 172.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -107.21 120.87 43.31 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 108.919 -0.771 . . . . 75.32 108.919 175.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -143.81 161.62 38.17 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.836 0.854 . . . . 74.35 109.452 -177.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 2.7 m -112.97 141.27 47.0 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 109.072 -0.714 . . . . 74.54 109.072 -178.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.52 HD11 HG23 ' A' ' 210' ' ' VAL . 37.6 tp -113.22 117.93 33.26 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.281 0.632 . . . . 74.25 111.052 -168.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -82.34 101.18 10.41 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.91 -0.774 . . . . 74.32 108.91 168.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.544 ' HA ' HG11 ' A' ' 210' ' ' VAL . 2.6 p -115.31 112.71 43.73 Favored Pre-proline 0 CA--C 1.546 0.79 0 N-CA-C 109.218 -0.66 . . . . 74.11 109.218 173.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -54.08 146.1 50.02 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 123.349 2.699 . . . . 55.15 113.029 175.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -49.38 -49.32 71.69 Favored Pre-proline 0 CA--C 1.561 1.383 0 O-C-N 124.356 1.035 . . . . 25.3 113.489 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -60.19 -42.13 45.47 Favored 'Trans proline' 0 C--N 1.393 2.91 0 C-N-CA 121.919 1.746 . . . . 61.2 112.528 177.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 43.0 mt -70.92 -27.33 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 123.602 0.761 . . . . 62.15 110.932 -177.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.05 -48.13 63.6 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.069 0.548 . . . . 52.22 110.709 175.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 88.6 t -68.12 -46.17 81.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 123.742 0.817 . . . . 63.53 111.591 -176.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 17.0 m -73.65 -33.13 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 CA-C-N 116.691 -0.231 . . . . 73.55 111.109 178.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 74.66 77.17 0.68 Allowed Glycine 0 C--N 1.349 1.268 0 CA-C-N 115.987 -0.551 . . . . 72.14 112.243 -173.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -107.58 -133.64 7.21 Favored Glycine 0 C--N 1.344 1.025 0 N-CA-C 111.566 -0.614 . . . . 75.5 111.566 178.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm -131.49 147.24 52.53 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.858 0.863 . . . . 70.04 109.633 171.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.544 HG11 ' HA ' ' A' ' 199' ' ' VAL . 17.4 m -133.62 143.57 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 124.401 1.08 . . . . 74.34 109.278 174.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . 0.432 ' HA ' ' O ' ' A' ' 219' ' ' VAL . 14.8 ttm180 -85.56 116.31 23.78 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 122.486 0.314 . . . . 73.45 110.882 -175.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -100.68 141.36 33.66 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.454 1.102 . . . . 73.32 110.113 177.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 2.2 mmt -88.23 125.03 34.43 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 123.881 0.873 . . . . 70.14 110.051 176.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 41.3 p -134.42 177.75 7.52 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.791 0.836 . . . . 54.13 110.605 178.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . 0.415 HD12 ' HE1' ' A' ' 240' ' ' PHE . 20.1 mt -69.19 -26.28 64.75 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 122.811 0.445 . . . . 73.44 110.503 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -79.84 -19.38 48.55 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.483 0.713 . . . . 73.21 110.967 178.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 127.47 -157.28 20.82 Favored Glycine 0 C--N 1.352 1.438 0 CA-C-O 119.797 -0.446 . . . . 71.41 112.653 178.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . 0.448 ' HG2' ' O ' ' A' ' 178' ' ' ALA . 58.7 Cg_endo -76.37 134.06 15.22 Favored 'Trans proline' 0 C--N 1.369 1.657 0 C-N-CA 122.744 2.296 . . . . 55.14 111.655 175.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' A' ' 211' ' ' ARG . 19.7 m -135.34 145.41 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 123.722 0.809 . . . . 74.34 109.106 -178.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.494 ' HG3' ' HB2' ' A' ' 178' ' ' ALA . 56.0 mt-10 -105.32 110.66 23.1 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 118.942 0.792 . . . . 73.3 109.545 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 45.5 t -97.06 122.43 48.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 124.975 1.31 . . . . 65.45 111.021 -170.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -65.25 105.31 1.08 Allowed 'General case' 0 C--O 1.241 0.641 0 C-N-CA 124.28 1.032 . . . . 54.41 110.94 175.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 51.5 t -76.8 128.14 82.36 Favored Pre-proline 0 CA--C 1.548 0.866 0 CA-C-N 114.741 -1.118 . . . . 65.21 109.008 173.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.48 141.99 96.86 Favored 'Trans proline' 0 CA--C 1.561 1.84 0 C-N-CA 122.504 2.136 . . . . 60.43 112.445 174.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -59.41 126.61 21.25 Favored 'Trans proline' 0 C--N 1.375 1.97 0 C-N-CA 122.696 2.264 . . . . 50.13 112.771 173.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 86.6 mtt-85 70.74 71.47 0.19 Allowed 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 125.638 1.575 . . . . 73.11 110.065 179.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.619 HG23 ' HD2' ' A' ' 231' ' ' ARG . 15.9 m -103.45 136.8 42.52 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 114.264 -1.335 . . . . 65.51 110.622 -177.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 22.3 mp0 -103.91 158.04 16.68 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.209 1.004 . . . . 64.33 109.764 177.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -74.47 144.97 43.97 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 109.424 -0.584 . . . . 63.43 109.424 173.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 89.89 2.0 75.77 Favored Glycine 0 C--N 1.341 0.86 0 CA-C-O 120.112 -0.271 . . . . 75.05 112.687 -175.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.619 ' HD2' HG23 ' A' ' 227' ' ' THR . 83.1 mtt180 -70.13 160.83 31.33 Favored 'General case' 0 C--N 1.356 0.848 0 CA-C-O 121.528 0.68 . . . . 60.34 110.179 170.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 16.1 pttp -130.53 138.42 50.2 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 114.863 -1.062 . . . . 74.14 108.885 175.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.454 HD22 ' HB2' ' A' ' 173' ' ' ALA . 67.0 mt -119.89 141.41 49.61 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.564 1.146 . . . . 74.23 107.925 178.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . 0.47 ' HB3' HG21 ' A' ' 170' ' ' VAL . 33.8 ttt180 -129.53 107.98 9.89 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.452 -0.944 . . . . 74.22 108.452 171.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.442 HD13 ' HD1' ' A' ' 175' ' ' TYR . 19.6 mt -81.08 83.99 6.62 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.833 1.253 . . . . 71.31 109.099 -177.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -69.75 134.43 48.6 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.108 0.963 . . . . 61.35 111.123 -175.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 65.18 21.95 68.59 Favored Glycine 0 C--N 1.35 1.338 0 O-C-N 123.892 0.745 . . . . 70.31 112.826 -176.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.439 ' HD3' HH21 ' A' ' 246' ' ' ARG . 29.5 mmtp -138.32 19.87 2.76 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.028 0.931 . . . . 74.2 110.899 -174.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -92.83 -133.25 6.35 Favored Glycine 0 N--CA 1.466 0.657 0 N-CA-C 111.919 -0.472 . . . . 72.15 111.919 174.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . 0.415 ' HE1' HD12 ' A' ' 215' ' ' LEU . 0.1 OUTLIER -61.35 138.72 94.75 Favored Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 123.888 0.875 . . . . 74.11 110.133 177.746 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_exo -48.12 146.18 9.81 Favored 'Trans proline' 0 C--N 1.377 2.045 0 C-N-CA 123.9 3.066 . . . . 74.23 115.107 177.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -159.79 138.67 5.71 Favored Glycine 0 CA--C 1.534 1.238 0 CA-C-O 118.559 -1.134 . . . . 72.5 110.469 177.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -65.82 -40.21 17.63 Favored 'Trans proline' 0 C--N 1.378 2.12 0 C-N-CA 123.274 2.649 . . . . 61.14 113.551 -171.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -97.55 -18.44 18.97 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.59 0.756 . . . . 32.1 111.454 -177.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 175.67 148.51 6.89 Favored Glycine 0 C--N 1.341 0.847 0 N-CA-C 110.76 -0.936 . . . . 71.34 110.76 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.439 HH21 ' HD3' ' A' ' 238' ' ' LYS . 21.0 mtm180 -90.12 170.53 10.24 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 117.18 0.49 . . . . 75.43 110.425 -176.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -78.27 -153.6 6.73 Favored Glycine 0 C--N 1.343 0.954 0 CA-C-N 115.862 -0.608 . . . . 64.41 112.19 173.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . 0.485 ' O ' ' HA ' ' A' ' 192' ' ' ASP . 4.6 p30 -122.92 155.78 36.03 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 117.617 0.708 . . . . 73.21 110.849 176.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 55.2 tp -121.76 108.41 13.48 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 108.907 -0.775 . . . . 74.41 108.907 174.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 42.7 t80 -90.45 108.69 19.94 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 115.099 -0.955 . . . . 74.12 110.105 -175.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 62.9 mt -105.91 121.93 45.09 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.721 0.808 . . . . 62.42 110.517 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -84.16 110.63 18.66 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 122.935 0.494 . . . . 71.43 109.795 172.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 57.6 t -64.84 119.27 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 123.83 0.852 . . . . 52.52 111.763 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 21.7 mmt180 -119.66 117.78 29.21 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 108.011 -1.107 . . . . 55.5 108.011 171.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 17.5 mt -75.53 117.38 19.84 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 N-CA-C 109.037 -0.727 . . . . 54.1 109.037 175.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 27.2 m . . . . . 0 C--O 1.25 1.115 0 C-N-CA 124.931 1.292 . . . . 74.44 108.848 -175.57 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 35.7 t70 . . . . . 0 N--CA 1.477 0.894 0 CA-C-O 121.398 0.618 . . . . 74.1 110.256 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.49 HG12 ' HG3' ' A' ' 232' ' ' LYS . 13.9 m -91.71 162.41 2.42 Favored 'Isoleucine or valine' 0 C--O 1.244 0.782 0 CA-C-N 115.043 -0.98 . . . . 75.3 109.377 173.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 16.7 tt -79.38 135.35 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 N-CA-C 107.694 -1.225 . . . . 74.13 107.694 166.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -70.92 142.89 51.08 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.365 0.666 . . . . 74.22 110.737 -172.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.442 ' HB2' HD22 ' A' ' 233' ' ' LEU . . . -149.17 162.14 40.58 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.418 0.687 . . . . 71.04 110.127 -178.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -136.51 156.63 48.32 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 123.795 0.838 . . . . 74.43 110.024 -177.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.494 ' H ' ' HD3' ' A' ' 238' ' ' LYS . 7.3 p90 -150.3 171.92 16.19 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.084 0.553 . . . . 53.33 111.486 167.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . 0.43 ' HE2' ' HD2' ' A' ' 177' ' ' PRO . 12.6 mmmm -137.79 140.41 29.57 Favored Pre-proline 0 C--O 1.241 0.629 0 C-N-CA 124.291 1.036 . . . . 72.42 108.564 173.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . 0.552 ' HA ' HG12 ' A' ' 219' ' ' VAL . 18.2 Cg_endo -61.29 109.05 0.66 Allowed 'Trans proline' 0 C--N 1.368 1.553 0 C-N-CA 122.486 2.124 . . . . 61.14 111.104 172.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . 0.551 ' HB2' ' HG3' ' A' ' 220' ' ' GLU . . . . . . . . 0 N--CA 1.475 0.795 0 C-N-CA 123.711 0.804 . . . . 60.12 110.691 177.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.449 ' HA ' ' HB2' ' A' ' 240' ' ' PHE . 91.5 mm-40 . . . . . 0 C--O 1.248 1.013 0 CA-C-O 120.929 0.395 . . . . 64.34 110.848 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -82.74 120.87 26.15 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.113 -0.949 . . . . 73.31 110.012 175.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 81.3 mt -110.49 147.8 33.38 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.916 0.886 . . . . 74.33 108.697 171.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -130.08 122.77 28.97 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.543 0.737 . . . . 74.02 109.664 -177.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.409 ' O ' ' HA ' ' A' ' 251' ' ' LEU . . . -160.68 169.9 21.9 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.584 0.754 . . . . 74.05 110.27 -178.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . 0.551 HG22 ' HB2' ' A' ' 252' ' ' GLU . 8.9 p -101.83 145.84 28.63 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.365 0.666 . . . . 75.12 109.783 174.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.575 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . 51.8 tp -113.75 113.72 25.35 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.276 1.031 . . . . 72.44 110.09 -174.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -75.51 101.81 5.0 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 109.557 -0.534 . . . . 71.31 109.557 173.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.522 ' HA ' HG11 ' A' ' 210' ' ' VAL . 44.7 t -104.92 118.84 55.19 Favored Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 108.404 -0.961 . . . . 75.33 108.404 174.131 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -55.23 140.28 81.29 Favored 'Trans proline' 0 C--N 1.372 1.799 0 C-N-CA 122.727 2.285 . . . . 65.25 111.514 169.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -51.75 -47.87 89.05 Favored Pre-proline 0 CA--C 1.559 1.308 0 N-CA-C 114.432 1.271 . . . . 74.22 114.432 -175.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . 0.441 ' O ' HG12 ' A' ' 206' ' ' VAL . 16.3 Cg_endo -55.93 -45.43 38.73 Favored 'Trans proline' 0 C--N 1.385 2.469 0 C-N-CA 122.218 1.945 . . . . 53.22 112.743 174.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 47.5 mt -65.83 -31.07 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 123.714 0.806 . . . . 63.43 110.902 -178.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . 0.419 ' HB1' ' O ' ' A' ' 227' ' ' THR . . . -70.91 -40.21 72.28 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.29 0.636 . . . . 73.43 111.415 177.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 64.8 t -72.47 -54.98 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 123.858 0.863 . . . . 73.31 111.512 -177.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.441 HG12 ' O ' ' A' ' 202' ' ' PRO . 8.3 p -86.97 -16.73 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 C-N-CA 122.492 0.317 . . . . 71.35 111.831 -174.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 83.02 162.18 32.03 Favored Glycine 0 C--N 1.349 1.251 0 N-CA-C 111.234 -0.746 . . . . 74.11 111.234 -173.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 161.47 -134.12 3.42 Favored Glycine 0 N--CA 1.464 0.533 0 CA-C-N 117.429 0.615 . . . . 73.45 112.326 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.452 ' HD3' ' HB3' ' A' ' 220' ' ' GLU . 92.8 mttt -134.69 144.83 48.01 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.875 0.87 . . . . 71.41 109.963 175.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.522 HG11 ' HA ' ' A' ' 199' ' ' VAL . 22.3 m -129.29 144.61 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 N-CA-C 108.451 -0.944 . . . . 74.02 108.451 168.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 36.3 ttp180 -86.63 110.91 20.16 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 109.612 -0.514 . . . . 73.31 109.612 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -101.89 151.71 21.77 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.176 0.591 . . . . 53.14 110.203 179.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -98.29 117.94 33.82 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 123.078 0.551 . . . . 75.33 109.724 178.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 43.6 p -111.84 179.02 4.13 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.387 0.675 . . . . 73.12 109.417 171.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . 0.415 HD12 ' HE1' ' A' ' 240' ' ' PHE . 20.7 mt -81.81 -7.49 59.61 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.075 0.55 . . . . 73.42 112.102 -173.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -98.9 -19.83 17.14 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.335 1.054 . . . . 75.03 110.859 178.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 144.36 -165.69 27.4 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-N 115.911 -0.586 . . . . 64.42 111.842 -177.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -74.78 147.45 34.99 Favored 'Trans proline' 0 C--N 1.367 1.501 0 C-N-CA 122.935 2.423 . . . . 74.51 112.224 176.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.552 HG12 ' HA ' ' A' ' 177' ' ' PRO . 14.1 m -135.56 157.15 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 123.762 0.825 . . . . 74.13 109.524 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.551 ' HG3' ' HB2' ' A' ' 178' ' ' ALA . 51.9 mt-10 -108.06 106.19 16.3 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 109.349 -0.612 . . . . 71.35 109.349 176.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 56.1 t -92.96 112.21 25.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 109.19 -0.67 . . . . 71.23 109.19 -177.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -65.06 101.09 0.48 Allowed 'General case' 0 CA--C 1.539 0.545 0 O-C-N 123.999 0.812 . . . . 72.34 109.436 173.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 64.7 t -73.46 127.39 88.93 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-N 115.018 -0.992 . . . . 75.12 109.231 174.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.94 157.57 57.73 Favored 'Trans proline' 0 CA--C 1.559 1.75 0 C-N-CA 121.491 1.461 . . . . 73.44 110.824 171.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -70.05 164.28 35.42 Favored 'Trans proline' 0 C--N 1.366 1.455 0 C-N-CA 122.064 1.843 . . . . 72.12 111.942 176.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 75.7 mtm180 59.32 25.8 14.53 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 124.834 1.254 . . . . 73.12 112.146 174.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.544 HG23 ' HD2' ' A' ' 231' ' ' ARG . 96.7 m -90.85 99.6 12.61 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.943 0.897 . . . . 75.44 110.064 -176.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 19.7 mp0 -84.76 166.78 16.69 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 121.318 0.58 . . . . 60.12 111.542 -176.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . 0.532 ' HB2' ' HB ' ' A' ' 255' ' ' ILE . . . -66.98 124.2 22.36 Favored 'General case' 0 C--N 1.346 0.455 0 CA-C-N 114.549 -1.205 . . . . 62.3 109.699 177.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 114.05 -12.46 22.16 Favored Glycine 0 C--N 1.335 0.518 0 CA-C-O 119.401 -0.666 . . . . 74.32 112.645 -174.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.544 ' HD2' HG23 ' A' ' 227' ' ' THR . 42.6 mtt180 -71.62 162.88 28.75 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.738 0.78 . . . . 72.05 111.459 172.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.49 ' HG3' HG12 ' A' ' 170' ' ' VAL . 20.4 pttm -129.04 136.23 50.0 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.84 1.256 . . . . 72.5 109.294 -178.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.442 HD22 ' HB2' ' A' ' 173' ' ' ALA . 96.1 mt -116.83 113.95 23.24 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.011 0.924 . . . . 60.32 108.749 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . 0.448 ' H ' HG21 ' A' ' 170' ' ' VAL . 19.9 ttt180 -96.45 101.02 12.58 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 107.381 -1.34 . . . . 73.41 107.381 170.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.437 HD13 ' CD1' ' A' ' 175' ' ' TYR . 22.2 mt -78.86 84.26 4.92 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 114.714 -1.13 . . . . 73.02 107.992 178.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 10.2 mtmp? -72.38 123.81 23.84 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 113.752 -1.567 . . . . 63.41 111.093 -172.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 67.28 32.05 78.77 Favored Glycine 0 C--N 1.346 1.133 0 O-C-N 123.733 0.646 . . . . 73.12 112.391 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.494 ' HD3' ' H ' ' A' ' 175' ' ' TYR . 10.3 mmpt? -125.3 -31.58 3.03 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.313 1.045 . . . . 73.04 112.248 -174.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -59.22 -112.09 0.01 OUTLIER Glycine 0 C--N 1.357 1.704 0 N-CA-C 116.092 1.197 . . . . 55.13 116.092 -168.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . 0.449 ' HB2' ' HA ' ' A' ' 191' ' ' GLN . 0.2 OUTLIER -71.54 136.16 83.62 Favored Pre-proline 0 N--CA 1.485 1.278 0 CA-C-N 117.393 0.596 . . . . 75.34 110.334 -178.805 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.58 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 13.7 Cg_exo -67.48 127.07 15.83 Favored 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.409 2.073 . . . . 73.02 111.981 -179.079 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -137.23 145.05 16.75 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-O 118.963 -0.91 . . . . 72.11 111.447 -179.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.6 -32.65 30.51 Favored 'Trans proline' 0 C--N 1.374 1.89 0 C-N-CA 123.215 2.61 . . . . 62.2 113.627 -174.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -91.96 -18.94 22.98 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.143 0.577 . . . . 74.41 110.935 178.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 163.26 151.87 6.6 Favored Glycine 0 C--N 1.343 0.948 0 N-CA-C 111.521 -0.631 . . . . 54.11 111.521 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.58 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 37.2 mtt-85 -78.52 164.05 25.04 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.371 0.669 . . . . 70.41 111.195 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . 0.407 ' HA3' ' HB3' ' A' ' 191' ' ' GLN . . . -83.17 -154.72 17.39 Favored Glycine 0 C--N 1.342 0.879 0 CA-C-N 115.249 -0.887 . . . . 74.22 113.078 178.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -119.25 127.02 52.86 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 117.122 0.461 . . . . 40.25 110.011 177.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.501 ' HG ' ' HG ' ' A' ' 251' ' ' LEU . 60.6 tp -100.22 108.01 20.0 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 107.547 -1.279 . . . . 73.43 107.547 170.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . 0.442 ' OH ' ' HD2' ' A' ' 232' ' ' LYS . 23.0 t80 -97.14 108.18 20.85 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.754 -0.832 . . . . 74.43 108.754 -175.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.575 ' HB3' ' HB2' ' A' ' 197' ' ' LEU . 55.3 mt -115.7 120.42 39.29 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.931 0.892 . . . . 74.21 110.894 -173.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . 0.551 ' HB2' HG22 ' A' ' 196' ' ' THR . 3.6 mp0 -84.76 115.13 22.54 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.15 0.58 . . . . 74.44 109.93 175.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.512 HG11 HG22 ' A' ' 227' ' ' THR . 61.5 t -65.84 109.05 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 C-N-CA 123.497 0.719 . . . . 73.33 111.744 -176.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -104.77 107.99 19.24 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.891 1.277 . . . . 74.4 108.322 171.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.532 ' HB ' ' HB2' ' A' ' 229' ' ' ALA . 16.2 mt -75.69 132.77 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 122.907 0.483 . . . . 73.31 109.782 177.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 20.7 p . . . . . 0 CA--C 1.557 1.226 0 C-N-CA 124.435 1.094 . . . . 64.31 108.924 -177.885 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 32.9 t70 . . . . . 0 N--CA 1.478 0.966 0 CA-C-O 120.627 0.251 . . . . 62.12 110.873 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.441 HG12 ' HG3' ' A' ' 232' ' ' LYS . 31.9 m -108.97 168.64 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 123.37 0.668 . . . . 73.44 110.688 177.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 10.4 tt -89.3 150.32 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.976 0 N-CA-C 108.489 -0.93 . . . . 53.15 108.489 167.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -58.07 142.36 47.16 Favored 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 124.75 1.22 . . . . 72.01 111.888 178.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -164.76 149.43 9.43 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.317 1.447 . . . . 62.42 108.394 176.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -146.43 154.85 42.08 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 123.346 0.658 . . . . 73.34 109.825 175.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.423 ' CD1' HD13 ' A' ' 235' ' ' LEU . 44.4 p90 -118.17 177.34 4.83 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.249 0.62 . . . . 73.45 111.052 -177.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -145.32 145.79 27.8 Favored Pre-proline 0 N--CA 1.472 0.667 0 CA-C-N 114.325 -1.307 . . . . 73.13 108.569 168.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . 0.461 ' HA ' HG12 ' A' ' 219' ' ' VAL . 20.9 Cg_endo -59.26 127.53 24.31 Favored 'Trans proline' 0 C--N 1.376 2.023 0 C-N-CA 122.747 2.298 . . . . 75.1 111.545 174.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.164 0 C-N-CA 124.133 0.973 . . . . 74.44 111.489 -178.704 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 . . . . . 0 C--O 1.24 0.58 0 CA-C-O 120.838 0.352 . . . . 74.53 110.387 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -91.16 127.5 36.61 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.81 0.844 . . . . 65.22 109.599 -176.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 76.8 mt -109.6 146.9 33.95 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.279 1.032 . . . . 64.21 108.978 177.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -128.02 123.29 34.32 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 108.22 -1.03 . . . . 74.31 108.22 177.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -152.28 162.0 41.78 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.768 0.827 . . . . 43.14 110.329 -178.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . 0.511 HG22 ' HE ' ' A' ' 254' ' ' ARG . 13.0 p -85.35 149.61 25.33 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.896 0.878 . . . . 71.44 110.691 174.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.582 HD13 HD13 ' A' ' 251' ' ' LEU . 43.7 tp -115.29 114.47 25.22 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.928 0.891 . . . . 70.14 109.017 179.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -88.83 101.2 13.8 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.254 0.622 . . . . 73.42 109.873 -177.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.566 ' HA ' HG11 ' A' ' 210' ' ' VAL . 7.4 p -118.39 123.12 29.54 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 123.784 0.834 . . . . 71.1 110.299 -177.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -57.73 146.3 85.98 Favored 'Trans proline' 0 C--N 1.372 1.796 0 C-N-CA 122.694 2.263 . . . . 63.24 112.311 168.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -51.77 -46.91 91.69 Favored Pre-proline 0 CA--C 1.559 1.319 0 N-CA-C 113.725 1.009 . . . . 64.31 113.725 179.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . 0.418 ' O ' HG22 ' A' ' 206' ' ' VAL . 11.3 Cg_endo -53.6 -48.75 20.18 Favored 'Trans proline' 0 C--N 1.398 3.159 0 C-N-CA 122.327 2.018 . . . . 62.3 112.995 173.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 31.4 mt -66.36 -31.3 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 123.778 0.831 . . . . 74.11 111.359 -177.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.52 -41.23 76.29 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 122.708 0.403 . . . . 73.45 111.515 178.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 84.8 t -72.87 -51.41 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 122.96 0.504 . . . . 63.53 111.433 -178.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.418 HG22 ' O ' ' A' ' 202' ' ' PRO . 19.3 m -85.73 -20.15 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 N-CA-C 112.497 0.554 . . . . 75.24 112.497 -174.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 90.98 162.65 38.34 Favored Glycine 0 N--CA 1.476 1.323 0 N-CA-C 111.249 -0.74 . . . . 63.11 111.249 -171.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 161.92 -147.93 14.75 Favored Glycine 0 N--CA 1.467 0.722 0 CA-C-N 117.635 0.718 . . . . 63.54 111.918 178.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 33.2 mtmm -133.13 139.52 47.13 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.239 0.616 . . . . 62.24 109.759 175.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.566 HG11 ' HA ' ' A' ' 199' ' ' VAL . 27.1 m -135.83 144.85 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 123.649 0.78 . . . . 73.42 109.404 175.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 25.1 ttm180 -85.8 116.42 24.04 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 123.196 0.598 . . . . 74.22 111.227 -171.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -102.81 164.66 11.5 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.564 1.146 . . . . 61.4 110.158 173.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -105.4 123.19 47.46 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.896 0.878 . . . . 71.35 110.183 -178.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 81.1 p -124.52 177.94 5.66 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.131 0.973 . . . . 72.01 109.936 175.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 14.7 mt -78.9 -9.7 59.57 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.058 0.543 . . . . 72.43 111.739 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -94.34 -18.65 21.39 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.699 0.8 . . . . 73.02 110.569 176.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 137.64 -164.21 25.45 Favored Glycine 0 C--N 1.349 1.292 0 CA-C-N 116.057 -0.52 . . . . 45.5 112.174 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -74.1 134.05 18.9 Favored 'Trans proline' 0 C--N 1.365 1.43 0 C-N-CA 122.439 2.093 . . . . 71.34 111.304 171.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.461 HG12 ' HA ' ' A' ' 177' ' ' PRO . 33.2 m -133.42 132.68 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 123.782 0.833 . . . . 75.31 109.071 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -91.72 116.47 28.91 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 122.028 -0.42 . . . . 73.11 110.014 179.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 36.9 t -96.54 127.22 48.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 C-N-CA 124.961 1.304 . . . . 73.02 109.995 -173.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -69.22 99.69 1.19 Allowed 'General case' 0 CA--C 1.54 0.589 0 O-C-N 123.959 0.787 . . . . 64.01 109.92 175.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 58.9 t -72.63 121.75 85.72 Favored Pre-proline 0 C--O 1.239 0.551 0 C-N-CA 124.583 1.153 . . . . 73.41 108.917 174.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -61.12 152.43 71.67 Favored 'Trans proline' 0 C--N 1.375 1.93 0 C-N-CA 122.297 1.998 . . . . 62.14 111.474 172.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_exo -64.57 157.4 55.53 Favored 'Trans proline' 0 C--N 1.37 1.66 0 C-N-CA 122.255 1.97 . . . . 63.2 111.87 171.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 62.41 33.42 16.26 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.925 1.29 . . . . 64.42 110.894 174.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.498 HG23 ' HD2' ' A' ' 231' ' ' ARG . 21.1 m -88.52 126.32 35.2 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.917 0.887 . . . . 73.42 110.477 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 -94.2 163.73 13.33 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.218 1.007 . . . . 72.2 111.361 -176.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -69.14 114.76 7.7 Favored 'General case' 0 C--N 1.348 0.528 0 CA-C-N 115.029 -0.987 . . . . 70.51 109.289 173.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 105.38 4.6 40.59 Favored Glycine 0 C--N 1.338 0.648 0 O-C-N 123.756 0.66 . . . . 63.22 112.799 -179.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.498 ' HD2' HG23 ' A' ' 227' ' ' THR . 28.3 mtt180 -63.68 152.9 37.81 Favored 'General case' 0 C--N 1.359 0.989 0 CA-C-N 117.404 0.602 . . . . 74.1 110.466 171.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.441 ' HG3' HG12 ' A' ' 170' ' ' VAL . 20.8 pttm -115.63 130.52 56.89 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 123.575 0.75 . . . . 65.32 109.877 -179.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 89.1 mt -120.44 132.67 55.33 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 107.766 -1.198 . . . . 63.32 107.766 176.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . 0.413 ' H ' HG21 ' A' ' 170' ' ' VAL . 35.5 ttm-85 -121.92 106.89 11.65 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 108.149 -1.056 . . . . 73.13 108.149 170.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.423 HD13 ' CD1' ' A' ' 175' ' ' TYR . 15.4 mt -76.06 82.57 2.91 Favored 'General case' 0 C--O 1.243 0.715 0 N-CA-C 107.375 -1.342 . . . . 51.41 107.375 174.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -71.28 133.04 45.77 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-N 115.318 -0.855 . . . . 72.4 110.746 -173.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 65.14 26.3 71.44 Favored Glycine 0 C--N 1.345 1.029 0 O-C-N 124.083 0.864 . . . . 61.11 112.563 -177.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -142.82 36.93 1.43 Allowed 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 124.008 0.923 . . . . 75.35 111.11 -177.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -100.97 -111.66 3.43 Favored Glycine 0 N--CA 1.478 1.498 0 CA-C-O 119.579 -0.567 . . . . 45.23 112.26 175.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -62.92 133.89 95.46 Favored Pre-proline 0 N--CA 1.487 1.411 0 CA-C-O 118.178 -0.915 . . . . 71.23 110.557 173.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -62.45 130.41 29.98 Favored 'Trans proline' 0 C--N 1.38 2.233 0 C-N-CA 123.119 2.546 . . . . 70.44 112.159 178.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -166.02 124.27 1.22 Allowed Glycine 0 CA--C 1.533 1.184 0 CA-C-O 118.71 -1.05 . . . . 61.41 111.42 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -68.68 -26.95 32.65 Favored 'Trans proline' 0 C--N 1.382 2.337 0 C-N-CA 123.528 2.819 . . . . 63.52 113.273 -176.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -80.97 -25.64 37.19 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.356 0.662 . . . . 71.0 111.083 178.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 161.79 117.78 0.44 Allowed Glycine 0 C--N 1.342 0.906 0 N-CA-C 111.232 -0.747 . . . . 70.52 111.232 -178.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 29.8 mtt-85 -69.58 164.99 22.04 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.668 0.787 . . . . 75.41 110.518 176.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -80.09 -158.21 16.1 Favored Glycine 0 N--CA 1.472 1.038 0 CA-C-N 115.886 -0.597 . . . . 74.32 112.387 172.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -115.39 153.57 30.8 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 108.998 -0.742 . . . . 75.51 108.998 173.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 46.7 tp -123.42 107.63 11.81 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 108.124 -1.065 . . . . 63.05 108.124 171.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 24.6 t80 -96.67 107.74 20.24 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 115.331 -0.85 . . . . 71.15 108.978 -172.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.582 HD13 HD13 ' A' ' 197' ' ' LEU . 76.5 mt -103.96 120.65 41.48 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 123.77 0.828 . . . . 73.02 110.639 -176.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -89.6 103.51 16.15 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.093 0.957 . . . . 73.45 108.448 177.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.479 HG11 HG22 ' A' ' 227' ' ' THR . 72.6 t -58.1 116.68 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 123.69 0.796 . . . . 73.51 111.179 -179.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . 0.511 ' HE ' HG22 ' A' ' 196' ' ' THR . 20.4 mmt180 -117.07 107.27 14.31 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 107.801 -1.185 . . . . 72.32 107.801 173.019 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 40.6 mt -75.95 135.47 26.9 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.929 0 N-CA-C 109.464 -0.569 . . . . 64.22 109.464 175.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 14.5 t . . . . . 0 C--O 1.26 1.607 0 C-N-CA 124.673 1.189 . . . . 62.41 109.718 -176.568 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . 0.402 ' O ' ' HE2' ' A' ' 232' ' ' LYS . 28.1 t70 . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 121.132 0.492 . . . . 65.41 110.038 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.6 HG21 ' HB3' ' A' ' 234' ' ' ARG . 33.2 m -106.93 162.15 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 CA-C-N 115.146 -0.934 . . . . 74.44 109.232 172.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 10.0 tt -83.38 147.8 5.56 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.08 0 N-CA-C 109.781 -0.451 . . . . 75.35 109.781 175.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -62.69 139.94 58.68 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.383 1.073 . . . . 72.42 111.941 -178.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.512 ' HB2' HD22 ' A' ' 233' ' ' LEU . . . -156.78 166.56 33.03 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 114.833 -1.076 . . . . 54.25 109.853 178.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -154.53 158.78 40.36 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 124.882 1.273 . . . . 73.3 108.268 173.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.646 ' HE1' ' HB3' ' A' ' 238' ' ' LYS . 45.6 p90 -118.52 -177.49 3.31 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 122.753 0.421 . . . . 63.31 110.102 173.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -144.21 129.27 9.5 Favored Pre-proline 0 N--CA 1.475 0.796 0 N-CA-C 107.61 -1.256 . . . . 64.52 107.61 170.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . 0.49 ' HA ' HG12 ' A' ' 219' ' ' VAL . 32.7 Cg_endo -62.81 111.63 1.42 Allowed 'Trans proline' 0 C--N 1.371 1.731 0 C-N-CA 122.823 2.349 . . . . 54.51 111.094 -179.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.068 0 C-N-CA 123.77 0.828 . . . . 55.44 111.179 -177.848 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 . . . . . 0 CA--C 1.544 0.713 0 N-CA-C 108.312 -0.996 . . . . 64.42 108.312 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.401 ' HA ' ' O ' ' A' ' 248' ' ' ASP . 21.3 t70 -98.98 155.56 17.36 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.143 0.977 . . . . 62.32 110.326 -177.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 48.0 mt -142.53 134.77 27.54 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.599 1.16 . . . . 63.12 109.128 169.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -106.5 122.44 46.3 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 108.479 -0.934 . . . . 75.42 108.479 171.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.463 ' O ' ' HA ' ' A' ' 251' ' ' LEU . . . -145.96 140.52 26.96 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 109.388 -0.597 . . . . 55.33 109.388 178.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 9.4 p -81.33 137.53 35.74 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 109.459 -0.571 . . . . 72.31 109.459 173.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.421 HD11 HG23 ' A' ' 210' ' ' VAL . 51.4 tp -106.76 111.5 24.05 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 108.39 -0.966 . . . . 73.51 108.39 -176.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -81.86 99.47 9.05 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 108.678 -0.86 . . . . 74.34 108.678 178.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.479 ' HA ' HG11 ' A' ' 210' ' ' VAL . 3.2 p -106.34 116.89 58.5 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 123.713 0.805 . . . . 52.23 109.321 178.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -54.94 140.05 79.18 Favored 'Trans proline' 0 C--N 1.367 1.534 0 C-N-CA 122.422 2.082 . . . . 73.42 112.206 172.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.409 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -49.04 -44.92 73.92 Favored Pre-proline 0 CA--C 1.559 1.311 0 N-CA-C 114.184 1.179 . . . . 55.54 114.184 179.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . 0.409 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 18.6 Cg_endo -57.4 -48.72 16.2 Favored 'Trans proline' 0 C--N 1.388 2.628 0 C-N-CA 121.838 1.692 . . . . 54.43 112.764 174.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 53.3 mt -65.79 -31.63 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 C-N-CA 123.781 0.833 . . . . 75.02 111.074 -178.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -64.1 -52.09 60.86 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.287 0.635 . . . . 74.1 110.746 177.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 91.8 t -67.63 -51.96 45.77 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-N 115.567 -0.742 . . . . 75.12 111.385 -176.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 15.5 m -79.68 -22.74 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 112.591 0.589 . . . . 74.02 112.591 -174.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 82.1 154.39 13.66 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 112.126 -0.39 . . . . 75.03 112.126 -171.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 164.58 -135.16 3.62 Favored Glycine 0 C--N 1.337 0.629 0 N-CA-C 111.74 -0.544 . . . . 51.52 111.74 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 9.4 mtmp? -133.87 153.19 51.92 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 124.12 0.968 . . . . 62.24 109.247 173.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.479 HG11 ' HA ' ' A' ' 199' ' ' VAL . 15.6 m -134.8 141.03 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 124.106 0.962 . . . . 40.21 108.817 172.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -81.7 114.16 20.17 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.175 0.59 . . . . 74.12 109.705 -177.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -106.51 154.83 20.29 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.583 1.153 . . . . 74.34 110.351 178.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.71 126.03 52.55 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.461 0.704 . . . . 50.21 109.9 173.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 65.2 p -126.62 -178.72 4.47 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.354 1.062 . . . . 62.41 109.539 177.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 10.3 mt -73.12 -20.42 60.94 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-O 120.721 0.296 . . . . 71.44 110.602 176.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -78.67 -19.78 51.73 Favored 'General case' 0 CA--C 1.561 1.376 0 C-N-CA 124.05 0.94 . . . . 72.54 110.827 173.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 120.05 -158.06 15.46 Favored Glycine 0 C--N 1.35 1.327 0 CA-C-O 119.614 -0.548 . . . . 55.52 112.294 178.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.78 126.87 11.75 Favored 'Trans proline' 0 C--N 1.369 1.649 0 C-N-CA 122.275 1.983 . . . . 63.31 111.294 178.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.49 HG12 ' HA ' ' A' ' 177' ' ' PRO . 28.7 m -136.72 128.02 42.38 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.977 0 C-N-CA 123.879 0.872 . . . . 72.43 109.325 178.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -85.01 113.45 21.45 Favored 'General case' 0 N--CA 1.482 1.128 0 O-C-N 121.972 -0.455 . . . . 73.13 110.405 177.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.506 ' HA ' ' HA ' ' A' ' 175' ' ' TYR . 58.7 t -93.51 120.77 43.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 C-N-CA 123.267 0.627 . . . . 71.4 109.648 -177.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -63.57 101.51 0.35 Allowed 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.054 0.942 . . . . 75.4 110.566 176.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 62.5 t -70.03 121.04 81.65 Favored Pre-proline 0 CA--C 1.544 0.74 0 CA-C-N 114.663 -1.153 . . . . 65.13 108.79 172.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -63.92 157.52 52.17 Favored 'Trans proline' 0 CA--C 1.571 2.338 0 C-N-CA 122.029 1.819 . . . . 51.55 111.674 174.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -66.79 127.0 16.24 Favored 'Trans proline' 0 C--N 1.368 1.579 0 C-N-CA 122.868 2.378 . . . . 71.5 112.243 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 38.5 mtm180 64.61 79.21 0.26 Allowed 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.984 1.314 . . . . 74.12 110.459 -175.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.557 HG22 HG11 ' A' ' 253' ' ' VAL . 99.3 m -117.12 106.81 13.75 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.11 0.964 . . . . 74.32 109.006 177.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -88.54 153.47 21.11 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.838 -0.619 . . . . 65.15 110.787 -173.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -62.9 138.69 58.61 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.108 0.963 . . . . 44.24 111.115 -178.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 89.94 10.66 64.4 Favored Glycine 0 C--N 1.338 0.646 0 CA-C-N 115.713 -0.676 . . . . 71.34 112.689 -174.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.486 ' HD2' HG23 ' A' ' 227' ' ' THR . 78.0 mtt180 -78.15 162.49 26.59 Favored 'General case' 0 C--O 1.244 0.778 0 CA-C-O 121.591 0.71 . . . . 73.11 110.429 169.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.402 ' HE2' ' O ' ' A' ' 169' ' ' ASP . 19.6 pttm -127.52 129.11 46.8 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 114.739 -1.119 . . . . 70.44 109.869 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.512 HD22 ' HB2' ' A' ' 173' ' ' ALA . 66.2 mt -110.45 134.09 52.67 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 107.517 -1.29 . . . . 72.15 107.517 172.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . 0.6 ' HB3' HG21 ' A' ' 170' ' ' VAL . 42.3 ttm105 -123.28 98.95 6.1 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 107.044 -1.465 . . . . 71.21 107.044 167.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.517 ' HB3' ' HB2' ' A' ' 238' ' ' LYS . 65.8 mt -74.43 82.93 1.95 Allowed 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 114.213 -1.358 . . . . 53.12 108.526 177.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -75.8 137.68 40.68 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 122.664 0.386 . . . . 71.25 110.434 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 69.86 24.48 76.37 Favored Glycine 0 C--N 1.339 0.724 0 O-C-N 124.066 0.854 . . . . 64.4 111.973 -175.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.646 ' HB3' ' HE1' ' A' ' 175' ' ' TYR . 73.8 mmtt -138.87 -9.35 1.36 Allowed 'General case' 0 CA--C 1.561 1.37 0 C-N-CA 124.171 0.988 . . . . 72.34 111.88 -170.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -80.8 -120.81 0.46 Allowed Glycine 0 N--CA 1.478 1.494 0 CA-C-O 119.93 -0.372 . . . . 72.53 113.8 -175.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.31 119.02 49.26 Favored Pre-proline 0 N--CA 1.485 1.315 0 CA-C-O 118.472 -0.775 . . . . 72.54 109.251 175.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.744 ' HA ' ' HG3' ' A' ' 246' ' ' ARG . 25.1 Cg_exo -59.45 128.59 27.81 Favored 'Trans proline' 0 C--N 1.38 2.215 0 C-N-CA 122.824 2.349 . . . . 52.41 111.747 -176.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -141.14 123.91 2.42 Favored Glycine 0 CA--C 1.534 1.222 0 CA-C-O 118.798 -1.001 . . . . 65.22 111.641 -176.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -70.76 -15.05 33.35 Favored 'Trans proline' 0 C--N 1.385 2.452 0 C-N-CA 123.09 2.527 . . . . 75.45 113.18 178.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -97.56 -6.45 33.48 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.211 0.604 . . . . 72.15 111.155 173.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 142.77 115.61 1.11 Allowed Glycine 0 C--N 1.344 0.988 0 N-CA-C 111.005 -0.838 . . . . 61.55 111.005 -177.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.744 ' HG3' ' HA ' ' A' ' 241' ' ' PRO . 8.0 ttm180 -65.64 139.85 58.45 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.226 1.011 . . . . 71.13 110.744 176.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -73.17 -155.14 3.03 Favored Glycine 0 C--N 1.347 1.179 0 O-C-N 123.459 0.475 . . . . 61.21 113.501 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . 0.401 ' O ' ' HA ' ' A' ' 192' ' ' ASP . 10.7 p-10 -126.51 132.89 51.29 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 117.738 0.769 . . . . 73.02 112.667 -176.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 51.9 tp -101.24 107.08 18.37 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.14 0.976 . . . . 61.22 108.949 175.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -89.6 108.24 19.55 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.313 0.645 . . . . 63.54 109.604 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.463 ' HA ' ' O ' ' A' ' 195' ' ' ALA . 68.1 mt -101.46 112.11 24.54 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 123.752 0.821 . . . . 73.23 110.597 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -79.77 103.38 9.63 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.589 0.756 . . . . 75.55 109.47 174.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.557 HG11 HG22 ' A' ' 227' ' ' THR . 75.0 t -61.66 114.59 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.306 1.042 . . . . 73.21 111.223 -177.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 67.4 mmt-85 -123.19 112.08 17.26 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.672 1.189 . . . . 74.1 108.565 175.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 48.8 mt -76.48 126.58 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 123.152 0.581 . . . . 75.51 109.91 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 24.0 p . . . . . 0 C--O 1.255 1.394 0 C-N-CA 124.99 1.316 . . . . 71.2 108.411 179.258 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 28.5 t70 . . . . . 0 N--CA 1.469 0.522 0 CA-C-O 121.468 0.651 . . . . 71.02 111.181 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.751 HG21 ' HB3' ' A' ' 234' ' ' ARG . 19.7 m -79.69 174.47 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 CA-C-N 114.587 -1.188 . . . . 53.53 110.218 175.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 14.8 tt -82.72 139.82 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 N-CA-C 108.467 -0.938 . . . . 74.34 108.467 167.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -70.12 93.32 0.8 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.535 0.734 . . . . 75.12 109.37 -179.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.411 ' HB2' HD22 ' A' ' 233' ' ' LEU . . . -98.37 152.23 19.69 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.838 -0.619 . . . . 64.13 110.113 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -140.84 149.28 41.8 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.285 0.634 . . . . 73.12 109.996 175.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.427 ' CD1' HD13 ' A' ' 235' ' ' LEU . 9.5 p90 -122.43 172.11 8.59 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 123.281 0.633 . . . . 72.03 110.554 176.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -138.04 121.88 11.61 Favored Pre-proline 0 N--CA 1.468 0.445 0 N-CA-C 107.268 -1.382 . . . . 72.22 107.268 175.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -64.51 141.41 73.56 Favored 'Trans proline' 0 C--N 1.367 1.544 0 C-N-CA 122.768 2.312 . . . . 70.54 110.801 -175.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.714 0 CA-C-O 121.586 0.708 . . . . 73.25 109.743 -178.167 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.562 ' HA ' ' HB2' ' A' ' 240' ' ' PHE . 10.7 mm100 . . . . . 0 C--O 1.244 0.782 0 CA-C-O 121.128 0.489 . . . . 70.12 110.358 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -86.17 135.64 33.51 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 114.959 -1.019 . . . . 72.11 108.374 172.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 94.6 mt -134.01 155.98 49.02 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.81 0.844 . . . . 75.14 109.817 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -130.08 136.81 49.75 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 108.008 -1.108 . . . . 72.12 108.008 173.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -160.42 171.34 19.23 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.211 0.529 . . . . 64.24 110.917 -177.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 17.6 p -104.83 151.62 23.59 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.6 0.76 . . . . 74.25 109.829 173.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.533 HD11 HG23 ' A' ' 210' ' ' VAL . 47.6 tp -123.13 118.3 27.37 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 123.863 0.865 . . . . 73.13 109.195 -175.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -82.61 100.11 9.96 Favored 'General case' 0 C--O 1.241 0.627 0 C-N-CA 123.329 0.652 . . . . 44.12 109.549 -178.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.533 HG22 HG21 ' A' ' 210' ' ' VAL . 23.6 t -110.06 109.02 59.12 Favored Pre-proline 0 CA--C 1.538 0.509 0 N-CA-C 108.489 -0.93 . . . . 73.24 108.489 176.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -54.2 138.46 71.92 Favored 'Trans proline' 0 C--N 1.377 2.062 0 C-N-CA 122.777 2.318 . . . . 61.41 112.008 172.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -48.41 -47.56 68.44 Favored Pre-proline 0 CA--C 1.564 1.504 0 N-CA-C 113.772 1.027 . . . . 62.04 113.772 -177.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -56.07 -45.52 37.77 Favored 'Trans proline' 0 C--N 1.391 2.785 0 C-N-CA 121.845 1.697 . . . . 61.4 112.775 173.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 45.3 mt -69.93 -27.89 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 123.917 0.887 . . . . 62.23 111.181 -176.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.88 -48.9 64.77 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.075 0.55 . . . . 63.51 110.59 177.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 61.9 t -67.34 -48.42 77.86 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 CA-C-N 115.488 -0.778 . . . . 72.3 111.701 -177.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 11.8 p -75.44 -34.05 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 C-N-CA 122.391 0.277 . . . . 45.35 111.459 -178.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 83.7 141.02 4.47 Favored Glycine 0 C--N 1.344 0.982 0 N-CA-C 112.119 -0.392 . . . . 65.55 112.119 -172.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -178.07 -129.66 1.3 Allowed Glycine 0 C--N 1.34 0.777 0 N-CA-C 111.417 -0.673 . . . . 74.42 111.417 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 60.5 mttm -137.98 144.86 41.34 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.246 0.619 . . . . 64.31 109.771 173.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.533 HG23 HD11 ' A' ' 197' ' ' LEU . 31.1 m -134.87 155.57 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 124.333 1.053 . . . . 63.04 108.506 171.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 35.0 mtm-85 -97.47 126.36 42.7 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 121.015 0.436 . . . . 74.52 111.718 -176.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . 0.53 ' HB2' HD13 ' A' ' 197' ' ' LEU . . . -101.47 133.87 45.44 Favored 'General case' 0 C--O 1.241 0.628 0 C-N-CA 124.687 1.195 . . . . 53.24 109.14 173.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.56 112.77 21.88 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 108.793 -0.817 . . . . 73.44 108.793 175.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 68.3 p -111.39 177.1 4.77 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.393 0.677 . . . . 64.34 109.192 175.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 26.5 mt -62.9 -39.02 93.22 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 122.831 0.453 . . . . 71.22 111.487 -172.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -86.0 -18.22 33.16 Favored 'General case' 0 CA--C 1.551 1.003 0 CA-C-N 115.824 -0.625 . . . . 74.3 111.364 -175.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 153.53 -166.06 31.63 Favored Glycine 0 C--N 1.352 1.444 0 N-CA-C 114.37 0.508 . . . . 74.12 114.37 174.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -77.8 142.9 20.53 Favored 'Trans proline' 0 C--N 1.376 1.988 0 C-N-CA 123.088 2.525 . . . . 62.03 111.858 176.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.406 ' HB ' ' CD2' ' A' ' 175' ' ' TYR . 11.7 m -135.91 140.44 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 N-CA-C 109.237 -0.653 . . . . 64.15 109.237 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -96.96 108.1 20.75 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 122.819 0.448 . . . . 64.01 110.123 -178.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 22.3 t -95.08 135.12 30.12 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 C-N-CA 124.404 1.082 . . . . 62.05 109.815 -175.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -77.38 109.2 11.1 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 123.305 0.642 . . . . 72.23 110.666 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 57.3 t -79.11 117.7 68.37 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 123.681 0.793 . . . . 65.2 109.07 173.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -60.69 158.02 34.72 Favored 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 122.458 2.105 . . . . 74.13 112.371 174.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -71.26 133.45 22.85 Favored 'Trans proline' 0 C--N 1.368 1.582 0 C-N-CA 121.5 1.467 . . . . 65.45 110.563 171.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 67.82 67.21 0.36 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.81 1.244 . . . . 71.04 110.141 -176.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.501 HG22 HG11 ' A' ' 253' ' ' VAL . 72.9 m -103.02 132.89 48.96 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.188 0.995 . . . . 55.22 109.595 176.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -110.7 155.48 22.38 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.632 0.773 . . . . 75.4 110.555 -177.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . 0.507 ' HB2' ' HB ' ' A' ' 255' ' ' ILE . . . -69.22 121.58 17.1 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.981 0.912 . . . . 71.12 110.225 -178.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 111.64 -7.6 28.02 Favored Glycine 0 C--N 1.333 0.398 0 CA-C-O 119.222 -0.765 . . . . 54.52 112.555 -176.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.478 ' HD2' HG23 ' A' ' 227' ' ' THR . 58.7 mtt180 -61.24 145.77 50.12 Favored 'General case' 0 C--N 1.361 1.097 0 CA-C-N 117.326 0.563 . . . . 61.41 109.915 174.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.47 ' HG3' HG12 ' A' ' 170' ' ' VAL . 20.1 pttm -117.06 104.35 11.16 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.282 -0.872 . . . . 72.24 109.215 -175.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.411 HD22 ' HB2' ' A' ' 173' ' ' ALA . 82.8 mt -90.11 97.35 11.14 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 108.723 -0.844 . . . . 64.41 108.723 176.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . 0.751 ' HB3' HG21 ' A' ' 170' ' ' VAL . 64.7 ttt180 -88.07 107.18 18.62 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 108.676 -0.861 . . . . 64.12 108.676 171.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.427 HD13 ' CD1' ' A' ' 175' ' ' TYR . 16.0 mt -77.67 84.23 4.02 Favored 'General case' 0 C--O 1.248 0.989 0 N-CA-C 107.659 -1.237 . . . . 70.53 107.659 174.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 10.5 mtmp? -71.43 118.49 14.31 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 113.835 -1.529 . . . . 73.21 111.988 -169.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 64.14 28.82 73.44 Favored Glycine 0 C--N 1.348 1.212 0 O-C-N 124.044 0.84 . . . . 34.54 112.803 179.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 30.8 mmtp -125.47 -6.92 6.94 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 118.278 -0.868 . . . . 73.41 112.774 -173.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -62.57 -108.17 0.01 OUTLIER Glycine 0 C--N 1.354 1.538 0 O-C-N 123.827 0.704 . . . . 53.32 114.731 -171.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . 0.562 ' HB2' ' HA ' ' A' ' 191' ' ' GLN . 0.1 OUTLIER -75.97 140.02 69.96 Favored Pre-proline 0 N--CA 1.477 0.91 0 CA-C-O 118.574 -0.727 . . . . 70.52 109.811 177.72 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.516 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 53.1 Cg_exo -57.37 149.07 67.63 Favored 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 122.587 2.192 . . . . 72.31 113.293 175.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -164.81 123.58 1.18 Allowed Glycine 0 CA--C 1.538 1.512 0 CA-C-O 118.414 -1.215 . . . . 62.42 111.661 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -57.54 -46.16 29.14 Favored 'Trans proline' 0 C--N 1.386 2.521 0 C-N-CA 123.806 3.004 . . . . 70.25 113.646 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -78.87 -24.13 44.47 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 122.756 0.422 . . . . 72.44 110.81 178.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 168.19 142.0 3.36 Favored Glycine 0 C--N 1.345 1.057 0 CA-C-N 115.782 -0.645 . . . . 75.41 111.798 178.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.516 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 27.3 mtt-85 -73.63 166.54 23.08 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.495 0.718 . . . . 70.14 110.969 178.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -85.23 -156.99 27.35 Favored Glycine 0 C--N 1.336 0.579 0 CA-C-N 115.391 -0.822 . . . . 53.43 111.463 168.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -131.61 157.99 42.19 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 109.077 -0.712 . . . . 74.43 109.077 -176.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 42.4 tp -141.42 112.18 7.15 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 109.652 -0.499 . . . . 51.34 109.652 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -102.77 109.36 20.91 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.759 0.824 . . . . 74.41 109.838 -176.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 65.9 mt -104.92 136.09 45.05 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.727 0.811 . . . . 72.2 110.156 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -97.69 116.56 30.15 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.691 0.796 . . . . 70.51 109.303 170.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.501 HG11 HG22 ' A' ' 227' ' ' THR . 94.1 t -61.33 106.38 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-O 121.506 0.67 . . . . 74.11 110.465 172.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 17.0 mmt85 -104.37 102.49 12.16 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-N 114.67 -1.15 . . . . 74.32 108.065 173.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.507 ' HB ' ' HB2' ' A' ' 229' ' ' ALA . 24.1 mt -76.36 119.0 23.68 Favored 'Isoleucine or valine' 0 C--O 1.245 0.83 0 C-N-CA 122.901 0.481 . . . . 63.35 109.767 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.5 t . . . . . 0 CA--C 1.558 1.288 0 N-CA-C 108.682 -0.858 . . . . 72.31 108.682 175.99 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 32.9 t70 . . . . . 0 N--CA 1.482 1.158 0 CA-C-O 121.638 0.733 . . . . 73.33 110.501 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.62 HG12 ' HG3' ' A' ' 232' ' ' LYS . 27.6 m -111.43 164.57 7.25 Favored 'Isoleucine or valine' 0 C--O 1.243 0.76 0 CA-C-N 114.305 -1.316 . . . . 65.55 109.16 175.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 17.6 tt -89.51 145.71 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 N-CA-C 108.236 -1.024 . . . . 75.0 108.236 168.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -58.75 122.21 12.98 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.671 0.788 . . . . 74.45 110.879 -179.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.454 ' HB2' HD22 ' A' ' 233' ' ' LEU . . . -135.99 154.78 50.97 Favored 'General case' 0 C--O 1.243 0.729 0 C-N-CA 124.5 1.12 . . . . 62.15 108.449 174.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -152.88 151.22 30.13 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.938 0.895 . . . . 71.42 109.404 -178.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.442 ' CD1' HD13 ' A' ' 235' ' ' LEU . 2.6 p90 -130.14 173.93 10.28 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-O 121.39 0.614 . . . . 71.41 111.025 176.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 78.2 mttt -139.23 144.39 40.26 Favored Pre-proline 0 C--O 1.243 0.746 0 CA-C-N 114.692 -1.14 . . . . 73.44 109.203 174.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -55.1 103.9 0.11 Allowed 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 123.279 2.652 . . . . 71.31 112.105 178.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . 0.502 ' HB2' ' HG3' ' A' ' 220' ' ' GLU . . . . . . . . 0 N--CA 1.478 0.948 0 C-N-CA 123.834 0.854 . . . . 74.41 111.345 -178.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 . . . . . 0 N--CA 1.479 1.017 0 N-CA-C 108.745 -0.835 . . . . 75.13 108.745 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -76.79 150.38 36.17 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 114.296 -1.32 . . . . 70.53 110.613 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 36.6 mt -133.92 139.31 46.06 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 124.89 1.276 . . . . 74.13 107.639 171.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -128.21 125.01 38.15 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.204 0.602 . . . . 73.5 109.498 -176.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -161.85 171.51 17.63 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 123.736 0.815 . . . . 45.43 110.756 -175.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 15.6 p -105.89 149.86 26.16 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.633 0.773 . . . . 55.23 109.967 173.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.552 HD13 HD13 ' A' ' 251' ' ' LEU . 51.7 tp -115.01 118.72 34.22 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.999 0.92 . . . . 61.1 109.875 -175.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -83.39 119.62 24.86 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 109.319 -0.623 . . . . 74.31 109.319 175.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.515 ' HA ' HG11 ' A' ' 210' ' ' VAL . 3.5 p -133.7 123.24 17.16 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 123.638 0.775 . . . . 75.24 109.675 178.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -59.02 139.61 91.58 Favored 'Trans proline' 0 C--N 1.375 1.968 0 C-N-CA 122.725 2.283 . . . . 73.14 111.447 171.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.454 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -49.11 -47.58 75.12 Favored Pre-proline 0 CA--C 1.557 1.232 0 CA-C-O 117.792 -1.099 . . . . 64.44 113.022 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -55.93 -45.28 39.81 Favored 'Trans proline' 0 C--N 1.395 2.978 0 C-N-CA 122.206 1.938 . . . . 65.12 113.019 175.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 39.9 mt -65.93 -31.98 56.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 123.458 0.703 . . . . 65.43 111.02 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -71.84 -37.86 70.23 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.269 0.628 . . . . 71.24 111.48 179.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 201' ' ' ALA . 98.9 t -74.54 -53.69 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 123.647 0.779 . . . . 62.22 111.359 -178.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 7.1 p -73.03 -31.03 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 122.627 0.371 . . . . 54.44 111.11 -178.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 84.94 117.43 0.8 Allowed Glycine 0 C--N 1.344 0.979 0 N-CA-C 111.357 -0.697 . . . . 55.33 111.357 -172.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -151.8 -136.88 2.51 Favored Glycine 0 C--N 1.34 0.789 0 N-CA-C 111.564 -0.614 . . . . 74.33 111.564 -178.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 34.3 mtmm -136.95 146.09 45.01 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.003 0.921 . . . . 75.23 109.383 175.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.515 HG11 ' HA ' ' A' ' 199' ' ' VAL . 24.2 m -133.05 142.3 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 123.855 0.862 . . . . 63.51 109.22 172.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . 0.433 ' NH1' ' HB1' ' A' ' 178' ' ' ALA . 24.1 ttm-85 -87.7 110.45 20.44 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 122.817 0.447 . . . . 64.51 110.15 -170.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -101.8 164.47 11.71 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.656 1.182 . . . . 72.21 110.634 -178.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 10.1 mmt -105.92 123.23 47.65 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.862 0.865 . . . . 74.11 110.784 -179.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . 0.467 HG22 HD22 ' A' ' 249' ' ' LEU . 47.5 p -114.63 171.29 7.73 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.304 1.042 . . . . 75.5 109.211 170.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 13.2 mt -72.28 -9.33 58.34 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 112.091 0.404 . . . . 73.13 112.091 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -99.97 -19.45 16.57 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 123.127 0.571 . . . . 63.22 111.772 175.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 143.58 -155.02 25.91 Favored Glycine 0 C--N 1.36 1.901 0 CA-C-O 119.695 -0.503 . . . . 53.33 113.995 174.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -76.64 136.33 17.07 Favored 'Trans proline' 0 C--N 1.379 2.14 0 C-N-CA 123.442 2.761 . . . . 75.2 113.229 178.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.479 ' HA ' ' H ' ' A' ' 178' ' ' ALA . 27.0 m -136.5 145.5 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 124.177 0.991 . . . . 74.44 109.293 177.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.502 ' HG3' ' HB2' ' A' ' 178' ' ' ALA . 37.4 mt-10 -102.3 112.11 24.68 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 109.52 -0.548 . . . . 62.44 109.52 178.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 46.7 t -94.7 118.09 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 124.41 1.084 . . . . 62.52 109.527 -174.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -66.96 102.19 0.94 Allowed 'General case' 0 C--O 1.24 0.561 0 C-N-CA 123.958 0.903 . . . . 71.22 110.427 176.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.458 HG11 HG21 ' A' ' 199' ' ' VAL . 64.6 t -80.24 120.88 80.89 Favored Pre-proline 0 CA--C 1.546 0.801 0 CA-C-N 115.162 -0.926 . . . . 74.53 108.969 174.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -60.6 162.38 18.26 Favored 'Trans proline' 0 CA--C 1.566 2.097 0 C-N-CA 122.904 2.403 . . . . 45.54 113.219 176.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -76.25 135.39 16.78 Favored 'Trans proline' 0 C--N 1.374 1.88 0 C-N-CA 122.622 2.215 . . . . 72.11 112.271 175.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 20.0 mtm180 66.54 57.25 0.71 Allowed 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 125.129 1.371 . . . . 73.54 110.631 -176.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.608 HG22 HG11 ' A' ' 253' ' ' VAL . 60.5 m -106.81 107.34 18.31 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.851 0.86 . . . . 52.33 109.381 178.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 22.5 mp0 -85.7 160.26 19.59 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.297 0.639 . . . . 73.24 111.678 -172.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -70.35 130.18 41.28 Favored 'General case' 0 C--N 1.352 0.682 0 N-CA-C 108.867 -0.79 . . . . 74.54 108.867 175.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 114.47 -19.08 17.16 Favored Glycine 0 N--CA 1.466 0.634 0 CA-C-O 119.636 -0.536 . . . . 71.41 111.897 -173.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.501 ' HD2' HG23 ' A' ' 227' ' ' THR . 81.2 mtt180 -67.19 161.85 23.84 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-O 121.579 0.704 . . . . 74.34 111.877 175.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.62 ' HG3' HG12 ' A' ' 170' ' ' VAL . 19.5 pttm -130.19 142.11 50.6 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.344 1.058 . . . . 60.5 109.42 177.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.454 HD22 ' HB2' ' A' ' 173' ' ' ALA . 75.2 mt -120.61 129.02 53.56 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 107.89 -1.152 . . . . 52.52 107.89 178.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 40.4 ttt180 -113.7 102.14 9.97 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 108.816 -0.809 . . . . 73.21 108.816 171.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.625 ' HB3' ' HB2' ' A' ' 238' ' ' LYS . 21.3 mt -76.19 84.01 3.01 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 114.246 -1.343 . . . . 62.31 108.632 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -72.65 127.37 32.35 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.641 -0.709 . . . . 61.43 110.67 -173.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 69.48 20.52 75.51 Favored Glycine 0 C--N 1.342 0.901 0 O-C-N 123.764 0.665 . . . . 65.54 112.053 -175.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.625 ' HB2' ' HB3' ' A' ' 235' ' ' LEU . 22.3 mmtp -136.37 58.05 1.75 Allowed 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.581 1.152 . . . . 71.41 108.54 -176.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -139.9 -113.48 1.08 Allowed Glycine 0 N--CA 1.472 1.093 0 CA-C-O 119.226 -0.764 . . . . 71.4 111.74 175.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -64.11 146.32 97.54 Favored Pre-proline 0 N--CA 1.484 1.254 0 CA-C-O 118.47 -0.776 . . . . 71.11 110.699 175.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -54.79 160.0 8.23 Favored 'Trans proline' 0 C--N 1.38 2.204 0 C-N-CA 123.488 2.792 . . . . 71.11 112.871 176.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -169.85 136.43 4.0 Favored Glycine 0 CA--C 1.525 0.702 0 CA-C-O 118.742 -1.032 . . . . 52.5 112.024 -178.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -70.23 -41.54 3.6 Favored 'Trans proline' 0 C--N 1.378 2.091 0 C-N-CA 123.184 2.59 . . . . 65.33 113.305 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -102.11 -18.79 15.41 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.702 0.801 . . . . 64.21 111.222 -177.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 175.66 145.68 5.57 Favored Glycine 0 C--N 1.341 0.847 0 N-CA-C 111.262 -0.735 . . . . 72.44 111.262 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 21.1 mtm180 -88.19 165.32 15.15 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.088 0.555 . . . . 74.24 110.589 -176.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -74.14 -168.07 17.54 Favored Glycine 0 C--N 1.35 1.312 0 N-CA-C 111.486 -0.646 . . . . 74.1 111.486 168.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -118.27 151.84 36.89 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 118.406 1.103 . . . . 71.22 111.247 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.467 HD22 HG22 ' A' ' 214' ' ' THR . 35.9 tp -113.75 118.21 33.66 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 108.559 -0.904 . . . . 71.01 108.559 171.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . 0.539 ' OH ' ' HD2' ' A' ' 232' ' ' LYS . 2.7 t80 -96.4 115.9 28.17 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.84 -1.17 . . . . 74.4 107.84 -178.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.552 HD13 HD13 ' A' ' 197' ' ' LEU . 57.6 mt -118.93 117.22 28.23 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.79 0.836 . . . . 70.02 110.38 -177.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -77.32 116.07 17.62 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 108.997 -0.742 . . . . 54.14 108.997 171.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.608 HG11 HG22 ' A' ' 227' ' ' THR . 94.8 t -62.09 104.27 0.3 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.934 0 CA-C-O 121.322 0.582 . . . . 71.04 110.433 176.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 19.6 mmm180 -110.15 106.37 15.79 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 107.952 -1.129 . . . . 62.23 107.952 175.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.447 HD11 ' O ' ' A' ' 227' ' ' THR . 45.0 mt -77.77 143.8 12.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 122.898 0.479 . . . . 73.34 110.483 178.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 4.9 t . . . . . 0 C--O 1.261 1.68 0 C-N-CA 124.48 1.112 . . . . 64.43 108.721 174.739 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 33.1 t70 . . . . . 0 CA--C 1.543 0.692 0 CA-C-O 120.296 0.093 . . . . 63.12 111.082 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 33.0 m -89.82 157.15 3.01 Favored 'Isoleucine or valine' 0 C--O 1.243 0.75 0 C-N-CA 122.835 0.454 . . . . 74.25 110.054 176.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.429 HG21 ' HD3' ' A' ' 231' ' ' ARG . 15.1 tt -83.09 146.73 6.59 Favored 'Isoleucine or valine' 0 C--O 1.249 1.057 0 N-CA-C 108.496 -0.927 . . . . 52.42 108.496 172.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -58.06 136.08 57.1 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.718 0.807 . . . . 70.22 111.52 -176.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.539 ' HB2' HD22 ' A' ' 233' ' ' LEU . . . -158.31 158.18 33.87 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 124.885 1.274 . . . . 74.54 109.337 173.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -164.27 149.42 10.25 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.924 0.89 . . . . 75.54 109.221 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.538 ' HB3' HG22 ' A' ' 221' ' ' VAL . 1.6 p90 -122.39 175.93 6.16 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 121.807 0.813 . . . . 74.43 112.34 177.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -138.22 129.31 15.64 Favored Pre-proline 0 C--O 1.241 0.629 0 CA-C-N 113.639 -1.619 . . . . 73.45 107.575 167.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . 0.434 ' HA ' HG12 ' A' ' 219' ' ' VAL . 35.7 Cg_exo -54.37 128.25 29.29 Favored 'Trans proline' 0 C--N 1.369 1.657 0 C-N-CA 123.486 2.791 . . . . 64.1 111.639 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.927 0 O-C-N 123.737 0.648 . . . . 75.33 110.429 -175.86 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 120.949 0.404 . . . . 74.23 111.145 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -85.59 153.51 22.35 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.574 0.75 . . . . 74.4 109.965 178.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 58.4 mt -131.81 152.93 50.64 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.546 0.738 . . . . 73.21 109.251 176.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -119.18 132.41 55.96 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 108.489 -0.93 . . . . 72.42 108.489 170.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -157.79 164.46 37.01 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.22 0.608 . . . . 53.24 110.022 178.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 99.4 m -96.03 146.67 24.44 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 115.647 -0.706 . . . . 74.23 109.64 175.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.506 HD11 HG23 ' A' ' 210' ' ' VAL . 42.7 tp -113.85 117.87 32.64 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.713 0.805 . . . . 71.2 109.288 175.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -89.26 100.71 13.44 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 123.783 0.833 . . . . 74.44 108.917 175.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.495 ' HA ' HG11 ' A' ' 210' ' ' VAL . 7.1 p -113.04 116.74 46.87 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 123.496 0.718 . . . . 74.52 109.839 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -56.18 145.91 73.91 Favored 'Trans proline' 0 C--N 1.374 1.904 0 C-N-CA 122.839 2.359 . . . . 54.3 112.4 173.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -50.28 -49.48 76.28 Favored Pre-proline 0 CA--C 1.558 1.285 0 O-C-N 124.542 1.151 . . . . 72.5 112.987 -179.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -55.06 -46.71 31.08 Favored 'Trans proline' 0 C--N 1.401 3.315 0 C-N-CA 122.484 2.123 . . . . 72.23 112.735 175.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.522 HG21 HG13 ' A' ' 210' ' ' VAL . 42.1 mt -68.73 -32.54 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 123.664 0.786 . . . . 74.53 110.798 -176.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.59 -44.9 73.37 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.62 0.768 . . . . 52.41 110.459 179.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 95.4 t -64.64 -55.82 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 122.999 0.519 . . . . 64.41 110.602 178.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 17.0 m -69.49 -30.31 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 O-C-N 123.531 0.52 . . . . 75.32 112.171 -173.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 78.3 69.96 1.35 Allowed Glycine 0 C--N 1.348 1.222 0 N-CA-C 111.648 -0.581 . . . . 60.14 111.648 -172.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -104.13 -136.84 9.02 Favored Glycine 0 C--N 1.348 1.247 0 N-CA-C 111.657 -0.577 . . . . 60.44 111.657 -177.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 35.1 mtmm -133.03 137.04 46.33 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.432 0.693 . . . . 74.11 109.31 176.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.522 HG13 HG21 ' A' ' 203' ' ' ILE . 14.9 m -127.9 142.32 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 123.645 0.778 . . . . 63.54 109.731 174.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 61.5 ttp180 -83.68 117.12 23.0 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 116.13 -0.486 . . . . 53.2 110.049 -178.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -100.79 156.72 17.19 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.685 0.794 . . . . 72.25 109.194 174.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 76.1 mmm -107.18 121.29 44.23 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 122.729 0.412 . . . . 54.3 110.159 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 36.2 p -108.86 173.51 6.29 Favored 'General case' 0 C--O 1.243 0.726 0 C-N-CA 124.351 1.06 . . . . 61.23 108.62 170.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 13.3 mt -67.4 -24.38 65.66 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 122.625 0.37 . . . . 71.45 111.472 -175.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -87.55 -20.59 26.25 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.431 0.693 . . . . 65.2 111.498 -178.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 149.66 -160.68 28.58 Favored Glycine 0 C--N 1.35 1.318 0 CA-C-O 119.772 -0.46 . . . . 72.23 113.135 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -84.65 147.56 10.94 Favored 'Trans proline' 0 C--N 1.364 1.344 0 C-N-CA 123.061 2.507 . . . . 72.1 112.583 178.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.434 HG12 ' HA ' ' A' ' 177' ' ' PRO . 21.3 m -137.07 147.24 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 108.499 -0.926 . . . . 73.14 108.499 178.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -103.01 108.4 19.56 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 109.044 -0.724 . . . . 72.4 109.044 179.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.538 HG22 ' HB3' ' A' ' 175' ' ' TYR . 49.1 t -94.49 120.5 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.565 1.146 . . . . 73.0 109.888 -174.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -71.95 107.55 4.75 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 109.662 -0.495 . . . . 70.33 109.662 174.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 41.8 t -71.65 129.88 87.92 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 124.152 0.981 . . . . 60.33 109.166 174.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -63.45 157.18 52.15 Favored 'Trans proline' 0 CA--C 1.56 1.797 0 C-N-CA 122.047 1.831 . . . . 74.1 111.799 170.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.7 151.1 85.47 Favored 'Trans proline' 0 C--N 1.366 1.491 0 C-N-CA 122.095 1.863 . . . . 73.43 111.646 173.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 73.3 mtt85 55.65 57.97 4.88 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.166 0.986 . . . . 71.41 111.661 177.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.557 HG23 ' HD2' ' A' ' 231' ' ' ARG . 28.1 m -98.85 113.94 26.3 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 114.719 -1.128 . . . . 64.32 110.476 -179.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -92.11 157.87 16.51 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.47 0.708 . . . . 73.22 110.03 177.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . 0.454 ' HB2' ' HB ' ' A' ' 255' ' ' ILE . . . -66.74 134.85 53.03 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 108.708 -0.849 . . . . 52.31 108.708 169.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 100.6 -3.06 56.11 Favored Glycine 0 C--O 1.241 0.585 0 O-C-N 123.53 0.519 . . . . 62.14 112.604 -173.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.557 ' HD2' HG23 ' A' ' 227' ' ' THR . 63.2 mtt-85 -69.61 159.65 33.01 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-O 121.382 0.611 . . . . 73.13 110.367 171.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 48.2 pttt -131.01 137.49 49.23 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.432 -0.804 . . . . 71.13 110.374 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.539 HD22 ' HB2' ' A' ' 173' ' ' ALA . 29.6 mt -123.52 135.14 53.87 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 108.156 -1.054 . . . . 74.24 108.156 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 18.9 ttt85 -122.4 101.59 7.59 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.364 -0.976 . . . . 73.53 108.364 167.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.533 HD13 ' HD1' ' A' ' 175' ' ' TYR . 13.3 mt -75.33 85.3 2.49 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 125.278 1.431 . . . . 60.4 109.441 -176.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.705 ' HA ' ' HB3' ' A' ' 248' ' ' ASP . 59.2 mttm -66.78 129.44 39.89 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.174 -0.921 . . . . 75.24 111.19 -176.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 75.89 12.43 83.94 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 123.811 0.695 . . . . 50.22 113.025 -178.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -137.21 49.97 2.0 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.588 1.155 . . . . 70.13 109.366 -176.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -113.68 -119.76 3.53 Favored Glycine 0 N--CA 1.473 1.157 0 N-CA-C 111.217 -0.753 . . . . 52.12 111.217 173.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -76.63 140.84 68.3 Favored Pre-proline 0 N--CA 1.48 1.058 0 C-N-CA 123.516 0.727 . . . . 63.4 109.853 176.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -66.88 128.1 18.18 Favored 'Trans proline' 0 C--N 1.376 2.004 0 C-N-CA 122.636 2.224 . . . . 71.14 111.3 170.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -129.09 161.16 22.6 Favored Glycine 0 N--CA 1.476 1.332 0 CA-C-O 119.548 -0.585 . . . . 43.11 112.196 176.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -68.5 -33.01 23.79 Favored 'Trans proline' 0 C--N 1.37 1.69 0 C-N-CA 122.457 2.105 . . . . 65.35 113.083 -177.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -99.03 -2.08 38.12 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.146 0.578 . . . . 65.42 112.298 -177.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 157.9 -151.07 22.23 Favored Glycine 0 C--N 1.344 0.981 0 N-CA-C 111.143 -0.783 . . . . 75.42 111.143 -177.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 29.8 mtt-85 -129.43 163.17 26.42 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 117.889 0.845 . . . . 71.43 111.019 174.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -87.61 -156.99 30.86 Favored Glycine 0 C--N 1.345 1.058 0 CA-C-N 115.051 -0.977 . . . . 53.15 111.641 167.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . 0.705 ' HB3' ' HA ' ' A' ' 236' ' ' LYS . 1.0 OUTLIER -130.07 135.6 48.42 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 122.935 0.494 . . . . 71.12 112.035 -177.78 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 34.5 tp -98.59 116.97 31.99 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.354 0.661 . . . . 72.35 109.586 178.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -91.01 107.8 19.44 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.69 0.796 . . . . 73.42 109.335 178.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 48.8 mt -97.23 141.85 29.85 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.201 0.6 . . . . 73.33 111.255 178.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -101.53 108.13 19.61 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.084 -0.962 . . . . 72.24 108.882 175.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 69.0 t -66.09 116.24 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-O 121.119 0.485 . . . . 64.13 111.025 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 36.7 mmm-85 -121.55 115.05 22.09 Favored 'General case' 0 C--O 1.242 0.677 0 N-CA-C 107.594 -1.261 . . . . 75.01 107.594 173.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.454 ' HB ' ' HB2' ' A' ' 229' ' ' ALA . 21.9 mt -75.07 129.03 37.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 N-CA-C 109.513 -0.551 . . . . 72.01 109.513 175.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 8.3 t . . . . . 0 CA--C 1.562 1.407 0 CA-C-O 117.418 -1.277 . . . . 70.45 108.3 178.439 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 37.4 t70 . . . . . 0 N--CA 1.475 0.815 0 N-CA-C 107.456 -1.313 . . . . 63.14 107.456 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.526 HG21 ' HB3' ' A' ' 234' ' ' ARG . 16.2 m -88.22 161.59 2.74 Favored 'Isoleucine or valine' 0 C--O 1.244 0.78 0 N-CA-C 108.249 -1.019 . . . . 72.43 108.249 161.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 16.2 tt -91.02 133.18 33.55 Favored 'Isoleucine or valine' 0 C--O 1.243 0.721 0 N-CA-C 107.07 -1.456 . . . . 73.52 107.07 164.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -68.57 117.89 10.9 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 123.659 0.784 . . . . 74.23 110.152 -170.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.467 ' HB2' HD22 ' A' ' 233' ' ' LEU . . . -123.57 172.61 8.64 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.662 1.185 . . . . 73.4 108.834 178.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -152.81 158.25 41.95 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.386 0.674 . . . . 71.13 109.659 177.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -141.21 168.39 19.9 Favored 'General case' 0 C--N 1.35 0.59 0 C-N-CA 122.731 0.412 . . . . 73.31 110.761 177.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -142.78 149.23 49.23 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 124.95 1.3 . . . . 72.21 108.705 173.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . 0.547 ' HA ' HG12 ' A' ' 219' ' ' VAL . 20.4 Cg_endo -58.76 123.78 14.29 Favored 'Trans proline' 0 C--N 1.377 2.051 0 C-N-CA 122.931 2.42 . . . . 61.11 111.757 176.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . 0.562 ' HB2' ' HG3' ' A' ' 220' ' ' GLU . . . . . . . . 0 N--CA 1.477 0.912 0 C-N-CA 123.694 0.798 . . . . 62.52 109.827 179.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.417 ' O ' ' HA3' ' A' ' 247' ' ' GLY . 25.0 mm-40 . . . . . 0 N--CA 1.477 0.913 0 CA-C-O 120.938 0.399 . . . . 73.1 111.423 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -93.41 157.72 16.08 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.462 0.705 . . . . 75.22 110.047 175.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 43.1 mt -136.24 143.35 44.25 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.323 1.049 . . . . 75.03 108.282 171.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -129.61 120.76 25.79 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 123.791 0.836 . . . . 72.33 109.079 -178.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -159.37 165.18 33.82 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 121.47 0.653 . . . . 74.51 110.931 -177.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 2.9 p -93.25 138.3 31.76 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.798 0.839 . . . . 70.21 109.56 173.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.56 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . 57.9 tp -108.6 119.34 39.22 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.597 1.159 . . . . 71.3 109.497 -177.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -82.2 103.2 11.63 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 109.562 -0.533 . . . . 72.02 109.562 176.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.515 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 47.5 t -106.21 111.17 64.36 Favored Pre-proline 0 CA--C 1.542 0.643 0 N-CA-C 108.195 -1.039 . . . . 71.55 108.195 175.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . 0.424 ' HD2' HD12 ' A' ' 203' ' ' ILE . 50.5 Cg_exo -57.38 142.1 94.98 Favored 'Trans proline' 0 C--N 1.373 1.862 0 C-N-CA 122.498 2.132 . . . . 72.15 111.874 172.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.404 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -50.66 -47.5 84.87 Favored Pre-proline 0 CA--C 1.559 1.298 0 CA-C-O 117.793 -1.099 . . . . 62.3 112.985 -177.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -55.49 -41.93 73.05 Favored 'Trans proline' 0 C--N 1.398 3.178 0 C-N-CA 122.095 1.863 . . . . 64.23 112.891 176.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.424 HD12 ' HD2' ' A' ' 200' ' ' PRO . 34.5 mt -69.71 -36.2 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 C-N-CA 123.379 0.671 . . . . 74.45 110.894 -177.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.24 -38.32 78.44 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.227 0.611 . . . . 64.42 111.651 -178.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 201' ' ' ALA . 89.3 t -72.7 -56.29 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 CA-C-N 115.689 -0.687 . . . . 74.34 110.82 -178.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 9.4 m -80.39 -24.69 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 CA-C-N 116.294 -0.412 . . . . 73.51 111.985 -172.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 82.47 136.92 2.56 Favored Glycine 0 C--N 1.349 1.254 0 O-C-N 123.433 0.458 . . . . 44.1 112.622 -175.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 179.49 -124.91 0.93 Allowed Glycine 0 C--N 1.341 0.844 0 N-CA-C 111.776 -0.529 . . . . 62.14 111.776 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.514 ' HD2' ' HB3' ' A' ' 220' ' ' GLU . 46.9 mtmt -137.63 153.02 49.93 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.654 0.781 . . . . 42.43 109.817 176.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.491 HG11 ' HA ' ' A' ' 199' ' ' VAL . 27.3 m -128.84 168.23 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.578 1.151 . . . . 72.32 108.707 170.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 45.9 ttp180 -94.78 141.48 28.58 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 109.761 -0.459 . . . . 70.13 109.761 173.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -129.77 154.78 46.87 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.02 0.928 . . . . 75.34 109.036 173.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -103.66 114.45 28.72 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 109.218 -0.66 . . . . 73.13 109.218 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 64.4 p -114.57 175.62 5.41 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.246 0.618 . . . . 64.31 109.439 174.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 11.8 mt -81.12 -3.17 51.14 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 116.109 -0.496 . . . . 55.35 110.283 173.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -91.54 -20.34 21.8 Favored 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 123.862 0.865 . . . . 72.24 110.403 170.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 133.23 -163.64 24.3 Favored Glycine 0 C--N 1.352 1.446 0 CA-C-O 119.752 -0.471 . . . . 62.14 112.595 177.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -74.93 131.03 13.91 Favored 'Trans proline' 0 C--N 1.37 1.705 0 C-N-CA 123.042 2.495 . . . . 75.13 110.278 172.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.547 HG12 ' HA ' ' A' ' 177' ' ' PRO . 17.9 m -131.19 161.83 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 123.538 0.735 . . . . 61.02 110.478 -173.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.562 ' HG3' ' HB2' ' A' ' 178' ' ' ALA . 35.4 mt-10 -112.18 113.25 25.4 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.645 0.778 . . . . 74.51 109.681 178.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 57.5 t -95.46 118.99 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.229 1.011 . . . . 54.41 109.059 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -67.54 100.13 0.84 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.777 0.831 . . . . 70.43 110.149 176.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 91.7 t -81.77 121.02 79.09 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 124.562 1.145 . . . . 72.13 109.858 176.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -65.56 155.27 69.84 Favored 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 122.22 1.947 . . . . 70.44 111.482 173.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -66.77 156.23 66.91 Favored 'Trans proline' 0 C--N 1.37 1.702 0 C-N-CA 122.322 2.015 . . . . 74.14 111.731 172.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 49.0 mtm-85 63.34 31.53 15.2 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.19 0.996 . . . . 73.13 111.151 172.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.429 HG23 ' HD2' ' A' ' 231' ' ' ARG . 92.1 m -86.84 122.62 30.97 Favored 'General case' 0 C--N 1.344 0.367 0 C-N-CA 123.58 0.752 . . . . 65.03 109.256 176.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -94.35 167.79 11.3 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.499 0.719 . . . . 75.04 110.715 177.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -78.71 149.21 32.81 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-N 114.936 -1.029 . . . . 74.12 109.816 177.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 87.34 1.43 83.88 Favored Glycine 0 C--N 1.339 0.716 0 CA-C-N 115.681 -0.69 . . . . 75.13 111.963 -173.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.429 ' HD2' HG23 ' A' ' 227' ' ' THR . 54.3 mtt-85 -79.25 163.05 25.27 Favored 'General case' 0 C--N 1.353 0.76 0 CA-C-O 121.419 0.628 . . . . 71.21 110.103 170.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 15.9 pttm -128.41 139.97 52.08 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 124.344 1.058 . . . . 72.25 109.491 -178.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.467 HD22 ' HB2' ' A' ' 173' ' ' ALA . 90.0 mt -120.29 105.95 11.42 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.25 1.02 . . . . 64.24 108.906 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . 0.526 ' HB3' HG21 ' A' ' 170' ' ' VAL . 71.4 ttt180 -90.49 101.45 14.19 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 107.278 -1.378 . . . . 64.34 107.278 170.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 22.8 mt -77.13 83.41 3.62 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 107.718 -1.215 . . . . 71.41 107.718 174.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -68.68 129.0 38.67 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-N 113.049 -1.887 . . . . 74.43 111.861 -169.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 60.62 32.2 77.61 Favored Glycine 0 C--N 1.347 1.188 0 O-C-N 124.738 1.274 . . . . 61.41 112.473 177.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -136.79 -2.92 2.09 Favored 'General case' 0 C--N 1.358 0.964 0 N-CA-C 113.641 0.978 . . . . 74.25 113.641 -176.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . 0.415 ' HA2' ' HB2' ' A' ' 249' ' ' LEU . . . -61.69 -107.33 0.01 OUTLIER Glycine 0 N--CA 1.485 1.965 0 N-CA-C 114.603 0.601 . . . . 71.52 114.603 -178.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -67.81 136.31 92.38 Favored Pre-proline 0 N--CA 1.486 1.351 0 CA-C-O 118.328 -0.844 . . . . 72.34 109.523 171.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.507 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 37.8 Cg_exo -60.88 135.65 60.93 Favored 'Trans proline' 0 C--N 1.371 1.75 0 C-N-CA 122.648 2.232 . . . . 52.25 112.532 175.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -164.86 120.56 0.94 Allowed Glycine 0 CA--C 1.54 1.613 0 CA-C-O 118.556 -1.136 . . . . 73.22 111.99 -177.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -72.25 -20.13 24.95 Favored 'Trans proline' 0 C--N 1.387 2.554 0 C-N-CA 123.506 2.804 . . . . 72.22 112.811 176.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -93.29 12.64 23.91 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.231 0.612 . . . . 62.45 110.695 175.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 118.97 120.24 2.91 Favored Glycine 0 C--N 1.353 1.477 0 N-CA-C 110.592 -1.003 . . . . 70.23 110.592 -177.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.507 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 28.0 mtt180 -72.29 162.67 29.15 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.291 0.636 . . . . 73.24 109.71 174.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . 0.417 ' HA3' ' O ' ' A' ' 191' ' ' GLN . . . -80.56 -157.86 16.77 Favored Glycine 0 C--N 1.348 1.234 0 N-CA-C 112.435 -0.266 . . . . 73.13 112.435 174.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -121.43 128.85 52.58 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 117.407 0.603 . . . . 61.5 109.786 177.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.415 ' HB2' ' HA2' ' A' ' 239' ' ' GLY . 50.2 tp -100.19 108.18 20.22 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 108.263 -1.014 . . . . 71.45 108.263 173.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -98.69 116.43 30.91 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 108.522 -0.918 . . . . 70.42 108.522 -174.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.56 ' HB3' ' HB2' ' A' ' 197' ' ' LEU . 49.1 mt -127.22 119.17 25.78 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.024 0.93 . . . . 74.31 110.271 -173.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -83.57 121.33 27.09 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 122.979 0.511 . . . . 75.43 110.192 176.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 61.2 t -66.87 105.49 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 C-N-CA 123.691 0.796 . . . . 75.13 110.46 179.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 47.6 mmm-85 -107.25 100.02 9.51 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 107.703 -1.221 . . . . 74.04 107.703 173.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.515 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 39.8 mt -76.94 119.37 25.21 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 CA-C-N 116.063 -0.517 . . . . 72.24 110.422 -178.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 29.5 p . . . . . 0 C--O 1.249 1.06 0 N-CA-C 108.393 -0.965 . . . . 44.02 108.393 175.614 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 20.3 t70 . . . . . 0 N--CA 1.474 0.76 0 CA-C-O 121.299 0.571 . . . . 63.53 109.707 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.44 HG12 ' HG3' ' A' ' 232' ' ' LYS . 33.5 m -92.03 156.09 3.05 Favored 'Isoleucine or valine' 0 C--O 1.244 0.784 0 CA-C-N 114.87 -1.059 . . . . 51.45 109.147 171.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 16.6 tt -83.3 143.43 11.95 Favored 'Isoleucine or valine' 0 C--O 1.245 0.863 0 N-CA-C 108.703 -0.851 . . . . 60.52 108.703 171.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -59.92 137.96 57.94 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.301 1.041 . . . . 74.32 110.787 -176.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.466 ' HB2' HD22 ' A' ' 233' ' ' LEU . . . -157.69 159.34 36.81 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.319 1.048 . . . . 53.34 109.537 -178.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -160.42 152.22 19.93 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.604 0.762 . . . . 65.43 109.742 174.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.546 ' HB3' HG22 ' A' ' 221' ' ' VAL . 34.6 p90 -113.7 -178.67 3.43 Favored 'General case' 0 C--N 1.349 0.561 0 CA-C-O 121.23 0.538 . . . . 70.5 111.704 -178.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -135.78 140.71 34.43 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-N 114.394 -1.275 . . . . 64.42 107.955 170.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -60.87 113.92 1.93 Allowed 'Trans proline' 0 C--N 1.366 1.487 0 C-N-CA 123.212 2.608 . . . . 75.34 111.134 175.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . 0.439 ' HB2' ' HG3' ' A' ' 220' ' ' GLU . . . . . . . . 0 N--CA 1.48 1.039 0 C-N-CA 123.497 0.719 . . . . 73.41 110.848 175.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.496 ' HA ' ' HB2' ' A' ' 240' ' ' PHE . 18.2 mm100 . . . . . 0 CA--C 1.553 1.061 0 N-CA-C 112.683 0.623 . . . . 55.22 112.683 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -93.02 141.18 28.69 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.427 0.691 . . . . 71.52 110.07 -178.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 17.6 mt -123.44 148.4 46.2 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 124.971 1.308 . . . . 72.24 109.22 174.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -127.86 120.64 28.19 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.21 0.604 . . . . 73.21 109.673 177.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.431 ' O ' ' HA ' ' A' ' 251' ' ' LEU . . . -145.35 160.06 42.11 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.729 0.812 . . . . 60.33 109.939 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 11.5 m -102.55 143.79 31.8 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 108.771 -0.826 . . . . 44.4 108.771 176.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.569 HD11 HG23 ' A' ' 210' ' ' VAL . 49.0 tp -113.95 124.97 53.45 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.634 1.174 . . . . 64.11 109.858 -173.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -96.97 102.86 14.72 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.375 0.67 . . . . 73.22 109.522 175.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.532 ' HA ' HG11 ' A' ' 210' ' ' VAL . 3.2 p -104.45 125.9 32.89 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 124.093 0.957 . . . . 71.32 109.675 173.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.86 148.44 66.93 Favored 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 122.698 2.265 . . . . 74.52 112.526 170.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.459 ' HA ' HG23 ' A' ' 255' ' ' ILE . . . -49.38 -52.39 49.75 Favored Pre-proline 0 CA--C 1.56 1.359 0 C-N-CA 124.269 1.027 . . . . 72.05 112.452 178.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . 0.436 ' O ' HG12 ' A' ' 206' ' ' VAL . 30.8 Cg_endo -61.28 -40.3 50.76 Favored 'Trans proline' 0 C--N 1.4 3.266 0 C-N-CA 121.752 1.635 . . . . 75.32 112.877 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 29.1 mt -68.7 -30.48 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 123.233 0.613 . . . . 73.04 110.669 -178.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.92 -42.52 73.19 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 122.827 0.451 . . . . 45.11 110.662 177.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 201' ' ' ALA . 61.4 t -71.05 -53.9 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 123.303 0.641 . . . . 75.33 111.438 -177.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.436 HG12 ' O ' ' A' ' 202' ' ' PRO . 7.7 p -80.09 -31.59 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 122.439 0.296 . . . . 73.11 111.787 -174.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 93.45 131.22 5.84 Favored Glycine 0 CA--C 1.532 1.105 0 N-CA-C 111.618 -0.593 . . . . 72.15 111.618 -172.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -166.72 -143.87 3.91 Favored Glycine 0 C--N 1.341 0.856 0 CA-C-O 119.339 -0.701 . . . . 62.43 111.899 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.466 ' HB3' ' HB3' ' A' ' 220' ' ' GLU . 9.6 mtmp? -132.96 145.71 51.13 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.886 0.874 . . . . 73.31 109.704 174.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.569 HG23 HD11 ' A' ' 197' ' ' LEU . 22.1 m -139.44 158.54 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 124.385 1.074 . . . . 74.42 110.219 177.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 29.2 mtp-105 -79.76 132.87 36.27 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 122.917 0.487 . . . . 71.0 111.598 -177.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -121.12 125.21 46.67 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 125.368 1.467 . . . . 65.35 108.016 172.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.65 106.89 18.82 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 123.478 0.711 . . . . 71.02 110.124 -175.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 29.8 p -117.38 172.51 7.27 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.402 0.681 . . . . 73.21 109.928 -179.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 9.3 mt -71.54 -24.77 62.0 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 109.541 -0.541 . . . . 72.11 109.541 175.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -79.52 -18.87 50.93 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.128 0.971 . . . . 75.14 110.767 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 135.19 -175.51 20.61 Favored Glycine 0 C--N 1.353 1.495 0 CA-C-N 116.064 -0.517 . . . . 53.51 112.948 172.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -66.76 126.48 15.43 Favored 'Trans proline' 0 C--N 1.372 1.809 0 C-N-CA 122.931 2.42 . . . . 53.31 110.644 168.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 35.4 m -133.16 138.68 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 122.882 0.473 . . . . 64.44 110.67 -178.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.466 ' HB3' ' HB3' ' A' ' 209' ' ' LYS . 46.9 mt-10 -92.99 108.55 20.09 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.178 0.591 . . . . 72.13 110.777 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.546 HG22 ' HB3' ' A' ' 175' ' ' TYR . 61.0 t -91.89 119.24 38.93 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 C-N-CA 124.451 1.101 . . . . 70.04 109.429 -176.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -65.04 102.61 0.64 Allowed 'General case' 0 C--O 1.239 0.534 0 O-C-N 124.309 1.005 . . . . 64.42 109.969 175.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.471 HG11 HG21 ' A' ' 199' ' ' VAL . 48.1 t -74.8 117.28 61.27 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 124.376 1.07 . . . . 70.03 109.061 172.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -59.62 156.64 35.96 Favored 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 122.32 2.013 . . . . 73.11 112.158 178.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -63.06 125.24 15.45 Favored 'Trans proline' 0 C--N 1.375 1.945 0 C-N-CA 122.389 2.059 . . . . 75.03 111.567 177.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 72.9 mtm180 68.13 83.51 0.16 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.962 1.305 . . . . 74.51 110.051 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.585 HG22 HG11 ' A' ' 253' ' ' VAL . 89.8 m -126.48 117.5 23.02 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.011 0.924 . . . . 73.01 109.464 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -85.79 158.35 20.02 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.939 0.895 . . . . 71.43 112.151 -172.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -72.54 124.33 24.99 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 114.635 -1.166 . . . . 60.3 109.951 179.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 102.28 2.85 51.07 Favored Glycine 0 C--N 1.335 0.52 0 CA-C-O 119.524 -0.598 . . . . 45.0 112.596 -176.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 87.1 mtt180 -72.66 161.27 30.98 Favored 'General case' 0 C--N 1.356 0.879 0 CA-C-O 121.264 0.554 . . . . 74.2 110.051 170.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.44 ' HG3' HG12 ' A' ' 170' ' ' VAL . 19.9 pttm -124.38 140.47 52.92 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.324 -0.853 . . . . 74.44 109.876 -179.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.466 HD22 ' HB2' ' A' ' 173' ' ' ALA . 61.4 mt -117.87 141.28 48.61 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 107.49 -1.3 . . . . 73.31 107.49 176.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 30.6 ttt180 -130.88 101.73 5.76 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 108.081 -1.081 . . . . 72.15 108.081 167.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.455 HD13 ' HD1' ' A' ' 175' ' ' TYR . 27.6 mt -71.03 87.31 0.74 Allowed 'General case' 0 C--O 1.24 0.603 0 CA-C-N 114.524 -1.216 . . . . 70.42 108.286 175.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 59.6 mtmt -68.75 122.98 19.7 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 114.272 -1.331 . . . . 75.1 111.006 -174.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 69.65 26.42 74.48 Favored Glycine 0 C--N 1.345 1.079 0 O-C-N 124.305 1.003 . . . . 71.15 112.303 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.447 ' HB3' ' CE1' ' A' ' 175' ' ' TYR . 31.3 mmtp -135.85 35.02 2.87 Favored 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 124.512 1.125 . . . . 71.24 110.985 -172.007 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -114.27 -115.36 3.14 Favored Glycine 0 N--CA 1.477 1.414 0 N-CA-C 111.952 -0.459 . . . . 51.04 111.952 177.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . 0.496 ' HB2' ' HA ' ' A' ' 191' ' ' GLN . 1.8 m-85 -69.83 142.03 90.49 Favored Pre-proline 0 N--CA 1.485 1.321 0 C-N-CA 123.17 0.588 . . . . 65.32 110.946 177.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -52.44 144.12 41.9 Favored 'Trans proline' 0 C--N 1.376 1.985 0 C-N-CA 123.687 2.925 . . . . 65.01 113.602 172.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -156.8 113.31 0.56 Allowed Glycine 0 CA--C 1.531 1.063 0 CA-C-O 118.399 -1.223 . . . . 73.23 110.248 -179.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.26 -14.98 45.33 Favored 'Trans proline' 0 C--N 1.386 2.521 0 C-N-CA 123.535 2.823 . . . . 61.53 114.565 -176.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -112.6 -12.24 13.46 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 123.529 0.732 . . . . 72.34 111.594 175.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 163.03 125.68 0.78 Allowed Glycine 0 C--N 1.344 0.998 0 N-CA-C 111.123 -0.791 . . . . 63.12 111.123 -178.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 12.3 mtm180 -73.63 162.32 29.33 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.135 0.574 . . . . 72.04 110.928 -178.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -83.82 -163.72 35.78 Favored Glycine 0 C--N 1.348 1.212 0 CA-C-N 115.894 -0.594 . . . . 65.15 112.971 178.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -108.36 157.46 18.37 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.213 0.605 . . . . 74.54 110.676 -176.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 45.6 tp -132.83 110.91 10.66 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.101 0.96 . . . . 74.34 108.571 170.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 21.9 t80 -96.28 120.97 37.55 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.382 1.073 . . . . 62.12 109.326 -176.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.431 ' HA ' ' O ' ' A' ' 195' ' ' ALA . 51.5 mt -120.02 126.98 52.14 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.727 0.811 . . . . 72.24 110.862 -176.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.99 116.52 25.1 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 122.886 0.474 . . . . 72.34 110.434 173.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.585 HG11 HG22 ' A' ' 227' ' ' THR . 96.7 t -65.71 115.58 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 123.381 0.673 . . . . 73.13 110.511 176.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -121.12 111.62 17.67 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.015 0.926 . . . . 71.42 109.193 172.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.459 HG23 ' HA ' ' A' ' 201' ' ' ALA . 44.7 mt -76.89 121.47 29.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 108.988 -0.745 . . . . 74.02 108.988 175.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 34.6 p . . . . . 0 C--O 1.253 1.254 0 N-CA-C 108.23 -1.026 . . . . 51.14 108.23 175.908 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 29.7 t70 . . . . . 0 N--CA 1.483 1.186 0 N-CA-C 113.409 0.892 . . . . 73.21 113.409 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.444 HG21 ' HB3' ' A' ' 234' ' ' ARG . 12.9 m -90.33 -174.82 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.019 0 C-N-CA 123.542 0.737 . . . . 73.13 110.651 -175.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 10.3 tt -93.85 137.46 22.73 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.124 0 N-CA-C 108.29 -1.004 . . . . 71.53 108.29 165.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -74.84 113.39 12.08 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.438 1.095 . . . . 52.54 110.02 -175.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.453 ' HB2' HD22 ' A' ' 233' ' ' LEU . . . -111.6 178.95 4.16 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.449 0.7 . . . . 70.42 110.711 -178.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -146.76 156.5 43.2 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.572 1.149 . . . . 72.43 109.456 178.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.403 ' HD1' HD13 ' A' ' 235' ' ' LEU . 2.5 p90 -130.67 172.06 12.38 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.086 0.47 . . . . 74.03 110.045 168.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -134.5 140.91 37.06 Favored Pre-proline 0 N--CA 1.476 0.837 0 C-N-CA 124.585 1.154 . . . . 52.54 108.27 175.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -64.04 106.08 0.63 Allowed 'Trans proline' 0 C--N 1.363 1.342 0 C-N-CA 122.775 2.317 . . . . 74.22 111.035 175.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.336 0 C-N-CA 123.535 0.734 . . . . 32.11 111.826 -175.652 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.482 ' HA ' ' HB2' ' A' ' 240' ' ' PHE . 23.9 mm-40 . . . . . 0 N--CA 1.477 0.904 0 CA-C-O 121.191 0.52 . . . . 51.42 110.084 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -89.6 146.92 24.22 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.031 0.932 . . . . 74.23 109.927 -170.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.424 HD23 ' HA ' ' A' ' 193' ' ' LEU . 13.7 mt -140.53 131.56 26.23 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 107.634 -1.247 . . . . 70.41 107.634 166.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -120.13 128.3 53.31 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 108.782 -0.822 . . . . 65.54 108.782 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -157.53 162.04 38.82 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.742 0.817 . . . . 52.21 110.157 178.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 17.2 p -91.87 149.12 21.74 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 109.033 -0.728 . . . . 64.41 109.033 170.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.619 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . 40.8 tp -113.4 115.01 27.4 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 123.622 0.769 . . . . 75.23 109.549 -175.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -80.03 100.96 8.42 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.625 0.77 . . . . 72.22 109.163 -179.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.578 ' HA ' HG11 ' A' ' 210' ' ' VAL . 40.9 t -109.84 104.39 55.38 Favored Pre-proline 0 CA--C 1.54 0.578 0 N-CA-C 108.509 -0.923 . . . . 60.54 108.509 178.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -53.22 139.79 62.62 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 122.723 2.282 . . . . 74.43 112.07 174.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.428 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -47.8 -47.84 61.78 Favored Pre-proline 0 CA--C 1.558 1.266 0 C-N-CA 124.377 1.071 . . . . 74.23 113.749 -175.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.1 -45.06 34.13 Favored 'Trans proline' 0 C--N 1.39 2.716 0 C-N-CA 121.977 1.785 . . . . 73.42 112.902 174.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 36.6 mt -66.1 -32.24 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 123.577 0.751 . . . . 64.43 110.84 -177.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -65.91 -50.64 63.75 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 122.994 0.518 . . . . 73.12 110.377 177.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 201' ' ' ALA . 81.4 t -64.3 -53.23 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 O-C-N 123.877 0.736 . . . . 73.51 111.685 -175.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 26.9 m -78.31 -26.28 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 N-CA-C 112.237 0.458 . . . . 73.33 112.237 -176.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 81.01 139.99 2.65 Favored Glycine 0 C--N 1.349 1.301 0 N-CA-C 112.147 -0.381 . . . . 74.03 112.147 -175.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -177.74 -124.27 0.84 Allowed Glycine 0 C--N 1.344 0.995 0 CA-C-N 117.202 0.501 . . . . 31.12 112.506 -178.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -136.59 153.13 51.05 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.977 0.911 . . . . 72.11 108.71 176.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.578 HG11 ' HA ' ' A' ' 199' ' ' VAL . 15.7 m -138.06 128.03 35.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 123.268 0.627 . . . . 72.5 109.381 171.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . 0.418 ' HG2' ' HG2' ' A' ' 220' ' ' GLU . 63.6 mtm-85 -81.95 110.29 17.09 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.38 0.672 . . . . 62.43 110.796 -176.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -100.46 161.14 13.8 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.677 1.191 . . . . 74.31 109.93 178.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 8.1 mmt -99.17 119.82 38.49 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.714 0.805 . . . . 70.0 109.889 -177.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 76.4 p -110.6 175.49 5.41 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.52 0.728 . . . . 60.11 109.113 170.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 29.1 mt -69.84 -10.43 58.41 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 112.712 0.634 . . . . 74.4 112.712 -174.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -117.43 -12.69 10.39 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.266 0.626 . . . . 51.35 112.284 -177.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 153.15 -169.62 32.05 Favored Glycine 0 C--N 1.356 1.655 0 N-CA-C 114.335 0.494 . . . . 71.34 114.335 173.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -70.22 141.23 42.85 Favored 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 123.558 2.839 . . . . 72.42 112.456 176.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 34.6 m -137.89 130.96 41.75 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 C-N-CA 123.547 0.739 . . . . 52.35 110.157 178.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.418 ' HG2' ' HG2' ' A' ' 211' ' ' ARG . 14.3 mt-10 -88.07 108.52 19.28 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.408 0.683 . . . . 71.34 110.173 -178.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 44.9 t -94.74 122.95 46.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 123.734 0.814 . . . . 73.24 109.682 -176.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -68.61 107.0 2.79 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.205 1.002 . . . . 73.51 111.452 -177.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 66.4 t -86.2 121.05 72.74 Favored Pre-proline 0 CA--C 1.553 1.065 0 C-N-CA 124.634 1.174 . . . . 71.12 110.047 176.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -63.52 164.38 20.98 Favored 'Trans proline' 0 C--N 1.379 2.183 0 C-N-CA 122.918 2.412 . . . . 65.42 112.527 174.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -66.28 128.35 19.25 Favored 'Trans proline' 0 C--N 1.376 2.008 0 C-N-CA 122.615 2.21 . . . . 72.3 112.184 173.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 63.3 mtm-85 62.81 70.54 0.55 Allowed 'General case' 0 C--N 1.353 0.746 0 C-N-CA 124.724 1.21 . . . . 72.3 110.846 178.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.631 HG22 HG11 ' A' ' 253' ' ' VAL . 56.8 m -101.57 114.72 29.01 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 114.829 -1.078 . . . . 63.11 109.376 -178.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 22.9 mp0 -84.79 153.03 23.25 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.271 0.628 . . . . 62.14 111.404 -174.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -73.15 127.89 33.91 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.734 -0.839 . . . . 64.13 108.734 174.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 110.08 -11.84 31.65 Favored Glycine 0 C--N 1.333 0.366 0 N-CA-C 111.533 -0.627 . . . . 55.14 111.533 -171.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.575 ' HD2' HG23 ' A' ' 227' ' ' THR . 90.7 mtt180 -66.81 156.79 34.61 Favored 'General case' 0 C--N 1.36 1.043 0 CA-C-O 121.361 0.601 . . . . 60.23 110.142 169.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 38.3 pttt -131.91 135.08 46.37 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 114.996 -1.002 . . . . 74.44 109.391 -176.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.453 HD22 ' HB2' ' A' ' 173' ' ' ALA . 75.9 mt -115.96 137.06 52.45 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 108.081 -1.081 . . . . 62.3 108.081 176.204 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . 0.444 ' HB3' HG21 ' A' ' 170' ' ' VAL . 40.8 ttm105 -119.52 120.49 36.92 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.565 -1.272 . . . . 75.5 107.565 166.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.514 ' O ' ' HA ' ' A' ' 248' ' ' ASP . 43.7 mt -101.88 78.82 1.84 Allowed 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 108.678 -0.86 . . . . 61.1 108.678 -177.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -75.95 144.15 41.17 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 122.883 0.473 . . . . 74.12 109.856 176.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 68.31 18.16 71.1 Favored Glycine 0 C--N 1.344 1.005 0 CA-C-N 115.639 -0.709 . . . . 63.11 112.336 -174.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 10.1 mmpt? -129.75 -30.58 2.04 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.352 1.061 . . . . 70.24 110.728 -175.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -66.84 -125.83 0.02 OUTLIER Glycine 0 C--N 1.36 1.863 0 N-CA-C 114.766 0.666 . . . . 64.41 114.766 -171.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . 0.482 ' HB2' ' HA ' ' A' ' 191' ' ' GLN . 1.1 m-85 -67.78 135.46 92.31 Favored Pre-proline 0 N--CA 1.482 1.15 0 CA-C-O 118.802 -0.618 . . . . 64.31 109.903 177.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.56 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 37.3 Cg_exo -42.51 138.46 3.41 Favored 'Trans proline' 0 C--N 1.378 2.101 0 C-N-CA 124.278 3.319 . . . . 74.42 114.92 175.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -164.46 113.16 0.54 Allowed Glycine 0 CA--C 1.531 1.046 0 N-CA-C 109.219 -1.552 . . . . 74.44 109.219 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -60.51 -40.13 59.43 Favored 'Trans proline' 0 C--N 1.379 2.142 0 C-N-CA 123.234 2.623 . . . . 72.11 113.296 -173.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -77.32 -25.05 50.81 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.057 0.543 . . . . 61.42 110.8 176.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 169.18 127.21 0.91 Allowed Glycine 0 C--N 1.338 0.673 0 N-CA-C 110.996 -0.842 . . . . 71.31 110.996 179.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.56 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 48.6 mtm180 -69.54 159.59 33.05 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.106 0.562 . . . . 73.33 109.874 178.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . 0.426 ' HA3' ' HB3' ' A' ' 191' ' ' GLN . . . -74.08 -156.56 4.55 Favored Glycine 0 C--N 1.339 0.702 0 CA-C-N 116.069 -0.514 . . . . 75.14 112.911 175.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . 0.514 ' HA ' ' O ' ' A' ' 235' ' ' LEU . 2.6 p30 -122.7 136.46 54.88 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 122.332 -0.511 . . . . 70.25 112.018 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 32.5 tp -100.57 104.6 15.95 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 107.241 -1.392 . . . . 74.3 107.241 168.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -89.28 108.03 19.39 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.172 0.989 . . . . 72.43 109.02 -178.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.619 ' HB3' ' HB2' ' A' ' 197' ' ' LEU . 63.8 mt -110.43 110.75 21.63 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.412 1.085 . . . . 73.41 110.349 -176.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -80.37 110.23 15.63 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.119 0.568 . . . . 74.54 109.694 176.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.631 HG11 HG22 ' A' ' 227' ' ' THR . 89.8 t -59.49 110.76 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.417 0.687 . . . . 71.01 111.017 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 30.8 mmm180 -114.23 113.0 24.04 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 125.053 1.341 . . . . 74.53 108.45 173.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.477 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 56.9 mt -75.62 126.14 36.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 N-CA-C 109.253 -0.647 . . . . 73.42 109.253 178.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 45.2 p . . . . . 0 C--O 1.248 1.003 0 C-N-CA 124.167 0.987 . . . . 73.43 108.623 -179.635 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 37.7 t70 . . . . . 0 N--CA 1.476 0.849 0 CA-C-O 121.283 0.563 . . . . 60.24 110.292 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.638 HG21 ' HB3' ' A' ' 234' ' ' ARG . 34.1 m -90.01 173.06 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-N 115.158 -0.928 . . . . 71.04 110.948 178.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 15.1 tt -96.34 143.81 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 N-CA-C 108.676 -0.861 . . . . 63.41 108.676 171.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -65.81 132.16 48.03 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.3 1.04 . . . . 74.2 112.065 -173.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.485 ' HB2' HD22 ' A' ' 233' ' ' LEU . . . -146.61 164.39 32.8 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.336 1.054 . . . . 40.11 110.816 -178.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -160.4 154.09 22.52 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.68 1.192 . . . . 74.34 109.161 179.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.533 ' HA ' ' HA ' ' A' ' 221' ' ' VAL . 31.7 p90 -117.72 -177.21 3.19 Favored 'General case' 0 C--N 1.347 0.475 0 CA-C-O 121.575 0.703 . . . . 74.31 110.953 178.341 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -136.15 131.81 18.88 Favored Pre-proline 0 N--CA 1.468 0.456 0 N-CA-C 107.438 -1.319 . . . . 71.23 107.438 173.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -65.25 95.25 0.26 Allowed 'Trans proline' 0 CA--C 1.551 1.359 0 C-N-CA 122.149 1.899 . . . . 52.51 110.787 177.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . 0.477 ' HB2' ' HG3' ' A' ' 220' ' ' GLU . . . . . . . . 0 N--CA 1.482 1.137 0 CA-C-N 115.522 -0.763 . . . . 73.52 110.294 176.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.614 ' HA ' ' HB2' ' A' ' 240' ' ' PHE . 16.8 mm100 . . . . . 0 N--CA 1.475 0.776 0 CA-C-O 121.15 0.5 . . . . 72.24 110.374 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.425 ' HA ' ' O ' ' A' ' 248' ' ' ASP . 8.0 p-10 -103.59 139.95 38.21 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.015 -0.539 . . . . 71.43 109.63 176.045 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 86.1 mt -118.83 150.8 39.22 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 108.632 -0.877 . . . . 74.11 108.632 -177.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -122.21 127.59 50.16 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 108.119 -1.067 . . . . 72.42 108.119 172.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -152.88 158.49 42.22 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 122.956 0.502 . . . . 72.45 110.203 -177.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 10.7 p -94.94 138.02 33.23 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 123.222 0.609 . . . . 72.13 109.917 174.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.456 HD11 HG23 ' A' ' 210' ' ' VAL . 52.0 tp -110.88 114.38 27.66 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.381 1.072 . . . . 63.44 109.543 -173.091 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -75.81 104.38 6.33 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 109.251 -0.648 . . . . 73.33 109.251 176.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.587 HG22 HG21 ' A' ' 210' ' ' VAL . 30.0 t -113.46 107.19 53.62 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 123.668 0.787 . . . . 51.15 108.936 175.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -54.19 140.66 71.44 Favored 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.796 2.331 . . . . 73.24 112.267 172.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -47.7 -50.14 53.11 Favored Pre-proline 0 CA--C 1.571 1.752 0 N-CA-C 113.992 1.108 . . . . 63.12 113.992 -177.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -58.1 -39.25 87.13 Favored 'Trans proline' 0 C--N 1.401 3.318 0 C-N-CA 121.838 1.692 . . . . 53.43 112.806 177.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 47.5 mt -72.01 -31.31 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 123.95 0.9 . . . . 71.42 110.829 -178.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.68 -46.63 68.56 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.239 0.615 . . . . 73.25 110.944 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 83.2 t -70.54 -40.99 77.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-N 115.284 -0.871 . . . . 62.32 111.705 -176.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 8.2 p -77.45 -31.02 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 CA-C-N 116.473 -0.33 . . . . 44.52 111.404 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 80.55 69.07 1.42 Allowed Glycine 0 C--N 1.349 1.296 0 CA-C-N 116.055 -0.521 . . . . 73.24 112.344 -173.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -101.29 -150.68 24.14 Favored Glycine 0 C--N 1.346 1.106 0 CA-C-O 119.715 -0.492 . . . . 71.12 112.158 -176.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 55.0 mttp -117.39 143.39 46.04 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.229 0.612 . . . . 71.22 109.56 173.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.587 HG21 HG22 ' A' ' 199' ' ' VAL . 27.7 m -136.72 142.28 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 124.14 0.976 . . . . 55.34 109.192 174.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 88.9 mtm180 -73.72 137.9 44.3 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.127 0.489 . . . . 75.45 111.086 176.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -116.59 121.13 40.83 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.268 1.427 . . . . 72.34 107.394 172.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.0 111.6 19.85 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 109.382 -0.599 . . . . 63.11 109.382 -178.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 81.4 p -120.83 -179.88 4.14 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.457 0.703 . . . . 55.43 111.07 -176.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 12.3 mt -70.31 -22.68 62.8 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 115.466 -0.788 . . . . 72.0 110.003 175.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -87.44 -12.87 44.86 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 123.93 0.892 . . . . 72.14 110.621 177.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 117.37 -158.97 14.29 Favored Glycine 0 C--N 1.354 1.535 0 CA-C-N 116.353 -0.385 . . . . 51.14 113.109 175.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.7 127.9 14.46 Favored 'Trans proline' 0 C--N 1.367 1.533 0 C-N-CA 122.669 2.246 . . . . 74.13 111.381 175.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 29.6 m -132.39 125.03 53.02 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.827 0 N-CA-C 109.919 -0.4 . . . . 63.42 109.919 173.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.477 ' HG3' ' HB2' ' A' ' 178' ' ' ALA . 45.4 mt-10 -84.14 105.82 15.3 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.316 0.647 . . . . 70.21 110.285 -178.293 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.533 ' HA ' ' HA ' ' A' ' 175' ' ' TYR . 46.5 t -90.03 116.94 32.34 Favored 'Isoleucine or valine' 0 C--O 1.243 0.717 0 C-N-CA 124.303 1.041 . . . . 73.25 108.576 -175.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -69.32 101.09 1.44 Allowed 'General case' 0 C--O 1.241 0.613 0 CA-C-N 114.873 -1.058 . . . . 52.53 109.146 176.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 47.1 t -69.18 131.55 90.47 Favored Pre-proline 0 CA--C 1.544 0.749 0 CA-C-N 114.781 -1.1 . . . . 64.42 109.05 176.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -62.81 159.49 37.37 Favored 'Trans proline' 0 CA--C 1.561 1.85 0 C-N-CA 122.06 1.84 . . . . 71.03 111.923 170.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -67.05 147.66 80.12 Favored 'Trans proline' 0 C--N 1.376 2.003 0 C-N-CA 122.159 1.906 . . . . 74.33 112.191 176.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 47.8 mtp180 53.54 54.79 9.5 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.919 1.288 . . . . 73.45 111.368 174.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.615 HG23 ' HD2' ' A' ' 231' ' ' ARG . 91.3 m -96.8 117.95 32.19 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 114.525 -1.216 . . . . 64.32 109.11 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 26.8 mp0 -90.38 161.67 15.48 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.277 0.631 . . . . 73.41 111.57 -177.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -64.42 127.62 32.27 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 114.454 -1.248 . . . . 55.54 110.239 177.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 103.85 -4.31 45.9 Favored Glycine 0 C--N 1.341 0.854 0 CA-C-O 119.374 -0.681 . . . . 73.44 113.526 -179.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.615 ' HD2' HG23 ' A' ' 227' ' ' THR . 87.5 mtt180 -68.65 162.07 26.78 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 117.741 0.771 . . . . 71.42 111.54 175.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -127.33 124.24 38.23 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 123.84 0.856 . . . . 75.42 110.679 -173.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.485 HD22 ' HB2' ' A' ' 173' ' ' ALA . 61.8 mt -113.32 100.0 8.22 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.049 0.939 . . . . 62.11 109.138 178.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . 0.638 ' HB3' HG21 ' A' ' 170' ' ' VAL . 22.6 ttt180 -85.4 102.15 13.19 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 107.966 -1.124 . . . . 65.21 107.966 169.074 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.414 HD13 ' HD1' ' A' ' 175' ' ' TYR . 53.5 mt -68.89 92.06 0.49 Allowed 'General case' 0 C--O 1.244 0.776 0 N-CA-C 107.808 -1.182 . . . . 75.43 107.808 172.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -71.28 114.11 9.0 Favored 'General case' 0 C--N 1.357 0.925 0 CA-C-N 114.137 -1.392 . . . . 74.41 111.813 -167.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . 0.405 ' O ' ' HD3' ' A' ' 246' ' ' ARG . . . 67.53 34.08 83.17 Favored Glycine 0 C--N 1.346 1.121 0 O-C-N 124.053 0.846 . . . . 44.32 112.056 178.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.461 ' HB3' ' CE1' ' A' ' 175' ' ' TYR . 32.9 mmtp -128.62 10.36 6.09 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.645 0.778 . . . . 74.42 111.97 -172.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -84.48 -129.14 1.82 Allowed Glycine 0 N--CA 1.47 0.948 0 N-CA-C 111.742 -0.543 . . . . 60.23 111.742 176.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . 0.614 ' HB2' ' HA ' ' A' ' 191' ' ' GLN . 3.2 m-85 -74.88 142.92 77.2 Favored Pre-proline 0 N--CA 1.48 1.072 0 C-N-CA 123.283 0.633 . . . . 74.12 110.894 175.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.723 ' HA ' ' HG3' ' A' ' 246' ' ' ARG . 21.3 Cg_exo -64.5 142.86 79.98 Favored 'Trans proline' 0 C--N 1.379 2.132 0 C-N-CA 123.003 2.469 . . . . 74.41 113.11 -176.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -157.48 118.25 0.82 Allowed Glycine 0 CA--C 1.535 1.291 0 CA-C-O 118.696 -1.058 . . . . 44.04 111.345 -179.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -64.04 -28.99 65.99 Favored 'Trans proline' 0 C--N 1.384 2.44 0 C-N-CA 123.131 2.554 . . . . 72.04 114.335 -178.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -86.61 -15.35 40.05 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.169 0.588 . . . . 61.51 111.18 176.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 163.29 118.33 0.45 Allowed Glycine 0 C--N 1.344 0.99 0 N-CA-C 110.072 -1.211 . . . . 63.24 110.072 178.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.723 ' HG3' ' HA ' ' A' ' 241' ' ' PRO . 45.4 ttt180 -69.25 140.27 54.47 Favored 'General case' 0 C--O 1.243 0.726 0 CA-C-N 117.505 0.653 . . . . 72.11 109.508 175.389 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -68.56 -169.47 5.54 Favored Glycine 0 C--N 1.351 1.4 0 O-C-N 123.563 0.539 . . . . 53.14 113.347 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . 0.425 ' O ' ' HA ' ' A' ' 192' ' ' ASP . 10.1 m-20 -122.11 169.7 10.6 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.134 0.573 . . . . 71.3 110.734 -175.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 43.2 tp -136.24 107.21 6.68 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 108.356 -0.979 . . . . 61.24 108.356 168.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -94.46 107.4 19.37 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 108.881 -0.785 . . . . 74.3 108.881 -174.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.401 HD12 HD11 ' A' ' 235' ' ' LEU . 66.2 mt -110.5 113.99 27.06 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.055 0.942 . . . . 75.04 110.117 -175.335 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -79.52 116.75 19.92 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 109.218 -0.66 . . . . 72.05 109.218 173.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.508 HG11 HG22 ' A' ' 227' ' ' THR . 69.5 t -65.45 105.42 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 CA-C-O 121.231 0.539 . . . . 75.13 110.168 177.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 15.3 mmt85 -103.17 106.75 17.33 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 108.043 -1.095 . . . . 62.11 108.043 172.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.48 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 15.3 mt -74.42 119.55 22.03 Favored 'Isoleucine or valine' 0 C--N 1.352 0.716 0 N-CA-C 109.265 -0.643 . . . . 64.04 109.265 179.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 23.5 p . . . . . 0 C--O 1.252 1.206 0 C-N-CA 124.736 1.214 . . . . 75.42 109.213 -176.141 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 27.5 t70 . . . . . 0 N--CA 1.477 0.885 0 CA-C-O 120.835 0.35 . . . . 75.23 110.233 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.466 HG21 ' HB3' ' A' ' 234' ' ' ARG . 25.6 m -98.13 167.86 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-N 115.083 -0.962 . . . . 72.23 110.468 175.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 16.8 tt -89.11 149.59 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.004 0 N-CA-C 108.953 -0.758 . . . . 72.11 108.953 171.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -60.56 142.44 55.4 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.77 1.228 . . . . 72.33 112.377 -175.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.514 ' HB2' HD22 ' A' ' 233' ' ' LEU . . . -159.94 155.45 25.55 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.805 1.242 . . . . 70.32 109.092 174.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -149.98 119.77 7.08 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 123.48 0.712 . . . . 75.34 110.013 177.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.557 ' HE1' ' HB3' ' A' ' 238' ' ' LYS . 17.7 p90 -93.11 164.76 13.14 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 109.451 -0.574 . . . . 75.15 109.451 174.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 46.3 mttm -138.9 143.83 38.96 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 123.519 0.728 . . . . 70.52 109.507 172.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -56.71 108.91 0.38 Allowed 'Trans proline' 0 C--N 1.382 2.312 0 C-N-CA 123.742 2.961 . . . . 61.42 112.984 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . 0.653 ' HB2' ' HG3' ' A' ' 220' ' ' GLU . . . . . . . . 0 N--CA 1.483 1.201 0 C-N-CA 123.131 0.572 . . . . 54.42 110.049 174.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 23.4 mp0 . . . . . 0 N--CA 1.478 0.953 0 CA-C-O 121.799 0.809 . . . . 74.24 109.039 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 19.2 p-10 -94.63 147.95 22.77 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 114.727 -1.124 . . . . 71.11 110.509 -178.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 95.6 mt -126.26 157.78 37.42 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.638 1.175 . . . . 73.0 109.667 178.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -135.31 122.95 22.2 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.911 0.884 . . . . 70.23 108.676 176.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -152.67 171.22 18.52 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.005 0.922 . . . . 73.42 109.711 178.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . 0.461 HG22 ' HB2' ' A' ' 252' ' ' GLU . 11.7 p -97.96 146.31 25.61 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.335 0.654 . . . . 71.12 109.944 173.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.561 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . 39.1 tp -114.45 111.28 21.16 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.19 0.996 . . . . 71.22 109.112 178.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -87.28 101.41 13.5 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.135 0.493 . . . . 75.01 109.899 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.481 ' HA ' HG11 ' A' ' 210' ' ' VAL . 46.9 t -102.55 121.97 47.91 Favored Pre-proline 0 CA--C 1.542 0.655 0 C-N-CA 124.379 1.071 . . . . 63.14 108.904 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -56.03 142.34 85.66 Favored 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 122.809 2.339 . . . . 65.23 111.602 170.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.467 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -49.48 -49.4 71.82 Favored Pre-proline 0 CA--C 1.56 1.329 0 CA-C-O 118.045 -0.979 . . . . 64.31 113.496 -179.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -60.05 -40.1 64.23 Favored 'Trans proline' 0 C--N 1.394 2.973 0 C-N-CA 121.995 1.797 . . . . 63.42 112.87 178.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 34.7 mt -69.2 -33.26 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 C-N-CA 123.761 0.824 . . . . 62.21 110.6 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.63 -38.03 80.21 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.414 0.685 . . . . 72.53 111.437 178.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 201' ' ' ALA . 99.1 t -74.13 -55.84 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.415 0.686 . . . . 74.21 110.96 -178.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 11.5 m -81.42 -23.37 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 N-CA-C 112.171 0.434 . . . . 74.02 112.171 -171.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 88.16 134.7 4.74 Favored Glycine 0 C--N 1.347 1.16 0 N-CA-C 111.378 -0.689 . . . . 63.23 111.378 -173.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -173.13 -147.54 5.93 Favored Glycine 0 C--N 1.338 0.692 0 N-CA-C 111.644 -0.582 . . . . 71.24 111.644 -177.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -137.02 134.89 37.08 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.22 0.608 . . . . 71.11 110.15 177.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.481 HG11 ' HA ' ' A' ' 199' ' ' VAL . 29.5 m -121.96 147.31 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 123.251 0.62 . . . . 75.14 109.73 179.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -86.68 111.89 21.11 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 116.169 -0.469 . . . . 62.34 109.767 -173.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -99.98 157.68 16.37 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.249 1.02 . . . . 63.3 109.917 177.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 2.0 mmt -105.28 108.81 20.52 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 115.336 -0.847 . . . . 65.1 109.747 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 45.4 p -109.79 -177.72 3.34 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.849 0.859 . . . . 61.33 109.039 171.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 19.0 mt -72.28 -26.74 62.09 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.125 0.57 . . . . 70.24 110.452 -175.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 10.6 mp0 -80.0 -20.54 45.2 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.27 1.028 . . . . 64.23 110.397 -178.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 133.46 -154.5 21.28 Favored Glycine 0 C--N 1.351 1.396 0 CA-C-O 119.56 -0.578 . . . . 53.23 112.104 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -67.83 142.18 56.63 Favored 'Trans proline' 0 C--N 1.369 1.641 0 C-N-CA 122.829 2.353 . . . . 63.52 112.313 172.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.435 ' HA ' ' H ' ' A' ' 178' ' ' ALA . 30.0 m -139.61 147.82 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 124.007 0.923 . . . . 74.11 109.639 175.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.653 ' HG3' ' HB2' ' A' ' 178' ' ' ALA . 42.5 mt-10 -100.78 109.24 21.22 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.131 0.572 . . . . 72.35 109.672 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.414 ' HA ' ' HA ' ' A' ' 175' ' ' TYR . 47.9 t -94.53 122.61 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 123.82 0.848 . . . . 74.31 109.734 -175.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -69.72 99.96 1.42 Allowed 'General case' 0 C--N 1.35 0.62 0 O-C-N 123.952 0.783 . . . . 52.13 110.022 177.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.468 HG11 HG11 ' A' ' 199' ' ' VAL . 57.9 t -77.82 121.01 83.54 Favored Pre-proline 0 C--O 1.243 0.728 0 CA-C-N 114.558 -1.201 . . . . 71.32 108.849 173.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -61.5 157.13 42.91 Favored 'Trans proline' 0 CA--C 1.563 1.963 0 C-N-CA 122.25 1.967 . . . . 73.54 111.97 172.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -66.31 144.15 73.13 Favored 'Trans proline' 0 C--N 1.372 1.788 0 C-N-CA 122.251 1.967 . . . . 53.55 111.448 172.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 88.6 mtt180 69.12 32.24 3.77 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 125.126 1.37 . . . . 71.1 111.367 172.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.547 HG23 ' HD2' ' A' ' 231' ' ' ARG . 97.4 m -77.32 121.6 23.96 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.451 1.1 . . . . 74.11 110.325 174.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -95.18 163.3 13.34 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 109.603 -0.517 . . . . 74.11 109.603 178.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -70.69 118.84 13.99 Favored 'General case' 0 C--N 1.348 0.51 0 CA-C-N 115.469 -0.787 . . . . 72.21 108.925 170.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 115.01 -1.47 22.8 Favored Glycine 0 N--CA 1.464 0.544 0 CA-C-O 119.73 -0.483 . . . . 71.34 112.518 -172.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.547 ' HD2' HG23 ' A' ' 227' ' ' THR . 38.8 mtt180 -75.55 158.52 32.4 Favored 'General case' 0 C--N 1.358 0.958 0 CA-C-O 121.451 0.643 . . . . 62.13 110.289 168.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.437 ' HG3' HG12 ' A' ' 170' ' ' VAL . 23.0 pttm -124.7 129.19 50.02 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.653 1.181 . . . . 74.22 108.731 -177.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.514 HD22 ' HB2' ' A' ' 173' ' ' ALA . 87.6 mt -117.91 104.16 10.65 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.966 0.907 . . . . 70.13 108.905 -178.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . 0.466 ' HB3' HG21 ' A' ' 170' ' ' VAL . 41.8 ttm180 -97.01 100.43 11.93 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 107.254 -1.388 . . . . 73.34 107.254 175.267 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 20.8 mt -73.4 84.22 1.46 Allowed 'General case' 0 C--O 1.24 0.555 0 N-CA-C 107.185 -1.413 . . . . 74.24 107.185 173.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 6.6 mtpm? -73.53 132.34 42.75 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 115.199 -0.91 . . . . 74.14 110.328 -172.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 69.01 23.5 76.03 Favored Glycine 0 C--N 1.342 0.897 0 O-C-N 123.899 0.749 . . . . 75.13 112.431 -176.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.557 ' HB3' ' HE1' ' A' ' 175' ' ' TYR . 60.8 mmtt -138.72 17.7 2.69 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.995 1.318 . . . . 73.13 111.136 -170.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . 0.464 ' HA2' ' HB2' ' A' ' 249' ' ' LEU . . . -82.18 -89.48 0.65 Allowed Glycine 0 N--CA 1.471 0.984 0 N-CA-C 110.499 -1.04 . . . . 72.24 110.499 173.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -95.85 120.62 62.84 Favored Pre-proline 0 N--CA 1.47 0.557 0 N-CA-C 108.339 -0.985 . . . . 73.12 108.339 167.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -77.82 132.01 11.59 Favored 'Trans proline' 0 C--N 1.372 1.808 0 C-N-CA 122.417 2.078 . . . . 74.45 111.41 175.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 168.29 146.69 5.06 Favored Glycine 0 C--N 1.345 1.073 0 CA-C-O 119.228 -0.762 . . . . 44.01 112.688 177.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -68.98 -18.82 40.54 Favored 'Trans proline' 0 C--N 1.376 2.001 0 C-N-CA 123.635 2.89 . . . . 61.21 114.82 -173.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -81.26 -28.96 34.51 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 118.403 0.547 . . . . 64.42 111.134 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -179.34 105.94 0.2 Allowed Glycine 0 C--N 1.346 1.094 0 O-C-N 123.478 0.486 . . . . 72.01 112.205 -178.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 61.2 mtt-85 -86.8 122.55 30.84 Favored 'General case' 0 C--N 1.349 0.577 0 N-CA-C 108.012 -1.107 . . . . 72.2 108.012 173.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -83.41 -168.12 42.82 Favored Glycine 0 N--CA 1.469 0.866 0 O-C-N 123.661 0.601 . . . . 64.41 113.945 -176.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -120.29 126.5 50.73 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 108.674 -0.862 . . . . 65.45 108.674 177.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.464 ' HB2' ' HA2' ' A' ' 239' ' ' GLY . 46.3 tp -97.77 106.3 18.59 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 106.888 -1.523 . . . . 71.33 106.888 175.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -99.25 122.39 42.35 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.311 -0.859 . . . . 74.25 109.034 -170.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.561 ' HB3' ' HB2' ' A' ' 197' ' ' LEU . 65.0 mt -123.24 122.18 37.73 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.708 0.803 . . . . 61.31 110.157 -172.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . 0.461 ' HB2' HG22 ' A' ' 196' ' ' THR . 28.2 mm-40 -90.71 109.67 20.85 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.836 0.854 . . . . 74.0 109.686 178.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.542 HG11 HG22 ' A' ' 227' ' ' THR . 84.4 t -63.48 113.74 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 CA-C-O 121.424 0.631 . . . . 63.41 111.409 -176.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 28.1 mmm180 -114.21 105.27 12.97 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.72 1.608 . . . . 75.35 108.02 173.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.405 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 39.8 mt -76.95 128.59 37.87 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 N-CA-C 110.0 -0.37 . . . . 52.44 110.0 178.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 19.2 p . . . . . 0 C--O 1.248 1.015 0 C-N-CA 124.793 1.237 . . . . 51.12 108.79 -176.735 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 24.7 t70 . . . . . 0 N--CA 1.472 0.672 0 N-CA-C 111.878 0.325 . . . . 73.54 111.878 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.491 HG21 ' HB3' ' A' ' 234' ' ' ARG . 25.4 m -85.43 171.96 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 O-C-N 123.755 0.659 . . . . 72.44 110.749 -179.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.431 HG21 ' HD3' ' A' ' 231' ' ' ARG . 15.7 tt -93.05 145.69 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 N-CA-C 109.334 -0.617 . . . . 72.23 109.334 173.326 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -60.13 129.02 39.66 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.92 1.288 . . . . 73.53 111.329 -177.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.487 ' HB2' HD22 ' A' ' 233' ' ' LEU . . . -152.18 163.06 40.17 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 124.624 1.169 . . . . 61.43 109.219 175.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -149.17 176.68 10.29 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 108.56 -0.904 . . . . 64.2 108.56 173.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.429 ' CE1' ' HB3' ' A' ' 238' ' ' LYS . 22.8 p90 -144.07 177.23 8.72 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 118.029 0.377 . . . . 74.21 111.244 175.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -136.88 131.1 17.9 Favored Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 124.031 0.933 . . . . 74.04 109.52 176.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . 0.511 ' HA ' HG12 ' A' ' 219' ' ' VAL . 44.1 Cg_endo -66.07 95.39 0.3 Allowed 'Trans proline' 0 C--N 1.369 1.637 0 C-N-CA 122.927 2.418 . . . . 65.3 111.548 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . 0.586 ' HB2' ' HG3' ' A' ' 220' ' ' GLU . . . . . . . . 0 N--CA 1.479 1.005 0 C-N-CA 124.1 0.96 . . . . 64.35 111.561 -176.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 . . . . . 0 N--CA 1.477 0.888 0 N-CA-C 109.073 -0.714 . . . . 64.21 109.073 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.44 ' HA ' ' O ' ' A' ' 248' ' ' ASP . 1.2 p30 -102.61 129.39 49.17 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.292 -0.867 . . . . 63.24 109.443 175.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 68.4 mt -109.18 135.35 50.44 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 108.174 -1.047 . . . . 72.1 108.174 177.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -120.23 121.9 39.74 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 108.227 -1.027 . . . . 72.55 108.227 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -154.29 166.35 33.45 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 123.358 0.663 . . . . 40.03 110.56 -173.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 4.9 m -102.24 145.12 29.89 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 109.185 -0.672 . . . . 62.33 109.185 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.529 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . 43.0 tp -119.75 121.72 39.81 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.476 0.71 . . . . 72.14 110.183 -172.231 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -83.77 115.24 22.12 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 109.349 -0.612 . . . . 75.1 109.349 173.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.532 ' HA ' HG11 ' A' ' 210' ' ' VAL . 98.1 t -119.26 110.44 37.72 Favored Pre-proline 0 CA--C 1.537 0.478 0 C-N-CA 123.98 0.912 . . . . 75.33 109.0 177.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -54.73 141.66 75.34 Favored 'Trans proline' 0 C--N 1.37 1.697 0 C-N-CA 122.755 2.303 . . . . 70.4 112.184 171.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.406 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -48.48 -47.78 68.72 Favored Pre-proline 0 CA--C 1.563 1.447 0 CA-C-O 117.784 -1.103 . . . . 74.11 113.426 177.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . 0.406 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 15.7 Cg_endo -54.79 -46.33 34.14 Favored 'Trans proline' 0 C--N 1.398 3.163 0 C-N-CA 122.3 2.0 . . . . 72.22 112.787 175.214 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.419 HG21 HG13 ' A' ' 210' ' ' VAL . 43.9 mt -68.74 -32.35 54.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 123.768 0.827 . . . . 74.5 111.115 -176.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -65.61 -44.9 85.1 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.251 0.62 . . . . 64.51 110.829 178.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 201' ' ' ALA . 60.3 t -71.35 -52.3 27.67 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-N 115.82 -0.627 . . . . 74.43 110.909 -178.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 14.6 m -71.49 -25.85 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 N-CA-C 111.958 0.355 . . . . 70.51 111.958 -176.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 74.15 74.5 0.84 Allowed Glycine 0 C--N 1.341 0.833 0 N-CA-C 111.674 -0.57 . . . . 62.45 111.674 -174.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -118.88 -164.16 12.72 Favored Glycine 0 N--CA 1.472 1.08 0 N-CA-C 111.75 -0.54 . . . . 34.44 111.75 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -103.16 142.46 34.11 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 117.434 0.617 . . . . 74.32 110.317 -179.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.532 HG11 ' HA ' ' A' ' 199' ' ' VAL . 22.5 m -120.73 147.15 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 124.672 1.189 . . . . 65.22 109.077 175.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 19.3 ttm180 -90.46 109.55 20.67 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 122.024 -0.423 . . . . 72.4 110.034 -178.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -100.25 158.63 15.73 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.689 1.196 . . . . 71.43 110.803 -175.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 2.0 mmt -105.87 108.63 20.25 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.636 0.774 . . . . 75.32 110.437 -178.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 68.7 p -111.32 175.41 5.43 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 109.434 -0.58 . . . . 75.23 109.434 170.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 19.3 mt -70.61 -17.82 62.88 Favored 'General case' 0 CA--C 1.55 0.978 0 CA-C-N 115.761 -0.654 . . . . 64.02 110.468 178.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -92.44 -0.32 57.37 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.868 1.267 . . . . 71.31 110.993 178.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 108.89 -161.76 13.07 Favored Glycine 0 C--N 1.349 1.264 0 C-N-CA 123.594 0.616 . . . . 74.14 113.281 175.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.46 132.16 18.66 Favored 'Trans proline' 0 C--N 1.363 1.313 0 C-N-CA 122.719 2.28 . . . . 74.43 112.864 178.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.511 HG12 ' HA ' ' A' ' 177' ' ' PRO . 34.2 m -130.13 160.24 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 124.344 1.058 . . . . 73.12 109.214 177.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.586 ' HG3' ' HB2' ' A' ' 178' ' ' ALA . 46.1 mt-10 -109.26 108.27 18.81 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.461 0.704 . . . . 73.2 110.297 178.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 72.9 t -92.69 116.13 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 123.363 0.665 . . . . 52.31 109.591 -176.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -66.57 100.45 0.67 Allowed 'General case' 0 CA--C 1.543 0.706 0 O-C-N 124.022 0.827 . . . . 52.11 109.647 174.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 61.1 t -75.16 131.11 78.98 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 124.944 1.297 . . . . 53.3 109.071 176.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . 0.41 ' HA ' ' HD3' ' A' ' 225' ' ' PRO . 18.4 Cg_endo -59.89 152.56 63.34 Favored 'Trans proline' 0 CA--C 1.565 2.055 0 C-N-CA 122.318 2.012 . . . . 73.43 112.76 173.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 224' ' ' PRO . 29.6 Cg_exo -65.49 146.44 85.06 Favored 'Trans proline' 0 C--N 1.371 1.738 0 C-N-CA 122.453 2.102 . . . . 72.33 112.88 175.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 35.1 mtp180 65.29 23.34 12.13 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 125.009 1.323 . . . . 75.04 112.207 174.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.528 HG23 ' HD2' ' A' ' 231' ' ' ARG . 4.1 m -54.81 139.13 40.75 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.612 1.165 . . . . 72.41 112.397 179.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -102.94 158.34 16.35 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.868 0.867 . . . . 63.54 109.816 175.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -73.83 131.26 41.33 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 108.893 -0.781 . . . . 72.13 108.893 172.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 100.2 2.22 55.81 Favored Glycine 0 N--CA 1.464 0.528 0 CA-C-O 119.197 -0.78 . . . . 71.14 112.385 -172.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.528 ' HD2' HG23 ' A' ' 227' ' ' THR . 60.5 mtt-85 -69.18 159.34 33.17 Favored 'General case' 0 C--N 1.359 1.021 0 CA-C-O 121.457 0.646 . . . . 73.03 110.338 172.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 48.9 pttt -130.86 132.93 45.48 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 114.927 -1.033 . . . . 73.12 109.727 -175.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.487 HD22 ' HB2' ' A' ' 173' ' ' ALA . 37.3 mt -121.47 127.3 50.94 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 108.213 -1.032 . . . . 65.41 108.213 178.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . 0.491 ' HB3' HG21 ' A' ' 170' ' ' VAL . 31.4 ttt180 -116.83 102.78 9.68 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 107.797 -1.186 . . . . 71.24 107.797 170.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.444 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 16.3 mt -83.52 84.58 7.48 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 114.948 -1.024 . . . . 75.24 109.279 -176.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -71.09 137.1 48.62 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.143 -0.935 . . . . 73.4 110.86 -178.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 67.39 16.56 67.41 Favored Glycine 0 C--N 1.352 1.425 0 O-C-N 123.987 0.804 . . . . 61.54 112.567 -177.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.429 ' HB3' ' CE1' ' A' ' 175' ' ' TYR . 31.3 mmtp -139.96 23.37 2.42 Favored 'General case' 0 C--O 1.217 -0.64 0 C-N-CA 124.54 1.136 . . . . 74.34 109.861 -175.297 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -89.37 -127.25 3.08 Favored Glycine 0 N--CA 1.468 0.829 0 O-C-N 121.869 -0.519 . . . . 54.0 111.899 171.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.52 147.06 62.65 Favored Pre-proline 0 N--CA 1.476 0.863 0 CA-C-O 118.326 -0.845 . . . . 71.43 110.434 176.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.503 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 86.2 Cg_exo -46.08 140.72 10.25 Favored 'Trans proline' 0 C--N 1.392 2.856 0 C-N-CA 123.837 3.025 . . . . 61.52 114.409 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -157.26 129.37 2.36 Favored Glycine 0 CA--C 1.536 1.353 0 CA-C-O 118.5 -1.167 . . . . 61.15 111.459 -179.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -62.47 -45.45 14.6 Favored 'Trans proline' 0 C--N 1.378 2.089 0 C-N-CA 123.137 2.558 . . . . 75.44 113.869 -178.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -78.21 -28.19 47.96 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-O 121.146 0.498 . . . . 22.15 110.461 177.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 169.52 145.92 4.85 Favored Glycine 0 C--N 1.334 0.471 0 CA-C-N 115.13 -0.941 . . . . 75.02 110.854 176.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.503 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 23.9 mtt180 -69.46 156.08 39.44 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.3 0.64 . . . . 75.34 110.665 177.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -73.13 -155.96 3.39 Favored Glycine 0 C--N 1.348 1.196 0 CA-C-N 116.076 -0.511 . . . . 65.11 113.218 178.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . 0.44 ' O ' ' HA ' ' A' ' 192' ' ' ASP . 21.6 m-20 -106.99 148.63 28.45 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.551 0.74 . . . . 61.24 110.479 179.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.444 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 50.0 tp -125.23 105.12 8.89 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 107.663 -1.236 . . . . 74.14 107.663 169.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -96.96 109.09 21.91 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 123.637 0.775 . . . . 73.11 109.527 -174.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.529 ' HB3' ' HB2' ' A' ' 197' ' ' LEU . 71.8 mt -112.84 116.36 29.93 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.119 0.968 . . . . 71.22 109.918 -178.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -86.64 113.64 22.68 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.644 0.778 . . . . 73.34 110.192 177.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.402 HG11 ' CG2' ' A' ' 227' ' ' THR . 97.0 t -65.68 125.0 21.84 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.218 0 C-N-CA 123.801 0.84 . . . . 62.32 112.314 -177.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 26.3 mmm180 -118.34 108.38 15.01 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.428 1.491 . . . . 74.25 107.905 170.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.491 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 34.6 mt -76.78 119.16 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 109.696 -0.483 . . . . 70.32 109.696 177.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 36.0 p . . . . . 0 CA--C 1.551 0.999 0 C-N-CA 124.437 1.095 . . . . 74.12 108.903 178.924 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 25.9 t70 . . . . . 0 N--CA 1.48 1.032 0 CA-C-O 121.772 0.796 . . . . 72.51 109.453 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.426 HG21 ' N ' ' A' ' 234' ' ' ARG . 27.1 m -107.28 -176.98 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-N 114.206 -1.361 . . . . 62.24 109.458 179.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 13.2 tt -84.83 139.77 17.0 Favored 'Isoleucine or valine' 0 C--O 1.246 0.891 0 N-CA-C 108.036 -1.098 . . . . 75.43 108.036 164.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -70.59 135.13 48.23 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 122.831 0.452 . . . . 75.23 110.065 177.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.452 ' HB2' HD22 ' A' ' 233' ' ' LEU . . . -138.98 175.37 9.61 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.062 0.945 . . . . 74.32 109.207 177.073 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -150.98 158.98 44.82 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 122.79 0.436 . . . . 64.22 110.337 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.532 ' HD1' HD13 ' A' ' 235' ' ' LEU . 9.8 p90 -140.63 176.12 9.05 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.346 0.593 . . . . 73.15 110.548 170.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -145.48 149.26 40.09 Favored Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 124.586 1.154 . . . . 71.21 108.614 170.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . 0.519 ' HA ' HG12 ' A' ' 219' ' ' VAL . 27.5 Cg_endo -58.24 123.79 14.42 Favored 'Trans proline' 0 C--N 1.373 1.85 0 C-N-CA 123.009 2.473 . . . . 73.21 111.99 -179.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . 0.579 ' HB2' ' HG3' ' A' ' 220' ' ' GLU . . . . . . . . 0 N--CA 1.476 0.846 0 N-CA-C 108.177 -1.046 . . . . 70.12 108.177 172.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.415 ' HA ' ' HB2' ' A' ' 240' ' ' PHE . 53.5 mt-30 . . . . . 0 N--CA 1.474 0.731 0 CA-C-O 120.989 0.423 . . . . 73.13 111.08 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 20.1 p-10 -85.18 126.5 33.7 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.311 0.644 . . . . 73.3 109.773 171.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 34.5 mt -108.9 145.07 35.97 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.191 1.396 . . . . 52.32 108.875 177.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -123.73 121.75 36.3 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 107.797 -1.186 . . . . 73.4 107.797 175.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.426 ' O ' ' HA ' ' A' ' 251' ' ' LEU . . . -149.51 165.59 31.71 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.065 0.946 . . . . 74.31 109.527 -171.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 10.5 m -108.77 140.72 41.81 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 109.969 -0.382 . . . . 74.3 109.969 -177.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.476 HD11 HG23 ' A' ' 210' ' ' VAL . 43.1 tp -108.79 121.52 45.24 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.748 0.819 . . . . 65.21 110.036 -176.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -93.11 103.02 15.35 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 109.161 -0.681 . . . . 62.43 109.161 172.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.56 HG21 HG11 ' A' ' 223' ' ' VAL . 2.7 p -106.57 119.52 51.4 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 123.676 0.791 . . . . 74.3 109.53 173.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -55.47 140.88 83.15 Favored 'Trans proline' 0 C--N 1.375 1.922 0 C-N-CA 122.331 2.021 . . . . 54.4 112.486 169.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.405 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -51.71 -49.17 84.72 Favored Pre-proline 0 CA--C 1.554 1.113 0 CA-C-O 118.077 -0.963 . . . . 73.55 113.451 -177.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -56.59 -39.83 88.62 Favored 'Trans proline' 0 C--N 1.39 2.724 0 C-N-CA 121.902 1.735 . . . . 54.35 112.877 176.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 28.4 mt -69.15 -34.28 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 123.259 0.624 . . . . 62.15 110.4 -178.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -66.33 -42.72 87.75 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.012 0.525 . . . . 72.0 111.073 178.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 201' ' ' ALA . 87.1 t -71.96 -49.51 44.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 123.682 0.793 . . . . 64.03 111.282 -176.24 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 16.2 m -75.01 -22.75 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 CA-C-N 116.668 -0.242 . . . . 70.45 111.496 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 76.4 76.05 0.84 Allowed Glycine 0 C--N 1.346 1.106 0 N-CA-C 112.179 -0.369 . . . . 61.52 112.179 -177.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -110.69 -159.18 16.42 Favored Glycine 0 C--N 1.339 0.706 0 N-CA-C 111.699 -0.561 . . . . 73.32 111.699 -179.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 33.7 mtmm -115.13 145.45 42.34 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 108.88 -0.785 . . . . 63.44 108.88 173.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.49 HG11 ' HA ' ' A' ' 199' ' ' VAL . 19.6 m -128.06 168.17 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 123.95 0.9 . . . . 73.11 109.829 177.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 35.4 mtp-105 -99.38 117.49 33.93 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 121.218 0.532 . . . . 73.44 110.498 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -101.02 128.09 47.22 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 107.633 -1.247 . . . . 24.45 107.633 171.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.25 112.1 23.06 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 109.158 -0.682 . . . . 75.41 109.158 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 69.3 p -110.39 -177.96 3.38 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.62 0.768 . . . . 65.31 109.823 177.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 17.4 mt -67.44 -23.48 65.53 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 122.488 0.315 . . . . 61.5 111.021 178.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -86.31 -19.14 30.3 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.748 0.819 . . . . 71.23 111.895 178.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 127.42 -151.77 18.56 Favored Glycine 0 C--N 1.345 1.043 0 CA-C-O 119.568 -0.573 . . . . 53.11 112.594 176.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.65 135.14 17.56 Favored 'Trans proline' 0 C--N 1.372 1.799 0 C-N-CA 122.7 2.267 . . . . 74.04 111.65 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.519 HG12 ' HA ' ' A' ' 177' ' ' PRO . 33.3 m -135.41 142.07 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 123.306 0.642 . . . . 73.03 109.813 175.349 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.579 ' HG3' ' HB2' ' A' ' 178' ' ' ALA . 43.2 mt-10 -90.49 106.74 18.7 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.028 0.531 . . . . 73.02 110.281 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.435 HG22 ' HB3' ' A' ' 175' ' ' TYR . 59.6 t -94.33 121.65 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 123.79 0.836 . . . . 60.45 109.423 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -71.19 107.95 4.46 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.257 0.623 . . . . 75.24 110.064 177.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.56 HG11 HG21 ' A' ' 199' ' ' VAL . 48.3 t -83.51 124.05 75.96 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 124.658 1.183 . . . . 75.05 108.897 175.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -58.97 152.49 57.97 Favored 'Trans proline' 0 CA--C 1.567 2.169 0 C-N-CA 122.675 2.25 . . . . 75.32 113.11 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -59.61 126.23 20.03 Favored 'Trans proline' 0 C--N 1.375 1.972 0 C-N-CA 122.511 2.141 . . . . 74.15 112.408 173.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 75.3 mtp180 65.52 61.58 0.69 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.97 1.308 . . . . 65.03 111.317 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.468 HG23 ' HD2' ' A' ' 231' ' ' ARG . 27.0 m -85.16 143.86 28.54 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.409 -0.814 . . . . 64.45 109.773 173.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -111.07 153.89 25.01 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.66 0.784 . . . . 74.35 110.863 179.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -70.46 135.82 48.98 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.576 0.75 . . . . 74.31 110.261 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.82 1.29 63.55 Favored Glycine 0 C--N 1.341 0.811 0 CA-C-O 119.689 -0.506 . . . . 71.31 113.174 -177.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.468 ' HD2' HG23 ' A' ' 227' ' ' THR . 52.4 mtt-85 -69.84 160.99 30.74 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 117.243 0.521 . . . . 63.42 110.551 171.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 20.9 pttm -126.98 135.06 50.34 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.864 -0.607 . . . . 73.51 110.603 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.452 HD22 ' HB2' ' A' ' 173' ' ' ALA . 74.4 mt -114.08 145.24 41.88 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.951 1.3 . . . . 63.4 108.173 175.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . 0.426 ' N ' HG21 ' A' ' 170' ' ' VAL . 51.7 ttt85 -136.53 102.18 4.86 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 107.952 -1.129 . . . . 74.52 107.952 166.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.532 HD13 ' HD1' ' A' ' 175' ' ' TYR . 14.8 mt -73.78 91.43 1.94 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.752 1.221 . . . . 63.32 109.433 179.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 51.9 mttp -62.29 124.74 21.7 Favored 'General case' 0 C--N 1.354 0.801 0 C-N-CA 123.437 0.695 . . . . 74.42 110.696 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 69.42 34.52 74.3 Favored Glycine 0 C--N 1.345 1.059 0 O-C-N 123.54 0.525 . . . . 51.34 113.061 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.487 ' HB3' ' CE1' ' A' ' 175' ' ' TYR . 32.8 mmtm -143.44 29.84 1.41 Allowed 'General case' 0 CA--C 1.559 1.321 0 C-N-CA 123.76 0.824 . . . . 74.4 112.616 -173.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -99.21 -111.05 3.15 Favored Glycine 0 N--CA 1.482 1.716 0 N-CA-C 111.134 -0.787 . . . . 52.12 111.134 175.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . 0.415 ' HB2' ' HA ' ' A' ' 191' ' ' GLN . 5.8 m-85 -71.19 151.88 94.57 Favored Pre-proline 0 N--CA 1.48 1.049 0 C-N-CA 123.728 0.811 . . . . 71.14 109.813 165.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.525 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 52.3 Cg_exo -57.3 155.68 28.86 Favored 'Trans proline' 0 C--N 1.373 1.838 0 C-N-CA 122.93 2.42 . . . . 54.42 112.418 165.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -162.76 125.03 1.35 Allowed Glycine 0 CA--C 1.535 1.296 0 CA-C-O 118.602 -1.11 . . . . 64.14 111.625 178.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -60.65 -49.01 9.58 Favored 'Trans proline' 0 C--N 1.381 2.237 0 C-N-CA 123.391 2.727 . . . . 74.43 112.644 177.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -76.31 -26.34 55.72 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 122.874 0.47 . . . . 64.52 110.692 178.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 165.01 145.17 4.31 Favored Glycine 0 C--N 1.344 1.005 0 CA-C-N 115.617 -0.72 . . . . 75.15 111.343 177.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.525 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 21.1 mtt180 -73.28 163.3 28.29 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.538 0.735 . . . . 73.1 111.127 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -81.55 -169.23 42.08 Favored Glycine 0 C--N 1.348 1.202 0 CA-C-N 115.824 -0.626 . . . . 74.45 111.768 170.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -107.37 152.1 24.62 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 118.003 0.902 . . . . 72.31 110.617 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 55.9 tp -120.92 106.7 11.87 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 108.706 -0.849 . . . . 61.04 108.706 173.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -91.37 123.66 34.97 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 123.806 0.843 . . . . 63.42 108.984 -177.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.426 ' HA ' ' O ' ' A' ' 195' ' ' ALA . 61.7 mt -119.53 122.37 41.48 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.374 0.67 . . . . 74.13 110.396 -176.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -81.07 114.0 19.63 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 108.975 -0.75 . . . . 71.11 108.975 172.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 88.4 t -66.92 109.52 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 122.905 0.482 . . . . 73.11 110.791 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 9.2 mmm180 -113.47 105.68 13.65 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 124.279 1.032 . . . . 73.21 108.848 173.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 28.9 mt -76.96 131.09 35.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-N 115.652 -0.703 . . . . 73.21 109.525 176.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 3.3 t . . . . . 0 CA--C 1.562 1.414 0 CA-C-O 117.849 -1.072 . . . . 62.45 108.763 -178.231 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 21.1 t70 . . . . . 0 N--CA 1.476 0.827 0 CA-C-O 120.976 0.417 . . . . 70.44 111.045 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.498 HG11 ' HB2' ' A' ' 234' ' ' ARG . 26.2 m -93.37 177.19 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 C-N-CA 123.061 0.545 . . . . 65.2 110.637 175.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.405 HG21 ' HD3' ' A' ' 231' ' ' ARG . 13.8 tt -103.17 147.59 9.37 Favored 'Isoleucine or valine' 0 C--O 1.245 0.863 0 N-CA-C 108.418 -0.956 . . . . 72.34 108.418 173.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -64.31 142.83 58.28 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.654 0.782 . . . . 52.44 110.656 -178.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.529 ' HB2' HD22 ' A' ' 233' ' ' LEU . . . -160.0 164.48 33.23 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 123.82 0.848 . . . . 53.45 109.616 -178.264 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -157.25 157.67 34.71 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.703 0.801 . . . . 73.02 109.665 -178.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.489 ' HD1' HD13 ' A' ' 235' ' ' LEU . 5.5 p90 -135.97 178.01 7.38 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.232 0.539 . . . . 75.53 111.537 177.124 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . 0.555 ' HE2' ' HA ' ' A' ' 176' ' ' LYS . 7.9 mmpt? -132.7 135.31 25.87 Favored Pre-proline 0 N--CA 1.472 0.632 0 C-N-CA 124.691 1.197 . . . . 73.22 108.924 174.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . 0.519 ' HA ' HG12 ' A' ' 219' ' ' VAL . 48.1 Cg_endo -65.86 94.96 0.28 Allowed 'Trans proline' 0 C--N 1.377 2.05 0 C-N-CA 122.74 2.294 . . . . 72.02 111.127 178.037 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . 0.58 ' H ' ' HA ' ' A' ' 219' ' ' VAL . . . . . . . . 0 N--CA 1.479 1.004 0 C-N-CA 124.371 1.068 . . . . 74.11 111.543 -177.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 . . . . . 0 N--CA 1.48 1.062 0 CA-C-O 121.184 0.516 . . . . 61.44 111.155 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.407 ' HA ' ' O ' ' A' ' 248' ' ' ASP . 6.7 p-10 -91.19 151.28 21.01 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 115.673 -0.694 . . . . 73.23 109.901 175.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 79.7 mt -132.76 130.79 40.39 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.792 0.837 . . . . 71.34 109.084 173.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -96.71 125.48 41.21 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 108.337 -0.986 . . . . 74.55 108.337 174.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.458 ' O ' ' HA ' ' A' ' 251' ' ' LEU . . . -148.63 143.23 26.41 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.408 0.683 . . . . 74.25 109.336 178.026 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 2.4 p -89.92 132.36 35.35 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 109.079 -0.712 . . . . 71.52 109.079 171.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.575 HD13 ' HB2' ' A' ' 212' ' ' ALA . 62.3 tp -107.3 110.96 23.1 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.81 0.844 . . . . 74.44 108.972 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -85.08 128.46 34.66 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-O 120.962 0.411 . . . . 75.21 109.918 175.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.514 ' HA ' HG11 ' A' ' 210' ' ' VAL . 3.1 p -133.29 123.67 17.85 Favored Pre-proline 0 CA--C 1.545 0.773 0 CA-C-N 114.775 -1.102 . . . . 71.13 108.954 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -57.61 143.15 95.51 Favored 'Trans proline' 0 C--N 1.37 1.662 0 C-N-CA 122.585 2.19 . . . . 71.55 111.653 171.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.431 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -50.42 -46.45 84.39 Favored Pre-proline 0 CA--C 1.563 1.443 0 CA-C-O 117.782 -1.104 . . . . 70.15 112.993 -178.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -55.51 -44.62 46.67 Favored 'Trans proline' 0 C--N 1.395 2.977 0 C-N-CA 122.3 2.0 . . . . 74.22 113.088 174.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.473 HG21 HG13 ' A' ' 210' ' ' VAL . 45.4 mt -68.4 -32.03 53.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 C-N-CA 123.467 0.707 . . . . 61.21 110.598 -178.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.42 -44.02 75.91 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.224 0.61 . . . . 74.35 110.957 178.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 201' ' ' ALA . 93.1 t -70.43 -48.19 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 123.532 0.733 . . . . 72.0 111.217 -177.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 7.2 p -72.47 -30.37 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 CA-C-O 120.601 0.239 . . . . 74.32 110.998 -179.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 78.76 67.57 1.59 Allowed Glycine 0 C--N 1.352 1.423 0 N-CA-C 111.637 -0.585 . . . . 43.02 111.637 -174.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -98.95 -145.71 19.1 Favored Glycine 0 C--N 1.352 1.444 0 N-CA-C 111.449 -0.66 . . . . 74.31 111.449 -177.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -120.73 146.68 46.22 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.561 0.745 . . . . 63.32 109.078 173.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.514 HG11 ' HA ' ' A' ' 199' ' ' VAL . 7.1 m -139.9 155.36 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 C-N-CA 124.679 1.192 . . . . 53.44 109.211 171.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 14.7 ttp180 -91.22 119.55 31.4 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-O 120.805 0.336 . . . . 72.11 111.126 -170.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . 0.575 ' HB2' HD13 ' A' ' 197' ' ' LEU . . . -100.53 151.78 21.17 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.969 0.907 . . . . 43.31 108.951 172.146 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -107.15 116.46 31.97 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 123.599 0.76 . . . . 73.24 110.222 -178.052 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 24.6 p -109.72 172.24 6.97 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.21 1.004 . . . . 72.41 108.631 172.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 17.5 mt -74.02 -5.9 44.22 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 122.819 0.448 . . . . 62.32 111.958 -176.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . 0.409 ' H ' ' HG2' ' A' ' 216' ' ' GLU . 6.2 pt-20 -107.16 -9.64 16.09 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.756 1.223 . . . . 75.23 111.349 -177.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 139.65 -165.92 25.72 Favored Glycine 0 C--N 1.352 1.439 0 CA-C-O 120.151 -0.25 . . . . 34.32 113.526 175.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.66 142.65 23.22 Favored 'Trans proline' 0 C--N 1.369 1.627 0 C-N-CA 123.225 2.617 . . . . 75.25 112.466 176.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.58 ' HA ' ' H ' ' A' ' 178' ' ' ALA . 24.8 m -137.29 143.58 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 123.849 0.86 . . . . 73.45 109.733 176.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.407 ' HG3' ' HB2' ' A' ' 178' ' ' ALA . 46.4 mt-10 -97.3 114.65 26.45 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 118.27 0.487 . . . . 74.54 109.78 175.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.446 HG22 ' HB3' ' A' ' 175' ' ' TYR . 52.9 t -95.47 126.02 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.277 1.031 . . . . 71.31 109.679 179.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -75.46 106.3 6.94 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 123.315 0.646 . . . . 53.34 109.397 175.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 44.9 t -68.39 132.09 91.53 Favored Pre-proline 0 CA--C 1.552 1.028 0 C-N-CA 124.417 1.087 . . . . 63.52 109.525 175.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -59.78 144.86 99.37 Favored 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 122.455 2.103 . . . . 63.23 111.853 173.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_exo -62.12 129.66 27.93 Favored 'Trans proline' 0 C--N 1.375 1.961 0 C-N-CA 122.667 2.245 . . . . 52.33 111.689 176.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 62.7 mtp180 67.33 79.18 0.23 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.247 1.419 . . . . 72.35 110.086 179.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.566 ' HA ' ' HE ' ' A' ' 231' ' ' ARG . 13.3 m -107.52 141.16 39.39 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 114.231 -1.35 . . . . 74.22 110.684 -177.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -118.11 147.23 43.5 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.356 1.062 . . . . 74.22 108.382 174.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -60.26 125.2 22.78 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.123 0.969 . . . . 72.33 110.571 -178.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 113.38 4.38 23.63 Favored Glycine 0 C--N 1.34 0.805 0 CA-C-O 119.537 -0.591 . . . . 74.43 113.12 -175.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.566 ' HE ' ' HA ' ' A' ' 227' ' ' THR . 72.4 mtt-85 -65.73 148.23 52.09 Favored 'General case' 0 C--N 1.363 1.162 0 N-CA-C 109.249 -0.649 . . . . 73.24 109.249 167.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 18.9 pttm -124.84 117.08 23.32 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.971 -1.122 . . . . 63.42 107.971 176.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.529 HD22 ' HB2' ' A' ' 173' ' ' ALA . 30.6 mt -103.89 97.42 7.42 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 108.066 -1.087 . . . . 71.03 108.066 -179.466 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . 0.498 ' HB2' HG11 ' A' ' 170' ' ' VAL . 40.6 ttt180 -93.54 101.13 13.3 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 108.823 -0.806 . . . . 75.23 108.823 177.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.492 ' HB3' ' HB2' ' A' ' 238' ' ' LYS . 21.8 mt -82.92 83.92 7.61 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.481 -1.236 . . . . 64.2 109.669 -174.133 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 55.4 mttp -62.75 137.63 58.31 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 116.098 -0.501 . . . . 60.42 110.082 177.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 64.59 23.66 68.93 Favored Glycine 0 C--N 1.347 1.151 0 O-C-N 123.679 0.612 . . . . 64.32 113.004 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.492 ' HB2' ' HB3' ' A' ' 235' ' ' LEU . 45.7 mmtm -140.51 16.86 2.37 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.308 1.043 . . . . 63.0 111.247 -176.201 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -93.47 -116.99 2.62 Favored Glycine 0 N--CA 1.467 0.741 0 N-CA-C 111.568 -0.613 . . . . 70.42 111.568 179.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -71.45 130.29 87.73 Favored Pre-proline 0 CA--C 1.546 0.817 0 CA-C-O 118.619 -0.705 . . . . 72.44 109.781 179.191 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.479 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 22.2 Cg_endo -60.41 129.16 28.58 Favored 'Trans proline' 0 C--N 1.373 1.824 0 C-N-CA 123.154 2.569 . . . . 71.5 112.533 175.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -150.81 135.44 5.16 Favored Glycine 0 CA--C 1.532 1.103 0 CA-C-O 118.651 -1.083 . . . . 71.44 110.557 179.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -61.73 -41.67 37.08 Favored 'Trans proline' 0 C--N 1.382 2.331 0 C-N-CA 123.54 2.827 . . . . 53.22 112.746 -176.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -78.01 -26.64 48.61 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.177 0.591 . . . . 73.24 111.258 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 169.24 148.11 5.69 Favored Glycine 0 C--N 1.347 1.172 0 N-CA-C 111.457 -0.657 . . . . 63.22 111.457 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.479 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 36.4 mtt-85 -86.45 161.37 18.66 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 122.769 0.428 . . . . 65.41 110.148 178.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -81.84 -155.86 15.99 Favored Glycine 0 C--N 1.34 0.785 0 CA-C-N 115.591 -0.732 . . . . 51.3 112.368 172.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . 0.407 ' O ' ' HA ' ' A' ' 192' ' ' ASP . 6.5 p-10 -118.45 131.53 56.26 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.442 0.697 . . . . 75.23 110.381 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 58.5 tp -98.16 106.89 19.24 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 107.76 -1.2 . . . . 53.43 107.76 173.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -89.3 108.58 19.7 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 115.496 -0.775 . . . . 74.32 109.053 -177.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.558 HD13 HD22 ' A' ' 197' ' ' LEU . 63.6 mt -103.13 139.35 38.76 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.79 0.836 . . . . 65.34 110.096 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -111.44 108.79 18.47 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.63 -0.878 . . . . 72.34 108.63 172.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 72.5 t -66.5 109.37 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 C-N-CA 123.922 0.889 . . . . 74.4 111.33 -178.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 31.5 mmm180 -108.52 102.95 11.99 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.381 1.472 . . . . 63.45 108.312 177.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 30.4 mt -77.14 142.78 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 N-CA-C 109.855 -0.424 . . . . 64.44 109.855 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.9 t . . . . . 0 CA--C 1.558 1.277 0 C-N-CA 124.092 0.957 . . . . 70.05 109.207 176.377 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 25.5 t70 . . . . . 0 N--CA 1.474 0.758 0 CA-C-O 121.069 0.461 . . . . 71.33 110.053 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.492 HG21 ' HB3' ' A' ' 234' ' ' ARG . 15.4 m -97.41 161.7 2.78 Favored 'Isoleucine or valine' 0 C--O 1.247 0.942 0 CA-C-N 114.905 -1.043 . . . . 74.34 109.188 172.149 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 12.6 tt -85.63 151.96 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 N-CA-C 108.92 -0.771 . . . . 63.33 108.92 174.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -56.15 128.81 37.36 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.471 1.109 . . . . 74.33 110.961 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.466 ' HB2' HD22 ' A' ' 233' ' ' LEU . . . -158.66 143.95 16.37 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.258 1.023 . . . . 74.21 109.754 179.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -146.56 169.13 19.58 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 108.244 -1.021 . . . . 74.24 108.244 172.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.511 ' CE1' ' HB3' ' A' ' 238' ' ' LYS . 37.5 p90 -129.61 -177.81 4.42 Favored 'General case' 0 C--O 1.243 0.733 0 CA-C-O 121.739 0.781 . . . . 74.43 111.65 -176.166 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 11.9 mmmm -132.61 122.03 17.59 Favored Pre-proline 0 C--O 1.232 0.178 0 CA-C-N 114.368 -1.287 . . . . 74.4 107.536 174.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . 0.411 ' HA ' HG12 ' A' ' 219' ' ' VAL . 57.3 Cg_endo -66.92 93.71 0.33 Allowed 'Trans proline' 0 C--N 1.359 1.105 0 C-N-CA 122.856 2.371 . . . . 73.43 111.63 -177.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . 0.452 ' HB2' ' HG3' ' A' ' 220' ' ' GLU . . . . . . . . 0 CA--C 1.542 0.658 0 N-CA-C 109.45 -0.574 . . . . 54.04 109.45 179.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.401 ' HA ' ' HB2' ' A' ' 240' ' ' PHE . 25.5 mm-40 . . . . . 0 N--CA 1.478 0.927 0 N-CA-C 110.152 -0.314 . . . . 64.04 110.152 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -95.09 154.21 17.28 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 122.726 0.41 . . . . 61.15 110.74 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 33.3 mt -128.09 156.33 42.99 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.147 0.979 . . . . 70.21 109.863 175.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -130.5 121.91 26.67 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.892 0.877 . . . . 74.23 108.716 173.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -149.6 167.35 26.61 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 124.003 0.921 . . . . 53.13 109.58 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 17.7 m -112.14 137.04 50.77 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.779 -0.646 . . . . 70.0 109.4 -178.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 43.8 tp -108.92 122.13 46.57 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.181 0.992 . . . . 74.51 110.117 -170.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -87.45 104.64 16.65 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.566 0.746 . . . . 72.0 109.613 176.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.537 ' HA ' HG11 ' A' ' 210' ' ' VAL . 59.7 t -109.21 113.74 58.51 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 123.489 0.716 . . . . 72.5 109.436 174.123 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -58.56 141.84 97.72 Favored 'Trans proline' 0 C--N 1.379 2.17 0 C-N-CA 123.039 2.493 . . . . 64.2 111.937 171.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -51.6 -45.51 91.1 Favored Pre-proline 0 CA--C 1.562 1.419 0 N-CA-C 113.931 1.086 . . . . 31.0 113.931 -176.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -55.37 -47.09 27.76 Favored 'Trans proline' 0 C--N 1.391 2.775 0 C-N-CA 121.957 1.771 . . . . 70.32 113.184 173.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 56.6 mt -66.86 -29.82 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 123.641 0.776 . . . . 75.33 110.734 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.8 -46.77 67.82 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.585 0.754 . . . . 71.11 111.486 179.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 85.5 t -66.44 -54.43 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 115.937 -0.574 . . . . 63.24 110.501 -178.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 18.2 m -69.47 -30.44 45.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 N-CA-C 112.072 0.397 . . . . 73.24 112.072 -177.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 74.68 68.3 1.58 Allowed Glycine 0 C--N 1.345 1.038 0 O-C-N 123.431 0.457 . . . . 71.44 112.28 -176.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -97.58 -126.51 5.43 Favored Glycine 0 C--N 1.348 1.222 0 N-CA-C 111.74 -0.544 . . . . 44.44 111.74 -178.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 49.1 mtmt -131.55 158.93 39.64 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.741 0.816 . . . . 71.32 108.982 171.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.537 HG11 ' HA ' ' A' ' 199' ' ' VAL . 6.0 m -136.77 137.29 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 123.545 0.738 . . . . 43.22 109.917 174.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 51.1 ttt-85 -83.58 109.04 17.08 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 108.913 -0.773 . . . . 73.01 108.913 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -101.12 155.26 18.1 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.493 1.117 . . . . 64.35 110.213 -177.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 16.1 mmt -105.62 118.45 36.61 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.022 0.929 . . . . 51.24 109.349 178.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 70.7 p -116.65 179.24 4.06 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.803 0.441 . . . . 72.02 109.825 170.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 20.8 mt -62.97 -36.15 82.52 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.752 -0.658 . . . . 71.13 111.091 -177.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -93.69 -20.14 20.44 Favored 'General case' 0 CA--C 1.554 1.1 0 CA-C-N 115.295 -0.866 . . . . 72.41 111.643 -170.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 155.56 177.73 29.09 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 120.881 -0.676 . . . . 43.44 114.183 177.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -64.5 142.11 76.68 Favored 'Trans proline' 0 C--N 1.376 1.975 0 C-N-CA 123.001 2.467 . . . . 73.12 112.513 174.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.411 HG12 ' HA ' ' A' ' 177' ' ' PRO . 34.4 m -139.3 128.49 29.34 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 C-N-CA 123.311 0.644 . . . . 74.41 109.84 179.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.452 ' HG3' ' HB2' ' A' ' 178' ' ' ALA . 36.7 mt-10 -83.42 104.02 13.24 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 109.778 -0.453 . . . . 72.5 109.778 177.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 48.1 t -93.49 118.13 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 109.121 -0.696 . . . . 74.13 109.121 -177.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -71.87 107.21 4.52 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 123.25 0.62 . . . . 72.11 110.16 -179.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 60.5 t -70.97 130.29 88.49 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 124.556 1.142 . . . . 74.52 109.709 -179.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -63.73 140.08 72.4 Favored 'Trans proline' 0 C--N 1.373 1.868 0 C-N-CA 122.387 2.058 . . . . 62.25 112.246 174.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -60.38 133.54 49.82 Favored 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 122.342 2.028 . . . . 70.43 111.758 174.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 82.1 mtt180 68.85 72.5 0.27 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.938 1.295 . . . . 73.05 109.795 -176.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.735 ' HA ' ' HE ' ' A' ' 231' ' ' ARG . 38.9 m -94.22 140.13 30.16 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 114.784 -1.098 . . . . 73.2 110.085 176.01 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -113.29 145.48 40.99 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 124.054 0.942 . . . . 73.42 108.738 174.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . 0.474 ' HB2' ' HB ' ' A' ' 255' ' ' ILE . . . -64.33 117.09 6.73 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.369 0.668 . . . . 62.53 109.587 178.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 108.47 9.74 26.64 Favored Glycine 0 CA--C 1.526 0.746 0 CA-C-O 119.426 -0.652 . . . . 55.41 112.565 -173.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.735 ' HE ' ' HA ' ' A' ' 227' ' ' THR . 57.5 mtt-85 -63.45 150.0 44.72 Favored 'General case' 0 C--N 1.361 1.072 0 N-CA-C 109.348 -0.612 . . . . 74.32 109.348 166.21 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 19.6 pttm -121.91 138.91 54.22 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 123.217 0.607 . . . . 65.41 109.762 174.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.466 HD22 ' HB2' ' A' ' 173' ' ' ALA . 57.4 mt -123.9 137.26 54.66 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.588 1.155 . . . . 65.34 108.221 177.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . 0.492 ' HB3' HG21 ' A' ' 170' ' ' VAL . 52.8 ttm-85 -128.75 102.41 6.55 Favored 'General case' 0 C--O 1.243 0.72 0 N-CA-C 108.734 -0.839 . . . . 73.31 108.734 176.114 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.44 HD13 ' CD1' ' A' ' 175' ' ' TYR . 17.0 mt -83.9 89.52 7.23 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.019 0.927 . . . . 71.41 109.361 -174.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -73.78 131.58 41.71 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.532 -0.758 . . . . 73.44 110.971 -175.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 66.81 24.82 72.98 Favored Glycine 0 C--N 1.35 1.348 0 O-C-N 123.858 0.724 . . . . 74.43 112.972 -178.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.511 ' HB3' ' CE1' ' A' ' 175' ' ' TYR . 32.1 mmtp -140.23 39.49 1.92 Allowed 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.038 0.935 . . . . 70.25 110.581 -172.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -120.85 -120.62 2.77 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-N 116.228 -0.442 . . . . 64.33 112.232 174.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . 0.401 ' HB2' ' HA ' ' A' ' 191' ' ' GLN . 2.9 m-85 -69.19 147.75 97.45 Favored Pre-proline 0 N--CA 1.49 1.557 0 C-N-CA 123.78 0.832 . . . . 74.34 111.684 178.417 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.504 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 22.6 Cg_endo -59.97 134.02 54.07 Favored 'Trans proline' 0 C--N 1.387 2.602 0 C-N-CA 123.329 2.686 . . . . 73.05 113.455 -179.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -151.04 131.74 3.62 Favored Glycine 0 CA--C 1.54 1.62 0 N-CA-C 110.287 -1.125 . . . . 62.21 110.287 179.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -65.27 -45.99 6.52 Favored 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 123.266 2.644 . . . . 74.53 113.69 -170.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -86.72 11.8 12.22 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 122.855 0.462 . . . . 73.45 111.828 -178.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 133.56 139.87 4.26 Favored Glycine 0 C--N 1.341 0.829 0 N-CA-C 109.766 -1.334 . . . . 62.1 109.766 -174.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.504 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 23.4 mtm180 -78.14 170.73 16.13 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-O 121.025 0.44 . . . . 71.03 111.248 -175.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.52 -156.93 8.45 Favored Glycine 0 C--N 1.344 1.027 0 CA-C-N 115.281 -0.872 . . . . 63.5 112.775 172.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -116.73 160.95 20.0 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.537 0.335 . . . . 73.23 111.148 -170.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 38.8 tp -140.66 106.87 5.23 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 108.258 -1.016 . . . . 73.54 108.258 173.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -94.98 116.31 28.53 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 109.277 -0.638 . . . . 74.21 109.277 -175.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 60.5 mt -116.13 117.99 31.61 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.542 0.737 . . . . 74.34 109.792 -178.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -89.74 112.4 23.67 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.65 0.78 . . . . 73.01 109.598 177.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.487 HG11 HG21 ' A' ' 227' ' ' THR . 60.2 t -71.2 118.79 16.44 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 CA-C-O 121.497 0.665 . . . . 50.42 112.059 -176.101 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 29.6 mmm180 -108.16 115.7 30.61 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 125.101 1.36 . . . . 73.33 108.293 170.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.474 ' HB ' ' HB2' ' A' ' 229' ' ' ALA . 30.5 mt -76.18 128.09 37.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 108.437 -0.949 . . . . 60.34 108.437 170.188 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 6.8 t . . . . . 0 CA--C 1.558 1.274 0 CA-C-O 117.427 -1.273 . . . . 64.04 107.927 -176.382 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 36.1 t70 . . . . . 0 N--CA 1.471 0.623 0 N-CA-C 109.743 -0.466 . . . . 73.33 109.743 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 33.3 m -109.67 -175.74 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 C-N-CA 124.586 1.155 . . . . 71.31 110.472 179.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 14.9 tt -91.94 144.7 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 N-CA-C 107.873 -1.158 . . . . 54.44 107.873 165.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -63.36 140.27 58.86 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.463 0.705 . . . . 60.12 112.745 -172.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.401 ' HB2' HD22 ' A' ' 233' ' ' LEU . . . -153.29 153.55 32.86 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.876 1.27 . . . . 74.22 108.494 171.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -147.42 156.5 42.93 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 108.244 -1.021 . . . . 62.23 108.244 172.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.442 ' CZ ' ' HB3' ' A' ' 238' ' ' LYS . 12.4 p90 -136.7 168.28 19.82 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.585 0.587 . . . . 74.03 112.585 179.078 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -140.25 150.11 60.33 Favored Pre-proline 0 N--CA 1.477 0.901 0 C-N-CA 125.042 1.337 . . . . 73.41 108.158 176.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . 0.492 ' HA ' HG12 ' A' ' 219' ' ' VAL . 38.8 Cg_endo -65.21 109.35 1.32 Allowed 'Trans proline' 0 C--N 1.374 1.885 0 C-N-CA 122.174 1.916 . . . . 72.44 110.909 179.395 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.03 0 C-N-CA 124.302 1.041 . . . . 52.31 111.382 -175.089 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.532 ' HB3' ' HA3' ' A' ' 247' ' ' GLY . 39.7 mt-30 . . . . . 0 N--CA 1.476 0.858 0 CA-C-O 120.527 0.204 . . . . 72.32 111.006 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -80.69 152.05 28.61 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.494 0.717 . . . . 63.23 111.107 177.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 13.5 mt -132.57 143.12 49.49 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.744 1.218 . . . . 73.23 108.707 168.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -111.8 135.39 52.48 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 106.474 -1.676 . . . . 65.24 106.474 166.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -159.73 171.61 19.22 Favored 'General case' 0 C--N 1.327 -0.382 0 O-C-N 123.696 0.622 . . . . 55.11 109.746 179.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 26.5 m -113.31 142.35 45.94 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.453 -0.943 . . . . 71.3 108.453 179.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.438 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . 51.2 tp -109.31 121.66 45.66 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 109.339 -0.615 . . . . 62.22 109.339 179.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -82.6 134.26 35.18 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 109.001 -0.74 . . . . 63.14 109.001 167.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.44 ' HA ' HG11 ' A' ' 210' ' ' VAL . 4.2 p -143.03 121.27 7.2 Favored Pre-proline 0 CA--C 1.539 0.553 0 N-CA-C 108.429 -0.952 . . . . 65.15 108.429 175.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.22 142.29 87.36 Favored 'Trans proline' 0 C--N 1.366 1.48 0 C-N-CA 122.58 2.186 . . . . 74.13 112.12 175.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -49.4 -45.87 77.43 Favored Pre-proline 0 CA--C 1.558 1.259 0 C-N-CA 123.729 0.812 . . . . 62.22 113.065 178.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -53.9 -55.16 3.73 Favored 'Trans proline' 0 C--N 1.397 3.103 0 C-N-CA 122.273 1.982 . . . . 75.42 113.109 171.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 52.3 mt -63.66 -30.45 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 C-N-CA 123.304 0.642 . . . . 74.41 111.779 -177.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.73 -42.41 74.01 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 122.949 0.5 . . . . 53.34 111.443 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 97.2 t -73.66 -54.48 15.16 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 C-N-CA 123.138 0.575 . . . . 73.11 111.107 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 14.8 m -76.74 -22.03 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 N-CA-C 112.03 0.382 . . . . 73.43 112.03 -174.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 86.67 170.59 47.02 Favored Glycine 0 C--N 1.348 1.239 0 N-CA-C 112.047 -0.421 . . . . 41.53 112.047 -174.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 145.96 -129.14 3.29 Favored Glycine 0 C--N 1.333 0.397 0 N-CA-C 111.071 -0.812 . . . . 35.5 111.071 175.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -139.73 158.51 43.98 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.883 0.873 . . . . 74.34 109.709 176.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.44 HG11 ' HA ' ' A' ' 199' ' ' VAL . 18.7 m -138.51 155.43 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 123.722 0.809 . . . . 73.45 109.535 171.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 48.2 mtm180 -82.72 127.85 33.81 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 109.353 -0.61 . . . . 54.52 109.353 173.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -116.36 146.38 42.51 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 124.373 1.069 . . . . 72.42 109.156 179.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 5.2 mmt -94.81 110.05 21.96 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 109.321 -0.622 . . . . 62.22 109.321 177.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 38.4 p -119.63 174.93 6.11 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 123.838 0.855 . . . . 71.13 109.416 174.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . 0.433 HD12 ' CE1' ' A' ' 240' ' ' PHE . 15.5 mt -78.72 -2.1 37.72 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 116.298 -0.41 . . . . 73.54 111.681 -177.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -100.67 -4.8 27.61 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.868 0.867 . . . . 73.23 110.936 171.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 114.67 -160.53 13.15 Favored Glycine 0 C--N 1.356 1.686 0 C-N-CA 123.611 0.624 . . . . 62.44 112.806 178.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.33 131.8 19.7 Favored 'Trans proline' 0 C--N 1.375 1.924 0 C-N-CA 122.771 2.314 . . . . 63.21 112.503 175.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.492 HG12 ' HA ' ' A' ' 177' ' ' PRO . 31.6 m -134.81 139.84 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 123.586 0.754 . . . . 52.23 110.484 -178.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -87.04 105.69 17.33 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 122.66 0.384 . . . . 75.2 110.139 178.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 76.8 t -92.5 117.66 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 N-CA-C 108.543 -0.91 . . . . 62.22 108.543 179.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -65.6 101.65 0.63 Allowed 'General case' 0 C--O 1.24 0.569 0 O-C-N 124.322 1.014 . . . . 74.54 110.254 178.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 63.0 t -77.84 117.98 69.26 Favored Pre-proline 0 CA--C 1.543 0.682 0 O-C-N 124.613 1.196 . . . . 64.33 108.823 174.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -65.31 151.62 84.68 Favored 'Trans proline' 0 CA--C 1.559 1.769 0 C-N-CA 122.033 1.822 . . . . 74.33 111.602 170.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_exo -63.62 141.53 80.07 Favored 'Trans proline' 0 C--N 1.373 1.867 0 C-N-CA 122.555 2.17 . . . . 70.33 112.357 178.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 51.7 mtm180 62.93 49.07 3.67 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.786 1.234 . . . . 71.44 110.638 176.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.536 HG22 HG11 ' A' ' 253' ' ' VAL . 55.3 m -98.85 109.2 22.0 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 114.271 -1.331 . . . . 65.23 109.244 173.287 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -85.47 161.49 19.37 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.606 -0.725 . . . . 64.22 111.773 -175.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -69.15 124.43 23.79 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.765 0.826 . . . . 74.31 110.084 177.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 111.43 -9.82 28.5 Favored Glycine 0 N--CA 1.471 0.992 0 O-C-N 123.306 0.378 . . . . 74.23 112.411 -175.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 66.0 mtt180 -70.15 162.69 27.84 Favored 'General case' 0 C--N 1.35 0.622 0 CA-C-O 121.532 0.682 . . . . 72.55 111.046 170.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 18.7 pttm -121.58 143.53 49.25 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 114.957 -1.02 . . . . 74.24 110.305 -177.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.401 HD22 ' HB2' ' A' ' 173' ' ' ALA . 93.1 mt -125.35 142.66 51.37 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.748 1.219 . . . . 74.24 108.325 174.277 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 65.8 ttt180 -133.18 124.27 27.14 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 108.22 -1.03 . . . . 72.11 108.22 -179.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.435 ' HB3' ' HG3' ' A' ' 238' ' ' LYS . 26.6 mt -120.88 84.04 2.17 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.671 0.788 . . . . 72.22 109.455 -166.117 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -79.32 140.01 37.66 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.875 0.87 . . . . 62.4 110.726 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 70.27 26.98 73.45 Favored Glycine 0 C--N 1.347 1.174 0 O-C-N 123.828 0.705 . . . . 45.02 112.336 -176.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.442 ' HB3' ' CZ ' ' A' ' 175' ' ' TYR . 8.0 mmpt? -128.75 -48.34 1.25 Allowed 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.982 0.913 . . . . 60.0 111.583 -172.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -55.39 -102.42 0.01 OUTLIER Glycine 0 CA--C 1.549 2.162 0 N-CA-C 116.25 1.26 . . . . 53.54 116.25 -164.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . 0.433 ' CE1' HD12 ' A' ' 215' ' ' LEU . 0.7 OUTLIER -84.17 153.41 62.88 Favored Pre-proline 0 N--CA 1.485 1.292 0 C-N-CA 123.098 0.559 . . . . 72.51 110.181 177.301 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.546 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 18.2 Cg_endo -56.28 154.27 29.81 Favored 'Trans proline' 0 C--N 1.373 1.86 0 C-N-CA 123.813 3.009 . . . . 73.23 114.076 170.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -165.23 143.55 8.56 Favored Glycine 0 CA--C 1.535 1.34 0 CA-C-O 119.017 -0.88 . . . . 62.14 111.974 175.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -63.7 -45.13 11.73 Favored 'Trans proline' 0 C--N 1.382 2.323 0 C-N-CA 123.372 2.715 . . . . 63.12 113.096 179.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -80.38 -26.18 38.73 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 122.747 0.419 . . . . 72.22 110.946 -179.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 166.73 160.02 13.29 Favored Glycine 0 C--N 1.336 0.536 0 N-CA-C 111.029 -0.828 . . . . 61.43 111.029 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.546 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 23.9 mtm180 -78.81 160.67 27.26 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 122.547 0.339 . . . . 61.23 110.682 -179.337 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . 0.532 ' HA3' ' HB3' ' A' ' 191' ' ' GLN . . . -88.02 -155.82 29.6 Favored Glycine 0 C--N 1.344 0.98 0 CA-C-N 115.833 -0.621 . . . . 65.31 113.529 -175.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -102.47 155.59 18.16 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.125 0.57 . . . . 72.51 109.826 -175.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 36.6 tp -136.73 115.75 12.37 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 107.829 -1.175 . . . . 74.15 107.829 168.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -100.04 107.96 20.03 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.009 -0.737 . . . . 62.34 109.009 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.438 ' HB3' ' HB2' ' A' ' 197' ' ' LEU . 43.0 mt -102.33 121.06 41.54 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.61 0.764 . . . . 55.54 110.225 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -91.23 115.52 28.09 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 109.361 -0.607 . . . . 74.12 109.361 174.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.536 HG11 HG22 ' A' ' 227' ' ' THR . 85.2 t -62.42 127.94 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.533 1.133 . . . . 52.31 111.751 -176.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -131.39 116.21 17.24 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.717 1.207 . . . . 75.54 107.942 172.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 34.9 mt -77.51 126.61 38.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 O-C-N 123.769 0.668 . . . . 75.23 109.653 176.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 25.7 p . . . . . 0 C--O 1.254 1.313 0 N-CA-C 108.314 -0.995 . . . . 72.31 108.314 173.083 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 34.7 t70 . . . . . 0 N--CA 1.478 0.927 0 N-CA-C 110.285 -0.265 . . . . 54.24 110.285 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.48 HG21 ' HB3' ' A' ' 234' ' ' ARG . 14.0 m -95.99 176.43 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 123.49 0.716 . . . . 73.11 111.037 -178.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 17.7 tt -96.35 138.32 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 N-CA-C 107.611 -1.255 . . . . 72.24 107.611 162.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -71.87 145.64 48.43 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.761 0.824 . . . . 71.34 111.268 -174.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.411 ' HB2' HD22 ' A' ' 233' ' ' LEU . . . -155.58 178.16 10.56 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.587 1.155 . . . . 73.42 109.74 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -156.32 152.16 27.3 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.751 0.82 . . . . 34.03 109.962 178.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.438 ' CD1' HD13 ' A' ' 235' ' ' LEU . 33.0 p90 -129.04 168.01 16.68 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 121.139 0.495 . . . . 72.42 110.863 175.003 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -145.26 150.45 44.89 Favored Pre-proline 0 CA--C 1.548 0.885 0 CA-C-N 114.635 -1.166 . . . . 75.31 109.078 176.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -57.78 110.59 0.65 Allowed 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 123.604 2.869 . . . . 71.02 112.91 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . 0.46 ' HB2' ' HG3' ' A' ' 220' ' ' GLU . . . . . . . . 0 N--CA 1.482 1.134 0 C-N-CA 123.581 0.753 . . . . 52.23 111.236 -178.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.479 ' HA ' ' HB2' ' A' ' 240' ' ' PHE . 83.5 mm-40 . . . . . 0 N--CA 1.47 0.531 0 N-CA-C 108.434 -0.951 . . . . 55.03 108.434 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -93.63 158.65 15.59 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 115.992 -0.549 . . . . 74.34 110.046 174.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 93.8 mt -136.25 149.97 48.75 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.03 0.932 . . . . 71.41 109.024 176.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -123.68 123.38 40.41 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.746 0.818 . . . . 73.33 108.819 173.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -157.44 170.92 21.35 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.19 0.596 . . . . 75.41 110.653 179.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 19.3 p -96.3 152.44 18.58 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.719 0.808 . . . . 74.11 109.822 174.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.696 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . 34.6 tp -116.77 114.42 23.95 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.392 0.677 . . . . 75.42 109.978 -176.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -74.97 100.74 4.23 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 109.366 -0.605 . . . . 73.54 109.366 176.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.485 ' HA ' HG11 ' A' ' 210' ' ' VAL . 54.8 t -110.6 110.5 57.56 Favored Pre-proline 0 N--CA 1.473 0.677 0 N-CA-C 108.807 -0.812 . . . . 62.42 108.807 177.011 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -53.33 138.35 64.67 Favored 'Trans proline' 0 C--N 1.379 2.133 0 C-N-CA 122.741 2.294 . . . . 74.14 111.626 173.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -46.13 -47.97 43.53 Favored Pre-proline 0 CA--C 1.569 1.679 0 N-CA-C 113.798 1.036 . . . . 61.41 113.798 -178.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -54.3 -46.16 35.59 Favored 'Trans proline' 0 C--N 1.4 3.249 0 C-N-CA 122.627 2.218 . . . . 70.12 112.557 174.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 49.9 mt -68.88 -30.12 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 124.148 0.979 . . . . 73.05 111.063 -176.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.55 -39.85 80.89 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 122.956 0.503 . . . . 64.34 111.197 177.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 88.3 t -70.96 -52.63 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 123.489 0.716 . . . . 74.33 111.089 179.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 18.5 m -80.0 -29.68 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 CA-C-N 116.046 -0.525 . . . . 60.25 112.379 -172.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 83.95 103.8 0.56 Allowed Glycine 0 C--N 1.345 1.079 0 O-C-N 123.554 0.533 . . . . 70.12 112.772 -176.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -158.7 178.43 34.91 Favored Glycine 0 C--N 1.342 0.896 0 N-CA-C 112.175 -0.37 . . . . 64.3 112.175 -178.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.535 ' HB3' ' HB3' ' A' ' 220' ' ' GLU . 34.6 mtmm -82.79 148.51 27.76 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 122.917 0.487 . . . . 41.52 111.364 -178.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.485 HG11 ' HA ' ' A' ' 199' ' ' VAL . 32.8 m -136.6 147.86 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 C-N-CA 123.93 0.892 . . . . 52.44 110.156 176.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 11.3 mtm180 -82.02 111.47 18.21 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-O 121.216 0.531 . . . . 75.11 111.521 -178.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -102.0 142.69 32.89 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 125.005 1.322 . . . . 64.12 109.167 171.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 34.2 tpp -100.88 116.3 32.42 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 122.763 0.425 . . . . 75.55 109.854 176.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 81.0 p -110.69 -178.59 3.52 Favored 'General case' 0 C--O 1.247 0.926 0 C-N-CA 124.101 0.96 . . . . 42.14 109.424 177.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 14.9 mt -77.32 -5.53 49.87 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 122.924 0.49 . . . . 60.12 110.609 -177.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -102.31 -19.23 15.09 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.332 1.053 . . . . 74.13 110.65 177.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 133.07 -160.35 23.86 Favored Glycine 0 C--N 1.356 1.69 0 CA-C-O 119.954 -0.359 . . . . 72.33 113.305 176.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -78.09 126.64 7.96 Favored 'Trans proline' 0 C--N 1.376 1.998 0 C-N-CA 123.172 2.581 . . . . 71.41 111.772 -179.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.455 ' HA ' ' H ' ' A' ' 178' ' ' ALA . 28.1 m -132.54 143.49 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 124.123 0.969 . . . . 73.15 109.489 -178.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.535 ' HB3' ' HB3' ' A' ' 209' ' ' LYS . 35.0 mt-10 -101.82 115.77 31.26 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.901 0.481 . . . . 75.3 110.484 176.166 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 24.1 t -95.64 116.46 37.33 Favored 'Isoleucine or valine' 0 C--N 1.346 0.413 0 C-N-CA 124.507 1.123 . . . . 65.52 109.138 -177.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -64.51 100.79 0.39 Allowed 'General case' 0 C--O 1.239 0.544 0 O-C-N 124.156 0.91 . . . . 72.41 110.109 174.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.403 HG11 HG11 ' A' ' 199' ' ' VAL . 21.3 t -82.73 127.73 68.96 Favored Pre-proline 0 N--CA 1.47 0.531 0 CA-C-N 114.927 -1.033 . . . . 74.51 108.652 177.283 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -61.46 156.79 44.65 Favored 'Trans proline' 0 CA--C 1.559 1.766 0 C-N-CA 122.277 1.985 . . . . 64.3 112.418 173.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -70.45 161.53 45.7 Favored 'Trans proline' 0 C--N 1.373 1.865 0 C-N-CA 122.388 2.058 . . . . 71.24 112.136 173.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 72.5 mtm-85 58.25 33.54 23.24 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.38 1.072 . . . . 74.25 111.782 175.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.638 HG23 ' HD2' ' A' ' 231' ' ' ARG . 25.5 m -92.72 126.57 37.87 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.397 1.079 . . . . 75.42 110.154 -178.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -93.8 162.18 14.03 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.361 0.664 . . . . 63.53 111.158 -178.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . 0.474 ' HB2' ' HB ' ' A' ' 255' ' ' ILE . . . -71.82 119.22 15.68 Favored 'General case' 0 C--N 1.35 0.613 0 CA-C-N 115.177 -0.919 . . . . 64.12 109.324 174.075 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 114.82 -2.7 23.01 Favored Glycine 0 C--N 1.333 0.366 0 CA-C-O 119.527 -0.596 . . . . 50.12 112.414 -174.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.638 ' HD2' HG23 ' A' ' 227' ' ' THR . 91.3 mtt180 -74.81 161.15 29.85 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-N 117.45 0.625 . . . . 73.22 110.209 170.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.483 ' HD2' ' OH ' ' A' ' 250' ' ' TYR . 20.8 pttm -129.06 134.53 48.14 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.875 0.87 . . . . 74.54 109.768 -176.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.411 HD22 ' HB2' ' A' ' 173' ' ' ALA . 73.8 mt -111.5 126.79 55.35 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.065 -1.087 . . . . 74.5 108.065 175.06 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . 0.48 ' HB3' HG21 ' A' ' 170' ' ' VAL . 54.3 ttm-85 -108.37 102.91 11.98 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 107.324 -1.361 . . . . 72.44 107.324 170.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.438 HD13 ' CD1' ' A' ' 175' ' ' TYR . 20.3 mt -79.1 91.06 4.87 Favored 'General case' 0 C--O 1.245 0.835 0 N-CA-C 108.104 -1.073 . . . . 74.02 108.104 179.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.438 ' HA ' ' OD2' ' A' ' 248' ' ' ASP . 90.8 mttt -72.97 122.97 22.57 Favored 'General case' 0 C--O 1.243 0.762 0 CA-C-N 113.711 -1.586 . . . . 72.42 111.771 -170.059 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 64.87 27.4 72.09 Favored Glycine 0 C--N 1.346 1.094 0 O-C-N 123.864 0.727 . . . . 72.51 111.658 -176.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.438 ' HB3' ' CE1' ' A' ' 175' ' ' TYR . 30.5 mmtp -140.65 59.35 1.55 Allowed 'General case' 0 C--O 1.22 -0.481 0 C-N-CA 124.858 1.263 . . . . 71.11 108.083 -175.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -120.39 -131.47 4.11 Favored Glycine 0 N--CA 1.467 0.725 0 N-CA-C 109.914 -1.274 . . . . 42.33 109.914 165.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . 0.479 ' HB2' ' HA ' ' A' ' 191' ' ' GLN . 4.3 m-85 -60.17 146.23 83.77 Favored Pre-proline 0 N--CA 1.484 1.245 0 C-N-CA 123.408 0.683 . . . . 74.02 111.537 173.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.597 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 37.5 Cg_endo -63.13 132.02 34.83 Favored 'Trans proline' 0 C--N 1.381 2.284 0 C-N-CA 123.146 2.564 . . . . 72.22 112.435 179.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -141.94 136.11 7.13 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-O 118.329 -1.261 . . . . 74.51 110.523 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -57.2 -53.86 4.3 Favored 'Trans proline' 0 C--N 1.378 2.105 0 C-N-CA 123.493 2.795 . . . . 72.31 113.762 -176.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -81.97 -26.44 33.92 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 122.964 0.505 . . . . 64.13 111.362 -178.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -177.63 140.47 4.77 Favored Glycine 0 C--N 1.341 0.812 0 N-CA-C 111.352 -0.699 . . . . 44.13 111.352 -177.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.597 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 57.4 mtm180 -78.87 169.46 18.19 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.221 0.609 . . . . 74.34 110.536 177.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -78.55 -159.7 14.61 Favored Glycine 0 C--N 1.339 0.718 0 CA-C-N 116.137 -0.483 . . . . 60.24 112.299 175.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . 0.438 ' OD2' ' HA ' ' A' ' 236' ' ' LYS . 27.7 m-20 -125.69 127.5 46.33 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 109.836 -0.431 . . . . 74.05 109.836 178.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 58.3 tp -100.74 109.63 21.67 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 108.159 -1.052 . . . . 40.41 108.159 177.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . 0.483 ' OH ' ' HD2' ' A' ' 232' ' ' LYS . 33.9 t80 -98.07 108.38 21.08 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.497 -0.774 . . . . 74.13 109.082 -174.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.696 ' HB3' ' HB2' ' A' ' 197' ' ' LEU . 69.9 mt -121.3 106.71 11.73 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.85 0.86 . . . . 60.41 110.336 -174.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 232' ' ' LYS . 53.5 mt-10 -80.29 110.99 16.25 Favored 'General case' 0 C--O 1.241 0.605 0 CA-C-N 115.177 -0.92 . . . . 63.32 110.365 178.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.475 HG11 HG22 ' A' ' 227' ' ' THR . 95.2 t -57.58 113.58 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 124.048 0.939 . . . . 53.43 111.363 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 28.7 mmm180 -113.22 116.18 29.37 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 107.241 -1.392 . . . . 70.4 107.241 169.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.474 ' HB ' ' HB2' ' A' ' 229' ' ' ALA . 58.1 mt -76.24 123.19 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 122.988 0.515 . . . . 74.32 109.78 -179.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.2 t . . . . . 0 CA--C 1.559 1.318 0 N-CA-C 107.802 -1.185 . . . . 75.13 107.802 175.031 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 29.0 t70 . . . . . 0 N--CA 1.475 0.781 0 CA-C-O 120.851 0.358 . . . . 72.42 110.438 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.446 HG21 ' HB3' ' A' ' 234' ' ' ARG . 35.5 m -79.04 155.61 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 109.72 -0.474 . . . . 71.11 109.72 173.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 12.7 tt -81.59 141.51 15.01 Favored 'Isoleucine or valine' 0 C--O 1.243 0.756 0 N-CA-C 108.99 -0.744 . . . . 71.32 108.99 173.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -62.97 133.17 54.21 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.208 1.003 . . . . 72.23 111.524 -172.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.499 ' HB2' HD22 ' A' ' 233' ' ' LEU . . . -147.52 171.33 15.72 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 124.594 1.158 . . . . 73.04 110.038 177.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -157.75 151.85 24.43 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.4 1.08 . . . . 75.05 108.374 176.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.43 ' HD1' HD13 ' A' ' 235' ' ' LEU . 6.4 p90 -128.3 167.02 17.51 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 109.898 -0.408 . . . . 70.25 109.898 172.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -140.67 136.41 16.43 Favored Pre-proline 0 N--CA 1.471 0.599 0 C-N-CA 123.281 0.632 . . . . 72.23 109.859 169.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . 0.534 ' HA ' HG12 ' A' ' 219' ' ' VAL . 13.7 Cg_endo -55.07 113.16 1.27 Allowed 'Trans proline' 0 C--N 1.378 2.088 0 C-N-CA 123.646 2.897 . . . . 73.43 112.881 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . 0.635 ' HB2' ' HG3' ' A' ' 220' ' ' GLU . . . . . . . . 0 N--CA 1.478 0.97 0 C-N-CA 123.735 0.814 . . . . 64.22 112.007 -175.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.501 ' HB3' ' HA3' ' A' ' 247' ' ' GLY . 77.1 mt-30 . . . . . 0 N--CA 1.479 0.99 0 CA-C-O 121.052 0.453 . . . . 75.14 111.507 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.517 ' HB3' ' HE1' ' A' ' 194' ' ' TYR . 4.1 m-20 -79.77 114.79 18.96 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 114.654 -1.157 . . . . 55.53 109.718 -179.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 69.0 mt -112.27 135.97 52.29 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 108.808 -0.812 . . . . 73.35 108.808 172.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . 0.517 ' HE1' ' HB3' ' A' ' 192' ' ' ASP . 46.3 m-85 -129.05 122.99 31.14 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 108.648 -0.871 . . . . 62.44 108.648 -178.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.408 ' O ' ' HA ' ' A' ' 251' ' ' LEU . . . -154.78 162.91 40.93 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 121.57 0.7 . . . . 55.2 110.333 -176.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 19.8 p -97.47 141.16 30.87 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-N 115.436 -0.802 . . . . 60.11 109.188 174.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.585 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . 45.7 tp -108.48 113.15 25.95 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.613 -0.721 . . . . 70.03 110.044 -175.345 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -79.32 99.89 7.32 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 109.22 -0.659 . . . . 62.54 109.22 178.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 43.1 t -106.86 118.43 54.21 Favored Pre-proline 0 N--CA 1.467 0.42 0 CA-C-N 115.334 -0.848 . . . . 71.11 108.721 176.03 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -54.74 143.25 70.96 Favored 'Trans proline' 0 C--N 1.371 1.747 0 C-N-CA 122.415 2.076 . . . . 74.24 111.796 169.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.413 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -53.75 -44.41 97.92 Favored Pre-proline 0 CA--C 1.562 1.413 0 CA-C-O 118.03 -0.986 . . . . 54.04 112.454 179.012 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . 0.413 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 13.7 Cg_endo -55.7 -47.17 26.71 Favored 'Trans proline' 0 C--N 1.403 3.412 0 C-N-CA 122.543 2.162 . . . . 73.54 111.97 172.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 33.2 mt -70.82 -24.73 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 C-N-CA 123.291 0.636 . . . . 73.01 111.238 -176.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -73.48 -41.72 62.78 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.169 0.588 . . . . 75.24 110.513 178.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 98.0 t -69.3 -55.24 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 123.616 0.767 . . . . 73.34 110.985 178.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 8.8 p -73.18 -31.62 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 C-N-CA 122.767 0.427 . . . . 74.34 111.507 -175.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 78.9 95.03 0.28 Allowed Glycine 0 C--N 1.345 1.062 0 N-CA-C 112.131 -0.388 . . . . 52.54 112.131 -175.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -141.21 -177.76 16.76 Favored Glycine 0 N--CA 1.467 0.765 0 N-CA-C 111.544 -0.622 . . . . 54.13 111.544 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.45 ' HD2' ' HB3' ' A' ' 220' ' ' GLU . 46.0 mtmt -84.17 137.09 33.7 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 109.443 -0.577 . . . . 74.31 109.443 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 26.8 m -119.75 157.51 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 123.775 0.83 . . . . 60.33 109.082 170.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 78.4 mtm180 -86.41 119.46 26.7 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 109.667 -0.494 . . . . 72.14 109.667 172.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -101.47 140.01 36.35 Favored 'General case' 0 C--O 1.245 0.848 0 C-N-CA 124.311 1.044 . . . . 73.14 108.273 174.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.66 103.23 15.15 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.435 -0.95 . . . . 71.22 108.435 -178.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 47.5 p -111.73 177.76 4.54 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.997 0.919 . . . . 71.52 109.86 -179.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 11.2 mt -67.67 -27.76 67.12 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 122.973 0.509 . . . . 72.44 110.916 -176.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -82.66 -18.92 39.33 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.994 0.918 . . . . 72.3 111.408 179.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 129.08 -154.28 20.2 Favored Glycine 0 C--N 1.353 1.489 0 CA-C-O 119.501 -0.61 . . . . 54.5 112.746 178.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -73.32 133.86 19.94 Favored 'Trans proline' 0 C--N 1.374 1.887 0 C-N-CA 122.722 2.281 . . . . 74.33 111.78 175.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.534 HG12 ' HA ' ' A' ' 177' ' ' PRO . 26.9 m -133.29 147.61 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 123.581 0.752 . . . . 75.34 110.164 177.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.635 ' HG3' ' HB2' ' A' ' 178' ' ' ALA . 48.3 mt-10 -90.73 106.02 18.22 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.143 0.577 . . . . 61.42 110.028 178.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 61.6 t -94.72 113.71 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 N-CA-C 109.096 -0.705 . . . . 63.35 109.096 176.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -68.02 100.04 0.94 Allowed 'General case' 0 C--O 1.242 0.658 0 O-C-N 124.028 0.83 . . . . 73.11 109.229 173.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.462 HG11 HG11 ' A' ' 199' ' ' VAL . 25.5 t -79.7 124.53 83.52 Favored Pre-proline 0 C--O 1.24 0.591 0 C-N-CA 123.884 0.874 . . . . 63.12 109.046 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -55.83 146.49 66.92 Favored 'Trans proline' 0 C--N 1.374 1.9 0 C-N-CA 122.485 2.124 . . . . 70.22 112.574 174.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -67.4 150.68 80.84 Favored 'Trans proline' 0 C--N 1.373 1.862 0 C-N-CA 122.144 1.896 . . . . 71.05 112.62 175.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 61.58 37.74 16.02 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 124.904 1.281 . . . . 75.21 111.705 177.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 45.5 m -96.96 116.01 28.45 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.816 0.846 . . . . 60.42 110.622 -178.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 24.1 mp0 -86.18 165.7 16.33 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.771 0.828 . . . . 63.43 111.287 -178.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -70.49 133.67 47.03 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 114.799 -1.091 . . . . 72.21 109.46 176.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 112.68 -24.95 12.51 Favored Glycine 0 C--N 1.334 0.461 0 N-CA-C 111.441 -0.664 . . . . 53.15 111.441 -176.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 60.6 mtt180 -63.82 160.65 16.93 Favored 'General case' 0 C--N 1.36 1.038 0 C-N-CA 123.504 0.722 . . . . 72.4 111.526 178.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 16.1 pttm -130.21 134.42 47.26 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.202 1.001 . . . . 71.23 110.145 -171.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.499 HD22 ' HB2' ' A' ' 173' ' ' ALA . 58.5 mt -120.0 100.24 7.1 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.648 1.179 . . . . 64.13 108.524 179.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . 0.446 ' HB3' HG21 ' A' ' 170' ' ' VAL . 67.8 ttt180 -93.92 101.1 13.16 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 108.5 -0.926 . . . . 52.53 108.5 177.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.463 HD11 HD12 ' A' ' 251' ' ' LEU . 21.3 mt -79.14 83.35 5.21 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.187 0.995 . . . . 54.0 109.343 -178.448 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -79.3 140.97 37.41 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.529 0.732 . . . . 73.34 110.628 -177.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 65.41 24.82 71.02 Favored Glycine 0 C--N 1.349 1.26 0 O-C-N 124.045 0.841 . . . . 34.42 111.65 -174.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -130.33 -26.01 2.37 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.713 0.805 . . . . 75.2 110.859 -174.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -67.96 -145.53 0.12 Allowed Glycine 0 C--N 1.358 1.751 0 O-C-N 123.653 0.596 . . . . 62.14 113.718 -175.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . 0.494 ' HB3' ' HA ' ' A' ' 191' ' ' GLN . 0.1 OUTLIER -67.06 120.68 73.8 Favored Pre-proline 0 CA--C 1.552 1.055 0 O-C-N 122.369 -0.489 . . . . 74.21 110.912 -173.21 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.564 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 15.7 Cg_exo -70.67 160.19 50.25 Favored 'Trans proline' 0 C--N 1.385 2.499 0 C-N-CA 123.746 2.964 . . . . 63.13 115.499 -173.518 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -159.43 164.26 33.89 Favored Glycine 0 CA--C 1.532 1.095 0 CA-C-N 113.188 -1.824 . . . . 70.52 110.43 175.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -70.51 -23.31 27.53 Favored 'Trans proline' 0 C--N 1.37 1.685 0 C-N-CA 122.945 2.43 . . . . 70.41 113.291 -177.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -89.42 -27.08 20.65 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.227 0.611 . . . . 72.43 110.783 177.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 166.95 -170.12 41.21 Favored Glycine 0 C--N 1.349 1.269 0 N-CA-C 112.183 -0.367 . . . . 22.11 112.183 -178.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.564 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 26.6 mtm180 -117.92 155.36 30.34 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.875 0.87 . . . . 71.4 110.412 -177.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . 0.501 ' HA3' ' HB3' ' A' ' 191' ' ' GLN . . . -86.84 -156.13 28.59 Favored Glycine 0 C--N 1.343 0.951 0 CA-C-N 115.706 -0.679 . . . . 75.11 111.952 171.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -122.56 154.26 38.16 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 121.287 0.565 . . . . 60.22 110.894 176.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.404 ' HG ' ' HG ' ' A' ' 251' ' ' LEU . 41.4 tp -116.77 107.28 14.45 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 107.485 -1.302 . . . . 64.21 107.485 170.143 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -90.75 105.75 18.04 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.77 0.828 . . . . 75.42 108.773 -176.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.585 ' HB3' ' HB2' ' A' ' 197' ' ' LEU . 49.5 mt -109.71 106.73 16.49 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.498 1.119 . . . . 55.03 110.654 -177.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -82.81 115.63 21.79 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 109.62 -0.511 . . . . 74.31 109.62 176.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 61.6 t -60.03 104.55 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 124.425 1.09 . . . . 64.14 111.455 -177.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 21.3 mmm180 -101.56 107.13 18.32 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 125.115 1.366 . . . . 60.31 107.997 171.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.469 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 48.3 mt -77.43 132.39 32.8 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 CA-C-O 120.913 0.387 . . . . 45.4 110.512 178.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 3.1 t . . . . . 0 C--O 1.251 1.16 0 C-N-CA 124.766 1.226 . . . . 65.41 109.294 177.805 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . 0.498 ' O ' ' HE3' ' A' ' 232' ' ' LYS . 23.1 t70 . . . . . 0 N--CA 1.479 1.007 0 N-CA-C 110.08 -0.341 . . . . 75.44 110.08 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 29.3 m -113.04 157.92 13.57 Favored 'Isoleucine or valine' 0 C--O 1.244 0.797 0 C-N-CA 123.752 0.821 . . . . 63.42 110.491 178.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 15.5 tt -81.15 147.03 6.58 Favored 'Isoleucine or valine' 0 C--O 1.248 0.979 0 N-CA-C 107.398 -1.334 . . . . 73.32 107.398 166.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -57.58 123.82 16.91 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.196 0.598 . . . . 75.31 110.761 -178.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.491 ' HB2' HD22 ' A' ' 233' ' ' LEU . . . -146.64 159.05 43.94 Favored 'General case' 0 C--O 1.244 0.789 0 CA-C-N 115.102 -0.954 . . . . 75.05 109.649 177.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -158.95 163.03 36.87 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.037 -0.983 . . . . 71.52 108.964 179.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.539 ' HD1' HD13 ' A' ' 235' ' ' LEU . 16.8 p90 -135.21 170.89 15.23 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-O 121.402 0.62 . . . . 71.32 111.406 176.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -137.27 141.15 33.06 Favored Pre-proline 0 CA--C 1.542 0.671 0 CA-C-N 113.584 -1.643 . . . . 72.03 107.734 173.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . 0.431 ' HA ' HG12 ' A' ' 219' ' ' VAL . 32.1 Cg_exo -59.13 117.55 4.3 Favored 'Trans proline' 0 CA--C 1.551 1.372 0 C-N-CA 123.196 2.597 . . . . 62.53 111.707 179.502 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . 0.507 ' HB2' ' HG3' ' A' ' 220' ' ' GLU . . . . . . . . 0 N--CA 1.488 1.459 0 CA-C-O 121.85 0.833 . . . . 73.22 109.662 -177.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.412 ' HA ' ' HB2' ' A' ' 240' ' ' PHE . 77.2 mt-30 . . . . . 0 N--CA 1.481 1.082 0 CA-C-O 120.94 0.4 . . . . 60.4 111.036 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -76.06 129.65 37.16 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 115.216 -0.902 . . . . 74.41 108.951 174.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 42.5 mt -116.94 147.1 42.54 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.731 1.212 . . . . 74.3 108.72 173.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -139.81 122.25 16.13 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.086 0.955 . . . . 73.22 108.92 -175.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.403 ' O ' ' HA ' ' A' ' 251' ' ' LEU . . . -163.1 169.03 20.05 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.009 0.524 . . . . 50.21 111.002 -175.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 8.7 p -95.56 149.74 21.1 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.54 0.736 . . . . 71.54 109.782 171.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.552 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . 38.4 tp -112.85 113.69 25.88 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.657 0.783 . . . . 64.02 109.926 -178.312 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -73.79 109.26 7.16 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 123.37 0.668 . . . . 74.13 109.76 174.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.451 ' HA ' HG11 ' A' ' 210' ' ' VAL . 89.5 t -118.83 120.37 31.55 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 108.716 -0.846 . . . . 74.55 108.716 175.61 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_exo -55.96 142.81 84.42 Favored 'Trans proline' 0 C--N 1.368 1.561 0 C-N-CA 123.147 2.565 . . . . 65.23 112.06 169.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.404 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -52.04 -46.18 93.15 Favored Pre-proline 0 CA--C 1.556 1.205 0 C-N-CA 124.512 1.125 . . . . 25.53 113.847 -179.149 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . 0.468 ' O ' HG12 ' A' ' 206' ' ' VAL . 12.7 Cg_endo -55.0 -50.43 13.25 Favored 'Trans proline' 0 C--N 1.394 2.923 0 C-N-CA 122.147 1.898 . . . . 70.11 112.835 173.543 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 36.6 mt -63.55 -30.43 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 123.842 0.857 . . . . 64.42 111.443 -177.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.44 -48.24 61.53 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.212 0.605 . . . . 71.32 111.407 177.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 201' ' ' ALA . 86.5 t -67.04 -52.57 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 C-N-CA 123.461 0.704 . . . . 71.13 111.605 -175.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.468 HG12 ' O ' ' A' ' 202' ' ' PRO . 12.9 p -82.54 -30.13 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 C-N-CA 122.613 0.365 . . . . 72.4 111.466 -176.339 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 89.13 126.58 2.85 Favored Glycine 0 C--N 1.349 1.297 0 N-CA-C 111.76 -0.536 . . . . 72.23 111.76 -175.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -159.65 -141.97 3.27 Favored Glycine 0 C--N 1.341 0.831 0 CA-C-O 119.997 -0.335 . . . . 73.12 112.425 -177.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm -134.68 134.2 40.86 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 108.555 -0.906 . . . . 63.01 108.555 175.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.451 HG11 ' HA ' ' A' ' 199' ' ' VAL . 35.1 m -119.5 163.07 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 C-N-CA 123.994 0.918 . . . . 52.41 108.823 173.255 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 80.2 mtm180 -98.79 123.65 43.17 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 121.324 0.583 . . . . 64.24 110.459 175.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -100.71 137.28 39.32 Favored 'General case' 0 C--O 1.246 0.899 0 CA-C-N 114.934 -1.03 . . . . 72.25 108.77 179.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 18.9 mmt -83.02 108.52 16.39 Favored 'General case' 0 C--O 1.238 0.465 0 O-C-N 124.179 0.925 . . . . 73.32 108.682 176.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 80.4 p -108.98 177.08 4.87 Favored 'General case' 0 C--O 1.244 0.768 0 N-CA-C 108.307 -0.997 . . . . 72.12 108.307 174.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 11.2 mt -66.78 -23.26 66.05 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 116.404 -0.362 . . . . 71.01 110.135 177.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -92.33 -19.61 21.95 Favored 'General case' 0 CA--C 1.558 1.259 0 C-N-CA 124.082 0.953 . . . . 74.45 111.509 -179.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 129.16 -149.56 18.59 Favored Glycine 0 C--N 1.355 1.589 0 CA-C-O 119.561 -0.577 . . . . 72.43 114.1 173.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -76.36 127.73 9.97 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 123.194 2.596 . . . . 61.03 112.066 -178.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.468 ' HA ' ' H ' ' A' ' 178' ' ' ALA . 33.8 m -130.4 131.47 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 122.989 0.516 . . . . 72.4 110.524 176.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.507 ' HG3' ' HB2' ' A' ' 178' ' ' ALA . 40.0 mt-10 -77.41 104.2 7.78 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 122.944 0.498 . . . . 64.04 109.963 178.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 59.7 t -92.7 122.4 44.14 Favored 'Isoleucine or valine' 0 C--O 1.245 0.821 0 N-CA-C 108.149 -1.056 . . . . 73.33 108.149 178.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -68.65 99.72 1.04 Allowed 'General case' 0 C--O 1.24 0.605 0 O-C-N 124.215 0.947 . . . . 63.12 109.379 177.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 69.4 t -77.39 120.37 81.24 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-N 115.152 -0.931 . . . . 70.52 108.596 174.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -64.06 156.5 58.49 Favored 'Trans proline' 0 C--N 1.377 2.053 0 C-N-CA 122.72 2.28 . . . . 73.51 112.241 177.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -65.11 143.43 78.19 Favored 'Trans proline' 0 C--N 1.372 1.809 0 C-N-CA 122.349 2.032 . . . . 74.12 111.332 170.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 71.6 mtm180 65.42 66.14 0.54 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.675 1.19 . . . . 73.32 110.339 178.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.613 HG23 ' HD2' ' A' ' 231' ' ' ARG . 97.1 m -107.77 134.31 50.91 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.062 -0.972 . . . . 72.35 110.038 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -108.33 157.7 18.15 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.958 0.903 . . . . 64.34 110.264 176.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -72.49 118.81 15.86 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.126 0.97 . . . . 61.32 109.277 173.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 114.54 -6.5 22.68 Favored Glycine 0 CA--C 1.521 0.467 0 CA-C-O 119.295 -0.725 . . . . 61.54 112.014 -171.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.613 ' HD2' HG23 ' A' ' 227' ' ' THR . 49.8 mtt-85 -67.15 157.93 32.49 Favored 'General case' 0 C--N 1.364 1.21 0 CA-C-N 117.941 0.87 . . . . 74.51 110.286 169.343 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.498 ' HE3' ' O ' ' A' ' 169' ' ' ASP . 32.7 pttt -130.23 138.31 50.49 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 123.756 0.822 . . . . 73.43 109.348 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.491 HD22 ' HB2' ' A' ' 173' ' ' ALA . 59.8 mt -127.3 100.52 6.09 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.032 1.333 . . . . 62.31 108.212 -178.103 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 22.6 ttp180 -90.64 102.0 14.74 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.162 -1.051 . . . . 75.34 108.162 176.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.539 HD13 ' HD1' ' A' ' 175' ' ' TYR . 14.5 mt -76.41 83.28 3.14 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 114.188 -1.369 . . . . 73.43 108.271 -179.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -66.62 134.96 53.38 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 114.465 -1.243 . . . . 74.21 111.234 -173.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 69.57 10.21 63.17 Favored Glycine 0 CA--C 1.538 1.526 0 O-C-N 123.73 0.644 . . . . 73.11 112.782 -178.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.458 ' HB3' ' CE1' ' A' ' 175' ' ' TYR . 33.4 mmtp -134.03 42.54 2.91 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 125.126 1.371 . . . . 74.12 110.523 -171.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -100.97 -102.4 2.55 Favored Glycine 0 N--CA 1.472 1.044 0 N-CA-C 109.714 -1.354 . . . . 65.44 109.714 165.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . 0.412 ' HB2' ' HA ' ' A' ' 191' ' ' GLN . 8.8 m-85 -82.08 126.33 75.02 Favored Pre-proline 0 N--CA 1.475 0.795 0 C-N-CA 123.076 0.55 . . . . 73.43 109.667 167.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.522 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 12.9 Cg_exo -71.79 158.3 53.39 Favored 'Trans proline' 0 C--N 1.37 1.684 0 C-N-CA 122.901 2.401 . . . . 72.44 111.928 175.057 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -178.64 151.93 10.9 Favored Glycine 0 CA--C 1.529 0.916 0 CA-C-O 119.17 -0.794 . . . . 75.13 112.004 -178.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -71.36 -28.82 17.69 Favored 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 123.149 2.566 . . . . 74.3 113.671 179.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -121.42 -26.49 4.98 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.49 0.716 . . . . 74.3 112.215 -178.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -134.38 117.74 1.87 Allowed Glycine 0 C--N 1.345 1.058 0 N-CA-C 111.434 -0.666 . . . . 54.41 111.434 -174.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.522 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 70.5 mtt180 -127.29 126.83 43.33 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 108.666 -0.864 . . . . 73.0 108.666 178.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -80.69 -161.37 25.35 Favored Glycine 0 C--N 1.351 1.401 0 O-C-N 123.354 0.409 . . . . 72.12 112.843 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -130.74 156.64 44.62 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.227 0.611 . . . . 71.25 110.314 175.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.459 ' HG ' ' HG ' ' A' ' 251' ' ' LEU . 36.9 tp -114.33 109.92 19.1 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 108.811 -0.811 . . . . 72.3 108.811 172.112 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -93.01 107.79 19.5 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.915 0.886 . . . . 73.43 108.971 -176.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.552 ' HB3' ' HB2' ' A' ' 197' ' ' LEU . 48.3 mt -113.31 116.95 30.52 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.101 0.96 . . . . 73.13 111.455 -173.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -86.99 108.48 18.86 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 109.166 -0.679 . . . . 73.25 109.166 173.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.407 HG11 ' CG2' ' A' ' 227' ' ' THR . 53.8 t -60.99 120.15 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 123.512 0.725 . . . . 73.52 110.68 179.198 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 26.2 mmm180 -117.21 113.53 22.36 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 106.898 -1.519 . . . . 73.24 106.898 173.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 55.5 mt -79.15 127.19 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 123.312 0.645 . . . . 62.42 110.906 -177.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 20.1 p . . . . . 0 C--O 1.25 1.096 0 C-N-CA 124.742 1.217 . . . . 73.32 108.304 177.447 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 64.5 mtt . . . . . 0 N--CA 1.476 0.862 0 N-CA-C 109.709 -0.478 . . . . 72.41 109.709 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -77.25 89.63 3.71 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 108.382 -0.97 . . . . 75.11 108.382 171.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -75.8 -77.68 0.13 Allowed 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 107.984 -1.117 . . . . 71.52 107.984 171.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.47 HG21 ' HB3' ' A' ' 234' ' ' ARG . 17.1 m -85.99 143.02 12.35 Favored 'Isoleucine or valine' 0 C--O 1.245 0.835 0 N-CA-C 108.016 -1.105 . . . . 63.21 108.016 167.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 15.2 tt -73.83 141.26 16.43 Favored 'Isoleucine or valine' 0 C--O 1.246 0.876 0 N-CA-C 108.701 -0.852 . . . . 41.32 108.701 174.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -63.93 118.57 8.61 Favored 'General case' 0 C--N 1.349 0.554 0 O-C-N 123.903 0.752 . . . . 73.13 110.906 -173.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.454 ' HB2' HD22 ' A' ' 233' ' ' LEU . . . -124.02 160.66 27.16 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.267 1.027 . . . . 72.45 109.813 -174.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -149.08 163.75 36.65 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.488 0.715 . . . . 74.35 109.75 -178.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.442 ' HD1' HD13 ' A' ' 235' ' ' LEU . 7.9 p90 -150.08 178.76 8.65 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 122.899 0.479 . . . . 74.22 110.773 174.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 41.4 mmtm -141.67 132.33 13.05 Favored Pre-proline 0 N--CA 1.483 1.222 0 C-N-CA 124.73 1.212 . . . . 75.04 109.007 175.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . 0.423 ' HA ' HG12 ' A' ' 219' ' ' VAL . 55.7 Cg_endo -67.54 105.54 1.09 Allowed 'Trans proline' 0 C--N 1.384 2.415 0 C-N-CA 122.946 2.431 . . . . 70.14 111.866 -177.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . 0.494 ' HB2' ' HG3' ' A' ' 220' ' ' GLU . . . -77.59 86.44 3.91 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.46 0.704 . . . . 50.15 109.235 178.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 68.18 13.47 9.08 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.883 1.273 . . . . 71.54 111.683 -174.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -69.12 149.67 49.31 Favored Glycine 0 C--N 1.36 1.888 0 CA-C-O 119.708 -0.496 . . . . 71.42 111.955 177.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 34.8 t -124.19 101.55 7.26 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 117.506 0.653 . . . . 74.13 110.413 -172.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -93.52 -146.2 19.26 Favored Glycine 0 CA--C 1.536 1.358 0 CA-C-N 115.945 -0.571 . . . . 71.41 112.503 176.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . 0.41 ' O ' ' HB3' ' A' ' 241' ' ' PRO . . . 166.66 -179.78 40.34 Favored Glycine 0 C--N 1.344 0.979 0 N-CA-C 110.619 -0.992 . . . . 52.24 110.619 -179.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 32.6 p -78.64 88.13 4.56 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 109.114 -0.699 . . . . 61.4 109.114 173.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -80.42 -122.81 0.49 Allowed Glycine 0 C--N 1.349 1.271 0 CA-C-N 115.619 -0.719 . . . . 45.23 113.172 -177.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 76.5 11.92 84.76 Favored Glycine 0 C--N 1.349 1.305 0 C-N-CA 122.752 0.215 . . . . 41.33 112.883 -177.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 34.1 p -81.76 -4.11 55.52 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.102 0.961 . . . . 74.52 111.57 -178.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 96.95 -118.36 6.03 Favored Glycine 0 C--N 1.349 1.286 0 N-CA-C 111.334 -0.707 . . . . 74.55 111.334 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 70.75 -88.51 0.37 Allowed Glycine 0 C--N 1.345 1.072 0 N-CA-C 110.911 -0.875 . . . . 64.22 110.911 -176.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 66.9 m -156.24 94.74 1.53 Allowed 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.534 1.133 . . . . 73.33 108.365 175.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -57.53 -44.26 84.99 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-O 121.708 0.766 . . . . 34.01 110.314 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.485 ' HA ' ' O ' ' A' ' 248' ' ' ASP . 3.7 p-10 -88.17 145.57 25.85 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 114.653 -1.158 . . . . 61.31 110.153 171.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 67.9 mt -127.11 140.43 52.28 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.682 0.793 . . . . 63.45 108.954 172.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -107.21 120.87 43.31 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 108.919 -0.771 . . . . 75.32 108.919 175.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -143.81 161.62 38.17 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.836 0.854 . . . . 74.35 109.452 -177.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 2.7 m -112.97 141.27 47.0 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 109.072 -0.714 . . . . 74.54 109.072 -178.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.52 HD11 HG23 ' A' ' 210' ' ' VAL . 37.6 tp -113.22 117.93 33.26 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.281 0.632 . . . . 74.25 111.052 -168.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -82.34 101.18 10.41 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.91 -0.774 . . . . 74.32 108.91 168.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.544 ' HA ' HG11 ' A' ' 210' ' ' VAL . 2.6 p -115.31 112.71 43.73 Favored Pre-proline 0 CA--C 1.546 0.79 0 N-CA-C 109.218 -0.66 . . . . 74.11 109.218 173.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -54.08 146.1 50.02 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 123.349 2.699 . . . . 55.15 113.029 175.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -49.38 -49.32 71.69 Favored Pre-proline 0 CA--C 1.561 1.383 0 O-C-N 124.356 1.035 . . . . 25.3 113.489 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -60.19 -42.13 45.47 Favored 'Trans proline' 0 C--N 1.393 2.91 0 C-N-CA 121.919 1.746 . . . . 61.2 112.528 177.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 43.0 mt -70.92 -27.33 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 123.602 0.761 . . . . 62.15 110.932 -177.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.05 -48.13 63.6 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.069 0.548 . . . . 52.22 110.709 175.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 88.6 t -68.12 -46.17 81.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 123.742 0.817 . . . . 63.53 111.591 -176.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 17.0 m -73.65 -33.13 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 CA-C-N 116.691 -0.231 . . . . 73.55 111.109 178.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 74.66 77.17 0.68 Allowed Glycine 0 C--N 1.349 1.268 0 CA-C-N 115.987 -0.551 . . . . 72.14 112.243 -173.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -107.58 -133.64 7.21 Favored Glycine 0 C--N 1.344 1.025 0 N-CA-C 111.566 -0.614 . . . . 75.5 111.566 178.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm -131.49 147.24 52.53 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.858 0.863 . . . . 70.04 109.633 171.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.544 HG11 ' HA ' ' A' ' 199' ' ' VAL . 17.4 m -133.62 143.57 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 124.401 1.08 . . . . 74.34 109.278 174.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . 0.432 ' HA ' ' O ' ' A' ' 219' ' ' VAL . 14.8 ttm180 -85.56 116.31 23.78 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 122.486 0.314 . . . . 73.45 110.882 -175.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -100.68 141.36 33.66 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.454 1.102 . . . . 73.32 110.113 177.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 2.2 mmt -88.23 125.03 34.43 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 123.881 0.873 . . . . 70.14 110.051 176.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 41.3 p -134.42 177.75 7.52 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.791 0.836 . . . . 54.13 110.605 178.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.415 HD12 ' HE1' ' A' ' 240' ' ' PHE . 20.1 mt -69.19 -26.28 64.75 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 122.811 0.445 . . . . 73.44 110.503 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -79.84 -19.38 48.55 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.483 0.713 . . . . 73.21 110.967 178.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 127.47 -157.28 20.82 Favored Glycine 0 C--N 1.352 1.438 0 CA-C-O 119.797 -0.446 . . . . 71.41 112.653 178.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . 0.448 ' HG2' ' O ' ' A' ' 178' ' ' ALA . 58.7 Cg_endo -76.37 134.06 15.22 Favored 'Trans proline' 0 C--N 1.369 1.657 0 C-N-CA 122.744 2.296 . . . . 55.14 111.655 175.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' A' ' 211' ' ' ARG . 19.7 m -135.34 145.41 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 123.722 0.809 . . . . 74.34 109.106 -178.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.494 ' HG3' ' HB2' ' A' ' 178' ' ' ALA . 56.0 mt-10 -105.32 110.66 23.1 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 118.942 0.792 . . . . 73.3 109.545 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 45.5 t -97.06 122.43 48.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 124.975 1.31 . . . . 65.45 111.021 -170.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -65.25 105.31 1.08 Allowed 'General case' 0 C--O 1.241 0.641 0 C-N-CA 124.28 1.032 . . . . 54.41 110.94 175.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 51.5 t -76.8 128.14 82.36 Favored Pre-proline 0 CA--C 1.548 0.866 0 CA-C-N 114.741 -1.118 . . . . 65.21 109.008 173.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.48 141.99 96.86 Favored 'Trans proline' 0 CA--C 1.561 1.84 0 C-N-CA 122.504 2.136 . . . . 60.43 112.445 174.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -59.41 126.61 21.25 Favored 'Trans proline' 0 C--N 1.375 1.97 0 C-N-CA 122.696 2.264 . . . . 50.13 112.771 173.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 86.6 mtt-85 70.74 71.47 0.19 Allowed 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 125.638 1.575 . . . . 73.11 110.065 179.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.619 HG23 ' HD2' ' A' ' 231' ' ' ARG . 15.9 m -103.45 136.8 42.52 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 114.264 -1.335 . . . . 65.51 110.622 -177.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 22.3 mp0 -103.91 158.04 16.68 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.209 1.004 . . . . 64.33 109.764 177.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -74.47 144.97 43.97 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 109.424 -0.584 . . . . 63.43 109.424 173.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 89.89 2.0 75.77 Favored Glycine 0 C--N 1.341 0.86 0 CA-C-O 120.112 -0.271 . . . . 75.05 112.687 -175.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.619 ' HD2' HG23 ' A' ' 227' ' ' THR . 83.1 mtt180 -70.13 160.83 31.33 Favored 'General case' 0 C--N 1.356 0.848 0 CA-C-O 121.528 0.68 . . . . 60.34 110.179 170.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 16.1 pttp -130.53 138.42 50.2 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 114.863 -1.062 . . . . 74.14 108.885 175.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.454 HD22 ' HB2' ' A' ' 173' ' ' ALA . 67.0 mt -119.89 141.41 49.61 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.564 1.146 . . . . 74.23 107.925 178.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . 0.47 ' HB3' HG21 ' A' ' 170' ' ' VAL . 33.8 ttt180 -129.53 107.98 9.89 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.452 -0.944 . . . . 74.22 108.452 171.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.442 HD13 ' HD1' ' A' ' 175' ' ' TYR . 19.6 mt -81.08 83.99 6.62 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.833 1.253 . . . . 71.31 109.099 -177.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -69.75 134.43 48.6 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.108 0.963 . . . . 61.35 111.123 -175.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 65.18 21.95 68.59 Favored Glycine 0 C--N 1.35 1.338 0 O-C-N 123.892 0.745 . . . . 70.31 112.826 -176.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.439 ' HD3' HH21 ' A' ' 246' ' ' ARG . 29.5 mmtp -138.32 19.87 2.76 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.028 0.931 . . . . 74.2 110.899 -174.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -92.83 -133.25 6.35 Favored Glycine 0 N--CA 1.466 0.657 0 N-CA-C 111.919 -0.472 . . . . 72.15 111.919 174.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . 0.415 ' HE1' HD12 ' A' ' 215' ' ' LEU . 0.1 OUTLIER -61.35 138.72 94.75 Favored Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 123.888 0.875 . . . . 74.11 110.133 177.746 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.41 ' HB3' ' O ' ' A' ' 183' ' ' GLY . 97.1 Cg_exo -48.12 146.18 9.81 Favored 'Trans proline' 0 C--N 1.377 2.045 0 C-N-CA 123.9 3.066 . . . . 74.23 115.107 177.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -159.79 138.67 5.71 Favored Glycine 0 CA--C 1.534 1.238 0 CA-C-O 118.559 -1.134 . . . . 72.5 110.469 177.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -65.82 -40.21 17.63 Favored 'Trans proline' 0 C--N 1.378 2.12 0 C-N-CA 123.274 2.649 . . . . 61.14 113.551 -171.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -97.55 -18.44 18.97 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.59 0.756 . . . . 32.1 111.454 -177.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 175.67 148.51 6.89 Favored Glycine 0 C--N 1.341 0.847 0 N-CA-C 110.76 -0.936 . . . . 71.34 110.76 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.439 HH21 ' HD3' ' A' ' 238' ' ' LYS . 21.0 mtm180 -90.12 170.53 10.24 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 117.18 0.49 . . . . 75.43 110.425 -176.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -78.27 -153.6 6.73 Favored Glycine 0 C--N 1.343 0.954 0 CA-C-N 115.862 -0.608 . . . . 64.41 112.19 173.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . 0.485 ' O ' ' HA ' ' A' ' 192' ' ' ASP . 4.6 p30 -122.92 155.78 36.03 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 117.617 0.708 . . . . 73.21 110.849 176.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 55.2 tp -121.76 108.41 13.48 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 108.907 -0.775 . . . . 74.41 108.907 174.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 42.7 t80 -90.45 108.69 19.94 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 115.099 -0.955 . . . . 74.12 110.105 -175.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 62.9 mt -105.91 121.93 45.09 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.721 0.808 . . . . 62.42 110.517 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -84.16 110.63 18.66 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 122.935 0.494 . . . . 71.43 109.795 172.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 57.6 t -64.84 119.27 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 123.83 0.852 . . . . 52.52 111.763 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 21.7 mmt180 -119.66 117.78 29.21 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 108.011 -1.107 . . . . 55.5 108.011 171.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 17.5 mt -75.53 117.38 19.84 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 N-CA-C 109.037 -0.727 . . . . 54.1 109.037 175.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 27.2 m . . . . . 0 C--O 1.25 1.115 0 C-N-CA 124.931 1.292 . . . . 74.44 108.848 -175.57 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 59.8 mtt . . . . . 0 N--CA 1.483 1.218 0 N-CA-C 108.847 -0.797 . . . . 71.54 108.847 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -82.1 69.36 8.8 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-O 122.608 1.194 . . . . 74.13 110.633 -174.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -87.59 -51.44 5.89 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 114.855 -1.066 . . . . 74.1 110.256 -175.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.49 HG12 ' HG3' ' A' ' 232' ' ' LYS . 13.9 m -91.71 162.41 2.42 Favored 'Isoleucine or valine' 0 C--O 1.244 0.782 0 CA-C-N 115.043 -0.98 . . . . 75.3 109.377 173.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 16.7 tt -79.38 135.35 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 N-CA-C 107.694 -1.225 . . . . 74.13 107.694 166.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -70.92 142.89 51.08 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.365 0.666 . . . . 74.22 110.737 -172.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.442 ' HB2' HD22 ' A' ' 233' ' ' LEU . . . -149.17 162.14 40.58 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.418 0.687 . . . . 71.04 110.127 -178.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -136.51 156.63 48.32 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 123.795 0.838 . . . . 74.43 110.024 -177.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.494 ' H ' ' HD3' ' A' ' 238' ' ' LYS . 7.3 p90 -150.3 171.92 16.19 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.084 0.553 . . . . 53.33 111.486 167.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.43 ' HE2' ' HD2' ' A' ' 177' ' ' PRO . 12.6 mmmm -137.79 140.41 29.57 Favored Pre-proline 0 C--O 1.241 0.629 0 C-N-CA 124.291 1.036 . . . . 72.42 108.564 173.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . 0.552 ' HA ' HG12 ' A' ' 219' ' ' VAL . 18.2 Cg_endo -61.29 109.05 0.66 Allowed 'Trans proline' 0 C--N 1.368 1.553 0 C-N-CA 122.486 2.124 . . . . 61.14 111.104 172.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . 0.551 ' HB2' ' HG3' ' A' ' 220' ' ' GLU . . . -74.51 -12.52 60.5 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.711 0.804 . . . . 60.12 110.691 177.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -67.35 138.93 57.14 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.221 1.008 . . . . 64.4 111.779 178.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -71.21 -20.64 78.21 Favored Glycine 0 C--N 1.353 1.5 0 CA-C-O 119.465 -0.631 . . . . 54.45 114.307 -173.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 13.1 m -70.54 -14.48 62.53 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 117.365 0.583 . . . . 71.45 110.741 175.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 82.55 7.18 87.84 Favored Glycine 0 C--N 1.353 1.493 0 C-N-CA 123.558 0.599 . . . . 75.03 114.131 173.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 65.49 64.46 3.45 Favored Glycine 0 C--N 1.344 0.994 0 N-CA-C 112.014 -0.434 . . . . 51.54 112.014 -174.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 31.7 m -84.74 107.93 17.18 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 123.359 0.663 . . . . 73.02 109.591 175.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -92.75 -155.71 32.18 Favored Glycine 0 C--N 1.347 1.146 0 CA-C-N 116.537 -0.301 . . . . 43.21 113.029 179.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 136.07 -51.19 0.82 Allowed Glycine 0 C--N 1.338 0.681 0 N-CA-C 110.784 -0.926 . . . . 63.42 110.784 -177.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 57.9 p -102.67 130.62 49.64 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.628 0.771 . . . . 54.21 109.921 177.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 123.47 98.02 1.32 Allowed Glycine 0 C--N 1.346 1.128 0 N-CA-C 111.713 -0.555 . . . . 74.21 111.713 178.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -71.17 -24.18 77.3 Favored Glycine 0 C--N 1.349 1.267 0 C-N-CA 122.639 0.161 . . . . 55.35 113.265 177.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 35.5 m -75.78 87.19 2.8 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.373 0.669 . . . . 53.41 110.302 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.449 ' HA ' ' HB2' ' A' ' 240' ' ' PHE . 91.5 mm-40 -76.43 -33.52 58.79 Favored 'General case' 0 C--O 1.248 1.013 0 CA-C-N 114.752 -1.113 . . . . 64.34 110.848 -178.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -82.74 120.87 26.15 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.113 -0.949 . . . . 73.31 110.012 175.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 81.3 mt -110.49 147.8 33.38 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.916 0.886 . . . . 74.33 108.697 171.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -130.08 122.77 28.97 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.543 0.737 . . . . 74.02 109.664 -177.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.409 ' O ' ' HA ' ' A' ' 251' ' ' LEU . . . -160.68 169.9 21.9 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.584 0.754 . . . . 74.05 110.27 -178.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . 0.551 HG22 ' HB2' ' A' ' 252' ' ' GLU . 8.9 p -101.83 145.84 28.63 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.365 0.666 . . . . 75.12 109.783 174.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.575 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . 51.8 tp -113.75 113.72 25.35 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.276 1.031 . . . . 72.44 110.09 -174.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -75.51 101.81 5.0 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 109.557 -0.534 . . . . 71.31 109.557 173.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.522 ' HA ' HG11 ' A' ' 210' ' ' VAL . 44.7 t -104.92 118.84 55.19 Favored Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 108.404 -0.961 . . . . 75.33 108.404 174.131 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -55.23 140.28 81.29 Favored 'Trans proline' 0 C--N 1.372 1.799 0 C-N-CA 122.727 2.285 . . . . 65.25 111.514 169.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -51.75 -47.87 89.05 Favored Pre-proline 0 CA--C 1.559 1.308 0 N-CA-C 114.432 1.271 . . . . 74.22 114.432 -175.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.441 ' O ' HG12 ' A' ' 206' ' ' VAL . 16.3 Cg_endo -55.93 -45.43 38.73 Favored 'Trans proline' 0 C--N 1.385 2.469 0 C-N-CA 122.218 1.945 . . . . 53.22 112.743 174.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 47.5 mt -65.83 -31.07 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 123.714 0.806 . . . . 63.43 110.902 -178.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . 0.419 ' HB1' ' O ' ' A' ' 227' ' ' THR . . . -70.91 -40.21 72.28 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.29 0.636 . . . . 73.43 111.415 177.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 64.8 t -72.47 -54.98 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 123.858 0.863 . . . . 73.31 111.512 -177.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.441 HG12 ' O ' ' A' ' 202' ' ' PRO . 8.3 p -86.97 -16.73 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 C-N-CA 122.492 0.317 . . . . 71.35 111.831 -174.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 83.02 162.18 32.03 Favored Glycine 0 C--N 1.349 1.251 0 N-CA-C 111.234 -0.746 . . . . 74.11 111.234 -173.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 161.47 -134.12 3.42 Favored Glycine 0 N--CA 1.464 0.533 0 CA-C-N 117.429 0.615 . . . . 73.45 112.326 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.452 ' HD3' ' HB3' ' A' ' 220' ' ' GLU . 92.8 mttt -134.69 144.83 48.01 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.875 0.87 . . . . 71.41 109.963 175.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.522 HG11 ' HA ' ' A' ' 199' ' ' VAL . 22.3 m -129.29 144.61 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 N-CA-C 108.451 -0.944 . . . . 74.02 108.451 168.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 36.3 ttp180 -86.63 110.91 20.16 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 109.612 -0.514 . . . . 73.31 109.612 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -101.89 151.71 21.77 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.176 0.591 . . . . 53.14 110.203 179.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -98.29 117.94 33.82 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 123.078 0.551 . . . . 75.33 109.724 178.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 43.6 p -111.84 179.02 4.13 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.387 0.675 . . . . 73.12 109.417 171.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.415 HD12 ' HE1' ' A' ' 240' ' ' PHE . 20.7 mt -81.81 -7.49 59.61 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.075 0.55 . . . . 73.42 112.102 -173.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -98.9 -19.83 17.14 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.335 1.054 . . . . 75.03 110.859 178.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 144.36 -165.69 27.4 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-N 115.911 -0.586 . . . . 64.42 111.842 -177.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -74.78 147.45 34.99 Favored 'Trans proline' 0 C--N 1.367 1.501 0 C-N-CA 122.935 2.423 . . . . 74.51 112.224 176.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.552 HG12 ' HA ' ' A' ' 177' ' ' PRO . 14.1 m -135.56 157.15 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 123.762 0.825 . . . . 74.13 109.524 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.551 ' HG3' ' HB2' ' A' ' 178' ' ' ALA . 51.9 mt-10 -108.06 106.19 16.3 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 109.349 -0.612 . . . . 71.35 109.349 176.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 56.1 t -92.96 112.21 25.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 109.19 -0.67 . . . . 71.23 109.19 -177.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -65.06 101.09 0.48 Allowed 'General case' 0 CA--C 1.539 0.545 0 O-C-N 123.999 0.812 . . . . 72.34 109.436 173.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 64.7 t -73.46 127.39 88.93 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-N 115.018 -0.992 . . . . 75.12 109.231 174.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.94 157.57 57.73 Favored 'Trans proline' 0 CA--C 1.559 1.75 0 C-N-CA 121.491 1.461 . . . . 73.44 110.824 171.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -70.05 164.28 35.42 Favored 'Trans proline' 0 C--N 1.366 1.455 0 C-N-CA 122.064 1.843 . . . . 72.12 111.942 176.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 75.7 mtm180 59.32 25.8 14.53 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 124.834 1.254 . . . . 73.12 112.146 174.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.544 HG23 ' HD2' ' A' ' 231' ' ' ARG . 96.7 m -90.85 99.6 12.61 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.943 0.897 . . . . 75.44 110.064 -176.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 19.7 mp0 -84.76 166.78 16.69 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 121.318 0.58 . . . . 60.12 111.542 -176.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . 0.532 ' HB2' ' HB ' ' A' ' 255' ' ' ILE . . . -66.98 124.2 22.36 Favored 'General case' 0 C--N 1.346 0.455 0 CA-C-N 114.549 -1.205 . . . . 62.3 109.699 177.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 114.05 -12.46 22.16 Favored Glycine 0 C--N 1.335 0.518 0 CA-C-O 119.401 -0.666 . . . . 74.32 112.645 -174.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.544 ' HD2' HG23 ' A' ' 227' ' ' THR . 42.6 mtt180 -71.62 162.88 28.75 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.738 0.78 . . . . 72.05 111.459 172.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.49 ' HG3' HG12 ' A' ' 170' ' ' VAL . 20.4 pttm -129.04 136.23 50.0 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.84 1.256 . . . . 72.5 109.294 -178.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.442 HD22 ' HB2' ' A' ' 173' ' ' ALA . 96.1 mt -116.83 113.95 23.24 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.011 0.924 . . . . 60.32 108.749 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . 0.448 ' H ' HG21 ' A' ' 170' ' ' VAL . 19.9 ttt180 -96.45 101.02 12.58 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 107.381 -1.34 . . . . 73.41 107.381 170.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.437 HD13 ' CD1' ' A' ' 175' ' ' TYR . 22.2 mt -78.86 84.26 4.92 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 114.714 -1.13 . . . . 73.02 107.992 178.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 10.2 mtmp? -72.38 123.81 23.84 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 113.752 -1.567 . . . . 63.41 111.093 -172.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 67.28 32.05 78.77 Favored Glycine 0 C--N 1.346 1.133 0 O-C-N 123.733 0.646 . . . . 73.12 112.391 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.494 ' HD3' ' H ' ' A' ' 175' ' ' TYR . 10.3 mmpt? -125.3 -31.58 3.03 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.313 1.045 . . . . 73.04 112.248 -174.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -59.22 -112.09 0.01 OUTLIER Glycine 0 C--N 1.357 1.704 0 N-CA-C 116.092 1.197 . . . . 55.13 116.092 -168.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . 0.449 ' HB2' ' HA ' ' A' ' 191' ' ' GLN . 0.2 OUTLIER -71.54 136.16 83.62 Favored Pre-proline 0 N--CA 1.485 1.278 0 CA-C-N 117.393 0.596 . . . . 75.34 110.334 -178.805 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.58 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 13.7 Cg_exo -67.48 127.07 15.83 Favored 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.409 2.073 . . . . 73.02 111.981 -179.079 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -137.23 145.05 16.75 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-O 118.963 -0.91 . . . . 72.11 111.447 -179.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.6 -32.65 30.51 Favored 'Trans proline' 0 C--N 1.374 1.89 0 C-N-CA 123.215 2.61 . . . . 62.2 113.627 -174.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -91.96 -18.94 22.98 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.143 0.577 . . . . 74.41 110.935 178.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 163.26 151.87 6.6 Favored Glycine 0 C--N 1.343 0.948 0 N-CA-C 111.521 -0.631 . . . . 54.11 111.521 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.58 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 37.2 mtt-85 -78.52 164.05 25.04 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.371 0.669 . . . . 70.41 111.195 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.407 ' HA3' ' HB3' ' A' ' 191' ' ' GLN . . . -83.17 -154.72 17.39 Favored Glycine 0 C--N 1.342 0.879 0 CA-C-N 115.249 -0.887 . . . . 74.22 113.078 178.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -119.25 127.02 52.86 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 117.122 0.461 . . . . 40.25 110.011 177.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.501 ' HG ' ' HG ' ' A' ' 251' ' ' LEU . 60.6 tp -100.22 108.01 20.0 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 107.547 -1.279 . . . . 73.43 107.547 170.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . 0.442 ' OH ' ' HD2' ' A' ' 232' ' ' LYS . 23.0 t80 -97.14 108.18 20.85 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.754 -0.832 . . . . 74.43 108.754 -175.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.575 ' HB3' ' HB2' ' A' ' 197' ' ' LEU . 55.3 mt -115.7 120.42 39.29 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.931 0.892 . . . . 74.21 110.894 -173.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . 0.551 ' HB2' HG22 ' A' ' 196' ' ' THR . 3.6 mp0 -84.76 115.13 22.54 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.15 0.58 . . . . 74.44 109.93 175.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.512 HG11 HG22 ' A' ' 227' ' ' THR . 61.5 t -65.84 109.05 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 C-N-CA 123.497 0.719 . . . . 73.33 111.744 -176.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -104.77 107.99 19.24 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.891 1.277 . . . . 74.4 108.322 171.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.532 ' HB ' ' HB2' ' A' ' 229' ' ' ALA . 16.2 mt -75.69 132.77 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 122.907 0.483 . . . . 73.31 109.782 177.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 20.7 p . . . . . 0 CA--C 1.557 1.226 0 C-N-CA 124.435 1.094 . . . . 64.31 108.924 -177.885 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . 0.452 ' SD ' ' N ' ' A' ' 167' ' ' MET . 1.3 mpt? . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.152 0.025 . . . . 73.51 111.042 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -78.39 91.59 4.49 Favored 'General case' 0 C--N 1.355 0.833 0 N-CA-C 108.546 -0.909 . . . . 55.2 108.546 174.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -64.15 -60.04 3.7 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 115.792 -0.64 . . . . 62.12 110.873 -179.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.441 HG12 ' HG3' ' A' ' 232' ' ' LYS . 31.9 m -108.97 168.64 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 123.37 0.668 . . . . 73.44 110.688 177.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 10.4 tt -89.3 150.32 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.976 0 N-CA-C 108.489 -0.93 . . . . 53.15 108.489 167.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -58.07 142.36 47.16 Favored 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 124.75 1.22 . . . . 72.01 111.888 178.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -164.76 149.43 9.43 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.317 1.447 . . . . 62.42 108.394 176.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -146.43 154.85 42.08 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 123.346 0.658 . . . . 73.34 109.825 175.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.423 ' CD1' HD13 ' A' ' 235' ' ' LEU . 44.4 p90 -118.17 177.34 4.83 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.249 0.62 . . . . 73.45 111.052 -177.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -145.32 145.79 27.8 Favored Pre-proline 0 N--CA 1.472 0.667 0 CA-C-N 114.325 -1.307 . . . . 73.13 108.569 168.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . 0.461 ' HA ' HG12 ' A' ' 219' ' ' VAL . 20.9 Cg_endo -59.26 127.53 24.31 Favored 'Trans proline' 0 C--N 1.376 2.023 0 C-N-CA 122.747 2.298 . . . . 75.1 111.545 174.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.33 -32.7 72.58 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.133 0.973 . . . . 74.44 111.489 -178.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -131.5 -161.93 1.18 Allowed 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.501 1.12 . . . . 51.42 108.257 176.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -76.36 67.38 2.51 Favored Glycine 0 C--N 1.348 1.243 0 N-CA-C 110.757 -0.937 . . . . 61.21 110.757 168.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 16.8 m -71.7 95.53 1.48 Allowed 'General case' 0 C--N 1.351 0.662 0 C-N-CA 123.979 0.912 . . . . 70.21 110.496 -172.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -124.67 33.19 3.83 Favored Glycine 0 C--N 1.339 0.743 0 CA-C-N 115.392 -0.822 . . . . 62.43 111.387 177.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -66.32 133.03 33.2 Favored Glycine 0 C--N 1.352 1.457 0 N-CA-C 111.044 -0.823 . . . . 71.34 111.044 175.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 70.1 p -62.1 121.6 13.46 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.668 0.787 . . . . 71.13 110.527 -177.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -61.68 121.67 26.64 Favored Glycine 0 C--N 1.354 1.532 0 O-C-N 123.896 0.748 . . . . 25.33 112.319 178.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -64.58 162.48 37.58 Favored Glycine 0 C--N 1.351 1.383 0 C-N-CA 123.123 0.392 . . . . 64.31 113.552 -177.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 50.8 m -63.66 123.48 18.97 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.103 0.961 . . . . 73.33 111.966 -175.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -169.41 127.85 1.57 Allowed Glycine 0 C--N 1.338 0.692 0 N-CA-C 111.246 -0.742 . . . . 44.24 111.246 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -84.62 50.66 4.44 Favored Glycine 0 C--N 1.35 1.36 0 N-CA-C 111.667 -0.573 . . . . 62.33 111.667 176.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 38.3 t -158.34 131.14 7.21 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 124.429 1.092 . . . . 63.04 108.089 179.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -81.3 -21.08 39.56 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 123.571 0.748 . . . . 74.53 110.387 173.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -91.16 127.5 36.61 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.81 0.844 . . . . 65.22 109.599 -176.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 76.8 mt -109.6 146.9 33.95 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.279 1.032 . . . . 64.21 108.978 177.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -128.02 123.29 34.32 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 108.22 -1.03 . . . . 74.31 108.22 177.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -152.28 162.0 41.78 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.768 0.827 . . . . 43.14 110.329 -178.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . 0.511 HG22 ' HE ' ' A' ' 254' ' ' ARG . 13.0 p -85.35 149.61 25.33 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.896 0.878 . . . . 71.44 110.691 174.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.582 HD13 HD13 ' A' ' 251' ' ' LEU . 43.7 tp -115.29 114.47 25.22 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.928 0.891 . . . . 70.14 109.017 179.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -88.83 101.2 13.8 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.254 0.622 . . . . 73.42 109.873 -177.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.566 ' HA ' HG11 ' A' ' 210' ' ' VAL . 7.4 p -118.39 123.12 29.54 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 123.784 0.834 . . . . 71.1 110.299 -177.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -57.73 146.3 85.98 Favored 'Trans proline' 0 C--N 1.372 1.796 0 C-N-CA 122.694 2.263 . . . . 63.24 112.311 168.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -51.77 -46.91 91.69 Favored Pre-proline 0 CA--C 1.559 1.319 0 N-CA-C 113.725 1.009 . . . . 64.31 113.725 179.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.418 ' O ' HG22 ' A' ' 206' ' ' VAL . 11.3 Cg_endo -53.6 -48.75 20.18 Favored 'Trans proline' 0 C--N 1.398 3.159 0 C-N-CA 122.327 2.018 . . . . 62.3 112.995 173.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 31.4 mt -66.36 -31.3 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 123.778 0.831 . . . . 74.11 111.359 -177.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.52 -41.23 76.29 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 122.708 0.403 . . . . 73.45 111.515 178.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 84.8 t -72.87 -51.41 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 122.96 0.504 . . . . 63.53 111.433 -178.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.418 HG22 ' O ' ' A' ' 202' ' ' PRO . 19.3 m -85.73 -20.15 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 N-CA-C 112.497 0.554 . . . . 75.24 112.497 -174.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 90.98 162.65 38.34 Favored Glycine 0 N--CA 1.476 1.323 0 N-CA-C 111.249 -0.74 . . . . 63.11 111.249 -171.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 161.92 -147.93 14.75 Favored Glycine 0 N--CA 1.467 0.722 0 CA-C-N 117.635 0.718 . . . . 63.54 111.918 178.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 33.2 mtmm -133.13 139.52 47.13 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.239 0.616 . . . . 62.24 109.759 175.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.566 HG11 ' HA ' ' A' ' 199' ' ' VAL . 27.1 m -135.83 144.85 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 123.649 0.78 . . . . 73.42 109.404 175.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 25.1 ttm180 -85.8 116.42 24.04 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 123.196 0.598 . . . . 74.22 111.227 -171.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -102.81 164.66 11.5 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.564 1.146 . . . . 61.4 110.158 173.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -105.4 123.19 47.46 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.896 0.878 . . . . 71.35 110.183 -178.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 81.1 p -124.52 177.94 5.66 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.131 0.973 . . . . 72.01 109.936 175.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 14.7 mt -78.9 -9.7 59.57 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.058 0.543 . . . . 72.43 111.739 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -94.34 -18.65 21.39 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.699 0.8 . . . . 73.02 110.569 176.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 137.64 -164.21 25.45 Favored Glycine 0 C--N 1.349 1.292 0 CA-C-N 116.057 -0.52 . . . . 45.5 112.174 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -74.1 134.05 18.9 Favored 'Trans proline' 0 C--N 1.365 1.43 0 C-N-CA 122.439 2.093 . . . . 71.34 111.304 171.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.461 HG12 ' HA ' ' A' ' 177' ' ' PRO . 33.2 m -133.42 132.68 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 123.782 0.833 . . . . 75.31 109.071 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -91.72 116.47 28.91 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 122.028 -0.42 . . . . 73.11 110.014 179.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 36.9 t -96.54 127.22 48.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 C-N-CA 124.961 1.304 . . . . 73.02 109.995 -173.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -69.22 99.69 1.19 Allowed 'General case' 0 CA--C 1.54 0.589 0 O-C-N 123.959 0.787 . . . . 64.01 109.92 175.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 58.9 t -72.63 121.75 85.72 Favored Pre-proline 0 C--O 1.239 0.551 0 C-N-CA 124.583 1.153 . . . . 73.41 108.917 174.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -61.12 152.43 71.67 Favored 'Trans proline' 0 C--N 1.375 1.93 0 C-N-CA 122.297 1.998 . . . . 62.14 111.474 172.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_exo -64.57 157.4 55.53 Favored 'Trans proline' 0 C--N 1.37 1.66 0 C-N-CA 122.255 1.97 . . . . 63.2 111.87 171.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 62.41 33.42 16.26 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.925 1.29 . . . . 64.42 110.894 174.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.498 HG23 ' HD2' ' A' ' 231' ' ' ARG . 21.1 m -88.52 126.32 35.2 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.917 0.887 . . . . 73.42 110.477 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 -94.2 163.73 13.33 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.218 1.007 . . . . 72.2 111.361 -176.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -69.14 114.76 7.7 Favored 'General case' 0 C--N 1.348 0.528 0 CA-C-N 115.029 -0.987 . . . . 70.51 109.289 173.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 105.38 4.6 40.59 Favored Glycine 0 C--N 1.338 0.648 0 O-C-N 123.756 0.66 . . . . 63.22 112.799 -179.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.498 ' HD2' HG23 ' A' ' 227' ' ' THR . 28.3 mtt180 -63.68 152.9 37.81 Favored 'General case' 0 C--N 1.359 0.989 0 CA-C-N 117.404 0.602 . . . . 74.1 110.466 171.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.441 ' HG3' HG12 ' A' ' 170' ' ' VAL . 20.8 pttm -115.63 130.52 56.89 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 123.575 0.75 . . . . 65.32 109.877 -179.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 89.1 mt -120.44 132.67 55.33 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 107.766 -1.198 . . . . 63.32 107.766 176.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . 0.413 ' H ' HG21 ' A' ' 170' ' ' VAL . 35.5 ttm-85 -121.92 106.89 11.65 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 108.149 -1.056 . . . . 73.13 108.149 170.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.423 HD13 ' CD1' ' A' ' 175' ' ' TYR . 15.4 mt -76.06 82.57 2.91 Favored 'General case' 0 C--O 1.243 0.715 0 N-CA-C 107.375 -1.342 . . . . 51.41 107.375 174.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -71.28 133.04 45.77 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-N 115.318 -0.855 . . . . 72.4 110.746 -173.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 65.14 26.3 71.44 Favored Glycine 0 C--N 1.345 1.029 0 O-C-N 124.083 0.864 . . . . 61.11 112.563 -177.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -142.82 36.93 1.43 Allowed 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 124.008 0.923 . . . . 75.35 111.11 -177.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -100.97 -111.66 3.43 Favored Glycine 0 N--CA 1.478 1.498 0 CA-C-O 119.579 -0.567 . . . . 45.23 112.26 175.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -62.92 133.89 95.46 Favored Pre-proline 0 N--CA 1.487 1.411 0 CA-C-O 118.178 -0.915 . . . . 71.23 110.557 173.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -62.45 130.41 29.98 Favored 'Trans proline' 0 C--N 1.38 2.233 0 C-N-CA 123.119 2.546 . . . . 70.44 112.159 178.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -166.02 124.27 1.22 Allowed Glycine 0 CA--C 1.533 1.184 0 CA-C-O 118.71 -1.05 . . . . 61.41 111.42 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -68.68 -26.95 32.65 Favored 'Trans proline' 0 C--N 1.382 2.337 0 C-N-CA 123.528 2.819 . . . . 63.52 113.273 -176.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -80.97 -25.64 37.19 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.356 0.662 . . . . 71.0 111.083 178.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 161.79 117.78 0.44 Allowed Glycine 0 C--N 1.342 0.906 0 N-CA-C 111.232 -0.747 . . . . 70.52 111.232 -178.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 29.8 mtt-85 -69.58 164.99 22.04 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.668 0.787 . . . . 75.41 110.518 176.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -80.09 -158.21 16.1 Favored Glycine 0 N--CA 1.472 1.038 0 CA-C-N 115.886 -0.597 . . . . 74.32 112.387 172.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -115.39 153.57 30.8 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 108.998 -0.742 . . . . 75.51 108.998 173.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 46.7 tp -123.42 107.63 11.81 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 108.124 -1.065 . . . . 63.05 108.124 171.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 24.6 t80 -96.67 107.74 20.24 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 115.331 -0.85 . . . . 71.15 108.978 -172.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.582 HD13 HD13 ' A' ' 197' ' ' LEU . 76.5 mt -103.96 120.65 41.48 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 123.77 0.828 . . . . 73.02 110.639 -176.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -89.6 103.51 16.15 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.093 0.957 . . . . 73.45 108.448 177.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.479 HG11 HG22 ' A' ' 227' ' ' THR . 72.6 t -58.1 116.68 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 123.69 0.796 . . . . 73.51 111.179 -179.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . 0.511 ' HE ' HG22 ' A' ' 196' ' ' THR . 20.4 mmt180 -117.07 107.27 14.31 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 107.801 -1.185 . . . . 72.32 107.801 173.019 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 40.6 mt -75.95 135.47 26.9 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.929 0 N-CA-C 109.464 -0.569 . . . . 64.22 109.464 175.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 14.5 t . . . . . 0 C--O 1.26 1.607 0 C-N-CA 124.673 1.189 . . . . 62.41 109.718 -176.568 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 90.4 mtp . . . . . 0 N--CA 1.477 0.888 0 N-CA-C 109.854 -0.424 . . . . 53.5 109.854 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -104.01 -37.64 7.29 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.185 0.594 . . . . 52.32 110.904 -178.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . 0.402 ' O ' ' HE2' ' A' ' 232' ' ' LYS . 28.1 t70 -59.8 -57.78 11.43 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.652 0.781 . . . . 65.41 110.038 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.6 HG21 ' HB3' ' A' ' 234' ' ' ARG . 33.2 m -106.93 162.15 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 CA-C-N 115.146 -0.934 . . . . 74.44 109.232 172.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 10.0 tt -83.38 147.8 5.56 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.08 0 N-CA-C 109.781 -0.451 . . . . 75.35 109.781 175.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -62.69 139.94 58.68 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.383 1.073 . . . . 72.42 111.941 -178.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.512 ' HB2' HD22 ' A' ' 233' ' ' LEU . . . -156.78 166.56 33.03 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 114.833 -1.076 . . . . 54.25 109.853 178.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -154.53 158.78 40.36 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 124.882 1.273 . . . . 73.3 108.268 173.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.646 ' HE1' ' HB3' ' A' ' 238' ' ' LYS . 45.6 p90 -118.52 -177.49 3.31 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 122.753 0.421 . . . . 63.31 110.102 173.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -144.21 129.27 9.5 Favored Pre-proline 0 N--CA 1.475 0.796 0 N-CA-C 107.61 -1.256 . . . . 64.52 107.61 170.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . 0.49 ' HA ' HG12 ' A' ' 219' ' ' VAL . 32.7 Cg_endo -62.81 111.63 1.42 Allowed 'Trans proline' 0 C--N 1.371 1.731 0 C-N-CA 122.823 2.349 . . . . 54.51 111.094 -179.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -72.1 76.97 0.95 Allowed 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 123.77 0.828 . . . . 55.44 111.179 -177.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 21.3 t70 64.74 2.58 1.73 Allowed 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 125.36 1.464 . . . . 65.53 112.609 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -141.71 131.19 4.68 Favored Glycine 0 C--N 1.346 1.11 0 N-CA-C 111.794 -0.522 . . . . 44.23 111.794 -173.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 21.0 t -144.87 162.4 36.93 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.7 0.8 . . . . 71.12 109.381 -178.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . 0.485 ' N ' ' HG3' ' A' ' 216' ' ' GLU . . . -88.01 -83.05 1.23 Allowed Glycine 0 C--N 1.344 1.009 0 O-C-N 123.5 0.5 . . . . 72.42 112.947 -173.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 157.73 -95.86 0.15 Allowed Glycine 0 C--N 1.343 0.926 0 N-CA-C 111.73 -0.548 . . . . 64.21 111.73 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 73.8 m -146.88 157.15 43.57 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.169 0.988 . . . . 62.44 110.033 178.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 170.99 -133.41 2.77 Favored Glycine 0 C--N 1.343 0.931 0 N-CA-C 110.762 -0.935 . . . . 73.11 110.762 -177.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 79.69 96.49 0.32 Allowed Glycine 0 C--N 1.351 1.383 0 N-CA-C 111.745 -0.542 . . . . 73.23 111.745 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 27.7 m -85.88 -175.2 5.49 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.035 0.534 . . . . 64.55 110.557 178.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -79.9 66.4 3.58 Favored Glycine 0 C--N 1.348 1.237 0 N-CA-C 112.154 -0.378 . . . . 54.2 112.154 177.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 153.85 -55.36 0.43 Allowed Glycine 0 C--N 1.34 0.78 0 N-CA-C 110.977 -0.849 . . . . 74.33 110.977 -177.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 35.6 p -80.89 75.9 7.83 Favored 'General case' 0 C--N 1.351 0.646 0 CA-C-O 121.918 0.866 . . . . 70.12 110.35 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -117.8 -19.63 9.18 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 114.29 -1.323 . . . . 64.42 108.312 168.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.401 ' HA ' ' O ' ' A' ' 248' ' ' ASP . 21.3 t70 -98.98 155.56 17.36 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.143 0.977 . . . . 62.32 110.326 -177.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 48.0 mt -142.53 134.77 27.54 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.599 1.16 . . . . 63.12 109.128 169.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -106.5 122.44 46.3 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 108.479 -0.934 . . . . 75.42 108.479 171.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.463 ' O ' ' HA ' ' A' ' 251' ' ' LEU . . . -145.96 140.52 26.96 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 109.388 -0.597 . . . . 55.33 109.388 178.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 9.4 p -81.33 137.53 35.74 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 109.459 -0.571 . . . . 72.31 109.459 173.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.421 HD11 HG23 ' A' ' 210' ' ' VAL . 51.4 tp -106.76 111.5 24.05 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 108.39 -0.966 . . . . 73.51 108.39 -176.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -81.86 99.47 9.05 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 108.678 -0.86 . . . . 74.34 108.678 178.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.479 ' HA ' HG11 ' A' ' 210' ' ' VAL . 3.2 p -106.34 116.89 58.5 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 123.713 0.805 . . . . 52.23 109.321 178.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -54.94 140.05 79.18 Favored 'Trans proline' 0 C--N 1.367 1.534 0 C-N-CA 122.422 2.082 . . . . 73.42 112.206 172.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.409 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -49.04 -44.92 73.92 Favored Pre-proline 0 CA--C 1.559 1.311 0 N-CA-C 114.184 1.179 . . . . 55.54 114.184 179.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.409 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 18.6 Cg_endo -57.4 -48.72 16.2 Favored 'Trans proline' 0 C--N 1.388 2.628 0 C-N-CA 121.838 1.692 . . . . 54.43 112.764 174.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 53.3 mt -65.79 -31.63 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 C-N-CA 123.781 0.833 . . . . 75.02 111.074 -178.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -64.1 -52.09 60.86 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.287 0.635 . . . . 74.1 110.746 177.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 91.8 t -67.63 -51.96 45.77 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-N 115.567 -0.742 . . . . 75.12 111.385 -176.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 15.5 m -79.68 -22.74 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 112.591 0.589 . . . . 74.02 112.591 -174.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 82.1 154.39 13.66 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 112.126 -0.39 . . . . 75.03 112.126 -171.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 164.58 -135.16 3.62 Favored Glycine 0 C--N 1.337 0.629 0 N-CA-C 111.74 -0.544 . . . . 51.52 111.74 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 9.4 mtmp? -133.87 153.19 51.92 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 124.12 0.968 . . . . 62.24 109.247 173.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.479 HG11 ' HA ' ' A' ' 199' ' ' VAL . 15.6 m -134.8 141.03 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 124.106 0.962 . . . . 40.21 108.817 172.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -81.7 114.16 20.17 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.175 0.59 . . . . 74.12 109.705 -177.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -106.51 154.83 20.29 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.583 1.153 . . . . 74.34 110.351 178.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.71 126.03 52.55 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.461 0.704 . . . . 50.21 109.9 173.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 65.2 p -126.62 -178.72 4.47 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.354 1.062 . . . . 62.41 109.539 177.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 10.3 mt -73.12 -20.42 60.94 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-O 120.721 0.296 . . . . 71.44 110.602 176.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . 0.485 ' HG3' ' N ' ' A' ' 182' ' ' GLY . 27.0 tt0 -78.67 -19.78 51.73 Favored 'General case' 0 CA--C 1.561 1.376 0 C-N-CA 124.05 0.94 . . . . 72.54 110.827 173.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 120.05 -158.06 15.46 Favored Glycine 0 C--N 1.35 1.327 0 CA-C-O 119.614 -0.548 . . . . 55.52 112.294 178.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.78 126.87 11.75 Favored 'Trans proline' 0 C--N 1.369 1.649 0 C-N-CA 122.275 1.983 . . . . 63.31 111.294 178.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.49 HG12 ' HA ' ' A' ' 177' ' ' PRO . 28.7 m -136.72 128.02 42.38 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.977 0 C-N-CA 123.879 0.872 . . . . 72.43 109.325 178.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -85.01 113.45 21.45 Favored 'General case' 0 N--CA 1.482 1.128 0 O-C-N 121.972 -0.455 . . . . 73.13 110.405 177.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.506 ' HA ' ' HA ' ' A' ' 175' ' ' TYR . 58.7 t -93.51 120.77 43.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 C-N-CA 123.267 0.627 . . . . 71.4 109.648 -177.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -63.57 101.51 0.35 Allowed 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.054 0.942 . . . . 75.4 110.566 176.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 62.5 t -70.03 121.04 81.65 Favored Pre-proline 0 CA--C 1.544 0.74 0 CA-C-N 114.663 -1.153 . . . . 65.13 108.79 172.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -63.92 157.52 52.17 Favored 'Trans proline' 0 CA--C 1.571 2.338 0 C-N-CA 122.029 1.819 . . . . 51.55 111.674 174.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -66.79 127.0 16.24 Favored 'Trans proline' 0 C--N 1.368 1.579 0 C-N-CA 122.868 2.378 . . . . 71.5 112.243 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 38.5 mtm180 64.61 79.21 0.26 Allowed 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.984 1.314 . . . . 74.12 110.459 -175.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.557 HG22 HG11 ' A' ' 253' ' ' VAL . 99.3 m -117.12 106.81 13.75 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.11 0.964 . . . . 74.32 109.006 177.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -88.54 153.47 21.11 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.838 -0.619 . . . . 65.15 110.787 -173.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -62.9 138.69 58.61 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.108 0.963 . . . . 44.24 111.115 -178.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 89.94 10.66 64.4 Favored Glycine 0 C--N 1.338 0.646 0 CA-C-N 115.713 -0.676 . . . . 71.34 112.689 -174.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.486 ' HD2' HG23 ' A' ' 227' ' ' THR . 78.0 mtt180 -78.15 162.49 26.59 Favored 'General case' 0 C--O 1.244 0.778 0 CA-C-O 121.591 0.71 . . . . 73.11 110.429 169.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.402 ' HE2' ' O ' ' A' ' 169' ' ' ASP . 19.6 pttm -127.52 129.11 46.8 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 114.739 -1.119 . . . . 70.44 109.869 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.512 HD22 ' HB2' ' A' ' 173' ' ' ALA . 66.2 mt -110.45 134.09 52.67 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 107.517 -1.29 . . . . 72.15 107.517 172.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . 0.6 ' HB3' HG21 ' A' ' 170' ' ' VAL . 42.3 ttm105 -123.28 98.95 6.1 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 107.044 -1.465 . . . . 71.21 107.044 167.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.517 ' HB3' ' HB2' ' A' ' 238' ' ' LYS . 65.8 mt -74.43 82.93 1.95 Allowed 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 114.213 -1.358 . . . . 53.12 108.526 177.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -75.8 137.68 40.68 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 122.664 0.386 . . . . 71.25 110.434 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 69.86 24.48 76.37 Favored Glycine 0 C--N 1.339 0.724 0 O-C-N 124.066 0.854 . . . . 64.4 111.973 -175.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.646 ' HB3' ' HE1' ' A' ' 175' ' ' TYR . 73.8 mmtt -138.87 -9.35 1.36 Allowed 'General case' 0 CA--C 1.561 1.37 0 C-N-CA 124.171 0.988 . . . . 72.34 111.88 -170.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -80.8 -120.81 0.46 Allowed Glycine 0 N--CA 1.478 1.494 0 CA-C-O 119.93 -0.372 . . . . 72.53 113.8 -175.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.31 119.02 49.26 Favored Pre-proline 0 N--CA 1.485 1.315 0 CA-C-O 118.472 -0.775 . . . . 72.54 109.251 175.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.744 ' HA ' ' HG3' ' A' ' 246' ' ' ARG . 25.1 Cg_exo -59.45 128.59 27.81 Favored 'Trans proline' 0 C--N 1.38 2.215 0 C-N-CA 122.824 2.349 . . . . 52.41 111.747 -176.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -141.14 123.91 2.42 Favored Glycine 0 CA--C 1.534 1.222 0 CA-C-O 118.798 -1.001 . . . . 65.22 111.641 -176.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -70.76 -15.05 33.35 Favored 'Trans proline' 0 C--N 1.385 2.452 0 C-N-CA 123.09 2.527 . . . . 75.45 113.18 178.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -97.56 -6.45 33.48 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.211 0.604 . . . . 72.15 111.155 173.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 142.77 115.61 1.11 Allowed Glycine 0 C--N 1.344 0.988 0 N-CA-C 111.005 -0.838 . . . . 61.55 111.005 -177.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.744 ' HG3' ' HA ' ' A' ' 241' ' ' PRO . 8.0 ttm180 -65.64 139.85 58.45 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.226 1.011 . . . . 71.13 110.744 176.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -73.17 -155.14 3.03 Favored Glycine 0 C--N 1.347 1.179 0 O-C-N 123.459 0.475 . . . . 61.21 113.501 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . 0.401 ' O ' ' HA ' ' A' ' 192' ' ' ASP . 10.7 p-10 -126.51 132.89 51.29 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 117.738 0.769 . . . . 73.02 112.667 -176.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 51.9 tp -101.24 107.08 18.37 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.14 0.976 . . . . 61.22 108.949 175.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -89.6 108.24 19.55 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.313 0.645 . . . . 63.54 109.604 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.463 ' HA ' ' O ' ' A' ' 195' ' ' ALA . 68.1 mt -101.46 112.11 24.54 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 123.752 0.821 . . . . 73.23 110.597 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -79.77 103.38 9.63 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.589 0.756 . . . . 75.55 109.47 174.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.557 HG11 HG22 ' A' ' 227' ' ' THR . 75.0 t -61.66 114.59 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.306 1.042 . . . . 73.21 111.223 -177.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 67.4 mmt-85 -123.19 112.08 17.26 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.672 1.189 . . . . 74.1 108.565 175.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 48.8 mt -76.48 126.58 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 123.152 0.581 . . . . 75.51 109.91 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 24.0 p . . . . . 0 C--O 1.255 1.394 0 C-N-CA 124.99 1.316 . . . . 71.2 108.411 179.258 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 22.5 ptp . . . . . 0 N--CA 1.484 1.231 0 CA-C-O 120.84 0.352 . . . . 74.2 110.411 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -102.06 49.31 0.86 Allowed 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 107.586 -1.265 . . . . 74.21 107.586 173.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -65.66 -52.92 47.91 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 114.047 -1.433 . . . . 71.02 111.181 -176.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.751 HG21 ' HB3' ' A' ' 234' ' ' ARG . 19.7 m -79.69 174.47 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 CA-C-N 114.587 -1.188 . . . . 53.53 110.218 175.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 14.8 tt -82.72 139.82 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 N-CA-C 108.467 -0.938 . . . . 74.34 108.467 167.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -70.12 93.32 0.8 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.535 0.734 . . . . 75.12 109.37 -179.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.411 ' HB2' HD22 ' A' ' 233' ' ' LEU . . . -98.37 152.23 19.69 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.838 -0.619 . . . . 64.13 110.113 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -140.84 149.28 41.8 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.285 0.634 . . . . 73.12 109.996 175.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.427 ' CD1' HD13 ' A' ' 235' ' ' LEU . 9.5 p90 -122.43 172.11 8.59 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 123.281 0.633 . . . . 72.03 110.554 176.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -138.04 121.88 11.61 Favored Pre-proline 0 N--CA 1.468 0.445 0 N-CA-C 107.268 -1.382 . . . . 72.22 107.268 175.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -64.51 141.41 73.56 Favored 'Trans proline' 0 C--N 1.367 1.544 0 C-N-CA 122.768 2.312 . . . . 70.54 110.801 -175.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -65.33 94.27 0.16 Allowed 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 121.586 0.708 . . . . 73.25 109.743 -178.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -80.91 142.32 33.67 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 114.398 -1.274 . . . . 74.13 111.811 -169.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -122.5 -57.3 0.2 Allowed Glycine 0 C--N 1.338 0.685 0 N-CA-C 110.592 -1.003 . . . . 14.23 110.592 173.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 66.6 m -129.87 -8.23 4.46 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.725 0.81 . . . . 55.45 111.622 177.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 89.86 158.8 34.81 Favored Glycine 0 C--N 1.348 1.239 0 N-CA-C 112.658 -0.177 . . . . 34.23 112.658 -171.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 144.22 112.91 0.85 Allowed Glycine 0 C--N 1.338 0.685 0 CA-C-O 119.526 -0.597 . . . . 74.25 111.682 176.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 42.6 p -167.72 102.07 0.48 Allowed 'General case' 0 C--O 1.242 0.701 0 C-N-CA 124.299 1.04 . . . . 74.33 109.407 175.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -89.34 -62.97 1.31 Allowed Glycine 0 C--N 1.344 0.973 0 N-CA-C 112.328 -0.309 . . . . 75.05 112.328 -178.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 153.77 77.33 0.02 OUTLIER Glycine 0 C--N 1.334 0.452 0 N-CA-C 111.42 -0.672 . . . . 63.22 111.42 -177.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 56.6 m -77.07 156.26 31.87 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.043 0.537 . . . . 41.31 110.277 178.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -127.5 147.37 17.06 Favored Glycine 0 C--N 1.343 0.921 0 O-C-N 123.231 0.332 . . . . 63.24 112.404 -175.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 157.13 -55.34 0.39 Allowed Glycine 0 C--N 1.341 0.816 0 N-CA-C 110.432 -1.067 . . . . 74.54 110.432 178.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 51.0 p -150.97 96.76 2.37 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 108.392 -0.966 . . . . 52.32 108.392 173.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.562 ' HA ' ' HB2' ' A' ' 240' ' ' PHE . 10.7 mm100 -75.49 -40.14 57.66 Favored 'General case' 0 C--O 1.244 0.782 0 CA-C-N 115.876 -0.602 . . . . 70.12 110.358 -177.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -86.17 135.64 33.51 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 114.959 -1.019 . . . . 72.11 108.374 172.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 94.6 mt -134.01 155.98 49.02 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.81 0.844 . . . . 75.14 109.817 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -130.08 136.81 49.75 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 108.008 -1.108 . . . . 72.12 108.008 173.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -160.42 171.34 19.23 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.211 0.529 . . . . 64.24 110.917 -177.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 17.6 p -104.83 151.62 23.59 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.6 0.76 . . . . 74.25 109.829 173.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.533 HD11 HG23 ' A' ' 210' ' ' VAL . 47.6 tp -123.13 118.3 27.37 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 123.863 0.865 . . . . 73.13 109.195 -175.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -82.61 100.11 9.96 Favored 'General case' 0 C--O 1.241 0.627 0 C-N-CA 123.329 0.652 . . . . 44.12 109.549 -178.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.533 HG22 HG21 ' A' ' 210' ' ' VAL . 23.6 t -110.06 109.02 59.12 Favored Pre-proline 0 CA--C 1.538 0.509 0 N-CA-C 108.489 -0.93 . . . . 73.24 108.489 176.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -54.2 138.46 71.92 Favored 'Trans proline' 0 C--N 1.377 2.062 0 C-N-CA 122.777 2.318 . . . . 61.41 112.008 172.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -48.41 -47.56 68.44 Favored Pre-proline 0 CA--C 1.564 1.504 0 N-CA-C 113.772 1.027 . . . . 62.04 113.772 -177.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -56.07 -45.52 37.77 Favored 'Trans proline' 0 C--N 1.391 2.785 0 C-N-CA 121.845 1.697 . . . . 61.4 112.775 173.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 45.3 mt -69.93 -27.89 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 123.917 0.887 . . . . 62.23 111.181 -176.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.88 -48.9 64.77 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.075 0.55 . . . . 63.51 110.59 177.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 61.9 t -67.34 -48.42 77.86 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 CA-C-N 115.488 -0.778 . . . . 72.3 111.701 -177.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 11.8 p -75.44 -34.05 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 C-N-CA 122.391 0.277 . . . . 45.35 111.459 -178.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 83.7 141.02 4.47 Favored Glycine 0 C--N 1.344 0.982 0 N-CA-C 112.119 -0.392 . . . . 65.55 112.119 -172.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -178.07 -129.66 1.3 Allowed Glycine 0 C--N 1.34 0.777 0 N-CA-C 111.417 -0.673 . . . . 74.42 111.417 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 60.5 mttm -137.98 144.86 41.34 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.246 0.619 . . . . 64.31 109.771 173.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.533 HG23 HD11 ' A' ' 197' ' ' LEU . 31.1 m -134.87 155.57 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 124.333 1.053 . . . . 63.04 108.506 171.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 35.0 mtm-85 -97.47 126.36 42.7 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 121.015 0.436 . . . . 74.52 111.718 -176.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.53 ' HB2' HD13 ' A' ' 197' ' ' LEU . . . -101.47 133.87 45.44 Favored 'General case' 0 C--O 1.241 0.628 0 C-N-CA 124.687 1.195 . . . . 53.24 109.14 173.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.56 112.77 21.88 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 108.793 -0.817 . . . . 73.44 108.793 175.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 68.3 p -111.39 177.1 4.77 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.393 0.677 . . . . 64.34 109.192 175.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 26.5 mt -62.9 -39.02 93.22 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 122.831 0.453 . . . . 71.22 111.487 -172.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -86.0 -18.22 33.16 Favored 'General case' 0 CA--C 1.551 1.003 0 CA-C-N 115.824 -0.625 . . . . 74.3 111.364 -175.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 153.53 -166.06 31.63 Favored Glycine 0 C--N 1.352 1.444 0 N-CA-C 114.37 0.508 . . . . 74.12 114.37 174.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -77.8 142.9 20.53 Favored 'Trans proline' 0 C--N 1.376 1.988 0 C-N-CA 123.088 2.525 . . . . 62.03 111.858 176.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.406 ' HB ' ' CD2' ' A' ' 175' ' ' TYR . 11.7 m -135.91 140.44 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 N-CA-C 109.237 -0.653 . . . . 64.15 109.237 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -96.96 108.1 20.75 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 122.819 0.448 . . . . 64.01 110.123 -178.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 22.3 t -95.08 135.12 30.12 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 C-N-CA 124.404 1.082 . . . . 62.05 109.815 -175.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -77.38 109.2 11.1 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 123.305 0.642 . . . . 72.23 110.666 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 57.3 t -79.11 117.7 68.37 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 123.681 0.793 . . . . 65.2 109.07 173.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -60.69 158.02 34.72 Favored 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 122.458 2.105 . . . . 74.13 112.371 174.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -71.26 133.45 22.85 Favored 'Trans proline' 0 C--N 1.368 1.582 0 C-N-CA 121.5 1.467 . . . . 65.45 110.563 171.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 67.82 67.21 0.36 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.81 1.244 . . . . 71.04 110.141 -176.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.501 HG22 HG11 ' A' ' 253' ' ' VAL . 72.9 m -103.02 132.89 48.96 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.188 0.995 . . . . 55.22 109.595 176.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -110.7 155.48 22.38 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.632 0.773 . . . . 75.4 110.555 -177.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . 0.507 ' HB2' ' HB ' ' A' ' 255' ' ' ILE . . . -69.22 121.58 17.1 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.981 0.912 . . . . 71.12 110.225 -178.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 111.64 -7.6 28.02 Favored Glycine 0 C--N 1.333 0.398 0 CA-C-O 119.222 -0.765 . . . . 54.52 112.555 -176.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.478 ' HD2' HG23 ' A' ' 227' ' ' THR . 58.7 mtt180 -61.24 145.77 50.12 Favored 'General case' 0 C--N 1.361 1.097 0 CA-C-N 117.326 0.563 . . . . 61.41 109.915 174.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.47 ' HG3' HG12 ' A' ' 170' ' ' VAL . 20.1 pttm -117.06 104.35 11.16 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.282 -0.872 . . . . 72.24 109.215 -175.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.411 HD22 ' HB2' ' A' ' 173' ' ' ALA . 82.8 mt -90.11 97.35 11.14 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 108.723 -0.844 . . . . 64.41 108.723 176.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . 0.751 ' HB3' HG21 ' A' ' 170' ' ' VAL . 64.7 ttt180 -88.07 107.18 18.62 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 108.676 -0.861 . . . . 64.12 108.676 171.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.427 HD13 ' CD1' ' A' ' 175' ' ' TYR . 16.0 mt -77.67 84.23 4.02 Favored 'General case' 0 C--O 1.248 0.989 0 N-CA-C 107.659 -1.237 . . . . 70.53 107.659 174.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 10.5 mtmp? -71.43 118.49 14.31 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 113.835 -1.529 . . . . 73.21 111.988 -169.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 64.14 28.82 73.44 Favored Glycine 0 C--N 1.348 1.212 0 O-C-N 124.044 0.84 . . . . 34.54 112.803 179.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 30.8 mmtp -125.47 -6.92 6.94 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 118.278 -0.868 . . . . 73.41 112.774 -173.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -62.57 -108.17 0.01 OUTLIER Glycine 0 C--N 1.354 1.538 0 O-C-N 123.827 0.704 . . . . 53.32 114.731 -171.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . 0.562 ' HB2' ' HA ' ' A' ' 191' ' ' GLN . 0.1 OUTLIER -75.97 140.02 69.96 Favored Pre-proline 0 N--CA 1.477 0.91 0 CA-C-O 118.574 -0.727 . . . . 70.52 109.811 177.72 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.516 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 53.1 Cg_exo -57.37 149.07 67.63 Favored 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 122.587 2.192 . . . . 72.31 113.293 175.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -164.81 123.58 1.18 Allowed Glycine 0 CA--C 1.538 1.512 0 CA-C-O 118.414 -1.215 . . . . 62.42 111.661 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -57.54 -46.16 29.14 Favored 'Trans proline' 0 C--N 1.386 2.521 0 C-N-CA 123.806 3.004 . . . . 70.25 113.646 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -78.87 -24.13 44.47 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 122.756 0.422 . . . . 72.44 110.81 178.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 168.19 142.0 3.36 Favored Glycine 0 C--N 1.345 1.057 0 CA-C-N 115.782 -0.645 . . . . 75.41 111.798 178.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.516 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 27.3 mtt-85 -73.63 166.54 23.08 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.495 0.718 . . . . 70.14 110.969 178.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -85.23 -156.99 27.35 Favored Glycine 0 C--N 1.336 0.579 0 CA-C-N 115.391 -0.822 . . . . 53.43 111.463 168.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -131.61 157.99 42.19 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 109.077 -0.712 . . . . 74.43 109.077 -176.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 42.4 tp -141.42 112.18 7.15 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 109.652 -0.499 . . . . 51.34 109.652 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -102.77 109.36 20.91 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.759 0.824 . . . . 74.41 109.838 -176.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 65.9 mt -104.92 136.09 45.05 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.727 0.811 . . . . 72.2 110.156 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -97.69 116.56 30.15 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.691 0.796 . . . . 70.51 109.303 170.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.501 HG11 HG22 ' A' ' 227' ' ' THR . 94.1 t -61.33 106.38 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-O 121.506 0.67 . . . . 74.11 110.465 172.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 17.0 mmt85 -104.37 102.49 12.16 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-N 114.67 -1.15 . . . . 74.32 108.065 173.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.507 ' HB ' ' HB2' ' A' ' 229' ' ' ALA . 24.1 mt -76.36 119.0 23.68 Favored 'Isoleucine or valine' 0 C--O 1.245 0.83 0 C-N-CA 122.901 0.481 . . . . 63.35 109.767 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.5 t . . . . . 0 CA--C 1.558 1.288 0 N-CA-C 108.682 -0.858 . . . . 72.31 108.682 175.99 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 64.0 mtt . . . . . 0 N--CA 1.478 0.927 0 N-CA-C 109.462 -0.57 . . . . 74.22 109.462 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -85.94 71.99 10.54 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 122.029 0.919 . . . . 72.5 109.401 176.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -65.47 -44.63 86.54 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 115.243 -0.89 . . . . 73.33 110.501 177.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.62 HG12 ' HG3' ' A' ' 232' ' ' LYS . 27.6 m -111.43 164.57 7.25 Favored 'Isoleucine or valine' 0 C--O 1.243 0.76 0 CA-C-N 114.305 -1.316 . . . . 65.55 109.16 175.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 17.6 tt -89.51 145.71 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 N-CA-C 108.236 -1.024 . . . . 75.0 108.236 168.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -58.75 122.21 12.98 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.671 0.788 . . . . 74.45 110.879 -179.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.454 ' HB2' HD22 ' A' ' 233' ' ' LEU . . . -135.99 154.78 50.97 Favored 'General case' 0 C--O 1.243 0.729 0 C-N-CA 124.5 1.12 . . . . 62.15 108.449 174.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -152.88 151.22 30.13 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.938 0.895 . . . . 71.42 109.404 -178.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.442 ' CD1' HD13 ' A' ' 235' ' ' LEU . 2.6 p90 -130.14 173.93 10.28 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-O 121.39 0.614 . . . . 71.41 111.025 176.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 78.2 mttt -139.23 144.39 40.26 Favored Pre-proline 0 C--O 1.243 0.746 0 CA-C-N 114.692 -1.14 . . . . 73.44 109.203 174.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -55.1 103.9 0.11 Allowed 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 123.279 2.652 . . . . 71.31 112.105 178.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . 0.502 ' HB2' ' HG3' ' A' ' 220' ' ' GLU . . . -68.41 -22.68 64.6 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.834 0.854 . . . . 74.41 111.345 -178.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -68.34 -38.24 81.32 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.883 0.873 . . . . 54.4 110.564 171.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 111.54 -22.91 18.96 Favored Glycine 0 C--N 1.353 1.517 0 CA-C-O 119.746 -0.474 . . . . 73.11 113.892 175.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 49.2 m -88.04 -64.41 1.15 Allowed 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 117.662 0.731 . . . . 72.41 109.997 178.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 81.36 -177.65 54.12 Favored Glycine 0 C--N 1.353 1.483 0 CA-C-N 116.528 -0.305 . . . . 51.43 112.994 -175.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -138.47 155.03 23.33 Favored Glycine 0 C--N 1.341 0.834 0 C-N-CA 122.58 0.133 . . . . 65.43 112.943 178.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 47.3 p -160.15 25.61 0.17 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.035 0.934 . . . . 75.42 110.667 -175.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -62.32 -87.59 0.04 OUTLIER Glycine 0 C--N 1.354 1.544 0 CA-C-N 115.594 -0.73 . . . . 64.0 114.219 -177.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -174.64 134.26 2.73 Favored Glycine 0 C--N 1.346 1.126 0 N-CA-C 112.052 -0.419 . . . . 45.33 112.052 -178.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 23.9 p -71.3 94.12 1.18 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.639 0.776 . . . . 71.13 110.289 178.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -80.74 79.34 1.78 Allowed Glycine 0 C--N 1.345 1.036 0 CA-C-N 115.726 -0.67 . . . . 71.32 112.781 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 85.16 -59.63 4.85 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 112.03 -0.428 . . . . 74.22 112.03 -179.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 48.8 m -80.46 139.22 36.53 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.073 0.549 . . . . 71.13 110.369 174.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -129.88 -49.29 1.13 Allowed 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.366 1.066 . . . . 75.13 108.745 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -76.79 150.38 36.17 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 114.296 -1.32 . . . . 70.53 110.613 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 36.6 mt -133.92 139.31 46.06 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 124.89 1.276 . . . . 74.13 107.639 171.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -128.21 125.01 38.15 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.204 0.602 . . . . 73.5 109.498 -176.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -161.85 171.51 17.63 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 123.736 0.815 . . . . 45.43 110.756 -175.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 15.6 p -105.89 149.86 26.16 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.633 0.773 . . . . 55.23 109.967 173.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.552 HD13 HD13 ' A' ' 251' ' ' LEU . 51.7 tp -115.01 118.72 34.22 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.999 0.92 . . . . 61.1 109.875 -175.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -83.39 119.62 24.86 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 109.319 -0.623 . . . . 74.31 109.319 175.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.515 ' HA ' HG11 ' A' ' 210' ' ' VAL . 3.5 p -133.7 123.24 17.16 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 123.638 0.775 . . . . 75.24 109.675 178.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -59.02 139.61 91.58 Favored 'Trans proline' 0 C--N 1.375 1.968 0 C-N-CA 122.725 2.283 . . . . 73.14 111.447 171.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.454 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -49.11 -47.58 75.12 Favored Pre-proline 0 CA--C 1.557 1.232 0 CA-C-O 117.792 -1.099 . . . . 64.44 113.022 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -55.93 -45.28 39.81 Favored 'Trans proline' 0 C--N 1.395 2.978 0 C-N-CA 122.206 1.938 . . . . 65.12 113.019 175.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 39.9 mt -65.93 -31.98 56.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 123.458 0.703 . . . . 65.43 111.02 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -71.84 -37.86 70.23 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.269 0.628 . . . . 71.24 111.48 179.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 201' ' ' ALA . 98.9 t -74.54 -53.69 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 123.647 0.779 . . . . 62.22 111.359 -178.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 7.1 p -73.03 -31.03 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 122.627 0.371 . . . . 54.44 111.11 -178.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 84.94 117.43 0.8 Allowed Glycine 0 C--N 1.344 0.979 0 N-CA-C 111.357 -0.697 . . . . 55.33 111.357 -172.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -151.8 -136.88 2.51 Favored Glycine 0 C--N 1.34 0.789 0 N-CA-C 111.564 -0.614 . . . . 74.33 111.564 -178.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 34.3 mtmm -136.95 146.09 45.01 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.003 0.921 . . . . 75.23 109.383 175.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.515 HG11 ' HA ' ' A' ' 199' ' ' VAL . 24.2 m -133.05 142.3 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 123.855 0.862 . . . . 63.51 109.22 172.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . 0.433 ' NH1' ' HB1' ' A' ' 178' ' ' ALA . 24.1 ttm-85 -87.7 110.45 20.44 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 122.817 0.447 . . . . 64.51 110.15 -170.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -101.8 164.47 11.71 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.656 1.182 . . . . 72.21 110.634 -178.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 10.1 mmt -105.92 123.23 47.65 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.862 0.865 . . . . 74.11 110.784 -179.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . 0.467 HG22 HD22 ' A' ' 249' ' ' LEU . 47.5 p -114.63 171.29 7.73 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.304 1.042 . . . . 75.5 109.211 170.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 13.2 mt -72.28 -9.33 58.34 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 112.091 0.404 . . . . 73.13 112.091 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -99.97 -19.45 16.57 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 123.127 0.571 . . . . 63.22 111.772 175.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 143.58 -155.02 25.91 Favored Glycine 0 C--N 1.36 1.901 0 CA-C-O 119.695 -0.503 . . . . 53.33 113.995 174.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -76.64 136.33 17.07 Favored 'Trans proline' 0 C--N 1.379 2.14 0 C-N-CA 123.442 2.761 . . . . 75.2 113.229 178.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.479 ' HA ' ' H ' ' A' ' 178' ' ' ALA . 27.0 m -136.5 145.5 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 124.177 0.991 . . . . 74.44 109.293 177.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.502 ' HG3' ' HB2' ' A' ' 178' ' ' ALA . 37.4 mt-10 -102.3 112.11 24.68 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 109.52 -0.548 . . . . 62.44 109.52 178.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 46.7 t -94.7 118.09 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 124.41 1.084 . . . . 62.52 109.527 -174.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -66.96 102.19 0.94 Allowed 'General case' 0 C--O 1.24 0.561 0 C-N-CA 123.958 0.903 . . . . 71.22 110.427 176.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.458 HG11 HG21 ' A' ' 199' ' ' VAL . 64.6 t -80.24 120.88 80.89 Favored Pre-proline 0 CA--C 1.546 0.801 0 CA-C-N 115.162 -0.926 . . . . 74.53 108.969 174.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -60.6 162.38 18.26 Favored 'Trans proline' 0 CA--C 1.566 2.097 0 C-N-CA 122.904 2.403 . . . . 45.54 113.219 176.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -76.25 135.39 16.78 Favored 'Trans proline' 0 C--N 1.374 1.88 0 C-N-CA 122.622 2.215 . . . . 72.11 112.271 175.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 20.0 mtm180 66.54 57.25 0.71 Allowed 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 125.129 1.371 . . . . 73.54 110.631 -176.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.608 HG22 HG11 ' A' ' 253' ' ' VAL . 60.5 m -106.81 107.34 18.31 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.851 0.86 . . . . 52.33 109.381 178.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 22.5 mp0 -85.7 160.26 19.59 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.297 0.639 . . . . 73.24 111.678 -172.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -70.35 130.18 41.28 Favored 'General case' 0 C--N 1.352 0.682 0 N-CA-C 108.867 -0.79 . . . . 74.54 108.867 175.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 114.47 -19.08 17.16 Favored Glycine 0 N--CA 1.466 0.634 0 CA-C-O 119.636 -0.536 . . . . 71.41 111.897 -173.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.501 ' HD2' HG23 ' A' ' 227' ' ' THR . 81.2 mtt180 -67.19 161.85 23.84 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-O 121.579 0.704 . . . . 74.34 111.877 175.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.62 ' HG3' HG12 ' A' ' 170' ' ' VAL . 19.5 pttm -130.19 142.11 50.6 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.344 1.058 . . . . 60.5 109.42 177.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.454 HD22 ' HB2' ' A' ' 173' ' ' ALA . 75.2 mt -120.61 129.02 53.56 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 107.89 -1.152 . . . . 52.52 107.89 178.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 40.4 ttt180 -113.7 102.14 9.97 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 108.816 -0.809 . . . . 73.21 108.816 171.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.625 ' HB3' ' HB2' ' A' ' 238' ' ' LYS . 21.3 mt -76.19 84.01 3.01 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 114.246 -1.343 . . . . 62.31 108.632 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -72.65 127.37 32.35 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.641 -0.709 . . . . 61.43 110.67 -173.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 69.48 20.52 75.51 Favored Glycine 0 C--N 1.342 0.901 0 O-C-N 123.764 0.665 . . . . 65.54 112.053 -175.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.625 ' HB2' ' HB3' ' A' ' 235' ' ' LEU . 22.3 mmtp -136.37 58.05 1.75 Allowed 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.581 1.152 . . . . 71.41 108.54 -176.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -139.9 -113.48 1.08 Allowed Glycine 0 N--CA 1.472 1.093 0 CA-C-O 119.226 -0.764 . . . . 71.4 111.74 175.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -64.11 146.32 97.54 Favored Pre-proline 0 N--CA 1.484 1.254 0 CA-C-O 118.47 -0.776 . . . . 71.11 110.699 175.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -54.79 160.0 8.23 Favored 'Trans proline' 0 C--N 1.38 2.204 0 C-N-CA 123.488 2.792 . . . . 71.11 112.871 176.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -169.85 136.43 4.0 Favored Glycine 0 CA--C 1.525 0.702 0 CA-C-O 118.742 -1.032 . . . . 52.5 112.024 -178.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -70.23 -41.54 3.6 Favored 'Trans proline' 0 C--N 1.378 2.091 0 C-N-CA 123.184 2.59 . . . . 65.33 113.305 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -102.11 -18.79 15.41 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.702 0.801 . . . . 64.21 111.222 -177.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 175.66 145.68 5.57 Favored Glycine 0 C--N 1.341 0.847 0 N-CA-C 111.262 -0.735 . . . . 72.44 111.262 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 21.1 mtm180 -88.19 165.32 15.15 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.088 0.555 . . . . 74.24 110.589 -176.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -74.14 -168.07 17.54 Favored Glycine 0 C--N 1.35 1.312 0 N-CA-C 111.486 -0.646 . . . . 74.1 111.486 168.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -118.27 151.84 36.89 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 118.406 1.103 . . . . 71.22 111.247 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.467 HD22 HG22 ' A' ' 214' ' ' THR . 35.9 tp -113.75 118.21 33.66 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 108.559 -0.904 . . . . 71.01 108.559 171.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . 0.539 ' OH ' ' HD2' ' A' ' 232' ' ' LYS . 2.7 t80 -96.4 115.9 28.17 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.84 -1.17 . . . . 74.4 107.84 -178.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.552 HD13 HD13 ' A' ' 197' ' ' LEU . 57.6 mt -118.93 117.22 28.23 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.79 0.836 . . . . 70.02 110.38 -177.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -77.32 116.07 17.62 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 108.997 -0.742 . . . . 54.14 108.997 171.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.608 HG11 HG22 ' A' ' 227' ' ' THR . 94.8 t -62.09 104.27 0.3 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.934 0 CA-C-O 121.322 0.582 . . . . 71.04 110.433 176.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 19.6 mmm180 -110.15 106.37 15.79 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 107.952 -1.129 . . . . 62.23 107.952 175.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.447 HD11 ' O ' ' A' ' 227' ' ' THR . 45.0 mt -77.77 143.8 12.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 122.898 0.479 . . . . 73.34 110.483 178.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 4.9 t . . . . . 0 C--O 1.261 1.68 0 C-N-CA 124.48 1.112 . . . . 64.43 108.721 174.739 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . 0.562 ' SD ' ' HE3' ' A' ' 236' ' ' LYS . 26.1 ptt? . . . . . 0 N--CA 1.488 1.458 0 CA-C-O 121.344 0.593 . . . . 72.44 110.243 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -78.61 6.79 7.96 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.653 1.181 . . . . 73.32 112.566 -175.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -56.74 -61.47 2.4 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.007 0.923 . . . . 63.12 111.082 178.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 33.0 m -89.82 157.15 3.01 Favored 'Isoleucine or valine' 0 C--O 1.243 0.75 0 C-N-CA 122.835 0.454 . . . . 74.25 110.054 176.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.429 HG21 ' HD3' ' A' ' 231' ' ' ARG . 15.1 tt -83.09 146.73 6.59 Favored 'Isoleucine or valine' 0 C--O 1.249 1.057 0 N-CA-C 108.496 -0.927 . . . . 52.42 108.496 172.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -58.06 136.08 57.1 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.718 0.807 . . . . 70.22 111.52 -176.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.539 ' HB2' HD22 ' A' ' 233' ' ' LEU . . . -158.31 158.18 33.87 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 124.885 1.274 . . . . 74.54 109.337 173.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -164.27 149.42 10.25 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.924 0.89 . . . . 75.54 109.221 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.538 ' HB3' HG22 ' A' ' 221' ' ' VAL . 1.6 p90 -122.39 175.93 6.16 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 121.807 0.813 . . . . 74.43 112.34 177.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -138.22 129.31 15.64 Favored Pre-proline 0 C--O 1.241 0.629 0 CA-C-N 113.639 -1.619 . . . . 73.45 107.575 167.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . 0.434 ' HA ' HG12 ' A' ' 219' ' ' VAL . 35.7 Cg_exo -54.37 128.25 29.29 Favored 'Trans proline' 0 C--N 1.369 1.657 0 C-N-CA 123.486 2.791 . . . . 64.1 111.639 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -63.99 99.26 0.25 Allowed 'General case' 0 CA--C 1.549 0.927 0 O-C-N 123.737 0.648 . . . . 75.33 110.429 -175.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 35.4 t70 70.25 15.0 7.54 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 125.801 1.64 . . . . 64.13 111.701 -178.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -114.17 165.14 12.03 Favored Glycine 0 C--N 1.346 1.133 0 C-N-CA 123.344 0.497 . . . . 54.0 112.516 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 24.9 p -90.63 132.86 35.51 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.353 0.661 . . . . 70.44 110.095 177.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -168.99 60.45 0.2 Allowed Glycine 0 C--N 1.338 0.682 0 N-CA-C 111.084 -0.806 . . . . 52.4 111.084 -177.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -95.57 81.51 0.83 Allowed Glycine 0 C--N 1.339 0.75 0 N-CA-C 111.515 -0.634 . . . . 60.2 111.515 176.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 49.4 m -137.35 156.06 48.67 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.286 0.634 . . . . 63.3 110.601 -178.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -139.76 -170.36 11.93 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 110.976 -0.85 . . . . 55.11 110.976 175.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 88.55 -151.2 22.32 Favored Glycine 0 C--N 1.343 0.96 0 CA-C-N 117.031 0.416 . . . . 62.35 112.661 -178.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 68.5 m -158.2 -172.65 3.97 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.268 1.027 . . . . 45.42 109.755 -177.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -178.25 135.78 2.77 Favored Glycine 0 C--N 1.34 0.76 0 CA-C-O 119.695 -0.503 . . . . 32.41 111.994 171.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -63.51 -22.16 65.48 Favored Glycine 0 C--N 1.358 1.8 0 CA-C-O 121.423 0.457 . . . . 64.55 112.257 172.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 50.3 m -115.55 173.75 6.37 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.703 1.201 . . . . 65.54 108.915 168.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 67.54 14.92 9.72 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 124.49 1.116 . . . . 74.23 111.145 -172.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -85.59 153.51 22.35 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.574 0.75 . . . . 74.4 109.965 178.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 58.4 mt -131.81 152.93 50.64 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.546 0.738 . . . . 73.21 109.251 176.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -119.18 132.41 55.96 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 108.489 -0.93 . . . . 72.42 108.489 170.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -157.79 164.46 37.01 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.22 0.608 . . . . 53.24 110.022 178.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 99.4 m -96.03 146.67 24.44 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 115.647 -0.706 . . . . 74.23 109.64 175.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.506 HD11 HG23 ' A' ' 210' ' ' VAL . 42.7 tp -113.85 117.87 32.64 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.713 0.805 . . . . 71.2 109.288 175.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -89.26 100.71 13.44 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 123.783 0.833 . . . . 74.44 108.917 175.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.495 ' HA ' HG11 ' A' ' 210' ' ' VAL . 7.1 p -113.04 116.74 46.87 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 123.496 0.718 . . . . 74.52 109.839 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -56.18 145.91 73.91 Favored 'Trans proline' 0 C--N 1.374 1.904 0 C-N-CA 122.839 2.359 . . . . 54.3 112.4 173.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -50.28 -49.48 76.28 Favored Pre-proline 0 CA--C 1.558 1.285 0 O-C-N 124.542 1.151 . . . . 72.5 112.987 -179.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -55.06 -46.71 31.08 Favored 'Trans proline' 0 C--N 1.401 3.315 0 C-N-CA 122.484 2.123 . . . . 72.23 112.735 175.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.522 HG21 HG13 ' A' ' 210' ' ' VAL . 42.1 mt -68.73 -32.54 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 123.664 0.786 . . . . 74.53 110.798 -176.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.59 -44.9 73.37 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.62 0.768 . . . . 52.41 110.459 179.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 95.4 t -64.64 -55.82 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 122.999 0.519 . . . . 64.41 110.602 178.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 17.0 m -69.49 -30.31 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 O-C-N 123.531 0.52 . . . . 75.32 112.171 -173.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 78.3 69.96 1.35 Allowed Glycine 0 C--N 1.348 1.222 0 N-CA-C 111.648 -0.581 . . . . 60.14 111.648 -172.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -104.13 -136.84 9.02 Favored Glycine 0 C--N 1.348 1.247 0 N-CA-C 111.657 -0.577 . . . . 60.44 111.657 -177.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 35.1 mtmm -133.03 137.04 46.33 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.432 0.693 . . . . 74.11 109.31 176.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.522 HG13 HG21 ' A' ' 203' ' ' ILE . 14.9 m -127.9 142.32 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 123.645 0.778 . . . . 63.54 109.731 174.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 61.5 ttp180 -83.68 117.12 23.0 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 116.13 -0.486 . . . . 53.2 110.049 -178.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -100.79 156.72 17.19 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.685 0.794 . . . . 72.25 109.194 174.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 76.1 mmm -107.18 121.29 44.23 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 122.729 0.412 . . . . 54.3 110.159 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 36.2 p -108.86 173.51 6.29 Favored 'General case' 0 C--O 1.243 0.726 0 C-N-CA 124.351 1.06 . . . . 61.23 108.62 170.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 13.3 mt -67.4 -24.38 65.66 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 122.625 0.37 . . . . 71.45 111.472 -175.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -87.55 -20.59 26.25 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.431 0.693 . . . . 65.2 111.498 -178.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 149.66 -160.68 28.58 Favored Glycine 0 C--N 1.35 1.318 0 CA-C-O 119.772 -0.46 . . . . 72.23 113.135 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -84.65 147.56 10.94 Favored 'Trans proline' 0 C--N 1.364 1.344 0 C-N-CA 123.061 2.507 . . . . 72.1 112.583 178.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.434 HG12 ' HA ' ' A' ' 177' ' ' PRO . 21.3 m -137.07 147.24 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 108.499 -0.926 . . . . 73.14 108.499 178.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -103.01 108.4 19.56 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 109.044 -0.724 . . . . 72.4 109.044 179.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.538 HG22 ' HB3' ' A' ' 175' ' ' TYR . 49.1 t -94.49 120.5 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.565 1.146 . . . . 73.0 109.888 -174.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -71.95 107.55 4.75 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 109.662 -0.495 . . . . 70.33 109.662 174.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 41.8 t -71.65 129.88 87.92 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 124.152 0.981 . . . . 60.33 109.166 174.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -63.45 157.18 52.15 Favored 'Trans proline' 0 CA--C 1.56 1.797 0 C-N-CA 122.047 1.831 . . . . 74.1 111.799 170.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.7 151.1 85.47 Favored 'Trans proline' 0 C--N 1.366 1.491 0 C-N-CA 122.095 1.863 . . . . 73.43 111.646 173.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 73.3 mtt85 55.65 57.97 4.88 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.166 0.986 . . . . 71.41 111.661 177.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.557 HG23 ' HD2' ' A' ' 231' ' ' ARG . 28.1 m -98.85 113.94 26.3 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 114.719 -1.128 . . . . 64.32 110.476 -179.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -92.11 157.87 16.51 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.47 0.708 . . . . 73.22 110.03 177.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . 0.454 ' HB2' ' HB ' ' A' ' 255' ' ' ILE . . . -66.74 134.85 53.03 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 108.708 -0.849 . . . . 52.31 108.708 169.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 100.6 -3.06 56.11 Favored Glycine 0 C--O 1.241 0.585 0 O-C-N 123.53 0.519 . . . . 62.14 112.604 -173.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.557 ' HD2' HG23 ' A' ' 227' ' ' THR . 63.2 mtt-85 -69.61 159.65 33.01 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-O 121.382 0.611 . . . . 73.13 110.367 171.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 48.2 pttt -131.01 137.49 49.23 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.432 -0.804 . . . . 71.13 110.374 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.539 HD22 ' HB2' ' A' ' 173' ' ' ALA . 29.6 mt -123.52 135.14 53.87 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 108.156 -1.054 . . . . 74.24 108.156 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 18.9 ttt85 -122.4 101.59 7.59 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.364 -0.976 . . . . 73.53 108.364 167.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.533 HD13 ' HD1' ' A' ' 175' ' ' TYR . 13.3 mt -75.33 85.3 2.49 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 125.278 1.431 . . . . 60.4 109.441 -176.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.705 ' HA ' ' HB3' ' A' ' 248' ' ' ASP . 59.2 mttm -66.78 129.44 39.89 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.174 -0.921 . . . . 75.24 111.19 -176.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 75.89 12.43 83.94 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 123.811 0.695 . . . . 50.22 113.025 -178.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -137.21 49.97 2.0 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.588 1.155 . . . . 70.13 109.366 -176.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -113.68 -119.76 3.53 Favored Glycine 0 N--CA 1.473 1.157 0 N-CA-C 111.217 -0.753 . . . . 52.12 111.217 173.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -76.63 140.84 68.3 Favored Pre-proline 0 N--CA 1.48 1.058 0 C-N-CA 123.516 0.727 . . . . 63.4 109.853 176.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -66.88 128.1 18.18 Favored 'Trans proline' 0 C--N 1.376 2.004 0 C-N-CA 122.636 2.224 . . . . 71.14 111.3 170.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -129.09 161.16 22.6 Favored Glycine 0 N--CA 1.476 1.332 0 CA-C-O 119.548 -0.585 . . . . 43.11 112.196 176.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -68.5 -33.01 23.79 Favored 'Trans proline' 0 C--N 1.37 1.69 0 C-N-CA 122.457 2.105 . . . . 65.35 113.083 -177.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -99.03 -2.08 38.12 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.146 0.578 . . . . 65.42 112.298 -177.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 157.9 -151.07 22.23 Favored Glycine 0 C--N 1.344 0.981 0 N-CA-C 111.143 -0.783 . . . . 75.42 111.143 -177.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 29.8 mtt-85 -129.43 163.17 26.42 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 117.889 0.845 . . . . 71.43 111.019 174.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -87.61 -156.99 30.86 Favored Glycine 0 C--N 1.345 1.058 0 CA-C-N 115.051 -0.977 . . . . 53.15 111.641 167.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . 0.705 ' HB3' ' HA ' ' A' ' 236' ' ' LYS . 1.0 OUTLIER -130.07 135.6 48.42 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 122.935 0.494 . . . . 71.12 112.035 -177.78 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 34.5 tp -98.59 116.97 31.99 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.354 0.661 . . . . 72.35 109.586 178.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -91.01 107.8 19.44 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.69 0.796 . . . . 73.42 109.335 178.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 48.8 mt -97.23 141.85 29.85 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.201 0.6 . . . . 73.33 111.255 178.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -101.53 108.13 19.61 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.084 -0.962 . . . . 72.24 108.882 175.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 69.0 t -66.09 116.24 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-O 121.119 0.485 . . . . 64.13 111.025 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 36.7 mmm-85 -121.55 115.05 22.09 Favored 'General case' 0 C--O 1.242 0.677 0 N-CA-C 107.594 -1.261 . . . . 75.01 107.594 173.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.454 ' HB ' ' HB2' ' A' ' 229' ' ' ALA . 21.9 mt -75.07 129.03 37.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 N-CA-C 109.513 -0.551 . . . . 72.01 109.513 175.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 8.3 t . . . . . 0 CA--C 1.562 1.407 0 CA-C-O 117.418 -1.277 . . . . 70.45 108.3 178.439 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 53.3 tpp . . . . . 0 N--CA 1.475 0.824 0 N-CA-C 109.733 -0.469 . . . . 71.53 109.733 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 19.9 t70 63.89 88.84 0.1 Allowed 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.774 1.23 . . . . 74.34 111.202 178.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -152.78 -63.84 0.16 Allowed 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 107.456 -1.313 . . . . 63.14 107.456 175.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.526 HG21 ' HB3' ' A' ' 234' ' ' ARG . 16.2 m -88.22 161.59 2.74 Favored 'Isoleucine or valine' 0 C--O 1.244 0.78 0 N-CA-C 108.249 -1.019 . . . . 72.43 108.249 161.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 16.2 tt -91.02 133.18 33.55 Favored 'Isoleucine or valine' 0 C--O 1.243 0.721 0 N-CA-C 107.07 -1.456 . . . . 73.52 107.07 164.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -68.57 117.89 10.9 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 123.659 0.784 . . . . 74.23 110.152 -170.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.467 ' HB2' HD22 ' A' ' 233' ' ' LEU . . . -123.57 172.61 8.64 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.662 1.185 . . . . 73.4 108.834 178.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -152.81 158.25 41.95 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.386 0.674 . . . . 71.13 109.659 177.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -141.21 168.39 19.9 Favored 'General case' 0 C--N 1.35 0.59 0 C-N-CA 122.731 0.412 . . . . 73.31 110.761 177.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -142.78 149.23 49.23 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 124.95 1.3 . . . . 72.21 108.705 173.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . 0.547 ' HA ' HG12 ' A' ' 219' ' ' VAL . 20.4 Cg_endo -58.76 123.78 14.29 Favored 'Trans proline' 0 C--N 1.377 2.051 0 C-N-CA 122.931 2.42 . . . . 61.11 111.757 176.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . 0.562 ' HB2' ' HG3' ' A' ' 220' ' ' GLU . . . -77.98 -38.98 43.83 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.694 0.798 . . . . 62.52 109.827 179.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -93.34 152.74 18.95 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 114.637 -1.165 . . . . 74.23 109.58 175.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -74.7 85.2 0.76 Allowed Glycine 0 C--N 1.35 1.316 0 N-CA-C 111.312 -0.715 . . . . 73.13 111.312 177.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 29.3 p -78.23 130.79 36.7 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.885 0.874 . . . . 74.34 110.904 -178.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -101.89 -21.82 10.74 Favored Glycine 0 C--N 1.348 1.243 0 CA-C-N 116.317 -0.401 . . . . 71.1 113.011 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -92.93 37.88 3.29 Favored Glycine 0 C--N 1.348 1.248 0 C-N-CA 123.029 0.347 . . . . 65.33 112.503 -177.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 20.6 p -79.62 84.71 5.43 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.616 0.767 . . . . 72.15 110.698 -178.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 176.94 135.39 2.17 Favored Glycine 0 C--N 1.347 1.163 0 CA-C-N 115.428 -0.806 . . . . 53.41 111.722 176.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -110.21 -150.93 12.94 Favored Glycine 0 C--N 1.351 1.415 0 C-N-CA 123.557 0.598 . . . . 71.41 111.763 176.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 70.8 m -155.16 -50.6 0.09 Allowed 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.205 0.602 . . . . 74.43 110.146 177.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 177.22 -157.22 21.89 Favored Glycine 0 C--N 1.342 0.886 0 CA-C-N 116.234 -0.439 . . . . 70.34 112.013 -177.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 76.48 -124.72 7.3 Favored Glycine 0 C--N 1.346 1.132 0 N-CA-C 111.775 -0.53 . . . . 71.25 111.775 -179.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 49.5 m -104.43 94.02 5.11 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.387 0.675 . . . . 70.44 109.645 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.417 ' O ' ' HA3' ' A' ' 247' ' ' GLY . 25.0 mm-40 -85.61 5.4 31.96 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 115.317 -0.856 . . . . 73.1 111.423 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -93.41 157.72 16.08 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.462 0.705 . . . . 75.22 110.047 175.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 43.1 mt -136.24 143.35 44.25 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.323 1.049 . . . . 75.03 108.282 171.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -129.61 120.76 25.79 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 123.791 0.836 . . . . 72.33 109.079 -178.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -159.37 165.18 33.82 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 121.47 0.653 . . . . 74.51 110.931 -177.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 2.9 p -93.25 138.3 31.76 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.798 0.839 . . . . 70.21 109.56 173.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.56 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . 57.9 tp -108.6 119.34 39.22 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.597 1.159 . . . . 71.3 109.497 -177.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -82.2 103.2 11.63 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 109.562 -0.533 . . . . 72.02 109.562 176.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.515 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 47.5 t -106.21 111.17 64.36 Favored Pre-proline 0 CA--C 1.542 0.643 0 N-CA-C 108.195 -1.039 . . . . 71.55 108.195 175.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . 0.424 ' HD2' HD12 ' A' ' 203' ' ' ILE . 50.5 Cg_exo -57.38 142.1 94.98 Favored 'Trans proline' 0 C--N 1.373 1.862 0 C-N-CA 122.498 2.132 . . . . 72.15 111.874 172.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.404 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -50.66 -47.5 84.87 Favored Pre-proline 0 CA--C 1.559 1.298 0 CA-C-O 117.793 -1.099 . . . . 62.3 112.985 -177.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -55.49 -41.93 73.05 Favored 'Trans proline' 0 C--N 1.398 3.178 0 C-N-CA 122.095 1.863 . . . . 64.23 112.891 176.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.424 HD12 ' HD2' ' A' ' 200' ' ' PRO . 34.5 mt -69.71 -36.2 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 C-N-CA 123.379 0.671 . . . . 74.45 110.894 -177.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.24 -38.32 78.44 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.227 0.611 . . . . 64.42 111.651 -178.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 201' ' ' ALA . 89.3 t -72.7 -56.29 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 CA-C-N 115.689 -0.687 . . . . 74.34 110.82 -178.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 9.4 m -80.39 -24.69 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 CA-C-N 116.294 -0.412 . . . . 73.51 111.985 -172.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 82.47 136.92 2.56 Favored Glycine 0 C--N 1.349 1.254 0 O-C-N 123.433 0.458 . . . . 44.1 112.622 -175.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 179.49 -124.91 0.93 Allowed Glycine 0 C--N 1.341 0.844 0 N-CA-C 111.776 -0.529 . . . . 62.14 111.776 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.514 ' HD2' ' HB3' ' A' ' 220' ' ' GLU . 46.9 mtmt -137.63 153.02 49.93 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.654 0.781 . . . . 42.43 109.817 176.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.491 HG11 ' HA ' ' A' ' 199' ' ' VAL . 27.3 m -128.84 168.23 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.578 1.151 . . . . 72.32 108.707 170.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 45.9 ttp180 -94.78 141.48 28.58 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 109.761 -0.459 . . . . 70.13 109.761 173.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -129.77 154.78 46.87 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.02 0.928 . . . . 75.34 109.036 173.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -103.66 114.45 28.72 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 109.218 -0.66 . . . . 73.13 109.218 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 64.4 p -114.57 175.62 5.41 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.246 0.618 . . . . 64.31 109.439 174.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 11.8 mt -81.12 -3.17 51.14 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 116.109 -0.496 . . . . 55.35 110.283 173.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -91.54 -20.34 21.8 Favored 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 123.862 0.865 . . . . 72.24 110.403 170.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 133.23 -163.64 24.3 Favored Glycine 0 C--N 1.352 1.446 0 CA-C-O 119.752 -0.471 . . . . 62.14 112.595 177.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -74.93 131.03 13.91 Favored 'Trans proline' 0 C--N 1.37 1.705 0 C-N-CA 123.042 2.495 . . . . 75.13 110.278 172.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.547 HG12 ' HA ' ' A' ' 177' ' ' PRO . 17.9 m -131.19 161.83 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 123.538 0.735 . . . . 61.02 110.478 -173.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.562 ' HG3' ' HB2' ' A' ' 178' ' ' ALA . 35.4 mt-10 -112.18 113.25 25.4 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.645 0.778 . . . . 74.51 109.681 178.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 57.5 t -95.46 118.99 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.229 1.011 . . . . 54.41 109.059 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -67.54 100.13 0.84 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.777 0.831 . . . . 70.43 110.149 176.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 91.7 t -81.77 121.02 79.09 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 124.562 1.145 . . . . 72.13 109.858 176.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -65.56 155.27 69.84 Favored 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 122.22 1.947 . . . . 70.44 111.482 173.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -66.77 156.23 66.91 Favored 'Trans proline' 0 C--N 1.37 1.702 0 C-N-CA 122.322 2.015 . . . . 74.14 111.731 172.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 49.0 mtm-85 63.34 31.53 15.2 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.19 0.996 . . . . 73.13 111.151 172.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.429 HG23 ' HD2' ' A' ' 231' ' ' ARG . 92.1 m -86.84 122.62 30.97 Favored 'General case' 0 C--N 1.344 0.367 0 C-N-CA 123.58 0.752 . . . . 65.03 109.256 176.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -94.35 167.79 11.3 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.499 0.719 . . . . 75.04 110.715 177.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -78.71 149.21 32.81 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-N 114.936 -1.029 . . . . 74.12 109.816 177.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 87.34 1.43 83.88 Favored Glycine 0 C--N 1.339 0.716 0 CA-C-N 115.681 -0.69 . . . . 75.13 111.963 -173.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.429 ' HD2' HG23 ' A' ' 227' ' ' THR . 54.3 mtt-85 -79.25 163.05 25.27 Favored 'General case' 0 C--N 1.353 0.76 0 CA-C-O 121.419 0.628 . . . . 71.21 110.103 170.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 15.9 pttm -128.41 139.97 52.08 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 124.344 1.058 . . . . 72.25 109.491 -178.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.467 HD22 ' HB2' ' A' ' 173' ' ' ALA . 90.0 mt -120.29 105.95 11.42 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.25 1.02 . . . . 64.24 108.906 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . 0.526 ' HB3' HG21 ' A' ' 170' ' ' VAL . 71.4 ttt180 -90.49 101.45 14.19 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 107.278 -1.378 . . . . 64.34 107.278 170.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 22.8 mt -77.13 83.41 3.62 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 107.718 -1.215 . . . . 71.41 107.718 174.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -68.68 129.0 38.67 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-N 113.049 -1.887 . . . . 74.43 111.861 -169.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 60.62 32.2 77.61 Favored Glycine 0 C--N 1.347 1.188 0 O-C-N 124.738 1.274 . . . . 61.41 112.473 177.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -136.79 -2.92 2.09 Favored 'General case' 0 C--N 1.358 0.964 0 N-CA-C 113.641 0.978 . . . . 74.25 113.641 -176.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . 0.415 ' HA2' ' HB2' ' A' ' 249' ' ' LEU . . . -61.69 -107.33 0.01 OUTLIER Glycine 0 N--CA 1.485 1.965 0 N-CA-C 114.603 0.601 . . . . 71.52 114.603 -178.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -67.81 136.31 92.38 Favored Pre-proline 0 N--CA 1.486 1.351 0 CA-C-O 118.328 -0.844 . . . . 72.34 109.523 171.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.507 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 37.8 Cg_exo -60.88 135.65 60.93 Favored 'Trans proline' 0 C--N 1.371 1.75 0 C-N-CA 122.648 2.232 . . . . 52.25 112.532 175.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -164.86 120.56 0.94 Allowed Glycine 0 CA--C 1.54 1.613 0 CA-C-O 118.556 -1.136 . . . . 73.22 111.99 -177.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -72.25 -20.13 24.95 Favored 'Trans proline' 0 C--N 1.387 2.554 0 C-N-CA 123.506 2.804 . . . . 72.22 112.811 176.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -93.29 12.64 23.91 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.231 0.612 . . . . 62.45 110.695 175.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 118.97 120.24 2.91 Favored Glycine 0 C--N 1.353 1.477 0 N-CA-C 110.592 -1.003 . . . . 70.23 110.592 -177.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.507 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 28.0 mtt180 -72.29 162.67 29.15 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.291 0.636 . . . . 73.24 109.71 174.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.417 ' HA3' ' O ' ' A' ' 191' ' ' GLN . . . -80.56 -157.86 16.77 Favored Glycine 0 C--N 1.348 1.234 0 N-CA-C 112.435 -0.266 . . . . 73.13 112.435 174.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -121.43 128.85 52.58 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 117.407 0.603 . . . . 61.5 109.786 177.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.415 ' HB2' ' HA2' ' A' ' 239' ' ' GLY . 50.2 tp -100.19 108.18 20.22 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 108.263 -1.014 . . . . 71.45 108.263 173.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -98.69 116.43 30.91 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 108.522 -0.918 . . . . 70.42 108.522 -174.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.56 ' HB3' ' HB2' ' A' ' 197' ' ' LEU . 49.1 mt -127.22 119.17 25.78 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.024 0.93 . . . . 74.31 110.271 -173.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -83.57 121.33 27.09 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 122.979 0.511 . . . . 75.43 110.192 176.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 61.2 t -66.87 105.49 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 C-N-CA 123.691 0.796 . . . . 75.13 110.46 179.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 47.6 mmm-85 -107.25 100.02 9.51 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 107.703 -1.221 . . . . 74.04 107.703 173.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.515 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 39.8 mt -76.94 119.37 25.21 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 CA-C-N 116.063 -0.517 . . . . 72.24 110.422 -178.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 29.5 p . . . . . 0 C--O 1.249 1.06 0 N-CA-C 108.393 -0.965 . . . . 44.02 108.393 175.614 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 67.2 mtm . . . . . 0 N--CA 1.48 1.072 0 N-CA-C 109.752 -0.462 . . . . 74.34 109.752 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -89.21 48.33 1.6 Allowed 'General case' 0 N--CA 1.48 1.074 0 CA-C-O 121.89 0.853 . . . . 62.41 110.148 177.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -58.14 -55.64 32.38 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 114.757 -1.111 . . . . 63.53 109.707 174.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.44 HG12 ' HG3' ' A' ' 232' ' ' LYS . 33.5 m -92.03 156.09 3.05 Favored 'Isoleucine or valine' 0 C--O 1.244 0.784 0 CA-C-N 114.87 -1.059 . . . . 51.45 109.147 171.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 16.6 tt -83.3 143.43 11.95 Favored 'Isoleucine or valine' 0 C--O 1.245 0.863 0 N-CA-C 108.703 -0.851 . . . . 60.52 108.703 171.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -59.92 137.96 57.94 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.301 1.041 . . . . 74.32 110.787 -176.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.466 ' HB2' HD22 ' A' ' 233' ' ' LEU . . . -157.69 159.34 36.81 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.319 1.048 . . . . 53.34 109.537 -178.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -160.42 152.22 19.93 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.604 0.762 . . . . 65.43 109.742 174.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.546 ' HB3' HG22 ' A' ' 221' ' ' VAL . 34.6 p90 -113.7 -178.67 3.43 Favored 'General case' 0 C--N 1.349 0.561 0 CA-C-O 121.23 0.538 . . . . 70.5 111.704 -178.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -135.78 140.71 34.43 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-N 114.394 -1.275 . . . . 64.42 107.955 170.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -60.87 113.92 1.93 Allowed 'Trans proline' 0 C--N 1.366 1.487 0 C-N-CA 123.212 2.608 . . . . 75.34 111.134 175.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . 0.439 ' HB2' ' HG3' ' A' ' 220' ' ' GLU . . . -99.98 -10.51 21.54 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.497 0.719 . . . . 73.41 110.848 175.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -55.52 -46.73 77.0 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.226 1.011 . . . . 74.44 111.956 -178.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 86.42 -10.73 65.73 Favored Glycine 0 C--N 1.345 1.047 0 N-CA-C 115.562 0.985 . . . . 63.14 115.562 168.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 61.9 p -151.1 14.54 0.71 Allowed 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 118.017 0.909 . . . . 71.24 111.925 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 77.95 109.19 0.18 Allowed Glycine 0 C--N 1.348 1.222 0 CA-C-O 119.338 -0.701 . . . . 55.14 111.502 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -68.92 -109.72 0.02 OUTLIER Glycine 0 C--N 1.352 1.447 0 CA-C-N 116.99 0.395 . . . . 53.44 112.862 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 12.3 t -133.8 28.45 3.89 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 109.011 -0.737 . . . . 73.14 109.011 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -69.9 94.0 0.42 Allowed Glycine 0 C--N 1.346 1.091 0 CA-C-N 115.238 -0.892 . . . . 33.32 112.817 -177.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -141.3 150.75 22.1 Favored Glycine 0 C--O 1.242 0.617 0 N-CA-C 109.57 -1.412 . . . . 64.24 109.57 171.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.551 ' HA ' ' HD2' ' A' ' 240' ' ' PHE . 27.4 p -75.66 79.78 2.63 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-O 121.72 0.771 . . . . 71.05 110.378 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -80.0 -29.72 45.46 Favored Glycine 0 C--N 1.343 0.959 0 CA-C-N 114.929 -1.032 . . . . 60.04 112.157 176.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 156.71 150.6 5.72 Favored Glycine 0 C--N 1.344 0.989 0 CA-C-O 119.105 -0.83 . . . . 64.31 111.225 177.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 16.7 m 58.59 103.61 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.544 1.138 . . . . 71.3 110.729 -175.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.496 ' HA ' ' HB2' ' A' ' 240' ' ' PHE . 18.2 mm100 -69.69 -24.38 63.58 Favored 'General case' 0 CA--C 1.553 1.061 0 N-CA-C 112.683 0.623 . . . . 55.22 112.683 -175.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -93.02 141.18 28.69 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.427 0.691 . . . . 71.52 110.07 -178.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 17.6 mt -123.44 148.4 46.2 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 124.971 1.308 . . . . 72.24 109.22 174.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -127.86 120.64 28.19 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.21 0.604 . . . . 73.21 109.673 177.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.431 ' O ' ' HA ' ' A' ' 251' ' ' LEU . . . -145.35 160.06 42.11 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.729 0.812 . . . . 60.33 109.939 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 11.5 m -102.55 143.79 31.8 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 108.771 -0.826 . . . . 44.4 108.771 176.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.569 HD11 HG23 ' A' ' 210' ' ' VAL . 49.0 tp -113.95 124.97 53.45 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.634 1.174 . . . . 64.11 109.858 -173.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -96.97 102.86 14.72 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.375 0.67 . . . . 73.22 109.522 175.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.532 ' HA ' HG11 ' A' ' 210' ' ' VAL . 3.2 p -104.45 125.9 32.89 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 124.093 0.957 . . . . 71.32 109.675 173.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.86 148.44 66.93 Favored 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 122.698 2.265 . . . . 74.52 112.526 170.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.459 ' HA ' HG23 ' A' ' 255' ' ' ILE . . . -49.38 -52.39 49.75 Favored Pre-proline 0 CA--C 1.56 1.359 0 C-N-CA 124.269 1.027 . . . . 72.05 112.452 178.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.436 ' O ' HG12 ' A' ' 206' ' ' VAL . 30.8 Cg_endo -61.28 -40.3 50.76 Favored 'Trans proline' 0 C--N 1.4 3.266 0 C-N-CA 121.752 1.635 . . . . 75.32 112.877 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 29.1 mt -68.7 -30.48 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 123.233 0.613 . . . . 73.04 110.669 -178.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.92 -42.52 73.19 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 122.827 0.451 . . . . 45.11 110.662 177.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 201' ' ' ALA . 61.4 t -71.05 -53.9 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 123.303 0.641 . . . . 75.33 111.438 -177.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.436 HG12 ' O ' ' A' ' 202' ' ' PRO . 7.7 p -80.09 -31.59 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 122.439 0.296 . . . . 73.11 111.787 -174.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 93.45 131.22 5.84 Favored Glycine 0 CA--C 1.532 1.105 0 N-CA-C 111.618 -0.593 . . . . 72.15 111.618 -172.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -166.72 -143.87 3.91 Favored Glycine 0 C--N 1.341 0.856 0 CA-C-O 119.339 -0.701 . . . . 62.43 111.899 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.466 ' HB3' ' HB3' ' A' ' 220' ' ' GLU . 9.6 mtmp? -132.96 145.71 51.13 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.886 0.874 . . . . 73.31 109.704 174.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.569 HG23 HD11 ' A' ' 197' ' ' LEU . 22.1 m -139.44 158.54 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 124.385 1.074 . . . . 74.42 110.219 177.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 29.2 mtp-105 -79.76 132.87 36.27 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 122.917 0.487 . . . . 71.0 111.598 -177.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -121.12 125.21 46.67 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 125.368 1.467 . . . . 65.35 108.016 172.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.65 106.89 18.82 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 123.478 0.711 . . . . 71.02 110.124 -175.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 29.8 p -117.38 172.51 7.27 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.402 0.681 . . . . 73.21 109.928 -179.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 9.3 mt -71.54 -24.77 62.0 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 109.541 -0.541 . . . . 72.11 109.541 175.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -79.52 -18.87 50.93 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.128 0.971 . . . . 75.14 110.767 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 135.19 -175.51 20.61 Favored Glycine 0 C--N 1.353 1.495 0 CA-C-N 116.064 -0.517 . . . . 53.51 112.948 172.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -66.76 126.48 15.43 Favored 'Trans proline' 0 C--N 1.372 1.809 0 C-N-CA 122.931 2.42 . . . . 53.31 110.644 168.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 35.4 m -133.16 138.68 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 122.882 0.473 . . . . 64.44 110.67 -178.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.466 ' HB3' ' HB3' ' A' ' 209' ' ' LYS . 46.9 mt-10 -92.99 108.55 20.09 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.178 0.591 . . . . 72.13 110.777 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.546 HG22 ' HB3' ' A' ' 175' ' ' TYR . 61.0 t -91.89 119.24 38.93 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 C-N-CA 124.451 1.101 . . . . 70.04 109.429 -176.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -65.04 102.61 0.64 Allowed 'General case' 0 C--O 1.239 0.534 0 O-C-N 124.309 1.005 . . . . 64.42 109.969 175.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.471 HG11 HG21 ' A' ' 199' ' ' VAL . 48.1 t -74.8 117.28 61.27 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 124.376 1.07 . . . . 70.03 109.061 172.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -59.62 156.64 35.96 Favored 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 122.32 2.013 . . . . 73.11 112.158 178.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -63.06 125.24 15.45 Favored 'Trans proline' 0 C--N 1.375 1.945 0 C-N-CA 122.389 2.059 . . . . 75.03 111.567 177.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 72.9 mtm180 68.13 83.51 0.16 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.962 1.305 . . . . 74.51 110.051 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.585 HG22 HG11 ' A' ' 253' ' ' VAL . 89.8 m -126.48 117.5 23.02 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.011 0.924 . . . . 73.01 109.464 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -85.79 158.35 20.02 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.939 0.895 . . . . 71.43 112.151 -172.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -72.54 124.33 24.99 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 114.635 -1.166 . . . . 60.3 109.951 179.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 102.28 2.85 51.07 Favored Glycine 0 C--N 1.335 0.52 0 CA-C-O 119.524 -0.598 . . . . 45.0 112.596 -176.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 87.1 mtt180 -72.66 161.27 30.98 Favored 'General case' 0 C--N 1.356 0.879 0 CA-C-O 121.264 0.554 . . . . 74.2 110.051 170.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.44 ' HG3' HG12 ' A' ' 170' ' ' VAL . 19.9 pttm -124.38 140.47 52.92 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.324 -0.853 . . . . 74.44 109.876 -179.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.466 HD22 ' HB2' ' A' ' 173' ' ' ALA . 61.4 mt -117.87 141.28 48.61 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 107.49 -1.3 . . . . 73.31 107.49 176.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 30.6 ttt180 -130.88 101.73 5.76 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 108.081 -1.081 . . . . 72.15 108.081 167.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.455 HD13 ' HD1' ' A' ' 175' ' ' TYR . 27.6 mt -71.03 87.31 0.74 Allowed 'General case' 0 C--O 1.24 0.603 0 CA-C-N 114.524 -1.216 . . . . 70.42 108.286 175.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 59.6 mtmt -68.75 122.98 19.7 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 114.272 -1.331 . . . . 75.1 111.006 -174.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 69.65 26.42 74.48 Favored Glycine 0 C--N 1.345 1.079 0 O-C-N 124.305 1.003 . . . . 71.15 112.303 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.447 ' HB3' ' CE1' ' A' ' 175' ' ' TYR . 31.3 mmtp -135.85 35.02 2.87 Favored 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 124.512 1.125 . . . . 71.24 110.985 -172.007 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -114.27 -115.36 3.14 Favored Glycine 0 N--CA 1.477 1.414 0 N-CA-C 111.952 -0.459 . . . . 51.04 111.952 177.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . 0.551 ' HD2' ' HA ' ' A' ' 187' ' ' SER . 1.8 m-85 -69.83 142.03 90.49 Favored Pre-proline 0 N--CA 1.485 1.321 0 C-N-CA 123.17 0.588 . . . . 65.32 110.946 177.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.404 ' O ' ' HB3' ' A' ' 187' ' ' SER . 81.1 Cg_exo -52.44 144.12 41.9 Favored 'Trans proline' 0 C--N 1.376 1.985 0 C-N-CA 123.687 2.925 . . . . 65.01 113.602 172.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -156.8 113.31 0.56 Allowed Glycine 0 CA--C 1.531 1.063 0 CA-C-O 118.399 -1.223 . . . . 73.23 110.248 -179.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.26 -14.98 45.33 Favored 'Trans proline' 0 C--N 1.386 2.521 0 C-N-CA 123.535 2.823 . . . . 61.53 114.565 -176.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -112.6 -12.24 13.46 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 123.529 0.732 . . . . 72.34 111.594 175.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 163.03 125.68 0.78 Allowed Glycine 0 C--N 1.344 0.998 0 N-CA-C 111.123 -0.791 . . . . 63.12 111.123 -178.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 12.3 mtm180 -73.63 162.32 29.33 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.135 0.574 . . . . 72.04 110.928 -178.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -83.82 -163.72 35.78 Favored Glycine 0 C--N 1.348 1.212 0 CA-C-N 115.894 -0.594 . . . . 65.15 112.971 178.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -108.36 157.46 18.37 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.213 0.605 . . . . 74.54 110.676 -176.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 45.6 tp -132.83 110.91 10.66 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.101 0.96 . . . . 74.34 108.571 170.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 21.9 t80 -96.28 120.97 37.55 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.382 1.073 . . . . 62.12 109.326 -176.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.431 ' HA ' ' O ' ' A' ' 195' ' ' ALA . 51.5 mt -120.02 126.98 52.14 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.727 0.811 . . . . 72.24 110.862 -176.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.99 116.52 25.1 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 122.886 0.474 . . . . 72.34 110.434 173.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.585 HG11 HG22 ' A' ' 227' ' ' THR . 96.7 t -65.71 115.58 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 123.381 0.673 . . . . 73.13 110.511 176.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -121.12 111.62 17.67 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.015 0.926 . . . . 71.42 109.193 172.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.459 HG23 ' HA ' ' A' ' 201' ' ' ALA . 44.7 mt -76.89 121.47 29.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 108.988 -0.745 . . . . 74.02 108.988 175.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 34.6 p . . . . . 0 C--O 1.253 1.254 0 N-CA-C 108.23 -1.026 . . . . 51.14 108.23 175.908 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 N--CA 1.484 1.257 0 N-CA-C 111.251 0.093 . . . . 72.04 111.251 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -74.65 105.73 5.88 Favored 'General case' 0 C--N 1.35 0.593 0 N-CA-C 108.759 -0.83 . . . . 75.22 108.759 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -49.06 -53.15 21.61 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 125.719 1.608 . . . . 73.21 113.409 -176.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.444 HG21 ' HB3' ' A' ' 234' ' ' ARG . 12.9 m -90.33 -174.82 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.019 0 C-N-CA 123.542 0.737 . . . . 73.13 110.651 -175.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 10.3 tt -93.85 137.46 22.73 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.124 0 N-CA-C 108.29 -1.004 . . . . 71.53 108.29 165.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -74.84 113.39 12.08 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.438 1.095 . . . . 52.54 110.02 -175.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.453 ' HB2' HD22 ' A' ' 233' ' ' LEU . . . -111.6 178.95 4.16 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.449 0.7 . . . . 70.42 110.711 -178.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -146.76 156.5 43.2 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.572 1.149 . . . . 72.43 109.456 178.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.403 ' HD1' HD13 ' A' ' 235' ' ' LEU . 2.5 p90 -130.67 172.06 12.38 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.086 0.47 . . . . 74.03 110.045 168.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -134.5 140.91 37.06 Favored Pre-proline 0 N--CA 1.476 0.837 0 C-N-CA 124.585 1.154 . . . . 52.54 108.27 175.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -64.04 106.08 0.63 Allowed 'Trans proline' 0 C--N 1.363 1.342 0 C-N-CA 122.775 2.317 . . . . 74.22 111.035 175.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -63.83 -36.87 85.34 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.535 0.734 . . . . 32.11 111.826 -175.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -94.67 -41.69 9.16 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.434 0.694 . . . . 62.03 110.057 176.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 128.12 10.3 3.49 Favored Glycine 0 C--N 1.353 1.494 0 CA-C-O 119.648 -0.529 . . . . 52.4 113.603 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 21.1 t -97.41 171.57 8.31 Favored 'General case' 0 N--CA 1.486 1.325 0 CA-C-N 117.638 0.719 . . . . 72.12 110.89 -179.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 117.85 92.69 1.59 Allowed Glycine 0 C--N 1.346 1.118 0 N-CA-C 110.596 -1.002 . . . . 75.24 110.596 -174.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -175.72 -32.82 0.04 OUTLIER Glycine 0 C--N 1.35 1.358 0 CA-C-N 117.229 0.515 . . . . 61.31 114.204 -177.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 34.6 p -110.49 10.13 23.2 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 112.967 0.729 . . . . 41.41 112.967 -173.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 0.41 ' N ' ' HG2' ' A' ' 241' ' ' PRO . . . -55.1 109.99 1.54 Allowed Glycine 0 C--N 1.348 1.23 0 O-C-N 123.502 0.501 . . . . 74.54 113.735 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -143.23 114.57 0.85 Allowed Glycine 0 C--N 1.341 0.847 0 N-CA-C 110.777 -0.929 . . . . 40.54 110.777 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 16.7 t -162.86 115.43 1.6 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.61 0.764 . . . . 63.25 109.803 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 73.93 8.03 77.11 Favored Glycine 0 C--N 1.356 1.649 0 O-C-N 123.612 0.57 . . . . 62.12 114.188 176.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 64.16 26.24 70.26 Favored Glycine 0 C--N 1.35 1.325 0 CA-C-N 116.812 0.306 . . . . 62.4 112.456 -174.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 29.0 m -83.68 156.15 22.78 Favored 'General case' 0 C--N 1.35 0.604 0 C-N-CA 123.714 0.806 . . . . 63.3 111.363 -175.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.482 ' HA ' ' HB2' ' A' ' 240' ' ' PHE . 23.9 mm-40 -114.47 -21.12 10.49 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.079 0.952 . . . . 51.42 110.084 168.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -89.6 146.92 24.22 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.031 0.932 . . . . 74.23 109.927 -170.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.424 HD23 ' HA ' ' A' ' 193' ' ' LEU . 13.7 mt -140.53 131.56 26.23 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 107.634 -1.247 . . . . 70.41 107.634 166.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -120.13 128.3 53.31 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 108.782 -0.822 . . . . 65.54 108.782 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -157.53 162.04 38.82 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.742 0.817 . . . . 52.21 110.157 178.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 17.2 p -91.87 149.12 21.74 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 109.033 -0.728 . . . . 64.41 109.033 170.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.619 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . 40.8 tp -113.4 115.01 27.4 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 123.622 0.769 . . . . 75.23 109.549 -175.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -80.03 100.96 8.42 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.625 0.77 . . . . 72.22 109.163 -179.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.578 ' HA ' HG11 ' A' ' 210' ' ' VAL . 40.9 t -109.84 104.39 55.38 Favored Pre-proline 0 CA--C 1.54 0.578 0 N-CA-C 108.509 -0.923 . . . . 60.54 108.509 178.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -53.22 139.79 62.62 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 122.723 2.282 . . . . 74.43 112.07 174.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.428 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -47.8 -47.84 61.78 Favored Pre-proline 0 CA--C 1.558 1.266 0 C-N-CA 124.377 1.071 . . . . 74.23 113.749 -175.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.1 -45.06 34.13 Favored 'Trans proline' 0 C--N 1.39 2.716 0 C-N-CA 121.977 1.785 . . . . 73.42 112.902 174.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 36.6 mt -66.1 -32.24 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 123.577 0.751 . . . . 64.43 110.84 -177.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -65.91 -50.64 63.75 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 122.994 0.518 . . . . 73.12 110.377 177.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 201' ' ' ALA . 81.4 t -64.3 -53.23 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 O-C-N 123.877 0.736 . . . . 73.51 111.685 -175.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 26.9 m -78.31 -26.28 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 N-CA-C 112.237 0.458 . . . . 73.33 112.237 -176.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 81.01 139.99 2.65 Favored Glycine 0 C--N 1.349 1.301 0 N-CA-C 112.147 -0.381 . . . . 74.03 112.147 -175.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -177.74 -124.27 0.84 Allowed Glycine 0 C--N 1.344 0.995 0 CA-C-N 117.202 0.501 . . . . 31.12 112.506 -178.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -136.59 153.13 51.05 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.977 0.911 . . . . 72.11 108.71 176.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.578 HG11 ' HA ' ' A' ' 199' ' ' VAL . 15.7 m -138.06 128.03 35.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 123.268 0.627 . . . . 72.5 109.381 171.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . 0.418 ' HG2' ' HG2' ' A' ' 220' ' ' GLU . 63.6 mtm-85 -81.95 110.29 17.09 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.38 0.672 . . . . 62.43 110.796 -176.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -100.46 161.14 13.8 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.677 1.191 . . . . 74.31 109.93 178.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 8.1 mmt -99.17 119.82 38.49 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.714 0.805 . . . . 70.0 109.889 -177.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 76.4 p -110.6 175.49 5.41 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.52 0.728 . . . . 60.11 109.113 170.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 29.1 mt -69.84 -10.43 58.41 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 112.712 0.634 . . . . 74.4 112.712 -174.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -117.43 -12.69 10.39 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.266 0.626 . . . . 51.35 112.284 -177.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 153.15 -169.62 32.05 Favored Glycine 0 C--N 1.356 1.655 0 N-CA-C 114.335 0.494 . . . . 71.34 114.335 173.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -70.22 141.23 42.85 Favored 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 123.558 2.839 . . . . 72.42 112.456 176.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 34.6 m -137.89 130.96 41.75 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 C-N-CA 123.547 0.739 . . . . 52.35 110.157 178.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.418 ' HG2' ' HG2' ' A' ' 211' ' ' ARG . 14.3 mt-10 -88.07 108.52 19.28 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.408 0.683 . . . . 71.34 110.173 -178.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 44.9 t -94.74 122.95 46.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 123.734 0.814 . . . . 73.24 109.682 -176.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -68.61 107.0 2.79 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.205 1.002 . . . . 73.51 111.452 -177.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 66.4 t -86.2 121.05 72.74 Favored Pre-proline 0 CA--C 1.553 1.065 0 C-N-CA 124.634 1.174 . . . . 71.12 110.047 176.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -63.52 164.38 20.98 Favored 'Trans proline' 0 C--N 1.379 2.183 0 C-N-CA 122.918 2.412 . . . . 65.42 112.527 174.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -66.28 128.35 19.25 Favored 'Trans proline' 0 C--N 1.376 2.008 0 C-N-CA 122.615 2.21 . . . . 72.3 112.184 173.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 63.3 mtm-85 62.81 70.54 0.55 Allowed 'General case' 0 C--N 1.353 0.746 0 C-N-CA 124.724 1.21 . . . . 72.3 110.846 178.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.631 HG22 HG11 ' A' ' 253' ' ' VAL . 56.8 m -101.57 114.72 29.01 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 114.829 -1.078 . . . . 63.11 109.376 -178.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 22.9 mp0 -84.79 153.03 23.25 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.271 0.628 . . . . 62.14 111.404 -174.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -73.15 127.89 33.91 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.734 -0.839 . . . . 64.13 108.734 174.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 110.08 -11.84 31.65 Favored Glycine 0 C--N 1.333 0.366 0 N-CA-C 111.533 -0.627 . . . . 55.14 111.533 -171.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.575 ' HD2' HG23 ' A' ' 227' ' ' THR . 90.7 mtt180 -66.81 156.79 34.61 Favored 'General case' 0 C--N 1.36 1.043 0 CA-C-O 121.361 0.601 . . . . 60.23 110.142 169.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 38.3 pttt -131.91 135.08 46.37 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 114.996 -1.002 . . . . 74.44 109.391 -176.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.453 HD22 ' HB2' ' A' ' 173' ' ' ALA . 75.9 mt -115.96 137.06 52.45 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 108.081 -1.081 . . . . 62.3 108.081 176.204 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . 0.444 ' HB3' HG21 ' A' ' 170' ' ' VAL . 40.8 ttm105 -119.52 120.49 36.92 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.565 -1.272 . . . . 75.5 107.565 166.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.514 ' O ' ' HA ' ' A' ' 248' ' ' ASP . 43.7 mt -101.88 78.82 1.84 Allowed 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 108.678 -0.86 . . . . 61.1 108.678 -177.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -75.95 144.15 41.17 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 122.883 0.473 . . . . 74.12 109.856 176.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 68.31 18.16 71.1 Favored Glycine 0 C--N 1.344 1.005 0 CA-C-N 115.639 -0.709 . . . . 63.11 112.336 -174.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 10.1 mmpt? -129.75 -30.58 2.04 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.352 1.061 . . . . 70.24 110.728 -175.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -66.84 -125.83 0.02 OUTLIER Glycine 0 C--N 1.36 1.863 0 N-CA-C 114.766 0.666 . . . . 64.41 114.766 -171.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . 0.482 ' HB2' ' HA ' ' A' ' 191' ' ' GLN . 1.1 m-85 -67.78 135.46 92.31 Favored Pre-proline 0 N--CA 1.482 1.15 0 CA-C-O 118.802 -0.618 . . . . 64.31 109.903 177.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.56 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 37.3 Cg_exo -42.51 138.46 3.41 Favored 'Trans proline' 0 C--N 1.378 2.101 0 C-N-CA 124.278 3.319 . . . . 74.42 114.92 175.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -164.46 113.16 0.54 Allowed Glycine 0 CA--C 1.531 1.046 0 N-CA-C 109.219 -1.552 . . . . 74.44 109.219 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -60.51 -40.13 59.43 Favored 'Trans proline' 0 C--N 1.379 2.142 0 C-N-CA 123.234 2.623 . . . . 72.11 113.296 -173.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -77.32 -25.05 50.81 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.057 0.543 . . . . 61.42 110.8 176.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 169.18 127.21 0.91 Allowed Glycine 0 C--N 1.338 0.673 0 N-CA-C 110.996 -0.842 . . . . 71.31 110.996 179.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.56 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 48.6 mtm180 -69.54 159.59 33.05 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.106 0.562 . . . . 73.33 109.874 178.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.426 ' HA3' ' HB3' ' A' ' 191' ' ' GLN . . . -74.08 -156.56 4.55 Favored Glycine 0 C--N 1.339 0.702 0 CA-C-N 116.069 -0.514 . . . . 75.14 112.911 175.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . 0.514 ' HA ' ' O ' ' A' ' 235' ' ' LEU . 2.6 p30 -122.7 136.46 54.88 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 122.332 -0.511 . . . . 70.25 112.018 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 32.5 tp -100.57 104.6 15.95 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 107.241 -1.392 . . . . 74.3 107.241 168.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -89.28 108.03 19.39 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.172 0.989 . . . . 72.43 109.02 -178.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.619 ' HB3' ' HB2' ' A' ' 197' ' ' LEU . 63.8 mt -110.43 110.75 21.63 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.412 1.085 . . . . 73.41 110.349 -176.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -80.37 110.23 15.63 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.119 0.568 . . . . 74.54 109.694 176.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.631 HG11 HG22 ' A' ' 227' ' ' THR . 89.8 t -59.49 110.76 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.417 0.687 . . . . 71.01 111.017 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 30.8 mmm180 -114.23 113.0 24.04 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 125.053 1.341 . . . . 74.53 108.45 173.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.477 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 56.9 mt -75.62 126.14 36.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 N-CA-C 109.253 -0.647 . . . . 73.42 109.253 178.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 45.2 p . . . . . 0 C--O 1.248 1.003 0 C-N-CA 124.167 0.987 . . . . 73.43 108.623 -179.635 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.484 1.267 0 CA-C-O 121.105 0.479 . . . . 70.4 110.263 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -83.59 72.21 10.31 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.785 0.803 . . . . 70.02 109.179 175.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -80.98 -41.6 22.52 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 114.983 -1.008 . . . . 60.24 110.292 -177.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.638 HG21 ' HB3' ' A' ' 234' ' ' ARG . 34.1 m -90.01 173.06 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-N 115.158 -0.928 . . . . 71.04 110.948 178.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 15.1 tt -96.34 143.81 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 N-CA-C 108.676 -0.861 . . . . 63.41 108.676 171.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -65.81 132.16 48.03 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.3 1.04 . . . . 74.2 112.065 -173.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.485 ' HB2' HD22 ' A' ' 233' ' ' LEU . . . -146.61 164.39 32.8 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.336 1.054 . . . . 40.11 110.816 -178.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -160.4 154.09 22.52 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.68 1.192 . . . . 74.34 109.161 179.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.533 ' HA ' ' HA ' ' A' ' 221' ' ' VAL . 31.7 p90 -117.72 -177.21 3.19 Favored 'General case' 0 C--N 1.347 0.475 0 CA-C-O 121.575 0.703 . . . . 74.31 110.953 178.341 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -136.15 131.81 18.88 Favored Pre-proline 0 N--CA 1.468 0.456 0 N-CA-C 107.438 -1.319 . . . . 71.23 107.438 173.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -65.25 95.25 0.26 Allowed 'Trans proline' 0 CA--C 1.551 1.359 0 C-N-CA 122.149 1.899 . . . . 52.51 110.787 177.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . 0.477 ' HB2' ' HG3' ' A' ' 220' ' ' GLU . . . -70.4 -24.64 62.96 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 115.522 -0.763 . . . . 73.52 110.294 176.061 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -62.27 154.27 28.19 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 123.917 0.887 . . . . 73.41 110.191 165.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -51.94 -60.34 7.67 Favored Glycine 0 C--N 1.359 1.842 0 O-C-N 123.62 0.575 . . . . 63.33 113.123 -177.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 23.1 t -177.32 85.19 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.18 0.992 . . . . 44.41 108.501 173.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 83.03 100.33 0.51 Allowed Glycine 0 C--N 1.347 1.177 0 CA-C-N 116.187 -0.46 . . . . 42.41 112.881 176.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -72.04 -69.8 1.33 Allowed Glycine 0 C--N 1.351 1.364 0 N-CA-C 111.992 -0.443 . . . . 62.32 111.992 176.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 35.6 p -167.72 174.35 7.72 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.31 0.644 . . . . 75.04 111.316 -176.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -91.51 -146.33 17.37 Favored Glycine 0 C--N 1.349 1.3 0 CA-C-N 115.506 -0.77 . . . . 62.3 113.028 177.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -156.54 169.79 33.96 Favored Glycine 0 C--N 1.345 1.05 0 N-CA-C 111.938 -0.465 . . . . 70.31 111.938 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 36.4 p -88.39 164.95 15.27 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.136 0.575 . . . . 75.33 111.423 -175.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 72.11 -81.95 0.55 Allowed Glycine 0 C--N 1.355 1.594 0 O-C-N 123.8 0.687 . . . . 61.14 111.725 -174.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 165.94 38.63 0.02 OUTLIER Glycine 0 C--N 1.338 0.652 0 N-CA-C 110.685 -0.966 . . . . 65.34 110.685 175.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 44.8 p -66.72 93.09 0.24 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.965 0.906 . . . . 44.33 112.414 -170.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.614 ' HA ' ' HB2' ' A' ' 240' ' ' PHE . 16.8 mm100 -74.26 -46.39 41.73 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.134 0.573 . . . . 72.24 110.374 176.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.425 ' HA ' ' O ' ' A' ' 248' ' ' ASP . 8.0 p-10 -103.59 139.95 38.21 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.015 -0.539 . . . . 71.43 109.63 176.045 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 86.1 mt -118.83 150.8 39.22 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 108.632 -0.877 . . . . 74.11 108.632 -177.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -122.21 127.59 50.16 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 108.119 -1.067 . . . . 72.42 108.119 172.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -152.88 158.49 42.22 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 122.956 0.502 . . . . 72.45 110.203 -177.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 10.7 p -94.94 138.02 33.23 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 123.222 0.609 . . . . 72.13 109.917 174.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.456 HD11 HG23 ' A' ' 210' ' ' VAL . 52.0 tp -110.88 114.38 27.66 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.381 1.072 . . . . 63.44 109.543 -173.091 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -75.81 104.38 6.33 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 109.251 -0.648 . . . . 73.33 109.251 176.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.587 HG22 HG21 ' A' ' 210' ' ' VAL . 30.0 t -113.46 107.19 53.62 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 123.668 0.787 . . . . 51.15 108.936 175.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -54.19 140.66 71.44 Favored 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.796 2.331 . . . . 73.24 112.267 172.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -47.7 -50.14 53.11 Favored Pre-proline 0 CA--C 1.571 1.752 0 N-CA-C 113.992 1.108 . . . . 63.12 113.992 -177.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -58.1 -39.25 87.13 Favored 'Trans proline' 0 C--N 1.401 3.318 0 C-N-CA 121.838 1.692 . . . . 53.43 112.806 177.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 47.5 mt -72.01 -31.31 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 123.95 0.9 . . . . 71.42 110.829 -178.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.68 -46.63 68.56 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.239 0.615 . . . . 73.25 110.944 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 83.2 t -70.54 -40.99 77.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-N 115.284 -0.871 . . . . 62.32 111.705 -176.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 8.2 p -77.45 -31.02 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 CA-C-N 116.473 -0.33 . . . . 44.52 111.404 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 80.55 69.07 1.42 Allowed Glycine 0 C--N 1.349 1.296 0 CA-C-N 116.055 -0.521 . . . . 73.24 112.344 -173.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -101.29 -150.68 24.14 Favored Glycine 0 C--N 1.346 1.106 0 CA-C-O 119.715 -0.492 . . . . 71.12 112.158 -176.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 55.0 mttp -117.39 143.39 46.04 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.229 0.612 . . . . 71.22 109.56 173.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.587 HG21 HG22 ' A' ' 199' ' ' VAL . 27.7 m -136.72 142.28 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 124.14 0.976 . . . . 55.34 109.192 174.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 88.9 mtm180 -73.72 137.9 44.3 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.127 0.489 . . . . 75.45 111.086 176.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -116.59 121.13 40.83 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.268 1.427 . . . . 72.34 107.394 172.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.0 111.6 19.85 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 109.382 -0.599 . . . . 63.11 109.382 -178.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 81.4 p -120.83 -179.88 4.14 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.457 0.703 . . . . 55.43 111.07 -176.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 12.3 mt -70.31 -22.68 62.8 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 115.466 -0.788 . . . . 72.0 110.003 175.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -87.44 -12.87 44.86 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 123.93 0.892 . . . . 72.14 110.621 177.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 117.37 -158.97 14.29 Favored Glycine 0 C--N 1.354 1.535 0 CA-C-N 116.353 -0.385 . . . . 51.14 113.109 175.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.7 127.9 14.46 Favored 'Trans proline' 0 C--N 1.367 1.533 0 C-N-CA 122.669 2.246 . . . . 74.13 111.381 175.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 29.6 m -132.39 125.03 53.02 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.827 0 N-CA-C 109.919 -0.4 . . . . 63.42 109.919 173.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.477 ' HG3' ' HB2' ' A' ' 178' ' ' ALA . 45.4 mt-10 -84.14 105.82 15.3 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.316 0.647 . . . . 70.21 110.285 -178.293 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.533 ' HA ' ' HA ' ' A' ' 175' ' ' TYR . 46.5 t -90.03 116.94 32.34 Favored 'Isoleucine or valine' 0 C--O 1.243 0.717 0 C-N-CA 124.303 1.041 . . . . 73.25 108.576 -175.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -69.32 101.09 1.44 Allowed 'General case' 0 C--O 1.241 0.613 0 CA-C-N 114.873 -1.058 . . . . 52.53 109.146 176.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 47.1 t -69.18 131.55 90.47 Favored Pre-proline 0 CA--C 1.544 0.749 0 CA-C-N 114.781 -1.1 . . . . 64.42 109.05 176.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -62.81 159.49 37.37 Favored 'Trans proline' 0 CA--C 1.561 1.85 0 C-N-CA 122.06 1.84 . . . . 71.03 111.923 170.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -67.05 147.66 80.12 Favored 'Trans proline' 0 C--N 1.376 2.003 0 C-N-CA 122.159 1.906 . . . . 74.33 112.191 176.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 47.8 mtp180 53.54 54.79 9.5 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.919 1.288 . . . . 73.45 111.368 174.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.615 HG23 ' HD2' ' A' ' 231' ' ' ARG . 91.3 m -96.8 117.95 32.19 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 114.525 -1.216 . . . . 64.32 109.11 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 26.8 mp0 -90.38 161.67 15.48 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.277 0.631 . . . . 73.41 111.57 -177.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -64.42 127.62 32.27 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 114.454 -1.248 . . . . 55.54 110.239 177.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 103.85 -4.31 45.9 Favored Glycine 0 C--N 1.341 0.854 0 CA-C-O 119.374 -0.681 . . . . 73.44 113.526 -179.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.615 ' HD2' HG23 ' A' ' 227' ' ' THR . 87.5 mtt180 -68.65 162.07 26.78 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 117.741 0.771 . . . . 71.42 111.54 175.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -127.33 124.24 38.23 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 123.84 0.856 . . . . 75.42 110.679 -173.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.485 HD22 ' HB2' ' A' ' 173' ' ' ALA . 61.8 mt -113.32 100.0 8.22 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.049 0.939 . . . . 62.11 109.138 178.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . 0.638 ' HB3' HG21 ' A' ' 170' ' ' VAL . 22.6 ttt180 -85.4 102.15 13.19 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 107.966 -1.124 . . . . 65.21 107.966 169.074 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.414 HD13 ' HD1' ' A' ' 175' ' ' TYR . 53.5 mt -68.89 92.06 0.49 Allowed 'General case' 0 C--O 1.244 0.776 0 N-CA-C 107.808 -1.182 . . . . 75.43 107.808 172.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -71.28 114.11 9.0 Favored 'General case' 0 C--N 1.357 0.925 0 CA-C-N 114.137 -1.392 . . . . 74.41 111.813 -167.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . 0.405 ' O ' ' HD3' ' A' ' 246' ' ' ARG . . . 67.53 34.08 83.17 Favored Glycine 0 C--N 1.346 1.121 0 O-C-N 124.053 0.846 . . . . 44.32 112.056 178.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.461 ' HB3' ' CE1' ' A' ' 175' ' ' TYR . 32.9 mmtp -128.62 10.36 6.09 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.645 0.778 . . . . 74.42 111.97 -172.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -84.48 -129.14 1.82 Allowed Glycine 0 N--CA 1.47 0.948 0 N-CA-C 111.742 -0.543 . . . . 60.23 111.742 176.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . 0.614 ' HB2' ' HA ' ' A' ' 191' ' ' GLN . 3.2 m-85 -74.88 142.92 77.2 Favored Pre-proline 0 N--CA 1.48 1.072 0 C-N-CA 123.283 0.633 . . . . 74.12 110.894 175.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.723 ' HA ' ' HG3' ' A' ' 246' ' ' ARG . 21.3 Cg_exo -64.5 142.86 79.98 Favored 'Trans proline' 0 C--N 1.379 2.132 0 C-N-CA 123.003 2.469 . . . . 74.41 113.11 -176.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -157.48 118.25 0.82 Allowed Glycine 0 CA--C 1.535 1.291 0 CA-C-O 118.696 -1.058 . . . . 44.04 111.345 -179.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -64.04 -28.99 65.99 Favored 'Trans proline' 0 C--N 1.384 2.44 0 C-N-CA 123.131 2.554 . . . . 72.04 114.335 -178.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -86.61 -15.35 40.05 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.169 0.588 . . . . 61.51 111.18 176.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 163.29 118.33 0.45 Allowed Glycine 0 C--N 1.344 0.99 0 N-CA-C 110.072 -1.211 . . . . 63.24 110.072 178.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.723 ' HG3' ' HA ' ' A' ' 241' ' ' PRO . 45.4 ttt180 -69.25 140.27 54.47 Favored 'General case' 0 C--O 1.243 0.726 0 CA-C-N 117.505 0.653 . . . . 72.11 109.508 175.389 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -68.56 -169.47 5.54 Favored Glycine 0 C--N 1.351 1.4 0 O-C-N 123.563 0.539 . . . . 53.14 113.347 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . 0.425 ' O ' ' HA ' ' A' ' 192' ' ' ASP . 10.1 m-20 -122.11 169.7 10.6 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.134 0.573 . . . . 71.3 110.734 -175.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 43.2 tp -136.24 107.21 6.68 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 108.356 -0.979 . . . . 61.24 108.356 168.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -94.46 107.4 19.37 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 108.881 -0.785 . . . . 74.3 108.881 -174.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.401 HD12 HD11 ' A' ' 235' ' ' LEU . 66.2 mt -110.5 113.99 27.06 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.055 0.942 . . . . 75.04 110.117 -175.335 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -79.52 116.75 19.92 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 109.218 -0.66 . . . . 72.05 109.218 173.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.508 HG11 HG22 ' A' ' 227' ' ' THR . 69.5 t -65.45 105.42 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 CA-C-O 121.231 0.539 . . . . 75.13 110.168 177.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 15.3 mmt85 -103.17 106.75 17.33 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 108.043 -1.095 . . . . 62.11 108.043 172.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.48 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 15.3 mt -74.42 119.55 22.03 Favored 'Isoleucine or valine' 0 C--N 1.352 0.716 0 N-CA-C 109.265 -0.643 . . . . 64.04 109.265 179.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 23.5 p . . . . . 0 C--O 1.252 1.206 0 C-N-CA 124.736 1.214 . . . . 75.42 109.213 -176.141 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 23.7 mmt . . . . . 0 N--CA 1.479 1.024 0 N-CA-C 109.089 -0.708 . . . . 74.11 109.089 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -75.63 77.11 2.62 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 121.682 0.754 . . . . 61.02 109.923 177.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -60.6 -50.64 72.71 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 115.146 -0.934 . . . . 75.23 110.233 -178.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.466 HG21 ' HB3' ' A' ' 234' ' ' ARG . 25.6 m -98.13 167.86 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-N 115.083 -0.962 . . . . 72.23 110.468 175.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 16.8 tt -89.11 149.59 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.004 0 N-CA-C 108.953 -0.758 . . . . 72.11 108.953 171.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -60.56 142.44 55.4 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.77 1.228 . . . . 72.33 112.377 -175.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.514 ' HB2' HD22 ' A' ' 233' ' ' LEU . . . -159.94 155.45 25.55 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.805 1.242 . . . . 70.32 109.092 174.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -149.98 119.77 7.08 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 123.48 0.712 . . . . 75.34 110.013 177.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.557 ' HE1' ' HB3' ' A' ' 238' ' ' LYS . 17.7 p90 -93.11 164.76 13.14 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 109.451 -0.574 . . . . 75.15 109.451 174.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 46.3 mttm -138.9 143.83 38.96 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 123.519 0.728 . . . . 70.52 109.507 172.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -56.71 108.91 0.38 Allowed 'Trans proline' 0 C--N 1.382 2.312 0 C-N-CA 123.742 2.961 . . . . 61.42 112.984 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . 0.653 ' HB2' ' HG3' ' A' ' 220' ' ' GLU . . . -88.51 -19.15 26.79 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.131 0.572 . . . . 54.42 110.049 174.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -64.73 -41.92 95.59 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.338 1.055 . . . . 74.52 110.173 174.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 148.11 -54.24 0.52 Allowed Glycine 0 C--N 1.342 0.878 0 CA-C-N 115.504 -0.771 . . . . 52.24 111.535 178.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 68.3 m -149.51 106.59 3.58 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.511 0.724 . . . . 72.41 110.317 -175.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -76.35 88.06 0.91 Allowed Glycine 0 C--N 1.347 1.18 0 N-CA-C 109.896 -1.282 . . . . 73.33 109.896 169.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -59.96 126.28 41.27 Favored Glycine 0 C--N 1.353 1.521 0 O-C-N 124.258 0.622 . . . . 25.2 113.316 -173.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 43.3 m -85.43 125.25 32.86 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 123.464 0.706 . . . . 52.31 110.4 179.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -94.15 -100.81 1.64 Allowed Glycine 0 C--N 1.34 0.78 0 N-CA-C 110.727 -0.949 . . . . 53.21 110.727 172.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . 0.484 ' HA2' ' HD2' ' A' ' 243' ' ' PRO . . . -161.8 -50.65 0.02 OUTLIER Glycine 0 C--N 1.335 0.525 0 N-CA-C 110.099 -1.201 . . . . 73.51 110.099 177.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 14.3 t -156.49 -161.99 1.2 Allowed 'General case' 0 CA--C 1.554 1.112 0 N-CA-C 107.606 -1.257 . . . . 71.52 107.606 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -179.1 -173.66 44.57 Favored Glycine 0 C--N 1.352 1.462 0 CA-C-N 118.561 0.619 . . . . 73.53 113.752 177.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -68.69 -29.08 72.74 Favored Glycine 0 C--N 1.349 1.269 0 N-CA-C 112.087 -0.405 . . . . 54.32 112.087 172.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 23.1 m -144.51 108.9 4.83 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.735 1.214 . . . . 74.1 108.125 175.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 23.4 mp0 -75.74 -40.91 54.65 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 121.799 0.809 . . . . 74.24 109.039 176.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 19.2 p-10 -94.63 147.95 22.77 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 114.727 -1.124 . . . . 71.11 110.509 -178.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 95.6 mt -126.26 157.78 37.42 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.638 1.175 . . . . 73.0 109.667 178.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -135.31 122.95 22.2 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.911 0.884 . . . . 70.23 108.676 176.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -152.67 171.22 18.52 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.005 0.922 . . . . 73.42 109.711 178.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . 0.461 HG22 ' HB2' ' A' ' 252' ' ' GLU . 11.7 p -97.96 146.31 25.61 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.335 0.654 . . . . 71.12 109.944 173.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.561 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . 39.1 tp -114.45 111.28 21.16 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.19 0.996 . . . . 71.22 109.112 178.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -87.28 101.41 13.5 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.135 0.493 . . . . 75.01 109.899 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.481 ' HA ' HG11 ' A' ' 210' ' ' VAL . 46.9 t -102.55 121.97 47.91 Favored Pre-proline 0 CA--C 1.542 0.655 0 C-N-CA 124.379 1.071 . . . . 63.14 108.904 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -56.03 142.34 85.66 Favored 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 122.809 2.339 . . . . 65.23 111.602 170.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.467 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -49.48 -49.4 71.82 Favored Pre-proline 0 CA--C 1.56 1.329 0 CA-C-O 118.045 -0.979 . . . . 64.31 113.496 -179.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -60.05 -40.1 64.23 Favored 'Trans proline' 0 C--N 1.394 2.973 0 C-N-CA 121.995 1.797 . . . . 63.42 112.87 178.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 34.7 mt -69.2 -33.26 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 C-N-CA 123.761 0.824 . . . . 62.21 110.6 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.63 -38.03 80.21 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.414 0.685 . . . . 72.53 111.437 178.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 201' ' ' ALA . 99.1 t -74.13 -55.84 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.415 0.686 . . . . 74.21 110.96 -178.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 11.5 m -81.42 -23.37 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 N-CA-C 112.171 0.434 . . . . 74.02 112.171 -171.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 88.16 134.7 4.74 Favored Glycine 0 C--N 1.347 1.16 0 N-CA-C 111.378 -0.689 . . . . 63.23 111.378 -173.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -173.13 -147.54 5.93 Favored Glycine 0 C--N 1.338 0.692 0 N-CA-C 111.644 -0.582 . . . . 71.24 111.644 -177.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -137.02 134.89 37.08 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.22 0.608 . . . . 71.11 110.15 177.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.481 HG11 ' HA ' ' A' ' 199' ' ' VAL . 29.5 m -121.96 147.31 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 123.251 0.62 . . . . 75.14 109.73 179.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -86.68 111.89 21.11 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 116.169 -0.469 . . . . 62.34 109.767 -173.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -99.98 157.68 16.37 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.249 1.02 . . . . 63.3 109.917 177.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 2.0 mmt -105.28 108.81 20.52 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 115.336 -0.847 . . . . 65.1 109.747 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 45.4 p -109.79 -177.72 3.34 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.849 0.859 . . . . 61.33 109.039 171.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 19.0 mt -72.28 -26.74 62.09 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.125 0.57 . . . . 70.24 110.452 -175.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 10.6 mp0 -80.0 -20.54 45.2 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.27 1.028 . . . . 64.23 110.397 -178.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 133.46 -154.5 21.28 Favored Glycine 0 C--N 1.351 1.396 0 CA-C-O 119.56 -0.578 . . . . 53.23 112.104 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -67.83 142.18 56.63 Favored 'Trans proline' 0 C--N 1.369 1.641 0 C-N-CA 122.829 2.353 . . . . 63.52 112.313 172.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.435 ' HA ' ' H ' ' A' ' 178' ' ' ALA . 30.0 m -139.61 147.82 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 124.007 0.923 . . . . 74.11 109.639 175.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.653 ' HG3' ' HB2' ' A' ' 178' ' ' ALA . 42.5 mt-10 -100.78 109.24 21.22 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.131 0.572 . . . . 72.35 109.672 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.414 ' HA ' ' HA ' ' A' ' 175' ' ' TYR . 47.9 t -94.53 122.61 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 123.82 0.848 . . . . 74.31 109.734 -175.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -69.72 99.96 1.42 Allowed 'General case' 0 C--N 1.35 0.62 0 O-C-N 123.952 0.783 . . . . 52.13 110.022 177.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.468 HG11 HG11 ' A' ' 199' ' ' VAL . 57.9 t -77.82 121.01 83.54 Favored Pre-proline 0 C--O 1.243 0.728 0 CA-C-N 114.558 -1.201 . . . . 71.32 108.849 173.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -61.5 157.13 42.91 Favored 'Trans proline' 0 CA--C 1.563 1.963 0 C-N-CA 122.25 1.967 . . . . 73.54 111.97 172.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -66.31 144.15 73.13 Favored 'Trans proline' 0 C--N 1.372 1.788 0 C-N-CA 122.251 1.967 . . . . 53.55 111.448 172.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 88.6 mtt180 69.12 32.24 3.77 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 125.126 1.37 . . . . 71.1 111.367 172.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.547 HG23 ' HD2' ' A' ' 231' ' ' ARG . 97.4 m -77.32 121.6 23.96 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.451 1.1 . . . . 74.11 110.325 174.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -95.18 163.3 13.34 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 109.603 -0.517 . . . . 74.11 109.603 178.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -70.69 118.84 13.99 Favored 'General case' 0 C--N 1.348 0.51 0 CA-C-N 115.469 -0.787 . . . . 72.21 108.925 170.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 115.01 -1.47 22.8 Favored Glycine 0 N--CA 1.464 0.544 0 CA-C-O 119.73 -0.483 . . . . 71.34 112.518 -172.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.547 ' HD2' HG23 ' A' ' 227' ' ' THR . 38.8 mtt180 -75.55 158.52 32.4 Favored 'General case' 0 C--N 1.358 0.958 0 CA-C-O 121.451 0.643 . . . . 62.13 110.289 168.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.437 ' HG3' HG12 ' A' ' 170' ' ' VAL . 23.0 pttm -124.7 129.19 50.02 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.653 1.181 . . . . 74.22 108.731 -177.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.514 HD22 ' HB2' ' A' ' 173' ' ' ALA . 87.6 mt -117.91 104.16 10.65 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.966 0.907 . . . . 70.13 108.905 -178.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . 0.466 ' HB3' HG21 ' A' ' 170' ' ' VAL . 41.8 ttm180 -97.01 100.43 11.93 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 107.254 -1.388 . . . . 73.34 107.254 175.267 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 20.8 mt -73.4 84.22 1.46 Allowed 'General case' 0 C--O 1.24 0.555 0 N-CA-C 107.185 -1.413 . . . . 74.24 107.185 173.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 6.6 mtpm? -73.53 132.34 42.75 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 115.199 -0.91 . . . . 74.14 110.328 -172.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 69.01 23.5 76.03 Favored Glycine 0 C--N 1.342 0.897 0 O-C-N 123.899 0.749 . . . . 75.13 112.431 -176.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.557 ' HB3' ' HE1' ' A' ' 175' ' ' TYR . 60.8 mmtt -138.72 17.7 2.69 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.995 1.318 . . . . 73.13 111.136 -170.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . 0.464 ' HA2' ' HB2' ' A' ' 249' ' ' LEU . . . -82.18 -89.48 0.65 Allowed Glycine 0 N--CA 1.471 0.984 0 N-CA-C 110.499 -1.04 . . . . 72.24 110.499 173.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -95.85 120.62 62.84 Favored Pre-proline 0 N--CA 1.47 0.557 0 N-CA-C 108.339 -0.985 . . . . 73.12 108.339 167.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -77.82 132.01 11.59 Favored 'Trans proline' 0 C--N 1.372 1.808 0 C-N-CA 122.417 2.078 . . . . 74.45 111.41 175.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 168.29 146.69 5.06 Favored Glycine 0 C--N 1.345 1.073 0 CA-C-O 119.228 -0.762 . . . . 44.01 112.688 177.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . 0.484 ' HD2' ' HA2' ' A' ' 186' ' ' GLY . 57.3 Cg_endo -68.98 -18.82 40.54 Favored 'Trans proline' 0 C--N 1.376 2.001 0 C-N-CA 123.635 2.89 . . . . 61.21 114.82 -173.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -81.26 -28.96 34.51 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 118.403 0.547 . . . . 64.42 111.134 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -179.34 105.94 0.2 Allowed Glycine 0 C--N 1.346 1.094 0 O-C-N 123.478 0.486 . . . . 72.01 112.205 -178.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 61.2 mtt-85 -86.8 122.55 30.84 Favored 'General case' 0 C--N 1.349 0.577 0 N-CA-C 108.012 -1.107 . . . . 72.2 108.012 173.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -83.41 -168.12 42.82 Favored Glycine 0 N--CA 1.469 0.866 0 O-C-N 123.661 0.601 . . . . 64.41 113.945 -176.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -120.29 126.5 50.73 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 108.674 -0.862 . . . . 65.45 108.674 177.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.464 ' HB2' ' HA2' ' A' ' 239' ' ' GLY . 46.3 tp -97.77 106.3 18.59 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 106.888 -1.523 . . . . 71.33 106.888 175.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -99.25 122.39 42.35 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.311 -0.859 . . . . 74.25 109.034 -170.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.561 ' HB3' ' HB2' ' A' ' 197' ' ' LEU . 65.0 mt -123.24 122.18 37.73 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.708 0.803 . . . . 61.31 110.157 -172.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . 0.461 ' HB2' HG22 ' A' ' 196' ' ' THR . 28.2 mm-40 -90.71 109.67 20.85 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.836 0.854 . . . . 74.0 109.686 178.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.542 HG11 HG22 ' A' ' 227' ' ' THR . 84.4 t -63.48 113.74 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 CA-C-O 121.424 0.631 . . . . 63.41 111.409 -176.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 28.1 mmm180 -114.21 105.27 12.97 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.72 1.608 . . . . 75.35 108.02 173.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.405 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 39.8 mt -76.95 128.59 37.87 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 N-CA-C 110.0 -0.37 . . . . 52.44 110.0 178.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 19.2 p . . . . . 0 C--O 1.248 1.015 0 C-N-CA 124.793 1.237 . . . . 51.12 108.79 -176.735 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 25.8 ptt? . . . . . 0 N--CA 1.488 1.439 0 CA-C-O 119.61 -0.233 . . . . 71.44 111.592 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 32.6 t70 55.07 79.07 0.16 Allowed 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 124.854 1.262 . . . . 62.43 109.558 -172.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -62.81 -72.29 0.14 Allowed 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.119 -0.946 . . . . 73.54 111.878 -167.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.491 HG21 ' HB3' ' A' ' 234' ' ' ARG . 25.4 m -85.43 171.96 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 O-C-N 123.755 0.659 . . . . 72.44 110.749 -179.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.431 HG21 ' HD3' ' A' ' 231' ' ' ARG . 15.7 tt -93.05 145.69 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 N-CA-C 109.334 -0.617 . . . . 72.23 109.334 173.326 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -60.13 129.02 39.66 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.92 1.288 . . . . 73.53 111.329 -177.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.487 ' HB2' HD22 ' A' ' 233' ' ' LEU . . . -152.18 163.06 40.17 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 124.624 1.169 . . . . 61.43 109.219 175.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -149.17 176.68 10.29 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 108.56 -0.904 . . . . 64.2 108.56 173.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.429 ' CE1' ' HB3' ' A' ' 238' ' ' LYS . 22.8 p90 -144.07 177.23 8.72 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 118.029 0.377 . . . . 74.21 111.244 175.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -136.88 131.1 17.9 Favored Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 124.031 0.933 . . . . 74.04 109.52 176.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . 0.511 ' HA ' HG12 ' A' ' 219' ' ' VAL . 44.1 Cg_endo -66.07 95.39 0.3 Allowed 'Trans proline' 0 C--N 1.369 1.637 0 C-N-CA 122.927 2.418 . . . . 65.3 111.548 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . 0.586 ' HB2' ' HG3' ' A' ' 220' ' ' GLU . . . -63.84 -37.21 86.53 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.1 0.96 . . . . 64.35 111.561 -176.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.429 ' HB2' ' HG2' ' A' ' 218' ' ' PRO . 29.0 t70 -95.95 101.35 13.01 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 109.39 -0.596 . . . . 62.1 109.39 176.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 58.82 -99.25 0.12 Allowed Glycine 0 C--N 1.351 1.389 0 O-C-N 124.469 1.106 . . . . 71.21 113.003 177.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 57.8 p -157.68 152.62 25.51 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 124.206 1.003 . . . . 75.2 108.983 179.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -74.07 135.51 20.15 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 111.059 -0.816 . . . . 72.5 111.059 171.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 176.39 35.63 0.05 OUTLIER Glycine 0 C--N 1.337 0.624 0 CA-C-O 120.199 -0.223 . . . . 63.43 112.595 179.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 42.5 t -69.97 109.61 4.61 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 109.737 -0.468 . . . . 71.45 109.737 179.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -74.38 73.88 1.32 Allowed Glycine 0 C--N 1.346 1.124 0 O-C-N 123.728 0.642 . . . . 52.0 112.707 -179.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . 0.465 ' HA3' ' HE2' ' A' ' 240' ' ' PHE . . . -102.85 150.31 17.84 Favored Glycine 0 C--N 1.342 0.89 0 N-CA-C 111.593 -0.603 . . . . 62.34 111.593 176.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 33.7 t -145.71 30.28 1.09 Allowed 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 123.538 0.735 . . . . 74.32 110.008 -177.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -89.59 13.2 64.69 Favored Glycine 0 C--N 1.352 1.439 0 CA-C-N 116.152 -0.476 . . . . 61.12 113.844 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 95.07 -23.9 31.14 Favored Glycine 0 C--N 1.352 1.442 0 CA-C-N 117.325 0.563 . . . . 64.31 113.233 178.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 15.2 m -73.85 89.24 1.84 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.332 0.653 . . . . 64.13 110.815 -178.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -92.91 -33.01 14.36 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 109.073 -0.714 . . . . 64.21 109.073 172.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.44 ' HA ' ' O ' ' A' ' 248' ' ' ASP . 1.2 p30 -102.61 129.39 49.17 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.292 -0.867 . . . . 63.24 109.443 175.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 68.4 mt -109.18 135.35 50.44 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 108.174 -1.047 . . . . 72.1 108.174 177.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -120.23 121.9 39.74 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 108.227 -1.027 . . . . 72.55 108.227 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -154.29 166.35 33.45 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 123.358 0.663 . . . . 40.03 110.56 -173.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 4.9 m -102.24 145.12 29.89 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 109.185 -0.672 . . . . 62.33 109.185 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.529 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . 43.0 tp -119.75 121.72 39.81 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.476 0.71 . . . . 72.14 110.183 -172.231 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -83.77 115.24 22.12 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 109.349 -0.612 . . . . 75.1 109.349 173.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.532 ' HA ' HG11 ' A' ' 210' ' ' VAL . 98.1 t -119.26 110.44 37.72 Favored Pre-proline 0 CA--C 1.537 0.478 0 C-N-CA 123.98 0.912 . . . . 75.33 109.0 177.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -54.73 141.66 75.34 Favored 'Trans proline' 0 C--N 1.37 1.697 0 C-N-CA 122.755 2.303 . . . . 70.4 112.184 171.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.406 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -48.48 -47.78 68.72 Favored Pre-proline 0 CA--C 1.563 1.447 0 CA-C-O 117.784 -1.103 . . . . 74.11 113.426 177.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.406 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 15.7 Cg_endo -54.79 -46.33 34.14 Favored 'Trans proline' 0 C--N 1.398 3.163 0 C-N-CA 122.3 2.0 . . . . 72.22 112.787 175.214 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.419 HG21 HG13 ' A' ' 210' ' ' VAL . 43.9 mt -68.74 -32.35 54.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 123.768 0.827 . . . . 74.5 111.115 -176.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -65.61 -44.9 85.1 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.251 0.62 . . . . 64.51 110.829 178.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 201' ' ' ALA . 60.3 t -71.35 -52.3 27.67 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-N 115.82 -0.627 . . . . 74.43 110.909 -178.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 14.6 m -71.49 -25.85 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 N-CA-C 111.958 0.355 . . . . 70.51 111.958 -176.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 74.15 74.5 0.84 Allowed Glycine 0 C--N 1.341 0.833 0 N-CA-C 111.674 -0.57 . . . . 62.45 111.674 -174.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -118.88 -164.16 12.72 Favored Glycine 0 N--CA 1.472 1.08 0 N-CA-C 111.75 -0.54 . . . . 34.44 111.75 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -103.16 142.46 34.11 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 117.434 0.617 . . . . 74.32 110.317 -179.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.532 HG11 ' HA ' ' A' ' 199' ' ' VAL . 22.5 m -120.73 147.15 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 124.672 1.189 . . . . 65.22 109.077 175.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 19.3 ttm180 -90.46 109.55 20.67 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 122.024 -0.423 . . . . 72.4 110.034 -178.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -100.25 158.63 15.73 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.689 1.196 . . . . 71.43 110.803 -175.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 2.0 mmt -105.87 108.63 20.25 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.636 0.774 . . . . 75.32 110.437 -178.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 68.7 p -111.32 175.41 5.43 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 109.434 -0.58 . . . . 75.23 109.434 170.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 19.3 mt -70.61 -17.82 62.88 Favored 'General case' 0 CA--C 1.55 0.978 0 CA-C-N 115.761 -0.654 . . . . 64.02 110.468 178.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -92.44 -0.32 57.37 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.868 1.267 . . . . 71.31 110.993 178.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 108.89 -161.76 13.07 Favored Glycine 0 C--N 1.349 1.264 0 C-N-CA 123.594 0.616 . . . . 74.14 113.281 175.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . 0.429 ' HG2' ' HB2' ' A' ' 179' ' ' ASP . 59.8 Cg_endo -72.46 132.16 18.66 Favored 'Trans proline' 0 C--N 1.363 1.313 0 C-N-CA 122.719 2.28 . . . . 74.43 112.864 178.398 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.511 HG12 ' HA ' ' A' ' 177' ' ' PRO . 34.2 m -130.13 160.24 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 124.344 1.058 . . . . 73.12 109.214 177.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.586 ' HG3' ' HB2' ' A' ' 178' ' ' ALA . 46.1 mt-10 -109.26 108.27 18.81 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.461 0.704 . . . . 73.2 110.297 178.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 72.9 t -92.69 116.13 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 123.363 0.665 . . . . 52.31 109.591 -176.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -66.57 100.45 0.67 Allowed 'General case' 0 CA--C 1.543 0.706 0 O-C-N 124.022 0.827 . . . . 52.11 109.647 174.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 61.1 t -75.16 131.11 78.98 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 124.944 1.297 . . . . 53.3 109.071 176.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . 0.41 ' HA ' ' HD3' ' A' ' 225' ' ' PRO . 18.4 Cg_endo -59.89 152.56 63.34 Favored 'Trans proline' 0 CA--C 1.565 2.055 0 C-N-CA 122.318 2.012 . . . . 73.43 112.76 173.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 224' ' ' PRO . 29.6 Cg_exo -65.49 146.44 85.06 Favored 'Trans proline' 0 C--N 1.371 1.738 0 C-N-CA 122.453 2.102 . . . . 72.33 112.88 175.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 35.1 mtp180 65.29 23.34 12.13 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 125.009 1.323 . . . . 75.04 112.207 174.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.528 HG23 ' HD2' ' A' ' 231' ' ' ARG . 4.1 m -54.81 139.13 40.75 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.612 1.165 . . . . 72.41 112.397 179.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -102.94 158.34 16.35 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.868 0.867 . . . . 63.54 109.816 175.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -73.83 131.26 41.33 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 108.893 -0.781 . . . . 72.13 108.893 172.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 100.2 2.22 55.81 Favored Glycine 0 N--CA 1.464 0.528 0 CA-C-O 119.197 -0.78 . . . . 71.14 112.385 -172.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.528 ' HD2' HG23 ' A' ' 227' ' ' THR . 60.5 mtt-85 -69.18 159.34 33.17 Favored 'General case' 0 C--N 1.359 1.021 0 CA-C-O 121.457 0.646 . . . . 73.03 110.338 172.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 48.9 pttt -130.86 132.93 45.48 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 114.927 -1.033 . . . . 73.12 109.727 -175.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.487 HD22 ' HB2' ' A' ' 173' ' ' ALA . 37.3 mt -121.47 127.3 50.94 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 108.213 -1.032 . . . . 65.41 108.213 178.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . 0.491 ' HB3' HG21 ' A' ' 170' ' ' VAL . 31.4 ttt180 -116.83 102.78 9.68 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 107.797 -1.186 . . . . 71.24 107.797 170.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.444 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 16.3 mt -83.52 84.58 7.48 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 114.948 -1.024 . . . . 75.24 109.279 -176.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -71.09 137.1 48.62 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.143 -0.935 . . . . 73.4 110.86 -178.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 67.39 16.56 67.41 Favored Glycine 0 C--N 1.352 1.425 0 O-C-N 123.987 0.804 . . . . 61.54 112.567 -177.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.429 ' HB3' ' CE1' ' A' ' 175' ' ' TYR . 31.3 mmtp -139.96 23.37 2.42 Favored 'General case' 0 C--O 1.217 -0.64 0 C-N-CA 124.54 1.136 . . . . 74.34 109.861 -175.297 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -89.37 -127.25 3.08 Favored Glycine 0 N--CA 1.468 0.829 0 O-C-N 121.869 -0.519 . . . . 54.0 111.899 171.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . 0.465 ' HE2' ' HA3' ' A' ' 186' ' ' GLY . 0.1 OUTLIER -80.52 147.06 62.65 Favored Pre-proline 0 N--CA 1.476 0.863 0 CA-C-O 118.326 -0.845 . . . . 71.43 110.434 176.491 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.503 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 86.2 Cg_exo -46.08 140.72 10.25 Favored 'Trans proline' 0 C--N 1.392 2.856 0 C-N-CA 123.837 3.025 . . . . 61.52 114.409 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -157.26 129.37 2.36 Favored Glycine 0 CA--C 1.536 1.353 0 CA-C-O 118.5 -1.167 . . . . 61.15 111.459 -179.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -62.47 -45.45 14.6 Favored 'Trans proline' 0 C--N 1.378 2.089 0 C-N-CA 123.137 2.558 . . . . 75.44 113.869 -178.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -78.21 -28.19 47.96 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-O 121.146 0.498 . . . . 22.15 110.461 177.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 169.52 145.92 4.85 Favored Glycine 0 C--N 1.334 0.471 0 CA-C-N 115.13 -0.941 . . . . 75.02 110.854 176.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.503 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 23.9 mtt180 -69.46 156.08 39.44 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.3 0.64 . . . . 75.34 110.665 177.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -73.13 -155.96 3.39 Favored Glycine 0 C--N 1.348 1.196 0 CA-C-N 116.076 -0.511 . . . . 65.11 113.218 178.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . 0.44 ' O ' ' HA ' ' A' ' 192' ' ' ASP . 21.6 m-20 -106.99 148.63 28.45 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.551 0.74 . . . . 61.24 110.479 179.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.444 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 50.0 tp -125.23 105.12 8.89 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 107.663 -1.236 . . . . 74.14 107.663 169.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -96.96 109.09 21.91 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 123.637 0.775 . . . . 73.11 109.527 -174.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.529 ' HB3' ' HB2' ' A' ' 197' ' ' LEU . 71.8 mt -112.84 116.36 29.93 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.119 0.968 . . . . 71.22 109.918 -178.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -86.64 113.64 22.68 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.644 0.778 . . . . 73.34 110.192 177.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.402 HG11 ' CG2' ' A' ' 227' ' ' THR . 97.0 t -65.68 125.0 21.84 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.218 0 C-N-CA 123.801 0.84 . . . . 62.32 112.314 -177.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 26.3 mmm180 -118.34 108.38 15.01 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.428 1.491 . . . . 74.25 107.905 170.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.491 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 34.6 mt -76.78 119.16 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 109.696 -0.483 . . . . 70.32 109.696 177.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 36.0 p . . . . . 0 CA--C 1.551 0.999 0 C-N-CA 124.437 1.095 . . . . 74.12 108.903 178.924 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 15.5 tpt . . . . . 0 N--CA 1.481 1.086 0 N-CA-C 109.396 -0.594 . . . . 71.32 109.396 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -113.77 108.2 16.77 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.778 0.831 . . . . 74.41 109.84 -179.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -72.29 -51.89 18.77 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 121.772 0.796 . . . . 72.51 109.453 170.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.426 HG21 ' N ' ' A' ' 234' ' ' ARG . 27.1 m -107.28 -176.98 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-N 114.206 -1.361 . . . . 62.24 109.458 179.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 13.2 tt -84.83 139.77 17.0 Favored 'Isoleucine or valine' 0 C--O 1.246 0.891 0 N-CA-C 108.036 -1.098 . . . . 75.43 108.036 164.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -70.59 135.13 48.23 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 122.831 0.452 . . . . 75.23 110.065 177.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.452 ' HB2' HD22 ' A' ' 233' ' ' LEU . . . -138.98 175.37 9.61 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.062 0.945 . . . . 74.32 109.207 177.073 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -150.98 158.98 44.82 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 122.79 0.436 . . . . 64.22 110.337 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.532 ' HD1' HD13 ' A' ' 235' ' ' LEU . 9.8 p90 -140.63 176.12 9.05 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.346 0.593 . . . . 73.15 110.548 170.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -145.48 149.26 40.09 Favored Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 124.586 1.154 . . . . 71.21 108.614 170.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . 0.519 ' HA ' HG12 ' A' ' 219' ' ' VAL . 27.5 Cg_endo -58.24 123.79 14.42 Favored 'Trans proline' 0 C--N 1.373 1.85 0 C-N-CA 123.009 2.473 . . . . 73.21 111.99 -179.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . 0.579 ' HB2' ' HG3' ' A' ' 220' ' ' GLU . . . -88.22 55.29 3.37 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 108.177 -1.046 . . . . 70.12 108.177 172.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 32.9 t70 60.83 91.25 0.06 Allowed 'General case' 0 C--N 1.356 0.885 0 C-N-CA 124.91 1.284 . . . . 71.43 110.448 -168.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 161.31 103.58 0.18 Allowed Glycine 0 C--N 1.342 0.879 0 CA-C-N 116.048 -0.523 . . . . 42.23 112.118 -179.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . 0.5 ' HA ' ' HB3' ' A' ' 216' ' ' GLU . 65.5 m -147.92 142.12 26.13 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.903 0.881 . . . . 64.51 110.115 175.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -156.84 -143.78 3.75 Favored Glycine 0 C--N 1.339 0.732 0 N-CA-C 110.48 -1.048 . . . . 55.51 110.48 -179.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 83.95 -66.99 3.8 Favored Glycine 0 C--N 1.342 0.917 0 CA-C-N 117.165 0.483 . . . . 63.22 114.061 172.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 24.9 m 77.79 -41.3 0.34 Allowed 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 125.944 1.698 . . . . 70.55 111.457 -172.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -166.07 -158.2 10.74 Favored Glycine 0 C--N 1.344 0.982 0 N-CA-C 111.521 -0.631 . . . . 50.03 111.521 172.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -166.82 23.49 0.12 Allowed Glycine 0 C--N 1.347 1.154 0 CA-C-N 116.872 0.336 . . . . 53.34 112.964 176.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 32.1 t -69.49 123.99 22.72 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.579 0.751 . . . . 53.3 110.658 -178.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 102.85 12.17 32.88 Favored Glycine 0 C--N 1.346 1.115 0 CA-C-N 116.357 -0.383 . . . . 54.22 112.505 -172.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -161.71 -179.31 36.31 Favored Glycine 0 C--N 1.344 0.983 0 N-CA-C 112.114 -0.394 . . . . 62.13 112.114 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 45.5 m -77.08 97.05 4.59 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 122.73 0.412 . . . . 74.13 110.352 -178.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.415 ' HA ' ' HB2' ' A' ' 240' ' ' PHE . 53.5 mt-30 -66.6 -20.37 65.99 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.435 0.694 . . . . 73.13 111.08 173.096 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 20.1 p-10 -85.18 126.5 33.7 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.311 0.644 . . . . 73.3 109.773 171.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 34.5 mt -108.9 145.07 35.97 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.191 1.396 . . . . 52.32 108.875 177.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -123.73 121.75 36.3 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 107.797 -1.186 . . . . 73.4 107.797 175.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.426 ' O ' ' HA ' ' A' ' 251' ' ' LEU . . . -149.51 165.59 31.71 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.065 0.946 . . . . 74.31 109.527 -171.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 10.5 m -108.77 140.72 41.81 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 109.969 -0.382 . . . . 74.3 109.969 -177.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.476 HD11 HG23 ' A' ' 210' ' ' VAL . 43.1 tp -108.79 121.52 45.24 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.748 0.819 . . . . 65.21 110.036 -176.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -93.11 103.02 15.35 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 109.161 -0.681 . . . . 62.43 109.161 172.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.56 HG21 HG11 ' A' ' 223' ' ' VAL . 2.7 p -106.57 119.52 51.4 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 123.676 0.791 . . . . 74.3 109.53 173.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -55.47 140.88 83.15 Favored 'Trans proline' 0 C--N 1.375 1.922 0 C-N-CA 122.331 2.021 . . . . 54.4 112.486 169.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.405 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -51.71 -49.17 84.72 Favored Pre-proline 0 CA--C 1.554 1.113 0 CA-C-O 118.077 -0.963 . . . . 73.55 113.451 -177.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -56.59 -39.83 88.62 Favored 'Trans proline' 0 C--N 1.39 2.724 0 C-N-CA 121.902 1.735 . . . . 54.35 112.877 176.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 28.4 mt -69.15 -34.28 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 123.259 0.624 . . . . 62.15 110.4 -178.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -66.33 -42.72 87.75 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.012 0.525 . . . . 72.0 111.073 178.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 201' ' ' ALA . 87.1 t -71.96 -49.51 44.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 123.682 0.793 . . . . 64.03 111.282 -176.24 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 16.2 m -75.01 -22.75 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 CA-C-N 116.668 -0.242 . . . . 70.45 111.496 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 76.4 76.05 0.84 Allowed Glycine 0 C--N 1.346 1.106 0 N-CA-C 112.179 -0.369 . . . . 61.52 112.179 -177.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -110.69 -159.18 16.42 Favored Glycine 0 C--N 1.339 0.706 0 N-CA-C 111.699 -0.561 . . . . 73.32 111.699 -179.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 33.7 mtmm -115.13 145.45 42.34 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 108.88 -0.785 . . . . 63.44 108.88 173.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.49 HG11 ' HA ' ' A' ' 199' ' ' VAL . 19.6 m -128.06 168.17 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 123.95 0.9 . . . . 73.11 109.829 177.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 35.4 mtp-105 -99.38 117.49 33.93 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 121.218 0.532 . . . . 73.44 110.498 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -101.02 128.09 47.22 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 107.633 -1.247 . . . . 24.45 107.633 171.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.25 112.1 23.06 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 109.158 -0.682 . . . . 75.41 109.158 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 69.3 p -110.39 -177.96 3.38 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.62 0.768 . . . . 65.31 109.823 177.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 17.4 mt -67.44 -23.48 65.53 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 122.488 0.315 . . . . 61.5 111.021 178.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . 0.5 ' HB3' ' HA ' ' A' ' 181' ' ' SER . 45.3 mt-10 -86.31 -19.14 30.3 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.748 0.819 . . . . 71.23 111.895 178.283 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 127.42 -151.77 18.56 Favored Glycine 0 C--N 1.345 1.043 0 CA-C-O 119.568 -0.573 . . . . 53.11 112.594 176.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.65 135.14 17.56 Favored 'Trans proline' 0 C--N 1.372 1.799 0 C-N-CA 122.7 2.267 . . . . 74.04 111.65 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.519 HG12 ' HA ' ' A' ' 177' ' ' PRO . 33.3 m -135.41 142.07 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 123.306 0.642 . . . . 73.03 109.813 175.349 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.579 ' HG3' ' HB2' ' A' ' 178' ' ' ALA . 43.2 mt-10 -90.49 106.74 18.7 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.028 0.531 . . . . 73.02 110.281 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.435 HG22 ' HB3' ' A' ' 175' ' ' TYR . 59.6 t -94.33 121.65 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 123.79 0.836 . . . . 60.45 109.423 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -71.19 107.95 4.46 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.257 0.623 . . . . 75.24 110.064 177.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.56 HG11 HG21 ' A' ' 199' ' ' VAL . 48.3 t -83.51 124.05 75.96 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 124.658 1.183 . . . . 75.05 108.897 175.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -58.97 152.49 57.97 Favored 'Trans proline' 0 CA--C 1.567 2.169 0 C-N-CA 122.675 2.25 . . . . 75.32 113.11 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -59.61 126.23 20.03 Favored 'Trans proline' 0 C--N 1.375 1.972 0 C-N-CA 122.511 2.141 . . . . 74.15 112.408 173.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 75.3 mtp180 65.52 61.58 0.69 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.97 1.308 . . . . 65.03 111.317 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.468 HG23 ' HD2' ' A' ' 231' ' ' ARG . 27.0 m -85.16 143.86 28.54 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.409 -0.814 . . . . 64.45 109.773 173.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -111.07 153.89 25.01 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.66 0.784 . . . . 74.35 110.863 179.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -70.46 135.82 48.98 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.576 0.75 . . . . 74.31 110.261 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.82 1.29 63.55 Favored Glycine 0 C--N 1.341 0.811 0 CA-C-O 119.689 -0.506 . . . . 71.31 113.174 -177.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.468 ' HD2' HG23 ' A' ' 227' ' ' THR . 52.4 mtt-85 -69.84 160.99 30.74 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 117.243 0.521 . . . . 63.42 110.551 171.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 20.9 pttm -126.98 135.06 50.34 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.864 -0.607 . . . . 73.51 110.603 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.452 HD22 ' HB2' ' A' ' 173' ' ' ALA . 74.4 mt -114.08 145.24 41.88 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.951 1.3 . . . . 63.4 108.173 175.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . 0.426 ' N ' HG21 ' A' ' 170' ' ' VAL . 51.7 ttt85 -136.53 102.18 4.86 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 107.952 -1.129 . . . . 74.52 107.952 166.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.532 HD13 ' HD1' ' A' ' 175' ' ' TYR . 14.8 mt -73.78 91.43 1.94 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.752 1.221 . . . . 63.32 109.433 179.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 51.9 mttp -62.29 124.74 21.7 Favored 'General case' 0 C--N 1.354 0.801 0 C-N-CA 123.437 0.695 . . . . 74.42 110.696 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 69.42 34.52 74.3 Favored Glycine 0 C--N 1.345 1.059 0 O-C-N 123.54 0.525 . . . . 51.34 113.061 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.487 ' HB3' ' CE1' ' A' ' 175' ' ' TYR . 32.8 mmtm -143.44 29.84 1.41 Allowed 'General case' 0 CA--C 1.559 1.321 0 C-N-CA 123.76 0.824 . . . . 74.4 112.616 -173.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -99.21 -111.05 3.15 Favored Glycine 0 N--CA 1.482 1.716 0 N-CA-C 111.134 -0.787 . . . . 52.12 111.134 175.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . 0.415 ' HB2' ' HA ' ' A' ' 191' ' ' GLN . 5.8 m-85 -71.19 151.88 94.57 Favored Pre-proline 0 N--CA 1.48 1.049 0 C-N-CA 123.728 0.811 . . . . 71.14 109.813 165.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.525 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 52.3 Cg_exo -57.3 155.68 28.86 Favored 'Trans proline' 0 C--N 1.373 1.838 0 C-N-CA 122.93 2.42 . . . . 54.42 112.418 165.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -162.76 125.03 1.35 Allowed Glycine 0 CA--C 1.535 1.296 0 CA-C-O 118.602 -1.11 . . . . 64.14 111.625 178.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -60.65 -49.01 9.58 Favored 'Trans proline' 0 C--N 1.381 2.237 0 C-N-CA 123.391 2.727 . . . . 74.43 112.644 177.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -76.31 -26.34 55.72 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 122.874 0.47 . . . . 64.52 110.692 178.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 165.01 145.17 4.31 Favored Glycine 0 C--N 1.344 1.005 0 CA-C-N 115.617 -0.72 . . . . 75.15 111.343 177.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.525 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 21.1 mtt180 -73.28 163.3 28.29 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.538 0.735 . . . . 73.1 111.127 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -81.55 -169.23 42.08 Favored Glycine 0 C--N 1.348 1.202 0 CA-C-N 115.824 -0.626 . . . . 74.45 111.768 170.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -107.37 152.1 24.62 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 118.003 0.902 . . . . 72.31 110.617 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 55.9 tp -120.92 106.7 11.87 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 108.706 -0.849 . . . . 61.04 108.706 173.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -91.37 123.66 34.97 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 123.806 0.843 . . . . 63.42 108.984 -177.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.426 ' HA ' ' O ' ' A' ' 195' ' ' ALA . 61.7 mt -119.53 122.37 41.48 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.374 0.67 . . . . 74.13 110.396 -176.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -81.07 114.0 19.63 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 108.975 -0.75 . . . . 71.11 108.975 172.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 88.4 t -66.92 109.52 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 122.905 0.482 . . . . 73.11 110.791 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 9.2 mmm180 -113.47 105.68 13.65 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 124.279 1.032 . . . . 73.21 108.848 173.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 28.9 mt -76.96 131.09 35.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-N 115.652 -0.703 . . . . 73.21 109.525 176.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 3.3 t . . . . . 0 CA--C 1.562 1.414 0 CA-C-O 117.849 -1.072 . . . . 62.45 108.763 -178.231 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 24.8 mmt . . . . . 0 N--CA 1.473 0.703 0 CA-C-O 121.198 0.523 . . . . 64.14 109.762 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -86.2 77.26 9.6 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 122.134 0.969 . . . . 73.34 109.159 175.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -70.33 -49.85 45.2 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 114.396 -1.274 . . . . 70.44 111.045 -178.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.498 HG11 ' HB2' ' A' ' 234' ' ' ARG . 26.2 m -93.37 177.19 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 C-N-CA 123.061 0.545 . . . . 65.2 110.637 175.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.405 HG21 ' HD3' ' A' ' 231' ' ' ARG . 13.8 tt -103.17 147.59 9.37 Favored 'Isoleucine or valine' 0 C--O 1.245 0.863 0 N-CA-C 108.418 -0.956 . . . . 72.34 108.418 173.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -64.31 142.83 58.28 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.654 0.782 . . . . 52.44 110.656 -178.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.529 ' HB2' HD22 ' A' ' 233' ' ' LEU . . . -160.0 164.48 33.23 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 123.82 0.848 . . . . 53.45 109.616 -178.264 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -157.25 157.67 34.71 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.703 0.801 . . . . 73.02 109.665 -178.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.489 ' HD1' HD13 ' A' ' 235' ' ' LEU . 5.5 p90 -135.97 178.01 7.38 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.232 0.539 . . . . 75.53 111.537 177.124 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.555 ' HE2' ' HA ' ' A' ' 176' ' ' LYS . 7.9 mmpt? -132.7 135.31 25.87 Favored Pre-proline 0 N--CA 1.472 0.632 0 C-N-CA 124.691 1.197 . . . . 73.22 108.924 174.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . 0.519 ' HA ' HG12 ' A' ' 219' ' ' VAL . 48.1 Cg_endo -65.86 94.96 0.28 Allowed 'Trans proline' 0 C--N 1.377 2.05 0 C-N-CA 122.74 2.294 . . . . 72.02 111.127 178.037 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . 0.58 ' H ' ' HA ' ' A' ' 219' ' ' VAL . . . -67.28 -21.79 65.68 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.371 1.068 . . . . 74.11 111.543 -177.111 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.48 ' HB2' ' HD2' ' A' ' 218' ' ' PRO . 15.2 t70 -63.83 -46.51 84.74 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.629 0.772 . . . . 72.02 110.014 170.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 115.54 -40.79 2.32 Favored Glycine 0 C--N 1.341 0.847 0 CA-C-N 114.883 -1.053 . . . . 63.22 111.107 -174.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 32.3 p -123.86 142.42 51.14 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.018 0.927 . . . . 74.11 109.345 179.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -150.19 108.94 0.41 Allowed Glycine 0 C--N 1.344 0.982 0 N-CA-C 111.439 -0.664 . . . . 75.32 111.439 -177.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -168.85 66.34 0.18 Allowed Glycine 0 C--N 1.349 1.262 0 CA-C-N 116.756 0.278 . . . . 60.03 112.752 -177.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.411 ' H ' ' HG3' ' A' ' 241' ' ' PRO . 47.0 m -66.48 151.16 47.8 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.687 0.795 . . . . 65.25 110.864 171.186 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -69.95 130.68 22.5 Favored Glycine 0 CA--C 1.529 0.961 0 N-CA-C 110.968 -0.853 . . . . 55.23 110.968 176.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -66.6 100.89 0.58 Allowed Glycine 0 C--N 1.349 1.274 0 N-CA-C 111.732 -0.547 . . . . 62.13 111.732 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 20.2 m -55.49 -60.22 3.72 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.666 1.187 . . . . 72.12 112.276 -176.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -179.61 -130.74 1.51 Allowed Glycine 0 N--CA 1.463 0.458 0 N-CA-C 111.03 -0.828 . . . . 65.54 111.03 -178.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -81.9 61.48 4.66 Favored Glycine 0 C--N 1.344 1.023 0 N-CA-C 112.165 -0.374 . . . . 64.13 112.165 176.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 60.8 m -147.21 48.43 1.12 Allowed 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.616 1.166 . . . . 41.11 108.579 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -65.97 -24.28 66.76 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 115.239 -0.891 . . . . 61.44 111.155 178.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.407 ' HA ' ' O ' ' A' ' 248' ' ' ASP . 6.7 p-10 -91.19 151.28 21.01 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 115.673 -0.694 . . . . 73.23 109.901 175.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 79.7 mt -132.76 130.79 40.39 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.792 0.837 . . . . 71.34 109.084 173.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -96.71 125.48 41.21 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 108.337 -0.986 . . . . 74.55 108.337 174.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.458 ' O ' ' HA ' ' A' ' 251' ' ' LEU . . . -148.63 143.23 26.41 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.408 0.683 . . . . 74.25 109.336 178.026 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 2.4 p -89.92 132.36 35.35 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 109.079 -0.712 . . . . 71.52 109.079 171.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.575 HD13 ' HB2' ' A' ' 212' ' ' ALA . 62.3 tp -107.3 110.96 23.1 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.81 0.844 . . . . 74.44 108.972 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -85.08 128.46 34.66 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-O 120.962 0.411 . . . . 75.21 109.918 175.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.514 ' HA ' HG11 ' A' ' 210' ' ' VAL . 3.1 p -133.29 123.67 17.85 Favored Pre-proline 0 CA--C 1.545 0.773 0 CA-C-N 114.775 -1.102 . . . . 71.13 108.954 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -57.61 143.15 95.51 Favored 'Trans proline' 0 C--N 1.37 1.662 0 C-N-CA 122.585 2.19 . . . . 71.55 111.653 171.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.431 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -50.42 -46.45 84.39 Favored Pre-proline 0 CA--C 1.563 1.443 0 CA-C-O 117.782 -1.104 . . . . 70.15 112.993 -178.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -55.51 -44.62 46.67 Favored 'Trans proline' 0 C--N 1.395 2.977 0 C-N-CA 122.3 2.0 . . . . 74.22 113.088 174.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.473 HG21 HG13 ' A' ' 210' ' ' VAL . 45.4 mt -68.4 -32.03 53.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 C-N-CA 123.467 0.707 . . . . 61.21 110.598 -178.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.42 -44.02 75.91 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.224 0.61 . . . . 74.35 110.957 178.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 201' ' ' ALA . 93.1 t -70.43 -48.19 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 123.532 0.733 . . . . 72.0 111.217 -177.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 7.2 p -72.47 -30.37 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 CA-C-O 120.601 0.239 . . . . 74.32 110.998 -179.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 78.76 67.57 1.59 Allowed Glycine 0 C--N 1.352 1.423 0 N-CA-C 111.637 -0.585 . . . . 43.02 111.637 -174.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -98.95 -145.71 19.1 Favored Glycine 0 C--N 1.352 1.444 0 N-CA-C 111.449 -0.66 . . . . 74.31 111.449 -177.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -120.73 146.68 46.22 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.561 0.745 . . . . 63.32 109.078 173.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.514 HG11 ' HA ' ' A' ' 199' ' ' VAL . 7.1 m -139.9 155.36 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 C-N-CA 124.679 1.192 . . . . 53.44 109.211 171.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 14.7 ttp180 -91.22 119.55 31.4 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-O 120.805 0.336 . . . . 72.11 111.126 -170.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.575 ' HB2' HD13 ' A' ' 197' ' ' LEU . . . -100.53 151.78 21.17 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.969 0.907 . . . . 43.31 108.951 172.146 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -107.15 116.46 31.97 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 123.599 0.76 . . . . 73.24 110.222 -178.052 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 24.6 p -109.72 172.24 6.97 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.21 1.004 . . . . 72.41 108.631 172.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 17.5 mt -74.02 -5.9 44.22 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 122.819 0.448 . . . . 62.32 111.958 -176.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . 0.409 ' H ' ' HG2' ' A' ' 216' ' ' GLU . 6.2 pt-20 -107.16 -9.64 16.09 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.756 1.223 . . . . 75.23 111.349 -177.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 139.65 -165.92 25.72 Favored Glycine 0 C--N 1.352 1.439 0 CA-C-O 120.151 -0.25 . . . . 34.32 113.526 175.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . 0.48 ' HD2' ' HB2' ' A' ' 179' ' ' ASP . 71.7 Cg_endo -76.66 142.65 23.22 Favored 'Trans proline' 0 C--N 1.369 1.627 0 C-N-CA 123.225 2.617 . . . . 75.25 112.466 176.02 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.58 ' HA ' ' H ' ' A' ' 178' ' ' ALA . 24.8 m -137.29 143.58 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 123.849 0.86 . . . . 73.45 109.733 176.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.407 ' HG3' ' HB2' ' A' ' 178' ' ' ALA . 46.4 mt-10 -97.3 114.65 26.45 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 118.27 0.487 . . . . 74.54 109.78 175.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.446 HG22 ' HB3' ' A' ' 175' ' ' TYR . 52.9 t -95.47 126.02 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.277 1.031 . . . . 71.31 109.679 179.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -75.46 106.3 6.94 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 123.315 0.646 . . . . 53.34 109.397 175.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 44.9 t -68.39 132.09 91.53 Favored Pre-proline 0 CA--C 1.552 1.028 0 C-N-CA 124.417 1.087 . . . . 63.52 109.525 175.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -59.78 144.86 99.37 Favored 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 122.455 2.103 . . . . 63.23 111.853 173.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_exo -62.12 129.66 27.93 Favored 'Trans proline' 0 C--N 1.375 1.961 0 C-N-CA 122.667 2.245 . . . . 52.33 111.689 176.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 62.7 mtp180 67.33 79.18 0.23 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.247 1.419 . . . . 72.35 110.086 179.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.566 ' HA ' ' HE ' ' A' ' 231' ' ' ARG . 13.3 m -107.52 141.16 39.39 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 114.231 -1.35 . . . . 74.22 110.684 -177.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -118.11 147.23 43.5 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.356 1.062 . . . . 74.22 108.382 174.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -60.26 125.2 22.78 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.123 0.969 . . . . 72.33 110.571 -178.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 113.38 4.38 23.63 Favored Glycine 0 C--N 1.34 0.805 0 CA-C-O 119.537 -0.591 . . . . 74.43 113.12 -175.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.566 ' HE ' ' HA ' ' A' ' 227' ' ' THR . 72.4 mtt-85 -65.73 148.23 52.09 Favored 'General case' 0 C--N 1.363 1.162 0 N-CA-C 109.249 -0.649 . . . . 73.24 109.249 167.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 18.9 pttm -124.84 117.08 23.32 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.971 -1.122 . . . . 63.42 107.971 176.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.529 HD22 ' HB2' ' A' ' 173' ' ' ALA . 30.6 mt -103.89 97.42 7.42 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 108.066 -1.087 . . . . 71.03 108.066 -179.466 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . 0.498 ' HB2' HG11 ' A' ' 170' ' ' VAL . 40.6 ttt180 -93.54 101.13 13.3 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 108.823 -0.806 . . . . 75.23 108.823 177.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.492 ' HB3' ' HB2' ' A' ' 238' ' ' LYS . 21.8 mt -82.92 83.92 7.61 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.481 -1.236 . . . . 64.2 109.669 -174.133 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 55.4 mttp -62.75 137.63 58.31 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 116.098 -0.501 . . . . 60.42 110.082 177.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 64.59 23.66 68.93 Favored Glycine 0 C--N 1.347 1.151 0 O-C-N 123.679 0.612 . . . . 64.32 113.004 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.492 ' HB2' ' HB3' ' A' ' 235' ' ' LEU . 45.7 mmtm -140.51 16.86 2.37 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.308 1.043 . . . . 63.0 111.247 -176.201 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -93.47 -116.99 2.62 Favored Glycine 0 N--CA 1.467 0.741 0 N-CA-C 111.568 -0.613 . . . . 70.42 111.568 179.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -71.45 130.29 87.73 Favored Pre-proline 0 CA--C 1.546 0.817 0 CA-C-O 118.619 -0.705 . . . . 72.44 109.781 179.191 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.479 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 22.2 Cg_endo -60.41 129.16 28.58 Favored 'Trans proline' 0 C--N 1.373 1.824 0 C-N-CA 123.154 2.569 . . . . 71.5 112.533 175.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -150.81 135.44 5.16 Favored Glycine 0 CA--C 1.532 1.103 0 CA-C-O 118.651 -1.083 . . . . 71.44 110.557 179.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -61.73 -41.67 37.08 Favored 'Trans proline' 0 C--N 1.382 2.331 0 C-N-CA 123.54 2.827 . . . . 53.22 112.746 -176.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -78.01 -26.64 48.61 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.177 0.591 . . . . 73.24 111.258 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 169.24 148.11 5.69 Favored Glycine 0 C--N 1.347 1.172 0 N-CA-C 111.457 -0.657 . . . . 63.22 111.457 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.479 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 36.4 mtt-85 -86.45 161.37 18.66 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 122.769 0.428 . . . . 65.41 110.148 178.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -81.84 -155.86 15.99 Favored Glycine 0 C--N 1.34 0.785 0 CA-C-N 115.591 -0.732 . . . . 51.3 112.368 172.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . 0.407 ' O ' ' HA ' ' A' ' 192' ' ' ASP . 6.5 p-10 -118.45 131.53 56.26 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.442 0.697 . . . . 75.23 110.381 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 58.5 tp -98.16 106.89 19.24 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 107.76 -1.2 . . . . 53.43 107.76 173.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -89.3 108.58 19.7 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 115.496 -0.775 . . . . 74.32 109.053 -177.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.558 HD13 HD22 ' A' ' 197' ' ' LEU . 63.6 mt -103.13 139.35 38.76 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.79 0.836 . . . . 65.34 110.096 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -111.44 108.79 18.47 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.63 -0.878 . . . . 72.34 108.63 172.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 72.5 t -66.5 109.37 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 C-N-CA 123.922 0.889 . . . . 74.4 111.33 -178.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 31.5 mmm180 -108.52 102.95 11.99 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.381 1.472 . . . . 63.45 108.312 177.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 30.4 mt -77.14 142.78 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 N-CA-C 109.855 -0.424 . . . . 64.44 109.855 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.9 t . . . . . 0 CA--C 1.558 1.277 0 C-N-CA 124.092 0.957 . . . . 70.05 109.207 176.377 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . 0.417 ' SD ' ' N ' ' A' ' 167' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.096 0 N-CA-C 109.088 -0.708 . . . . 73.3 109.088 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -89.87 57.91 4.02 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-O 122.045 0.926 . . . . 70.02 109.365 177.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -56.69 -55.46 33.89 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 114.589 -1.187 . . . . 71.33 110.053 -179.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.492 HG21 ' HB3' ' A' ' 234' ' ' ARG . 15.4 m -97.41 161.7 2.78 Favored 'Isoleucine or valine' 0 C--O 1.247 0.942 0 CA-C-N 114.905 -1.043 . . . . 74.34 109.188 172.149 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 12.6 tt -85.63 151.96 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 N-CA-C 108.92 -0.771 . . . . 63.33 108.92 174.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -56.15 128.81 37.36 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.471 1.109 . . . . 74.33 110.961 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.466 ' HB2' HD22 ' A' ' 233' ' ' LEU . . . -158.66 143.95 16.37 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.258 1.023 . . . . 74.21 109.754 179.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -146.56 169.13 19.58 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 108.244 -1.021 . . . . 74.24 108.244 172.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.511 ' CE1' ' HB3' ' A' ' 238' ' ' LYS . 37.5 p90 -129.61 -177.81 4.42 Favored 'General case' 0 C--O 1.243 0.733 0 CA-C-O 121.739 0.781 . . . . 74.43 111.65 -176.166 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 11.9 mmmm -132.61 122.03 17.59 Favored Pre-proline 0 C--O 1.232 0.178 0 CA-C-N 114.368 -1.287 . . . . 74.4 107.536 174.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . 0.411 ' HA ' HG12 ' A' ' 219' ' ' VAL . 57.3 Cg_endo -66.92 93.71 0.33 Allowed 'Trans proline' 0 C--N 1.359 1.105 0 C-N-CA 122.856 2.371 . . . . 73.43 111.63 -177.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . 0.452 ' HB2' ' HG3' ' A' ' 220' ' ' GLU . . . -67.48 91.47 0.27 Allowed 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 109.45 -0.574 . . . . 54.04 109.45 179.097 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 67.59 14.94 9.69 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 124.52 1.128 . . . . 61.31 111.583 -174.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -88.3 115.04 4.32 Favored Glycine 0 C--N 1.348 1.199 0 N-CA-C 111.622 -0.591 . . . . 42.12 111.622 -178.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 22.8 t -164.24 96.78 0.79 Allowed 'General case' 0 C--O 1.242 0.697 0 N-CA-C 108.696 -0.853 . . . . 72.24 108.696 177.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -88.55 -179.01 46.56 Favored Glycine 0 C--N 1.347 1.165 0 CA-C-N 116.171 -0.468 . . . . 54.14 112.224 175.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -78.68 -97.66 0.24 Allowed Glycine 0 C--N 1.343 0.925 0 N-CA-C 112.218 -0.353 . . . . 52.34 112.218 175.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 33.1 t -150.04 162.75 39.78 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 122.946 0.498 . . . . 62.13 110.882 -177.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -100.12 -53.2 1.11 Allowed Glycine 0 C--N 1.348 1.208 0 CA-C-N 115.358 -0.837 . . . . 70.43 112.02 -179.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 64.52 -112.62 5.15 Favored Glycine 0 C--N 1.349 1.269 0 O-C-N 123.924 0.426 . . . . 71.2 112.076 -177.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 35.3 t -79.92 79.47 6.44 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.749 0.82 . . . . 74.51 108.899 172.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -138.82 94.72 0.21 Allowed Glycine 0 C--N 1.347 1.148 0 N-CA-C 111.033 -0.827 . . . . 61.35 111.033 -177.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -55.17 -43.2 83.74 Favored Glycine 0 C--N 1.352 1.446 0 O-C-N 124.39 0.7 . . . . 63.21 113.999 -175.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 18.2 m -70.11 96.65 1.09 Allowed 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 109.454 -0.573 . . . . 53.53 109.454 174.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.401 ' HA ' ' HB2' ' A' ' 240' ' ' PHE . 25.5 mm-40 -96.12 -36.41 10.99 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.025 0.53 . . . . 64.04 110.152 171.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -95.09 154.21 17.28 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 122.726 0.41 . . . . 61.15 110.74 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 33.3 mt -128.09 156.33 42.99 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.147 0.979 . . . . 70.21 109.863 175.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -130.5 121.91 26.67 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.892 0.877 . . . . 74.23 108.716 173.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -149.6 167.35 26.61 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 124.003 0.921 . . . . 53.13 109.58 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 17.7 m -112.14 137.04 50.77 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.779 -0.646 . . . . 70.0 109.4 -178.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 43.8 tp -108.92 122.13 46.57 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.181 0.992 . . . . 74.51 110.117 -170.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -87.45 104.64 16.65 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.566 0.746 . . . . 72.0 109.613 176.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.537 ' HA ' HG11 ' A' ' 210' ' ' VAL . 59.7 t -109.21 113.74 58.51 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 123.489 0.716 . . . . 72.5 109.436 174.123 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -58.56 141.84 97.72 Favored 'Trans proline' 0 C--N 1.379 2.17 0 C-N-CA 123.039 2.493 . . . . 64.2 111.937 171.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -51.6 -45.51 91.1 Favored Pre-proline 0 CA--C 1.562 1.419 0 N-CA-C 113.931 1.086 . . . . 31.0 113.931 -176.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -55.37 -47.09 27.76 Favored 'Trans proline' 0 C--N 1.391 2.775 0 C-N-CA 121.957 1.771 . . . . 70.32 113.184 173.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 56.6 mt -66.86 -29.82 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 123.641 0.776 . . . . 75.33 110.734 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.8 -46.77 67.82 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.585 0.754 . . . . 71.11 111.486 179.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 85.5 t -66.44 -54.43 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 115.937 -0.574 . . . . 63.24 110.501 -178.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 18.2 m -69.47 -30.44 45.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 N-CA-C 112.072 0.397 . . . . 73.24 112.072 -177.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 74.68 68.3 1.58 Allowed Glycine 0 C--N 1.345 1.038 0 O-C-N 123.431 0.457 . . . . 71.44 112.28 -176.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -97.58 -126.51 5.43 Favored Glycine 0 C--N 1.348 1.222 0 N-CA-C 111.74 -0.544 . . . . 44.44 111.74 -178.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 49.1 mtmt -131.55 158.93 39.64 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.741 0.816 . . . . 71.32 108.982 171.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.537 HG11 ' HA ' ' A' ' 199' ' ' VAL . 6.0 m -136.77 137.29 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 123.545 0.738 . . . . 43.22 109.917 174.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 51.1 ttt-85 -83.58 109.04 17.08 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 108.913 -0.773 . . . . 73.01 108.913 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -101.12 155.26 18.1 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.493 1.117 . . . . 64.35 110.213 -177.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 16.1 mmt -105.62 118.45 36.61 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.022 0.929 . . . . 51.24 109.349 178.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 70.7 p -116.65 179.24 4.06 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.803 0.441 . . . . 72.02 109.825 170.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 20.8 mt -62.97 -36.15 82.52 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.752 -0.658 . . . . 71.13 111.091 -177.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -93.69 -20.14 20.44 Favored 'General case' 0 CA--C 1.554 1.1 0 CA-C-N 115.295 -0.866 . . . . 72.41 111.643 -170.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 155.56 177.73 29.09 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 120.881 -0.676 . . . . 43.44 114.183 177.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -64.5 142.11 76.68 Favored 'Trans proline' 0 C--N 1.376 1.975 0 C-N-CA 123.001 2.467 . . . . 73.12 112.513 174.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.411 HG12 ' HA ' ' A' ' 177' ' ' PRO . 34.4 m -139.3 128.49 29.34 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 C-N-CA 123.311 0.644 . . . . 74.41 109.84 179.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.452 ' HG3' ' HB2' ' A' ' 178' ' ' ALA . 36.7 mt-10 -83.42 104.02 13.24 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 109.778 -0.453 . . . . 72.5 109.778 177.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 48.1 t -93.49 118.13 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 109.121 -0.696 . . . . 74.13 109.121 -177.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -71.87 107.21 4.52 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 123.25 0.62 . . . . 72.11 110.16 -179.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 60.5 t -70.97 130.29 88.49 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 124.556 1.142 . . . . 74.52 109.709 -179.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -63.73 140.08 72.4 Favored 'Trans proline' 0 C--N 1.373 1.868 0 C-N-CA 122.387 2.058 . . . . 62.25 112.246 174.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -60.38 133.54 49.82 Favored 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 122.342 2.028 . . . . 70.43 111.758 174.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 82.1 mtt180 68.85 72.5 0.27 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.938 1.295 . . . . 73.05 109.795 -176.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.735 ' HA ' ' HE ' ' A' ' 231' ' ' ARG . 38.9 m -94.22 140.13 30.16 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 114.784 -1.098 . . . . 73.2 110.085 176.01 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -113.29 145.48 40.99 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 124.054 0.942 . . . . 73.42 108.738 174.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . 0.474 ' HB2' ' HB ' ' A' ' 255' ' ' ILE . . . -64.33 117.09 6.73 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.369 0.668 . . . . 62.53 109.587 178.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 108.47 9.74 26.64 Favored Glycine 0 CA--C 1.526 0.746 0 CA-C-O 119.426 -0.652 . . . . 55.41 112.565 -173.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.735 ' HE ' ' HA ' ' A' ' 227' ' ' THR . 57.5 mtt-85 -63.45 150.0 44.72 Favored 'General case' 0 C--N 1.361 1.072 0 N-CA-C 109.348 -0.612 . . . . 74.32 109.348 166.21 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 19.6 pttm -121.91 138.91 54.22 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 123.217 0.607 . . . . 65.41 109.762 174.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.466 HD22 ' HB2' ' A' ' 173' ' ' ALA . 57.4 mt -123.9 137.26 54.66 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.588 1.155 . . . . 65.34 108.221 177.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . 0.492 ' HB3' HG21 ' A' ' 170' ' ' VAL . 52.8 ttm-85 -128.75 102.41 6.55 Favored 'General case' 0 C--O 1.243 0.72 0 N-CA-C 108.734 -0.839 . . . . 73.31 108.734 176.114 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.44 HD13 ' CD1' ' A' ' 175' ' ' TYR . 17.0 mt -83.9 89.52 7.23 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.019 0.927 . . . . 71.41 109.361 -174.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -73.78 131.58 41.71 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.532 -0.758 . . . . 73.44 110.971 -175.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 66.81 24.82 72.98 Favored Glycine 0 C--N 1.35 1.348 0 O-C-N 123.858 0.724 . . . . 74.43 112.972 -178.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.511 ' HB3' ' CE1' ' A' ' 175' ' ' TYR . 32.1 mmtp -140.23 39.49 1.92 Allowed 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.038 0.935 . . . . 70.25 110.581 -172.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -120.85 -120.62 2.77 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-N 116.228 -0.442 . . . . 64.33 112.232 174.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . 0.401 ' HB2' ' HA ' ' A' ' 191' ' ' GLN . 2.9 m-85 -69.19 147.75 97.45 Favored Pre-proline 0 N--CA 1.49 1.557 0 C-N-CA 123.78 0.832 . . . . 74.34 111.684 178.417 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.504 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 22.6 Cg_endo -59.97 134.02 54.07 Favored 'Trans proline' 0 C--N 1.387 2.602 0 C-N-CA 123.329 2.686 . . . . 73.05 113.455 -179.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -151.04 131.74 3.62 Favored Glycine 0 CA--C 1.54 1.62 0 N-CA-C 110.287 -1.125 . . . . 62.21 110.287 179.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -65.27 -45.99 6.52 Favored 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 123.266 2.644 . . . . 74.53 113.69 -170.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -86.72 11.8 12.22 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 122.855 0.462 . . . . 73.45 111.828 -178.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 133.56 139.87 4.26 Favored Glycine 0 C--N 1.341 0.829 0 N-CA-C 109.766 -1.334 . . . . 62.1 109.766 -174.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.504 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 23.4 mtm180 -78.14 170.73 16.13 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-O 121.025 0.44 . . . . 71.03 111.248 -175.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.52 -156.93 8.45 Favored Glycine 0 C--N 1.344 1.027 0 CA-C-N 115.281 -0.872 . . . . 63.5 112.775 172.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -116.73 160.95 20.0 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.537 0.335 . . . . 73.23 111.148 -170.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 38.8 tp -140.66 106.87 5.23 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 108.258 -1.016 . . . . 73.54 108.258 173.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -94.98 116.31 28.53 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 109.277 -0.638 . . . . 74.21 109.277 -175.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 60.5 mt -116.13 117.99 31.61 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.542 0.737 . . . . 74.34 109.792 -178.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -89.74 112.4 23.67 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.65 0.78 . . . . 73.01 109.598 177.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.487 HG11 HG21 ' A' ' 227' ' ' THR . 60.2 t -71.2 118.79 16.44 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 CA-C-O 121.497 0.665 . . . . 50.42 112.059 -176.101 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 29.6 mmm180 -108.16 115.7 30.61 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 125.101 1.36 . . . . 73.33 108.293 170.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.474 ' HB ' ' HB2' ' A' ' 229' ' ' ALA . 30.5 mt -76.18 128.09 37.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 108.437 -0.949 . . . . 60.34 108.437 170.188 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 6.8 t . . . . . 0 CA--C 1.558 1.274 0 CA-C-O 117.427 -1.273 . . . . 64.04 107.927 -176.382 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 20.3 mmt . . . . . 0 N--CA 1.475 0.822 0 N-CA-C 109.592 -0.521 . . . . 75.1 109.592 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -148.1 131.16 16.3 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 107.695 -1.224 . . . . 75.24 107.695 175.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -72.32 -65.94 0.71 Allowed 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.062 -0.517 . . . . 73.33 109.743 178.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 33.3 m -109.67 -175.74 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 C-N-CA 124.586 1.155 . . . . 71.31 110.472 179.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 14.9 tt -91.94 144.7 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 N-CA-C 107.873 -1.158 . . . . 54.44 107.873 165.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -63.36 140.27 58.86 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.463 0.705 . . . . 60.12 112.745 -172.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.401 ' HB2' HD22 ' A' ' 233' ' ' LEU . . . -153.29 153.55 32.86 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.876 1.27 . . . . 74.22 108.494 171.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -147.42 156.5 42.93 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 108.244 -1.021 . . . . 62.23 108.244 172.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.442 ' CZ ' ' HB3' ' A' ' 238' ' ' LYS . 12.4 p90 -136.7 168.28 19.82 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.585 0.587 . . . . 74.03 112.585 179.078 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -140.25 150.11 60.33 Favored Pre-proline 0 N--CA 1.477 0.901 0 C-N-CA 125.042 1.337 . . . . 73.41 108.158 176.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . 0.492 ' HA ' HG12 ' A' ' 219' ' ' VAL . 38.8 Cg_endo -65.21 109.35 1.32 Allowed 'Trans proline' 0 C--N 1.374 1.885 0 C-N-CA 122.174 1.916 . . . . 72.44 110.909 179.395 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -58.88 -44.11 91.06 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.302 1.041 . . . . 52.31 111.382 -175.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -80.02 -30.09 39.46 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 114.759 -1.109 . . . . 74.11 110.729 177.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 90.73 35.64 7.18 Favored Glycine 0 C--N 1.348 1.2 0 CA-C-N 115.988 -0.551 . . . . 55.44 113.281 176.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 29.6 t -121.11 170.19 9.79 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 122.999 0.52 . . . . 65.11 109.6 171.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -137.11 99.67 0.3 Allowed Glycine 0 C--N 1.345 1.028 0 N-CA-C 111.785 -0.526 . . . . 62.0 111.785 -177.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -73.89 75.25 1.1 Allowed Glycine 0 C--N 1.353 1.482 0 N-CA-C 111.722 -0.551 . . . . 65.12 111.722 176.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.486 ' HA ' ' HG3' ' A' ' 241' ' ' PRO . 4.4 p -96.94 89.81 4.98 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.077 0.951 . . . . 63.2 111.131 -172.041 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -74.19 131.36 13.49 Favored Glycine 0 C--N 1.35 1.331 0 CA-C-N 115.224 -0.898 . . . . 43.51 112.961 175.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -78.59 100.12 1.67 Allowed Glycine 0 C--N 1.35 1.316 0 CA-C-O 119.761 -0.466 . . . . 54.1 112.336 -177.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 26.3 m 65.81 79.59 0.24 Allowed 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 125.095 1.358 . . . . 54.21 110.354 -179.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -95.98 28.83 11.25 Favored Glycine 0 C--N 1.347 1.194 0 CA-C-N 115.412 -0.813 . . . . 71.04 113.306 -175.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.5 -57.68 4.46 Favored Glycine 0 C--N 1.347 1.143 0 CA-C-N 116.635 0.218 . . . . 64.34 112.722 176.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 49.9 m -131.13 154.28 48.49 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.938 0.895 . . . . 75.52 109.829 -179.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.532 ' HB3' ' HA3' ' A' ' 247' ' ' GLY . 39.7 mt-30 -94.08 -21.47 19.11 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.531 0.733 . . . . 72.32 111.006 176.009 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -80.69 152.05 28.61 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.494 0.717 . . . . 63.23 111.107 177.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 13.5 mt -132.57 143.12 49.49 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.744 1.218 . . . . 73.23 108.707 168.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -111.8 135.39 52.48 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 106.474 -1.676 . . . . 65.24 106.474 166.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -159.73 171.61 19.22 Favored 'General case' 0 C--N 1.327 -0.382 0 O-C-N 123.696 0.622 . . . . 55.11 109.746 179.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 26.5 m -113.31 142.35 45.94 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.453 -0.943 . . . . 71.3 108.453 179.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.438 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . 51.2 tp -109.31 121.66 45.66 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 109.339 -0.615 . . . . 62.22 109.339 179.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -82.6 134.26 35.18 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 109.001 -0.74 . . . . 63.14 109.001 167.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.44 ' HA ' HG11 ' A' ' 210' ' ' VAL . 4.2 p -143.03 121.27 7.2 Favored Pre-proline 0 CA--C 1.539 0.553 0 N-CA-C 108.429 -0.952 . . . . 65.15 108.429 175.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.22 142.29 87.36 Favored 'Trans proline' 0 C--N 1.366 1.48 0 C-N-CA 122.58 2.186 . . . . 74.13 112.12 175.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -49.4 -45.87 77.43 Favored Pre-proline 0 CA--C 1.558 1.259 0 C-N-CA 123.729 0.812 . . . . 62.22 113.065 178.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -53.9 -55.16 3.73 Favored 'Trans proline' 0 C--N 1.397 3.103 0 C-N-CA 122.273 1.982 . . . . 75.42 113.109 171.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 52.3 mt -63.66 -30.45 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 C-N-CA 123.304 0.642 . . . . 74.41 111.779 -177.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.73 -42.41 74.01 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 122.949 0.5 . . . . 53.34 111.443 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 97.2 t -73.66 -54.48 15.16 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 C-N-CA 123.138 0.575 . . . . 73.11 111.107 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 14.8 m -76.74 -22.03 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 N-CA-C 112.03 0.382 . . . . 73.43 112.03 -174.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 86.67 170.59 47.02 Favored Glycine 0 C--N 1.348 1.239 0 N-CA-C 112.047 -0.421 . . . . 41.53 112.047 -174.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 145.96 -129.14 3.29 Favored Glycine 0 C--N 1.333 0.397 0 N-CA-C 111.071 -0.812 . . . . 35.5 111.071 175.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -139.73 158.51 43.98 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.883 0.873 . . . . 74.34 109.709 176.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.44 HG11 ' HA ' ' A' ' 199' ' ' VAL . 18.7 m -138.51 155.43 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 123.722 0.809 . . . . 73.45 109.535 171.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 48.2 mtm180 -82.72 127.85 33.81 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 109.353 -0.61 . . . . 54.52 109.353 173.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -116.36 146.38 42.51 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 124.373 1.069 . . . . 72.42 109.156 179.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 5.2 mmt -94.81 110.05 21.96 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 109.321 -0.622 . . . . 62.22 109.321 177.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 38.4 p -119.63 174.93 6.11 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 123.838 0.855 . . . . 71.13 109.416 174.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.433 HD12 ' CE1' ' A' ' 240' ' ' PHE . 15.5 mt -78.72 -2.1 37.72 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 116.298 -0.41 . . . . 73.54 111.681 -177.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -100.67 -4.8 27.61 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.868 0.867 . . . . 73.23 110.936 171.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 114.67 -160.53 13.15 Favored Glycine 0 C--N 1.356 1.686 0 C-N-CA 123.611 0.624 . . . . 62.44 112.806 178.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.33 131.8 19.7 Favored 'Trans proline' 0 C--N 1.375 1.924 0 C-N-CA 122.771 2.314 . . . . 63.21 112.503 175.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.492 HG12 ' HA ' ' A' ' 177' ' ' PRO . 31.6 m -134.81 139.84 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 123.586 0.754 . . . . 52.23 110.484 -178.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -87.04 105.69 17.33 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 122.66 0.384 . . . . 75.2 110.139 178.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 76.8 t -92.5 117.66 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 N-CA-C 108.543 -0.91 . . . . 62.22 108.543 179.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -65.6 101.65 0.63 Allowed 'General case' 0 C--O 1.24 0.569 0 O-C-N 124.322 1.014 . . . . 74.54 110.254 178.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 63.0 t -77.84 117.98 69.26 Favored Pre-proline 0 CA--C 1.543 0.682 0 O-C-N 124.613 1.196 . . . . 64.33 108.823 174.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -65.31 151.62 84.68 Favored 'Trans proline' 0 CA--C 1.559 1.769 0 C-N-CA 122.033 1.822 . . . . 74.33 111.602 170.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_exo -63.62 141.53 80.07 Favored 'Trans proline' 0 C--N 1.373 1.867 0 C-N-CA 122.555 2.17 . . . . 70.33 112.357 178.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 51.7 mtm180 62.93 49.07 3.67 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.786 1.234 . . . . 71.44 110.638 176.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.536 HG22 HG11 ' A' ' 253' ' ' VAL . 55.3 m -98.85 109.2 22.0 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 114.271 -1.331 . . . . 65.23 109.244 173.287 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -85.47 161.49 19.37 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.606 -0.725 . . . . 64.22 111.773 -175.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -69.15 124.43 23.79 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.765 0.826 . . . . 74.31 110.084 177.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 111.43 -9.82 28.5 Favored Glycine 0 N--CA 1.471 0.992 0 O-C-N 123.306 0.378 . . . . 74.23 112.411 -175.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 66.0 mtt180 -70.15 162.69 27.84 Favored 'General case' 0 C--N 1.35 0.622 0 CA-C-O 121.532 0.682 . . . . 72.55 111.046 170.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 18.7 pttm -121.58 143.53 49.25 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 114.957 -1.02 . . . . 74.24 110.305 -177.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.401 HD22 ' HB2' ' A' ' 173' ' ' ALA . 93.1 mt -125.35 142.66 51.37 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.748 1.219 . . . . 74.24 108.325 174.277 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 65.8 ttt180 -133.18 124.27 27.14 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 108.22 -1.03 . . . . 72.11 108.22 -179.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.435 ' HB3' ' HG3' ' A' ' 238' ' ' LYS . 26.6 mt -120.88 84.04 2.17 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.671 0.788 . . . . 72.22 109.455 -166.117 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -79.32 140.01 37.66 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.875 0.87 . . . . 62.4 110.726 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 70.27 26.98 73.45 Favored Glycine 0 C--N 1.347 1.174 0 O-C-N 123.828 0.705 . . . . 45.02 112.336 -176.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.442 ' HB3' ' CZ ' ' A' ' 175' ' ' TYR . 8.0 mmpt? -128.75 -48.34 1.25 Allowed 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.982 0.913 . . . . 60.0 111.583 -172.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -55.39 -102.42 0.01 OUTLIER Glycine 0 CA--C 1.549 2.162 0 N-CA-C 116.25 1.26 . . . . 53.54 116.25 -164.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . 0.433 ' CE1' HD12 ' A' ' 215' ' ' LEU . 0.7 OUTLIER -84.17 153.41 62.88 Favored Pre-proline 0 N--CA 1.485 1.292 0 C-N-CA 123.098 0.559 . . . . 72.51 110.181 177.301 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.546 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 18.2 Cg_endo -56.28 154.27 29.81 Favored 'Trans proline' 0 C--N 1.373 1.86 0 C-N-CA 123.813 3.009 . . . . 73.23 114.076 170.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -165.23 143.55 8.56 Favored Glycine 0 CA--C 1.535 1.34 0 CA-C-O 119.017 -0.88 . . . . 62.14 111.974 175.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -63.7 -45.13 11.73 Favored 'Trans proline' 0 C--N 1.382 2.323 0 C-N-CA 123.372 2.715 . . . . 63.12 113.096 179.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -80.38 -26.18 38.73 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 122.747 0.419 . . . . 72.22 110.946 -179.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 166.73 160.02 13.29 Favored Glycine 0 C--N 1.336 0.536 0 N-CA-C 111.029 -0.828 . . . . 61.43 111.029 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.546 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 23.9 mtm180 -78.81 160.67 27.26 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 122.547 0.339 . . . . 61.23 110.682 -179.337 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.532 ' HA3' ' HB3' ' A' ' 191' ' ' GLN . . . -88.02 -155.82 29.6 Favored Glycine 0 C--N 1.344 0.98 0 CA-C-N 115.833 -0.621 . . . . 65.31 113.529 -175.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -102.47 155.59 18.16 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.125 0.57 . . . . 72.51 109.826 -175.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 36.6 tp -136.73 115.75 12.37 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 107.829 -1.175 . . . . 74.15 107.829 168.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -100.04 107.96 20.03 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.009 -0.737 . . . . 62.34 109.009 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.438 ' HB3' ' HB2' ' A' ' 197' ' ' LEU . 43.0 mt -102.33 121.06 41.54 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.61 0.764 . . . . 55.54 110.225 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -91.23 115.52 28.09 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 109.361 -0.607 . . . . 74.12 109.361 174.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.536 HG11 HG22 ' A' ' 227' ' ' THR . 85.2 t -62.42 127.94 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.533 1.133 . . . . 52.31 111.751 -176.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -131.39 116.21 17.24 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.717 1.207 . . . . 75.54 107.942 172.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 34.9 mt -77.51 126.61 38.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 O-C-N 123.769 0.668 . . . . 75.23 109.653 176.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 25.7 p . . . . . 0 C--O 1.254 1.313 0 N-CA-C 108.314 -0.995 . . . . 72.31 108.314 173.083 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 66.0 mtm . . . . . 0 N--CA 1.478 0.95 0 N-CA-C 108.695 -0.854 . . . . 61.34 108.695 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 25.3 t70 67.86 106.23 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.577 1.151 . . . . 74.4 110.354 -175.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -97.84 -63.89 1.09 Allowed 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.675 0.79 . . . . 54.24 110.285 -176.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.48 HG21 ' HB3' ' A' ' 234' ' ' ARG . 14.0 m -95.99 176.43 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 123.49 0.716 . . . . 73.11 111.037 -178.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 17.7 tt -96.35 138.32 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 N-CA-C 107.611 -1.255 . . . . 72.24 107.611 162.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -71.87 145.64 48.43 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.761 0.824 . . . . 71.34 111.268 -174.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.411 ' HB2' HD22 ' A' ' 233' ' ' LEU . . . -155.58 178.16 10.56 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.587 1.155 . . . . 73.42 109.74 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -156.32 152.16 27.3 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.751 0.82 . . . . 34.03 109.962 178.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.438 ' CD1' HD13 ' A' ' 235' ' ' LEU . 33.0 p90 -129.04 168.01 16.68 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 121.139 0.495 . . . . 72.42 110.863 175.003 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -145.26 150.45 44.89 Favored Pre-proline 0 CA--C 1.548 0.885 0 CA-C-N 114.635 -1.166 . . . . 75.31 109.078 176.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -57.78 110.59 0.65 Allowed 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 123.604 2.869 . . . . 71.02 112.91 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . 0.46 ' HB2' ' HG3' ' A' ' 220' ' ' GLU . . . -71.12 -25.32 62.53 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.581 0.753 . . . . 52.23 111.236 -178.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -64.77 -29.52 70.49 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 115.64 -0.709 . . . . 73.44 111.24 174.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 140.02 -80.47 0.27 Allowed Glycine 0 C--N 1.342 0.874 0 N-CA-C 110.464 -1.054 . . . . 75.02 110.464 -178.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 35.2 t -117.18 153.79 32.22 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 123.516 0.726 . . . . 42.22 109.193 175.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -113.11 128.18 8.27 Favored Glycine 0 C--N 1.343 0.952 0 N-CA-C 110.818 -0.913 . . . . 62.52 110.818 179.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -86.13 128.27 8.75 Favored Glycine 0 C--N 1.348 1.21 0 N-CA-C 111.374 -0.69 . . . . 55.41 111.374 178.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 57.8 m -70.47 88.64 0.67 Allowed 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 121.389 0.614 . . . . 72.11 110.446 178.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -146.13 123.97 1.95 Allowed Glycine 0 C--N 1.337 0.627 0 CA-C-N 115.084 -0.962 . . . . 75.24 110.738 177.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -77.28 72.06 2.18 Favored Glycine 0 C--N 1.35 1.324 0 N-CA-C 112.166 -0.374 . . . . 74.33 112.166 -179.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 23.0 m -75.84 81.08 2.76 Favored 'General case' 0 C--N 1.352 0.692 0 C-N-CA 123.967 0.907 . . . . 72.53 109.577 -179.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 123.18 144.47 6.62 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.84 -0.904 . . . . 44.24 110.84 -175.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -84.07 74.07 2.56 Favored Glycine 0 C--N 1.348 1.234 0 CA-C-N 116.893 0.346 . . . . 62.23 112.667 -176.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 67.5 m -152.03 164.88 36.29 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.231 1.013 . . . . 62.11 109.763 177.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.479 ' HA ' ' HB2' ' A' ' 240' ' ' PHE . 83.5 mm-40 -120.32 -51.89 2.18 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.434 -0.951 . . . . 55.03 108.434 167.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -93.63 158.65 15.59 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 115.992 -0.549 . . . . 74.34 110.046 174.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 93.8 mt -136.25 149.97 48.75 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.03 0.932 . . . . 71.41 109.024 176.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -123.68 123.38 40.41 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.746 0.818 . . . . 73.33 108.819 173.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -157.44 170.92 21.35 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.19 0.596 . . . . 75.41 110.653 179.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 19.3 p -96.3 152.44 18.58 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.719 0.808 . . . . 74.11 109.822 174.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.696 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . 34.6 tp -116.77 114.42 23.95 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.392 0.677 . . . . 75.42 109.978 -176.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -74.97 100.74 4.23 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 109.366 -0.605 . . . . 73.54 109.366 176.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.485 ' HA ' HG11 ' A' ' 210' ' ' VAL . 54.8 t -110.6 110.5 57.56 Favored Pre-proline 0 N--CA 1.473 0.677 0 N-CA-C 108.807 -0.812 . . . . 62.42 108.807 177.011 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -53.33 138.35 64.67 Favored 'Trans proline' 0 C--N 1.379 2.133 0 C-N-CA 122.741 2.294 . . . . 74.14 111.626 173.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -46.13 -47.97 43.53 Favored Pre-proline 0 CA--C 1.569 1.679 0 N-CA-C 113.798 1.036 . . . . 61.41 113.798 -178.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -54.3 -46.16 35.59 Favored 'Trans proline' 0 C--N 1.4 3.249 0 C-N-CA 122.627 2.218 . . . . 70.12 112.557 174.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 49.9 mt -68.88 -30.12 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 124.148 0.979 . . . . 73.05 111.063 -176.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.55 -39.85 80.89 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 122.956 0.503 . . . . 64.34 111.197 177.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 88.3 t -70.96 -52.63 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 123.489 0.716 . . . . 74.33 111.089 179.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 18.5 m -80.0 -29.68 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 CA-C-N 116.046 -0.525 . . . . 60.25 112.379 -172.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 83.95 103.8 0.56 Allowed Glycine 0 C--N 1.345 1.079 0 O-C-N 123.554 0.533 . . . . 70.12 112.772 -176.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -158.7 178.43 34.91 Favored Glycine 0 C--N 1.342 0.896 0 N-CA-C 112.175 -0.37 . . . . 64.3 112.175 -178.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.535 ' HB3' ' HB3' ' A' ' 220' ' ' GLU . 34.6 mtmm -82.79 148.51 27.76 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 122.917 0.487 . . . . 41.52 111.364 -178.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.485 HG11 ' HA ' ' A' ' 199' ' ' VAL . 32.8 m -136.6 147.86 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 C-N-CA 123.93 0.892 . . . . 52.44 110.156 176.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 11.3 mtm180 -82.02 111.47 18.21 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-O 121.216 0.531 . . . . 75.11 111.521 -178.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -102.0 142.69 32.89 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 125.005 1.322 . . . . 64.12 109.167 171.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 34.2 tpp -100.88 116.3 32.42 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 122.763 0.425 . . . . 75.55 109.854 176.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 81.0 p -110.69 -178.59 3.52 Favored 'General case' 0 C--O 1.247 0.926 0 C-N-CA 124.101 0.96 . . . . 42.14 109.424 177.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 14.9 mt -77.32 -5.53 49.87 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 122.924 0.49 . . . . 60.12 110.609 -177.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -102.31 -19.23 15.09 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.332 1.053 . . . . 74.13 110.65 177.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 133.07 -160.35 23.86 Favored Glycine 0 C--N 1.356 1.69 0 CA-C-O 119.954 -0.359 . . . . 72.33 113.305 176.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -78.09 126.64 7.96 Favored 'Trans proline' 0 C--N 1.376 1.998 0 C-N-CA 123.172 2.581 . . . . 71.41 111.772 -179.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.455 ' HA ' ' H ' ' A' ' 178' ' ' ALA . 28.1 m -132.54 143.49 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 124.123 0.969 . . . . 73.15 109.489 -178.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.535 ' HB3' ' HB3' ' A' ' 209' ' ' LYS . 35.0 mt-10 -101.82 115.77 31.26 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.901 0.481 . . . . 75.3 110.484 176.166 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 24.1 t -95.64 116.46 37.33 Favored 'Isoleucine or valine' 0 C--N 1.346 0.413 0 C-N-CA 124.507 1.123 . . . . 65.52 109.138 -177.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -64.51 100.79 0.39 Allowed 'General case' 0 C--O 1.239 0.544 0 O-C-N 124.156 0.91 . . . . 72.41 110.109 174.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.403 HG11 HG11 ' A' ' 199' ' ' VAL . 21.3 t -82.73 127.73 68.96 Favored Pre-proline 0 N--CA 1.47 0.531 0 CA-C-N 114.927 -1.033 . . . . 74.51 108.652 177.283 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -61.46 156.79 44.65 Favored 'Trans proline' 0 CA--C 1.559 1.766 0 C-N-CA 122.277 1.985 . . . . 64.3 112.418 173.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -70.45 161.53 45.7 Favored 'Trans proline' 0 C--N 1.373 1.865 0 C-N-CA 122.388 2.058 . . . . 71.24 112.136 173.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 72.5 mtm-85 58.25 33.54 23.24 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.38 1.072 . . . . 74.25 111.782 175.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.638 HG23 ' HD2' ' A' ' 231' ' ' ARG . 25.5 m -92.72 126.57 37.87 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.397 1.079 . . . . 75.42 110.154 -178.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -93.8 162.18 14.03 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.361 0.664 . . . . 63.53 111.158 -178.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . 0.474 ' HB2' ' HB ' ' A' ' 255' ' ' ILE . . . -71.82 119.22 15.68 Favored 'General case' 0 C--N 1.35 0.613 0 CA-C-N 115.177 -0.919 . . . . 64.12 109.324 174.075 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 114.82 -2.7 23.01 Favored Glycine 0 C--N 1.333 0.366 0 CA-C-O 119.527 -0.596 . . . . 50.12 112.414 -174.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.638 ' HD2' HG23 ' A' ' 227' ' ' THR . 91.3 mtt180 -74.81 161.15 29.85 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-N 117.45 0.625 . . . . 73.22 110.209 170.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.483 ' HD2' ' OH ' ' A' ' 250' ' ' TYR . 20.8 pttm -129.06 134.53 48.14 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.875 0.87 . . . . 74.54 109.768 -176.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.411 HD22 ' HB2' ' A' ' 173' ' ' ALA . 73.8 mt -111.5 126.79 55.35 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.065 -1.087 . . . . 74.5 108.065 175.06 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . 0.48 ' HB3' HG21 ' A' ' 170' ' ' VAL . 54.3 ttm-85 -108.37 102.91 11.98 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 107.324 -1.361 . . . . 72.44 107.324 170.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.438 HD13 ' CD1' ' A' ' 175' ' ' TYR . 20.3 mt -79.1 91.06 4.87 Favored 'General case' 0 C--O 1.245 0.835 0 N-CA-C 108.104 -1.073 . . . . 74.02 108.104 179.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.438 ' HA ' ' OD2' ' A' ' 248' ' ' ASP . 90.8 mttt -72.97 122.97 22.57 Favored 'General case' 0 C--O 1.243 0.762 0 CA-C-N 113.711 -1.586 . . . . 72.42 111.771 -170.059 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 64.87 27.4 72.09 Favored Glycine 0 C--N 1.346 1.094 0 O-C-N 123.864 0.727 . . . . 72.51 111.658 -176.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.438 ' HB3' ' CE1' ' A' ' 175' ' ' TYR . 30.5 mmtp -140.65 59.35 1.55 Allowed 'General case' 0 C--O 1.22 -0.481 0 C-N-CA 124.858 1.263 . . . . 71.11 108.083 -175.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -120.39 -131.47 4.11 Favored Glycine 0 N--CA 1.467 0.725 0 N-CA-C 109.914 -1.274 . . . . 42.33 109.914 165.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . 0.479 ' HB2' ' HA ' ' A' ' 191' ' ' GLN . 4.3 m-85 -60.17 146.23 83.77 Favored Pre-proline 0 N--CA 1.484 1.245 0 C-N-CA 123.408 0.683 . . . . 74.02 111.537 173.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.597 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 37.5 Cg_endo -63.13 132.02 34.83 Favored 'Trans proline' 0 C--N 1.381 2.284 0 C-N-CA 123.146 2.564 . . . . 72.22 112.435 179.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -141.94 136.11 7.13 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-O 118.329 -1.261 . . . . 74.51 110.523 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -57.2 -53.86 4.3 Favored 'Trans proline' 0 C--N 1.378 2.105 0 C-N-CA 123.493 2.795 . . . . 72.31 113.762 -176.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -81.97 -26.44 33.92 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 122.964 0.505 . . . . 64.13 111.362 -178.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -177.63 140.47 4.77 Favored Glycine 0 C--N 1.341 0.812 0 N-CA-C 111.352 -0.699 . . . . 44.13 111.352 -177.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.597 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 57.4 mtm180 -78.87 169.46 18.19 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.221 0.609 . . . . 74.34 110.536 177.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -78.55 -159.7 14.61 Favored Glycine 0 C--N 1.339 0.718 0 CA-C-N 116.137 -0.483 . . . . 60.24 112.299 175.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . 0.438 ' OD2' ' HA ' ' A' ' 236' ' ' LYS . 27.7 m-20 -125.69 127.5 46.33 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 109.836 -0.431 . . . . 74.05 109.836 178.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 58.3 tp -100.74 109.63 21.67 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 108.159 -1.052 . . . . 40.41 108.159 177.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . 0.483 ' OH ' ' HD2' ' A' ' 232' ' ' LYS . 33.9 t80 -98.07 108.38 21.08 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.497 -0.774 . . . . 74.13 109.082 -174.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.696 ' HB3' ' HB2' ' A' ' 197' ' ' LEU . 69.9 mt -121.3 106.71 11.73 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.85 0.86 . . . . 60.41 110.336 -174.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 232' ' ' LYS . 53.5 mt-10 -80.29 110.99 16.25 Favored 'General case' 0 C--O 1.241 0.605 0 CA-C-N 115.177 -0.92 . . . . 63.32 110.365 178.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.475 HG11 HG22 ' A' ' 227' ' ' THR . 95.2 t -57.58 113.58 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 124.048 0.939 . . . . 53.43 111.363 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 28.7 mmm180 -113.22 116.18 29.37 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 107.241 -1.392 . . . . 70.4 107.241 169.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.474 ' HB ' ' HB2' ' A' ' 229' ' ' ALA . 58.1 mt -76.24 123.19 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 122.988 0.515 . . . . 74.32 109.78 -179.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.2 t . . . . . 0 CA--C 1.559 1.318 0 N-CA-C 107.802 -1.185 . . . . 75.13 107.802 175.031 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 26.0 mmt . . . . . 0 N--CA 1.476 0.855 0 N-CA-C 109.786 -0.45 . . . . 74.41 109.786 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -86.23 64.23 8.44 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-O 122.067 0.937 . . . . 75.02 108.504 175.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -90.65 -56.33 3.23 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.176 -0.92 . . . . 72.42 110.438 -170.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.446 HG21 ' HB3' ' A' ' 234' ' ' ARG . 35.5 m -79.04 155.61 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 109.72 -0.474 . . . . 71.11 109.72 173.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 12.7 tt -81.59 141.51 15.01 Favored 'Isoleucine or valine' 0 C--O 1.243 0.756 0 N-CA-C 108.99 -0.744 . . . . 71.32 108.99 173.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -62.97 133.17 54.21 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.208 1.003 . . . . 72.23 111.524 -172.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.499 ' HB2' HD22 ' A' ' 233' ' ' LEU . . . -147.52 171.33 15.72 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 124.594 1.158 . . . . 73.04 110.038 177.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -157.75 151.85 24.43 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.4 1.08 . . . . 75.05 108.374 176.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.43 ' HD1' HD13 ' A' ' 235' ' ' LEU . 6.4 p90 -128.3 167.02 17.51 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 109.898 -0.408 . . . . 70.25 109.898 172.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -140.67 136.41 16.43 Favored Pre-proline 0 N--CA 1.471 0.599 0 C-N-CA 123.281 0.632 . . . . 72.23 109.859 169.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . 0.534 ' HA ' HG12 ' A' ' 219' ' ' VAL . 13.7 Cg_endo -55.07 113.16 1.27 Allowed 'Trans proline' 0 C--N 1.378 2.088 0 C-N-CA 123.646 2.897 . . . . 73.43 112.881 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . 0.635 ' HB2' ' HG3' ' A' ' 220' ' ' GLU . . . -87.0 -10.64 52.64 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.735 0.814 . . . . 64.22 112.007 -175.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -109.53 -75.69 0.62 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.311 0.644 . . . . 75.21 109.591 178.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -126.58 -104.35 1.35 Allowed Glycine 0 C--N 1.347 1.143 0 N-CA-C 110.441 -1.064 . . . . 61.23 110.441 -178.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 74.0 m -157.64 160.46 38.06 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.612 1.165 . . . . 73.13 109.732 174.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -66.77 124.1 23.31 Favored Glycine 0 C--N 1.345 1.036 0 N-CA-C 111.343 -0.703 . . . . 61.34 111.343 171.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -84.42 154.63 30.14 Favored Glycine 0 C--N 1.343 0.953 0 N-CA-C 111.972 -0.451 . . . . 64.31 111.972 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.483 ' HB2' ' HB2' ' A' ' 241' ' ' PRO . 39.2 t -123.88 108.67 12.7 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.685 0.794 . . . . 35.21 109.008 179.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -99.92 52.97 0.99 Allowed Glycine 0 C--N 1.342 0.9 0 N-CA-C 111.494 -0.642 . . . . 54.41 111.494 177.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 103.76 -132.32 11.0 Favored Glycine 0 N--CA 1.468 0.828 0 N-CA-C 110.814 -0.914 . . . . 60.33 110.814 -172.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 29.5 p -77.58 -2.21 34.6 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 123.703 0.801 . . . . 75.22 112.053 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 95.92 -6.56 67.0 Favored Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.611 -0.549 . . . . 64.14 113.342 176.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 67.42 -84.3 0.14 Allowed Glycine 0 C--N 1.359 1.822 0 N-CA-C 111.731 -0.548 . . . . 44.11 111.731 -177.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 50.6 m -113.13 98.48 7.17 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 108.162 -1.051 . . . . 74.23 108.162 169.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.501 ' HB3' ' HA3' ' A' ' 247' ' ' GLY . 77.1 mt-30 -68.42 -25.28 64.95 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.298 0.639 . . . . 75.14 111.507 179.203 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.517 ' HB3' ' HE1' ' A' ' 194' ' ' TYR . 4.1 m-20 -79.77 114.79 18.96 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 114.654 -1.157 . . . . 55.53 109.718 -179.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 69.0 mt -112.27 135.97 52.29 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 108.808 -0.812 . . . . 73.35 108.808 172.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . 0.517 ' HE1' ' HB3' ' A' ' 192' ' ' ASP . 46.3 m-85 -129.05 122.99 31.14 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 108.648 -0.871 . . . . 62.44 108.648 -178.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.408 ' O ' ' HA ' ' A' ' 251' ' ' LEU . . . -154.78 162.91 40.93 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 121.57 0.7 . . . . 55.2 110.333 -176.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 19.8 p -97.47 141.16 30.87 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-N 115.436 -0.802 . . . . 60.11 109.188 174.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.585 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . 45.7 tp -108.48 113.15 25.95 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.613 -0.721 . . . . 70.03 110.044 -175.345 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -79.32 99.89 7.32 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 109.22 -0.659 . . . . 62.54 109.22 178.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 43.1 t -106.86 118.43 54.21 Favored Pre-proline 0 N--CA 1.467 0.42 0 CA-C-N 115.334 -0.848 . . . . 71.11 108.721 176.03 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -54.74 143.25 70.96 Favored 'Trans proline' 0 C--N 1.371 1.747 0 C-N-CA 122.415 2.076 . . . . 74.24 111.796 169.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.413 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -53.75 -44.41 97.92 Favored Pre-proline 0 CA--C 1.562 1.413 0 CA-C-O 118.03 -0.986 . . . . 54.04 112.454 179.012 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.413 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 13.7 Cg_endo -55.7 -47.17 26.71 Favored 'Trans proline' 0 C--N 1.403 3.412 0 C-N-CA 122.543 2.162 . . . . 73.54 111.97 172.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 33.2 mt -70.82 -24.73 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 C-N-CA 123.291 0.636 . . . . 73.01 111.238 -176.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -73.48 -41.72 62.78 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.169 0.588 . . . . 75.24 110.513 178.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 98.0 t -69.3 -55.24 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 123.616 0.767 . . . . 73.34 110.985 178.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 8.8 p -73.18 -31.62 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 C-N-CA 122.767 0.427 . . . . 74.34 111.507 -175.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 78.9 95.03 0.28 Allowed Glycine 0 C--N 1.345 1.062 0 N-CA-C 112.131 -0.388 . . . . 52.54 112.131 -175.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -141.21 -177.76 16.76 Favored Glycine 0 N--CA 1.467 0.765 0 N-CA-C 111.544 -0.622 . . . . 54.13 111.544 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.45 ' HD2' ' HB3' ' A' ' 220' ' ' GLU . 46.0 mtmt -84.17 137.09 33.7 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 109.443 -0.577 . . . . 74.31 109.443 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 26.8 m -119.75 157.51 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 123.775 0.83 . . . . 60.33 109.082 170.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 78.4 mtm180 -86.41 119.46 26.7 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 109.667 -0.494 . . . . 72.14 109.667 172.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -101.47 140.01 36.35 Favored 'General case' 0 C--O 1.245 0.848 0 C-N-CA 124.311 1.044 . . . . 73.14 108.273 174.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.66 103.23 15.15 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.435 -0.95 . . . . 71.22 108.435 -178.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 47.5 p -111.73 177.76 4.54 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.997 0.919 . . . . 71.52 109.86 -179.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 11.2 mt -67.67 -27.76 67.12 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 122.973 0.509 . . . . 72.44 110.916 -176.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -82.66 -18.92 39.33 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.994 0.918 . . . . 72.3 111.408 179.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 129.08 -154.28 20.2 Favored Glycine 0 C--N 1.353 1.489 0 CA-C-O 119.501 -0.61 . . . . 54.5 112.746 178.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -73.32 133.86 19.94 Favored 'Trans proline' 0 C--N 1.374 1.887 0 C-N-CA 122.722 2.281 . . . . 74.33 111.78 175.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.534 HG12 ' HA ' ' A' ' 177' ' ' PRO . 26.9 m -133.29 147.61 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 123.581 0.752 . . . . 75.34 110.164 177.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.635 ' HG3' ' HB2' ' A' ' 178' ' ' ALA . 48.3 mt-10 -90.73 106.02 18.22 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.143 0.577 . . . . 61.42 110.028 178.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 61.6 t -94.72 113.71 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 N-CA-C 109.096 -0.705 . . . . 63.35 109.096 176.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -68.02 100.04 0.94 Allowed 'General case' 0 C--O 1.242 0.658 0 O-C-N 124.028 0.83 . . . . 73.11 109.229 173.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.462 HG11 HG11 ' A' ' 199' ' ' VAL . 25.5 t -79.7 124.53 83.52 Favored Pre-proline 0 C--O 1.24 0.591 0 C-N-CA 123.884 0.874 . . . . 63.12 109.046 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -55.83 146.49 66.92 Favored 'Trans proline' 0 C--N 1.374 1.9 0 C-N-CA 122.485 2.124 . . . . 70.22 112.574 174.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -67.4 150.68 80.84 Favored 'Trans proline' 0 C--N 1.373 1.862 0 C-N-CA 122.144 1.896 . . . . 71.05 112.62 175.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 61.58 37.74 16.02 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 124.904 1.281 . . . . 75.21 111.705 177.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 45.5 m -96.96 116.01 28.45 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.816 0.846 . . . . 60.42 110.622 -178.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 24.1 mp0 -86.18 165.7 16.33 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.771 0.828 . . . . 63.43 111.287 -178.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -70.49 133.67 47.03 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 114.799 -1.091 . . . . 72.21 109.46 176.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 112.68 -24.95 12.51 Favored Glycine 0 C--N 1.334 0.461 0 N-CA-C 111.441 -0.664 . . . . 53.15 111.441 -176.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 60.6 mtt180 -63.82 160.65 16.93 Favored 'General case' 0 C--N 1.36 1.038 0 C-N-CA 123.504 0.722 . . . . 72.4 111.526 178.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 16.1 pttm -130.21 134.42 47.26 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.202 1.001 . . . . 71.23 110.145 -171.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.499 HD22 ' HB2' ' A' ' 173' ' ' ALA . 58.5 mt -120.0 100.24 7.1 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.648 1.179 . . . . 64.13 108.524 179.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . 0.446 ' HB3' HG21 ' A' ' 170' ' ' VAL . 67.8 ttt180 -93.92 101.1 13.16 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 108.5 -0.926 . . . . 52.53 108.5 177.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.463 HD11 HD12 ' A' ' 251' ' ' LEU . 21.3 mt -79.14 83.35 5.21 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.187 0.995 . . . . 54.0 109.343 -178.448 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -79.3 140.97 37.41 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.529 0.732 . . . . 73.34 110.628 -177.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 65.41 24.82 71.02 Favored Glycine 0 C--N 1.349 1.26 0 O-C-N 124.045 0.841 . . . . 34.42 111.65 -174.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -130.33 -26.01 2.37 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.713 0.805 . . . . 75.2 110.859 -174.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -67.96 -145.53 0.12 Allowed Glycine 0 C--N 1.358 1.751 0 O-C-N 123.653 0.596 . . . . 62.14 113.718 -175.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . 0.494 ' HB3' ' HA ' ' A' ' 191' ' ' GLN . 0.1 OUTLIER -67.06 120.68 73.8 Favored Pre-proline 0 CA--C 1.552 1.055 0 O-C-N 122.369 -0.489 . . . . 74.21 110.912 -173.21 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.564 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 15.7 Cg_exo -70.67 160.19 50.25 Favored 'Trans proline' 0 C--N 1.385 2.499 0 C-N-CA 123.746 2.964 . . . . 63.13 115.499 -173.518 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -159.43 164.26 33.89 Favored Glycine 0 CA--C 1.532 1.095 0 CA-C-N 113.188 -1.824 . . . . 70.52 110.43 175.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -70.51 -23.31 27.53 Favored 'Trans proline' 0 C--N 1.37 1.685 0 C-N-CA 122.945 2.43 . . . . 70.41 113.291 -177.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -89.42 -27.08 20.65 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.227 0.611 . . . . 72.43 110.783 177.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 166.95 -170.12 41.21 Favored Glycine 0 C--N 1.349 1.269 0 N-CA-C 112.183 -0.367 . . . . 22.11 112.183 -178.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.564 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 26.6 mtm180 -117.92 155.36 30.34 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.875 0.87 . . . . 71.4 110.412 -177.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.501 ' HA3' ' HB3' ' A' ' 191' ' ' GLN . . . -86.84 -156.13 28.59 Favored Glycine 0 C--N 1.343 0.951 0 CA-C-N 115.706 -0.679 . . . . 75.11 111.952 171.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -122.56 154.26 38.16 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 121.287 0.565 . . . . 60.22 110.894 176.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.404 ' HG ' ' HG ' ' A' ' 251' ' ' LEU . 41.4 tp -116.77 107.28 14.45 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 107.485 -1.302 . . . . 64.21 107.485 170.143 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -90.75 105.75 18.04 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.77 0.828 . . . . 75.42 108.773 -176.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.585 ' HB3' ' HB2' ' A' ' 197' ' ' LEU . 49.5 mt -109.71 106.73 16.49 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.498 1.119 . . . . 55.03 110.654 -177.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -82.81 115.63 21.79 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 109.62 -0.511 . . . . 74.31 109.62 176.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 61.6 t -60.03 104.55 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 124.425 1.09 . . . . 64.14 111.455 -177.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 21.3 mmm180 -101.56 107.13 18.32 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 125.115 1.366 . . . . 60.31 107.997 171.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.469 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 48.3 mt -77.43 132.39 32.8 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 CA-C-O 120.913 0.387 . . . . 45.4 110.512 178.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 3.1 t . . . . . 0 C--O 1.251 1.16 0 C-N-CA 124.766 1.226 . . . . 65.41 109.294 177.805 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 25.7 ptt? . . . . . 0 N--CA 1.472 0.667 0 N-CA-C 109.752 -0.462 . . . . 52.15 109.752 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 60.04 98.08 0.03 OUTLIER 'General case' 0 C--N 1.359 1.009 0 C-N-CA 125.404 1.482 . . . . 72.2 111.031 178.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . 0.498 ' O ' ' HE3' ' A' ' 232' ' ' LYS . 23.1 t70 -53.94 -50.6 66.11 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.435 0.694 . . . . 75.44 110.08 -179.347 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 29.3 m -113.04 157.92 13.57 Favored 'Isoleucine or valine' 0 C--O 1.244 0.797 0 C-N-CA 123.752 0.821 . . . . 63.42 110.491 178.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 15.5 tt -81.15 147.03 6.58 Favored 'Isoleucine or valine' 0 C--O 1.248 0.979 0 N-CA-C 107.398 -1.334 . . . . 73.32 107.398 166.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -57.58 123.82 16.91 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.196 0.598 . . . . 75.31 110.761 -178.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.491 ' HB2' HD22 ' A' ' 233' ' ' LEU . . . -146.64 159.05 43.94 Favored 'General case' 0 C--O 1.244 0.789 0 CA-C-N 115.102 -0.954 . . . . 75.05 109.649 177.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -158.95 163.03 36.87 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.037 -0.983 . . . . 71.52 108.964 179.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.539 ' HD1' HD13 ' A' ' 235' ' ' LEU . 16.8 p90 -135.21 170.89 15.23 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-O 121.402 0.62 . . . . 71.32 111.406 176.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -137.27 141.15 33.06 Favored Pre-proline 0 CA--C 1.542 0.671 0 CA-C-N 113.584 -1.643 . . . . 72.03 107.734 173.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . 0.431 ' HA ' HG12 ' A' ' 219' ' ' VAL . 32.1 Cg_exo -59.13 117.55 4.3 Favored 'Trans proline' 0 CA--C 1.551 1.372 0 C-N-CA 123.196 2.597 . . . . 62.53 111.707 179.502 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . 0.507 ' HB2' ' HG3' ' A' ' 220' ' ' GLU . . . -65.67 -46.28 79.73 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.85 0.833 . . . . 73.22 109.662 -177.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -88.44 158.21 18.43 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 114.096 -1.411 . . . . 73.45 109.153 170.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -76.34 66.81 2.57 Favored Glycine 0 C--N 1.349 1.304 0 N-CA-C 111.285 -0.726 . . . . 52.44 111.285 172.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 11.6 t -139.91 134.35 31.48 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 107.868 -1.16 . . . . 75.11 107.868 -176.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 169.24 84.18 0.05 OUTLIER Glycine 0 C--N 1.333 0.404 0 N-CA-C 110.499 -1.04 . . . . 73.41 110.499 -176.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -70.09 -176.91 19.27 Favored Glycine 0 C--N 1.343 0.939 0 N-CA-C 112.158 -0.377 . . . . 75.41 112.158 173.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 51.2 m -144.89 145.88 31.78 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 117.405 0.602 . . . . 61.23 110.533 -176.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -163.57 -87.32 0.06 OUTLIER Glycine 0 C--N 1.337 0.599 0 N-CA-C 110.354 -1.099 . . . . 22.42 110.354 179.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 59.27 40.37 95.8 Favored Glycine 0 C--N 1.352 1.439 0 O-C-N 123.883 0.402 . . . . 71.43 113.554 -178.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 28.6 p -72.7 -49.02 34.11 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.691 0.796 . . . . 74.22 112.085 -174.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 158.19 4.38 0.07 OUTLIER Glycine 0 N--CA 1.469 0.887 0 CA-C-N 115.973 -0.558 . . . . 34.24 113.061 -178.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -78.85 -157.19 10.61 Favored Glycine 0 C--N 1.352 1.456 0 CA-C-N 117.071 0.436 . . . . 61.43 112.889 175.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 22.5 p -69.33 86.46 0.42 Allowed 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 123.759 0.824 . . . . 75.24 110.587 177.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.412 ' HA ' ' HB2' ' A' ' 240' ' ' PHE . 77.2 mt-30 -84.74 -27.23 27.1 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.478 1.111 . . . . 60.4 111.036 177.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -76.06 129.65 37.16 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 115.216 -0.902 . . . . 74.41 108.951 174.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 42.5 mt -116.94 147.1 42.54 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.731 1.212 . . . . 74.3 108.72 173.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -139.81 122.25 16.13 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.086 0.955 . . . . 73.22 108.92 -175.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.403 ' O ' ' HA ' ' A' ' 251' ' ' LEU . . . -163.1 169.03 20.05 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.009 0.524 . . . . 50.21 111.002 -175.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 8.7 p -95.56 149.74 21.1 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.54 0.736 . . . . 71.54 109.782 171.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.552 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . 38.4 tp -112.85 113.69 25.88 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.657 0.783 . . . . 64.02 109.926 -178.312 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -73.79 109.26 7.16 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 123.37 0.668 . . . . 74.13 109.76 174.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.451 ' HA ' HG11 ' A' ' 210' ' ' VAL . 89.5 t -118.83 120.37 31.55 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 108.716 -0.846 . . . . 74.55 108.716 175.61 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_exo -55.96 142.81 84.42 Favored 'Trans proline' 0 C--N 1.368 1.561 0 C-N-CA 123.147 2.565 . . . . 65.23 112.06 169.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.404 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -52.04 -46.18 93.15 Favored Pre-proline 0 CA--C 1.556 1.205 0 C-N-CA 124.512 1.125 . . . . 25.53 113.847 -179.149 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.468 ' O ' HG12 ' A' ' 206' ' ' VAL . 12.7 Cg_endo -55.0 -50.43 13.25 Favored 'Trans proline' 0 C--N 1.394 2.923 0 C-N-CA 122.147 1.898 . . . . 70.11 112.835 173.543 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 36.6 mt -63.55 -30.43 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 123.842 0.857 . . . . 64.42 111.443 -177.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.44 -48.24 61.53 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.212 0.605 . . . . 71.32 111.407 177.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 201' ' ' ALA . 86.5 t -67.04 -52.57 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 C-N-CA 123.461 0.704 . . . . 71.13 111.605 -175.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.468 HG12 ' O ' ' A' ' 202' ' ' PRO . 12.9 p -82.54 -30.13 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 C-N-CA 122.613 0.365 . . . . 72.4 111.466 -176.339 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 89.13 126.58 2.85 Favored Glycine 0 C--N 1.349 1.297 0 N-CA-C 111.76 -0.536 . . . . 72.23 111.76 -175.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -159.65 -141.97 3.27 Favored Glycine 0 C--N 1.341 0.831 0 CA-C-O 119.997 -0.335 . . . . 73.12 112.425 -177.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm -134.68 134.2 40.86 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 108.555 -0.906 . . . . 63.01 108.555 175.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.451 HG11 ' HA ' ' A' ' 199' ' ' VAL . 35.1 m -119.5 163.07 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 C-N-CA 123.994 0.918 . . . . 52.41 108.823 173.255 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 80.2 mtm180 -98.79 123.65 43.17 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 121.324 0.583 . . . . 64.24 110.459 175.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -100.71 137.28 39.32 Favored 'General case' 0 C--O 1.246 0.899 0 CA-C-N 114.934 -1.03 . . . . 72.25 108.77 179.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 18.9 mmt -83.02 108.52 16.39 Favored 'General case' 0 C--O 1.238 0.465 0 O-C-N 124.179 0.925 . . . . 73.32 108.682 176.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 80.4 p -108.98 177.08 4.87 Favored 'General case' 0 C--O 1.244 0.768 0 N-CA-C 108.307 -0.997 . . . . 72.12 108.307 174.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 11.2 mt -66.78 -23.26 66.05 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 116.404 -0.362 . . . . 71.01 110.135 177.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -92.33 -19.61 21.95 Favored 'General case' 0 CA--C 1.558 1.259 0 C-N-CA 124.082 0.953 . . . . 74.45 111.509 -179.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 129.16 -149.56 18.59 Favored Glycine 0 C--N 1.355 1.589 0 CA-C-O 119.561 -0.577 . . . . 72.43 114.1 173.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -76.36 127.73 9.97 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 123.194 2.596 . . . . 61.03 112.066 -178.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.468 ' HA ' ' H ' ' A' ' 178' ' ' ALA . 33.8 m -130.4 131.47 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 122.989 0.516 . . . . 72.4 110.524 176.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.507 ' HG3' ' HB2' ' A' ' 178' ' ' ALA . 40.0 mt-10 -77.41 104.2 7.78 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 122.944 0.498 . . . . 64.04 109.963 178.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 59.7 t -92.7 122.4 44.14 Favored 'Isoleucine or valine' 0 C--O 1.245 0.821 0 N-CA-C 108.149 -1.056 . . . . 73.33 108.149 178.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -68.65 99.72 1.04 Allowed 'General case' 0 C--O 1.24 0.605 0 O-C-N 124.215 0.947 . . . . 63.12 109.379 177.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 69.4 t -77.39 120.37 81.24 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-N 115.152 -0.931 . . . . 70.52 108.596 174.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -64.06 156.5 58.49 Favored 'Trans proline' 0 C--N 1.377 2.053 0 C-N-CA 122.72 2.28 . . . . 73.51 112.241 177.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -65.11 143.43 78.19 Favored 'Trans proline' 0 C--N 1.372 1.809 0 C-N-CA 122.349 2.032 . . . . 74.12 111.332 170.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 71.6 mtm180 65.42 66.14 0.54 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.675 1.19 . . . . 73.32 110.339 178.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.613 HG23 ' HD2' ' A' ' 231' ' ' ARG . 97.1 m -107.77 134.31 50.91 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.062 -0.972 . . . . 72.35 110.038 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -108.33 157.7 18.15 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.958 0.903 . . . . 64.34 110.264 176.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -72.49 118.81 15.86 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.126 0.97 . . . . 61.32 109.277 173.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 114.54 -6.5 22.68 Favored Glycine 0 CA--C 1.521 0.467 0 CA-C-O 119.295 -0.725 . . . . 61.54 112.014 -171.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.613 ' HD2' HG23 ' A' ' 227' ' ' THR . 49.8 mtt-85 -67.15 157.93 32.49 Favored 'General case' 0 C--N 1.364 1.21 0 CA-C-N 117.941 0.87 . . . . 74.51 110.286 169.343 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.498 ' HE3' ' O ' ' A' ' 169' ' ' ASP . 32.7 pttt -130.23 138.31 50.49 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 123.756 0.822 . . . . 73.43 109.348 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.491 HD22 ' HB2' ' A' ' 173' ' ' ALA . 59.8 mt -127.3 100.52 6.09 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.032 1.333 . . . . 62.31 108.212 -178.103 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 22.6 ttp180 -90.64 102.0 14.74 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.162 -1.051 . . . . 75.34 108.162 176.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.539 HD13 ' HD1' ' A' ' 175' ' ' TYR . 14.5 mt -76.41 83.28 3.14 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 114.188 -1.369 . . . . 73.43 108.271 -179.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -66.62 134.96 53.38 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 114.465 -1.243 . . . . 74.21 111.234 -173.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 69.57 10.21 63.17 Favored Glycine 0 CA--C 1.538 1.526 0 O-C-N 123.73 0.644 . . . . 73.11 112.782 -178.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.458 ' HB3' ' CE1' ' A' ' 175' ' ' TYR . 33.4 mmtp -134.03 42.54 2.91 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 125.126 1.371 . . . . 74.12 110.523 -171.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -100.97 -102.4 2.55 Favored Glycine 0 N--CA 1.472 1.044 0 N-CA-C 109.714 -1.354 . . . . 65.44 109.714 165.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . 0.412 ' HB2' ' HA ' ' A' ' 191' ' ' GLN . 8.8 m-85 -82.08 126.33 75.02 Favored Pre-proline 0 N--CA 1.475 0.795 0 C-N-CA 123.076 0.55 . . . . 73.43 109.667 167.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.522 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 12.9 Cg_exo -71.79 158.3 53.39 Favored 'Trans proline' 0 C--N 1.37 1.684 0 C-N-CA 122.901 2.401 . . . . 72.44 111.928 175.057 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -178.64 151.93 10.9 Favored Glycine 0 CA--C 1.529 0.916 0 CA-C-O 119.17 -0.794 . . . . 75.13 112.004 -178.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -71.36 -28.82 17.69 Favored 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 123.149 2.566 . . . . 74.3 113.671 179.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -121.42 -26.49 4.98 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.49 0.716 . . . . 74.3 112.215 -178.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -134.38 117.74 1.87 Allowed Glycine 0 C--N 1.345 1.058 0 N-CA-C 111.434 -0.666 . . . . 54.41 111.434 -174.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.522 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 70.5 mtt180 -127.29 126.83 43.33 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 108.666 -0.864 . . . . 73.0 108.666 178.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -80.69 -161.37 25.35 Favored Glycine 0 C--N 1.351 1.401 0 O-C-N 123.354 0.409 . . . . 72.12 112.843 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -130.74 156.64 44.62 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.227 0.611 . . . . 71.25 110.314 175.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.459 ' HG ' ' HG ' ' A' ' 251' ' ' LEU . 36.9 tp -114.33 109.92 19.1 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 108.811 -0.811 . . . . 72.3 108.811 172.112 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -93.01 107.79 19.5 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.915 0.886 . . . . 73.43 108.971 -176.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.552 ' HB3' ' HB2' ' A' ' 197' ' ' LEU . 48.3 mt -113.31 116.95 30.52 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.101 0.96 . . . . 73.13 111.455 -173.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -86.99 108.48 18.86 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 109.166 -0.679 . . . . 73.25 109.166 173.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.407 HG11 ' CG2' ' A' ' 227' ' ' THR . 53.8 t -60.99 120.15 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 123.512 0.725 . . . . 73.52 110.68 179.198 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 26.2 mmm180 -117.21 113.53 22.36 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 106.898 -1.519 . . . . 73.24 106.898 173.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 55.5 mt -79.15 127.19 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 123.312 0.645 . . . . 62.42 110.906 -177.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 20.1 p . . . . . 0 C--O 1.25 1.096 0 C-N-CA 124.742 1.217 . . . . 73.32 108.304 177.447 . . . . . . . . 0 0 . 1 stop_ save_